| 1 | Estrogen receptors and the pattern of relapse in breast cancer. (Qazi R, Chuang JL, Drobyski W) Arch Intern Med 1984 Dec;144(12):2365-7 27 Citations |
| 1 | Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients (Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU) Oncology (Switzerland) 1985;42:41-50 10 Citations |
| 1 | In vitro cellular cytotoxicity for a human colon cancer cell line by mucosal mononuclear cells of patients with colon cancer and other disorders. (Beeken WL, Gundel RM, St Andre-Ukena S, McAuliffe T) Cancer 1985 Mar 01;55(5):1024-9 11 Citations |
| 1 | Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment. (Allegretta GJ, Weisman SJ, Altman AJ) Pediatr Clin North Am 1985 Jun;32(3):613-24 13 Citations |
| 1 | Oncologic emergencies I. Metabolic and space-occupying consequences of cancer and cancer treatment. (Allegretta GJ, Weisman SJ, Altman AJ) Pediatr Clin North Am 1985 Jun;32(3):601-11 14 Citations |
| 1 | Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. (Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU) Cancer Res 1985 Jun;45(6):2866-72 186 Citations |
| 1 | Clinical toxicity of interferons in cancer patients: a review. (Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU) J Clin Oncol 1986 Feb;4(2):234-43 603 Citations |
| 1 | Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. (Kurzrock R, Rohde MF, Quesada JR, Gianturco SH, Bradley WA, Sherwin SA, Gutterman JU) J Exp Med 1986 Oct 01;164(4):1093-101 69 Citations |
| 1 | Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon. (Kleinerman ES, Kurzrock R, Wyatt D, Quesada JR, Gutterman JU, Fidler IJ) Cancer Res 1986 Oct;46(10):5401-5 97 Citations |
| 1 | Natural killer cell activity and head and neck cancer: a clinical assessment. (Schantz SP, Shillitoe EJ, Brown B, Campbell B) J Natl Cancer Inst 1986 Oct;77(4):869-75 118 Citations |
| 1 | Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients. (Kurzrock R, Rosenblum MG, Quesada JR, Sherwin SA, Itri LM, Gutterman JU) J Clin Oncol 1986 Nov;4(11):1677-83 44 Citations |
| 1 | Phase I study of i.v. administered recombinant gamma interferon in cancer patients. (Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU) Cancer Treat Rep 1986 Dec;70(12):1357-64 36 Citations |
| 1 | Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer. (Weisman SJ, Cates KL, Allegretta GJ, Quinn JJ, Altman AJ) J Pediatr 1987 Nov;111(5):727-9 14 Citations |
| 1 | A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax. (Robins HI, Longo WL, Steeves RA, Lagoni RK, Hugander A, Neville AJ, O'Keefe S, Giese W, Schmitt CL) Int J Radiat Oncol Biol Phys 1988 Aug;15(2):427-31 14 Citations |
| 1 | A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients. (Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S, Gutterman JU) J Clin Oncol 1988 Aug;6(8):1328-34 225 Citations |
| 1 | Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. (Robins HI, Longo WL, Lagoni RK, Neville AJ, Hugander A, Schmitt CL, Riggs C) Cancer Res 1988 Nov 15;48(22):6587-92 29 Citations |
| 1 | Endocrine late effects among survivors of cancer. (Hobbie WL, Schwartz CL) Semin Oncol Nurs 1989 Feb;5(1):14-21 4 Citations |
| 1 | Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients. (Kurzrock R, Feinberg B, Talpaz M, Saks S, Gutterman JU) J Interferon Res 1989 Aug;9(4):435-44 23 Citations |
| 1 | Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. (Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RR) J Surg Oncol 1990 Jul;44(3):157-65 14 Citations |
| 1 | American Academy of Pediatrics Report of the Subcommittee on Disease-Related Pain in Childhood Cancer. (Berde C, Ablin A, Glazer J, Miser A, Shapiro B, Weisman S, Zeltzer P) Pediatrics 1990 Nov;86(5 Pt 2):818-25 29 Citations |
| 1 | Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res. (McDougall CJ, Ngoi SS, Goldman IS, Godwin T, Felix JC, DeCosse JJ, Rigas B: ) |
| 1 | Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients. (Hansen R, Erickson B, Komaki R, Janjan N, Cox J, Wilson JF, Anderson T) Breast Cancer Res Treat 1991;17(3):171-7 1 Citation |
| 1 | [Perineal pain and rectal cancer--prevalence in local recurrence]. (Radbruch L, Zech D, Grond S, Meuser T, Lehmann KA) Med Klin (Munich) 1991 Apr 15;86(4):180-5, 228 6 Citations |
| 1 | Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization. (Coutlée F, Shah KV, Rader JS, Currie JL, Viscidi RP) J Clin Microbiol 1991 May;29(5):968-74 3 Citations |
| 1 | Paraneoplastic cerebellar autoantibodies associated with gynecological cancer bind to myenteric plexus neurons. (Altermatt HJ, Williams CL, Lennon VA) Ann Neurol 1991 Jun;29(6):687-8 10 Citations |
| 1 | 2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies (Estey EH, Kurzrock R, Kantarjian HM, Koller CA, O'Brien S, Beran M, Keating MJ, McCredie K, Freireich EJ) Cancer Bulletin 1991;43(3):253-258 4 Citations |
| 1 | Effect of obesity on plasma insulin-like growth factor-I in cancer patients. (Colletti RB, Copeland KC, Devlin JT, Roberts JD, McAuliffe TL) Int J Obes 1991 Aug;15(8):523-7 26 Citations |
| 1 | Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. (Whittle J, Steinberg EP, Anderson GF, Herbert R) Chest 1991 Sep;100(3):729-34 60 Citations |
| 1 | Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans. (Whittle J, Steinberg EP, Anderson GF, Herbert R) Med Care 1991 Dec;29(12):1226-36 81 Citations |
| 1 | Pancreatic cancer: Biology and changing clinical managment (Byrd DR, Mansfield PF, Evans DB) Cancer Bulletin 1992;44(4):292-300 |
| 1 | Impact of the diagnostic procedure on outcome measures of swallowing rehabilitation in head and neck cancer patients. (Logemann JA, Roa Pauloski B, Rademaker A, Cook B, Graner D, Milianti F, Beery Q, Stein D, Bowman J, Lazarus C) Dysphagia 1992;7(4):179-86 39 Citations |
| 1 | Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. (Lew Y, Jones DV, Mars WM, Evans D, Byrd D, Frazier ML) Pancreas 1992;7(2):144-52 52 Citations |
| 1 | Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. (Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, Schumm M, Horowitz MM, Gale RP, Fliedner TM) Bone Marrow Transplant 1992;10 Suppl 1:135-8 24 Citations |
| 1 | Therapeutic advances in ovarian cancer. (Rader JS) Curr Opin Obstet Gynecol 1992 Feb;4(1):120-7 |
| 1 | Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. (Rabkin CS, Hilgartner MW, Hedberg KW, Aledort LM, Hatzakis A, Eichinger S, Eyster ME, White GC 2nd, Kessler CM, Lederman MM) JAMA 1992 Feb 26;267(8):1090-4 116 Citations |
| 1 | Geographic variation in the use of breast-conserving treatment for breast cancer. (Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS) N Engl J Med 1992 Apr 23;326(17):1102-7 513 Citations |
| 1 | What is the best strategy for autotransplants in cancer? (Gale RP, Butturini A, Horowitz M) Bone Marrow Transplant 1992 May;9(5):303 3 Citations |
| 1 | Results of colectomy in elderly patients with colon cancer, based on Medicare claims data. (Whittle J, Steinberg EP, Anderson GF, Herbert R) Am J Surg 1992 Jun;163(6):572-6 51 Citations |
| 1 | Cancer presentation in the emergency department: a failure of primary care. (Hargarten SW, Richards MJ, Anderson AJ) Am J Emerg Med 1992 Jul;10(4):290-3 41 Citations |
| 1 | A long-term survey of morphine in cancer pain patients. (Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B) J Pain Symptom Manage 1992 Jul;7(5):259-66 154 Citations |
| 1 | Cancer and clotting--Trousseau's warning. (Silverstein RL, Nachman RL) N Engl J Med 1992 Oct 15;327(16):1163-4 51 Citations |
| 1 | Tripe palms and cancer. (Cohen PR, Grossman ME, Silvers DN, Kurzrock R) Clin Dermatol 1993;11(1):165-73 54 Citations |
| 1 | Vasculitis and cancer. (Kurzrock R, Cohen PR) Clin Dermatol 1993;11(1):175-87 80 Citations |
| 1 | Sweet's syndrome and cancer. (Cohen PR, Kurzrock R) Clin Dermatol 1993;11(1):149-57 192 Citations |
| 1 | Venous thrombosis and cancer. (O'Connor N) N Engl J Med 1993 Mar 25;328(12):885-6; author reply 886-7 12 Citations |
| 1 | Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients. (Robins HI, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Longo W, Heiss C) J Clin Oncol 1993 Sep;11(9):1787-94 86 Citations |
| 1 | Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. (Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB) J Clin Oncol 1993 Oct;11(10):1906-10 94 Citations |
| 1 | Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. (Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, Borden EC) Cancer Res 1993 Nov 01;53(21):5176-80 79 Citations |
| 1 | Surgical variables affecting postoperative swallowing efficiency in oral cancer patients: a pilot study. (McConnel FM, Logemann JA, Rademaker AW, Pauloski BR, Baker SR, Lewin J, Shedd D, Heiser MA, Cardinale S, Collins S) Laryngoscope 1994 Jan;104(1 Pt 1):87-90 91 Citations |
| 1 | Educating patients with limited literacy skills: the effectiveness of printed and videotaped materials about colon cancer. (Meade CD, McKinney WP, Barnas GP) Am J Public Health 1994 Jan;84(1):119-21 182 Citations |
| 1 | Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. (Rich TA, Evans DB, Curley SA, Ajani JA) Ann Oncol 1994;5 Suppl 3:75-80 25 Citations |
| 1 | Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. (Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS) J Clin Oncol 1994 Mar;12(3):475-82 447 Citations |
| 1 | Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. (Chen G, Waxman DJ) Biochem Pharmacol 1994 Mar 15;47(6):1079-87 77 Citations |
| 2 | Trends in the stage of cancer at the time of diagnosis. (Redlich PN, McAuliffe TL, Robinson LA, Reith KL) Wis Med J 1994 May;93(5):207-12 1 Citation |
| 1 | DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer. (Sandlow J, Cohen MB, Robinson RA, Dreicer R, Williams RD) Urology 1994 Jun;43(6):787-91 16 Citations |
| 1 | Geographic and Hospital Variation in the Management of Older Women With Breast Cancer. (Nattinger AB, Goodwin JS) Cancer Control 1994 Jul;1(4):334-338 |
| 1 | Stat bite: Autologous bone marrow transplates for cancer, 1989–1993 (Horowitz MM) Journal of the National Cancer Institute 20 July 1994;86(14):1045 1 Citation |
| 1 | Urinary bladder cancer: mechanisms of development and progression. (Kroft SH, Oyasu R) Lab Invest 1994 Aug;71(2):158-74 102 Citations |
| 1 | Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. (Assem M, Bonvalot S, Beltramo JL, Garrido C, Dimanche-Boitrel MT, Genne P, Rebibou JM, Caillot D, Chauffert B) Br J Cancer 1994 Oct;70(4):631-5 22 Citations |
| 1 | Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines. (Adler LM, Herzog TJ, Williams S, Rader JS, Mutch DG) Cancer 1994 Oct 01;74(7):1891-8 24 Citations |
| 1 | Clostridium difficile toxin A therapy for HCT 116 human colon cancer in nude mice. (Redlich PN, Kushnaryov VM, Hernandez I, Grossberg SE) J Surg Oncol 1994 Nov;57(3):191-5 3 Citations |
| 1 | Current clinical trials and investigational programs for patients with resectable and advanced pancreatic cancer (Byrd DR, Hoffman JP, Yeo CJ, Fernandez-del Castillo C, Foo ML, Evans DB) Cancer Bulletin 1994;46(6):532-537 |
| 1 | Preoperative combined modality therapy for pancreatic cancer. (Rich TA, Evans DB) World J Surg 1995;19(2):264-9 31 Citations |
| 1 | Management of the mandible in oral cancer. (Larson DL, Sanger JR) Semin Surg Oncol 1995;11(3):190-9 12 Citations |
| 1 | Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. (Chen G, Waxman DJ) Biochem Pharmacol 1995 May 26;49(11):1691-701 46 Citations |
| 1 | Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. (Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM, Kurzrock R) Am J Med 1995 Jun;98(6):551-8 67 Citations |
| 1 | Circumvention of confluence-dependent resistance in a human multi-drug-resistant colon-cancer cell line. (Garrido C, Chauffert B, Pinard D, Tibaut F, Genne P, Assem M, Dimanche-Boitrel MT) Int J Cancer 1995 Jun 09;61(6):873-9 24 Citations |
| 1 | Late effects of treatment in long-term survivors of cancer. (Schwartz CL) Cancer Treat Rev 1995 Jul;21(4):355-66 41 Citations |
| 1 | Effect of season and climate on choice of therapy for breast cancer in older women. (Goodwin JS, Nattinger AB) J Am Geriatr Soc 1995 Sep;43(9):962-6 2 Citations |
| 3 | Risk factors which predict persistent cancer in the abnormal larynx following definitive irradiation. (Schultz CJ, Campbell BH, Freije JE, Brook BJ, McAuliffe TL) Eur J Cancer B Oral Oncol 1995 Sep;31B(5):310-4 8 Citations |
| 1 | Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. (Chen G, Waxman DJ) J Pharmacol Exp Ther 1995 Sep;274(3):1271-7 18 Citations |
| 1 | Incidence of cancer among patients with systemic sclerosis. (Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O) Cancer 1995 Sep 01;76(5):910-4 190 Citations |
| 1 | Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells. (Chen G, Hutter KJ, Zeller WJ) Cell Biol Toxicol 1995 Oct;11(5):273-81 28 Citations |
| 1 | Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. (Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB) J Interferon Cytokine Res 1995 Oct;15(10):905-13 47 Citations |
| 2 | Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. (Schapira MM, McAuliffe TL, Nattinger AB) Med Care 1995 Nov;33(11):1079-88 65 Citations |
| 1 | Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. (Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF) Cancer Res 1995 Dec 01;55(23):5693-8 145 Citations |
| 1 | Effects of Intraoral Prostheses on Speech in Oropharyngeal Cancer Patients (Colangelo LA, Pauloski BR, Logemann JA, Stein DW, Beery QC, Heiser MA, Cardinale S) American Journal of Speech-Language Pathology November 1996;5(4):43-55 1 Citation |
| 1 | Effect of Intraoral Prostheses on Swallowing Function in Postsurgical Oral and Oropharyngeal Cancer Patients (Pauloski BR, Logemann JA, Colangelo LA, Stein D, Beery Q, Heiser MA, Cardinale S) American Journal of Speech-Language Pathology August 1996;5(3):31-46 9 Citations |
| 1 | Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? (Urrutia R, DiMagno EP) Gastroenterology 1996 Jan;110(1):306-10 25 Citations |
| 1 | Longitudinal assessment of quality of life in laryngeal cancer patients. (List MA, Ritter-Sterr CA, Baker TM, Colangelo LA, Matz G, Pauloski BR, Logemann JA) Head Neck 1996;18(1):1-10 131 Citations |
| 1 | Association between prostate cancer in black Americans and an allele of the PADPRP pseudogene locus on chromosome 13. (Doll JA, Suarez BK, Donis-Keller H) Am J Hum Genet 1996 Feb;58(2):425-8 10 Citations |
| 1 | Breast cancer in men. (Donegan WL, Redlich PN) Surg Clin North Am 1996 Apr;76(2):343-63 100 Citations |
| 1 | Hypercoagulability in cancer. (Green KB, Silverstein RL) Hematol Oncol Clin North Am 1996 Apr;10(2):499-530 156 Citations |
| 1 | T stage and functional outcome in oral and oropharyngeal cancer patients. (Colangelo LA, Logemann JA, Pauloski BR, Pelzer JR, Rademaker AW) Head Neck 1996;18(3):259-68 56 Citations |
| 1 | Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27. (Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo AP, Chauffert B) Eur J Biochem 1996 May 01;237(3):653-9 79 Citations |
| 1 | Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. (Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL) Ann Surg Oncol 1996 May;3(3):241-6 23 Citations |
| 1 | Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. (Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R, Estrov Z) Int J Cancer 1996 May 16;66(4):515-9 87 Citations |
| 1 | A change in practice: current urologic practice in response to reports concerning vasectomy and prostate cancer. (Sandlow JI, Kreder KJ) Fertil Steril 1996 Aug;66(2):281-4 12 Citations |
| 1 | Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. (Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M) Laryngoscope 1996 Sep;106(9 Pt 1):1157-66 243 Citations |
| 1 | Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. (Lambe M, Hsieh C, Tsaih S, Ekbom A, Adami HO, Trichopoulos D) Cancer Causes Control 1996 Sep;7(5):533-8 45 Citations |
| 1 | Bladder cancer screening. (Kryger JV, Messing E) Semin Oncol 1996 Oct;23(5):585-97 25 Citations |
| 1 | Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. (Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC) J Interferon Cytokine Res 1996 Nov;16(11):891-902 13 Citations |
| 1 | Involving parents in cancer risk reduction: a program for Hispanic American families. (Fitzgibbon ML, Stolley MR, Avellone ME, Sugerman S, Chavez N) Health Psychol 1996 Nov;15(6):413-22 37 Citations |
| 1 | Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. (Chen G, Teicher BA, Frei E 3rd) Anticancer Res 1996;16(6B):3499-505 15 Citations |
| 1 | Microsatellite instability in sporadic human breast cancers. (Toyama T, Iwase H, Yamashita H, Iwata H, Yamashita T, Ito K, Hara Y, Suchi M, Kato T, Nakamura T, Kobayashi S) Int J Cancer 1996 Nov 15;68(4):447-51 54 Citations |
| 1 | Microsatellite instability in in situ and invasive sporadic breast cancers of Japanese women. (Toyama T, Iwase H, Iwata H, Hara Y, Omoto Y, Suchi M, Kato T, Nakamura T, Kobayashi S) Cancer Lett 1996 Nov 29;108(2):205-9 21 Citations |
| 1 | [Experience with surgery for synchronous double cancer of rectum and lung detected after long-term follow-up for pneumoconiosis]. (Tsuji K, Hori K, Kimura S, Takagaki M, Nakai M, Kohmoto T, Ando T, Kuyama A) Kyobu Geka 1996 Dec;49(13):1130-3 |
| 1 | Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine. (Liebmann J, Friedman K) Am J Med 1996 Dec;101(6):658-9 6 Citations |
| 1 | NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. (O'Reilly R, Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C) Oncology (Williston Park) 1996 Dec;10(12):1799-806, 1812 7 Citations |
| 1 | Allelotyping of all chromosomal arms in invasive cervical cancer. (Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS) Oncogene 1996 Dec 19;13(12):2737-41 89 Citations |
| 1 | Foreword: Brachytherapy in cancer management (Brady LW, Wilson JF, Erickson B, Micaily B) Seminars in Surgical Oncology 1997;13(3):155-156 |
| 1 | Intracavitary applications in the treatment of cancer of the cervix, part I: Low dose rate techniques (Erickson BA) Journal of Brachytherapy International 1997;13(2):179-205 5 Citations |
| 1 | Intracavitary applications in the treatment of cancer of the cervix, Part II: High dose rate techniques (Erickson BA) Journal of Brachytherapy International 1997;13(3):271-287 6 Citations |
| 1 | Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients (Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA) Journal of Clinical Oncology January 1997;15(1):158-164 60 Citations |
| 1 | Neutrophilia and organomegaly in two patients with cancer. (Wright JJ, Hoffmeister KJ, Cotelingam JD, Allegra CJ) Hosp Pract (1995) 1997 Jan 15;32(1):135-6, 139-42 |
| 1 | Basic science of small cell lung cancer. (Williams CL) Chest Surg Clin N Am 1997 Feb;7(1):1-19 26 Citations |
| 1 | Enhanced decision-making: the use of a videotape decision-aid for patients with prostate cancer. (Schapira MM, Meade C, Nattinger AB) Patient Educ Couns 1997 Feb;30(2):119-27 62 Citations |
| 1 | The multidisciplinary structured clinical instruction module as a vehicle for cancer education. (Sloan DA, Donnelly MB, Schwartz RW, Plymale MA, Strodel WE, Kenady DE, McGrath PC, Edwards MJ, Singletary SE, Evans DB, Souba WW, Bland KI) Am J Surg 1997 Mar;173(3):220-5 11 Citations |
| 1 | Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. (Abbruzzese JL, Evans DB, Raijman I, Larry L, King T, Leach SD, Frazier ML) Anticancer Res 1997;17(2A):795-801 23 Citations |
| 1 | Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. (Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ) Genes Chromosomes Cancer 1997 Mar;18(3):219-27 108 Citations |
| 1 | Solid cancers after bone marrow transplantation. (Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr) N Engl J Med 1997 Mar 27;336(13):897-904 841 Citations |
| 1 | Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. (Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM) Gynecol Oncol 1997 May;65(2):336-42 45 Citations |
| 1 | Second cancer risk in hairy cell leukemia: analysis of 350 patients. (Kurzrock R, Strom SS, Estey E, O'Brien S, Keating MJ, Jiang H, Adams T, Talpaz M) J Clin Oncol 1997 May;15(5):1803-10 110 Citations |
| 1 | Speech and swallowing rehabilitation for head and neck cancer patients. (Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA) Oncology (Williston Park) 1997 May;11(5):651-6, 659; discussion 659, 663-4 112 Citations |
| 1 | High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM) J Clin Oncol 1997 May;15(5):1870-9 309 Citations |
| 1 | The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia. (Talpaz M, Kantarjian HM, O'Brien S, Kurzrock R) Baillieres Clin Haematol 1997 Jun;10(2):291-305 13 Citations |
| 1 | Gastric cancer surgical practice guidelines. Gastric Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1067-72 3 Citations |
| 1 | Pancreatic cancer surgical practice guidelines. Pancreatic Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1074-9 7 Citations |
| 1 | Estrogen-progestin replacement therapy and endometrial cancer. (Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM) J Natl Cancer Inst 1997 Aug 06;89(15):1110-6 289 Citations |
| 1 | Super-supraglottic swallow in irradiated head and neck cancer patients. (Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA) Head Neck 1997 Sep;19(6):535-40 99 Citations |
| 1 | Topotecan in platinum- and paclitaxel-resistant ovarian cancer. (Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ) Gynecol Oncol 1997 Sep;66(3):480-6 147 Citations |
| 1 | Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. (Roman LD, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP) Obstet Gynecol 1997 Nov;90(5):759-64 64 Citations |
| 2 | Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. (Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ) Head Neck 1998 Mar;20(2):132-7 102 Citations |
| 1 | Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. (Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS) JAMA 1998 Mar 11;279(10):762-6 116 Citations |
| 1 | Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? (Goodwin JS, Freeman JL, Freeman D, Nattinger AB) Am J Public Health 1998 Mar;88(3):458-60 31 Citations |
| 1 | Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. (Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC) Gynecol Oncol 1998 Apr;69(1):23-31 71 Citations |
| 1 | Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. (Roman LD, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP) Gynecol Oncol 1998 Mar;68(3):220-5 82 Citations |
| 1 | Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. (Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA) Otolaryngol Head Neck Surg 1998 May;118(5):616-24 177 Citations |
| 1 | Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer. (Pauloski BR, Logemann JA, Colangelo LA, Rademaker AW, McConnel FM, Heiser MA, Cardinale S, Shedd D, Stein D, Beery Q, Myers E, Lewin J, Haxer M, Esclamado R) Laryngoscope 1998 Jun;108(6):908-16 105 Citations |
| 1 | Cell cycle regulation of human pancreatic cancer by tamoxifen. (Robinson EK, Grau AM, Evans DB, Smid CM, Chiao PJ, Abbruzzese JL, Grimm EA) Ann Surg Oncol 1998 Jun;5(4):342-9 20 Citations |
| 1 | Venous thromboembolism and cancer. (Sander RW, Flynn CA) J Fam Pract 1998 Jul;47(1):13-4 |
| 1 | Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States. (Herrero-Jimenez P, Thilly G, Southam PJ, Tomita-Mitchell A, Morgenthaler S, Furth EE, Thilly WG) Mutat Res 1998 May 25;400(1-2):553-78 43 Citations |
| 1 | Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair. (Swisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A, Goodfellow PJ) J Soc Gynecol Investig 1998;5(4):210-6 19 Citations |
| 1 | Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval. (Peiffer-Schneider S, Noonan FC, Mutch DG, Simpkins SB, Herzog T, Rader J, Elbendary A, Gersell DJ, Call K, Goodfellow PJ) Genomics 1998 Aug 15;52(1):9-16 31 Citations |
| 1 | Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer. (Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, Mutch DG, Herzog TJ) Obstet Gynecol 1998 Oct;92(4 Pt 1):589-95 11 Citations |
| 2 | Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation. (Demeure MJ, Doffek KM, Komorowski RA, Redlich PN, Zhu YR, Erickson BA, Ritch PS, Pitt HA, Wilson SD) Surgery 1998 Oct;124(4):663-9 49 Citations |
| 1 | Gene therapy and pancreatic cancer. (Pearson AS, Bouvet M, Evans DB, Roth JA) Front Biosci 1998 Nov 01;3:E230-7 25 Citations |
| 1 | Inhibition of endometrial cancer cell lines by mifepristone (RU 486). (Schneider CC, Gibb RK, Taylor DD, Wan T, Gerçel-Taylor C) J Soc Gynecol Investig 1998;5(6):334-8 53 Citations |
| 1 | Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. (Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL) Surgery 1998 Dec;124(6):1115-22 103 Citations |
| 1 | Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. (Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA) Ann Surg Oncol 1998 Dec;5(8):681-8 119 Citations |
| 1 | Detection of prostaglandin H synthase (cyclooxygenase)-1 and -2 expression in single cancer cells by confocal Raman microspectroscopy (Nithipatikom K, McCoy MJ, Kajdacsy-Balla A, Kaul S, Lindholm PF, Hawi SR, Rochanakij S, Adar F, Campbell WB) Proceedings of SPIE - The International Society for Optical Engineering 1999;3608:20-27 1 Citation |
| 1 | p53 mutations and expression in ovarian cancers: correlation with overall survival. (Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF) Int J Gynecol Pathol 1999 Jan;18(1):29-41 132 Citations |
| 1 | Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. (Huang H, Reed CP, Mordi A, Lomberk G, Wang L, Shridhar V, Hartmann L, Jenkins R, Smith DI) Genes Chromosomes Cancer 1999 Jan;24(1):48-55 40 Citations |
| 1 | Assessment and treatment of neuropathic cancer pain following WHO guidelines. (Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA) Pain 1999 Jan;79(1):15-20 222 Citations |
| 1 | Chemoradiation for localized pancreatic cancer: another perspective. (Evans DB, Abbruzzese JL) Ann Surg Oncol 1999;6(1):4-7 4 Citations |
| 1 | Factors related to dropout in a study of head and neck cancer patients after surgery. (Colangelo LA, Logemann JA, Rademaker AW, Pauloski BR, Smith CH, McConnel FM, Stein DW, Beery QC, Myers EN, Heiser MA, Cardinale S, Shedd DP) Otolaryngol Head Neck Surg 1999 Mar;120(3):368-74 10 Citations |
| 1 | Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. (Kantarjian HM, Talpaz M, O'Brien S, Kurzrock R, Gutterman J, Keating MJ, McCredie KB, Freireich EJ) Clin Cancer Res 1997 Dec;3(12 Pt 2):2723-33 15 Citations |
| 1 | Long-term survivors of childhood cancer: the late effects of therapy. (Schwartz CL) Oncologist 1999;4(1):45-54 156 Citations |
| 1 | Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5. (Carey I, Williams CL, Ways DK, Noti JD) Int J Oncol 1999 Jul;15(1):127-36 22 Citations |
| 1 | Antinuclear antibodies as potential markers of lung cancer. (Fernández-Madrid F, VandeVord PJ, Yang X, Karvonen RL, Simpson PM, Kraut MJ, Granda JL, Tomkiel JE) Clin Cancer Res 1999 Jun;5(6):1393-400 55 Citations |
| 1 | Screening for cancers of the head and neck: addressing the problem. (Ellison MD, Campbell BH) Surg Oncol Clin N Am 1999 Oct;8(4):725-34, vii 6 Citations |
| 1 | Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry. (McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K) Bone Marrow Transplant 1999 Aug;24(4):365-8 9 Citations |
| 1 | Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability. (Basil JB, Swisher EM, Herzog TJ, Rader JS, Elbendary A, Mutch DG, Goodfellow PJ) Gynecol Oncol 1999 Sep;74(3):395-9 14 Citations |
| 1 | Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB) J Gastrointest Surg 1999;3(3):263-77 45 Citations |
| 1 | Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. (Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB) J Gastrointest Surg 1999;3(3):233-43 114 Citations |
| 1 | Failure of cricopharyngeal myotomy to improve dysphagia following head and neck cancer surgery. (Jacobs JR, Logemann J, Pajak TF, Pauloski BR, Collins S, Casiano RR, Schuller DE) Arch Otolaryngol Head Neck Surg 1999 Sep;125(9):942-6 29 Citations |
| 1 | Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. (Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F) Cancer Res 1999 Sep 15;59(18):4662-7 55 Citations |
| 1 | Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. (Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, Trimboli AJ, Fonteh AN, Dawson PA, Chilton FH) Carcinogenesis 1999 Oct;20(10):1905-11 172 Citations |
| 1 | High-dose tramadol in comparison to low-dose morphine for cancer pain relief. (Grond S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann KA) J Pain Symptom Manage 1999 Sep;18(3):174-9 106 Citations |
| 1 | Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43 67 Citations |
| 1 | Information sources and professional consultations sought by men newly diagnosed as having prostate cancer (Schapira MM, Meade CD, McAuliffe TL, Lawrence WF, Nattinger AB) Journal of Cancer Education December 1999;14(4):243-247 9 Citations |
| 1 | Information sources and professional consultations sought by men newly diagnosed as having prostate cancer () Journal of Cancer Education December 1999;14(4):243-247 |
| 1 | Relating speech and swallow function to dropout in a longitudinal study of head and neck cancer. (Colangelo LA, Logemann JA, Rademaker AW, Pauloski BR, Smith CH, McConnel FM, Stein DW, Beery QC, Myers EN, Heiser MA, Cardinale S, Shedd DP) Otolaryngol Head Neck Surg 1999 Dec;121(6):713-9 13 Citations |
| 1 | Breast cancer in Poland syndrome. (Havlik RJ, Sian KU, Wagner JD, Binford R, Broadie TA) Plast Reconstr Surg 1999 Jul;104(1):180-2 29 Citations |
| 1 | Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells. (Trimboli AJ, Waite BM, Atsumi G, Fonteh AN, Namen AM, Clay CE, Kute TE, High KP, Willingham MC, Chilton FH) Cancer Res 1999 Dec 15;59(24):6171-7 29 Citations |
| 1 | Older women, mammography, and mortality from breast cancer. (Nattinger AB) Am J Med 2000 Feb;108(2):174-5 12 Citations |
| 1 | Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. (Neuman RJ, Huettner PC, Li L, Mardis ER, Duffy BF, Wilson RK, Rader JS) Obstet Gynecol 2000 Jan;95(1):134-40 24 Citations |
| 1 | A multispecialty approach to the diagnosis and management of pancreatic cancer. (Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL) Am J Gastroenterol 2000 Jan;95(1):17-31 168 Citations |
| 1 | RAS inhibitors in hematologic cancers: biologic considerations and clinical applications. (Beaupre DM, Kurzrock R) Invest New Drugs 1999;17(2):137-43 7 Citations |
| 1 | Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. (Pisters PW, Hudec WA, Lee JE, Raijman I, Lahoti S, Janjan NA, Rich TA, Crane CH, Lenzi R, Wolff RA, Abbruzzese JL, Evans DB) J Clin Oncol 2000 Feb;18(4):860-7 82 Citations |
| 1 | Impact of tongue base and posterior pharyngeal wall biomechanics on pharyngeal clearance in irradiated postsurgical oral and oropharyngeal cancer patients. (Pauloski BR, Logemann JA) Head Neck 2000 Mar;22(2):120-31 96 Citations |
| 1 | Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. (Herrero-Jimenez P, Tomita-Mitchell A, Furth EE, Morgenthaler S, Thilly WG) Mutat Res 2000 Jan 17;447(1):73-116 44 Citations |
| 2 | Underutilization of mammography in older breast cancer survivors. (Schapira MM, McAuliffe TL, Nattinger AB) Med Care 2000 Mar;38(3):281-9 90 Citations |
| 1 | Cervical cancer suppressor gene is within 1 cM on 6p23. (Rader JS, Li Y, Huettner PC, Xu Z, Gerhard DS) Genes Chromosomes Cancer 2000 Apr;27(4):373-9 12 Citations |
| 1 | Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility. (Murata K, Kameyama M, Fukui F, Ohigashi H, Hiratsuka M, Sasaki Y, Kabuto T, Mukai M, Mammoto T, Akedo H, Ishikawa O, Imaoka S) Clin Exp Metastasis 1999;17(6):525-30 33 Citations |
| 1 | Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. (Pignon JP, Bourhis J, Domenge C, Designé L) Lancet 2000 Mar 18;355(9208):949-55 2340 Citations |
| 1 | Lumpectomy margins, reexcision, and local recurrence of breast cancer. (Tartter PI, Kaplan J, Bleiweiss I, Gajdos C, Kong A, Ahmed S, Zapetti D) Am J Surg 2000 Feb;179(2):81-5 173 Citations |
| 1 | Gut peptide receptor expression in human pancreatic cancers. (Ehlers RA, Kim Sh, Zhang Y, Ethridge RT, Murrilo C, Hellmich MR, Evans DB, Townsend CM Jr, Mark Evers B) Ann Surg 2000 Jun;231(6):838-48 69 Citations |
| 1 | Quality of life and recurrence concern in survivors of head and neck cancer. (Campbell BH, Marbella A, Layde PM) Laryngoscope 2000 Jun;110(6):895-906 133 Citations |
| 1 | Thyroid cancer: 1999 update. (Tyler DS, Shaha AR, Udelsman RA, Sherman SI, Thompson NW, Moley JF, Evans DB) Ann Surg Oncol 2000 Jun;7(5):376-98 44 Citations |
| 1 | Pretreatment swallowing function in patients with head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Stein D, Beery Q, Newman L, Hanchett C, Tusant S, MacCracken E) Head Neck 2000 Aug;22(5):474-82 143 Citations |
| 1 | Care for breast cancer: the adoption of newer clinical paradigms. (Nattinger AB) Med Care 2000 Jul;38(7):693-5 1 Citation |
| 1 | Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. (Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS) Med Care 2000 Jul;38(7):719-27 99 Citations |
| 1 | Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability. (Cohn DE, Basil JB, Venegoni AR, Mutch DG, Rader JS, Herzog TJ, Gersell DJ, Goodfellow PJ) Gynecol Oncol 2000 Oct;79(1):101-6 26 Citations |
| 1 | p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. (Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ) Surgery 2000 Oct;128(4):520-30 30 Citations |
| 1 | High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. (Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM) Ann Intern Med 2000 Oct 03;133(7):504-15 48 Citations |
| 1 | Radical hysterectomy for cervical cancer in obese women. (Cohn DE, Swisher EM, Herzog TJ, Rader JS, Mutch DG) Obstet Gynecol 2000 Nov;96(5 Pt 1):727-31 20 Citations |
| 1 | Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727 8 Citations |
| 1 | Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. (Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC) J Clin Oncol 2000 Dec 15;18(24):4077-85 173 Citations |
| 1 | Erratum: Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability (Gynecologic Oncology (1999) 74:3 (395-399)) (Basil JB, Swisher EM, Herzog TJ, Rader JS, Elbendary A, Mutch DG, Goodfellow PJ) Gynecologic Oncology 2001;80(1):109 |
| 1 | Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. (Formenti S, Felix J, Salonga D, Danenberg K, Pike MC, Danenberg P) Clin Cancer Res 2000 Dec;6(12):4653-7 12 Citations |
| 1 | Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. (Weng LP, Gimm O, Kum JB, Smith WM, Zhou XP, Wynford-Thomas D, Leone G, Eng C) Hum Mol Genet 2001 Feb 01;10(3):251-8 82 Citations |
| 1 | No evidence for BCL10 mutation in endometrial cancers with microsatellite instability. (Cohn D, Mutch D, Elbendary A, Rader J, Herzog T, Goodfellow P) Hum Mutat 2001 Feb;17(2):117-21 5 Citations |
| 1 | Chemoprevention of skin cancer. (Horn MA, Gordon KB) Cancer Treat Res 2001;106:255-82 3 Citations |
| 2 | Effect of treatment on quality of life among men with clinically localized prostate cancer. (Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB) Med Care 2001 Mar;39(3):243-53 80 Citations |
| 1 | Cyclooxygenase-2 is overexpressed in human cervical cancer. (Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ) Clin Cancer Res 2001 Feb;7(2):429-34 318 Citations |
| 1 | Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. (Swisher EM, Babb S, Whelan A, Mutch DG, Rader JS) J Reprod Med 2001 Feb;46(2):87-94 38 Citations |
| 1 | Laparoscopy in the staging of pancreatic cancer. (Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB) Br J Surg 2001 Mar;88(3):325-37 217 Citations |
| 1 | Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells. (Tsujino I, Anderson GS, Sieber F) Photochem Photobiol 2001 Feb;73(2):191-8 20 Citations |
| 1 | Statistical methods in cancer research. (Simpson PM, Spratt JA, Spratt JS) J Surg Oncol 2001 Mar;76(3):201-23 5 Citations |
| 1 | [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression]. (Chapusot C, Assem M, Martin L, Chalabreyssse L, Benhamiche AM, Lignier MA, Chauffert B, Teyssier JR, Faivre J, Piard F) Pathol Biol (Paris) 2001 Mar;49(2):115-23 |
| 1 | Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. (Onaitis MW, Noone RB, Hartwig M, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Seigler HF, Tyler DS) Ann Surg 2001 Jun;233(6):778-85 139 Citations |
| 1 | Swallowing and tongue function following treatment for oral and oropharyngeal cancer. (Lazarus CL, Logemann JA, Pauloski BR, Rademaker AW, Larson CR, Mittal BB, Pierce M) J Speech Lang Hear Res 2000 Aug;43(4):1011-23 162 Citations |
| 1 | Erratum: Pretreatment swallowing function in patients with head and neck cancer (Head and Neck (2000) 22 (474-482)) (Pauloski BR, Rademaker AW, Logemann JA, Stein D, Beery Q, Newman L, Hanchett C, Tusant S, MacCracken E) Head and Neck 2001;23(6):521 |
| 1 | Neoadjuvant strategies for pancreatic cancer. (Evans DB, Wolff RA, Crane CH) Oncology (Williston Park) 2001 Jun;15(6):727-37; discussion 741-4, 747 13 Citations |
| 1 | Preoperative chemoradiation therapy for pancreatic cancer. (Evans DB, Pisters PW) Surg Clin North Am 2001 Jun;81(3):709-13 3 Citations |
| 1 | Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. (Alvi AJ, Rader JS, Broggini M, Latif F, Maher ER) Mol Pathol 2001 Aug;54(4):240-3 17 Citations |
| 2 | Ballistic-choreic movements as the presenting feature of renal cancer. (Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG) Arch Neurol 2001 Jul;58(7):1133-5 41 Citations |
| 1 | Multimodality management of localized pancreatic cancer. (Wayne JD, Wolff RA, Pisters PW, Evans DB) Cancer J 2001;7 Suppl 1:S35-46 14 Citations |
| 1 | Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. (Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA) Semin Oncol 2001 Jun;28(3 Suppl 10):25-33 57 Citations |
| 1 | Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. (Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S) Pain 2001 Sep;93(3):247-257 487 Citations |
| 1 | Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. (Clay CE, Namen AM, Atsumi G, Trimboli AJ, Fonteh AN, High KP, Chilton FH) J Investig Med 2001 Sep;49(5):413-20 64 Citations |
| 1 | Relationship of distance from a radiotherapy facility and initial breast cancer treatment. (Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA) J Natl Cancer Inst 2001 Sep 05;93(17):1344-6 228 Citations |
| 1 | Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18 74 Citations |
| 1 | The role of cytokines in cancer-related fatigue. (Kurzrock R) Cancer 2001 Sep 15;92(6 Suppl):1684-8 245 Citations |
| 1 | Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. (Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2001;51(3 Suppl 2):58-9 1 Citation |
| 2 | Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer. (Mai J, Erickson B, Rownd J, Gillin M) Int J Radiat Oncol Biol Phys 2001 Nov 15;51(4):1131-41 30 Citations |
| 1 | Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha. (Williams CL, Noti JD) Int J Oncol 2001 Dec;19(6):1227-33 7 Citations |
| 1 | DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer. (Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M, Abbruzzese JL) Mutat Res 2002 Jan 15;513(1-2):37-48 75 Citations |
| 1 | RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R) Int J Radiat Oncol Biol Phys 2001 Dec 01;51(5):1299-304 159 Citations |
| 1 | Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. (Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB) Surgery 2001 Dec;130(6):921-30 113 Citations |
| 1 | Statistical methods in cancer research. (Gardner B) J Surg Oncol 2001 Dec;78(4):281-3 |
| 1 | Cytokine deregulation in cancer. (Kurzrock R) Biomed Pharmacother 2001 Nov;55(9-10):543-7 88 Citations |
| 1 | Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. (Onaitis MW, Noone RB, Fields R, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Seigler HF, Tyler DS) Ann Surg Oncol 2001 Dec;8(10):801-6 119 Citations |
| 1 | High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM) J Clin Oncol 2002 Feb 01;20(3):743-50 58 Citations |
| 1 | Use of complementary and alternative medicine among women with gynecologic cancers. (Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG) Gynecol Oncol 2002 Mar;84(3):363-7 102 Citations |
| 1 | Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy. (Babb SA, Swisher EM, Heller HN, Whelan AJ, Mutch DG, Herzog TJ, Rader JS) J Genet Couns 2002 Apr;11(2):81-96 25 Citations |
| 1 | Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. (Cohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA, Herzog TJ) Gynecol Oncol 2002 Apr;85(1):179-84 161 Citations |
| 1 | Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). (Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC) Cancer Causes Control 2002 Mar;13(2):113-20 27 Citations |
| 1 | Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA) Int J Radiat Oncol Biol Phys 2002 Apr 01;52(5):1293-302 201 Citations |
| 2 | Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57 175 Citations |
| 2 | The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition. (Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF, Chen G) J Biol Chem 2002 Jul 19;277(29):25884-92 97 Citations |
| 1 | Survival of women after breast conserving surgery for early stage breast cancer. (Du Xianglin, Freeman JL, Nattinger AB, Goodwin JS) Breast Cancer Res Treat 2002 Mar;72(1):23-31 33 Citations |
| 1 | Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. (Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB) J Gerontol A Biol Sci Med Sci 2002 Jun;57(6):M401-6 18 Citations |
| 1 | Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer. (Alvi AJ, Hogg R, Rader JS, Kuo MJ, Maher ER, Latif F) Mol Pathol 2002 Jun;55(3):153-5 11 Citations |
| 1 | Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. (Ivanovich J, Babb S, Goodfellow P, Mutch D, Herzog T, Rader J, Whelan A) Clin Cancer Res 2002 Jun;8(6):1849-56 37 Citations |
| 2 | Autologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80 15 Citations |
| 1 | Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. (Horowitz N, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb R, Bocker-Edmonston T, Goodfellow PJ) Gynecol Oncol 2002 Jul;86(1):62-8 29 Citations |
| 1 | The role of a second transurethral resection for high-grade bladder cancer. (Langenstroer P, See W) Curr Urol Rep 2000 Oct;1(3):204-7 7 Citations |
| 1 | Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. (Lenzi R, Yalcin S, Evans DB, Abbruzzese JL) Cancer Invest 2002;20(4):464-72 41 Citations |
| 1 | Swallow function and perception of dysphagia in patients with head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A, MacCracken E, Gaziano J, Stachowiak L) Head Neck 2002 Jun;24(6):555-65 142 Citations |
| 1 | Therapeutic options and treatment of muscle invasive bladder cancer. (O'Connor RC, Alsikafi NF, Steinberg GD) Expert Rev Anticancer Ther 2001 Dec;1(4):511-22 8 Citations |
| 1 | MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. (Whelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ) Int J Cancer 2002 Jun 10;99(5):697-704 36 Citations |
| 2 | Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). (Mammoto T, Higashiyama S, Mukai M, Mammoto A, Ayaki M, Mashimo T, Hayashi Y, Kishi Y, Nakamura H, Akedo H) J Cell Physiol 2002 Sep;192(3):351-8 54 Citations |
| 1 | Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. (Baruah H, Rector CL, Monnier SM, Bierbach U) Biochem Pharmacol 2002 Jul 15;64(2):191-200 88 Citations |
| 2 | Intravenous anesthetic, propofol inhibits invasion of cancer cells. (Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y, Nakamura H) Cancer Lett 2002 Oct 28;184(2):165-70 149 Citations |
| 1 | Scalp metastases as the first manifestation of pancreatic cancer. (Gawrieh S, Massey BT, Komorowski RA) Dig Dis Sci 2002 Jul;47(7):1469-71 7 Citations |
| 1 | Identifying cancer relapse using SEER-Medicare data. (Earle CC, Nattinger AB, Potosky AL, Lang K, Mallick R, Berger M, Warren JL) Med Care 2002 Aug;40(8 Suppl):IV-75-81 117 Citations |
| 1 | The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. (Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ) Oncogene 2002 Sep 19;21(42):6510-9 158 Citations |
| 1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology) Blood 2002 Oct 01;100(7):2303-20 204 Citations |
| 2 | Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 01;54(2):357-64 188 Citations |
| 1 | Bladder cancer among chemical workers exposed to nitrogen products and other substances. (Marsh GM, Gula MJ, Youk AO, Cassidy LD) Am J Ind Med 2002 Oct;42(4):286-95 9 Citations |
| 1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology) J Clin Oncol 2002 Oct 01;20(19):4083-107 402 Citations |
| 1 | Breast cancer: adaptation of fine-needle aspiration to office practice. (Hindle WH, Arias RD, Felix JC, Sueda A) Clin Obstet Gynecol 2002 Sep;45(3):761-6 4 Citations |
| 1 | Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. (Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP) Am J Gastroenterol 2002 Oct;97(10):2553-8 80 Citations |
| 1 | Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. (Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ) Clin Cancer Res 2002 Nov;8(11):3628-38 59 Citations |
| 1 | Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. (Anderson GS, Miyagi K, Sampson RW, Sieber F) J Photochem Photobiol B 2002 Nov;68(2-3):101-8 24 Citations |
| 1 | Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study. (Hawes D, Liu PY, Muggia FM, Wilczynski S, Cote R, Felix J, Terada K, Belt RJ, Alberts DS) Gynecol Oncol 2002 Oct;87(1):17-23 12 Citations |
| 1 | Case selection and outcome of radical perineal prostatectomy in localized prostate cancer (Holzbeierlein JM, Langenstroer P, Porter HJ, Thrasher JB) International Braz J Urol July/August 2003;29(4):291-299 12 Citations |
| 1 | Colorectal cancer screening. Clinical practice guidelines in oncology. (Levin B, Ludwig KA, Steinbach G, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2003 Jan;1(1):72-93 8 Citations |
| 1 | Oral cancer treatment. (Day TA, Davis BK, Gillespie MB, Joe JK, Kibbey M, Martin-Harris B, Neville B, Reed SG, Richardson MS, Rosenzweig S, Sharma AK, Smith MM, Stewart S, Stuart RK) Curr Treat Options Oncol 2003 Feb;4(1):27-41 109 Citations |
| 1 | Sustained tyrosine-phosphorylation of FAK through Rho-dependent adhesion to fibronectin is essential for cancer cell migration. (Mukai M, Togawa A, Imamura F, Iwasaki T, Ayaki M, Mammoto T, Nakamura H, Tatsuta M, Inoue M) Anticancer Res 2002;22(6A):3175-84 16 Citations |
| 1 | Function of nuclear factor kappaB in pancreatic cancer metastasis. (Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Clin Cancer Res 2003 Jan;9(1):346-54 214 Citations |
| 1 | The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening. (Marsh GM, Cassidy LD) Am J Ind Med 2003 Feb;43(2):142-8 22 Citations |
| 1 | Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis. (Meurer LN, Lená S) J Fam Pract 2002 Dec;51(12):1056-62 33 Citations |
| 1 | Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. (Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI) Oncogene 2003 Jan 30;22(4):590-601 64 Citations |
| 1 | Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225. (Sclabas GM, Fujioka S, Schmidt C, Fan Z, Evans DB, Chiao PJ) J Gastrointest Surg 2003 Jan;7(1):37-43; discussion 43 65 Citations |
| 1 | Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. (Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PWT, Evans DB) J Gastrointest Surg 2003 Jan;7(1):118-128 276 Citations |
| 1 | Quality of life assessment in nonmelanoma cervicofacial skin cancer. (Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M) Laryngoscope 2003 Feb;113(2):215-20 50 Citations |
| 1 | Quality of care for breast cancer. (Nattinger AB) Med Care 2003 Mar;41(3):341-3 8 Citations |
| 1 | Emerging cellular and molecular themes in pancreatic cancer research. (Urrutia R) Int J Gastrointest Cancer 2002;31(1-3):1-4 2 Citations |
| 1 | Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. (Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S) Clin Cancer Res 2003 Mar;9(3):991-7 316 Citations |
| 1 | Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein. (Toth K, Tarakanova V, Doronin K, Ward P, Kuppuswamy M, Locke JE, Dawson JE, Kim HJ, Wold WS) Cancer Gene Ther 2003 Mar;10(3):193-200 41 Citations |
| 1 | Determination of cyclooxygenase and arachidonic acid metabolites in invasive human prostate cancer cells. (Nithipatikom K, Borscheid CL, Kajdacsy-Balla A, Kaul S, Lindholm PF, Pytynia KB, Campbell WB) Adv Exp Med Biol 2002;507:269-74 4 Citations |
| 1 | The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs. (Veldman RJ, Mita A, Cuvillier O, Garcia V, Klappe K, Medin JA, Campbell JD, Carpentier S, Kok JW, Levade T) FASEB J 2003 Jun;17(9):1144-6 40 Citations |
| 1 | Diagnosis, staging, and surveillance of pancreatic cancer. (Tamm EP, Silverman PM, Charnsangavej C, Evans DB) AJR Am J Roentgenol 2003 May;180(5):1311-23 79 Citations |
| 1 | Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. (Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY, Mutch DG) Proc Natl Acad Sci U S A 2003 May 13;100(10):5908-13 206 Citations |
| 1 | An axillary recurrence of breast cancer following a negative sentinel lymph node biopsy. (Yen TW, Mann GN, Lawton TJ, Livingston RB, Anderson BO) Breast J 2003;9(3):234-6 9 Citations |
| 1 | Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. (Meadows SM, Mulkerin D, Berlin J, Bailey H, Kolesar J, Warren D, Thomas JP) Int J Gastrointest Cancer 2002;32(2-3):125-8 66 Citations |
| 2 | Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5 4 Citations |
| 1 | Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer. (Gore EM) Oncology (Williston Park) 2003 Jun;17(6):775-9; discussion 779-80, 784, 787 passim 10 Citations |
| 1 | Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. (Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI) Genes Chromosomes Cancer 2003 Sep;38(1):40-52 122 Citations |
| 1 | Fundamentals of transcription factors and their impact on pancreatic development and cancer. (Fernandez-Zapico ME, Bramati PS, Zakaria S, Kaczynski JA, Urrutia R) Pancreatology 2003;3(4):276-83 3 Citations |
| 1 | NF-kappaB in pancreatic cancer. (Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ) Int J Gastrointest Cancer 2003;33(1):15-26 55 Citations |
| 1 | Effect of nurse case management on the treatment of older women with breast cancer. (Goodwin JS, Satish S, Anderson ET, Nattinger AB, Freeman JL) J Am Geriatr Soc 2003 Sep;51(9):1252-9 117 Citations |
| 1 | Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 148 Citations |
| 1 | A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. (Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI, Rader JS) Gynecol Oncol 2003 Sep;90(3):560-5 37 Citations |
| 1 | Health status of childhood cancer survivors: cure is more than the eradication of cancer. (Schwartz CL) JAMA 2003 Sep 24;290(12):1641-3 27 Citations |
| 1 | A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. (Rader JS, Clarke-Pearson D, Moore M, Carson L, Holloway R, Kao MS, Wiznitzer I, Douglass EC) Gynecol Oncol 2003 Nov;91(2):318-25 14 Citations |
| 2 | Cancer prevention in underserved African American communities: barriers and effective strategies--a review of the literature. (Wolff M, Bates T, Beck B, Young S, Ahmed SM, Maurana C) WMJ 2003;102(5):36-40 82 Citations |
| 1 | Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. (Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA) Int J Radiat Oncol Biol Phys 2003 Dec 01;57(5):1219-30 182 Citations |
| 2 | Estrogen receptor inhibits c-Jun-dependent stress-induced cell death by binding and modifying c-Jun activity in human breast cancer cells. (Qi X, Borowicz S, Pramanik R, Schultz RM, Han J, Chen G) J Biol Chem 2004 Feb 20;279(8):6769-77 29 Citations |
| 1 | The relationships between xerostomia and dysphagia after chemoradiation of head and neck cancer. (Eisbruch A, Terrell JE) Head Neck 2003 Dec;25(12):1082; author reply 1082-3 6 Citations |
| 1 | Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. (Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, Newman LA, May AH, MacCracken E, Gaziano J, Stachowiak L) Head Neck 2003 Dec;25(12):1034-41 60 Citations |
| 1 | Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB) Surgery 2003 Dec;134(6):946-54; discussion 954-5 448 Citations |
| 1 | Psychological functioning in long-term survivors of childhood cancer [Abstract]. (Bingen, K., Schmidt, D., Anderson, L., Maloney, K., Warwick, A., Margolis, D., and Kupst, M. ) Psycho-Oncology 13 (Suppl.1), 56 |
| 1 | Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series. (Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock R) Cancer 2004 Jan 15;100(2):342-9 72 Citations |
| 1 | Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. (Wang TS, Dubner S, Sznyter LA, Heller KS) Arch Otolaryngol Head Neck Surg 2004 Jan;130(1):110-3 90 Citations |
| 1 | Addressing multiple breast cancer risk factors in African-American women. (Stolley MR, Fitzgibbon ML, Wells A, Martinovich Z) J Natl Med Assoc 2004 Jan;96(1):76-86 5 Citations |
| 1 | Four-year prostate cancer screening interval is effective (Schellhase KG) Journal of Family Practice February 2004;53(2):101-102 |
| 1 | Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. (Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK, Huettner P, Edmonston TB, Goodfellow PJ) Clin Cancer Res 2004 Jan 15;10(2):481-90 44 Citations |
| 1 | Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients. (List MA, Rutherford JL, Stracks J, Pauloski BR, Logemann JA, Lundy D, Sullivan P, Goodwin W, Kies M, Vokes EE) Head Neck 2004 Feb;26(2):163-70 70 Citations |
| 1 | Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. (Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ) Am J Clin Oncol 2004 Feb;27(1):51-6 94 Citations |
| 1 | Four-year prostate cancer screening interval is effective. (Schellhase KG) J Fam Pract 2004 Feb;53(2):101-2 |
| 1 | Epstein-Barr virus and cancer. (Thompson MP, Kurzrock R) Clin Cancer Res 2004 Feb 01;10(3):803-21 665 Citations |
| 2 | Quality of life and sun-protective behavior in patients with skin cancer. (Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB) Arch Otolaryngol Head Neck Surg 2004 Feb;130(2):141-6 52 Citations |
| 1 | Synchronous ovarian metastases at the time of laparotomy for colon cancer. (Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Huettner PC, Herzog TJ) Gynecol Oncol 2004 Mar;92(3):851-5 32 Citations |
| 1 | Pharyngeal cancer mortality among chemical plant workers exposed to formaldehyde. (Marsh GM, Youk AO, Buchanich JM, Cassidy LD, Lucas LJ, Esmen NA, Gathuru IM) Toxicol Ind Health 2002 Jul;18(6):257-68 35 Citations |
| 1 | The role of intraoperative radiotherapy in pancreatic cancer. (Crane CH, Beddar AS, Evans DB) Surg Oncol Clin N Am 2003 Oct;12(4):965-77 22 Citations |
| 1 | Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study. (Schwartz CL) J Pediatr 2004 Mar;144(3):407-8 |
| 2 | p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. (Qi X, Tang J, Pramanik R, Schultz RM, Shirasawa S, Sasazuki T, Han J, Chen G) J Biol Chem 2004 May 21;279(21):22138-44 60 Citations |
| 2 | Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. (Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB) Dermatol Surg 2004 Apr;30(4 Pt 1):525-9 65 Citations |
| 3 | Predictors of pessimistic breast cancer risk perceptions in a primary care population. (Davids SL, Schapira MM, McAuliffe TL, Nattinger AB) J Gen Intern Med 2004 Apr;19(4):310-5 81 Citations |
| 1 | Fatigue in adolescents with cancer: a review of the literature. (Erickson JM) Clin J Oncol Nurs 2004 Apr;8(2):139-45 30 Citations |
| 1 | Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. (Dai Z, Popkie AP, Zhu WG, Timmers CD, Raval A, Tannehill-Gregg S, Morrison CD, Auer H, Kratzke RA, Niehans G, Amatschek S, Sommergruber W, Leone GW, Rosol T, Otterson GA, Plass C) Oncogene 2004 Apr 29;23(20):3521-9 52 Citations |
| 1 | Synchronous ovarian metastases at the time of laparotomy for colon cancer (Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Huettner PC, Herzog TJ, Fujiwara K) Women's Oncology Review June 2004;4(2):109-110 3 Citations |
| 1 | Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. (Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA) Obstet Gynecol 2004 Jun;103(6):1204-10 86 Citations |
| 1 | Lymph node control in cervical cancer. (Grigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I) Int J Radiat Oncol Biol Phys 2004 Jul 01;59(3):706-12 95 Citations |
| 3 | Agreement between scales in the measurement of breast cancer risk perceptions. (Schapira MM, Davids SL, McAuliffe TL, Nattinger AB) Risk Anal 2004 Jun;24(3):665-73 72 Citations |
| 1 | Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. (Pauloski BR, Rademaker AW, Logemann JA, McConnel FM, Heiser MA, Cardinale S, Lazarus CL, Pelzer H, Stein D, Beery Q) Head Neck 2004 Jul;26(7):625-36 107 Citations |
| 1 | Surgical and endoscopic palliation for pancreatic cancer. (Andtbacka RH, Evans DB, Pisters PW) Minerva Chir 2004 Apr;59(2):123-36 28 Citations |
| 1 | Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. (Barber FD, Mavligit G, Kurzrock R) Cancer Treat Rev 2004 Aug;30(5):425-36 39 Citations |
| 1 | A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer. (Wong SJ, Sadasiwan C, Erickson B, Ota D, Mulkerin D, Thomas J, Holen K, Meadows S, Telford G, Gore E) J Clin Oncol 2004 Jul 15;22(14_suppl):3771 |
| 1 | Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? (Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Aug;94(2):249-55 31 Citations |
| 1 | KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. (Ellenrieder V, Buck A, Harth A, Jungert K, Buchholz M, Adler G, Urrutia R, Gress TM) Gastroenterology 2004 Aug;127(2):607-20 79 Citations |
| 1 | Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium. (Schlicht M, Matysiak B, Brodzeller T, Wen X, Liu H, Zhou G, Dhir R, Hessner MJ, Tonellato P, Suckow M, Pollard M, Datta MW) BMC Genomics 2004 Aug 20;5(1):58 27 Citations |
| 1 | Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix 54 Citations |
| 4 | Decentralization of breast cancer surgery in the United States. (Neuner JM, Gilligan MA, Sparapani R, Laud PW, Haggstrom D, Nattinger AB) Cancer 2004 Sep 15;101(6):1323-9 35 Citations |
| 1 | Aspiration, weight loss, and quality of life in head and neck cancer survivors. (Campbell BH, Spinelli K, Marbella AM, Myers KB, Kuhn JC, Layde PM) Arch Otolaryngol Head Neck Surg 2004 Sep;130(9):1100-3 108 Citations |
| 1 | A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? (Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Oct;95(1):70-6 54 Citations |
| 1 | Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. (Wang SJ, Saadi W, Lin F, Minh-Canh Nguyen C, Li Jeon N) Exp Cell Res 2004 Oct 15;300(1):180-9 234 Citations |
| 1 | Speech intelligibility and quality of life in head and neck cancer survivors. (Meyer TK, Kuhn JC, Campbell BH, Marbella AM, Myers KB, Layde PM) Laryngoscope 2004 Nov;114(11):1977-81 52 Citations |
| 1 | Hysteroscopy and cytology in endometrial cancer. (Bradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF) Obstet Gynecol 2004 Nov;104(5 Pt 1):1030-3 50 Citations |
| 4 | An algorithm for the use of Medicare claims data to identify women with incident breast cancer. (Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL) Health Serv Res 2004 Dec;39(6 Pt 1):1733-49 178 Citations |
| 1 | A new key in breast cancer metastasis. (Benovic JL, Marchese A) Cancer Cell 2004 Nov;6(5):429-30 38 Citations |
| 1 | Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. (Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, Nephew KP, Huang TH) Cancer Res 2004 Nov 15;64(22):8184-92 174 Citations |
| 1 | Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation? (Gore E, Choy H) Semin Radiat Oncol 2004 Oct;14(4):292-7 13 Citations |
| 1 | Resolution and contrast in magnetic resonance electrical impedance tomography (MREIT) and its application to cancer imaging. (Muftuler LT, Hamamura M, Birgul O, Nalcioglu O) Technol Cancer Res Treat 2004 Dec;3(6):599-609 64 Citations |
| 1 | Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. (Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG) Gynecol Oncol 2004 Dec;95(3):546-51 134 Citations |
| 1 | IGSF4 promoter methylation and expression silencing in human cervical cancer. (Li J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS) Gynecol Oncol 2005 Jan;96(1):150-8 37 Citations |
| 1 | Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R) Ann Oncol 2005 Jan;16(1):139-45 53 Citations |
| 2 | 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. (Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB) Cancer Res 2004 Dec 15;64(24):8826-30 125 Citations |
| 1 | Borderline resectable pancreatic cancer (Varadhachary GR, Tamm EP, Crane C, Evans DB, Wolff RA) Current Treatment Options in Gastroenterology October 2005;8(5):377-384 56 Citations |
| 1 | Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. (Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD) Cancer Cell 2005 Jan;7(1):39-49 184 Citations |
| 1 | Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. (Wietzke JA, Ward EC, Schneider J, Welsh J) Mol Cell Endocrinol 2005 Jan 31;230(1-2):59-68 22 Citations |
| 1 | Psychosocial effects in long-term head and neck cancer survivors. (Holloway RL, Hellewell JL, Marbella AM, Layde PM, Myers KB, Campbell BH) Head Neck 2005 Apr;27(4):281-8 45 Citations |
| 1 | Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):444-9 30 Citations |
| 1 | Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. (Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS) Genes Chromosomes Cancer 2005 May;43(1):95-103 14 Citations |
| 2 | Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ) Blood 2005 May 15;105(10):3802-11 281 Citations |
| 1 | Celecoxib and radiation therapy in non-small-cell lung cancer. (Gore E) Oncology (Williston Park) 2004 Dec;18(14 Suppl 14):10-4 23 Citations |
| 1 | The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. (Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S) Prostate Cancer Prostatic Dis 2005;8(1):22-30 116 Citations |
| 2 | Expression profiling in pancreatic cancer research: the initial steps and the road ahead. (Fernandez-Zapico ME, Callahan G, Delgado S, Urrutia R) Curr Opin Gastroenterol 2003 Sep;19(5):467-72 |
| 1 | Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. (Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR, Zhang W, Fidler IJ, Chiao PJ) Clin Cancer Res 2005 Jan 15;11(2 Pt 1):440-9 122 Citations |
| 1 | Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H-0022 dosimetric criteria. (Zhu XR, Schultz CJ, Gillin MT) J Appl Clin Med Phys 2004;5(4):80-95 8 Citations |
| 1 | Case selection and outcome of radical perineal prostatectomy in localized prostate cancer. (Holzbeierlein JM, Langenstroer P, Porter HJ 2nd, Thrasher JB) Int Braz J Urol 2003;29(4):291-9 |
| 1 | The first initiative targeted to increase the training of African-American scientists in pancreatic cancer research: the Mayo Clinic College of Medicine-Oakwood College alliance. (Randriamahefa A, Fernandez-Zapico ME, Mladek AC, Evans L, Melbourne L, Osborne S, Cochran RL, Knight M, Beckford D, Gullo S, Paul A, McGee R, Urrutia R) Pancreas 2005 Apr;30(3):288-91 1 Citation |
| 1 | Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. (Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD) Cancer Res 2005 Mar 15;65(6):2076-81 308 Citations |
| 1 | Dental status and quality of life in long-term head and neck cancer survivors. (Duke RL, Campbell BH, Indresano AT, Eaton DJ, Marbella AM, Myers KB, Layde PM) Laryngoscope 2005 Apr;115(4):678-83 91 Citations |
| 1 | Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. (Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM) J Am Coll Surg 2005 Apr;200(4):516-26 264 Citations |
| 1 | Relationship between surgeon caseload and sphincter preservation in patients with rectal cancer. (Purves H, Pietrobon R, Hervey S, Guller U, Miller W, Ludwig K) Dis Colon Rectum 2005 Feb;48(2):195-202; discussion 202-4 56 Citations |
| 1 | Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics. (Tibes R, Trent J, Kurzrock R) Annu Rev Pharmacol Toxicol 2005;45:357-84 107 Citations |
| 2 | Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). (Pötter R, Dimopoulos J, Kirisits C, Lang S, Haie-Meder C, Briot E, Dumas I, Van Limbergen E, De Brabandere M, Nulens A, Erickson B, Rownd J, Petrow P) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):293-5; author reply 295-6 30 Citations |
| 1 | Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative. (Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, Klein EA, Mohideen N, Hurwitz MD, Fraas BA, Roach M 3rd, Gore EM, Tepper JE) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):3-19 54 Citations |
| 1 | A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer. (Dy GK, Thomas JP, Wilding G, Bruzek L, Mandrekar S, Erlichman C, Alberti D, Binger K, Pitot HC, Alberts SR, Hanson LJ, Marnocha R, Tutsch K, Kaufmann SH, Adjei AA) Clin Cancer Res 2005 May 01;11(9):3410-6 66 Citations |
| 1 | Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. (Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G, Société Française de Greffe de Moëlle et Thérapie Cellulaire, Dana Farber Cancer Institute, International Bone Marrow Transplant Registry) Blood 2005 Aug 15;106(4):1495-500 178 Citations |
| 1 | A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. (Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB) Biochem Biophys Res Commun 2005 Jul 15;332(4):1028-33 49 Citations |
| 1 | 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. (Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1470-6 62 Citations |
| 1 | Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. (Langenstroer P, Carroll P, Thrasher JB) J Urol 2005 Jul;174(1):118-20 5 Citations |
| 1 | Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. (Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M, Gallick GE, Ellis LM) Br J Cancer 2005 Jul 25;93(2):233-41 107 Citations |
| 1 | Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW) Arch Surg 2005 Jun;140(6):584-9; discussion 589-91 96 Citations |
| 1 | Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM) Carcinogenesis 2006 Jan;27(1):103-11 88 Citations |
| 2 | Creation of a quality of life instrument for nonmelanoma skin cancer patients. (Rhee JS, Matthews BA, Neuburg M, Burzynski M, Nattinger AB) Laryngoscope 2005 Jul;115(7):1178-85 61 Citations |
| 1 | Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. (Uyar D, Frasure HE, Markman M, von Gruenigen VE) Gynecol Oncol 2005 Sep;98(3):403-8 108 Citations |
| 1 | Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer. (Langenstroer P, Kramer B, Cutting B, Amling C, Poultan T, Lance R, Thrasher JB) J Urol 2005 Aug;174(2):642-5 28 Citations |
| 1 | RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. (Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman SI, Lee JE, Evans DB) Thyroid 2005 Jun;15(6):531-44 257 Citations |
| 1 | Anal canal cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):510-5 12 Citations |
| 1 | Rectal cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):492-508 21 Citations |
| 1 | Colon cancer clinical practice guidelines in oncology. (Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2005 Jul;3(4):468-91 58 Citations |
| 1 | Colorectal cancer screening behavior and health insurance status (United States). (Matthews BA, Anderson RC, Nattinger AB) Cancer Causes Control 2005 Aug;16(6):735-42 61 Citations |
| 1 | Colon cancer: Preface (Ludwig KA) Clinics in Colon and Rectal Surgery August 2005;18(3):131 |
| 1 | Laparoscopic colectomy for colon cancer: comparable to conventional oncologic surgery? (Bonnor RM, Ludwig KA) Clin Colon Rectal Surg 2005 Aug;18(3):174-81 12 Citations |
| 2 | When developmental signaling pathways go wrong and their impact on pancreatic cancer development. (Lomberk G, Fernandez-Zapico ME, Urrutia R) Curr Opin Gastroenterol 2005 Sep;21(5):555-60 7 Citations |
| 1 | [Left atrial thrombus in an 80-year-old woman scheduled to have an operation for uterus cancer; report of a case]. (Nokamura K, Kohmoto T, Kawada M, Shimizu S, Kuroko Y, Kawabata T, Sano S) Kyobu Geka 2005 Aug;58(9):838-40 1 Citation |
| 1 | American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. (Small W Jr, Erickson B, Kwakwa F) Int J Radiat Oncol Biol Phys 2005 Dec 01;63(5):1502-7 87 Citations |
| 1 | Resource utilization for ovarian cancer patients at the end of life: how much is too much? (Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ) Gynecol Oncol 2005 Nov;99(2):261-6 59 Citations |
| 1 | Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomy. (Kamat AM, Jacobsohn KM, Troncoso P, Shen Y, Wen S, Babaian RJ) J Urol 2005 Oct;174(4 Pt 1):1262-5 27 Citations |
| 1 | Borderline resectable pancreatic cancer. (Varadhachary GR, Tamm EP, Crane C, Evans DB, Wolff RA) Curr Treat Options Gastroenterol 2005 Oct;8(5):377-84 55 Citations |
| 1 | RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer. (Gore E) Clin Adv Hematol Oncol 2005 Aug;3(8):625-6 12 Citations |
| 1 | Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. (Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD) Gynecol Oncol 2006 Feb;100(2):288-93 56 Citations |
| 1 | Complications after cystectomy and urinary diversion in patients previously treated for localized prostate cancer. (Tolhurst SR, Rapp DE, O'Connor RC, Lyon MB, Orvieto MA, Steinberg GD) Urology 2005 Oct;66(4):824-9 30 Citations |
| 1 | Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing? (Stadler WM, Michaelis LC, Ratain MJ) J Clin Oncol 2005 Nov 01;23(31):8124-5; author reply 8125-6 2 Citations |
| 1 | Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer. (Strock CJ, Park JI, Rosen DM, Ruggeri B, Denmeade SR, Ball DW, Nelkin BD) J Clin Endocrinol Metab 2006 Jan;91(1):79-84 44 Citations |
| 1 | Value of laparoscopy in the staging of pancreatic cancer. (Camacho D, Reichenbach D, Duerr GD, Venema TL, Sweeney JF, Fisher WE) JOP 2005 Nov 10;6(6):552-61 40 Citations |
| 1 | Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. (Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D) Head Neck 2006 Jan;28(1):64-73 135 Citations |
| 1 | The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation. (Myers JN, O'neil KM, Walsh TE, Hoffmeister KJ, Venzon DJ, Johnson BE) Chest 2005 Nov;128(5):3261-8 9 Citations |
| 1 | Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center. (Geller DA, Tsung A, Marsh JW, Dvorchik I, Gamblin TC, Carr BI) J Gastrointest Surg 2006 Jan;10(1):63-8 20 Citations |
| 1 | Suppression of anti-cancer immunity by regulatory T cells: back to the future. (Orentas RJ, Kohler ME, Johnson BD) Semin Cancer Biol 2006 Apr;16(2):137-49 65 Citations |
| 1 | Epidemiology of primary and secondary liver cancers (Ananthakrishnan A, Gogineni V, Saeian K) Seminars in Interventional Radiology March 2006;23(1):47-63 165 Citations |
| 1 | A population model of prostate cancer incidence. (Tsodikov A, Szabo A, Wegelin J) Stat Med 2006 Aug 30;25(16):2846-66 42 Citations |
| 1 | Preoperative chemoradiation for pancreatic cancer. (Evans DB) Semin Oncol 2005 Dec;32(6 Suppl 9):S25-9 14 Citations |
| 2 | Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C, GEC ESTRO Working Group) Radiother Oncol 2006 Jan;78(1):67-77 1474 Citations |
| 2 | Erratum: Clarification note to an algorithm for the use of medicare claims data to identify women with incident breast cancer (Health Services Research (December 2004) 39, 6, 1 (1733-1750)) (Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL) Health Services Research February 2006;41(1):302 5 Citations |
| 1 | Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. (Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI) J Clin Oncol 2006 Feb 01;24(4):656-62 132 Citations |
| 1 | The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. (Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D) Cancer Lett 2007 Jan 08;245(1-2):61-8 50 Citations |
| 1 | Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2006;31(5):568-74 62 Citations |
| 1 | Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. (du Manoir JM, Francia G, Man S, Mossoba M, Medin JA, Viloria-Petit A, Hicklin DJ, Emmenegger U, Kerbel RS) Clin Cancer Res 2006 Feb 01;12(3 Pt 1):904-16 129 Citations |
| 1 | Metastatic colon cancer to the hand. (Gamblin TC, Santos RS, Baratz M, Landreneau RJ) Am Surg 2006 Jan;72(1):98-100 11 Citations |
| 1 | Epidemiology of primary and secondary liver cancers. (Ananthakrishnan A, Gogineni V, Saeian K) Semin Intervent Radiol 2006 Mar;23(1):47-63 164 Citations |
| 1 | Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 01;24(7):1145-51 199 Citations |
| 1 | Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer. (Gore E) Clin Lung Cancer 2006 Jan;7(4):276-8 4 Citations |
| 1 | The management of treatment-related esophageal complications in children and adolescents with cancer. (Lal DR, Foroutan HR, Su WT, Wolden SL, Boulad F, La Quaglia MP) J Pediatr Surg 2006 Mar;41(3):495-9 28 Citations |
| 1 | Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. (Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL) J Clin Oncol 2006 Apr 10;24(11):1720-8 131 Citations |
| 3 | Effect of model of care delivery on mammography use among elderly breast cancer survivors. (Etim AE, Schellhase KG, Sparapani R, Nattinger AB) Breast Cancer Res Treat 2006 Apr;96(3):293-9 22 Citations |
| 1 | Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. (Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Cancer Res 2006 Mar 15;66(6):3323-30 73 Citations |
| 1 | The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. (Crane CH, Varadhachary G, Wolff RA, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):365-82 46 Citations |
| 1 | Venous resection in pancreatic cancer surgery. (Tseng JF, Tamm EP, Lee JE, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):349-64 82 Citations |
| 1 | Colorectal Cancer Screening Clinical Practice Guidelines. (Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW Jr, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ) J Natl Compr Canc Netw 2006 Apr;4(4):384-420 35 Citations |
| 3 | Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. (Huh J, Liepins A, Zielonka J, Andrekopoulos C, Kalyanaraman B, Sorokin A) Cancer Res 2006 Apr 01;66(7):3726-36 58 Citations |
| 1 | Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. (Zhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, Li J, Rader JS) Oncogene 2006 Aug 31;25(39):5436-45 34 Citations |
| 1 | Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. (Wright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS) Gynecol Oncol 2006 Nov;103(2):489-93 100 Citations |
| 1 | CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan. (Gossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ) Gynecol Oncol 2006 Oct;103(1):212-8 18 Citations |
| 1 | Gene expression patterns in advanced human cervical cancer. (Grigsby PW, Watson M, Powell MA, Zhang Z, Rader JS) Int J Gynecol Cancer 2006;16(2):562-7 28 Citations |
| 1 | A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis. (Saadi W, Wang SJ, Lin F, Jeon NL) Biomed Microdevices 2006 Jun;8(2):109-18 180 Citations |
| 1 | Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. (Gamblin TC, Finkelstein SD, Upsal N, Kaye JD, Blumberg D) Am Surg 2006 May;72(5):445-53 6 Citations |
| 2 | Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). (Firat S, Pleister A, Byhardt RW, Gore E) Am J Clin Oncol 2006 Jun;29(3):252-7 48 Citations |
| 1 | A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. (Argiris A, Cohen E, Karrison T, Esparaz B, Mauer A, Ansari R, Wong S, Lu Y, Pins M, Dancey J, Vokes E) Cancer Biol Ther 2006 Jul;5(7):766-70 106 Citations |
| 1 | Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? (Wong SJ, Machtay M, Li Y) J Clin Oncol 2006 Jun 10;24(17):2653-8 117 Citations |
| 1 | Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer. (Herzog TJ, Powell MA, Rader JS, Gibb R, Mutch DG) Gynecol Oncol 2006 Nov;103(2):637-41 11 Citations |
| 1 | Imaging of oral cavity cancer. (Rumboldt Z, Day TA, Michel M) Oral Oncol 2006 Oct;42(9):854-65 30 Citations |
| 1 | Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. (Amezcua CA, MacDonald HR, Lum CA, Yi W, Muderspach LI, Roman LD, Felix JC) Int J Gynecol Cancer 2006;16(3):1336-41 17 Citations |
| 1 | Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. (Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J, Stachowiak L) Head Neck 2006 Dec;28(12):1069-76 79 Citations |
| 1 | Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? (Siker ML, Tomé WA, Mehta MP) Int J Radiat Oncol Biol Phys 2006 Sep 01;66(1):135-41 105 Citations |
| 1 | Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D) Cancer Detect Prev 2006;30(3):284-91 71 Citations |
| 1 | Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis. (Wang H, Doll JA, Jiang K, Cundiff DL, Czarnecki JS, Wilson M, Ridge KM, Soff GA) Cancer Res 2006 Jul 15;66(14):7211-5 27 Citations |
| 1 | Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. (Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA) Ann Surg Oncol 2006 Aug;13(8):1035-46 783 Citations |
| 2 | Development of the facial skin care index: a health-related outcomes index for skin cancer patients. (Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB) Dermatol Surg 2006 Jul;32(7):924-34; discussion 934 40 Citations |
| 1 | MLH3 mutation in endometrial cancer. (Taylor NP, Powell MA, Gibb RK, Rader JS, Huettner PC, Thibodeau SN, Mutch DG, Goodfellow PJ) Cancer Res 2006 Aug 01;66(15):7502-8 23 Citations |
| 2 | p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion. (Qi X, Tang J, Loesch M, Pohl N, Alkan S, Chen G) Cancer Res 2006 Aug 01;66(15):7540-7 41 Citations |
| 1 | Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. (Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD) Cancer Res 2006 Aug 01;66(15):7509-15 137 Citations |
| 1 | Emerging use of nanoparticles in diagnosis and treatment of breast cancer. (Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O'Regan RM) Lancet Oncol 2006 Aug;7(8):657-67 492 Citations |
| 1 | Key role of Krüppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias. (Buttar NS, Fernandez-Zapico ME, Urrutia R) Curr Opin Gastroenterol 2006 Sep;22(5):505-11 13 Citations |
| 1 | Health behaviors and breast cancer: experiences of urban African American women. (Stolley MR, Sharp LK, Wells AM, Simon N, Schiffer L) Health Educ Behav 2006 Oct;33(5):604-24 38 Citations |
| 2 | The influence of graphic format on breast cancer risk communication. (Schapira MM, Nattinger AB, McAuliffe TL) J Health Commun 2006 Sep;11(6):569-82 92 Citations |
| 1 | Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): is there a link? (Atallah E, Schiffer CA) Leuk Res 2007 May;31(5):720-1 2 Citations |
| 1 | Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP et al.) Abdom Imaging 2006 Sep 12: |
| 1 | Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. (Society of Gynecologic Oncologists Education Resource Panel Writing group, Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J) Gynecol Oncol 2006 Sep;102(3):552-62 43 Citations |
| 3 | Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Arch Facial Plast Surg 2006;8(5):314-8 99 Citations |
| 1 | Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. (Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ) Mol Cancer Ther 2006 Sep;5(9):2251-60 125 Citations |
| 1 | Applications of microarray technology to pancreatic cancer research and drug development. (Truty MJ, Urrutia R) Expert Opin Drug Discov 2006 Oct;1(5):447-58 |
| 1 | Chronic health conditions in adult survivors of childhood cancer. (Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study) N Engl J Med 2006 Oct 12;355(15):1572-82 3029 Citations |
| 1 | Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis. (Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC) Cancer 2006 Nov 15;107(10):2392-400 58 Citations |
| 1 | Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions: Commentary (Hwang R, Evans D) Archives of Surgery 2006;141(10):974 |
| 1 | Prognostic influence of multiple hepatic metastases from colorectal cancer. (Malik HZ, Hamady ZZ, Adair R, Finch R, Al-Mukhtar A, Toogood GJ, Prasad KR, Lodge JP) Eur J Surg Oncol 2007 May;33(4):468-73 54 Citations |
| 1 | Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. (Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW) Radiat Med 2006 Nov;24(9):625-30 36 Citations |
| 1 | Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. (McCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA) Gynecol Oncol 2007 Mar;104(3):535-9 57 Citations |
| 1 | Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. (Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM) J Clin Oncol 2006 Dec 20;24(36):5711-5 513 Citations |
| 1 | Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. (Mossoba ME, Medin JA) Expert Rev Vaccines 2006 Oct;5(5):717-32 24 Citations |
| 1 | Invited commentary: medullary thyroid cancer: the importance of RET testing. (Evans DB, Shapiro SE, Cote GJ) Surgery 2007 Jan;141(1):96-9 14 Citations |
| 1 | WE‐D‐M100J‐05: Estimation of Tumor Control Probability Model Parameters for Early Stage Non‐Small‐Cell Lung Cancer (NSCLC) (Semenenko V, Gore E, li X) Medical Physics June 2007;34(6):2603 |
| 2 | TU‐FF‐A2‐03: Image‐Guided Helical Tomotherapy to Treat Advanced Cancers of the Scalp: Prospects for Dose Conformity and Clinical Outcome (Kainz K, Wilson JF, Schultz C, Jursinic P, li XA) Medical Physics June 2007;34(6):2576 |
| 1 | SU‐FF‐J‐45: A Comparison of Daily Megavoltage CT and Ultrasound Imaging Guided Radiation Therapy for Prostate Cancer (Peng C, Kainz K, Lawton C, li X) Medical Physics June 2007;34(6):2378 |
| 1 | Surviving (and Thriving with) Cancer. (Grady A, Ciccotelli B) Virtual Mentor 2007 Jan 01;9(1):62-8 |
| 1 | Connecting inadequate health insurance to poorer cancer treatment outcomes. (Grady A) Virtual Mentor 2007 Jan 01;9(1):26-9 |
| 1 | Using zip® codes as geocodes in cancer research (Beyer KMM, Schultz AF, Rushton G) Geocoding Health Data: The Use of Geographic Codes in Cancer Prevention and Control, Research and Practice 1 January 2007:37-67 23 Citations |
| 1 | K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. (Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D) Pancreas 2007 Jan;34(1):55-62 77 Citations |
| 1 | In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'. (Atallah E, Kantarjian H, Cortes J) Nat Med 2007 Jan;13(1):14; author reply 15-6 38 Citations |
| 1 | A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. (Mohile SG, Bylow K, Dale W, Dignam J, Martin K, Petrylak DP, Stadler WM, Rodin M) Cancer 2007 Feb 15;109(4):802-10 228 Citations |
| 4 | Surgeon characteristics and variations in treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB) Arch Surg 2007 Jan;142(1):17-22 47 Citations |
| 1 | Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. (Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, Maccracken E, Mittal BB, Vokes EE, Haraf DJ) Head Neck 2007 Jul;29(7):632-7 91 Citations |
| 1 | Effects of base excision repair gene polymorphisms on pancreatic cancer survival. (Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Int J Cancer 2007 Apr 15;120(8):1748-54 44 Citations |
| 1 | Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH, Li D) Cancer 2007 Mar 01;109(5):840-8 48 Citations |
| 4 | Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB) Am J Public Health 2007 Mar;97(3):539-44 51 Citations |
| 4 | Disparities in colon cancer screening in the Medicare population. (Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM) Arch Intern Med 2007 Feb 12;167(3):258-64 116 Citations |
| 1 | Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. (Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM) Cancer 2007 Mar 15;109(6):1030-9 91 Citations |
| 1 | Cancer Vaccines: Progress and Promise (Orentas RJ, Johnson B, Hodge J) Cancer Vaccines and Tumor Immunity 1 March 2007:1-11 |
| 1 | Cancer Vaccines and Tumor Immunity (Orentas R, Hodge JW, Johnson BD) Cancer Vaccines and Tumor Immunity 1 March 2007:1-334 3 Citations |
| 1 | Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. (Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH) Gastrointest Cancer Res 2007 Mar;1(2):44-8 |
| 1 | Development of a church-based cancer education curriculum using CBPR. (Beck B, Young S, Ahmed S, Wolff M) J Health Care Poor Underserved 2007 Feb;18(1):28-34 13 Citations |
| 3 | The skin cancer index: clinical responsiveness and predictors of quality of life. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Laryngoscope 2007 Mar;117(3):399-405 119 Citations |
| 1 | Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. (Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2007 Oct;33(8):1003-9 63 Citations |
| 2 | Objective risk, subjective risk, and colorectal cancer screening among a clinic sample. (Matthews BA, Nattinger AB, Venkatesan T, Shaker R, Anderson RC) Psychol Health Med 2007 Mar;12(2):135-47 4 Citations |
| 1 | Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K) Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1081-7 125 Citations |
| 1 | Dietary mutagen exposure and risk of pancreatic cancer. (Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, Evans DB, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2007 Apr;16(4):655-61 52 Citations |
| 2 | Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. (Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR) J Clin Oncol 2007 Apr 10;25(11):1403-11 172 Citations |
| 1 | Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. (Li L, Ahmed B, Mehta K, Kurzrock R) Mol Cancer Ther 2007 Apr;6(4):1276-82 325 Citations |
| 1 | Nanotechnology applications in cancer. (Nie S, Xing Y, Kim GJ, Simons JW) Annu Rev Biomed Eng 2007;9:257-88 1025 Citations |
| 1 | Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. (Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK) Nat Clin Pract Oncol 2007 May;4(5):316-21 51 Citations |
| 1 | Rectourethral fistula after combination radiotherapy for prostate cancer. (Marguet C, Raj GV, Brashears JH, Anscher MS, Ludwig K, Mouraviev V, Robertson CN, Polascik TJ) Urology 2007 May;69(5):898-901 45 Citations |
| 1 | External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. (Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW) Gynecol Oncol 2007 Jul;106(1):215-20 45 Citations |
| 1 | Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. (Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D) Cancer 2007 Jun 15;109(12):2547-56 49 Citations |
| 1 | Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. (Czito BG, Bendell JC, Willett CG, Morse MA, Blobe GC, Tyler DS, Thomas J, Ludwig KA, Mantyh CR, Ashton J, Yu D, Hurwitz HI) Int J Radiat Oncol Biol Phys 2007 Jun 01;68(2):472-8 133 Citations |
| 1 | Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. (Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Clin Cancer Res 2007 May 15;13(10):3100-4 46 Citations |
| 1 | Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. (Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C) J Pain Symptom Manage 2007 Sep;34(3):244-52 43 Citations |
| 1 | Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP et al.) Abdom Imaging 2007 May 24: |
| 1 | Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. (Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS) Clin Chem 2007 Jul;53(7):1273-9 61 Citations |
| 1 | Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. (Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH) Cancer 2007 Jul 01;110(1):47-55 241 Citations |
| 1 | Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid. (Ryan CW, Huo D, Bylow K, Demers LM, Stadler WM, Henderson TO, Vogelzang NJ) BJU Int 2007 Jul;100(1):70-5 51 Citations |
| 1 | Contemporary imaging for thyroid cancer. (Wang TS, Cheng DW, Udelsman R) Surg Oncol Clin N Am 2007 Apr;16(2):431-45 4 Citations |
| 1 | Psychosocial management of distress in interventional radiology patients with cancer. (Sims MJ, Rilling WS) Tech Vasc Interv Radiol 2006 Sep;9(3):101-5 8 Citations |
| 2 | Colorectal cancer screening among midwestern community-based residents: indicators of success. (Matthews BA, Nattinger AB, Venkatesan T, Shaker R) J Community Health 2007 Apr;32(2):103-20 9 Citations |
| 1 | Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. (Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC) J Clin Oncol 2007 Aug 01;25(22):3251-8 45 Citations |
| 1 | American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. (Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel) J Clin Oncol 2007 Sep 01;25(25):3991-4008 669 Citations |
| 2 | Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD) Biol Blood Marrow Transplant 2007 Jul;13(7):778-89 10 Citations |
| 1 | Quality of life in adult survivors of childhood cancer. (Sharp LK, Kinahan KE, Didwania A, Stolley M) J Pediatr Oncol Nurs 2007;24(4):220-6 21 Citations |
| 1 | Role of lymph node dissection in primary surgery for thyroid cancer. (Grubbs EG, Evans DB) J Natl Compr Canc Netw 2007 Jul;5(6):623-30 26 Citations |
| 1 | Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. (Sun Y, Sun D, Li F, Tian L, Li C, Li L, Lin R, Wang S) Lung Cancer 2007 Oct;58(1):21-9 68 Citations |
| 1 | A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. (Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG) Int J Gynecol Cancer 2008;18(3):400-6 37 Citations |
| 1 | Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. (Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, Rader JS, Mutch DG) Cancer 2007 Sep 15;110(6):1281-6 190 Citations |
| 1 | Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. (Mittendorf EA, Wang X, Perrier ND, Francis AM, Edeiken BS, Shapiro SE, Lee JE, Evans DB) J Am Coll Surg 2007 Aug;205(2):239-47 23 Citations |
| 1 | Sphincter-sparing resection for rectal cancer. (Ludwig KA) Clin Colon Rectal Surg 2007 Aug;20(3):203-12 19 Citations |
| 2 | Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. (Kotamraju S, Williams CL, Kalyanaraman B) Cancer Res 2007 Aug 01;67(15):7386-94 137 Citations |
| 1 | Future chemoradiation strategies in pancreatic cancer. (Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA) Semin Oncol 2007 Aug;34(4):335-46 28 Citations |
| 1 | B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. (Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED) Cancer Res 2007 Aug 15;67(16):7893-900 222 Citations |
| 1 | Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. (Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, Thomas JP, Fields AL, Mayer RJ) J Clin Oncol 2007 Aug 10;25(23):3456-61 401 Citations |
| 1 | Orthostatic intolerance in survivors of childhood cancer. (Terlou A, Ruble K, Stapert AF, Chang HC, Rowe PC, Schwartz CL) Eur J Cancer 2007 Dec;43(18):2685-90 4 Citations |
| 1 | Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer. (Wright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK) Gynecol Oncol 2007 Nov;107(2):280-4 3 Citations |
| 1 | Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C) Abdom Imaging 2007;32(5):660-7 67 Citations |
| 1 | Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots. (Xing Y, Smith AM, Agrawal A, Ruan G, Nie S) Int J Nanomedicine 2006;1(4):473-81 48 Citations |
| 1 | Red meat and colon cancer: heme proteins and nitrite in the gut. A commentary on "diet-induced endogenous formation of nitroso compounds in the GI tract". (Hogg N) Free Radic Biol Med 2007 Oct 01;43(7):1037-9 32 Citations |
| 1 | Risk factors for pancreatic cancer: case-control study. (Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D) Am J Gastroenterol 2007 Dec;102(12):2696-707 262 Citations |
| 1 | Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. (Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM) Ann Surg Oncol 2007 Dec;14(12):3481-91 357 Citations |
| 1 | Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. (Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK) Br J Cancer 2007 Oct 08;97(7):895-901 120 Citations |
| 1 | Interleukin-6 and its receptor in cancer: implications for translational therapeutics. (Hong DS, Angelo LS, Kurzrock R) Cancer 2007 Nov 01;110(9):1911-28 356 Citations |
| 1 | Erratum: Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways (Cancer Research (2007) 67, (7386-7394)) (Kotamraju S, Williams CL, Kalyanaraman B) Cancer Research 15 September 2007;67(18):8973 1 Citation |
| 1 | Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. (Khasabova IA, Stucky CL, Harding-Rose C, Eikmeier L, Beitz AJ, Coicou LG, Hanson AE, Simone DA, Seybold VS) J Neurosci 2007 Sep 19;27(38):10289-98 62 Citations |
| 1 | Basics of TGF-beta and pancreatic cancer. (Truty MJ, Urrutia R) Pancreatology 2007;7(5-6):423-35 139 Citations |
| 1 | Clinical benefit of palliative radiation therapy in advanced gastric cancer. (Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S) Acta Oncol 2008;47(3):421-7 87 Citations |
| 4 | Exploring the surgeon volume outcome relationship among women with breast cancer. (Nattinger AB, Laud PW, Sparapani RA, Zhang X, Neuner JM, Gilligan MA) Arch Intern Med 2007 Oct 08;167(18):1958-63 32 Citations |
| 1 | Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program. (Chung CH, Wong S, Ang KK, Hammond EH, Dicker AP, Harari PM, Le QT) Int J Radiat Oncol Biol Phys 2007;69(2 Suppl):S67-78 11 Citations |
| 1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE) Blood 2008 Jan 01;111(1):25-41 145 Citations |
| 1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2008 Jan 01;26(1):132-49 262 Citations |
| 1 | Surgical Therapy of Barrett's Esophagus and Cancer (Lal DR, Oelschlager BK) Barrett's Esophagus and Esophageal Adenocarcinoma: Second Edition 25 October 2007:222-235 |
| 1 | Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review. (Bylow K, Mohile SG, Stadler WM, Dale W) Cancer 2007 Dec 15;110(12):2604-13 107 Citations |
| 1 | Rectal cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2007 Oct;5(9):940-81 8 Citations |
| 1 | Colon cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, Fox Chase Cancer Center Partners) J Natl Compr Canc Netw 2007 Oct;5(9):884-925 10 Citations |
| 1 | Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. (Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Feb;34(2):180-4 5 Citations |
| 1 | XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. (Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D) Am J Gastroenterol 2008 Feb;103(2):360-7 68 Citations |
| 1 | Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. (Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, Reeve BB, Smith AW, Stone AA, Weinfurt K) J Clin Oncol 2007 Nov 10;25(32):5106-12 330 Citations |
| 1 | Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. (Hobbs JE, Zakarija A, Cundiff DL, Doll JA, Hymen E, Cornwell M, Crawford SE, Liu N, Signaevsky M, Soff GA) Thromb Res 2007;120 Suppl 2:S13-21 81 Citations |
| 1 | Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. (Tierney RM, Powell MA, Mutch DG, Gibb RK, Rader JS, Grigsby PW) Radiat Med 2007 Nov;25(9):439-45 15 Citations |
| 1 | Quantifying the role of PSA screening in the US prostate cancer mortality decline. (Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E) Cancer Causes Control 2008 Mar;19(2):175-81 340 Citations |
| 1 | The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. (Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD) J Clin Endocrinol Metab 2008 Feb;93(2):504-15 314 Citations |
| 1 | Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. (Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, Park JA, Kim MH) J Korean Med Sci 2007 Sep;22 Suppl(Suppl):S104-8 53 Citations |
| 1 | CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. (Zhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, Rader JS) Cancer Res 2007 Dec 01;67(23):11202-8 30 Citations |
| 1 | Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. (Solorzano CC, Evans DB) Surgery 2007 Dec;142(6):973-5 6 Citations |
| 1 | The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines. (Lyu MA, Kurzrock R, Rosenblum MG) Biochem Pharmacol 2008 Feb 15;75(4):836-46 19 Citations |
| 1 | Allogeneic hematopoietic cell transplantation for metastatic breast cancer. (Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D) Bone Marrow Transplant 2008 Mar;41(6):537-45 44 Citations |
| 1 | Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. (Reyes-Gibby CC, Spitz M, Wu X, Merriman K, Etzel C, Bruera E, Kurzrock R, Shete S) Cancer Epidemiol Biomarkers Prev 2007 Dec;16(12):2745-51 61 Citations |
| 1 | Cancer after renal transplantation. (Vasudev B, Hariharan S) Curr Opin Nephrol Hypertens 2007 Nov;16(6):523-8 50 Citations |
| 1 | Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital. (Shaw PH, Ritchey AK) J Pediatr Hematol Oncol 2007 Dec;29(12):811-4 54 Citations |
| 3 | TH‐C‐AUD C‐04: An Online Correction Method for Interfractional Variations in Head and Neck Cancer (Ahunbay E, Chen G, Peng C, Schultz C, Li X) Medical Physics June 2008;35(6):2972 |
| 1 | SU‐GG‐J‐113: Interfraction Dose Variations for Head and Neck Cancer Assessed Using Daily KVCT (Peng C, Ahunbay E, Wood C, Wang D, Li X) Medical Physics June 2008;35(6):2705 |
| 1 | Characterization of the CXCR4 signaling in pancreatic cancer cells. (Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K, Urrutia R) Int J Gastrointest Cancer 2006;37(4):110-9 55 Citations |
| 1 | Predicting cancer on excision of atypical ductal hyperplasia. (Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, Yao K) Am J Surg 2008 Mar;195(3):358-61; discussion 361-2 34 Citations |
| 1 | Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8 79 Citations |
| 1 | Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer. (Nguyen TT, Wright JD, Powell MA, Gibb RK, Rader JS, Allsworth JE, Mutch DG) Int J Gynecol Cancer 2008;18(6):1194-9 14 Citations |
| 2 | Direct evidence for epithelial-mesenchymal transitions in breast cancer. (Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, Ostrowski MC, Leone G) Cancer Res 2008 Feb 01;68(3):937-45 323 Citations |
| 1 | Cancer-associated stromal fibroblasts promote pancreatic tumor progression. (Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD) Cancer Res 2008 Feb 01;68(3):918-26 941 Citations |
| 1 | Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. (Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB) Ann Surg Oncol 2008 May;15(5):1356-66 56 Citations |
| 1 | Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides. (Cen P, Duvic M, Cohen PR, Kurzrock R) J Am Acad Dermatol 2008 Mar;58(3):382-6 6 Citations |
| 1 | Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer. (Yang Q, Feng Y, Schultz CJ, Li XA, Wu H, Wang D) Cancer Gene Ther 2008 May;15(5):323-30 10 Citations |
| 1 | A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer. (LoConte NK, Thomas JP, Alberti D, Heideman J, Binger K, Marnocha R, Utecht K, Geiger P, Eickhoff J, Wilding G, Kolesar J) Cancer Chemother Pharmacol 2008 Dec;63(1):109-15 18 Citations |
| 1 | Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. (Evans DB, Multidisciplinary Pancreatic Cancer Study Group) HPB (Oxford) 2006;8(5):365-8 25 Citations |
| 1 | The risk of gallbladder cancer from polyps in a large multiethnic series. (Aldouri AQ, Malik HZ, Waytt J, Khan S, Ranganathan K, Kummaraganti S, Hamilton W, Dexter S, Menon K, Lodge JP, Prasad KR, Toogood GJ) Eur J Surg Oncol 2009 Jan;35(1):48-51 77 Citations |
| 1 | Recent advances in thyroid cancer. In brief. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):149-51 3 Citations |
| 1 | Recent advances in thyroid cancer. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):156-250 60 Citations |
| 1 | Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. (Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R) Mol Cancer Ther 2008 Mar;7(3):464-73 409 Citations |
| 1 | C-reactive protein in liver cancer surgery. (Morris-Stiff G, Gomez D, Prasad KR) Eur J Surg Oncol 2008 Jul;34(7):727-9 73 Citations |
| 1 | Variability in reporting resection margin status in pancreatic cancer (Raut CP, Evans DB) Annals of Surgery April 2008;247(4):717-718 2 Citations |
| 1 | Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. (Okazaki T, Jiao L, Chang P, Evans DB, Abbruzzese JL, Li D) Clin Cancer Res 2008 Apr 01;14(7):2042-8 48 Citations |
| 1 | Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. (Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME) Cancer Res 2008 Apr 01;68(7):2489-97 57 Citations |
| 1 | Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. (Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S) Int J Radiat Oncol Biol Phys 2008 May 01;71(1):167-72 15 Citations |
| 1 | Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. (Hong D, Ye L, Gagel R, Chintala L, El Naggar AK, Wright J, Kurzrock R) Mol Cancer Ther 2008 May;7(5):1001-6 51 Citations |
| 1 | Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF) J Am Coll Surg 2008 May;206(5):833-46; discussion 846-8 724 Citations |
| 1 | Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. (Layfield LJ, Abrams J, Cochand-Priollet B, Evans D, Gharib H, Greenspan F, Henry M, LiVolsi V, Merino M, Michael CW, Wang H, Wells SA) Diagn Cytopathol 2008 Jun;36(6):442-8 86 Citations |
| 1 | Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers. (Rader JS, Aylsworth CF, Juckett DA, Mutch DG, Powell MA, Lippmann L, Dimitrov NV) Clin Cancer Res 2008 May 15;14(10):3089-97 8 Citations |
| 1 | The impact of IMC nodal drainage on primary breast cancer outcome. (Kong AL, Hunt KK, Yi M, Weatherspoon K, Bedrosian I, Tereffe W, Hwang R, Ross MI, Buchholz TA, Meric-Bernstam F) J Clin Oncol 2008 May 20;26(15_suppl):534 |
| 1 | Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. (Loisel-Meyer S, Foley R, Medin JA) Front Biosci 2008 May 01;13:3202-14 21 Citations |
| 1 | Association of family history with cancer recurrence and survival among patients with stage III colon cancer. (Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS) JAMA 2008 Jun 04;299(21):2515-23 73 Citations |
| 1 | The added value of multidisciplinary care for patients with pancreatic cancer. (Evans DB, Crane CH, Charnsangavej C, Wolff RA) Ann Surg Oncol 2008 Aug;15(8):2078-80 15 Citations |
| 1 | Brain metastases in very young patients with lung cancer are still brain metastases. (Gore EM) Onkologie 2008 Jun;31(6):297-8 1 Citation |
| 1 | Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. (Mosadegh B, Saadi W, Wang SJ, Jeon NL) Biotechnol Bioeng 2008 Aug 15;100(6):1205-13 62 Citations |
| 1 | Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. (Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG) Urology 2008 Aug;72(2):422-7 136 Citations |
| 1 | Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. (Li J, Olson LM, Zhang Z, Li L, Bidder M, Nguyen L, Pfeifer J, Rader JS) Int J Med Sci 2008 Jun 06;5(3):133-42 24 Citations |
| 2 | Expression and function of fatty acid amide hydrolase in prostate cancer. (Endsley MP, Thill R, Choudhry I, Williams CL, Kajdacsy-Balla A, Campbell WB, Nithipatikom K) Int J Cancer 2008 Sep 15;123(6):1318-26 84 Citations |
| 2 | Detection of medullary thyroid cancer: a focus on serum calcitonin levels. (Wang TS, Roman SA, Sosa JA) Expert Rev Endocrinol Metab 2008 Jul;3(4):493-501 1 Citation |
| 1 | Measuring post-traumatic growth in people diagnosed with hepatobiliary cancer: directions for future research. (Steel JL, Gamblin TC, Carr BI) Oncol Nurs Forum 2008 Jul;35(4):643-50 20 Citations |
| 3 | Behavior modification and risk perception in patients with nonmelanoma skin cancer. (Rhee JS, Davis-Malesevich M, Logan BR, Neuburg M, Burzynski M, Nattinger AB) WMJ 2008 Apr;107(2):62-8 25 Citations |
| 1 | Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. (Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L) Cancer Res 2008 Jul 01;68(13):5226-35 309 Citations |
| 1 | Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. (Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM) PLoS One 2008 Jul 02;3(7):e2557 654 Citations |
| 1 | Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. (Braiteh F, Kurzrock R, Johnson FM) J Clin Oncol 2008 Jul 10;26(20):3460-2 37 Citations |
| 1 | Phase II trial of curcumin in patients with advanced pancreatic cancer. (Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R) Clin Cancer Res 2008 Jul 15;14(14):4491-9 1213 Citations |
| 1 | Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3 4 Citations |
| 1 | Roles of Eicosanoids in Prostate Cancer. (Nithipatikom K, Campbell WB) Future Lipidol 2008 Aug 01;3(4):453-467 16 Citations |
| 1 | Molecular epidemiology, cancer-related symptoms, and cytokines pathway. (Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S) Lancet Oncol 2008 Aug;9(8):777-85 91 Citations |
| 1 | Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. (Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Cancer Lett 2008 Dec 08;272(1):32-9 12 Citations |
| 1 | Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. (Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC) Int J Radiat Oncol Biol Phys 2009 Mar 01;73(3):779-88 96 Citations |
| 1 | Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 53 Citations |
| 1 | Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches (Cancer Research (July 1, 2008) 68 (5226-5235)) (Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L) Cancer Research 1 September 2008;68(17):7246 1 Citation |
| 1 | A stochastic model for cancer stem cell origin in metastatic colon cancer. (Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, Gollin SM, Gamblin TC, Geller DA, Lagasse E) Cancer Res 2008 Sep 01;68(17):6932-41 140 Citations |
| 1 | Informed decision-making and colorectal cancer screening: is it occurring in primary care? (Ling BS, Trauth JM, Fine MJ, Mor MK, Resnick A, Braddock CH, Bereknyei S, Weissfeld JL, Schoen RE, Ricci EM, Whittle J) Med Care 2008 Sep;46(9 Suppl 1):S23-9 67 Citations |
| 1 | Effects of cancer treatment on ovarian function. (Stroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW) Fertil Steril 2009 Aug;92(2):417-27 83 Citations |
| 1 | Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. (Symes JC, Kurin M, Fleshner NE, Medin JA) Mol Cancer Ther 2008 Sep;7(9):3018-28 22 Citations |
| 1 | Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. (Overman MJ, Fogelman D, Al-Kali A, Crane CH, Evans D, Abdalla EK, Pisters P, Kopetz S, Eng C, Wolff RA) Clin Colorectal Cancer 2008 Sep;7(5):338-42 |
| 1 | Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. (Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO) Head Neck 2009 Mar;31(3):419-23 21 Citations |
| 1 | CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. (Lu C, Dong J, Ma H, Jin G, Hu Z, Peng Y, Guo X, Wang X, Shen H) Breast Cancer Res Treat 2009 Aug;116(3):571-5 29 Citations |
| 1 | Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. (Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT, Women's Health Initiative Investigators) Cancer Epidemiol Biomarkers Prev 2008 Oct;17(10):2609-18 83 Citations |
| 1 | Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. (Braiteh F, Soriano AO, Garcia-Manero G, Hong D, Johnson MM, Silva Lde P, Yang H, Alexander S, Wolff J, Kurzrock R) Clin Cancer Res 2008 Oct 01;14(19):6296-301 152 Citations |
| 1 | Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer. (Herzog TJ, Powell MA, Rader JS, Gibb RK, Lippmann L, Coleman RL, Mutch DG) Gynecol Oncol 2008 Dec;111(3):467-73 3 Citations |
| 1 | Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. (de la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR) J Gastrointest Surg 2009 Feb;13(2):269-74 55 Citations |
| 1 | Laparoscopic liver resection for cancer. (Nguyen KT, Gamblin TC, Geller DA) Future Oncol 2008 Oct;4(5):661-70 28 Citations |
| 1 | Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. (Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW) Gynecol Oncol 2009 Jan;112(1):104-9 93 Citations |
| 1 | Rehabilitation of dysphagia following head and neck cancer. (Pauloski BR) Phys Med Rehabil Clin N Am 2008 Nov;19(4):889-928, x 148 Citations |
| 1 | Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. (Pauloski BR, Rademaker AW, Lazarus C, Boeckxstaens G, Kahrilas PJ, Logemann JA) Dysphagia 2009 Jun;24(2):196-203 40 Citations |
| 2 | Solid cancers after allogeneic hematopoietic cell transplantation. (Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers ME, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ) Blood 2009 Jan 29;113(5):1175-83 423 Citations |
| 1 | SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. (Zhi H, Yang XJ, Kuhnmuench J, Berg T, Thill R, Yang H, See WA, Becker CG, Williams CL, Li R) J Pathol 2009 Feb;217(3):389-97 22 Citations |
| 1 | DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. (Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, De Marzo AM, Nelson WG) Cancer Res 2008 Nov 01;68(21):8954-67 244 Citations |
| 1 | Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment. (Trask CL, Welch JJ, Manley P, Jelalian E, Schwartz CL) Pediatr Blood Cancer 2009 Feb;52(2):273-9 20 Citations |
| 1 | The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. (Reyes-Gibby CC, El Osta B, Spitz MR, Parsons H, Kurzrock R, Wu X, Shete S, Bruera E) Cancer Epidemiol Biomarkers Prev 2008 Nov;17(11):3262-7 54 Citations |
| 1 | Calcium plus vitamin D supplementation and the risk of breast cancer. (Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators) J Natl Cancer Inst 2008 Nov 19;100(22):1581-91 383 Citations |
| 1 | Anal cancer and human papillomaviruses in heterosexual men. (Nyitray A) Curr Oncol 2008 Oct;15(5):204-5 8 Citations |
| 1 | Molecular biology of head and neck cancer: risks and pathways. (Stadler ME, Patel MR, Couch ME, Hayes DN) Hematol Oncol Clin North Am 2008 Dec;22(6):1099-124, vii 62 Citations |
| 1 | Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. (Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Ann Surg Oncol 2009 Feb;16(2):431-9 47 Citations |
| 1 | Clinical outcome following prostatic capsule- and seminal-sparing cystectomy for bladder cancer in 25 men. (Thorstenson A, O'connor RC, Ahonen R, Jonsson MN, Wijkstrom H, Akre O, Hosseini A, Wiklund NP, Henningsohn L) Scand J Urol Nephrol 2009;43(2):127-32 11 Citations |
| 1 | Premonitory symptoms preceding metastatic medullary thyroid cancer in multiple endocrine neoplasia type 2B: An exploratory analysis (Rich TA, Waguespack SG, Evans DB) Surgery December 2008;144(6):1052-1053 |
| 1 | A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening. (Rader JS, Malone JP, Gross J, Gilmore P, Brooks RA, Nguyen L, Crimmins DL, Feng S, Wright JD, Taylor N, Zighelboim I, Funk MC, Huettner PC, Ladenson JH, Gius D, Townsend RR) Proteomics Clin Appl 2008 Dec;2(12):1658-69 15 Citations |
| 1 | Cancer: the road to Amiens. (Stewart DJ, Kurzrock R) J Clin Oncol 2009 Jan 20;27(3):328-33 94 Citations |
| 1 | A weight loss intervention for African American breast cancer survivors, 2006. (Stolley MR, Sharp LK, Oh A, Schiffer L) Prev Chronic Dis 2009 Jan;6(1):A22 61 Citations |
| 1 | Mapping cancer for community engagement. (Beyer KM, Rushton G) Prev Chronic Dis 2009 Jan;6(1):A03 38 Citations |
| 1 | Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells. (Bass R, Perry B, Langenstroer P, Thrasher JB, Dennis KL, Tawfik O, Holzbeierlein J) J Urol 2009 Feb;181(2):615-9; discussion 619-20 24 Citations |
| 1 | Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells. (Symes JC, Siatskas C, Fowler DH, Medin JA) Cancer Gene Ther 2009 May;16(5):439-52 8 Citations |
| 1 | Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. (Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS) Int J Radiat Oncol Biol Phys 2009 Jul 15;74(4):1083-91 134 Citations |
| 1 | Biomarkers for detection of early ovarian cancer: Nosov et al (Massad LS, Parks L, Rimel BJ, Kizer N, Ogutha J) American Journal of Obstetrics and Gynecology June 2009;200(6):691-692 |
| 1 | Neurosurgical treatment of cancer pain (Hurley RW, Lenz FA) Cancer Pain: Assessment and Management, Second Edition 1 January 2009:329-340 |
| 2 | SU‐FF‐T‐591: Improvement of IMRT Plan Quality with Non‐Isocentric Beam Arrangement for Head and Neck Cancers (Chen G, Hu B, Qi S, Schultz C, Wang D, Li X) Medical Physics June 2009;36(6):2660 |
| 1 | General dietary management of liver cancer (Issa M, Saeian K) Nutrition, Diet Therapy, and the Liver 1 January 2009:231-245 |
| 1 | Response: Solid cancers after allogeneic hematopoietic cell transplantation (Rizzo JD, Curtis RE, Deeg HJ, Travis LB) Blood 2009;114(1):225-226 1 Citation |
| 1 | WE‐C‐BRC‐08: A Method to Evaluate Region‐Specific Pulmonary Function Using 4D CT Images for Lung Cancer Patients Undergoing Radiation Therapy (Zhong H, Fragoso M, Patel S, Ajlouni M, Movsas B, Chetty I) Medical Physics June 2009;36(6):2762 1 Citation |
| 2 | SU‐DD‐A3‐01: Swallowing‐Induced Target Motion and Dosimetric Impact for Head and Neck Cancer Radiotherapy as Assessed by Dynamic MRI (Paulson E, Bradley J, Ahunbay E, Wang D, li X) Medical Physics June 2009;36(6):2424 1 Citation |
| 1 | Pancreatic Cancer: State of the Art and Current Situation in the Islamic Republic of Iran (Kamgar M, Jamali A, Massarrat S, Sotoudeh M, Larijani B, Adler G, Seufferlein T) Govaresh Govaresh. 2009;14(3):189-197 |
| 1 | Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. (Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z) Clin Cancer Res 2009 Jan 01;15(1):400-5 86 Citations |
| 3 | The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research. (Lomberk G, Mathison AJ, Grzenda A, Urrutia R) Curr Opin Gastroenterol 2008 Sep;24(5):597-602 19 Citations |
| 1 | Chemical genomics of cancer chemopreventive dithiolethiones. (Tran QT, Xu L, Phan V, Goodwin SB, Rahman M, Jin VX, Sutter CH, Roebuck BD, Kensler TW, George EO, Sutter TR) Carcinogenesis 2009 Mar;30(3):480-6 22 Citations |
| 1 | Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation. (Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS) Gynecol Oncol 2009 Mar;112(3):553-7 16 Citations |
| 1 | Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. (Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan TH, Wang H) Cancer Res 2009 Feb 01;69(3):1063-70 30 Citations |
| 1 | Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. (Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M) BMC Cancer 2009 Jan 17;9:24 52 Citations |
| 1 | The changing face of phase 1 cancer clinical trials: new challenges in study requirements. (Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, Karp DD) Cancer 2009 Apr 15;115(8):1592-7 20 Citations |
| 1 | Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience. (Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, Feng L, Kurzrock R) Cancer 2009 Mar 01;115(5):1091-9 72 Citations |
| 1 | The integration of chemoradiation in the care of patient with localized pancreatic cancer. (Crane CH, Varadhachary G, Settle SH, Fleming JB, Evans DB, Wolff RA) Cancer Radiother 2009 Apr;13(2):123-43 16 Citations |
| 1 | A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. (Peng C, Kainz K, Lawton C, Li XA) Med Phys 2008 Dec;35(12):5619-28 25 Citations |
| 1 | Neoadjuvant Treatment of Pancreatic Cancer: Borderline-Resectable Disease (Varadhachary G, Crane CH, Tamm EP, Wang H, Wolff RA, Evans DB) The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery: Second Edition 4 February 2009:727-740 |
| 1 | Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells. (Benavente S, Huang S, Armstrong EA, Chi A, Hsu KT, Wheeler DL, Harari PM) Clin Cancer Res 2009 Mar 01;15(5):1585-92 84 Citations |
| 1 | Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. (Jeffery DD, Tzeng JP, Keefe FJ, Porter LS, Hahn EA, Flynn KE, Reeve BB, Weinfurt KP) Cancer 2009 Mar 15;115(6):1142-53 71 Citations |
| 4 | A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. (Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB) Ann Surg Oncol 2009 Apr;16(4):979-88 80 Citations |
| 1 | Breast cancer after use of estrogen plus progestin in postmenopausal women. (Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G, WHI Investigators) N Engl J Med 2009 Feb 05;360(6):573-87 413 Citations |
| 1 | Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward W, White JR, Radiation Therapy Oncology Group Multi-Institutional and Multiobserver Study) Int J Radiat Oncol Biol Phys 2009 Mar 01;73(3):944-51 333 Citations |
| 1 | Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. (Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D) J Clin Oncol 2009 Apr 01;27(10):1592-9 45 Citations |
| 1 | Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteome. (Symes J, Evangelou A, Ignatchenko A, Fleshner N, Kislinger T, Medin JA) Proteomics Clin Appl 2009 Mar;3(3):347-58 |
| 1 | Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. (Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM) J Clin Oncol 2009 Apr 01;27(10):1557-63 49 Citations |
| 1 | Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. (Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ) Clin Cancer Res 2009 Mar 15;15(6):2174-80 74 Citations |
| 1 | Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 92 Citations |
| 1 | Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study. (Fortune BE, Li X, Kosuri KV, Weatherby LM, Thomas JP, Bekaii-Saab TS) Oncology 2009;76(5):333-7 21 Citations |
| 1 | Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. (Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD) Ann Thorac Surg 2009 Apr;87(4):1048-54; discussion 1054-5 235 Citations |
| 1 | Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. (Franco TH, Khan A, Joshi V, Thomas B) Ther Clin Risk Manag 2008 Dec;4(6):1367-70 50 Citations |
| 1 | Globalization: exporting the risk of pancreatic cancer to the West? (Urrutia R) Pancreatology 2009;9(1-2):III-IV 1 Citation |
| 1 | Method of breast cancer presentation and depressed mood 1 year after diagnosis in women with locally advanced disease. (Roth EB, Jeffe DB, Margenthaler JA, Aft RL) Ann Surg Oncol 2009 Jun;16(6):1637-41 2 Citations |
| 1 | Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. (Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD) Ann Surg Oncol 2009 Jul;16(7):1736-44 192 Citations |
| 1 | Cardiac arrest during laparotomy with argon beam coagulation of metastatic ovarian cancer. (Kizer N, Zighelboim I, Rader JS) Int J Gynecol Cancer 2009 Feb;19(2):237-8 4 Citations |
| 3 | Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. (George B, Wirostko WJ, Connor TB, Choong NW) J Thorac Oncol 2009 May;4(5):661-2 35 Citations |
| 1 | Pediatric Gynecologic Cancer (Bradley W, Rahaman J) Pediatric, Adolescent, & Young Adult Gynecology 6 May 2009:390-396 |
| 1 | Cancer's craving for sugar: an opportunity for clinical exploitation. (Yeluri S, Madhok B, Prasad KR, Quirke P, Jayne DG) J Cancer Res Clin Oncol 2009 Jul;135(7):867-77 48 Citations |
| 1 | Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience. (Vemulapalli S, Chintala L, Tsimberidou AM, Dhillon N, Lei X, Hong D, Kurzrock R) Am J Hematol 2009 Jul;84(7):408-13 13 Citations |
| 1 | Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB. (Melisi D, Niu J, Chang Z, Xia Q, Peng B, Ishiyama S, Evans DB, Chiao PJ) Mol Cancer Res 2009 May;7(5):624-33 82 Citations |
| 1 | Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. (Miller TW, Pérez-Torres M, Narasanna A, Guix M, Stål O, Pérez-Tenorio G, Gonzalez-Angulo AM, Hennessy BT, Mills GB, Kennedy JP, Lindsley CW, Arteaga CL) Cancer Res 2009 May 15;69(10):4192-201 152 Citations |
| 1 | WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer. (Mohile SG et al.) Crit Rev Oncol Hematol 2009 May 14: |
| 1 | Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. (de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT) Bone Marrow Transplant 2009 Jul;44(2):81-7 9 Citations |
| 1 | CD83 polymorphisms and cervical cancer risk. (Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A) Gynecol Oncol 2009 Aug;114(2):319-22 19 Citations |
| 1 | A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214. (Gore EM, Bae K, Wong S, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Werner-Wasik M, Choy H) J Clin Oncol 2009 May 20;27(15_suppl):7506 |
| 1 | Thyroid cancer in young adults. (Ying AK, Huh W, Bottomley S, Evans DB, Waguespack SG) Semin Oncol 2009 Jun;36(3):258-74 17 Citations |
| 1 | Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer. (Owen JB, White JR, Zelefsky MJ, Wilson JF) J Am Coll Radiol 2009 Jun;6(6):442-7 16 Citations |
| 1 | ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. (Zighelboim I, Schmidt AP, Gao F, Thaker PH, Powell MA, Rader JS, Gibb RK, Mutch DG, Goodfellow PJ) J Clin Oncol 2009 Jul 01;27(19):3091-6 56 Citations |
| 1 | Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. (Kidd EA, Spencer CR, Huettner PC, Siegel BA, Dehdashti F, Rader JS, Grigsby PW) Cancer 2009 Aug 01;115(15):3548-54 77 Citations |
| 1 | Medullary thyroid cancer: management guidelines of the American Thyroid Association. (American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr) Thyroid 2009 Jun;19(6):565-612 1125 Citations |
| 1 | Automated registration of large deformations for adaptive radiation therapy of prostate cancer. (Godley A, Ahunbay E, Peng C, Li XA) Med Phys 2009 Apr;36(4):1433-41 53 Citations |
| 1 | Discussion: 'Biomarkers for detection of early ovarian cancer' by Nosov et al. (Massad LS, Parks L, Rimel BJ, Kizer N, Ogutha J) Am J Obstet Gynecol 2009 Jun;200(6):e1-3 |
| 1 | Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. (Zhou X, Han S, Wang S, Chen X, Dong J, Shi X, Xia Y, Wang X, Hu Z, Shen H) Gynecol Oncol 2009 Aug;114(2):327-31 28 Citations |
| 1 | A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. (Moulder S, Dhillon N, Ng C, Hong D, Wheler J, Naing A, Tse S, La Paglia A, Dorr R, Hersh E, Boytim M, Kurzrock R) Invest New Drugs 2010 Oct;28(5):634-40 32 Citations |
| 1 | Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. (Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y, Dong J, Chen F, Wang X, Shen H) Eur J Hum Genet 2009 Dec;17(12):1668-75 93 Citations |
| 1 | Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications. (Guturu P, Shah V, Urrutia R) J Gastrointest Cancer 2009;40(1-2):1-9 16 Citations |
| 1 | Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. (Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK) Mol Cancer Ther 2009 Jun;8(6):1596-605 57 Citations |
| 1 | Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. (Mach CM, Mathew L, Mosley SA, Kurzrock R, Smith JA) Anticancer Res 2009 Jun;29(6):1895-9 56 Citations |
| 1 | Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. (Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC) Clin Cancer Res 2009 Jul 15;15(14):4712-21 77 Citations |
| 1 | HPV screening for cervical cancer in rural India. (Cremer ML, Conlisk E, Felix JC) N Engl J Med 2009 Jul 16;361(3):305; author reply 306 5 Citations |
| 1 | Approaches to measure sleep-wake disturbances in adolescents with cancer. (Erickson JM) J Pediatr Nurs 2009 Aug;24(4):255-69 11 Citations |
| 1 | Project Zero Delay: a process for accelerating the activation of cancer clinical trials. (Kurzrock R, Pilat S, Bartolazzi M, Sanders D, Van Wart Hood J, Tucker SD, Webster K, Mallamaci MA, Strand S, Babcock E, Bast RC Jr) J Clin Oncol 2009 Sep 10;27(26):4433-40 18 Citations |
| 1 | Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. (Fortune-Greeley AK, Flynn KE, Jeffery DD, Williams MS, Keefe FJ, Reeve BB, Willis GB, Weinfurt KP, PROMIS Sexual Function Domain Committee) Qual Life Res 2009 Oct;18(8):1085-93 47 Citations |
| 1 | Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. (Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH) Int J Radiat Oncol Biol Phys 2010 May 01;77(1):60-5 93 Citations |
| 1 | Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. (Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, Kurzrock R) Cancer 2009 Nov 15;115(22):5309-18 257 Citations |
| 1 | Dual LOX/COX inhibitors: potential novel anti-cancer drugs. (Vijayakrishnan R) Ir J Med Sci 2009 Dec;178(4):517 2 Citations |
| 1 | Design and recruitment of the Chicago Healthy Living Study: a study of health behaviors in a diverse cohort of adult childhood cancer survivors. (Stolley MR, Sharp LK, Arroyo C, Ruffin C, Restrepo J, Campbell R) Cancer 2009 Sep 15;115(18 Suppl):4385-96 10 Citations |
| 1 | Use of 16s rRNA Gene Sequencing to Identify a Case of Pediococcus parvulus Bacteremia in a Patient with Metastatic Testicular Cancer (Figueroa Castro CE, Knezetic JA, Cavalieri SJ) LabMedicine LabMedicine 2010;41:93-95 |
| 1 | NCCN Clinical Practice Guidelines in Oncology: colon cancer. (Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer Network) J Natl Compr Canc Netw 2009 Sep;7(8):778-831 324 Citations |
| 1 | Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. (Li N, Dong J, Hu Z, Shen H, Dai M) Breast Cancer Res Treat 2010 May;121(1):177-84 48 Citations |
| 1 | Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. (Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA, Women's Health Initiative Investigators) Lancet 2009 Oct 10;374(9697):1243-51 281 Citations |
| 1 | TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. (Li Z, Chang Z, Chiao LJ, Kang Y, Xia Q, Zhu C, Fleming JB, Evans DB, Chiao PJ) Cancer Res 2009 Oct 01;69(19):7851-9 45 Citations |
| 1 | Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. (Whelan KF, Stratton K, Kawashima T, Waterbor JW, Castleberry RP, Stovall M, Sklar CA, Packer RJ, Mitby P, Aitken CL, Blatt J, Robison LL, Mertens AC) Pediatr Blood Cancer 2010 Jan;54(1):103-9 81 Citations |
| 1 | The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. (Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, Wingard JR) Biol Blood Marrow Transplant 2010 Feb;16(2):207-14 62 Citations |
| 1 | Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. (Nguyen KT, Laurent A, Dagher I, Geller DA, Steel J, Thomas MT, Marvin M, Ravindra KV, Mejia A, Lainas P, Franco D, Cherqui D, Buell JF, Gamblin TC) Ann Surg 2009 Nov;250(5):842-8 215 Citations |
| 1 | Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience. (Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, Kurzrock R) J Clin Endocrinol Metab 2009 Nov;94(11):4423-32 30 Citations |
| 1 | Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts. (Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS) Clin Cancer Res 2009 Oct 15;15(20):6358-66 39 Citations |
| 2 | Emerging roles of E2Fs in cancer: an exit from cell cycle control. (Chen HZ, Tsai SY, Leone G) Nat Rev Cancer 2009 Nov;9(11):785-97 834 Citations |
| 1 | Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. (Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE) Nat Protoc 2009;4(11):1670-80 326 Citations |
| 1 | Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Grigsby PW) Int J Radiat Oncol Biol Phys 2010 Jul 15;77(4):1085-91 179 Citations |
| 1 | Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. (Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz DL) Head Neck 2010 Jul;32(7):829-36 78 Citations |
| 2 | The economic consequences of breast cancer adjuvant hormonal treatments. (Pezzin LE, O'Niel MB, Nattinger AB) J Gen Intern Med 2009 Nov;24 Suppl 2(Suppl 2):S446-50 25 Citations |
| 1 | Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. (Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK) Mol Cancer Ther 2009 Nov;8(11):3117-29 203 Citations |
| 1 | Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. (Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, Dong J, Wang X, Shen H, Hu Z) J Cancer Res Clin Oncol 2010 May;136(5):709-16 54 Citations |
| 2 | Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. (Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS) Gynecol Oncol 2010 Mar;116(3):539-43 34 Citations |
| 1 | Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells. (Miller TW, Forbes JT, Shah C, Wyatt SK, Manning HC, Olivares MG, Sanchez V, Dugger TC, de Matos Granja N, Narasanna A, Cook RS, Kennedy JP, Lindsley CW, Arteaga CL) Clin Cancer Res 2009 Dec 01;15(23):7266-76 115 Citations |
| 1 | Hematological issues in critically ill patients with cancer. (Carlson KS, DeSancho MT) Crit Care Clin 2010 Jan;26(1):107-32 17 Citations |
| 1 | Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. (Marshall CL, Lee JE, Xing Y, Perrier ND, Edeiken BS, Evans DB, Grubbs EG) Surgery 2009 Dec;146(6):1063-72 32 Citations |
| 1 | Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 5 Citations |
| 1 | Recent advances in the surgical management of cervical cancer. (Zakashansky K, Bradley WH, Chuang L, Rahaman J, Dottino P) Mt Sinai J Med 2009 Dec;76(6):567-76 13 Citations |
| 1 | Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)). (Flynn KE, Shelby RA, Mitchell SA, Fawzy MR, Hardy NC, Husain AM, Keefe FJ, Krystal AD, Porter LS, Reeve BB, Weinfurt KP) Psychooncology 2010 Oct;19(10):1086-93 25 Citations |
| 1 | 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. (Showalter TN, Miller TR, Huettner P, Rader J, Grigsby PW) Int J Gynecol Cancer 2009 Nov;19(8):1412-4 32 Citations |
| 1 | "Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer. (Zighelboim I, Kizer N, Taylor NP, Case AS, Gao F, Thaker PH, Rader JS, Massad LS, Mutch DG, Powell MA) Gynecol Oncol 2010 Mar;116(3):370-3 54 Citations |
| 1 | Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). (Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE) Leukemia 2010 Feb;24(2):320-34 266 Citations |
| 1 | Pterostilbene inhibits lung cancer through induction of apoptosis. (Schneider JG, Alosi JA, McDonald DE, McFadden DW) J Surg Res 2010 Jun 01;161(1):18-22 68 Citations |
| 1 | Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. (Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW) J Surg Res 2010 Jun 15;161(2):195-201 89 Citations |
| 2 | SU‐GG‐T‐509: Development of a Database and Software Tools for Outcome Analysis of Breast Cancer Radiotherapy (Prior P, Chen G, White J, li X) Medical Physics June 2010;37(6):3304 |
| 3 | SU‐GG‐J‐113: Considering Respiration Motion in Radiation Treatment Planning for Pancreatic Cancers (Liang Z, Tai A, Erickson B, Kelly T, li X) Medical Physics June 2010;37(6):3171 |
| 1 | SU‐GG‐J‐43: Accumulating Delivered Doses Based on Daily CT in Head and Neck Cancer Radiotherapy (hu B, Godley A, Ahunbay E, Wang K, li X) Medical Physics June 2010;37(6):3154 |
| 4 | SU‐GG‐T‐23: Feasibility of an Online Adaptive Replanning Scheme for Pancreatic Cancer Radiotherapy (Peng C, Liu F, Ahunbay E, Tai A, Erickson B, Kelly T, li X) Medical Physics June 2010;37(6):3188 |
| 2 | SU‐GG‐J‐136: High Fidelity, Low Distortion Diffusion‐Weighted MRI for Head and Neck Cancer Radiotherapy Planning (Paulson E, Ahunbay E, li X) Medical Physics June 2010;37(6):3177 |
| 1 | Candidate variants at 6p21.33 and 6p22.1 and risk of non-small cell lung cancer in a Chinese population. (Zhang M, Hu L, Shen H, Dong J, Shu Y, Xu L, Jin G, Tian T, Hu Z, Shen H) Int J Mol Epidemiol Genet 2010;1(1):11-8 |
| 1 | Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer (Liss MA, Schlicht M, Kahler A, Fitzgerald R, Thomassi T, Degueme A, Hessner M, Datta MW) Cancer Genomics and Proteomics September-October 2010;7(5):245-252 21 Citations |
| 1 | Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases. (Cho SW, Kitisin K, Buck D, Steel J, Brufsky A, Gillespie R, Tsung A, Marsh JW, Geller DA, Gamblin TC) Int J Surg Oncol 2010;2010:251621 |
| 1 | Dosimetric impact of surgical clips in electron beam treatment of breast cancer. (Gossman MS, Zhao L, Cao M, Lopez JP, Das IJ) Med Dosim 2010;35(2):85-6 3 Citations |
| 1 | Use of 16s rRNA gene sequencing to identify a case of Pediococcus parvulus bacteremia in a patient with metastatic testicular cancer (Figueroa Castro CE, Knezetic JA, Cavalieri SJ) Laboratory Medicine February 2010;41(2):93-95 2 Citations |
| 1 | ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? (Famakinwa OM, Roman SA, Wang TS, Sosa JA) Am J Surg 2010 Feb;199(2):189-98 39 Citations |
| 1 | A microRNA expression signature for cervical cancer prognosis. (Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X) Cancer Res 2010 Feb 15;70(4):1441-8 278 Citations |
| 1 | Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience. (Wheler J, Tsimberidou AM, Moulder S, Cristofanilli M, Hong D, Naing A, Pathak R, Liu S, Feng L, Kurzrock R) Clin Breast Cancer 2010 Feb;10(1):46-51 |
| 1 | Pterostilbene inhibits pancreatic cancer in vitro. (Mannal PW, Alosi JA, Schneider JG, McDonald DE, McFadden DW) J Gastrointest Surg 2010 May;14(5):873-9 56 Citations |
| 1 | To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States. (Wang TS, Cheung K, Mehta P, Roman SA, Walker HD, Sosa JA) J Clin Endocrinol Metab 2010 Apr;95(4):1672-80 39 Citations |
| 1 | A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population. (Zhang M, Hu Z, Huang J, Shu Y, Dai J, Jin G, Tang R, Dong J, Chen Y, Xu L, Huang X, Shen H) Clin Cancer Res 2010 Feb 15;16(4):1236-44 39 Citations |
| 1 | Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. (Stinchcombe TE, Gore EM) Oncologist 2010;15(2):187-95 87 Citations |
| 2 | Management of borderline resectable pancreatic cancer. (Lal A, Christians K, Evans DB) Surg Oncol Clin N Am 2010 Apr;19(2):359-70 9 Citations |
| 1 | Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. (Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB) Ann Surg Oncol 2010 Jul;17(7):1794-801 134 Citations |
| 1 | TP53, MDM2, NQO1, and susceptibility to cervical cancer. (Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS) Cancer Epidemiol Biomarkers Prev 2010 Mar;19(3):755-61 51 Citations |
| 1 | Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. (Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R) Cancer Chemother Pharmacol 2010 Nov;66(6):1087-93 16 Citations |
| 1 | Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. (Nechuta S, Paneth N, Velie EM) Cancer Causes Control 2010 Jul;21(7):967-89 75 Citations |
| 1 | Evaluation of a survivorship educational program for adolescent and young adult survivors of childhood cancer. (Bingen K, Kupst MJ) J Cancer Educ 2010 Dec;25(4):530-7 19 Citations |
| 1 | Stereotactic body radiation therapy for inoperable early stage lung cancer. (Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H) JAMA 2010 Mar 17;303(11):1070-6 2171 Citations |
| 1 | Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW) J Clin Oncol 2010 Apr 20;28(12):2108-13 268 Citations |
| 1 | Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. (Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z, Lynch PM, Moyer MP, Wen XF, Wu X) Nature 2010 Apr 15;464(7291):1058-61 127 Citations |
| 1 | Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience. (Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka D, Coleman R, Lu K, Xiao L, Kurzrock R) Gynecol Oncol 2010 Jun;117(3):467-72 14 Citations |
| 1 | Late effects in adult survivors of childhood cancer: Considerations for the general practitioner. (Schmidt, D., Anderson, L., Bingen, K., Hoag, J., Kupst, M.J., & Warwick, A.B. ) Wisconsin Medical Journal 109(2):98-107 |
| 1 | In the clinic. Breast cancer screening and prevention. (Nattinger AB) Ann Intern Med 2010 Apr 06;152(7):ITC41 14 Citations |
| 1 | Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. (Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) J Clin Oncol 2010 May 10;28(14):2475-80 130 Citations |
| 5 | Elderly breast cancer survivors accurately self-report key treatment information. (Yen TW, Sparapani RA, Guo C, Neuner JM, Laud PW, Nattinger AB) J Am Geriatr Soc 2010 Feb;58(2):410-2 12 Citations |
| 1 | A molecularly targeted theranostic probe for ovarian cancer. (Chen W, Bardhan R, Bartels M, Perez-Torres C, Pautler RG, Halas NJ, Joshi A) Mol Cancer Ther 2010 Apr;9(4):1028-38 80 Citations |
| 1 | Antitumor effects on primary tumor and metastatic lymph nodes by superselective intra-arterial concurrent chemoradiotherapy for oral cancer. (Uehara M, Shiraishi T, Tobita T, Nonaka M, Asahina I) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Aug;110(2):172-7 8 Citations |
| 1 | Multiple health behavior changes in a cancer prevention intervention for construction workers, 2001-2003. (Harley AE, Devine CM, Beard B, Stoddard AM, Hunt MK, Sorensen G) Prev Chronic Dis 2010 May;7(3):A55 26 Citations |
| 1 | Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population. (Dong J, Dai J, Shu Y, Pan S, Xu L, Chen W, Wang Y, Jin G, Ma H, Zhang M, Hu Z, Shen H) Carcinogenesis 2010 Jun;31(6):1080-6 35 Citations |
| 1 | Equipoise lost: ethics, costs, and the regulation of cancer clinical research. (Stewart DJ, Whitney SN, Kurzrock R) J Clin Oncol 2010 Jun 10;28(17):2925-35 92 Citations |
| 1 | When to stop screening: a review of breast, gynecologic, and colorectal cancer screening in women over age 65. (Bernstein R, DeJoseph D, Buchanan EM) Care Manag J 2010;11(1):48-57 6 Citations |
| 4 | Late effects in adult survivors of childhood cancer: considerations for the general practitioner. (Schmidt D, Anderson L, Bingen K, Hoag J, Kupst MJ, Warwick AB) WMJ 2010 Apr;109(2):98-107 13 Citations |
| 1 | A systematic review of dental disease in patients undergoing cancer therapy. (Hong CH, Napeñas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)) Support Care Cancer 2010 Aug;18(8):1007-21 203 Citations |
| 1 | [Relationship between polymorphisms of X-ray repair cross-complementing group 1 gene Arg194Trp, Arg399Gln and susceptibility of breast cancer]. (Qian Y, Zhang JP, Dong J, Wang FR, Lin YD, Xu M, Wu LL, Shi P, Shen HB) Zhonghua Yu Fang Yi Xue Za Zhi 2010 Mar;44(3):242-6 7 Citations |
| 1 | A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. (Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) Int J Radiat Oncol Biol Phys 2010 Jun 01;77(2):367-72 115 Citations |
| 1 | Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. (Herbst RS, Eckhardt SG, Kurzrock R, Ebbinghaus S, O'Dwyer PJ, Gordon MS, Novotny W, Goldwasser MA, Tohnya TM, Lum BL, Ashkenazi A, Jubb AM, Mendelson DS) J Clin Oncol 2010 Jun 10;28(17):2839-46 395 Citations |
| 1 | Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. (Steel JL, Kim KH, Dew MA, Unruh ML, Antoni MH, Olek MC, Geller DA, Carr BI, Butterfield LH, Gamblin TC) J Pain Symptom Manage 2010 May;39(5):859-71 52 Citations |
| 1 | Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. (Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium) Int J Radiat Oncol Biol Phys 2011 Feb 01;79(2):348-55 380 Citations |
| 1 | Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment. (Garrido-Laguna I, Janku F, Falchook GS, Fu S, Hong DS, Naing A, Aaron J, Wang X, Kies M, Kurzrock R) Clin Cancer Res 2010 Aug 01;16(15):4031-7 15 Citations |
| 1 | Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. (Miller TW, Hennessy BT, González-Angulo AM, Fox EM, Mills GB, Chen H, Higham C, García-Echeverría C, Shyr Y, Arteaga CL) J Clin Invest 2010 Jul;120(7):2406-13 465 Citations |
| 1 | Salirasib in the treatment of pancreatic cancer. (Bustinza-Linares E, Kurzrock R, Tsimberidou AM) Future Oncol 2010 Jun;6(6):885-91 45 Citations |
| 1 | Use of cross species genomic profiling identifies pathways and genes differentially regulated in prostate cancer cells treated with soy protein isolates or purified genistein. (Liss MA, Schlicht M, Degueme A, Hessner M, Datta MW) Cancer Genomics Proteomics 2010;7(3):111-28 5 Citations |
| 1 | Targeted therapy in non-small-cell lung cancer--is it becoming a reality? (Janku F, Stewart DJ, Kurzrock R) Nat Rev Clin Oncol 2010 Jul;7(7):401-14 247 Citations |
| 1 | Diet and physical activity in childhood cancer survivors: a review of the literature. (Stolley MR, Restrepo J, Sharp LK) Ann Behav Med 2010 Jun;39(3):232-49 108 Citations |
| 1 | Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. (Hui D, Parsons H, Nguyen L, Palla SL, Yennurajalingam S, Kurzrock R, Bruera E) Cancer 2010 Sep 15;116(18):4402-9 53 Citations |
| 1 | Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells. (Arthan D, Hong SK, Park JI) Cancer Lett 2010 Nov 01;297(1):31-41 45 Citations |
| 1 | Cancer information sources used by patients to inform and influence treatment decisions. (Walsh MC, Trentham-Dietz A, Schroepfer TA, Reding DJ, Campbell B, Foote ML, Kaufman S, Barrett M, Remington PL, Cleary JF) J Health Commun 2010 Jun;15(4):445-63 84 Citations |
| 3 | The relationship of health numeracy to cancer screening. (Schapira MM, Neuner J, Fletcher KE, Gilligan MA, Hayes E, Laud P) J Cancer Educ 2011 Mar;26(1):103-10 16 Citations |
| 1 | Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis. (Dong J, Dai J, Zhang M, Hu Z, Shen H) J Gastroenterol Hepatol 2010 Jun;25(6):1042-50 51 Citations |
| 1 | Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. (Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ) Int J Radiat Oncol Biol Phys 2011 Apr 01;79(5):1343-9 32 Citations |
| 1 | Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents. (Konson A, Pradeep S, Seger R) Cancer Res 2010 Aug 01;70(15):6247-57 33 Citations |
| 1 | A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer. (Lubner SJ, Loconte NK, Holen KD, Schelman W, Thomas JP, Jumonville A, Eickhoff JC, Seo S, Mulkerin DL) Clin Colorectal Cancer 2010 Jul;9(3):157-61 7 Citations |
| 2 | The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1394-9 29 Citations |
| 1 | Higher physician density is associated with lower incidence of late-stage colorectal cancer. (Ananthakrishnan AN, Hoffmann RG, Saeian K) J Gen Intern Med 2010 Nov;25(11):1164-71 65 Citations |
| 1 | Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. (Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, Zhang S, Fang F, Lan X, Li M, Kennedy B, Bigsby RM, Huang TH, Nephew KP) Epigenetics 2010;5(8):716-29 41 Citations |
| 1 | International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. (Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, Champagne B, Heriot AG, Leblanc F, Delaney CP, International Rectal Cancer Study Group (IRCSG)) World J Surg 2010 Nov;34(11):2689-700 85 Citations |
| 1 | A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma. (Drake PM, Schilling B, Niles RK, Braten M, Johansen E, Liu H, Lerch M, Sorensen DJ, Li B, Allen S, Hall SC, Witkowska HE, Regnier FE, Gibson BW, Fisher SJ) Anal Biochem 2011 Jan 01;408(1):71-85 57 Citations |
| 2 | Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. (Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):909-14 65 Citations |
| 1 | Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Lundy D, Bernstein M, McBreen C, Santa D, Campanelli A, Kelchner L, Klaben B, Discekici-Harris M) Head Neck 2011 Jun;33(6):774-9 18 Citations |
| 1 | Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. (Vaklavas C, Tsimberidou AM, Wen S, Hong D, Wheler J, Ng CS, Naing A, Uehara C, Wolff RA, Kurzrock R) Cancer 2011 Jan 01;117(1):77-85 7 Citations |
| 2 | Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 61 Citations |
| 2 | The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. (Rao VA, Klein SR, Bonar SJ, Zielonka J, Mizuno N, Dickey JS, Keller PW, Joseph J, Kalyanaraman B, Shacter E) J Biol Chem 2010 Nov 05;285(45):34447-59 126 Citations |
| 1 | The underrecognized role of impaired muscle function in cancer-related fatigue. (Ng AV) J Support Oncol 2010;8(4):177-8 3 Citations |
| 5 | Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. (Yen TW, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, Nattinger AB) Cancer 2011 Jan 15;117(2):398-405 19 Citations |
| 1 | A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. (Naing A, Kurzrock R, Adams LM, Kleha JF, Laubscher KH, Bonate PL, Weller S, Fitzgerald C, Xu Y, LoRusso PM) Invest New Drugs 2012 Feb;30(1):327-34 17 Citations |
| 1 | HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. (Martin MP, Borecki IB, Zhang Z, Nguyen L, Ma D, Gao X, Qi Y, Carrington M, Rader JS) Immunogenetics 2010 Dec;62(11-12):761-5 32 Citations |
| 1 | A population-based case-control study of fetal growth, gestational age, and maternal breast cancer. (Nechuta S, Paneth N, Pathak DR, Gardiner J, Copeland G, Velie EM) Am J Epidemiol 2010 Oct 15;172(8):962-70 4 Citations |
| 1 | Differentiated thyroid cancer: an update. (Wang TS, Roman SA, Sosa JA) Curr Opin Oncol 2011 Jan;23(1):7-12 6 Citations |
| 1 | Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. (Cheng YC, Valero V, Davis ML, Green MC, Gonzalez-Angulo AM, Theriault RL, Murray JL, Hortobagyi GN, Ueno NT) Br J Cancer 2010 Oct 26;103(9):1331-4 8 Citations |
| 1 | A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer. (Moore AM, Gamblin TC, Geller DA, Youssef MN, Hoffman KE, Gemmell L, Likumahuwa SM, Bovbjerg DH, Marsland A, Steel JL) Psychooncology 2011 May;20(5):479-87 75 Citations |
| 1 | Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). (Flynn KE, Jeffery DD, Keefe FJ, Porter LS, Shelby RA, Fawzy MR, Gosselin TK, Reeve BB, Weinfurt KP) Psychooncology 2011 Apr;20(4):378-86 125 Citations |
| 1 | Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. (Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H) J Thorac Oncol 2010 Nov;5(11):1748-54 |
| 1 | Does obesity impact lymph node retrieval in colon cancer surgery? (Linebarger JH, Mathiason MA, Kallies KJ, Shapiro SB) Am J Surg 2010 Oct;200(4):478-82 38 Citations |
| 1 | Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. (Hu Z, Shu Y, Chen Y, Chen J, Dong J, Liu Y, Pan S, Xu L, Xu J, Wang Y, Dai J, Ma H, Jin G, Shen H) Am J Respir Crit Care Med 2011 Mar 01;183(5):641-8 52 Citations |
| 1 | Therapeutic targeting of C-terminal binding protein in human cancer. (Straza MW, Paliwal S, Kovi RC, Rajeshkumar B, Trenh P, Parker D, Whalen GF, Lyle S, Schiffer CA, Grossman SR) Cell Cycle 2010 Sep 15;9(18):3740-50 56 Citations |
| 1 | Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. (Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1292-300 129 Citations |
| 3 | Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. (Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G) Blood 2011 Jan 06;117(1):316-22 179 Citations |
| 1 | Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. (Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, Alaoui-Jamali MA) J Exp Med 2010 Oct 25;207(11):2421-37 142 Citations |
| 1 | Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement. (Tsimberidou AM, Letourneau K, Fu S, Hong D, Naing A, Wheler J, Uehara C, McRae SE, Wen S, Kurzrock R) Cancer Chemother Pharmacol 2011 Jul;68(1):247-53 19 Citations |
| 1 | Non-surgical management of stage I lung cancer. (Gore EM) F1000 Med Rep 2010 Mar 25;2 1 Citation |
| 1 | Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer. (Liss MA, Schlicht M, Kahler A, Fitzgerald R, Thomassi T, Degueme A, Hessner M, Datta MW) Cancer Genomics Proteomics 2010;7(5):245-52 |
| 1 | Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. (Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, WHI Investigators) JAMA 2010 Oct 20;304(15):1684-92 471 Citations |
| 1 | Explaining place-based colorectal cancer health disparities: evidence from a rural context. (Beyer KM, Comstock S, Seagren R, Rushton G) Soc Sci Med 2011 Feb;72(3):373-82 31 Citations |
| 1 | American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee) Blood 2010 Nov 18;116(20):4045-59 183 Citations |
| 1 | American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2010 Nov 20;28(33):4996-5010 233 Citations |
| 1 | Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells (Dumrongkiet Arthan, Seung-Keun Hong, Jong-In Park) Cancer letters |
| 1 | MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. (Srivastava RK, Kurzrock R, Shankar S) Mol Cancer Ther 2010 Dec;9(12):3254-66 116 Citations |
| 1 | Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. (Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, Young A, De Cicco M, Biffi R, van Rooden CJ, Huisman MV, Fagnani D, Cimminiello C, Moia M, Magagnoli M, Povoski SP, Malak SF, Lee AY) J Thromb Haemost 2011 Feb;9(2):312-9 182 Citations |
| 1 | Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. (Bardhan R, Chen W, Bartels M, Perez-Torres C, Botero MF, McAninch RW, Contreras A, Schiff R, Pautler RG, Halas NJ, Joshi A) Nano Lett 2010 Dec 08;10(12):4920-8 151 Citations |
| 2 | PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. (Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A, Chen G) Oncogene 2011 Apr 07;30(14):1706-15 35 Citations |
| 2 | Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8 257 Citations |
| 2 | Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. (Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):279-86 321 Citations |
| 1 | Sentinel lymph node dissection is technically feasible in older breast cancer patients. (Valero V 3rd, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA) Clin Breast Cancer 2010 Dec 01;10(6):477-82 4 Citations |
| 1 | Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer. (Hagemann AR, Zighelboim I, Odibo AO, Rader JS, Mutch DG, Powell MA) Breast J 2011;17(1):103-5 8 Citations |
| 1 | Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer. (Tsimberidou AM, Akerley W, Schabel MC, Hong DS, Uehara C, Chhabra A, Warren T, Mather GG, Evans BA, Woodland DP, Swabb EA, Kurzrock R) Mol Cancer Ther 2010 Dec;9(12):3410-9 48 Citations |
| 1 | Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. (Gu F, Hsu HK, Hsu PY, Wu J, Ma Y, Parvin J, Huang TH, Jin VX) BMC Syst Biol 2010 Dec 17;4:170 41 Citations |
| 5 | Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. (Neuner JM, Yen TW, Sparapani RA, Laud PW, Nattinger AB) Osteoporos Int 2011 Nov;22(11):2847-55 32 Citations |
| 1 | Radiation therapy and cancer treatment: From the basics to combination therapies that ignite immunity (Moretti A, Jaffray DA, Medin JA) Experimental and Applied Immunotherapy 2011:357-388 |
| 1 | SU‐E‐T‐780: Evaluation of Margin‐Reduction Using a Framework for Image‐Guided Adaptive Radiotherapy (IGART) of Prostate Cancer in the Clinical Setting () Medical Physics June 2011;38(6):3670 |
| 2 | TH‐C‐BRA‐04: Online Adaptive Radiotherapy for Prostate Cancer: Clinical Implementation and Initial Experience (li XA, Ahunbay E, Peng C, Chen G, Liu F, Lawton C) Medical Physics June 2011;38(6):3852-3853 |
| 2 | SU‐E‐T‐44: Model Prediction of Radiation Induced Duodenal Toxicity for a Dose Escalation in Radiation Therapy of Pancreatic Cancer Using Published Reports (Prior P, Erickson B, li X) Medical Physics June 2011;38(6):3495 |
| 1 | Adaptive Radiation Therapy for Breast Cancer (Kainz K, Li XA, White J) Adaptive Radiation Therapy 1 January 2011:275-291 |
| 2 | SU‐E‐J‐142: A Comparison of TomoTherapy and Respiratory‐Gated IG‐IMRT for the Treatment of Pancreatic Cancer (Prah D, Erickson B, li X) Medical Physics June 2011;38(6):3475 1 Citation |
| 1 | Adaptive Radiation Therapy for Gynecologic Cancers (Erickson B, Lim K, Stewart J, Donnelly E, Small W, Fyles A, Milosevic M) Adaptive Radiation Therapy 1 January 2011:351-368 2 Citations |
| 1 | Generalized morphea after breast cancer radiation therapy. (Kushi J, Csuka ME) Case Rep Rheumatol 2011;2011:951948 |
| 1 | Radiation therapy and cancer treatment: From the basics to combination therapies that ignite immunity () Experimental and Applied Immunotherapy 2011:357-388 |
| 1 | Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. (Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin VX, Huang TH) Cancer Res 2011 Mar 01;71(5):1752-62 53 Citations |
| 1 | ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. (Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Int J Radiat Oncol Biol Phys 2011 Nov 01;81(3):609-14 66 Citations |
| 1 | PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. (Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R) Mol Cancer Ther 2011 Mar;10(3):558-65 311 Citations |
| 1 | Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. (Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L, Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP) J Neurooncol 2011 Aug;104(1):351-6 36 Citations |
| 1 | ICGA-PSO-ELM approach for accurate multiclass cancer classification resulting in reduced gene sets in which genes encoding secreted proteins are highly represented. (Saraswathi S, Sundaram S, Sundararajan N, Zimmermann M, Nilsen-Hamilton M) IEEE/ACM Trans Comput Biol Bioinform 2011;8(2):452-63 110 Citations |
| 1 | MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. (Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H) Mol Carcinog 2011 Jun;50(6):433-8 20 Citations |
| 1 | Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study. (Bylow K, Hemmerich J, Mohile SG, Stadler WM, Sajid S, Dale W) Urology 2011 Apr;77(4):934-40 55 Citations |
| 1 | Helical tomotherapy for anal cancer: Initial clinical outcomes and organ motion. (Siker ML, Qi XS, Hu B, Wong SJ, Li XA, Erickson B) J Clin Oncol 2011 Feb;29(4_suppl):530 |
| 9 | Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. (Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e825-32 37 Citations |
| 3 | Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer. (Bradley JA, Paulson ES, Ahunbay E, Schultz C, Li XA, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e803-12 39 Citations |
| 2 | Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors. (Alt CA, Gore EM, Montagnini ML, Ng AV) Muscle Nerve 2011 Mar;43(3):415-24 12 Citations |
| 1 | Oral complications in the treatment of cancer patients. (Mosel DD, Bauer RL, Lynch DP, Hwang ST) Oral Dis 2011 Sep;17(6):550-9 100 Citations |
| 1 | Epigenetic silencing of tumor suppressor genes in pancreatic cancer. (Lomberk GA) J Gastrointest Cancer 2011 Jun;42(2):93-9 18 Citations |
| 1 | Polycomb and the emerging epigenetics of pancreatic cancer. (Grzenda A, Ordog T, Urrutia R) J Gastrointest Cancer 2011 Jun;42(2):100-11 15 Citations |
| 1 | Mind-mapping for lung cancer: towards a personalized therapeutics approach. (Mollberg N, Surati M, Demchuk C, Fathi R, Salama AK, Husain AN, Hensing T, Salgia R) Adv Ther 2011 Mar;28(3):173-94 23 Citations |
| 1 | Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic. (Janku F, Tsimberidou AM, Wang X, Hong DS, Naing A, Gong J, Garrido-Laguna I, Parsons HA, Zinner RG, Kurzrock R) Oncologist 2011;16(3):327-35 7 Citations |
| 1 | A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. (Miller TW, Balko JM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, González-Angulo AM, Mills GB, Miller WR, Wu H, Shyr Y, Arteaga CL) Clin Cancer Res 2011 Apr 01;17(7):2024-34 84 Citations |
| 1 | A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer. (McArthur HL, Rugo H, Nulsen B, Hawks L, Grothusen J, Melisko M, Moasser M, Paulson M, Traina T, Patil S, Zhou Q, Steingart R, Dang C, Morrow M, Cordeiro P, Fornier M, Park J, Seidman A, Lake D, Gilewski T, Theodoulou M, Modi S, D'Andrea G, Sklarin N, Robson M, Moynahan ME, Sugarman S, Sealey JE, Laragh JH, Merali C, Norton L, Hudis CA, Dickler MN) Clin Cancer Res 2011 May 15;17(10):3398-407 26 Citations |
| 1 | American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S) J Oncol Pract 2010 Nov;6(6):317-20 39 Citations |
| 1 | Predictive and prognostic markers in colorectal cancer. (George B, Kopetz S) Curr Oncol Rep 2011 Jun;13(3):206-15 44 Citations |
| 1 | Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. (Evans DB, Wolff RA) Ann Surg Oncol 2011 May;18(5):1224-8 1 Citation |
| 1 | Patient experiences with communication about sex during and after treatment for cancer. (Flynn KE, Reese JB, Jeffery DD, Abernethy AP, Lin L, Shelby RA, Porter LS, Dombeck CB, Weinfurt KP) Psychooncology 2012 Jun;21(6):594-601 253 Citations |
| 1 | Initial and continued adherence with bladder cancer screening in an occupationally exposed cohort. (Cassidy LD, Marsh GM, Talbott EO, Kelsey SF) J Occup Environ Med 2011 Apr;53(4):455-60 |
| 1 | Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese. (Dai J, Hu Z, Dong J, Xu L, Pan S, Jiang Y, Jin G, Chen Y, Shen H) Int J Cancer 2012 Feb 01;130(3):671-6 16 Citations |
| 1 | Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience. (Tsimberidou AM, Letourneau K, Wen S, Wheler J, Hong D, Naing A, Iskander NG, Uehara C, Kurzrock R) Clin Cancer Res 2011 Jun 15;17(12):4110-8 21 Citations |
| 1 | Managing the "known unknowns": theranostic cancer nanomedicine and informed consent. (Jotterand F, Alexander AA) Methods Mol Biol 2011;726:413-29 18 Citations |
| 1 | The challenge in treating the elderly colorectal cancer patient. (Ludwig KA) Ann Surg Oncol 2011 Jun;18(6):1520-1 |
| 1 | Microwave beamforming for non-invasive patient-specific hyperthermia treatment of pediatric brain cancer. (Burfeindt MJ, Zastrow E, Hagness SC, Van Veen BD, Medow JE) Phys Med Biol 2011 May 07;56(9):2743-54 48 Citations |
| 1 | Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. (Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RC Jr) Cancer 2011 Apr 15;117(8):1661-9 152 Citations |
| 1 | Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. (Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R) J Clin Oncol 2011 Jul 01;29(19):e572-5 63 Citations |
| 1 | Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer. (Tsimberidou AM, Lewis N, Reid T, Burris H, Urban P, Tan EY, Anand S, Uehara C, Kurzrock R) Cancer Chemother Pharmacol 2011 Dec;68(6):1507-16 5 Citations |
| 1 | The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. (Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE) Eur J Cancer 2011 Jun;47(9):1373-9 107 Citations |
| 1 | Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. (Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, Tseng MJ, Tsai SJ, Chang YS, Wu CS, Sun HS, Tsai KD, Jeng LB, Nephew KP, Huang TH, Hsiao SH, Leu YW) Cancer Res 2011 Jul 01;71(13):4653-63 93 Citations |
| 1 | Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population. (Han J, Jiang T, Bai H, Gu H, Dong J, Ma H, Hu Z, Shen H) Breast Cancer Res Treat 2011 Oct;129(3):901-7 17 Citations |
| 1 | Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. (Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R) Cancer 2011 Nov 15;117(22):5142-50 52 Citations |
| 1 | Natural Products Genomics: A novel approach for the discovery of anti-cancer therapeutics. (Monks NR, Li B, Gunjan S, Rogers DT, Kulshrestha M, Falcone DL, Littleton JM) J Pharmacol Toxicol Methods 2011;64(3):217-25 11 Citations |
| 1 | Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. (Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H) Clin Lung Cancer 2011 Mar;12(2):125-30 25 Citations |
| 1 | Improvement of survival and prospect of cure in patients with metastatic breast cancer. (Cheng YC, Ueno NT) Breast Cancer 2012 Jul;19(3):191-9 61 Citations |
| 1 | Intracameral bevacizumab administered for non-small cell lung cancer metastasis to iris. (Schell JC, Koenig SB, Bastin K, Wirostko WJ) Clin Pract 2011 May 16;1(2):e39 |
| 1 | Evaluating popular media and internet-based hospital quality ratings for cancer surgery. (Osborne NH, Ghaferi AA, Nicholas LH, Dimick JB, Mph M) Arch Surg 2011 May;146(5):600-4 21 Citations |
| 1 | Autophagy as a target for anticancer therapy. (Janku F, McConkey DJ, Hong DS, Kurzrock R) Nat Rev Clin Oncol 2011 May 17;8(9):528-39 717 Citations |
| 1 | Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Haddock MG, Erickson B, Willett CG) J Clin Oncol 2011 May 20;29(15_suppl):3517 |
| 1 | Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database. (Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, Salama AK, Arif Q, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Hensing TA, Krausz T, Vokes EE, Husain AN, Ferguson MK, Karrison TG, Salgia R) J Clin Bioinforma 2011 Feb 28;1(8):1-11 12 Citations |
| 1 | Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. (Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Müller T, Ratain MJ, Salgia R) J Clin Oncol 2011 Jul 01;29(19):2660-6 508 Citations |
| 1 | [Signaling and metabolic predispositions linked to the colorectal cancer]. (Olivier S, Mir AM, Michalski JC, Lefebvre T) Med Sci (Paris) 2011 May;27(5):514-20 2 Citations |
| 1 | Theranostic nanoshells: from probe design to imaging and treatment of cancer. (Bardhan R, Lal S, Joshi A, Halas NJ) Acc Chem Res 2011 Oct 18;44(10):936-46 846 Citations |
| 1 | Regulation of glycosyltransferase genes in apoptotic breast cancer cells induced by L: -PPMP and cisplatin. (Ma R, Hopp EA, Decker NM, Loucks A, Johnson JR, Moskal J, Basu M, Banerjee S, Basu S) Adv Exp Med Biol 2011;705:621-42 4 Citations |
| 1 | Photodynamic therapy of cancer: an update. (Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J) CA Cancer J Clin 2011;61(4):250-81 4503 Citations |
| 3 | Internal margin assessment using cine MRI analysis of deglutition in head and neck cancer radiotherapy. (Paulson ES, Bradley JA, Wang D, Ahunbay EE, Schultz C, Li XA) Med Phys 2011 Apr;38(4):1740-7 17 Citations |
| 2 | Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid. (Singh SK, Baumgart S, Singh G, König AO, Reutlinger K, Hofbauer LC, Barth P, Gress TM, Lomberk G, Urrutia R, Fernandez-Zapico ME, Ellenrieder V) J Biol Chem 2011 Aug 19;286(33):28761-28771 23 Citations |
| 1 | Assessing gynecologic and breast cancer survivors' sexual health care needs. (Hill EK, Sandbo S, Abramsohn E, Makelarski J, Wroblewski K, Wenrich ER, McCoy S, Temkin SM, Yamada SD, Lindau ST) Cancer 2011 Jun 15;117(12):2643-51 155 Citations |
| 1 | In vivo cancer imaging by poly(ethylene glycol)-b-poly(ɛ-caprolactone) micelles containing a near-infrared probe. (Cho H, Indig GL, Weichert J, Shin HC, Kwon GS) Nanomedicine 2012 Feb;8(2):228-36 75 Citations |
| 1 | Cancer screening practices among Amish and non-Amish adults living in Ohio Appalachia. (Katz ML, Ferketich AK, Paskett ED, Harley A, Reiter PL, Lemeshow S, Westman JA, Clinton SK, Bloomfield CD) J Rural Health 2011;27(3):302-9 14 Citations |
| 1 | Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned. (Steel J, Geller DA, Tsung A, Marsh JW, Dew MA, Spring M, Grady J, Likumahuwa S, Dunlavy A, Youssef M, Antoni M, Butterfield LH, Schulz R, Day R, Helgeson V, Kim KH, Gamblin TC) Clin Trials 2011 Jun;8(3):298-310 20 Citations |
| 1 | Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. (Dong J, Hu Z, Shu Y, Pan S, Chen W, Wang Y, Hu L, Jiang Y, Dai J, Ma H, Jin G, Shen H) Mol Carcinog 2012 Jul;51(7):546-52 48 Citations |
| 1 | Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. (Naing A, Kurzrock R, Burger A, Gupta S, Lei X, Busaidy N, Hong D, Chen HX, Doyle LA, Heilbrun LK, Rohren E, Ng C, Chandhasin C, LoRusso P) Clin Cancer Res 2011 Sep 15;17(18):6052-60 105 Citations |
| 1 | Using tandem mass spectrometry in targeted mode to identify activators of class IA PI3K in cancer. (Yang X, Turke AB, Qi J, Song Y, Rexer BN, Miller TW, Jänne PA, Arteaga CL, Cantley LC, Engelman JA, Asara JM) Cancer Res 2011 Sep 15;71(18):5965-75 14 Citations |
| 2 | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 67 Citations |
| 1 | Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? (Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA) AJR Am J Roentgenol 2011 Aug;197(2):334-40 46 Citations |
| 1 | Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. (Howard DH, Kenline C, Lazarus HM, Lemaistre CF, Maziarz RT, McCarthy PL Jr, Parsons SK, Szwajcer D, Douglas Rizzo J, Majhail NS) Health Serv Res 2011 Dec;46(6pt1):1762-77 26 Citations |
| 1 | ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer. (Kennedy BA, Deatherage DE, Gu F, Tang B, Chan MW, Nephew KP, Huang TH, Jin VX) PLoS One 2011;6(7):e22606 30 Citations |
| 4 | Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells. (Cheng G, Lopez M, Zielonka J, Hauser AD, Joseph J, McAllister D, Rowe JJ, Sugg SL, Williams CL, Kalyanaraman B) Cancer Biol Ther 2011 Oct 15;12(8):707-17 26 Citations |
| 1 | Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines. (Brard L, Lange TS, Robison K, Kim KK, Ara T, McCallum MM, Arnold LA, Moore RG, Singh RK) Gynecol Oncol 2011 Nov;123(2):370-8 14 Citations |
| 1 | Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center. (Garrido-Laguna I, Janku F, Vaklavas C, Falchook GS, Fu S, Hong DS, Naing A, Tsimberidou AM, Wen S, Kurzrock R) Cancer 2012 Mar 01;118(5):1422-8 86 Citations |
| 1 | PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. (Janku F, Lee JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Luthra R, Garrido-Laguna I, Kurzrock R) PLoS One 2011;6(7):e22769 170 Citations |
| 1 | A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer. (Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L, Callies S, André V, Kadam SK, Nasir A, Holzer TR, Meric-Bernstam F, Fishman M, Simon G) Clin Cancer Res 2011 Oct 15;17(20):6582-91 114 Citations |
| 1 | Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program. (Fu S, Hong DS, Naing A, Wheler J, Falchook G, Wen S, Howard A, Barber D, Nates J, Price K, Kurzrock R) J Clin Oncol 2011 Sep 10;29(26):3547-52 26 Citations |
| 1 | Novel therapeutic targets in non-small cell lung cancer. (Janku F, Garrido-Laguna I, Petruzelka LB, Stewart DJ, Kurzrock R) J Thorac Oncol 2011 Sep;6(9):1601-12 123 Citations |
| 6 | Socioeconomic and racial differences in treatment for breast cancer at a low-volume hospital. (Kong AL, Yen TW, Pezzin LE, Miao H, Sparapani RA, Laud PW, Nattinger AB) Ann Surg Oncol 2011 Oct;18(11):3220-7 24 Citations |
| 1 | Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience. (El-Osta H, Hong D, Wheler J, Fu S, Naing A, Falchook G, Hicks M, Wen S, Tsimberidou AM, Kurzrock R) Oncologist 2011;16(9):1292-8 58 Citations |
| 1 | The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. (Hong SK, Kim JH, Lin MF, Park JI) Exp Cell Res 2011 Nov 01;317(18):2671-82 36 Citations |
| 1 | Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons. (Qi X, Hou S, Lepp A, Li R, Basir Z, Lou Z, Chen G) J Biol Chem 2011 Oct 14;286(41):35883-35890 25 Citations |
| 1 | Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K) Int J Gynecol Cancer 2011 Oct;21(7):1266-75 36 Citations |
| 1 | An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. (He R, Mott BT, Rosenthal AS, Genna DT, Posner GH, Arav-Boger R) PLoS One 2011;6(8):e24334 60 Citations |
| 1 | Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. (Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD) J Natl Cancer Inst 2011 Oct 05;103(19):1452-60 1094 Citations |
| 1 | The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. (Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL) Pediatr Blood Cancer 2011 Dec 01;57(6):1062-6 34 Citations |
| 1 | A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. (Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL) Cancer Res 2011 Nov 01;71(21):6773-84 138 Citations |
| 1 | Lymphedema and arm symptoms following three-dimensional conformal radiation therapy (3DCRT) for node-positive breast cancer (BC) patients. (Sparks I, Prior P, Xiang Q, Li XA, Yen TW, White JR) J Clin Oncol 2011 Sep 20;29(27_suppl):130 |
| 1 | SmgGDS splice variants: Potential novel targets for breast cancer therapeutics. (Bergom C, Hauser A, Lorimer EL, Li R, Mackinnon AC, Williams CL) J Clin Oncol 2011 Sep 20;29(27_suppl):225 |
| 1 | Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008. (Tarlov E, Stroupe KT, Lee TA, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Browning MM, Hynes DM) Support Care Cancer 2012 Aug;20(8):1649-57 14 Citations |
| 1 | Towards a field-compatible optical spectroscopic device for cervical cancer screening in resource-limited settings: effects of calibration and pressure. (Chang VT, Merisier D, Yu B, Walmer DK, Ramanujam N) Opt Express 2011 Sep 12;19(19):17908-24 16 Citations |
| 1 | The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation. (McCormack D, Schneider J, McDonald D, McFadden D) Am J Surg 2011 Nov;202(5):541-4 39 Citations |
| 1 | Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain. (Budde MD, Gold E, Jordan EK, Smith-Brown M, Frank JA) NMR Biomed 2012 May;25(5):726-36 17 Citations |
| 1 | Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. (Miller TW, Balko JM, Arteaga CL) J Clin Oncol 2011 Nov 20;29(33):4452-61 357 Citations |
| 1 | BRAF mutations in advanced cancers: clinical characteristics and outcomes. (El-Osta H, Falchook G, Tsimberidou A, Hong D, Naing A, Kim K, Wen S, Janku F, Kurzrock R) PLoS One 2011;6(10):e25806 83 Citations |
| 1 | A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. (Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, Wang M, Miao X, Zhou Y, Lu F, Zhang H, Hu L, Jiang Y, Li Z, Chu M, Ma H, Chen J, Jin G, Tan W, Wu T, Zhang Z, Lin D, Shen H) Nat Genet 2011 Oct 30;43(12):1215-8 248 Citations |
| 1 | The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells (Seung-Keun Hong, Jin-Hwan Kim, Ming-Fong Lin, Jong-In Park) Experimental cell research |
| 1 | Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. (Budde MD, Gold E, Jordan EK, Frank JA) Clin Exp Metastasis 2012 Jan;29(1):51-62 25 Citations |
| 1 | ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. (Miller TW, Balko JM, Fox EM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, Jiang A, Smith RA, Maira SM, Manning HC, González-Angulo AM, Mills GB, Higham C, Chanthaphaychith S, Kuba MG, Miller WR, Shyr Y, Arteaga CL) Cancer Discov 2011 Sep;1(4):338-51 278 Citations |
| 1 | Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. (Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME) Breast Cancer Res Treat 2012 Jan;131(2):713-21 17 Citations |
| 1 | A multi-method assessment of psychosocial functioning and late effects in survivors of childhood cancer and hematopoietic cell transplant. (Bingen, K., Schroedl, R.L., Anderson, L., Schmidt, D., Hoag, J., Christiansen, H., & Kupst, M.J.) Journal of Pediatric Hematology and Oncology |
| 4 | A multimethod assessment of psychosocial functioning and late effects in survivors of childhood cancer and hematopoietic cell transplant. (Bingen K, Schroedl RL, Anderson L, Schmidt D, Hoag J, Christiansen H, Kupst MJ) J Pediatr Hematol Oncol 2012 Jan;34(1):22-8 9 Citations |
| 1 | Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. (Miller TW, Rexer BN, Garrett JT, Arteaga CL) Breast Cancer Res 2011;13(6):224 375 Citations |
| 1 | ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. (Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR, American College of Radiology (ACR)) Gynecol Oncol 2012 Apr;125(1):256-62 15 Citations |
| 1 | Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. (Sabel MS, Jorns JM, Wu A, Myers J, Newman LA, Breslin TM) Am J Surg 2012 Jul;204(1):66-77 23 Citations |
| 1 | The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31 108 Citations |
| 1 | TU‐C‐213CD‐09: Dosimetric Impact of the Interplay Effect on RapidArc versus IMRT Delivery of Lung Cancer Treatment Using SBRT (li HS, Chin K, Nurushev T, Kim J, Zhong H, Ryu S, Ajlouni M, Movsas B, Chetty IJ) Medical Physics June 2012;39(6):3904 |
| 2 | TH‐E‐218‐09: Extracting Patient‐Specific Radiobiological Parameters for Radiobiologically Adaptive Radiotherapy Based on Radiation Response for Lung Cancer (Tai A, Gore E, li X) Medical Physics June 2012;39(6):4019 |
| 1 | Brachytherapy for Gynecologic Cancers (Erickson B, Kudrimoti M, Haie-Meder C) Comprehensive Brachytherapy: Physical and Clinical Aspects 1 January 2012:295-318 2 Citations |
| 1 | Distress and Resilience After Cancer in Veterans. (Jahn AL, Herman L, Schuster J, Naik A, Moye J) Res Hum Dev 2012;9(3):229-247 18 Citations |
| 1 | Limitation of in vivo models investigating angiogenesis in breast cancer. (Gehmert S, Gehmert S, Bai X, Klein S, Ortmann O, Prantl L) Clin Hemorheol Microcirc 2011;49(1-4):519-26 11 Citations |
| 1 | Perception of cancer recurrence risk: more information is better. (Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L, Abraham J, Agnese D) Patient Educ Couns 2013 Mar;90(3):361-6 24 Citations |
| 1 | Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy. (Parsons HA, Tsimberidou AM, Pontikos M, Fu S, Hong D, Wen S, Baracos VE, Kurzrock R) Nutr Cancer 2012;64(2):206-17 29 Citations |
| 1 | Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. (Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R) PLoS One 2012;7(1):e29330 90 Citations |
| 1 | Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. (Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW) Clin Cancer Res 2012 Mar 01;18(5):1464-71 97 Citations |
| 2 | American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. (Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, Yashar C, Rownd JJ, Viswanathan AN, American Brachytherapy Society) Brachytherapy 2012;11(1):68-75 157 Citations |
| 1 | Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. (Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H, Shen H) Breast Cancer Res 2012 Jan 23;14(1):R17 63 Citations |
| 1 | Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. (Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C) Clin Colorectal Cancer 2012 Sep;11(3):191-4 24 Citations |
| 1 | Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. (Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H) Carcinogenesis 2012 Apr;33(4):828-34 197 Citations |
| 1 | Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women. (Ma H, Li H, Jin G, Dai J, Dong J, Qin Z, Chen J, Wang S, Wang X, Hu Z, Shen H) DNA Cell Biol 2012 Jun;31(6):1114-20 3 Citations |
| 1 | Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. (Nace GW, Steel JL, Amesur N, Zajko A, Nastasi BE, Joyce J, Sheetz M, Gamblin TC) Int J Surg Oncol 2011;2011:571261 |
| 1 | Initiating breast cancer by PIK3CA mutation. (Miller TW) Breast Cancer Res 2012 Feb 07;14(1):301 17 Citations |
| 1 | Prophylactic cranial irradiation in non-small cell lung cancer (Gore E) Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC): Fourth Edition 13 February 2012:837-844 1 Citation |
| 1 | Management of cancer in the older adult. (Kilari D, Mohile SG) Clin Geriatr Med 2012 Feb;28(1):33-49 13 Citations |
| 1 | Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. (Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS) Ann Surg 2012 Mar;255(3):478-85 178 Citations |
| 2 | Pancreaticoduodenectomy (whipple operation) and total pancreatectomy for cancer (Evans DB, Christians KK, Foley WD) Fischer's Mastery of Surgery: Sixth Edition 20 February 2012;1 7 Citations |
| 1 | Synchronous resection of colorectal cancer and liver metastases: comparative views of colorectal and liver surgeons. (Qureshi MS, Goldsmith PJ, Maslekar S, Prasad KR, Botterill ID) Colorectal Dis 2012 Aug;14(8):e477-85 14 Citations |
| 1 | Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection. (de la Fuente SG, Ludwig KA, Tyler DS, Mantyh CR) Ann Surg Oncol 2012 Jun;19(6):1954-8 2 Citations |
| 1 | BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency. (Hong DS, Vence L, Falchook G, Radvanyi LG, Liu C, Goodman V, Legos JJ, Blackman S, Scarmadio A, Kurzrock R, Lizee G, Hwu P) Clin Cancer Res 2012 Apr 15;18(8):2326-35 95 Citations |
| 1 | Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience. (Wheler JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R) Ann Oncol 2012 Aug;23(8):1963-1967 16 Citations |
| 1 | Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer. (Neschadim A, Wang JC, Lavie A, Medin JA) Cancer Gene Ther 2012 May;19(5):320-7 20 Citations |
| 2 | p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription. (Qi X, Zhi H, Lepp A, Wang P, Huang J, Basir Z, Chitambar CR, Myers CR, Chen G) J Biol Chem 2012 Apr 27;287(18):14681-91 26 Citations |
| 1 | Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. (Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC) J Am Coll Surg 2012 May;214(5):769-77 121 Citations |
| 3 | Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. (Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr, Joseph J, Kalyanaraman B) Cancer Res 2012 May 15;72(10):2634-44 220 Citations |
| 1 | Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. (Liu F, Erickson B, Peng C, Li XA) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e423-9 98 Citations |
| 1 | Vascular invasion in pancreatic cancer: predictive values for endoscopic ultrasound and computed tomography imaging. (Tellez-Avila FI, Chavez-Tapia NC, López-Arce G, Franco-Guzmán AM, Sosa-Lozano LA, Alfaro-Lara R, Chan-Nuñez C, Giovannini M, Elizondo-Rivera J, Ramírez-Luna MA) Pancreas 2012 May;41(4):636-8 32 Citations |
| 1 | Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. (Diers AR, Broniowska KA, Chang CF, Hogg N) Biochem J 2012 Jun 15;444(3):561-71 108 Citations |
| 2 | A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 11 Citations |
| 2 | Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. (Aadam AA, Evans DB, Khan A, Oh Y, Dua K) Gastrointest Endosc 2012 Jul;76(1):67-75 90 Citations |
| 1 | Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. (Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC Jr, Mills GB) Gynecol Oncol 2012 Jul;126(1):47-53 69 Citations |
| 1 | Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. (Kosinski L, Habr-Gama A, Ludwig K, Perez R) CA Cancer J Clin 2012;62(3):173-202 92 Citations |
| 1 | Blogging through cancer: young women's persistent problems shared online. (Keim-Malpass J, Baernholdt M, Erickson JM, Ropka ME, Schroen AT, Steeves RH) Cancer Nurs 2013;36(2):163-72 57 Citations |
| 1 | Calibrating the imaging and therapy performance of magneto-fluorescent gold nanoshells for breast cancer (Dowell A, Chen W, Biswal N, Ayala-Orozco C, Giuliano M, Schiff R, Halas NJ, Joshi A) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2012;8233 1 Citation |
| 1 | Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. (Moore RG, Lange TS, Robinson K, Kim KK, Uzun A, Horan TC, Kawar N, Yano N, Chu SR, Mao Q, Brard L, DePaepe ME, Padbury JF, Arnold LA, Brodsky A, Shen TL, Singh RK) PLoS One 2012;7(4):e34443 16 Citations |
| 1 | Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experience. (Hong DS, Patel JC, Wheler J, Naing A, Garrido-Laguna I, Falchook G, Fu S, Tsimberidou AM, Kopetz S, Win S, Kurzrock R) Clin Colorectal Cancer 2012 Dec;11(4):297-303 8 Citations |
| 1 | Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. (Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore H, Budd GT, Dietz J, Crowe JP, Macklis R) Int J Radiat Oncol Biol Phys 2012 Aug 01;83(5):e577-81 88 Citations |
| 2 | Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. (Hamidi T, Algül H, Cano CE, Sandi MJ, Molejon MI, Riemann M, Calvo EL, Lomberk G, Dagorn JC, Weih F, Urrutia R, Schmid RM, Iovanna JL) J Clin Invest 2012 Jun;122(6):2092-103 106 Citations |
| 1 | Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. (Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, Chi YI, Evers BM, Zhou BP) Oncogene 2013 Mar 14;32(11):1351-62 182 Citations |
| 1 | The effectiveness of repeat celiac plexus neurolysis for pancreatic cancer: a pilot study. (McGreevy K, Hurley RW, Erdek MA, Aner MM, Li S, Cohen SP) Pain Pract 2013 Feb;13(2):89-95 47 Citations |
| 1 | Variation in mortality after high-risk cancer surgery: failure to rescue. (Ghaferi AA, Dimick JB) Surg Oncol Clin N Am 2012 Jul;21(3):389-95, vii 57 Citations |
| 1 | Multivariate analysis of factors affecting overall survival in minority-based population of young colorectal cancer patients: A single-institution experience. (Shivi Jain , Kireet Agrawal , Shinoj Pattali , Abhijai Singh , Kamal Agrawal , Barbara Cleveland, Michael Russell Mullane) Journal of clinical oncology DOI: 10.1200/jco.2012.30.15_suppl.e14186 Journal of Clinical Oncology 30, no. 15_suppl |
| 2 | SU-E-T-256: Radiation Dose Responses for Chemoradiation Therapy of Pancreatic Cancer: An Analysis of Compiled Clinical Data Using Biophysical Models. (Moraru I, Tai A, Erickson B, Li X) Med Phys 2012 Jun;39(6Part13):3762 |
| 1 | TU-E-BRA-01: A Comparison of Various Online Strategies to Account for Interfractional Variations for Pancreatic Cancer. (Ahunbay E, Liu F, Yang C, Li X) Med Phys 2012 Jun;39(6Part24):3910 |
| 2 | SU-E-T-438: Optimal Proton Beam Energy to Treat Adult CNS, Adult Head and Neck, and Pediatric Cancers. (Kainz K, Firat S, Wilson J, Li X) Med Phys 2012 Jun;39(6Part16):3805 |
| 1 | Stable Isotope Resolved Metabolomics Analysis of Ribonucleotide and RNA Metabolism in Human Lung Cancer Cells. (Fan TW, Tan J, McKinney MM, Lane AN) Metabolomics 2012 Jun;8(3):517-527 41 Citations |
| 1 | Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. (Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F) Cancer 2012 Dec 15;118(24):6287-96 37 Citations |
| 1 | Stable Isotope Resolved Metabolomics Analysis of Ribonucleotide and RNA Metabolism in Human Lung Cancer Cells (Teresa W-M Fan, Jinlian Tan, Martin M McKinney, Andrew N Lane ) Metabolomics |
| 1 | KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. (Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, Wheler JJ, Luthra R, Naing A, Wang X, Kurzrock R) PLoS One 2012;7(5):e38033 47 Citations |
| 1 | Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. (Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, González-Angulo AM, Mills GB, Pinto JA, Gómez HL, Arteaga CL) Nat Med 2012 Jul;18(7):1052-9 221 Citations |
| 1 | ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. (Wang G, Liu G, Wang X, Sethi S, Ali-Fehmi R, Abrams J, Zheng Z, Zhang K, Ethier S, Yang ZQ) BMC Cancer 2012 Jun 08;12:225 36 Citations |
| 1 | Retreatment of recurrent head and neck cancer in a previously irradiated field. (Wong SJ, Bourhis J, Langer CJ) Semin Radiat Oncol 2012 Jul;22(3):214-9 13 Citations |
| 1 | Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs. (Naing A, Veasey-Rodrigues H, Hong DS, Fu S, Falchook GS, Wheler JJ, Tsimberidou AM, Wen S, Fessahaye SN, Golden EC, Aaron J, Ewer MS, Kurzrock R) Ann Oncol 2012 Nov;23(11):2960-2963 39 Citations |
| 1 | TU-E-BRA-01: A Comparison of Various Online Strategies to Account for Interfractional Variations for Pancreatic Cancer. (Ahunbay E, Liu F, Yang C, Li X) Med Phys 2012 Jun;39(6):3910 |
| 1 | SU-E-T-438: Optimal Proton Beam Energy to Treat Adult CNS, Adult Head and Neck, and Pediatric Cancers. (Kainz K, Firat S, Wilson J, Li X) Med Phys 2012 Jun;39(6):3805 |
| 1 | Surgical treatment of peritoneal carcinomatosis from gastric cancer. (Turaga KK, Gamblin TC, Pappas S) Int J Surg Oncol 2012;2012:405652 7 Citations |
| 1 | Advance care planning in patients with cancer referred to a phase I clinical trials program: the MD Anderson Cancer Center experience. (Fu S, Barber FD, Naing A, Wheler J, Hong D, Falchook G, Piha-Paul S, Tsimberidou A, Howard A, Kurzrock R) J Clin Oncol 2012 Aug 10;30(23):2891-6 27 Citations |
| 1 | Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. (Dong J, Hu Z, Wu C, Guo H, Zhou B, Lv J, Lu D, Chen K, Shi Y, Chu M, Wang C, Zhang R, Dai J, Jiang Y, Cao S, Qin Z, Yu D, Ma H, Jin G, Gong J, Sun C, Zhao X, Yin Z, Yang L, Li Z, Deng Q, Wang J, Wu W, Zheng H, Zhou G, Chen H, Guan P, Peng Z, Chen Y, Shu Y, Xu L, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Amos CI, Chen F, Tan W, Jin L, Wu T, Lin D, Shen H) Nat Genet 2012 Jul 15;44(8):895-9 131 Citations |
| 1 | 20-HETE-producing enzymes are up-regulated in human cancers. (Alexanian A, Miller B, Roman RJ, Sorokin A) Cancer Genomics Proteomics 2012;9(4):163-9 52 Citations |
| 1 | Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. (Wu F, Zhang J, Wang P, Ye X, Jung K, Bone KM, Pearson JD, Ingham RJ, McMullen TP, Ma Y, Lai R) Cell Signal 2012 Nov;24(11):1989-98 43 Citations |
| 1 | ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. (Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK) Am J Clin Oncol 2012 Aug;35(4):399-405 14 Citations |
| 1 | The role of taxanes in the management of gastroesphageal cancer. (Jimenez P, Pathak A, Phan AT) J Gastrointest Oncol 2011 Dec;2(4):240-9 |
| 2 | Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. (Cano CE, Sandí MJ, Hamidi T, Calvo EL, Turrini O, Bartholin L, Loncle C, Secq V, Garcia S, Lomberk G, Kroemer G, Urrutia R, Iovanna JL) EMBO Mol Med 2012 Sep;4(9):964-79 65 Citations |
| 1 | Extension of the intravoxel incoherent motion model to non-gaussian diffusion in head and neck cancer. (Lu Y, Jansen JF, Mazaheri Y, Stambuk HE, Koutcher JA, Shukla-Dave A) J Magn Reson Imaging 2012 Nov;36(5):1088-96 81 Citations |
| 1 | Nasal septum perforation induced by bevacizumab therapy in patients with breast cancer (Chaudhary L, Wilkinson R, Armeni M, Jordan C, Price A, Filburn S, Abraham J) Community Oncology August 2012;9(8):259-262 1 Citation |
| 1 | Secondary Neoplasms in Childhood Cancer Survivors. (Leuthner, L., Anderson, L., & Schmidt, D. ) The Oncology Nurse |
| 1 | Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment. (Wen N, Glide-Hurst C, Nurushev T, Xing L, Kim J, Zhong H, Liu D, Liu M, Burmeister J, Movsas B, Chetty IJ) Phys Med Biol 2012 Sep 07;57(17):5361-79 38 Citations |
| 1 | Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. (Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H) Clin Cancer Res 2012 Oct 01;18(19):5507-14 54 Citations |
| 1 | Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification. (Balko JM, Mayer IA, Sanders ME, Miller TW, Kuba MG, Meszoely IM, Wagle N, Garraway LA, Arteaga CL) Mol Cancer Ther 2012 Oct;11(10):2301-5 20 Citations |
| 1 | Body composition changes in females treated for breast cancer: a review of the evidence. (Sheean PM, Hoskins K, Stolley M) Breast Cancer Res Treat 2012 Oct;135(3):663-80 83 Citations |
| 1 | Effects of enhanced bolus flavors on oropharyngeal swallow in patients treated for head and neck cancer. (Pauloski BR, Logemann JA, Rademaker AW, Lundy D, Sullivan PA, Newman LA, Lazarus C, Bacon M) Head Neck 2013 Aug;35(8):1124-31 32 Citations |
| 1 | Gastric cardia cancer: how much is it from fat? (Sinh P, Sharma P) Dig Dis Sci 2012 Oct;57(10):2493-6 3 Citations |
| 1 | Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. (Sangai T, Akcakanat A, Chen H, Tarco E, Wu Y, Do KA, Miller TW, Arteaga CL, Mills GB, Gonzalez-Angulo AM, Meric-Bernstam F) Clin Cancer Res 2012 Oct 15;18(20):5816-28 138 Citations |
| 1 | An observational study of plasma vascular endothelial growth factors (vegf) a and d expression in non-localized prostate cancer (Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M) Journal of Men's Health September 2012;9(3):182-189 1 Citation |
| 1 | An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. (Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M) J Mens Health 2012 Sep 01;9(3):182-189 1 Citation |
| 1 | Negative Predictive Value (NPV) of FDG PET_CT for nodal disease in clinically node-negative early stage lung cancer and identification of risk factors for nodal metastasis. (Paravati, A, Seltzer M, Johnstone D, JOHNSTONE C.) Practical Radiation Oncology |
| 1 | Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study. (Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RK, Schwartz LH, Koutcher JA, Zakian KL) NMR Biomed 2013 Feb;26(2):204-12 8 Citations |
| 1 | Targeted therapy in rare cancers--adopting the orphans. (Munoz J, Kurzrock R) Nat Rev Clin Oncol 2012 Nov;9(11):631-42 33 Citations |
| 1 | Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. (Tsimberidou AM, Iskander NG, Hong DS, Wheler JJ, Falchook GS, Fu S, Piha-Paul S, Naing A, Janku F, Luthra R, Ye Y, Wen S, Berry D, Kurzrock R) Clin Cancer Res 2012 Nov 15;18(22):6373-83 456 Citations |
| 1 | Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. (Rich TA, Winter K, Safran H, Hoffman JP, Erickson B, Anne PR, Myerson RJ, Cline-Burkhardt VJ, Perez K, Willett C) Onco Targets Ther 2012;5:161-70 17 Citations |
| 1 | Evaluation and management of elderly patients with lung cancer. (Gore E, Movsas B, Santana-Davila R, Langer C) Semin Radiat Oncol 2012 Oct;22(4):304-10 11 Citations |
| 1 | Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. (Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T) Mol Cell Proteomics 2012 Dec;11(12):1870-84 80 Citations |
| 1 | Long-term outcome from RTOG 9517: A phase I/II study of accelerated partial breast irradiation (APBI) with mulitcatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. (Winter KA, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch R, Kelly TR, Toonkel LM, Vicini FA, McCormick B) J Clin Oncol 2012 Sep 20;30(27_suppl):147 |
| 1 | Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. (Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)) Support Care Cancer 2013 Jan;21(1):333-41 192 Citations |
| 5 | Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. (Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW) Ann Surg Oncol 2012 Dec;19(13):4217-22 66 Citations |
| 1 | Outcomes of phase II clinical trials with single-agent therapies in advanced/metastatic non-small cell lung cancer published between 2000 and 2009. (Janku F, Berry DA, Gong J, Parsons HA, Stewart DJ, Kurzrock R) Clin Cancer Res 2012 Nov 15;18(22):6356-63 21 Citations |
| 1 | Post-radiation damage to the pelvic girdle in cervical cancer patients: Is intensity modulated radiation therapy safer than conventional radiation? (Ioffe Y, Hillen T, Zhou G, Schwarz J, Mutch D, Powell M, Rader J, Zighelboim I, Hagemann A, Thaker P) Gynecol Oncol 2012 Oct;127(1 Suppl):S10 |
| 1 | The impact of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. (Froman JP, Mathiason MA, Kallies KJ, Bottner WA, Shapiro SB) Am J Surg 2012 Dec;204(6):944-50; discussion 950-1 25 Citations |
| 1 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. (Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS) Int J Radiat Oncol Biol Phys 2013 Jan 01;85(1):e21-8 53 Citations |
| 2 | NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells. (Hamidi T, Cano CE, Grasso D, Garcia MN, Sandi MJ, Calvo EL, Dagorn JC, Lomberk G, Goruppi S, Urrutia R, Carracedo A, Velasco G, Iovanna JL) Autophagy 2013 Jan;9(1):95-7 25 Citations |
| 1 | Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer. (Fox EM, Arteaga CL, Miller TW) Front Oncol 2012;2:145 |
| 1 | Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. (Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y, Lu J, Miao X, Wang M, Zhou Y, Chen J, Li H, Pan S, Chu M, Lu F, Yu D, Jiang Y, Dong J, Hu L, Chen Y, Xu L, Shu Y, Pan S, Tan W, Zhou B, Lu D, Wu T, Zhang Z, Chen F, Wang X, Hu Z, Lin D, Shen H) Am J Hum Genet 2012 Nov 02;91(5):928-34 78 Citations |
| 1 | Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes. (Stroupe KT, Tarlov E, Lee TA, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Durazo-Arvizu R, Browning MM, Hynes DM) Pharmacotherapy 2012 Nov;32(11):988-97 5 Citations |
| 1 | Stratification of postprostatectomy urinary function using expanded prostate cancer index composite. (Ellison JS, He C, Wood DP) Urology 2013 Jan;81(1):56-60 22 Citations |
| 1 | Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. (Havlik R, Srovnal J, Klos D, Benedikova A, Lovecek M, Ghothim M, Cahova D, Neoral C, Hajduch M) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013 Sep;157(3):233-8 7 Citations |
| 1 | Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. (Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD 3rd, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Lin D, Chanock SJ, Rothman N) Nat Genet 2012 Dec;44(12):1330-5 276 Citations |
| 1 | Cancer testis antigens: A new paradigm for cancer therapy. (Suri A, Saini S, Sinha A, Agarwal S, Verma A, Parashar D, Singh S, Gupta N, Jagadish N) Oncoimmunology 2012 Oct 01;1(7):1194-1196 44 Citations |
| 2 | Current staging systems for pancreatic cancer. (Appel BL, Tolat P, Evans DB, Tsai S) Cancer J 2012;18(6):539-49 66 Citations |
| 1 | An often overlooked diagnosis: imaging features of gallbladder cancer. (Pilgrim CH, Groeschl RT, Pappas SG, Gamblin TC) J Am Coll Surg 2013 Feb;216(2):333-9 14 Citations |
| 1 | Cancer omics: from regulatory networks to clinical outcomes. (Tang B, Hsu PY, Huang TH, Jin VX) Cancer Lett 2013 Nov 01;340(2):277-83 9 Citations |
| 1 | Obesity and colorectal cancer. (Gribovskaja-Rupp I, Kosinski L, Ludwig KA) Clin Colon Rectal Surg 2011 Dec;24(4):229-43 37 Citations |
| 1 | Symptoms and symptom clusters in adolescents receiving cancer treatment: a review of the literature. (Erickson JM, Macpherson CF, Ameringer S, Baggott C, Linder L, Stegenga K) Int J Nurs Stud 2013 Jun;50(6):847-69 72 Citations |
| 1 | Warning signal: unaware of an in absentia conviction, South African cancer specialist jailed on return to the United Arab Emirates. (Cohen PR, Kurzrock R, Parish LC) Clin Dermatol 2013;31(1):128-30 2 Citations |
| 2 | Survivorship care plans for patients with head and neck cancer. (Campbell BH, Massey BL, Myers KB) Arch Otolaryngol Head Neck Surg 2012 Dec;138(12):1116-9 15 Citations |
| 1 | Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. (Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB) J Am Coll Radiol 2013 Feb;10(2):128-34 17 Citations |
| 1 | PIK3CA mutations in advanced cancers: characteristics and outcomes. (Janku F, Wheler JJ, Naing A, Stepanek VM, Falchook GS, Fu S, Garrido-Laguna I, Tsimberidou AM, Piha-Paul SA, Moulder SL, Lee JJ, Luthra R, Hong DS, Kurzrock R) Oncotarget 2012 Dec;3(12):1566-75 85 Citations |
| 2 | SU‐E‐CAMPUS‐J‐05: Extracting Patient‐Specific Radiobiological Parameters From Tumor Regression for Biologically‐Based Adaptive Radiation Therapy of Head and Neck Cancer (Tai A, Schultz C, li X) Medical Physics June 2013;40(6):379 |
| 1 | SU‐D‐500‐03: A Correction of Partial Volume Effect for Using PET to Define Metabolically Active Tumor Volume for Pancreatic Cancer (Dalah E, Cungeng Y, Moraru I, Erickson B, li X) Medical Physics June 2013;40(6):105-106 |
| 2 | SU‐E‐J‐112: Improving Target Delineation by Using Deformably Registered Multi‐Modality Images for Radiation Therapy of Pancreatic Cancer (Cungeng Y, Moraru I, Dalah E, Hart V, Paulson E, Erickson B, li X) Medical Physics June 2013;40(6):176 |
| 1 | Telemedicine in cancer control programs in developing countries (Wanat KA, Quinley KE, Kovarik CL) Breast and Gynecological Cancers: An Integrated Approach for Screening and Early Diagnosis in Developing Countries 1 January 2013:285-299 1 Citation |
| 1 | SU‐E‐T‐277: Modeling Normal Tissue Complication Probability Based On Compiled Clinical Data From Skin Cancer Radiotherapy (Prior P, Wilson J, li X) Medical Physics June 2013;40(6):267-268 1 Citation |
| 1 | Anthocyanins, anthocyanin derivatives, and colorectal cancer (Wang LS, Kuo CT, Peiffer D, Seguin C, Stoner K, Huang YW, Huang THM, Salzman N, Liu Z, Rosenberg D, Yang GY, Yang W, Bi X, Carmella S, Hecht S, Stoner G) Anthocyanins in Health and Disease 1 January 2013:225-243 2 Citations |
| 4 | SU‐E‐CAMPUS‐T‐01: Dosimetric Benefits of Online Adaptive Replanning for Lung Cancer with Multiple Targets (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, li X) Medical Physics June 2013;40(6):379 |
| 2 | SU‐E‐T‐464: Dosimetric Assessment of a New Multi‐Center Protocol for Radiotherapy of Multiple Ipsilateral Breast Cancers (Chen G, Currey A, Yen T, li X) Medical Physics June 2013;40(6):312 |
| 1 | Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. (Komaki R, Khalid N, Langer CJ, Kong FM, Owen JB, Crozier CL, Wilson JF, Wei X, Movsas B) Int J Radiat Oncol Biol Phys 2013 Mar 15;85(4):1082-9 49 Citations |
| 1 | Recent advances in systemic therapies and radiotherapy for gallbladder cancer. (Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin TC) Surg Oncol 2013 Mar;22(1):61-7 32 Citations |
| 1 | Do older Americans undergo stoma reversal following low anterior resection for rectal cancer? (Dodgion CM, Neville BA, Lipsitz SR, Hu YY, Schrag D, Breen E, Greenberg CC) J Surg Res 2013 Jul;183(1):238-45 26 Citations |
| 3 | Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin. (Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B, Evans DB) Surgery 2013 Jul;154(1):123-31 43 Citations |
| 1 | Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment. (Falchook GS, Janku F, Tsao AS, Bastida CC, Stewart DJ, Kurzrock R) J Thorac Oncol 2013 Feb;8(2):e19-20 25 Citations |
| 1 | Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas in Wisconsin. (Cetnar JP, Hampton JM, Williamson AA, Downs T, Wang D, Owen JB, Crouse B, Jones N, Wilson JF, Trentham-Dietz A) Urology 2013 Mar;81(3):540-6 14 Citations |
| 1 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. (Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS) J Urol 2013 Jul;190(1):102-8 52 Citations |
| 1 | Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer. (Iovanna JL, Marks DL, Fernandez-Zapico ME, Urrutia R) Am J Pathol 2013 Apr;182(4):1078-86 15 Citations |
| 1 | Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. (Nangia-Makker P, Raz T, Tait L, Shekhar MP, Li H, Balan V, Makker H, Fridman R, Maddipati K, Raz A) Cancer Biol Ther 2013 May;14(5):417-27 32 Citations |
| 1 | Endoscopic mis-sizing of polyps changes colorectal cancer surveillance recommendations. (Eichenseer PJ, Dhanekula R, Jakate S, Mobarhan S, Melson JE) Dis Colon Rectum 2013 Mar;56(3):315-21 66 Citations |
| 1 | Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. (Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R) Oncotarget 2013 Jan;4(1):156-65 31 Citations |
| 1 | Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation. (Janku F, Wheler JJ, Hong DS, Kurzrock R) Target Oncol 2013 Sep;8(3):183-188 6 Citations |
| 1 | Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial. (Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D) Menopause 2013 Aug;20(8):840-4 |
| 1 | Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancer. (Falchook GS, Naing A, Hong DS, Zinner R, Fu S, Piha-Paul SA, Tsimberidou AM, Morgan-Linnell SK, Jiang Y, Bastida C, Wheler JJ, Kurzrock R) Oncotarget 2013 Jan;4(1):118-27 31 Citations |
| 1 | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. (Fogeron ML, Müller H, Schade S, Dreher F, Lehmann V, Kühnel A, Scholz AK, Kashofer K, Zerck A, Fauler B, Lurz R, Herwig R, Zatloukal K, Lehrach H, Gobom J, Nordhoff E, Lange BM) Nat Commun 2013;4:1531 59 Citations |
| 1 | Regional therapies for cancer. (Gamblin TC, Alexander HR, Edwards R, Bartlett DL) Ann Surg Oncol 2013 Apr;20(4):1053-5 1 Citation |
| 1 | Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy. (Hong DS, George GC, Iwuanyanwu EC, Tavana B, Falchook GS, Piha-Paul SA, Wheler JJ, Mistry RH, Lei X, Kurzrock R) J Cancer Res Clin Oncol 2013 Jun;139(6):963-70 8 Citations |
| 1 | Compliance in early-phase cancer clinical trials research. (Kurzrock R, Stewart DJ) Oncologist 2013;18(3):308-13 12 Citations |
| 1 | Thyroid gland: Can a nomogram predict death in patients with thyroid cancer? (Wang TS, Sosa JA) Nat Rev Endocrinol 2013 Apr;9(4):192-3 4 Citations |
| 2 | Modern perspectives on factors predisposing to the development of gallbladder cancer. (Pilgrim CH, Groeschl RT, Christians KK, Gamblin TC) HPB (Oxford) 2013 Nov;15(11):839-44 46 Citations |
| 1 | Evaluation of Adherence to Quality Measures for Prostate Cancer Radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) Survey. (Zelefsky MJ, Lee WR, Zietman A, Khalid N, Crozier C, Owen J, Wilson JF) Pract Radiat Oncol 2013 Jan;3(1):2-8 20 Citations |
| 1 | Expression and humoral response of A-kinase anchor protein 4 in cervical cancer. (Agarwal S, Saini S, Parashar D, Verma A, Jagadish N, Batra A, Suri S, Bhatnagar A, Gupta A, Ansari AS, Lohiya NK, Suri A) Int J Gynecol Cancer 2013 May;23(4):650-8 22 Citations |
| 1 | Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer. (Flynn KE, Reeve BB, Lin L, Cyranowski JM, Bruner DW, Weinfurt KP) Health Qual Life Outcomes 2013 Mar 11;11:40 46 Citations |
| 1 | Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. (Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP) J Sex Med 2013 Feb;10 Suppl 1(0 1):43-52 139 Citations |
| 1 | The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool. (Popovic M, Lao N, Zeng L, Zhang L, Cella D, Beaumont JL, Chow R, Chiu N, Chiu L, Lam H, Poon M, Chow E) Support Care Cancer 2013 Aug;21(8):2267-77 6 Citations |
| 1 | Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. (Goicoechea SM, García-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ, Kim HJ, Otey CA) Oncogene 2014 Mar 06;33(10):1265-73 99 Citations |
| 1 | Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. (Morris PG, Zhou XK, Milne GL, Goldstein D, Hawks LC, Dang CT, Modi S, Fornier MN, Hudis CA, Dannenberg AJ) Cancer Prev Res (Phila) 2013 May;6(5):428-36 61 Citations |
| 1 | Black women's awareness of breast cancer disparity and perceptions of the causes of disparity. (Kaiser K, Cameron KA, Curry G, Stolley M) J Community Health 2013 Aug;38(4):766-72 11 Citations |
| 2 | Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration. (Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM) Biol Blood Marrow Transplant 2013 Jun;19(6):858-9 2 Citations |
| 1 | High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer. (Pavlovich CP, Cornish TC, Mullins JK, Fradin J, Mettee LZ, Connor JT, Reese AC, Askin FB, Luck R, Epstein JI, Burke HB) Urol Oncol 2014 Jan;32(1):34.e27-32 46 Citations |
| 1 | Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential. (Alexanian A, Sorokin A) Onco Targets Ther 2013;6:243-55 39 Citations |
| 1 | Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. (Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Alvarez Secord A, Lippmann LT, Dehdashti F, Rader JS) Gynecol Oncol 2013 Jul;130(1):64-8 72 Citations |
| 1 | Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B) Int J Radiat Oncol Biol Phys 2013 Jul 15;86(4):656-64 169 Citations |
| 2 | Morbidities of lung cancer surgery in obese patients. (Dhakal B, Eastwood D, Sukumaran S, Hassler G, Tisol W, Gasparri M, Choong N, Santana-Davila R) J Thorac Cardiovasc Surg 2013 Aug;146(2):379-84 28 Citations |
| 1 | Does initial laparoscopic cholecystectomy influence the outcomes of definitive oncologic resection for gallbladder cancer? (Ballo RM, Saeed M, Daly S, Pinzon M, Francescatti A, Millikan KW, Myers JA, Bines SF, Luu MB) Gastroenterology, abstract supplement 144(5):S-1115 |
| 1 | MicroRNAs and Recent Insights into Pediatric Ovarian Cancers. (Francis JC, Kolomeyevskaya N, Mach CM, Dietrich JE, Anderson ML) Front Oncol 2013;3:95 1 Citation |
| 1 | Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors. (Ludwig K, Tse ES, Wang JY) BMC Cancer 2013 May 02;13:221 20 Citations |
| 1 | Cognitive adaptation theory and quality of life in late-stage cancer patients. (Christianson HF, Weis JM, Fouad NA) J Psychosoc Oncol 2013;31(3):266-81 11 Citations |
| 1 | P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy. (Said R, Hong DS, Warneke CL, Lee JJ, Wheler JJ, Janku F, Naing A, Falchook GS, Fu S, Piha-Paul S, Tsimberidou AM, Kurzrock R) Oncotarget 2013 May;4(5):705-14 102 Citations |
| 1 | Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study. (Mott BT, He R, Chen X, Fox JM, Civin CI, Arav-Boger R, Posner GH) Bioorg Med Chem 2013 Jul 01;21(13):3702-7 36 Citations |
| 1 | Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience. (Lu Y, Jansen JF, Stambuk HE, Gupta G, Lee N, Gonen M, Moreira A, Mazaheri Y, Patel SG, Deasy JO, Shah JP, Shukla-Dave A) J Comput Assist Tomogr 2013;37(3):346-52 45 Citations |
| 1 | Patient barriers to follow-up care for breast and cervical cancer abnormalities. (Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA) J Womens Health (Larchmt) 2013 Jun;22(6):507-17 72 Citations |
| 1 | AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion (Seung-Keun Hong, Joseph H Jeong, Andrew M Chan, Jong-In Park) Experimental cell research |
| 3 | Diagnosis and treatment of lymphedema after breast cancer: a population-based study. (Sayko O, Pezzin LE, Yen TW, Nattinger AB) PM R 2013 Nov;5(11):915-23 16 Citations |
| 1 | Key factors influencing prognosis in relation to gallbladder cancer. (Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC) Dig Dis Sci 2013 Sep;58(9):2455-62 27 Citations |
| 1 | AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion. (Hong SK, Jeong JH, Chan AM, Park JI) Exp Cell Res 2013 Jul 15;319(12):1732-1743 21 Citations |
| 1 | Molecular profiling and the reclassification of cancer: divide and conquer. (Munoz J, Swanton C, Kurzrock R) Am Soc Clin Oncol Educ Book 2013:127-34 28 Citations |
| 1 | Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. (Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H) Radiother Oncol 2013 Jun;107(3):372-6 73 Citations |
| 1 | Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study. (Hoang T, Campbell TC, Zhang C, Kim K, Kolesar JM, Oettel KR, Blank JH, Robinson EG, Ahuja HG, Kirschling RJ, Johnson PH, Huie MS, Wims ME, Larson MM, Hernan HR, Traynor AM) Invest New Drugs 2014 Feb;32(1):195-9 36 Citations |
| 1 | Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise. (Gameiro SR, Jammeh ML, Hodge JW) Expert Rev Vaccines 2013 Jun;12(6):617-29 14 Citations |
| 1 | Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer. (Ganesan P, Piha-Paul S, Naing A, Falchook G, Wheler J, Fu S, Hong DS, Kurzrock R, Janku F, Laday S, Bedikian AY, Kies M, Wolff RA, Tsimberidou AM) Invest New Drugs 2014 Apr;32(2):279-86 14 Citations |
| 1 | The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. (Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, Lohiya NK, Suri A) Oncoimmunology 2013 May 01;2(5):e24270 39 Citations |
| 1 | Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo. (Saini S, Agarwal S, Sinha A, Verma A, Parashar D, Gupta N, Ansari AS, Lohiya NK, Jagadish N, Suri A) Cancer Gene Ther 2013 Jul;20(7):413-20 22 Citations |
| 1 | Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses. (Wheler J, Hong D, Swisher SG, Falchook G, Tsimberidou AM, Helgason T, Naing A, Stephen B, Janku F, Stephens PJ, Yelensky R, Kurzrock R) Oncotarget 2013 Jun;4(6):890-8 39 Citations |
| 4 | Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. (Cheng G, Zielonka J, McAllister DM, Mackinnon AC Jr, Joseph J, Dwinell MB, Kalyanaraman B) BMC Cancer 2013 Jun 13;13:285 111 Citations |
| 1 | A comparison of community-based and hospital-based head and neck cancer screening campaigns: identifying high-risk individuals and early disease. (Harris MS, Phillips DR, Sayer JL, Moore MG) JAMA Otolaryngol Head Neck Surg 2013 Jun;139(6):568-73 15 Citations |
| 1 | Dietary habits and esophageal cancer. (Palladino-Davis AG, Mendez BM, Fisichella PM, Davis CS) Dis Esophagus 2015 Jan;28(1):59-67 43 Citations |
| 1 | Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population. (Wheler J, Falchook G, Tsimberidou AM, Hong D, Naing A, Piha-Paul S, Chen SS, Heymach J, Fu S, Stephen B, Fok JY, Janku F, Kurzrock R) Oncotarget 2013 May;4(5):772-84 19 Citations |
| 2 | Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan. (Bischof AG, Yüksel D, Mammoto T, Mammoto A, Krause S, Ingber DE) Integr Biol (Camb) 2013 Aug;5(8):1045-56 35 Citations |
| 1 | A comparison of cancer survivors from the PROMIS study selecting telephone versus online questionnaires. (Williams MS, Snyder DC, Sloane R, Levens J, Flynn KE, Dombeck CB, Demark-Wahnefried W, Weinfurt KP) Psychooncology 2013 Nov;22(11):2632-5 5 Citations |
| 1 | Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer. (Suh SY, Choi YS, Yeom CH, Kwak SM, Yoon HM, Kim DG, Koh SJ, Park J, Lee MA, Lee YJ, Seo AR, Ahn HY, Yim E) Support Care Cancer 2013 Nov;21(11):3071-7 38 Citations |
| 2 | Comparison of various online strategies to account for interfractional variations for pancreatic cancer. (Ahunbay EE, Kimura B, Liu F, Erickson BA, Li XA) Int J Radiat Oncol Biol Phys 2013 Aug 01;86(5):914-21 12 Citations |
| 1 | Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. (Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL) Breast Cancer Res 2013;15(4):R55 77 Citations |
| 1 | A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. (Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA) Ann Surg Oncol 2013 Oct;20(11):3477-83 148 Citations |
| 1 | Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. (Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E) J Clin Oncol 2013 Sep 01;31(25):3076-82 272 Citations |
| 1 | Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer. (Cardnell RJ, Rabender CS, Ross GR, Guo C, Howlett EL, Alam A, Wang XY, Akbarali HI, Mikkelsen RB) J Pharmacol Exp Ther 2013 Oct;347(1):117-25 17 Citations |
| 1 | Endometrial echo complex thickness in postmenopausal endometrial cancer. (Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L) Gynecol Oncol 2013 Oct;131(1):109-12 14 Citations |
| 1 | Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. (Ma D, Hovey RL, Zhang Z, Fye S, Huettner PC, Borecki IB, Rader JS) Gynecol Oncol 2013 Nov;131(2):445-50 10 Citations |
| 1 | Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'? (Varadhachary GR, Evans DB) Ann Surg Oncol 2013 Nov;20(12):3712-4 5 Citations |
| 1 | Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. (Hsu PY, Hsu HK, Lan X, Juan L, Yan PS, Labanowska J, Heerema N, Hsiao TH, Chiu YC, Chen Y, Liu Y, Li L, Li R, Thompson IM, Nephew KP, Sharp ZD, Kirma NB, Jin VX, Huang TH) Cancer Cell 2013 Aug 12;24(2):197-212 45 Citations |
| 1 | Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations. (Wheler JJ, Tsimberidou AM, Falchook GS, Zinner RG, Hong DS, Fok JY, Fu S, Piha-Paul SA, Naing A, Kurzrock R) Mol Cancer Ther 2013 Oct;12(10):2167-75 33 Citations |
| 1 | Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. (Balko JM, Schwarz LJ, Bhola NE, Kurupi R, Owens P, Miller TW, Gómez H, Cook RS, Arteaga CL) Cancer Res 2013 Oct 15;73(20):6346-58 128 Citations |
| 1 | Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. (Wallace JA, Li F, Balakrishnan S, Cantemir-Stone CZ, Pecot T, Martin C, Kladney RD, Sharma SM, Trimboli AJ, Fernandez SA, Yu L, Rosol TJ, Stromberg PC, Lesurf R, Hallett M, Park M, Leone G, Ostrowski MC) PLoS One 2013;8(8):e71533 34 Citations |
| 2 | Corrigendum to "Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis" [Cancer Lett. 328 (2) (2012) 212-221] (McCleary-Wheeler AL, Lomberk GA, Weiss FU, Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna JL, Ellenrieder V, Urrutia R, Fernandez-Zapico ME) Cancer Letters 28 August 2013;337(1):143-144 |
| 3 | The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer. (O'Connell K, Yen TW, Quiroz F, Evans DB, Wang TS) Surgery 2013 Oct;154(4):697-701; discussion 701-3 52 Citations |
| 1 | Breast cancer patients' risk perceptions and treatment values following surgical consult. (Cameron KA, Stolley M, Bethke KP, Hansen NM, Jeruss JS, Clayman ML, Khan SA) J Clin Oncol 2013 Sep 10;31(26_suppl):36 |
| 1 | Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies. (Avigan D, Hari P, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Hsu KC) Biol Blood Marrow Transplant 2013 Dec;19(12):1661-9 11 Citations |
| 1 | Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells. (Kim J, Escalante LE, Dollar BA, Hanson SE, Hematti P) Cancer Invest 2013 Oct;31(8):550-4 22 Citations |
| 2 | Genomics of cervical cancer and the role of human papillomavirus pathobiology. (Uyar D, Rader J) Clin Chem 2014 Jan;60(1):144-6 44 Citations |
| 1 | Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528. (Gadgeel SM, Lew DL, Synold TW, LoRusso P, Chung V, Christensen SD, Smith DC, Kingsbury L, Hoering A, Kurzrock R) Cancer Chemother Pharmacol 2013 Nov;72(5):1089-96 25 Citations |
| 1 | Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. (Chen W, Ayala-Orozco C, Biswal NC, Perez-Torres C, Bartels M, Bardhan R, Stinnet G, Liu XD, Ji B, Deorukhkar A, Brown LV, Guha S, Pautler RG, Krishnan S, Halas NJ, Joshi A) Nanomedicine (Lond) 2014;9(8):1209-22 62 Citations |
| 1 | Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. (Kang Y, Hu W, Ivan C, Dalton HJ, Miyake T, Pecot CV, Zand B, Liu T, Huang J, Jennings NB, Rupaimoole R, Taylor M, Pradeep S, Wu SY, Lu C, Wen Y, Huang J, Liu J, Sood AK) J Natl Cancer Inst 2013 Oct 02;105(19):1485-95 165 Citations |
| 1 | The Cancer Genome Atlas Pan-Cancer analysis project. (Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM) Nat Genet 2013 Oct;45(10):1113-20 5911 Citations |
| 1 | RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. (Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA) Prostate Cancer Prostatic Dis 2013 Dec;16(4):382-6 29 Citations |
| 1 | Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model. (Bhowmick R, Girotti AW) Cancer Lett 2014 Feb 01;343(1):115-22 59 Citations |
| 1 | Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. (Ganesan P, Janku F, Naing A, Hong DS, Tsimberidou AM, Falchook GS, Wheler JJ, Piha-Paul SA, Fu S, Stepanek VM, Lee JJ, Luthra R, Overman MJ, Kopetz ES, Wolff RA, Kurzrock R) Mol Cancer Ther 2013 Dec;12(12):2857-63 41 Citations |
| 1 | Single-cell analysis reveals early manifestation of cancerous phenotype in pre-malignant esophageal cells. (Wang J, Shi X, Johnson RH, Kelbauskas L, Zhang W, Meldrum DR) PLoS One 2013;8(10):e75365 139 Citations |
| 2 | Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. (Zimmerman NP, Roy I, Hauser AD, Wilson JM, Williams CL, Dwinell MB) Mol Carcinog 2015 Mar;54(3):203-15 48 Citations |
| 1 | Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. (Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH) J Gastrointest Surg 2014 Feb;18(2):269-78; discussion 278 105 Citations |
| 1 | An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy. (Wen N, Kumarasiri A, Nurushev T, Burmeister J, Xing L, Liu D, Glide-Hurst C, Kim J, Zhong H, Movsas B, Chetty IJ) Phys Med Biol 2013 Nov 07;58(21):7733-44 17 Citations |
| 2 | Patient-reported outcomes in patients with nonmelanomatous skin cancers of the face treated with orthovoltage radiation therapy: a cross-sectional survey. (Kharofa J, Currey A, Wilson JF) Int J Radiat Oncol Biol Phys 2013 Nov 15;87(4):636-7 13 Citations |
| 1 | Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit. (Fu S, McQuinn L, Naing A, Wheler JJ, Janku F, Falchook GS, Piha-Paul SA, Tu D, Howard A, Tsimberidou A, Zinner R, Hong DS, Kurzrock R) Oncologist 2013;18(12):1315-20 17 Citations |
| 1 | Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. (Falchook GS, Moulder SL, Wheler JJ, Jiang Y, Bastida CC, Kurzrock R) Ann Oncol 2013 Dec;24(12):3004-11 29 Citations |
| 1 | Review of estrogen receptor, progesterone receptor, and HER-2/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution. (Jorns JM, Healy P, Zhao L) Arch Pathol Lab Med 2013 Nov;137(11):1660-3 14 Citations |
| 1 | A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy. (Kim J, Kumar S, Liu C, Zhong H, Pradhan D, Shah M, Cattaneo R, Yechieli R, Robbins JR, Elshaikh MA, Chetty IJ) Phys Med Biol 2013 Nov 21;58(22):8077-97 33 Citations |
| 1 | Predictive value of phase I trials for safety in later trials and final approved dose: analysis of 61 approved cancer drugs. (Jardim DL, Hess KR, Lorusso P, Kurzrock R, Hong DS) Clin Cancer Res 2014 Jan 15;20(2):281-8 44 Citations |
| 1 | The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer. (Sato T, Neschadim A, Lavie A, Yanagisawa T, Medin JA) PLoS One 2013;8(10):e78711 28 Citations |
| 1 | Sensitizing cancer cells to TRAIL-induced death by micellar delivery of mitoxantrone. (Grandhi TS, Potta T, Taylor DJ, Tian Y, Johnson RH, Meldrum DR, Rege K) Nanomedicine (Lond) 2014;9(12):1775-88 6 Citations |
| 1 | The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer. (Hauser AD, Bergom C, Schuld NJ, Chen X, Lorimer EL, Huang J, Mackinnon AC, Williams CL) Mol Cancer Res 2014 Jan;12(1):130-42 24 Citations |
| 1 | The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. (Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W) J Am Geriatr Soc 2013 Nov;61(11):2043-4 12 Citations |
| 2 | Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. (Wang B, Zhao B, North P, Kong A, Huang J, Miao QR) PLoS One 2013;8(11):e78083 40 Citations |
| 1 | Protein-tyrosine phosphatase H1 increases breast cancer sensitivity to antiestrogens by dephosphorylating estrogen receptor at Tyr537. (Suresh PS, Ma S, Migliaccio A, Chen G) Mol Cancer Ther 2014 Jan;13(1):230-8 22 Citations |
| 3 | Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer". (Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS) Surgery 2013 Dec;154(6):1307-13; discussion 1313-4 32 Citations |
| 1 | Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. (Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH) J Gastrointest Surg 2014 Jan;18(1):16-24; discussion 24-5 171 Citations |
| 1 | Variation in referral practice for patients with colorectal cancer liver metastases. (Young AL, Adair R, Culverwell A, Guthrie JA, Botterill ID, Toogood GJ, Lodge JP, Prasad KR) Br J Surg 2013 Nov;100(12):1627-32 30 Citations |
| 1 | Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. (Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS) Oncogene 2014 Nov 20;33(47):5450-6 18 Citations |
| 1 | Enhanced luminescence of CaMoO₄:Eu by core@shell formation and its hyperthermia study after hybrid formation with Fe₃O₄: cytotoxicity assessment on human liver cancer cells and mesenchymal stem cells. (Parchur AK, Ansari AA, Singh BP, Hasan TN, Syed NA, Rai SB, Ningthoujam RS) Integr Biol (Camb) 2014 Jan;6(1):53-64 71 Citations |
| 1 | Genetic variations at microRNA and processing genes and risk of oral cancer. (Roy R, De Sarkar N, Ghose S, Paul RR, Pal M, Bhattacharya C, Chowdhury SK, Ghosh S, Roy B) Tumour Biol 2014 Apr;35(4):3409-14 30 Citations |
| 1 | Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation. (Zhang Y, Dayalan Naidu S, Samarasinghe K, Van Hecke GC, Pheely A, Boronina TN, Cole RN, Benjamin IJ, Cole PA, Ahn YH, Dinkova-Kostova AT) Br J Cancer 2014 Jan 07;110(1):71-82 26 Citations |
| 1 | A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese. (Chu M, Zhang R, Zhao Y, Wu C, Guo H, Zhou B, Lu J, Shi Y, Dai J, Jin G, Ma H, Dong J, Wei Y, Wang C, Gong J, Sun C, Zhu M, Qiu Y, Wu T, Hu Z, Lin D, Shen H, Chen F) Carcinogenesis 2014 Mar;35(3):572-7 29 Citations |
| 1 | Multivariate analysis of factors effecting overall survival in minority based population of breast cancer patients receiving neoadjuvant chemotherapy: A single institution experience (M Shah; S Jain; S Abhijai) Cancer Research Cancer Res (2013) 73 (24_Supplement): P6-06-51. |
| 1 | Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy. (Sinha A, Agarwal S, Parashar D, Verma A, Saini S, Jagadish N, Ansari AS, Lohiya NK, Suri A) J Exp Clin Cancer Res 2013 Sep 19;32(1):69 42 Citations |
| 1 | Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. (Prabhu RS, Magliocca KR, Hanasoge S, Aiken AH, Hudgins PA, Hall WA, Chen SA, Eaton BR, Higgins KA, Saba NF, Beitler JJ) Int J Radiat Oncol Biol Phys 2014 Jan 01;88(1):122-9 86 Citations |
| 5 | Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein. (Pilgrim CH, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK) J Gastrointest Surg 2014 May;18(5):917-21 35 Citations |
| 1 | Managing breast cancers with low estrogen receptor and HER2 by drugging both. (Miller TW) Clin Cancer Res 2014 Feb 01;20(3):528-30 2 Citations |
| 4 | Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. (Yen TW, Laud PW, Sparapani RA, Nattinger AB) JAMA Surg 2014 Feb;149(2):185-92 29 Citations |
| 1 | Erratum: Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy (Abdominal Imaging (2006) 31 (568-574) DOI: 10.1007/s00261-005-0194-y) (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdominal Imaging February 2014;39(1):236 |
| 1 | Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors. (Wang C, Zimmermann MT, Prodduturi N, Chute CG, Jiang G) AMIA Annu Symp Proc 2014;2014:1160-9 2 Citations |
| 1 | PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models. (Kawar N, Maclaughlan S, Horan TC, Uzun A, Lange TS, Kim KK, Hopson R, Singh AP, Sidhu PS, Glass KA, Shaw S, Padbury JF, Vorsa N, Arnold LA, Moore RG, Brard L, Singh RK) Genes Cancer 2013 Nov;4(11-12):524-34 10 Citations |
| 1 | Therapeutic targeting of cancers with loss of PTEN function. (Dillon LM, Miller TW) Curr Drug Targets 2014 Jan;15(1):65-79 194 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 39 Citations |
| 1 | NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. (Schroeder RD, Angelo LS, Kurzrock R) Oncotarget 2014 Jan 15;5(1):67-77 52 Citations |
| 1 | Optimizing rectal cancer management: analysis of current evidence. (Abbas MA, Chang GJ, Read TE, Rothenberger DA, Garcia-Aguilar J, Peters W, Monson JR, Sharma A, Dietz DW, Madoff RD, Fleshman JW, Greene FL, Wexner SD, Remzi FH, Consortium for Optimizing Surgical Treatment of Rectal Cancer) Dis Colon Rectum 2014 Feb;57(2):252-9 27 Citations |
| 1 | A cancer trial scandal and its regulatory backlash. (Kurzrock R, Kantarjian H, Stewart DJ) Nat Biotechnol 2014 Jan;32(1):27-31 13 Citations |
| 1 | Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. (Eifel PJ, Ho A, Khalid N, Erickson B, Owen J) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):249-56 81 Citations |
| 1 | Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer. (Wu D, Sunkel B, Chen Z, Liu X, Ye Z, Li Q, Grenade C, Ke J, Zhang C, Chen H, Nephew KP, Huang TH, Liu Z, Jin VX, Wang Q) Nucleic Acids Res 2014 Apr;42(6):3607-22 109 Citations |
| 1 | Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers. (Wheler JJ, Janku F, Falchook GS, Jackson TL, Fu S, Naing A, Tsimberidou AM, Moulder SL, Hong DS, Yang H, Piha-Paul SA, Atkins JT, Garcia-Manero G, Kurzrock R) Cancer Chemother Pharmacol 2014 Mar;73(3):495-501 53 Citations |
| 1 | Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all! (Kharfan-Dabaja MA, Hamadani M, Sibai H, Savani BN) Bone Marrow Transplant 2014 May;49(5):599-606 27 Citations |
| 1 | Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. (Kerns SL, Ostrer H, Rosenstein BS) Cancer Discov 2014 Feb;4(2):155-65 97 Citations |
| 1 | Regulation of ferroptotic cancer cell death by GPX4. (Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR) Cell 2014 Jan 16;156(1-2):317-331 5297 Citations |
| 1 | Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long? (White RR, Evans DB) Ann Surg Oncol 2014 May;21(5):1508-9 1 Citation |
| 1 | Th17 cells in cancer (Paulos CM, Nelson MH, Yu XZ) Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal 1 February 2014:37-75 1 Citation |
| 1 | Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study. [26, 2, 204-212] (Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RKG, Schwartz LH, Koutcher JA, Zakian KL) NMR in Biomedicine February 2014;27(2):235 |
| 1 | S-Nitrosation of monocarboxylate transporter 1: inhibition of pyruvate-fueled respiration and proliferation of breast cancer cells. (Diers AR, Broniowska KA, Chang CF, Hill RB, Hogg N) Free Radic Biol Med 2014 Apr;69:229-38 16 Citations |
| 1 | Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. (Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ) Cancer 2014 May 15;120(10):1499-506 58 Citations |
| 1 | Comorbidity burden and guideline-concordant care for breast cancer. (Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF, Lund MJ, Cress R, Anderson RT, Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Am Geriatr Soc 2014 Mar;62(3):482-8 34 Citations |
| 1 | Social networking site usage among childhood cancer survivors--a potential tool for research recruitment? (Seltzer ED, Stolley MR, Mensah EK, Sharp LK) J Cancer Surviv 2014 Sep;8(3):349-54 16 Citations |
| 1 | SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers. (Schuld NJ, Hauser AD, Gastonguay AJ, Wilson JM, Lorimer EL, Williams CL) Cell Cycle 2014;13(6):941-52 18 Citations |
| 1 | Regional therapies for advanced cancer. (Turaga KK, Gamblin TC) Ann Surg Oncol 2014 May;21(5):1426-8 2 Citations |
| 1 | Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study. (Venkatasubramanian PN, Brendler CB, Plunkett BA, Crawford SE, Fitchev PS, Morgan G, Cornwell ML, McGuire MS, Wyrwicz AM, Doll JA) Prostate 2014 Feb;74(3):326-35 34 Citations |
| 6 | Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? (Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B) Oncologist 2014 Mar;19(3):266-74 173 Citations |
| 1 | Acr appropriateness Criteria management of vaginal cancer. (Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK) Oncology (Williston Park) 2013 Nov;27(11):1166-73 22 Citations |
| 1 | EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. (Lee YJ, Suh SY, Choi YS, Shim JY, Seo AR, Choi SE, Ahn HY, Yim E) Support Care Cancer 2014 Jul;22(7):1941-8 35 Citations |
| 1 | Polymeric micelles for apoptosis-targeted optical imaging of cancer and intraoperative surgical guidance. (Cho H, Cho CS, Indig GL, Lavasanifar A, Vakili MR, Kwon GS) PLoS One 2014;9(2):e89968 16 Citations |
| 1 | Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancer. (Tsimberidou AM, Adamopoulos AM, Ye Y, Piha-Paul S, Janku F, Fu S, Hong D, Falchook GS, Naing A, Wheler J, Fortier A, Kurzrock R, Hess KR) J Natl Compr Canc Netw 2014 Feb;12(2):194-203 3 Citations |
| 1 | Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. (Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O'Grady E, Rilling WS, Walker D, Martin RC) J Vasc Interv Radiol 2014 Mar;25(3):365-9 52 Citations |
| 1 | Cost effectiveness of routine laparoscopic ultrasound for assessment of resectability of gallbladder cancer. (Nadeem H, Jayakrishnan TT, Groeschl RT, Zacharias A, Clark Gamblin T, Turaga KK) Ann Surg Oncol 2014 Jul;21(7):2413-9 2 Citations |
| 1 | HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. (Rath KS, Naidu SK, Lata P, Bid HK, Rivera BK, McCann GA, Tierney BJ, Elnaggar AC, Bravo V, Leone G, Houghton P, Hideg K, Kuppusamy P, Cohn DE, Selvendiran K) Cancer Res 2014 Apr 15;74(8):2316-27 76 Citations |
| 1 | Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82 62 Citations |
| 2 | CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400 78 Citations |
| 1 | Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol. (Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA) Int J Radiat Oncol Biol Phys 2014 Mar 15;88(4):771-7 43 Citations |
| 1 | MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. (Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)) Cancer 2014 May 15;120(10):1453-61 874 Citations |
| 1 | Socioeconomic disparities in mortality after cancer surgery: failure to rescue. (Reames BN, Birkmeyer NJ, Dimick JB, Ghaferi AA) JAMA Surg 2014 May;149(5):475-81 108 Citations |
| 2 | Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models. (Moraru IC, Tai A, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):13-9 37 Citations |
| 1 | CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. (Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer Res 2014 May 15;74(10):2677-87 35 Citations |
| 1 | Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. (Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S, SIOG Radiotherapy Task Force) Ann Oncol 2014 Nov;25(11):2134-2146 89 Citations |
| 1 | Hepatic arterial infusion therapy in advanced cancer and liver-predominant disease: the MD Anderson Experience. (Tsimberidou AM, Vaklavas C, Fu S, Wen S, Lim JA, Hong D, Wheler J, Naing A, Uehara C, Wallace M, Kurzrock R) Hepatogastroenterology 2013 Oct;60(127):1611-23 11 Citations |
| 1 | Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. (Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD) J Comp Eff Res 2014 Mar;3(2):135-44 15 Citations |
| 1 | A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility. (Zhang R, Chu M, Zhao Y, Wu C, Guo H, Shi Y, Dai J, Wei Y, Jin G, Ma H, Dong J, Yi H, Bai J, Gong J, Sun C, Zhu M, Wu T, Hu Z, Lin D, Shen H, Chen F) Carcinogenesis 2014 Jul;35(7):1528-35 52 Citations |
| 1 | HER2 aberrations in cancer: implications for therapy. (Yan M, Parker BA, Schwab R, Kurzrock R) Cancer Treat Rev 2014 Jul;40(6):770-80 194 Citations |
| 1 | The Role of STAT3 in Thyroid Cancer. (Sosonkina N, Starenki D, Park JI) Cancers (Basel) 2014 Mar 06;6(1):526-44 31 Citations |
| 2 | Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data. (Santana-Davila R, Szabo A, Arce-Lara C, Williams CD, Kelley MJ, Whittle J) J Thorac Oncol 2014 May;9(5):702-9 46 Citations |
| 1 | Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study. (Mittal BB, Pauloski BR, Rademaker AW, Discekici-Harris M, Helenowski IB, Mellot A, Agulnik M, Logemann JA) Head Neck 2015 Apr;37(4):567-72 14 Citations |
| 1 | Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways. (Zheng Y, Chow SO, Boernert K, Basel D, Mikuscheva A, Kim S, Fong-Yee C, Trivedi T, Buttgereit F, Sutherland RL, Dunstan CR, Zhou H, Seibel MJ) J Bone Miner Res 2014 Sep;29(9):1938-49 38 Citations |
| 3 | Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. (Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Pappas S, Gamblin TC, Turaga KK) Surg Endosc 2014 May;28(5):1505-14 8 Citations |
| 1 | Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. (Baumgart S, Chen NM, Siveke JT, König A, Zhang JS, Singh SK, Wolf E, Bartkuhn M, Esposito I, Heßmann E, Reinecke J, Nikorowitsch J, Brunner M, Singh G, Fernandez-Zapico ME, Smyrk T, Bamlet WR, Eilers M, Neesse A, Gress TM, Billadeau DD, Tuveson D, Urrutia R, Ellenrieder V) Cancer Discov 2014 Jun;4(6):688-701 99 Citations |
| 1 | Associations between religion-related factors and breast cancer screening among American Muslims. (Padela AI, Murrar S, Adviento B, Liao C, Hosseinian Z, Peek M, Curlin F) J Immigr Minor Health 2015 Jun;17(3):660-9 79 Citations |
| 1 | Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. (Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, Hu Z) Gene 2014 Jun 10;543(1):101-7 55 Citations |
| 1 | AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. (Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Rader J, Grigsby PW, Schwarz JK) PLoS One 2014;9(4):e92948 76 Citations |
| 1 | Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. (Butterfield LH, Economou JS, Gamblin TC, Geller DA) J Transl Med 2014 Apr 05;12:86 50 Citations |
| 1 | Emerging Optical Techniques for Detection of Oral, Cervical and Anal Cancer in Low-Resource Settings (Bing Yu, Daron G. Ferris, Yang Liu, Vivek Krishna Nagarajan) Austin J Biomed Eng |
| 1 | Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function. (Mouradian M, Kikawa KD, Dranka BP, Komas SM, Kalyanaraman B, Pardini RS) Mol Carcinog 2015 Sep;54(9):810-20 46 Citations |
| 1 | Preliminary evaluation of the dosimetric accuracy of the in vivo plastic scintillation detector OARtrac system for prostate cancer treatments. (Klawikowski SJ, Zeringue C, Wootton LS, Ibbott GS, Beddar S) Phys Med Biol 2014 May 07;59(9):N27-36 13 Citations |
| 1 | Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed. (Patki M, Gadgeel S, Huang Y, McFall T, Shields AF, Matherly LH, Bepler G, Ratnam M) J Thorac Oncol 2014 Apr;9(4):519-26 27 Citations |
| 2 | Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 103 Citations |
| 1 | Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. (Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AE, Silverstein RL, Gladson CL, DiDonato JA, Brown JM, McIntyre T, Hazen SL, Horbinski C, Rich JN, Lathia JD) Stem Cells 2014 Jul;32(7):1746-58 194 Citations |
| 1 | MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit. (Jardim DL, de Melo Gagliato D, Falchook GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S, Murphy MB, Ajani J, Tang C, Hess K, Hamilton SR, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS) Oncotarget 2014 Apr 15;5(7):1837-45 28 Citations |
| 1 | Notch3 pathway alterations in ovarian cancer. (Hu W, Liu T, Ivan C, Sun Y, Huang J, Mangala LS, Miyake T, Dalton HJ, Pradeep S, Rupaimoole R, Previs RA, Han HD, Bottsford-Miller J, Zand B, Kang Y, Pecot CV, Nick AM, Wu SY, Lee JS, Sehgal V, Ram P, Liu J, Tucker SL, Lopez-Berestein G, Baggerly KA, Coleman RL, Sood AK) Cancer Res 2014 Jun 15;74(12):3282-93 59 Citations |
| 1 | MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. (Hong DS, Hui D, Bruera E, Janku F, Naing A, Falchook GS, Piha-Paul S, Wheler JJ, Fu S, Tsimberidou AM, Stecher M, Mohanty P, Simard J, Kurzrock R) Lancet Oncol 2014 May;15(6):656-66 178 Citations |
| 1 | Hospital variation in sphincter preservation for elderly rectal cancer patients. (Dodgion CM, Neville BA, Lipsitz SR, Schrag D, Breen E, Zinner MJ, Greenberg CC) J Surg Res 2014 Sep;191(1):161-8 13 Citations |
| 1 | Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer. (Gharpure KM, Chu KS, Bowerman CJ, Miyake T, Pradeep S, Mangala SL, Han HD, Rupaimoole R, Armaiz-Pena GN, Rahhal TB, Wu SY, Luft JC, Napier ME, Lopez-Berestein G, DeSimone JM, Sood AK) Mol Cancer Ther 2014 Jul;13(7):1750-7 29 Citations |
| 2 | Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. (Dalah E, Moraru I, Paulson E, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2014 Jul 01;89(3):633-40 36 Citations |
| 1 | Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy. (Bilen MA, Durand JB, McQuinn L, Hess KR, Fu S, Falchook GS, Hong DS, Wheler JJ, Said R, Ewer MS, Kurzrock R, Naing A) Invest New Drugs 2014 Aug;32(4):717-22 3 Citations |
| 1 | Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology survey. (Rengan R, Ho A, Owen JB, Komaki R, Khalid N, Wilson JF, Movsas B) Pract Radiat Oncol 2014;4(3):e167-e179 2 Citations |
| 1 | The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. (Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN) Pract Radiat Oncol 2014;4(3):137-144 163 Citations |
| 1 | Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Bodurka D, Schmeler K, Tsimberidou A, Janku F, Zinner R, Piha-Paul S, Hu CY, Lu K, Kurzrock R, Fu S) Anticancer Res 2014 May;34(5):2349-55 7 Citations |
| 1 | Radiation therapy for non-melanoma skin cancer in immunosuppressed patients and cutaneous toxicity from this therapy (Currey AD, Olasz EB, Wilson JF, Lazarova Z) Skin Diseases in the Immunocompromised 1 May 2014:171-182 |
| 1 | Variability in assessing treatment response: metastatic colorectal cancer as a paradigm. (Zhao B, Lee SM, Lee HJ, Tan Y, Qi J, Persigehl T, Mozley DP, Schwartz LH) Clin Cancer Res 2014 Jul 01;20(13):3560-8 15 Citations |
| 1 | Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity. (Kong R, Liu T, Zhu X, Ahmad S, Williams AL, Phan AT, Zhao H, Scott JE, Yeh LA, Wong ST) Clin Cancer Res 2014 Jul 01;20(13):3521-30 82 Citations |
| 5 | Arterial resection at the time of pancreatectomy for cancer. (Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB) Surgery 2014 May;155(5):919-26 87 Citations |
| 1 | Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. (Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Siddik ZH) Lung Cancer 2014 Jul;85(1):88-93 71 Citations |
| 1 | Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. (Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R) Oncologist 2014 Jun;19(6):631-6 158 Citations |
| 1 | Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. (Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, Moulder S, Valero V, Schwaederle M, Yelensky R, Miller VA, Stephens MP, Meric-Bernstam F, Kurzrock R) Oncotarget 2014 May 15;5(9):2349-54 52 Citations |
| 1 | Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells. (Opyrchal M, Salisbury JL, Zhang S, McCubrey J, Hawse J, Goetz MP, Lomberk GA, Haddad T, Degnim A, Lange C, Ingle JN, Galanis E, D'Assoro AB) PLoS One 2014;9(5):e96995 29 Citations |
| 2 | Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. (Nudelman KN, Wang Y, McDonald BC, Conroy SK, Smith DJ, West JD, O'Neill DP, Schneider BP, Saykin AJ) PLoS One 2014;9(5):e96713 49 Citations |
| 7 | 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25 30 Citations |
| 1 | Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer. (Reusser NM, Dalton HJ, Pradeep S, Gonzalez-Villasana V, Jennings NB, Vasquez HG, Wen Y, Rupaimoole R, Nagaraja AS, Gharpure K, Miyake T, Huang J, Hu W, Lopez-Berestein G, Sood AK) Cancer Biol Ther 2014 Aug;15(8):1061-7 32 Citations |
| 4 | Molecular profiling in gastric cancer: examining potential targets for chemotherapy. (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2014 Sep;110(3):302-6 9 Citations |
| 4 | Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. (Cheng G, Zielonka J, McAllister D, Tsai S, Dwinell MB, Kalyanaraman B) Br J Cancer 2014 Jul 08;111(1):85-93 74 Citations |
| 1 | SU-F-BRF-15: Interfractional Dose Variations in Parotid and Submandibular Glands in IG-IMRT for Head and Neck Cancer. (Chen X, Botros M, Ahunbay E, Wang D, Schultz C, Li X) Med Phys 2014 Jun;41(6):402 |
| 2 | SU-E-J-241: Creation of Ventilation CT From Daily 4D CTs Or 4D Conebeam CTs Acquired During IGRT for Thoracic Cancers. (Tai A, Ahunbay E, Li X) Med Phys 2014 Jun;41(6):213 |
| 1 | Quality of life, shoulder range of motion, and spinal accessory nerve status in 5-year survivors of head and neck cancer. (Eickmeyer SM, Walczak CK, Myers KB, Lindstrom DR, Layde P, Campbell BH) PM R 2014 Dec;6(12):1073-80 41 Citations |
| 1 | SU-E-J-239: IMRT Planning of Prostate Cancer for a MRI-Linac Based On MRI Only. (Chen X, Prior P, Paulson E, Lawton C, Li X) Med Phys 2014 Jun;41(6):212 |
| 1 | SU-E-J-193: Feasibility of MRI-Only Based IMRT Planning for Pancreatic Cancer. (Prior P, Botros M, Chen X, Paulson E, Erickson B, Li X) Med Phys 2014 Jun;41(6):201 |
| 3 | MO-C-17A-06: Online Adaptive Re-Planning to Account for Independent Motions Between Multiple Targets During Radiotherapy of Lung Cancer. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):415 |
| 2 | SU-E-J-190: Characterization of Radiation Induced CT Number Changes in Tumor and Normal Lung During Radiation Therapy for Lung Cancer. (Yang C, Liu F, Tai A, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):200 |
| 1 | SU-E-J-136: Multimodality-Image-Based Target Delineation for Dose Painting of Pancreatic Cancer. (Dalah E, Paulson E, Erickson B, Li X) Med Phys 2014 Jun;41(6):187 |
| 1 | Association between risk of oral precancer and genetic variations in microRNA and related processing genes. (Roy R, De Sarkar N, Ghose S, Paul RR, Ray A, Mukhopadhyay I, Roy B) J Biomed Sci 2014 May 17;21(1):48 18 Citations |
| 1 | Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshells. (Ayala-Orozco C, Urban C, Knight MW, Urban AS, Neumann O, Bishnoi SW, Mukherjee S, Goodman AM, Charron H, Mitchell T, Shea M, Roy R, Nanda S, Schiff R, Halas NJ, Joshi A) ACS Nano 2014 Jun 24;8(6):6372-81 332 Citations |
| 1 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. (Barrdahl M, Canzian F, Joshi AD, Travis RC, Chang-Claude J, Auer PL, Gapstur SM, Gaudet M, Diver WR, Henderson BE, Haiman CA, Schumacher FR, Le Marchand L, Berg CD, Chanock SJ, Hoover RN, Rudolph A, Ziegler RG, Giles GG, Baglietto L, Severi G, Hankinson SE, Lindström S, Willet W, Hunter DJ, Buring JE, Lee IM, Zhang S, Dossus L, Cox DG, Khaw KT, Lund E, Naccarati A, Peeters PH, Quirós JR, Riboli E, Sund M, Trichopoulos D, Prentice RL, Kraft P, Kaaks R, Campa D) Hum Mol Genet 2014 Oct 01;23(19):5260-70 34 Citations |
| 1 | Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Discekici-Harris M, Mittal BB) Head Neck 2015 Nov;37(11):1575-82 41 Citations |
| 1 | Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. (Padela AI, Peek M, Johnson-Agbakwu CE, Hosseinian Z, Curlin F) J Low Genit Tract Dis 2014 Oct;18(4):326-32 68 Citations |
| 1 | Improving enrollment in clinical trials for adolescents with cancer. (Shaw PH, Hayes-Lattin B, Johnson R, Bleyer A) Pediatrics 2014 Jun;133 Suppl 3:S109-13 31 Citations |
| 1 | MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells. (Brower JV, Clark PA, Lyon W, Kuo JS) Neurochem Int 2014 Nov;77:68-77 75 Citations |
| 3 | Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer. (Qi X, Xie C, Hou S, Li G, Yin N, Dong L, Lepp A, Chesnik MA, Mirza SP, Szabo A, Tsai S, Basir Z, Wu S, Chen G) Oncotarget 2014 Jun 30;5(12):4269-82 19 Citations |
| 1 | End-of-life care characteristics for young adults with cancer who die in the hospital. (Keim-Malpass J, Erickson JM, Malpass HC) J Palliat Med 2014 Dec;17(12):1359-64 39 Citations |
| 1 | Post-translational regulation of COX2 activity by FYN in prostate cancer cells. (Alexanian A, Miller B, Chesnik M, Mirza S, Sorokin A) Oncotarget 2014 Jun 30;5(12):4232-43 22 Citations |
| 1 | ACR appropriateness Criteria® advanced stage endometrial cancer. (Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK, Expert Panel on Radiation Oncology-Gynecology:) Am J Clin Oncol 2014 Aug;37(4):391-6 11 Citations |
| 1 | Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer. (Liu S, Meng X, Chen H, Liu W, Miller T, Murph M, Lu Y, Zhang F, Gagea M, Arteaga CL, Mills GB, Meric-Bernstam F, González-Angulo AM) Oncotarget 2014 Oct 15;5(19):9049-64 23 Citations |
| 1 | Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study. (Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CR, Duppen JC, Thomas CR Jr, Okunieff P, Jones WE 3rd, Kachnic LA, Papanikolaou N, Fuller CD, Southwest Oncology Group Radiation Oncology Committee) Radiother Oncol 2014 Sep;112(3):418-24 16 Citations |
| 2 | Deleted in Breast Cancer 1 regulates cellular senescence during obesity. (Escande C, Nin V, Pirtskhalava T, Chini CC, Thereza Barbosa M, Mathison A, Urrutia R, Tchkonia T, Kirkland JL, Chini EN) Aging Cell 2014 Oct;13(5):951-3 27 Citations |
| 1 | Childhood cancer survivors and adherence to the American Cancer Society Guidelines on Nutrition and Physical Activity. (Berdan CA, Tangney CC, Scala C, Stolley M) J Cancer Surviv 2014 Dec;8(4):671-9 44 Citations |
| 1 | Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses. (Tsimberidou AM, Wen S, Hong DS, Wheler JJ, Falchook GS, Fu S, Piha-Paul S, Naing A, Janku F, Aldape K, Ye Y, Kurzrock R, Berry D) Clin Cancer Res 2014 Sep 15;20(18):4827-36 175 Citations |
| 1 | Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. (Park JI) Front Biol (Beijing) 2014 Feb;9(2):95-103 42 Citations |
| 1 | Characteristics and survival of patients with advanced cancer and p53 mutations. (Said R, Ye Y, Hong DS, Janku F, Fu S, Naing A, Wheler JJ, Kurzrock R, Thomas C, Palmer GA, Hess KR, Aldape K, Tsimberidou AM) Oncotarget 2014 Jun 15;5(11):3871-9 11 Citations |
| 4 | Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT). (Chen X, Lu H, Tai A, Johnstone C, Gore E, Li XA) Int J Radiat Oncol Biol Phys 2014 Sep 01;90(1):102-9 14 Citations |
| 2 | Hematogenous metastasis of ovarian cancer: rethinking mode of spread. (Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM, Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK) Cancer Cell 2014 Jul 14;26(1):77-91 255 Citations |
| 5 | Quality of life among a population-based cohort of older patients with breast cancer. (Neuner JM, Zokoe N, McGinley EL, Pezzin LE, Yen TW, Schapira MM, Nattinger AB) Breast 2014 Oct;23(5):609-16 38 Citations |
| 2 | Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. (Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS) Biol Blood Marrow Transplant 2014 Nov;20(11):1777-84 54 Citations |
| 1 | EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. (Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S) Int J Cancer 2015 Jun 15;136(12):2752-60 243 Citations |
| 1 | Impact of ageing and body mass on cancer immunotherapy outcomes (Sckisel GD, Monjazeb AM, Mirsoian A, Zamora AE, Grossenbacher S, Murphy WJ) ,Tumor Immunology and Immunotherapy, pp.15-30, Oxford: Oxford University Press |
| 1 | Negative predictive value (NPV) of FDG PET-CT for nodal disease in clinically node-negative early stage lung cancer (AJCC 7th ed T1-2aN0) and identification of risk factors for occult nodal (pN1-N2) metastasis: Implications for SBRT (Paravati AJ, Johnstone DW, Seltzer MA, Johnstone CA) Translational Cancer Research 1 August 2014;3(4):313-319 13 Citations |
| 1 | A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. (Halperin DM, Phan AT, Hoff AO, Aaron M, Yao JC, Hoff PM) BMC Cancer 2014 Aug 02;14:561 13 Citations |
| 1 | Surgical resection of synchronously metastatic adrenocortical cancer. (Dy BM, Strajina V, Cayo AK, Richards ML, Farley DR, Grant CS, Harmsen WS, Evans DB, Grubbs EG, Bible KC, Young WF, Perrier ND, Que FG, Nagorney DM, Lee JE, Thompson GB) Ann Surg Oncol 2015 Jan;22(1):146-51 42 Citations |
| 3 | Anticancer activity of VDR-coregulator inhibitor PS121912. (Sidhu PS, Teske K, Feleke B, Yuan NY, Guthrie ML, Fernstrum GB, Vyas ND, Han L, Preston J, Bogart JW, Silvaggi NR, Cook JM, Singh RK, Bikle DD, Arnold LA) Cancer Chemother Pharmacol 2014 Oct;74(4):787-98 20 Citations |
| 1 | A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers. (De Sarkar N, Roy R, Mitra JK, Ghose S, Chakraborty A, Paul RR, Mukhopadhyay I, Roy B) PLoS One 2014;9(8):e104839 31 Citations |
| 5 | Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. (Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Feb;17(2):131-9 19 Citations |
| 1 | Polymorphisms in immune mediators associate with risk of cervical cancer. (Zhang Z, Fye S, Borecki IB, Rader JS) Gynecol Oncol 2014 Oct;135(1):69-73 15 Citations |
| 1 | Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. (Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN, Boardman L, Kohli M, Wang L) Eur Urol 2015 Jan;67(1):33-41 566 Citations |
| 1 | Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome. (Du M, Yuan T, Schilter KF, Dittmar RL, Mackinnon A, Huang X, Tschannen M, Worthey E, Jacob H, Xia S, Gao J, Tillmans L, Lu Y, Liu P, Thibodeau SN, Wang L) Hum Mol Genet 2015 Jan 01;24(1):154-66 48 Citations |
| 1 | Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines (Nadiya Sosonkina, Seung-Keun Hong, Dmytro Starenki, Jong-In Park) Genes & Genomics |
| 1 | A planning comparison of 7 irradiation options allowed in RTOG 1005 for early-stage breast cancer. (Chen GP, Liu F, White J, Vicini FA, Freedman GM, Arthur DW, Li XA) Med Dosim 2015;40(1):21-5 24 Citations |
| 5 | CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. (Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ) Cancer Res 2014 Nov 15;74(22):6419-29 26 Citations |
| 4 | An algorithm to identify the development of lymphedema after breast cancer treatment. (Yen TW, Laud PW, Sparapani RA, Li J, Nattinger AB) J Cancer Surviv 2015 Jun;9(2):161-71 6 Citations |
| 1 | Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. (Wu X, Zhang W, Font-Burgada J, Palmer T, Hamil AS, Biswas SK, Poidinger M, Borcherding N, Xie Q, Ellies LG, Lytle NK, Wu LW, Fox RG, Yang J, Dowdy SF, Reya T, Karin M) Proc Natl Acad Sci U S A 2014 Sep 23;111(38):13870-5 90 Citations |
| 2 | The effect of margin status and molecular subtype on women with invasive breast cancer treated with breast-conservation therapy. (Currey AD, Tuyishimire B, Lin J, Kong AL) J Clin Oncol 2014 Sep 10;32(26_suppl):83 |
| 1 | Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways. (Hosford SR, Miller TW) Pharmgenomics Pers Med 2014;7:203-15 134 Citations |
| 1 | Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. (Fu X, Creighton CJ, Biswal NC, Kumar V, Shea M, Herrera S, Contreras A, Gutierrez C, Wang T, Nanda S, Giuliano M, Morrison G, Nardone A, Karlin KL, Westbrook TF, Heiser LM, Anur P, Spellman P, Guichard SM, Smith PD, Davies BR, Klinowska T, Lee AV, Mills GB, Rimawi MF, Hilsenbeck SG, Gray JW, Joshi A, Osborne CK, Schiff R) Breast Cancer Res 2014 Sep 11;16(5):430 66 Citations |
| 1 | Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. (Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD) Radiother Oncol 2014 Sep;112(3):321-5 107 Citations |
| 5 | Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. (Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S) J Gastrointest Surg 2014 Nov;18(11):2016-25 43 Citations |
| 1 | Invasive procedures in the elderly after stage IV cancer diagnosis. (Kwok AC, Hu YY, Dodgion CM, Jiang W, Ting GV, Taback N, Lipsitz SR, Weeks JC, Greenberg CC) J Surg Res 2015 Feb;193(2):754-63 18 Citations |
| 1 | Volume-outcome in cancer surgery: why has the data not affected policy change? (Evans DB, Tsai S) Ann Surg Oncol 2014 Dec;21(13):4056-8 12 Citations |
| 1 | How we treat early systemic prostate cancer in older men. (Kilari D, Dale W, Mohile SG) J Geriatr Oncol 2014 Oct 01;5(4):337-42 9 Citations |
| 2 | IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. (Garcia MN, Grasso D, Lopez-Millan MB, Hamidi T, Loncle C, Tomasini R, Lomberk G, Porteu F, Urrutia R, Iovanna JL) J Clin Invest 2014 Nov;124(11):4709-22 38 Citations |
| 1 | Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents. (Ganesan P, Moulder S, Lee JJ, Janku F, Valero V, Zinner RG, Naing A, Fu S, Tsimberidou AM, Hong D, Stephen B, Stephens P, Yelensky R, Meric-Bernstam F, Kurzrock R, Wheler JJ) Mol Cancer Ther 2014 Dec;13(12):3175-84 33 Citations |
| 1 | Novel approaches in anaplastic thyroid cancer therapy. (Hsu KT, Yu XM, Audhya AW, Jaume JC, Lloyd RV, Miyamoto S, Prolla TA, Chen H) Oncologist 2014 Nov;19(11):1148-55 47 Citations |
| 1 | Skin Cancers of the Head and Neck: A 21-Year Single-Institution Experience (Rice SR, Liang E, Geye HM, Kimple RJ. ) |
| 2 | Upper esophageal and pharyngeal cancers. (Bock JM, Howell AB, Johnston N, Kresty LA, Lew D) Ann N Y Acad Sci 2014 Sep;1325:49-56 3 Citations |
| 1 | Electronic Personal Health Records for Childhood Cancer Survivors: An Exploratory Study. (Sharp LK, Carvalho P, Southward M, Schmidt ML, Jabine LN, Stolley MR, Gerber BS) J Adolesc Young Adult Oncol 2014 Sep 01;3(3):117-122 |
| 1 | Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. (Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC) Nat Commun 2014 Oct 03;5:5092 105 Citations |
| 1 | BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer. (Falchook GS, Millward M, Hong D, Naing A, Piha-Paul S, Waguespack SG, Cabanillas ME, Sherman SI, Ma B, Curtis M, Goodman V, Kurzrock R) Thyroid 2015 Jan;25(1):71-7 186 Citations |
| 1 | P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. (Dillon LM, Bean JR, Yang W, Shee K, Symonds LK, Balko JM, McDonald WH, Liu S, Gonzalez-Angulo AM, Mills GB, Arteaga CL, Miller TW) Oncogene 2015 Jul 23;34(30):3968-76 67 Citations |
| 1 | Functional annotation of putative regulatory elements at cancer susceptibility Loci. (Rosse SA, Auer PL, Carlson CS) Cancer Inform 2014;13(Suppl 2):5-17 5 Citations |
| 1 | Classification, predictive modelling, and statistical analysis of cancer data (a). (Jiang H, An L, Baladandayuthapani V, Auer PL) Cancer Inform 2014;13(Suppl 2):1-3 6 Citations |
| 1 | Alexander, A.A., & F. Jotterand (2014) “Nanomedicine: Benchtop to Patient Challenges” in X. Chen, & S. Wong (Eds.) Cancer Theranostics (471-491). Philadelphia, PA: Elsevier, Inc. (Alexander AA, Jotterand F) |
| 1 | Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. (Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W) Int J Radiat Oncol Biol Phys 2014 Oct 01;90(2):320-8 167 Citations |
| 1 | Characterization of HPV and host genome interactions in primary head and neck cancers. (Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R, Cancer Genome Atlas Network) Proc Natl Acad Sci U S A 2014 Oct 28;111(43):15544-9 307 Citations |
| 1 | Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials. (Said R, Ye Y, Falchook GS, Janku F, Naing A, Zinner R, Blumenschein GR Jr, Fu S, Hong DS, Piha-Paul SA, Wheler JJ, Kurzrock R, Palmer GA, Aldape K, Hess KR, Tsimberidou AM) Oncotarget 2014 Oct 15;5(19):8937-46 6 Citations |
| 1 | Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. (Yap KL, Kiyotani K, Tamura K, Antic T, Jang M, Montoya M, Campanile A, Yew PY, Ganshert C, Fujioka T, Steinberg GD, O'Donnell PH, Nakamura Y) Clin Cancer Res 2014 Dec 15;20(24):6605-17 73 Citations |
| 1 | A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer. (Falchook GS, Moulder S, Naing A, Wheler JJ, Hong DS, Piha-Paul SA, Tsimberidou AM, Fu S, Zinner R, Janku F, Jiang Y, Huang M, Parkhurst KL, Kurzrock R) Invest New Drugs 2015 Feb;33(1):177-86 20 Citations |
| 1 | Unique molecular landscapes in cancer: implications for individualized, curated drug combinations. (Wheler J, Lee JJ, Kurzrock R) Cancer Res 2014 Dec 15;74(24):7181-4 57 Citations |
| 3 | Medicare Part D low-income subsidy and disparities in breast cancer treatment. (Neuner J, Smith E, Charlson JA, Pezzin L, Laud P) J Clin Oncol 2014 Oct 20;32(30_suppl):2 |
| 3 | One-unit versus two-unit cord-blood transplantation for hematologic cancers. (Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2014 Oct 30;371(18):1685-94 243 Citations |
| 1 | Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. (Jung SK, Lee MH, Lim DY, Kim JE, Singh P, Lee SY, Jeong CH, Lim TG, Chen H, Chi YI, Kundu JK, Lee NH, Lee CC, Cho YY, Bode AM, Lee KW, Dong Z) J Biol Chem 2014 Dec 26;289(52):35839-48 106 Citations |
| 1 | Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. (Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA) J Thorac Oncol 2015 Mar;10(3):462-71 97 Citations |
| 2 | Is local resection adequate for T1 stage ampullary cancer? (Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Jan;17(1):66-71 33 Citations |
| 1 | Nanoparticles for cancer imaging: The good, the bad, and the promise. (Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, Woloschak G, Yang L) Nano Today 2013 Oct;8(5):454-460 146 Citations |
| 4 | Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. (Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J) J Clin Oncol 2015 Feb 20;33(6):567-74 115 Citations |
| 1 | Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions. (Allam H, Aoki K, Benigno BB, McDonald JF, Mackintosh SG, Tiemeyer M, Abbott KL) J Proteome Res 2015 Jan 02;14(1):434-46 43 Citations |
| 2 | Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23 31 Citations |
| 5 | Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. (Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B) Radiother Oncol 2014 Oct;113(1):41-6 44 Citations |
| 1 | Cancer cell metabolism and the modulating effects of nitric oxide. (Chang CF, Diers AR, Hogg N) Free Radic Biol Med 2015 Feb;79:324-36 93 Citations |
| 1 | Differential platelet levels affect response to taxane-based therapy in ovarian cancer. (Bottsford-Miller J, Choi HJ, Dalton HJ, Stone RL, Cho MS, Haemmerle M, Nick AM, Pradeep S, Zand B, Previs RA, Pecot CV, Crane EK, Hu W, Lutgendorf SK, Afshar-Kharghan V, Sood AK) Clin Cancer Res 2015 Feb 01;21(3):602-10 85 Citations |
| 1 | Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. (Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD) Int J Comput Assist Radiol Surg 2015 Oct;10(10):1667-73 4 Citations |
| 2 | Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers. (Chaluvally-Raghavan P, Zhang F, Pradeep S, Hamilton MP, Zhao X, Rupaimoole R, Moss T, Lu Y, Yu S, Pecot CV, Aure MR, Peuget S, Rodriguez-Aguayo C, Han HD, Zhang D, Venkatanarayan A, Krohn M, Kristensen VN, Gagea M, Ram P, Liu W, Lopez-Berestein G, Lorenzi PL, Børresen-Dale AL, Chin K, Gray J, Dusetti NJ, McGuire SE, Flores ER, Sood AK, Mills GB) Cancer Cell 2014 Dec 08;26(6):863-879 48 Citations |
| 1 | Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. (Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA, SIRFLOX Study Group) BMC Cancer 2014 Dec 01;14:897 55 Citations |
| 1 | The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. (Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW) Breast Cancer Res Treat 2015 Jan;149(1):69-79 14 Citations |
| 1 | Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients. (Ebenezer GJ, Carlson K, Donovan D, Cobham M, Chuang E, Moore A, Cigler T, Ward M, Lane ME, Ramnarain A, Vahdat LT, Polydefkis M) Ann Clin Transl Neurol 2014 Sep;1(9):639-49 27 Citations |
| 1 | Trial prospector: matching patients with cancer research studies using an automated and scalable approach. (Sahoo SS, Tao S, Parchman A, Luo Z, Cui L, Mergler P, Lanese R, Barnholtz-Sloan JS, Meropol NJ, Zhang GQ) Cancer Inform 2014;13:157-66 21 Citations |
| 1 | MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. (Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE) Cell Stem Cell 2014 Dec 04;15(6):762-74 153 Citations |
| 1 | Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. (Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD 3rd, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein RJ, Chung CC, Oh IJ, Chen KY, Berndt SI, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen RC, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wong MP, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Zheng W, Lin D, Chanock SJ, Rothman N, Lan Q) Int J Cancer 2015 Jul 15;137(2):311-9 89 Citations |
| 2 | Additional support for neoadjuvant therapy in the management of pancreatic cancer. (Christians KK, Evans DB) Ann Surg Oncol 2015 Jun;22(6):1755-8 5 Citations |
| 1 | Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 130 Citations |
| 1 | MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness. (Iordanescu G, Brendler C, Crawford SE, Wyrwicz AM, Venkatasubramanian PN, Doll JA) J Magn Reson Imaging 2015 Sep;42(3):651-7 17 Citations |
| 1 | Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines. (Sosonkina N, Hong SK, Starenki D, Park JI) Genes Genomics 2014 Dec;36(6):829-841 10 Citations |
| 1 | Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer. (Weber CE, Kothari AN, Wai PY, Li NY, Driver J, Zapf MA, Franzen CA, Gupta GN, Osipo C, Zlobin A, Syn WK, Zhang J, Kuo PC, Mi Z) Oncogene 2015 Sep 10;34(37):4821-33 175 Citations |
| 1 | Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. (Chen Z, Lan X, Thomas-Ahner JM, Wu D, Liu X, Ye Z, Wang L, Sunkel B, Grenade C, Chen J, Zynger DL, Yan PS, Huang J, Nephew KP, Huang TH, Lin S, Clinton SK, Li W, Jin VX, Wang Q) EMBO J 2015 Feb 12;34(4):502-16 72 Citations |
| 1 | Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. (Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM) J Clin Oncol 2015 Feb 01;33(4):332-9 111 Citations |
| 1 | Chemoprevention of non-melanoma skin cancer (Daniel R. Knabel, Edit B. Olasz) The Dermatologist Vol 22, Issue 12, December 2014 |
| 1 | Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. (Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK) Cancer Metastasis Rev 2015 Mar;34(1):19-40 77 Citations |
| 1 | Ovarian cancer (Rose PG, Uyar DS) Clinical Gynecology, Second Edition 1 January 2015:790-812 |
| 1 | Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2014 Dec;18(101):323-30 8 Citations |
| 1 | Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2014 Dec;18(101):331-9 14 Citations |
| 1 | Chapter 32: Esophageal Cancer (Ballo RM and Millikan KW) Common Surgical Diseases: An Algorithmic Approach to Problem Solving Springer, New York, pp 133-135 |
| 1 | Hematopoietic stem cell transplantation and lymphodepletion for the treatment of cancer (Barr KM, Gershan JA, Johnson BD) Cancer Immunology: Bench to Bedside Immunotherapy of Cancers 1 January 2015:189-201 |
| 1 | Morphological analysis of tumor regression and its impact on deformable image registration for adaptive radiotherapy of lung cancer patients (Zhong H, Kim J, Gordon JJ, Brown SL, Movsas B, Chetty IJ) IFMBE Proceedings 2015;51:579-582 6 Citations |
| 2 | Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation. (Patch SK, Hull D, Thomas M, Griep SK, Jacobsohn K, See WA) Phys Med Biol 2015 Jan 21;60(2):689-708 17 Citations |
| 3 | New cancers after autotransplantations for multiple myeloma. (Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN) Biol Blood Marrow Transplant 2015 Apr;21(4):738-45 40 Citations |
| 1 | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase. (Geifman N, Haviv I, Kurzrock R, Rubin E) J Pers Med 2014 Dec 15;4(4):475-88 |
| 1 | Health behaviors of minority childhood cancer survivors. (Stolley MR, Sharp LK, Tangney CC, Schiffer LA, Arroyo C, Kim Y, Campbell RT, Schmidt ML, Breen K, Kinahan KE, Dilley KJ, Henderson TO, Korenblit AD, Seligman K) Cancer 2015 May 15;121(10):1671-80 18 Citations |
| 1 | Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. (Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A) Int J Nanomedicine 2015;10:125-45 32 Citations |
| 1 | Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database. (Shukla ME, Yu C, Reddy CA, Stephans KL, Klein EA, Abdel-Wahab M, Ciezki J, Tendulkar RD) Clin Genitourin Cancer 2015 Feb;13(1):17-21 17 Citations |
| 1 | Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. (Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, MacDonald RG, Meza JL, Caplan S, Batra SK, Solheim JC) Oncotarget 2015 Feb 10;6(4):2064-75 26 Citations |
| 1 | Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. (Corrales-Medina FF, Herzog C, Hess K, Egas-Bejar D, Hong DS, Falchook G, Anderson P, Nunez C, Huh WW, Naing A, Tsimberidou AM, Wheler J, Paul SP, Janku F, Kleinerman ES, Kurzrock R, Subbiah V) Oncoscience 2014 Jul 27;1(7):522-530 6 Citations |
| 1 | Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer? (Peterson CY, Weiser MR, Paty PB, Guillem JG, Nash GM, Garcia-Aguilar J, Patil S, Temple LK) Dis Colon Rectum 2015 Feb;58(2):193-8 8 Citations |
| 1 | Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer. (Falchook GS, Naing A, Wheler JJ, Tsimberidou AM, Zinner R, Hong DS, Fu S, Piha-Paul SA, Janku F, Hess KR, Bastida C, Kurzrock R) Oncoscience 2014;1(8):540-9 15 Citations |
| 1 | MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors. (Tang C, Jardim DL, Falchook GS, Hess K, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, De Melo Galgiato D, Westin SN, Meric-Bernstam F, Kurzrock R, Hong DS) Oncoscience 2014;1(1):5-13 27 Citations |
| 1 | Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells. (Karkhanis M, Park JI) Cell Signal 2015 Mar;27(3):479-86 30 Citations |
| 1 | Androgen receptors beyond prostate cancer: an old marker as a new target. (Munoz J, Wheler JJ, Kurzrock R) Oncotarget 2015 Jan 20;6(2):592-603 34 Citations |
| 1 | Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. (Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del C Monroig P, Velazquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein G) Clin Cancer Res 2015 May 01;21(9):2127-37 66 Citations |
| 1 | Cyclin alterations in diverse cancers: Outcome and co-amplification network. (Schwaederlé M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R) Oncotarget 2015 Feb 20;6(5):3033-42 34 Citations |
| 2 | Neoadjuvant therapy for localized pancreatic cancer: support is growing? (Evans DB, Ritch PS, Erickson BA) Ann Surg 2015 Jan;261(1):18-20 19 Citations |
| 1 | Prostate cancer and vasectomy: déjà vu! (Sokal DC, Labrecque M, Belker AM, Faraday MM, Honig S, Marmar JL, Ross LS, Sandlow JI, Sharlip ID) J Clin Oncol 2015 Feb 20;33(6):669-70 4 Citations |
| 1 | Capsule Commentary on Bell et al., Impact of a Randomized Control Educational Trial to Improve Physician Practice Behaviors Around Screening for Inherited Breast Cancer. (Neuner J) J Gen Intern Med 2016 Mar;31(3):326 |
| 1 | Mobile fiber-optic sensor for detection of oral and cervical cancer in the developing world. (Yu B, Nagarajan VK, Ferris DG) Methods Mol Biol 2015;1256:155-70 1 Citation |
| 1 | Does initial laparoscopic cholecystectomy influence the outcomes of definitive oncologic resection for gallbladder cancer? (Ballo R, Saeed M, Daly S, Pinzon M, Francescatti A, Millikan KW, Myers JA, Bines SF, Luu MB) Am Surg 2015 Feb;81(2):E54-6 2 Citations |
| 1 | The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. (Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ) Int J Cancer 2015 Aug 15;137(4):893-902 37 Citations |
| 1 | Phase I trial of valproic acid and lenalidomide in patients with advanced cancer. (Bilen MA, Fu S, Falchook GS, Ng CS, Wheler JJ, Abdelrahim M, Erguvan-Dogan B, Hong DS, Tsimberidou AM, Kurzrock R, Naing A) Cancer Chemother Pharmacol 2015 Apr;75(4):869-74 26 Citations |
| 6 | Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4(1):54 13 Citations |
| 1 | VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy. (Schwaederlé M, Lazar V, Validire P, Hansson J, Lacroix L, Soria JC, Pawitan Y, Kurzrock R) Cancer Res 2015 Apr 01;75(7):1187-90 105 Citations |
| 1 | Comparative effectiveness in thyroid cancer: key questions and how to answer them. (Asare EA, Wang TS) Cancer Treat Res 2015;164:67-87 3 Citations |
| 1 | Arf6 regulates EGF-induced internalization of E-cadherin in breast cancer cells. (Xu R, Zhang Y, Gu L, Zheng J, Cui J, Dong J, Du J) Cancer Cell Int 2015;15(1):11 18 Citations |
| 1 | Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines. (Naing A, Dalal S, Abdelrahim M, Wheler J, Hess K, Fu S, Hong DS, Janku F, Falchook GS, Ilustre A, Ouyang F, Kurzrock R) Support Care Cancer 2015 Sep;23(9):2649-54 31 Citations |
| 1 | SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. (Gonzalez-Angulo AM, Krop I, Akcakanat A, Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S, Moulder-Thompson S, Velez-Bravo V, Sahin AA, Doyle LA, Do KA, Winer EP, Mills GB, Kurzrock R, Meric-Bernstam F) J Natl Cancer Inst 2015 Mar;107(3) 31 Citations |
| 1 | Management of incidental splanchnic vein thrombosis in cancer patients. (Kreuziger LB, Ageno W, Lee A) Hematology Am Soc Hematol Educ Program 2014 Dec 05;2014(1):318-20 7 Citations |
| 1 | PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy. (Patel SP, Kurzrock R) Mol Cancer Ther 2015 Apr;14(4):847-56 1861 Citations |
| 1 | Molecular landscape of pancreatic cancer: implications for current clinical trials. (Heestand GM, Kurzrock R) Oncotarget 2015 Mar 10;6(7):4553-61 86 Citations |
| 1 | HER2 expression status in diverse cancers: review of results from 37,992 patients. (Yan M, Schwaederle M, Arguello D, Millis SZ, Gatalica Z, Kurzrock R) Cancer Metastasis Rev 2015 Mar;34(1):157-64 373 Citations |
| 1 | Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2015 Feb;19(103):101-8 2 Citations |
| 1 | Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2015 Feb;19(103):109-16 15 Citations |
| 2 | A one-to-one mentoring support service for breast cancer survivors. (Amin AL, Neuner J, Duthie EA, Finn VR, Kong AL) WMJ 2014 Oct;113(5):185-9 7 Citations |
| 1 | Prognostic impact of hyponatraemia in patients with colorectal cancer. (Farid SG, Prasad KR) Colorectal Dis 2015 May;17(5):451 4 Citations |
| 1 | Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer. (Tsigelny IF, Wheler JJ, Greenberg JP, Kouznetsova VL, Stewart DJ, Bazhenova L, Kurzrock R) Oncotarget 2015 Mar 20;6(8):6029-39 33 Citations |
| 1 | Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer. (Jadhav RR, Ye Z, Huang RL, Liu J, Hsu PY, Huang YW, Rangel LB, Lai HC, Roa JC, Kirma NB, Huang TH, Jin VX) Clin Epigenetics 2015;7(1):13 39 Citations |
| 1 | An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy. (Zhong H, Wen N, Gordon JJ, Elshaikh MA, Movsas B, Chetty IJ) Phys Med Biol 2015 Apr 07;60(7):2837-51 30 Citations |
| 1 | Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers. (Glenn JA, Turaga KK, Gamblin TC, Hohmann SF, Johnston FM) Surg Endosc 2015 Dec;29(12):3768-75 25 Citations |
| 1 | Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy. (Tsimberidou AM, Said R, Culotta K, Wistuba I, Jelinek J, Fu S, Falchook G, Naing A, Piha-Paul S, Zinner R, Siddik ZH, He G, Hess K, Stewart DJ, Kurzrock R, Issa JP) Clin Epigenetics 2015;7(1):29 13 Citations |
| 1 | Lentiviral vectors in cancer immunotherapy. (Oldham RA, Berinstein EM, Medin JA) Immunotherapy 2015;7(3):271-84 29 Citations |
| 1 | Response to Yasri, "Associations between religion-related factors and cervical cancer screening among Muslims in Greater Chicago." J Low Genit Tract Dis. 2014 June 9. [E-pub ahead of print]. (Padela AI) J Low Genit Tract Dis 2015 Apr;19(2):e45 |
| 1 | Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer. (Lu Y, Moreira AL, Hatzoglou V, Stambuk HE, Gonen M, Mazaheri Y, Deasy JO, Shaha AR, Tuttle RM, Shukla-Dave A) Thyroid 2015 Jun;25(6):672-80 33 Citations |
| 1 | Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study. (Sheean P, Liang H, Schiffer L, Arroyo C, Troy K, Stolley M) J Cancer Surviv 2016 Feb;10(1):21-30 8 Citations |
| 1 | Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. (Hong DS, Janku F, Naing A, Falchook GS, Piha-Paul S, Wheler JJ, Fu S, Tsimberidou AM, Stecher M, Mohanty P, Simard J, Kurzrock R) Invest New Drugs 2015 Jun;33(3):621-31 57 Citations |
| 2 | Secondary solid cancer screening following hematopoietic cell transplantation. (Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS) Bone Marrow Transplant 2015 Aug;50(8):1013-23 138 Citations |
| 1 | Radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer. (Chaudhary LN, Knapp S, Wen S, Xiao J, Murano G, Kurian S, Layne G, Jacobson G, Abraham J) J Community Support Oncol 2015 Jan;13(1):27-9 1 Citation |
| 2 | Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer. (Feng M, Yang C, Chen X, Xu S, Moraru I, Lang J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1041-7 22 Citations |
| 1 | VEGF and dual-EGFR inhibition in colorectal cancer. (Falchook GS, Kurzrock R) Cell Cycle 2015;14(8):1129-30 16 Citations |
| 2 | Neoadjuvant Chemotherapy and Radiochemotherapy: Is There a Survival Advantage for Pancreatic Cancer Patients? (Tsai S, George B, Christians KK, Evans DB) Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management 7 April 2015:103-119 1 Citation |
| 1 | NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. (Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK) Cancer 2015 Jul 01;121(13):2156-63 43 Citations |
| 5 | The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer. (Lai V, Yen TW, Rose BT, Fareau GG, Misustin SM, Evans DB, Wang TS) Ann Surg Oncol 2015 Dec;22(13):4181-6 10 Citations |
| 1 | Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients. (Chaudhary LN, Wen S, Xiao J, Swisher AK, Kurian S, Abraham J) J Community Support Oncol 2014 Oct;12(10):355-60 13 Citations |
| 1 | On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients. (Schwaederle M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R) Mol Cancer Ther 2015 Jun;14(6):1488-94 79 Citations |
| 1 | Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. (Moulder S, Helgason T, Janku F, Wheler J, Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K, Gilcrease M, Kurzrock R) Ann Oncol 2015 Jul;26(7):1346-52 52 Citations |
| 1 | Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells. (Kunnimalaiyaan S, Trevino J, Tsai S, Gamblin TC, Kunnimalaiyaan M) Mol Cancer Ther 2015 Jun;14(6):1395-403 49 Citations |
| 1 | Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer staging. (Marcal LP, Fox PS, Evans DB, Fleming JB, Varadhachary GR, Katz MH, Tamm EP) Abdom Imaging 2015 Oct;40(7):2391-7 40 Citations |
| 1 | Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial. (Rodon J, Soria JC, Berger R, Batist G, Tsimberidou A, Bresson C, Lee JJ, Rubin E, Onn A, Schilsky RL, Miller WH, Eggermont AM, Mendelsohn J, Lazar V, Kurzrock R) Ann Oncol 2015 Aug;26(8):1791-8 68 Citations |
| 1 | Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer. (He H, Li W, Liyanarachchi S, Srinivas M, Wang Y, Akagi K, Wang Y, Wu D, Wang Q, Jin V, Symer DE, Shen R, Phay J, Nagy R, de la Chapelle A) Proc Natl Acad Sci U S A 2015 May 12;112(19):6128-33 76 Citations |
| 1 | Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. (Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L) Oncotarget 2015 Jun 30;6(18):16411-21 39 Citations |
| 1 | Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer. (Schwaederle M, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R) Cell Cycle 2015;14(11):1730-7 9 Citations |
| 1 | A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer. (Lazar V, Rubin E, Depil S, Pawitan Y, Martini JF, Gomez-Navarro J, Yver A, Kan Z, Dry JR, Kehren J, Validire P, Rodon J, Vielh P, Ducreux M, Galbraith S, Lehnert M, Onn A, Berger R, Pierotti MA, Porgador A, Pramesh CS, Ye DW, Carvalho AL, Batist G, Le Chevalier T, Morice P, Besse B, Vassal G, Mortlock A, Hansson J, Berindan-Neagoe I, Dann R, Haspel J, Irimie A, Laderman S, Nechushtan H, Al Omari AS, Haywood T, Bresson C, Soo KC, Osman I, Mata H, Lee JJ, Jhaveri K, Meurice G, Palmer G, Lacroix L, Koscielny S, Eterovic KA, Blay JY, Buller R, Eggermont A, Schilsky RL, Mendelsohn J, Soria JC, Rothenberg M, Scoazec JY, Hong WK, Kurzrock R) Oncotarget 2015 Jun 10;6(16):14139-52 28 Citations |
| 1 | Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics. (Parish A, Schwaederle M, Daniels G, Piccioni D, Fanta P, Schwab R, Shimabukuro K, Parker BA, Helsten T, Kurzrock R) Cell Cycle 2015;14(13):2121-8 41 Citations |
| 1 | Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM) Pract Radiat Oncol 2015;5(3):149-155 44 Citations |
| 1 | Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM) Pract Radiat Oncol 2015;5(3):141-148 77 Citations |
| 1 | Exploring Diet, Physical Activity, and Quality of Life in Females with Metastatic Breast Cancer: A Pilot Study to Support Future Intervention. (Sheean P, Kabir C, Rao R, Hoskins K, Stolley M) J Acad Nutr Diet 2015 Oct;115(10):1690-8 19 Citations |
| 1 | Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. (Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R) Oncotarget 2015 May 20;6(14):12809-21 81 Citations |
| 1 | Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. (Said R, Kurzrock R, Naing A, Hong DS, Fu S, Piha-Paul SA, Wheler JJ, Janku F, Kee BK, Bidyasar S, Lim J, Wallace M, Tsimberidou AM) Invest New Drugs 2015 Aug;33(4):911-20 7 Citations |
| 1 | Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014. (Jeffery DD, Barbera L, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE) J Psychosoc Oncol 2015;33(4):433-66 21 Citations |
| 1 | An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer. (Epperla N, George B) J Gastrointest Cancer 2016 Jun;47(2):206-9 |
| 1 | Multiple gene aberrations and breast cancer: lessons from super-responders. (Wheler JJ, Atkins JT, Janku F, Moulder SL, Yelensky R, Stephens PJ, Kurzrock R) BMC Cancer 2015 May 29;15:442 15 Citations |
| 1 | Oligometastatic prostate cancer to the navicular bone: case report. (Reyes DK, Miller JA, Cerrato RA, Pienta KJ) Urol Case Rep 2015 May 01;3(3):59-62 4 Citations |
| 1 | Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes. (Kurzrock R, Giles FJ) Cell Cycle 2015;14(14):2219-21 65 Citations |
| 1 | Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. (Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ) J Community Support Oncol 2015 May;13(5):195-201 5 Citations |
| 1 | Cancer-related distress in young adults compared to middle-aged and senior adults. (Burgoyne, M.J., *BINGEN, K., Leuck, J., Dasgupta, M., Ryan, P., & Hoffmann, R.G. ) Journal of Adolescent and Young Adult Oncology Burgoyne, M.J., *BINGEN, K., Leuck, J., Dasgupta, M., Ryan, P., & Hoffmann, R.G. (2015, June). Cancer-related distress in young adults compared to middle-aged and senior adults. Journal of Adolescent and Young Adult Oncology, 4(2), 56-63. |
| 1 | Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study. (Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF) J Oncol Pract 2015 Jul;11(4):e460-7 17 Citations |
| 1 | The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab. (Busaidy NL, LoRusso P, Lawhorn K, Hess KR, Habra MA, Fu S, Hong DS, Chen HX, Doyle LA, Kurzrock R, Naing A) Oncologist 2015 Jul;20(7):737-41 12 Citations |
| 1 | Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival. (Stany MP, Stone PJ, Felix JC, Amezcua CA, Groshen S, Ye W, Kyser KL, Howard RS, Zahn CM, Muderspach LI, Lentz SE, Chernofsky MR) Int J Gynecol Pathol 2015 Jul;34(4):379-84 19 Citations |
| 1 | ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. (Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY) J Nucl Med 2015 Jul;56(7):1003-1010 172 Citations |
| 1 | Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide. (Fahey JM, Girotti AW) Nitric Oxide 2015 Sep 15;49:47-55 70 Citations |
| 1 | Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis. (Sato T, Neschadim A, Nakagawa R, Yanagisawa T, Medin JA) Methods Mol Biol 2015;1317:55-67 3 Citations |
| 1 | XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. (Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, Rattay T, Suga T, Kerns SL, Bourgier C, Vallis KA, Sautter-Bihl ML, Claßen J, Debus J, Schnabel T, Rosenstein BS, Wenz F, West CM, Popanda O, Chang-Claude J) Int J Radiat Oncol Biol Phys 2015 Aug 01;92(5):1084-1092 64 Citations |
| 1 | Measures and Methods for Symptom and Symptom Cluster Assessment in Adolescents and Young Adults with Cancer (Linder, L., Ameringer, S., Baggott, C., Erickson, J., Macpherson, C., Rodgers, C.) Seminars in Oncology Nursing |
| 1 | Feasibility and Acceptability of an iPad Application to Explore Symptom Clusters in Adolescents and Young Adults With Cancer (Macpherson CF, Linder LA, Ameringer S, Erickson J, Stegenga K, Woods NF) Pediatric Blood and Cancer 2014;61:1996– 2003 |
| 4 | p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion. (Qi X, Yin N, Ma S, Lepp A, Tang J, Jing W, Johnson B, Dwinell MB, Chitambar CR, Chen G) Stem Cells 2015 Sep;33(9):2738-47 30 Citations |
| 2 | Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). (Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS) Ann Surg Oncol 2015 Nov;22(12):3990-5 133 Citations |
| 1 | The ZNF304-integrin axis protects against anoikis in cancer. (Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G) Nat Commun 2015 Jun 17;6:7351 51 Citations |
| 1 | Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. (Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V) PLoS One 2015;10(6):e0131095 10 Citations |
| 1 | Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. (Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB) Cancer 2015 Oct 01;121(19):3491-8 201 Citations |
| 1 | Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 27 Citations |
| 2 | Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines. (Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston FM) Fam Cancer 2015 Dec;14(4):641-9 12 Citations |
| 1 | Prognostic Significance of QOL Deterioration During Early Lung Cancer Survivorship: Secondary Analysis of RTOG 0212 and 0214. Proc of American Society of Clinical Oncology (ASCO) Annual Meeting; June 3-7, 2011; Chicago, IL. (Gondi V, Paulus R, Bruner D, Meyers C, GORE E, Wolfson A, Werner-Wasik M, Choy H, Movsas B.) J Clin Oncol 2011;29(15; May 20 suppl):abstr 6061. |
| 1 | Using During RT PET to Individualize Adaptive RT for Patients with Stage III NSCLC: A Multicenter Planning Study. Proc of 14th World Conference on Lung Cancer (IASLC); July 3-7, 2011; Amsterdam, Netherlands. (Kong F, Xiao Y, Machtay M, Werner-Wasnik M, Videtic G, Loo B, Wagner H, GORE E, Varlotto J, Faria S, Dilling T, Sun A, Swanson T, Wang L, Galvin J, Ten Haken R, Bradley J.) Journal of Thoracic Oncology 2011;6(6 suppl 2):S834-835. |
| 1 | Decline in Tested and Patient-reported Cognitive Functioning Following Prophylactic Cranial Irradiation for Lung Cancer: Secondary Analysis of RTOG 0212 and 0214. Amer Soc Thera Rad Onc (ASTRO); October 2-6, 2011; Miami Beach, FL. (Gondi V, Paulus R, Bruner D, Meyers C, GORE E, Wolfson A, Werner-Wasik M, Choy H, Movsas B.) Int J Radiat Oncol Biol Phys 2011;81(2; suppl):S50. |
| 1 | RTOG 0214: A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer: 5 Year Update: Chicago Multidisciplinary Symposium in Thoracic Oncology 2012 Plenary Session presentation Abstr #4; ASTRO Annual Meeting 2012 Oral Presentation. (GORE E, Paulus R, Wong SJ, Sun A, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar L, Choy H.) |
| 1 | The Anticancer Role of Capsaicin in Experimentallyinduced Lung Carcinogenesis. (Anandakumar P, Kamaraj S, Jagan S, Ramakrishnan G, Asokkumar S, Naveenkumar C, Raghunandhakumar S, Vanitha MK, Devaki T) J Pharmacopuncture 2015 Jun;18(2):19-25 |
| 1 | Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. (Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, Prasad KR) Br J Cancer 2015 Jul 14;113(2):204-11 101 Citations |
| 2 | Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy. (Evans DB, George B, Tsai S) Ann Surg Oncol 2015 Oct;22(11):3409-13 71 Citations |
| 1 | Feasibility of liposuction for treatment of arm lymphedema from breast cancer, A prospective study and review of the literature (Doren EL, Smith PD, Sun W, Lacevic M, Fulp W, Reid R, Laronga C.) Integr Cancer Sci Therap |
| 1 | TH-AB-304-04: Tumor Control Probability Modeling for Stereotactic Body Radiation Therapy of Early-Stage Lung Cancer Using Multiple Bio-Physical Models. (Liu F, Tai A, Lee P, Biswas T, Ding G, El Naqa I, Grimm J, Jackson A, Kong F, LaCouture T, Loo B, Miften M, Solberg T, Li X) Med Phys 2015 Jun;42(6):3701 |
| 1 | WE-G-BRD-07: Automated MR Image Standardization and Auto-Contouring Strategy for MRI-Based Adaptive Brachytherapy for Cervix Cancer. (Saleh HA, Erickson B, Paulson E) Med Phys 2015 Jun;42(6):3689 |
| 2 | SU-E-J-271: Correlation of CT Number Change with Radiation Treatment Response for Pancreatic Cancer. (Dalah E, Tai A, Oshima K, Hall W, Knechtges P, Erickson B, Li X) Med Phys 2015 Jun;42(6):3329 |
| 1 | SU-E-P-14: Dosimetric Effects of Magnetic Field in MRI-Guided Radiation Therapy Delivery for Breast Cancer. (Chen G, Currey A, Li X) Med Phys 2015 Jun;42(6):3229 |
| 2 | SU-E-J-31: Monitor Interfractional Variation of Tumor Respiratory Motion Using 4D KV Conebeam Computed Tomography for Stereotactic Body Radiation Therapy of Lung Cancer. (Tai A, Prior P, Gore E, Johnstone C, Li X) Med Phys 2015 Jun;42(6):3270 |
| 1 | A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy. (Trinh L, Arbour-Nicitopoulos KP, Sabiston CM, Alibhai SM, Jones JM, Berry SR, Loblaw A, Faulkner GE) Oncol Nurs Forum 2015 Jul;42(4):398-406 19 Citations |
| 1 | Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression. (Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M) HPB (Oxford) 2015 Sep;17(9):770-6 34 Citations |
| 1 | Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. (Feijoo ER, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Prapotnich D, Cathala N, Mombet A, Cathelineau X) Eur Urol 2016 Feb;69(2):214-20 134 Citations |
| 1 | Polymorphisms in alternative splicing associated genes are associated with lung cancer risk in a Chinese population. (Shen W, Yin R, Wang C, Zhu M, Zhou W, Qin N, Sun J, Liu J, Dong J, Jin G, Ma H, Hu Z, Shen H, Xu L, Dai J) Lung Cancer 2015 Sep;89(3):238-42 7 Citations |
| 1 | Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps. (Cobain EF, Chinnaiyan AM, Kurzrock R, Baker LH) JAMA Oncol 2015 Jul;1(4):542 1 Citation |
| 1 | Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer. (Sokolowski KM, Koprowski S, Kunnimalaiyaan S, Balamurugan M, Gamblin TC, Kunnimalaiyaan M) Anticancer Agents Med Chem 2016;16(1):29-37 18 Citations |
| 1 | MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer. (Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan M, Jeon YJ, Li B, Vicentini C, Peng Y, Lee TJ, Luo Z, Liu L, Xu D, Tili E, Jin V, Middleton J, Chakravarti A, Lautenschlaeger T, Croce CM) Proc Natl Acad Sci U S A 2015 Aug 04;112(31):E4288-97 138 Citations |
| 4 | Institutional experience with lateral neck dissections for thyroid cancer. (Glenn JA, Yen TW, Fareau GG, Carr AA, Evans DB, Wang TS) Surgery 2015 Oct;158(4):972-8; discussion 978-80 17 Citations |
| 1 | Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. (Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A) Brachytherapy 2015;14(5):587-99 89 Citations |
| 1 | A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy. (Di Trapani E, Sanchez-Salas R, Gandaglia G, Rocchini L, Moschini M, Lizee D, Carneiro A, Sivaraman A, Barret E, Rozet F, Galiano M, Bennamoun M, Colombo R, Suardi N, Briganti A, Montorsi F, Cathelineau X) World J Urol 2016 Feb;34(2):207-13 16 Citations |
| 1 | VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells. (Yoshida A, Shimizu A, Asano H, Kadonosono T, Kondoh SK, Geretti E, Mammoto A, Klagsbrun M, Seo MK) Biol Open 2015 Jul 24;4(9):1063-76 33 Citations |
| 1 | β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells. (Wilson JM, Lorimer E, Tyburski MD, Williams CL) Cancer Biol Ther 2015;16(9):1364-74 44 Citations |
| 1 | Molecular landscape of prostate cancer: implications for current clinical trials. (Khemlina G, Ikeda S, Kurzrock R) Cancer Treat Rev 2015 Nov;41(9):761-6 60 Citations |
| 1 | In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. (Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC Jr, Bennett JM, Benz EJ Jr, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ Jr, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA) Mayo Clin Proc 2015 Aug;90(8):996-1000 129 Citations |
| 1 | Targeting c-MYC in Platinum-Resistant Ovarian Cancer. (Reyes-González JM, Armaiz-Peña GN, Mangala LS, Valiyeva F, Ivan C, Pradeep S, Echevarría-Vargas IM, Rivera-Reyes A, Sood AK, Vivas-Mejía PE) Mol Cancer Ther 2015 Oct;14(10):2260-9 103 Citations |
| 1 | Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells. (Lee SH, Nam HJ, Kang HJ, Samuels TL, Johnston N, Lim YC) Oncol Rep 2015 Oct;34(4):2065-71 19 Citations |
| 4 | Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. (Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S) Surgery 2015 Dec;158(6):1545-55 30 Citations |
| 1 | Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center. (Parker BA, Schwaederlé M, Scur MD, Boles SG, Helsten T, Subramanian R, Schwab RB, Kurzrock R) J Oncol Pract 2015 Nov;11(6):442-9 55 Citations |
| 4 | Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 54 Citations |
| 1 | Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis. (Nagaraja AS, Dorniak PL, Sadaoui NC, Kang Y, Lin T, Armaiz-Pena G, Wu SY, Rupaimoole R, Allen JK, Gharpure KM, Pradeep S, Zand B, Previs RA, Hansen JM, Ivan C, Rodriguez-Aguayo C, Yang P, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK) Oncogene 2016 May 05;35(18):2390-7 76 Citations |
| 1 | The role of hypofractionated radiation in the management of non-osseous metastatic or uncontrolled local cancer. (JOHNSTONE C, Lutz ST.) Ann Palliat Med Oct 2014;3(4):291-303. |
| 1 | The radiobiology of palliative radiation oncology. Radiation Oncology in Palliative Cancer Care. (JOHNSTONE, C.) Edited by Stephen Lutz, Edward Chow, and Peter Hoskin. Radiation Oncology in Palliative Cancer Care March 2013, 2:15-21 John Wiley & Sons |
| 1 | The importance of 3-D CT treatment planning to optimize outcomes from accelerated partial breast irradiation(APBI) with brachytherapy in in early stage breast cancer. (CURREY AD, Kelly TR, Bovi JA, Rownd J, Morrow N, White JR) Poster presentation at ASTRO Oct 28-31, 2012, Boston MA. |
| 1 | Impact of sociodemographic factors on management of breast cancer: Results of QRRO survey. (CURREY AD, Ho A, Owens JB, Khalid N, Tao M, White JR, Wilson JF:) Poster Presentation at ASTRO Oct 28-31, 2012, Boston MA |
| 5 | Neoadjuvant therapy for localized pancreatic cancer: guiding principles. (Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB, Tsai S) J Gastrointest Oncol 2015 Aug;6(4):418-29 51 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer. 2014 Feb 15;120(4):499-506 PMID: 24390739 |
| 1 | Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population. (Shay SG, Chang E, Lewis MS, Wang MB) JAMA Otolaryngol Head Neck Surg 2015 Sep;141(9):790-6 16 Citations |
| 3 | Perceived Neighborhood Quality and Cancer Screening Behavior: Evidence from the Survey of the Health of Wisconsin. (Beyer KM, Malecki KM, Hoormann KA, Szabo A, Nattinger AB) J Community Health 2016 Feb;41(1):134-7 23 Citations |
| 1 | Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. (Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH) Oncogene 2016 May 05;35(18):2379-89 16 Citations |
| 1 | A Semantic Web-based System for Mining Genetic Mutations in Cancer Clinical Trials. (Priya S, Jiang G, Dasari S, Zimmermann MT, Wang C, Heflin J, Chute CG) AMIA Jt Summits Transl Sci Proc 2015;2015:142-6 |
| 1 | Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery. (Jiang G, Sohn S, Zimmermann MT, Wang C, Liu H, Chute CG) AMIA Jt Summits Transl Sci Proc 2015;2015:72-6 |
| 1 | Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy. (Wang C, Zimmermann MT, Chute CG, Jiang G) AMIA Jt Summits Transl Sci Proc 2015;2015:51-5 |
| 1 | Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. (Caserta E, Egriboz O, Wang H, Martin C, Koivisto C, Pecót T, Kladney RD, Shen C, Shim KS, Pham T, Karikomi MK, Mauntel MJ, Majumder S, Cuitino MC, Tang X, Srivastava A, Yu L, Wallace J, Mo X, Park M, Fernandez SA, Pilarski R, La Perle KM, Rosol TJ, Coppola V, Castrillon DH, Timmers C, Cohn DE, O'Malley DM, Backes F, Suarez AA, Goodfellow P, Chamberlin HM, Macrae ER, Shapiro CL, Ostrowski MC, Leone G) Genes Dev 2015 Aug 15;29(16):1707-20 26 Citations |
| 1 | Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. (Schwaederle M, Zhao M, Lee JJ, Eggermont AM, Schilsky RL, Mendelsohn J, Lazar V, Kurzrock R) J Clin Oncol 2015 Nov 10;33(32):3817-25 374 Citations |
| 2 | The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure. (Lomberk GA, Urrutia R) Surg Clin North Am 2015 Oct;95(5):935-52 22 Citations |
| 1 | Survivors of childhood and adolescent cancer: A multidisciplinary approach: Third Edition (Schwartz CL, Hobbie WL, Constine LS, Ruccione KS) Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach: Third Edition 3 September 2015:1-436 9 Citations |
| 1 | Re: can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. (Sivaraman A, Sanchez-Salas R) Eur Urol 2015 Oct;68(4):738 17 Citations |
| 4 | Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling. (Roy I, McAllister DM, Gorse E, Dixon K, Piper CT, Zimmerman NP, Getschman AE, Tsai S, Engle DD, Evans DB, Volkman BF, Kalyanaraman B, Dwinell MB) Cancer Res 2015 Sep 01;75(17):3529-42 58 Citations |
| 1 | Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. (McFall T, Patki M, Rosati R, Ratnam M) Oncotarget 2015 Oct 20;6(32):33146-64 14 Citations |
| 1 | Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08. (Voog JC, Paulus R, Shipley WU, Smith MR, McGowan DG, Jones CU, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Husain SM, Gore E, Raben A, Chafe S, Sandler HM, Efstathiou JA) Eur Urol 2016 Feb;69(2):204-10 38 Citations |
| 1 | Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. (Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK) Oncogene 2016 May 19;35(20):2645-54 62 Citations |
| 1 | Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. (Chen Z, Lan X, Wu D, Sunkel B, Ye Z, Huang J, Liu Z, Clinton SK, Jin VX, Wang Q) Nat Commun 2015 Sep 16;6:8323 77 Citations |
| 3 | Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. (Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC) HPB (Oxford) 2015 Dec;17(12):1119-23 12 Citations |
| 1 | The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing. (Helsten T, Elkin S, Arthur E, Tomson BN, Carter J, Kurzrock R) Clin Cancer Res 2016 Jan 01;22(1):259-67 631 Citations |
| 1 | Potentially functional polymorphisms in PAK1 are associated with risk of lung cancer in a Chinese population. (Zheng M, Liu J, Zhu M, Yin R, Dai J, Sun J, Shen W, Ji Y, Jin G, Ma H, Dong J, Xu L, Hu Z, Shen H) Cancer Med 2015 Nov;4(11):1781-7 6 Citations |
| 2 | Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer. (Fang TC, Oh YS, Szabo A, Khan A, Dua KS) Dis Esophagus 2016 Aug;29(6):642-8 16 Citations |
| 1 | Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer. (Eng KH, Hanlon BM, Bradley WH, Szender JB) Gynecol Oncol 2015 Nov;139(2):228-35 22 Citations |
| 1 | Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. (Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R, Pierobon M, Sun P, Cunningham E, Little S, Orford K, Motwani M, Bai Y, Patel K, Venook AP, Kopetz S) J Clin Oncol 2015 Dec 01;33(34):4023-31 449 Citations |
| 1 | Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer. (Datta S, Ray A, Singh R, Mondal P, Basu A, De Sarkar N, Majumder M, Maiti G, Baral A, Jha GN, Mukhopadhyay I, Panda C, Chowdhury S, Ghosh S, Roychoudhury S, Roy B) Mitochondrion 2015 Nov;25:28-33 11 Citations |
| 1 | Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. (Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R) Oncotarget 2015 Sep 15;6(27):24581 2 Citations |
| 2 | IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. (Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL) Cancer Res 2015 Nov 15;75(22):4852-62 98 Citations |
| 3 | Identifying patterns of breast cancer care provided at high-volume hospitals: a classification and regression tree analysis. (Kong AL, Pezzin LE, Nattinger AB) Breast Cancer Res Treat 2015 Oct;153(3):689-98 19 Citations |
| 1 | Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry. (Tay KJ, Polascik TJ, Elshafei A, Cher ML, Given RW, Mouraviev V, Ross AE, Jones JS) J Endourol 2016 Jan;30(1):43-8 28 Citations |
| 6 | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:531 |
| 2 | Reducing the Human Burden of Breast Cancer: Advanced Radiation Therapy Yields Improved Treatment Outcomes. (Currey AD, Bergom C, Kelly TR, Wilson JF) Breast J 2015;21(6):610-20 8 Citations |
| 1 | Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? (Franqui-Machin R, Wendlandt EB, Janz S, Zhan F, Tricot G) Oncotarget 2015 Dec 01;6(38):40496-506 45 Citations |
| 1 | Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. (Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R) Oncotarget 2015 Oct 20;6(32):32602-9 16 Citations |
| 2 | Identifying patterns of breast cancer care provided at high volume hospitals: A classification and regression tree analysis. (Pezzin LE, Nattinger AB) J Clin Oncol 2015 Oct;33(28_suppl):69 |
| 1 | WWP2 and its association with PTEN in endometrial cancer. (Clements AE, Bravo V, Koivisto C, Cohn DE, Leone G) Gynecol Oncol Rep 2015 Aug;13:26-9 22 Citations |
| 1 | Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. (Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A) Pract Radiat Oncol 2015;5(6):e557-65 8 Citations |
| 1 | The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers. (Schott AF, Welch JJ, Verschraegen CF, Kurzrock R) Semin Oncol 2015 Oct;42(5):731-9 19 Citations |
| 1 | Long-term outcomes of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. (Van Osdol AD, Borgert AJ, Kallies KJ, Froman JP, Bottner WA, Shapiro SB) Am J Surg 2015 Dec;210(6):990-4; discussion 995 11 Citations |
| 1 | Symptoms and Symptom Clusters Identified by Adolescents and Young Adults With Cancer Using a Symptom Heuristics App. (Ameringer S, Erickson JM, Macpherson CF, Stegenga K, Linder LA) Res Nurs Health 2015 Dec;38(6):436-48 40 Citations |
| 1 | Efficacy of electrical stimulation and exercise for dysphagia in patients with head and neck cancer: A randomized clinical trial. (Langmore SE, McCulloch TM, Krisciunas GP, Lazarus CL, Van Daele DJ, Pauloski BR, Rybin D, Doros G) Head Neck 2016 Apr;38 Suppl 1(Suppl 1):E1221-31 85 Citations |
| 1 | High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. (Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh)) Ann Surg 2015 Dec;262(6):891-8 137 Citations |
| 1 | Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program. (Alfaro KM, Gage JC, Rosenbaum AJ, Ditzian LR, Maza M, Scarinci IC, Miranda E, Villalta S, Felix JC, Castle PE, Cremer ML) BMC Public Health 2015 Oct 16;15:1058 18 Citations |
| 1 | Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response. (Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ) BMC Cancer 2015 Oct 16;15:713 43 Citations |
| 5 | Reexamining the Relationship of Breast Cancer Hospital and Surgical Volume to Mortality: An Instrumental Variable Analysis. (Pezzin LE, Laud P, Yen TW, Neuner J, Nattinger AB) Med Care 2015 Dec;53(12):1033-9 29 Citations |
| 1 | Predicting the Presence of Nonmelanoma Skin Cancers After Biopsy: A Method to Reduce Unnecessary Surgical Procedures. (Sasor SE, Nosrati NN, Katona T, Wooden WA, Cohen A, Munshi IA, Tholpady SS) JAMA Surg 2016 Mar;151(3):289-90 3 Citations |
| 1 | Targeted Therapy in Translational Cancer Research (Tsimberidou AM, Kurzrock R, Anderson KC) Targeted Therapy in Translational Cancer Research 30 October 2015:1-378 3 Citations |
| 1 | Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. (Previs RA, Armaiz-Pena GN, Lin YG, Davis AN, Pradeep S, Dalton HJ, Hansen JM, Merritt WM, Nick AM, Langley RR, Coleman RL, Sood AK) Mol Cancer Ther 2015 Dec;14(12):2677-86 9 Citations |
| 1 | Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. (Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, Giralt S, Carter S, Horowitz MM, Linker C, Alyea EP) J Clin Oncol 2015 Dec 10;33(35):4167-75 136 Citations |
| 1 | Clinical-Economic Modeling Analysis Of Human Papillomavirus (Hpv) Co-Testing With Genotyping Versus Primary Hpv Testing For Cervical Cancer Screening. (Felix JC, Lacey MJ, Miller JD, Lenhart GM, Kulkarni R) Value Health 2015 Nov;18(7):A353 |
| 1 | The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer. (Huntington JT, Tang X, Kent LN, Schmidt CR, Leone G) J Cell Physiol 2016 Jul;231(7):1438-49 10 Citations |
| 1 | AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. (Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, Nadella MV, Mohseni M, Lawson D, Reimer C, Blakey DC, Xiao X, Hsu J, Revenko A, Monia BP, MacLeod AR) Sci Transl Med 2015 Nov 18;7(314):314ra185 377 Citations |
| 1 | A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. (Jagadish N, Parashar D, Gupta N, Agarwal S, Purohit S, Kumar V, Sharma A, Fatima R, Topno AP, Shaha C, Suri A) J Exp Clin Cancer Res 2015 Nov 21;34:142 42 Citations |
| 2 | Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer. (Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A) Cancer Epidemiol 2016 Feb;40:7-14 23 Citations |
| 5 | Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 105 Citations |
| 1 | Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer. (Branham MT, Campoy E, Laurito S, Branham R, Urrutia G, Orozco J, Gago F, Urrutia R, Roqué M) Breast Cancer Res Treat 2016 Jan;155(1):13-23 12 Citations |
| 1 | Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society. (Harkenrider MM, Grover S, Erickson BA, Viswanathan AN, Small C, Kliethermes S, Small W Jr) Brachytherapy 2016;15(1):23-9 63 Citations |
| 1 | Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel. (Tam AL, Lim HJ, Wistuba II, Tamrazi A, Kuo MD, Ziv E, Wong S, Shih AJ, Webster RJ 3rd, Fischer GS, Nagrath S, Davis SE, White SB, Ahrar K) J Vasc Interv Radiol 2016 Jan;27(1):8-19 81 Citations |
| 1 | Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers. (Awan MJ, Siddiqui F, Schwartz D, Yuan J, Machtay M, Yao M) World J Radiol 2015 Nov 28;7(11):382-93 |
| 2 | Venous shunting procedures for borderline resectable pancreatic cancer (Fathi AH, Tsai S, Lee JE, Evans DB, Christians KK) Multimodality Management of Borderline Resectable Pancreatic Cancer 10 December 2015:237-245 |
| 1 | Outcomes with multimodal therapy for elderly patients with rectal cancer. (Thiels CA, Bergquist JR, Meyers AJ, Johnson CL, Behm KT, Hayman AV, Habermann EB, Larson DW, Mathis KL) Br J Surg 2016 Jan;103(2):e106-14 20 Citations |
| 1 | Rejection of Breast Reconstruction Among Lesbian Breast Cancer Patients. (Wandrey RL, Qualls WD, Mosack KE) LGBT Health 2016 Feb;3(1):74-78 |
| 1 | Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. (Rupaimoole R, Lee J, Haemmerle M, Ling H, Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, Millward NMZ, Nagaraja AS, Gharpure KM, McGuire M, Sam N, Armaiz-Pena GN, Sadaoui NC, Rodriguez-Aguayo C, Calin GA, Drapkin RI, Kovacs J, Mills GB, Zhang W, Lopez-Berestein G, Bhattacharya PK, Sood AK) Cell Rep 2015 Dec 22;13(11):2395-2402 100 Citations |
| 1 | BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. (Clarke CN, Kopetz ES) J Gastrointest Oncol 2015 Dec;6(6):660-7 180 Citations |
| 1 | Study design and protocol for moving forward: a weight loss intervention trial for African-American breast cancer survivors. (Stolley MR, Sharp LK, Fantuzzi G, Arroyo C, Sheean P, Schiffer L, Campbell R, Gerber B) BMC Cancer 2015 Dec 29;15:1018 23 Citations |
| 1 | A patient with a large minimally invasive follicular thyroid cancer (Wang TS, Goffredo P, Sosa JA) Thyroid Cancer: A Case-Based Approach 1 January 2016:95-104 |
| 1 | Gynecologic Brachytherapy: Vaginal Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:279-285 |
| 1 | Gynecologic Brachytherapy: Endometrial Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:253-268 |
| 1 | Gynecologic Brachytherapy: Cervical Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:269-278 |
| 1 | Primary HPV testing vs. Co-testing for cervical cancer screening: Outcome and economic support that co-testing is superior (Felix JC) Contemporary Ob/Gyn 2016;61(9):2-5 1 Citation |
| 1 | Molecular dynamics use in personalized cancer medicine example of MET Y501C mutation (Tsigelny IF, Kurzrock R, Skjevik AA, Kouznetsova VL, Ikeda S) SIMULTECH 2016 - Proceedings of the 6th International Conference on Simulation and Modeling Methodologies, Technologies and Applications 2016:71-74 2 Citations |
| 3 | Metakaryotic cancer stem cells are constitutively resistant to X-rays and chemotherapeutic agents, but sensitive to many common drugs (Gostjeva EV, Koledova VV, Bai L, Duan KC, Kamath T, Nelson M, Agnihotri P, Moshinski DJ, Ping Wu L, Zukerberg L, Chung DC, Tsai S, Evans DB, Tomita-Mitchell A, Mitchell M, Thilly WG) Issues in Toxicology 2016;2016-January(29):196-249 4 Citations |
| 2 | Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus. (Mboko WP, Olteanu H, Ray A, Xin G, Darrah EJ, Kumar SN, Kulinski JM, Cui W, Dittel BN, Gauld SB, Tarakanova VL) J Virol 2015 Dec 30;90(6):2818-29 26 Citations |
| 1 | Toward Quantitative Whole Organ Thermoacoustics With a Clinical Array Plus One Very Low-Frequency Channel Applied to Prostate Cancer Imaging. (Patch SK, Hull D, See WA, Hanson GW) IEEE Trans Ultrason Ferroelectr Freq Control 2016 Feb;63(2):245-55 42 Citations |
| 1 | Regional Therapies for Advanced Cancer: Update for 2016. (Turaga KK, Gamblin TC, Alexander HR, Edwards R, Bartlett DL) Ann Surg Oncol 2016 May;23(5):1452-3 |
| 1 | Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer. (Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW) Clin Cancer Res 2016 May 01;22(9):2250-60 28 Citations |
| 1 | Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. (Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, Huang TH, Wang Q) Nucleic Acids Res 2016 May 19;44(9):4105-22 33 Citations |
| 1 | Metastatic Cancer to the Larynx: A Case Report and Update. (Zenga J, Mehrad M, Bradley JP) J Voice 2016 Nov;30(6):774.e9-774.e12 12 Citations |
| 2 | Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon. (Robinson KM, Piacentine LB, Waltke LJ, Ng AV, Tjoe JA) J Clin Nurs 2016 Jan;25(1-2):247-56 15 Citations |
| 1 | Focal Therapy for Prostate Cancer: An "À la Carte" Approach. (Sivaraman A, Barret E) Eur Urol 2016 Jun;69(6):973-5 88 Citations |
| 1 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. (Gaudet MM, Barrdahl M, Lindström S, Travis RC, Auer PL, Buring JE, Chanock SJ, Eliassen AH, Gapstur SM, Giles GG, Gunter M, Haiman C, Hunter DJ, Joshi AD, Kaaks R, Khaw KT, Lee IM, Le Marchand L, Milne RL, Peeters PH, Sund M, Tamimi R, Trichopoulou A, Weiderpass E, Yang XR, Prentice RL, Feigelson HS, Canzian F, Kraft P) Breast Cancer Res Treat 2016 Feb;155(3):531-40 1 Citation |
| 1 | Self-Reported Cancer Prevalence among Hispanics in the US: Results from the Hispanic Community Health Study/Study of Latinos. (Penedo FJ, Yanez B, Castañeda SF, Gallo L, Wortman K, Gouskova N, Simon M, Arguelles W, Llabre M, Sanchez-Johnsen L, Brintz C, Gonzalez P, Van Horn L, Rademaker AW, Ramirez AG) PLoS One 2016;11(1):e0146268 11 Citations |
| 1 | Cancer-Related Distress in Young Adults Compared to Middle-Aged and Senior Adults. (Burgoyne MJ, Bingen K, Leuck J, Dasgupta M, Ryan P, Hoffmann RG) J Adolesc Young Adult Oncol 2015 Jun;4(2):56-63 49 Citations |
| 1 | Role of Increased n-acetylaspartate Levels in Cancer. (Zand B, Previs RA, Zacharias NM, Rupaimoole R, Mitamura T, Nagaraja AS, Guindani M, Dalton HJ, Yang L, Baddour J, Achreja A, Hu W, Pecot CV, Ivan C, Wu SY, McCullough CR, Gharpure KM, Shoshan E, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Wang Y, Nick AM, Davies MA, Armaiz-Pena G, Liu J, Lutgendorf SK, Baggerly KA, Eli MB, Lopez-Berestein G, Nagrath D, Bhattacharya PK, Sood AK) J Natl Cancer Inst 2016 Jan 26;108(6):djv426 56 Citations |
| 1 | Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers. (Liu S, Nikanjam M, Kurzrock R) Oncotarget 2016 Mar 08;7(10):11310-20 43 Citations |
| 1 | Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. (Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM) Cancer Immunol Immunother 2016 Mar;65(3):247-59 35 Citations |
| 1 | Erratum: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval (Journal of the National Cancer Institute (2015) 107:11 (djv253) DOI:10.1093/jnci/djv253) (Fontes Jardim DL, Schwaederle M, Wei M, Lee JJ, Hong DS, Eggermont AM, Schilsky RL, Mendelsohn J, Lazar V, Kurzrock R) Journal of the National Cancer Institute 1 February 2016;108(2) |
| 1 | Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer. (Jansen JF, Lu Y, Gupta G, Lee NY, Stambuk HE, Mazaheri Y, Deasy JO, Shukla-Dave A) World J Radiol 2016 Jan 28;8(1):90-7 |
| 1 | Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay. (Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Banks KC, Lanman RB, Talasaz A, Parker BA, Kurzrock R) Oncotarget 2016 Mar 01;7(9):9707-17 123 Citations |
| 1 | Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients. (Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES) Anticancer Res 2016 Feb;36(2):495-501 46 Citations |
| 1 | Perceived cognitive changes with chemotherapy for breast cancer: A pilot study. (Piacentine LB, Miller JF, Haberlein S, Bloom AS) Appl Nurs Res 2016 Feb;29:9-11 10 Citations |
| 1 | Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design. (Sicklick JK, Fanta PT, Shimabukuro K, Kurzrock R) Cancer Metastasis Rev 2016 Jun;35(2):263-75 54 Citations |
| 1 | Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K. (Yueh AE, Payne SN, Leystra AA, Van De Hey DR, Foley TM, Pasch CA, Clipson L, Matkowskyj KA, Deming DA) PLoS One 2016;11(2):e0148730 16 Citations |
| 1 | Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer. (Zenga J, Graboyes EM, Haughey BH, Paniello RC, Mehrad M, Lewis JS Jr, Thorstad WL, Nussenbaum B, Rich JT) Otolaryngol Head Neck Surg 2016 Apr;154(4):657-66 18 Citations |
| 1 | Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. (Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R) Mol Cancer Ther 2016 Apr;15(4):743-52 154 Citations |
| 1 | Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study. (Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA, EMBRACE Collaborative Group) Int J Radiat Oncol Biol Phys 2016 Apr 01;94(5):1088-98 86 Citations |
| 1 | PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling. (Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y) Cancer Res 2016 Apr 15;76(8):2243-2253 55 Citations |
| 1 | Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. (Sivaraman A, Ordaz Jurado G, Cathelineau X, Barret E, Dell'Oglio P, Joniau S, Bianchi M, Briganti A, Spahn M, Bastian P, Chun J, Chlosta P, Gontero P, Graefen M, Jeffrey Karnes R, Marchioro G, Tombal B, Tosco L, van der Poel HH, Sanchez-Salas R) World J Urol 2016 Oct;34(10):1367-72 15 Citations |
| 1 | VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer. (Xie W, Liu F, Wang Y, Ren X, Wang T, Chen Z, Tang M, Sun F, Li Z, Wang M, Zhang J) Oncotarget 2016 Mar 29;7(13):16445-61 18 Citations |
| 1 | Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. (Dwivedi SK, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, Ling H, Ivan C, Mukherjee P, Calin GA, Lopez-Berestein G, Sood AK, Bhattacharya R) Oncotarget 2016 Mar 22;7(12):15093-104 71 Citations |
| 1 | Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. (Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange PH, Shendure J, Vessella RL, Nelson PS) Nat Med 2016 Apr;22(4):369-78 569 Citations |
| 1 | Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. (Hayano K, Kulkarni NM, Duda DG, Heist RS, Sahani DV) AJR Am J Roentgenol 2016 May;206(5):987-93 31 Citations |
| 1 | The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. (Parsons HA, Baracos VE, Hong DS, Abbruzzese J, Bruera E, Kurzrock R) Oncotarget 2016 Apr 12;7(15):20293-304 25 Citations |
| 3 | A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer. (Hopp EE, Osborne JL, Schneider DK, Bojar CJ, Uyar DS) Gynecol Oncol Rep 2016 Jan;15:25-8 25 Citations |
| 4 | A Comparison of Lumpectomy Cavity Delineations Between Use of Magnetic Resonance Imaging and Computed Tomography Acquired With Patient in Prone Position for Radiation Therapy Planning of Breast Cancer. (Huang W, Currey A, Chen X, Li B, Bergom C, Kelly T, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2016 Mar 15;94(4):832-40 17 Citations |
| 1 | Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm. (Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Subbiah V, Rodon J, Kurzrock R) Mol Cancer Ther 2016 Apr;15(4):533-47 69 Citations |
| 1 | Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study. (Cohoon KP, Ransom JE, Leibson CL, Ashrani AA, Petterson TM, Long KH, Bailey KR, Heit JA) Am J Med 2016 Sep;129(9):1000.e15-25 31 Citations |
| 1 | The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis. (Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M, Kulkarni R) J Womens Health (Larchmt) 2016 Jun;25(6):606-16 32 Citations |
| 1 | Diagnostic Delays and Errors in Head and Neck Cancer Patients: Opportunities for Improvement. (Franco J, Elghouche AN, Harris MS, Kokoska MS) Am J Med Qual 2017;32(3):330-335 18 Citations |
| 1 | Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer. (Xu S, Wu Z, Yang C, Ma L, Qu B, Chen G, Yao W, Wang S, Liu Y, Li XA) Br J Radiol 2016 Jun;89(1062):20140819 8 Citations |
| 1 | A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. (Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H, McGuire MH, Haemmerle M, Vidal-Anaya V, Olsen C, Rodriguez-Aguayo C, Filant J, Ehsanipour EA, Herbrich SM, Maiti SN, Huang L, Kim JH, Zhang X, Han HD, Armaiz-Pena GN, Seviour EG, Tucker S, Zhang M, Yang D, Cooper LJ, Ali-Fehmi R, Bar-Eli M, Lee JS, Ram PT, Baggerly KA, Lopez-Berestein G, Hung MC, Sood AK) Nat Commun 2016 Apr 04;7:11169 114 Citations |
| 1 | Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer. (Hong D, Infante J, Janku F, Jones S, Nguyen LM, Burris H, Naing A, Bauer TM, Piha-Paul S, Johnson FM, Kurzrock R, Golden L, Hynes S, Lin J, Lin AB, Bendell J) J Clin Oncol 2016 May 20;34(15):1764-71 138 Citations |
| 1 | A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer. (Jagadish N, Parashar D, Gupta N, Agarwal S, Sharma A, Fatima R, Suri V, Kumar R, Gupta A, Lohiya NK, Suri A) Oncoimmunology 2016 Feb;5(2):e1078965 24 Citations |
| 1 | Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center. (Grivas PD, Devata S, Khoriaty R, Boonstra PS, Ruch J, McDonnell K, Hernandez-Aya L, Wilfong J, Smerage J, Ison MG, Eisenberg JNS, Silveira M, Cooney KA, Worden FP) J Cancer Educ 2017 Dec;32(4):871-877 7 Citations |
| 4 | Breast and Colorectal Cancer Survival Disparities in Southeastern Wisconsin. (Beyer KM, Zhou Y, Matthews K, Hoormann K, Bemanian A, Laud PW, Nattinger AB) WMJ 2016 Feb;115(1):17-21 20 Citations |
| 1 | Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. (Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, Eeles R, West CM) Br J Cancer 2016 May 10;114(10):1165-74 19 Citations |
| 1 | Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors. (Rauscher GH, Campbell RT, Wiley EL, Hoskins K, Stolley MR, Warnecke RB) Am J Epidemiol 2016 May 15;183(10):884-93 23 Citations |
| 1 | Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis. (Subbiah V, Kurzrock R) JAMA Oncol 2016 Jun 01;2(6):719-20 36 Citations |
| 2 | Missed Breast Cancer: What Can We Learn? (Wadhwa A, Sullivan JR, Gonyo MB) Curr Probl Diagn Radiol 2016;45(6):402-419 35 Citations |
| 1 | "Ethics Related to Breast Cancer" (Patten, C.) ASBS Ethics BESAP Questions Patten, C. Ethics Related to Breast Cancer. American Society of Breast Surgeons Breast Education and Self-Assessment Program, Ethics Questions. April 16, 2016. |
| 1 | Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. (Said R, Kakadiaris E, Piha-Paul S, Fu S, Falchook G, Janku F, Wheler JJ, Zinner R, Hong DS, Kurzrock R, Tsimberidou AM) Cancer Chemother Pharmacol 2016 May;77(5):1097-102 5 Citations |
| 3 | MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers. (Prior P, Chen X, Botros M, Paulson ES, Lawton C, Erickson B, Li XA) Phys Med Biol 2016 May 21;61(10):3819-42 36 Citations |
| 1 | Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers. (Muller KE, Marotti JD, de Abreu FB, Peterson JD, Miller TW, Chamberlin MD, Tsongalis GJ, Tafe LJ) Exp Mol Pathol 2016 Jun;100(3):421-5 28 Citations |
| 1 | Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer. (Felder TM, Do DP, Lu ZK, Lal LS, Heiney SP, Bennett CL) Breast Cancer Res Treat 2016 May;157(1):193-200 5 Citations |
| 2 | An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model. (Tai A, Liu F, Gore E, Li XA) Phys Med Biol 2016 May 21;61(10):3903-13 19 Citations |
| 1 | Correction: AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake (PLoS One.(2014)9:4 (e92948)Doi: 10.1371/journal.pone.0092948) (Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader J) PLoS ONE May 2016;11(5) 1 Citation |
| 1 | Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer. (Chamberlin MD, Bernhardt EB, Miller TW) J Cell Biochem 2016 Nov;117(11):2454-63 11 Citations |
| 1 | Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. (O'Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF) Clin Genitourin Cancer 2016 Dec;14(6):511-517 5 Citations |
| 1 | Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. (Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND) Ann Surg Oncol 2016 Sep;23(9):2889-97 44 Citations |
| 2 | Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. (Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB) Cell Rep 2016 May 17;15(7):1493-1504 84 Citations |
| 4 | New spatially continuous indices of redlining and racial bias in mortgage lending: links to survival after breast cancer diagnosis and implications for health disparities research. (Beyer KM, Zhou Y, Matthews K, Bemanian A, Laud PW, Nattinger AB) Health Place 2016 Jul;40:34-43 108 Citations |
| 1 | mRNA-based hrHPV assay in cotesting for cervical cancer screening. (Felix J) MLO Med Lab Obs 2016 Apr;48(4):22-3 |
| 1 | Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. (Chugh S, Meza J, Sheinin YM, Ponnusamy MP, Batra SK) Br J Cancer 2016 Jun 14;114(12):1376-86 40 Citations |
| 1 | Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. (Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES) PLoS One 2016;11(5):e0155503 6 Citations |
| 1 | RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. (Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y) Oncogene 2016 Dec 08;35(49):6319-6329 58 Citations |
| 1 | Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study. (Wheler JJ, Janku F, Naing A, Li Y, Stephen B, Zinner R, Subbiah V, Fu S, Karp D, Falchook GS, Tsimberidou AM, Piha-Paul S, Anderson R, Ke D, Miller V, Yelensky R, Lee JJ, Hong DS, Kurzrock R) Cancer Res 2016 Jul 01;76(13):3690-701 198 Citations |
| 1 | Gaps in nutritional research among older adults with cancer. (Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W) J Geriatr Oncol 2016 Jul;7(4):281-92 51 Citations |
| 1 | Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. (Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM) J Geriatr Oncol 2016 Jul;7(4):293-304 58 Citations |
| 1 | BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System. (Janku F, Huang HJ, Claes B, Falchook GS, Fu S, Hong D, Ramzanali NM, Nitti G, Cabrilo G, Tsimberidou AM, Naing A, Piha-Paul SA, Wheler JJ, Karp DD, Holley VR, Zinner RG, Subbiah V, Luthra R, Kopetz S, Overman MJ, Kee BK, Patel S, Devogelaere B, Sablon E, Maertens G, Mills GB, Kurzrock R, Meric-Bernstam F) Mol Cancer Ther 2016 Jun;15(6):1397-404 74 Citations |
| 6 | Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells. (Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, Barrios CS, Weber JJ, Johnson BD, Hardy M, Dwinell MB, Kalyanaraman B) Cancer Res 2016 Jul 01;76(13):3904-15 166 Citations |
| 1 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindström S, Overvad K, Romieu I, Sanchez MJ, Southey MC, Stram DO, Tumino R, VanderWeele TJ, Willett WC, Zhang S, Buring JE, Canzian F, Gapstur SM, Henderson BE, Hunter DJ, Giles GG, Prentice RL, Ziegler RG, Kraft P, Garcia-Closas M, Chatterjee N) JAMA Oncol 2016 Oct 01;2(10):1295-1302 277 Citations |
| 4 | The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. (Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader JS) PLoS One 2016;11(5):e0156274 141 Citations |
| 1 | Locoregional Recurrent or Second Primary Head and Neck Cancer: Management Strategies and Challenges. (Wong SJ, Heron DE, Stenson K, Ling DC, Vargo JA) Am Soc Clin Oncol Educ Book 2016;35:e284-92 27 Citations |
| 1 | Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines. (Steenackers A, Olivier-Van Stichelen S, Baldini SF, Dehennaut V, Toillon RA, Le Bourhis X, El Yazidi-Belkoura I, Lefebvre T) Front Endocrinol (Lausanne) 2016;7:46 49 Citations |
| 1 | Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. (Akinyemiju T, Moore JX, Ojesina AI, Waterbor JW, Altekruse SF) Breast Cancer Res Treat 2016 Jun;157(3):575-86 70 Citations |
| 3 | Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer. (Asare EA, Evans DB, Erickson BA, Aburajab M, Tolat P, Tsai S) J Surg Oncol 2016 Sep;114(3):291-5 17 Citations |
| 1 | The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. (Luo H, Chen X, Zhang Q, Wang L, Qiao L, Liang N, Xie J, Yu X, Song M, Liu Z, Lv Y, Liu F, Tian Y, Cheng J, Deng G, Zhang J, Li XA, Zhang J) J BUON 2016;21(2):419-26 |
| 2 | Breast Cancer Screening and Prevention. (Nattinger AB, Mitchell JL) Ann Intern Med 2016 Jun 07;164(11):ITC81-ITC96 28 Citations |
| 1 | Therapeutic Advances in Localized Pancreatic Cancer. (Tsai S, Evans DB) JAMA Surg 2016 Sep 01;151(9):862-8 52 Citations |
| 1 | TNFRSF10C copy number variation is associated with metastatic colorectal cancer. (Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS) J Gastrointest Oncol 2016 Jun;7(3):306-14 16 Citations |
| 1 | The PREX1/Rac signaling axis: Potential as a biomarker and therapeutic target in breast cancer. (Dillon LM, Miller TW) Mol Cell Oncol 2015;2(3):e996016 6 Citations |
| 1 | Colon cancer operations at high- and low-mortality hospitals. (Healy MA, Grenda TR, Suwanabol PA, Yin H, Ghaferi AA, Birkmeyer JD, Wong SL) Surgery 2016 Aug;160(2):359-65 6 Citations |
| 2 | The promise of epigenomic therapeutics in pancreatic cancer. (Lomberk GA, Iovanna J, Urrutia R) Epigenomics 2016 Jun;8(6):831-42 44 Citations |
| 1 | Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer. (Teagle AR, Gilbert DC, Jones JR, Burkill GJ, McKinna F, Dizdarevic S) Nucl Med Commun 2016 Oct;37(10):1038-45 15 Citations |
| 1 | Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. (Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB) J Clin Oncol 2016 Aug 10;34(23):2712-20 208 Citations |
| 2 | Catalyzing Transdisciplinarity: A Systems Ethnography of Cancer-Obesity Comorbidity and Risk Coincidence. (Graham SS, Harley A, Kessler MM, Roberts L, DeVasto D, Card DJ, Neuner JM, Kim SY) Qual Health Res 2017 May;27(6):877-892 4 Citations |
| 1 | Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells. (Rosati R, Chen B, Patki M, McFall T, Ou S, Heath E, Ratnam M, Qin Z) Mol Pharmacol 2016 Sep;90(3):225-37 20 Citations |
| 2 | Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body. (Campoy EM, Laurito SR, Branham MT, Urrutia G, Mathison A, Gago F, Orozco J, Urrutia R, Mayorga LS, Roqué M) PLoS One 2016;11(7):e0157416 7 Citations |
| 1 | The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model. (Bellamkonda K, Chandrashekar NK, Osman J, Selvanesan BC, Savari S, Sjölander A) BMC Cancer 2016 Jul 07;16:425 26 Citations |
| 1 | Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. (Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM) Pharmacol Res 2016 Sep;111:422-433 28 Citations |
| 1 | Prophylactic cranial irradiation for patients with lung cancer. (Péchoux CL, Sun A, Slotman BJ, De Ruysscher D, Belderbos J, Gore EM) Lancet Oncol 2016 Jul;17(7):e277-e293 99 Citations |
| 3 | Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. (Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM) J Natl Compr Canc Netw 2016 Jul;14(7):875-80 6 Citations |
| 1 | High intensity focused ultrasound for Focal Therapy of prostate cancer. (Sivaraman A) Arch Esp Urol 2016 Jul;69(6):311-6 6 Citations |
| 1 | ATM Mutations in Cancer: Therapeutic Implications. (Choi M, Kipps T, Kurzrock R) Mol Cancer Ther 2016 Aug;15(8):1781-91 360 Citations |
| 1 | [Localized prostate cancer Focal Therapy: "A la carte" Model]. (Linares Espinós E, Barret E, Sivaraman A, Pérez-Reggeti JI, Sánchez-Salas R, Rozet F, Galiano M, Cathelineau X) Arch Esp Urol 2016 Jul;69(6):345-52 8 Citations |
| 2 | The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation. (Loncle C, Molejon MI, Lac S, Tellechea JI, Lomberk G, Gramatica L, Fernandez Zapico MF, Dusetti N, Urrutia R, Iovanna JL) Cell Death Dis 2016 Jul 14;7(7):e2295 30 Citations |
| 1 | Morbidity of curative cancer surgery and suicide risk. (Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga KK) Psychooncology 2017 Nov;26(11):1792-1798 9 Citations |
| 1 | Preoperative evaluation of the patient with medullary thyroid cancer (Callender GG, Wang TS) Medullary Thyroid Cancer 20 July 2016:77-83 |
| 1 | Genetic evaluation of the patient with medullary thyroid cancer (Geurts JL) Medullary Thyroid Cancer 20 July 2016:65-75 |
| 1 | Surgical management of recurrent medullary thyroid cancer (Glenn JA, Wang TS) Medullary Thyroid Cancer 20 July 2016:189-197 |
| 2 | Medullary thyroid cancer (Wang TS, Evans DB) Medullary Thyroid Cancer 20 July 2016:1-205 2 Citations |
| 1 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. (Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS) N Engl J Med 2016 Aug 04;375(5):443-53 1292 Citations |
| 1 | Medullary thyroid cancer () Medullary Thyroid Cancer 20 July 2016:1-205 |
| 1 | MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells. (Deng W, Wang Y, Gu L, Duan B, Cui J, Zhang Y, Chen Y, Sun S, Dong J, Du J) BMC Cancer 2016 Jul 18;16:489 53 Citations |
| 1 | Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers. (Illendula A, Gilmour J, Grembecka J, Tirumala VSS, Boulton A, Kuntimaddi A, Schmidt C, Wang L, Pulikkan JA, Zong H, Parlak M, Kuscu C, Pickin A, Zhou Y, Gao Y, Mishra L, Adli M, Castilla LH, Rajewski RA, Janes KA, Guzman ML, Bonifer C, Bushweller JH) EBioMedicine 2016 Jun;8:117-131 82 Citations |
| 1 | Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. (Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE, Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF) Clin Cancer Res 2017 Jan 15;23(2):536-548 28 Citations |
| 1 | Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J, International Radiogenomics Consortium (RgC)) Radiother Oncol 2016 Dec;121(3):431-439 100 Citations |
| 1 | Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells. (Jagadish N, Gupta N, Agarwal S, Parashar D, Sharma A, Fatima R, Topno AP, Kumar V, Suri A) Tumour Biol 2016 Oct;37(10):13101-13110 20 Citations |
| 1 | Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications. (Mohamed AS, Rosenthal DI, Awan MJ, Garden AS, Kocak-Uzel E, Belal AM, El-Gowily AG, Phan J, Beadle BM, Gunn GB, Fuller CD) Radiat Oncol 2016 Jul 26;11(1):95 37 Citations |
| 1 | Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. (Thurlings I, Martínez-López LM, Westendorp B, Zijp M, Kuiper R, Tooten P, Kent LN, Leone G, Vos HJ, Burgering B, de Bruin A) Oncogene 2017 Feb 09;36(6):829-839 54 Citations |
| 1 | Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth. (Jagadish N, Parashar D, Gupta N, Agarwal S, Suri V, Kumar R, Suri V, Sadasukhi TC, Gupta A, Ansari AS, Lohiya NK, Suri A) BMC Cancer 2016 Jul 29;16:561 52 Citations |
| 1 | Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. (White J, Winter K, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch RA, Kelly T, Toonkel LM, Vicini FA, McCormick B) Int J Radiat Oncol Biol Phys 2016 Aug 01;95(5):1460-1465 49 Citations |
| 1 | Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. (Miranda F, Mannion D, Liu S, Zheng Y, Mangala LS, Redondo C, Herrero-Gonzalez S, Xu R, Taylor C, Chedom DF, Carrami EM, Albukhari A, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Salah E, Abdul Azeez KR, Elkins JM, Campo L, Myers KA, Klotz D, Bivona S, Dhar S, Bast RC Jr, Saya H, Choi HG, Gray NS, Fischer R, Kessler BM, Yau C, Sood AK, Motohara T, Knapp S, Ahmed AA) Cancer Cell 2016 Aug 08;30(2):273-289 145 Citations |
| 1 | The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. (Margonis GA, Buettner S, Sasaki K, Kim Y, Ratti F, Russolillo N, Ferrero A, Berger N, Gamblin TC, Poultsides G, Tran T, Postlewait LM, Maithel S, Michaels AD, Bauer TW, Marques H, Barroso E, Aldrighetti L, Pawlik TM) HPB (Oxford) 2016 Aug;18(8):700-5 46 Citations |
| 1 | Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors. (Wheler JJ, Atkins JT, Janku F, Moulder SL, Stephens PJ, Yelensky R, Valero V, Miller V, Kurzrock R, Meric-Bernstam F) Oncoscience 2016;3(5-6):164-72 37 Citations |
| 1 | Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns. (Resetca D, Neschadim A, Medin JA) J Immunother 2016 Sep;39(7):249-59 8 Citations |
| 1 | ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy. (Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W) Oncotarget 2017 Oct 24;8(51):88410-88420 12 Citations |
| 2 | Cancer-related microangiopathic hemolytic anemia. (Choy B, Alvarez Argote J, Treml A) Transfusion 2016 Aug;56(8):1937 2 Citations |
| 4 | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer. (Yen TWF, Li J, Sparapani RA, Laud PW, Nattinger AB) Medicine (Baltimore) 2016 Aug;95(31):e4392 19 Citations |
| 1 | Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells. (Nandakumar V, Hansen N, Glenn HL, Han JH, Helland S, Hernandez K, Senechal P, Johnson RH, Bussey KJ, Meldrum DR) Sci Rep 2016 Aug 09;6:30593 3 Citations |
| 7 | Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. (Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, Szabo A, Wilson JF, Currey AD, White J) Int J Radiat Oncol Biol Phys 2016 Sep 01;96(1):65-71 24 Citations |
| 1 | Characterizing the role of a high-volume cancer resection ecosystem on low-volume, high-quality surgical care. (Kothari AN, Blanco BA, Brownlee SA, Evans AE, Chang VA, Abood GJ, Settimi R, Raicu DS, Kuo PC) Surgery 2016 Oct;160(4):839-849 11 Citations |
| 1 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. (Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM, Radiogenomics Consortium) EBioMedicine 2016 Aug;10:150-63 69 Citations |
| 5 | A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care. (Pezzin LE, Laud P, Neuner J, Yen TW, Nattinger AB) Contemp Clin Trials 2016 Sep;50:150-6 3 Citations |
| 1 | Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer. (Ahallal Y, Sanchez-Salas R, Sivaraman A, Barret E, Secin FP, Validire P, Rozet F, Galiano M, Cathelineau X) Actas Urol Esp 2016 Dec;40(10):615-620 3 Citations |
| 1 | Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group. (Key NS, Khorana AA, Mackman N, McCarty OJ, White GC, Francis CW, McCrae KR, Palumbo JS, Raskob GE, Chan AT, Sood AK) Cancer Res 2016 Jul 01;76(13):3671-5 30 Citations |
| 4 | Disseminated Mycotic Aneurysms following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer: Case Discussion and Systematic Treatment Algorithm. (Lee CJ, Davila D, Dua A, Keyashian B, Dux J, Seabrook GR, Brown K, Malinowski M, Hieb RA, Lewis B) Ann Vasc Surg 2017 Feb;39:284.e5-284.e10 7 Citations |
| 1 | MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer. (Pai P, Rachagani S, Dhawan P, Sheinin YM, Macha MA, Qazi AK, Chugh S, Ponnusamy MP, Mallya K, Pothuraju R, Batra SK) Genes Cancer 2016 May;7(5-6):154-168 19 Citations |
| 1 | Signaling and Chromatin Networks in Cancer Biology (Hessmann E, Urrutia R, Koenig A) Chromatin Signaling and Diseases 24 August 2016:241-253 |
| 1 | Surgical Treatment For T4 Oropharyngeal Cancer-Reply. (Nussenbaum B, Zenga J) JAMA Otolaryngol Head Neck Surg 2017 Jan 01;143(1):97 |
| 1 | Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls. (Sheean P, Liang H, Schiffer L, Arroyo C, Stolley M) J Cancer Surviv 2017 Feb;11(1):102-110 8 Citations |
| 1 | Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients. (Zimmermann MT, Jiang G, Wang C) AMIA Jt Summits Transl Sci Proc 2016;2016:94-100 |
| 1 | Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis. (de Geus SW, Evans DB, Bliss LA, Eskander MF, Smith JK, Wolff RA, Miksad RA, Weinstein MC, Tseng JF) Eur J Surg Oncol 2016 Oct;42(10):1552-60 51 Citations |
| 1 | RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. (Jones RA, Robinson TJ, Liu JC, Shrestha M, Voisin V, Ju Y, Chung PE, Pellecchia G, Fell VL, Bae S, Muthuswamy L, Datti A, Egan SE, Jiang Z, Leone G, Bader GD, Schimmer A, Zacksenhaus E) J Clin Invest 2016 Oct 03;126(10):3739-3757 106 Citations |
| 1 | A two-stage approach for combining gene expression and mutation with clinical data improves survival prediction in myelodysplastic syndromes and ovarian cancer. (Li Y, Zhang X, Akinyemiju T, Ojesina AI, Szychowski JM, Liu N, Xu B, Yi N) J Bioinform Genom 2016 Sep;1(1) |
| 2 | Preliminary results on the feasibility of using ultrasound to monitor intrafractional motion during radiation therapy for pancreatic cancer. (Omari EA, Erickson B, Ehlers C, Quiroz F, Noid G, Cooper DT, Lachaine M, Li XA) Med Phys 2016 Sep;43(9):5252 17 Citations |
| 1 | Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer. (Chattopadhyay E, Singh R, Ray A, Roy R, De Sarkar N, Paul RR, Pal M, Aich R, Roy B) Sci Rep 2016 Sep 06;6:32735 30 Citations |
| 4 | Evolution of the Management of Resectable Pancreatic Cancer. (Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB) J Oncol Pract 2016 Sep;12(9):772-8 24 Citations |
| 1 | Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. (Huang Y, Lichtenberger LM, Taylor M, Bottsford-Miller JN, Haemmerle M, Wagner MJ, Lyons Y, Pradeep S, Hu W, Previs RA, Hansen JM, Fang D, Dorniak PL, Filant J, Dial EJ, Shen F, Hatakeyama H, Sood AK) Mol Cancer Ther 2016 Dec;15(12):2894-2904 44 Citations |
| 1 | Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. (Flynn T, Guancial EA, Kilari M, Kilari D) Clin Genitourin Cancer 2017 Feb;15(1):e95-e97 11 Citations |
| 2 | Exploiting agonist biased signaling of chemokines to target cancer. (Roy I, Getschman AE, Volkman BF, Dwinell MB) Mol Carcinog 2017 Mar;56(3):804-813 16 Citations |
| 1 | Cervical cancer screening: How our approach may change. (Hofmeister S) J Fam Pract 2016 Aug;65(8):551-3 1 Citation |
| 1 | Dose-Volume Relationship for Laryngeal Substructures and Aspiration in Patients With Head and Neck Cancers. (Mittal BB, Refaat T, Rademaker A, Pauloski BR, Choi M, Thomas TO, Logemann JA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E328-E329 |
| 1 | Postmastectomy Radiation Therapy Reduces Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes: Eight-Year Results. (Pham YD, Rehman S, Reddy CA, Shukla ME, Moore H, Budd T, Crowe JP, Shah CS, Cherian S, Tendulkar RD) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E20 |
| 1 | RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients. (Kato S, Subbiah V, Marchlik E, Elkin SK, Carter JL, Kurzrock R) Clin Cancer Res 2017 Apr 15;23(8):1988-1997 231 Citations |
| 1 | Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer (Jonathan R. Thompson, Smitha P. Menon, Grace K. Dy) ADMET & DMPK ADMET & DMPK 4(3)(2016) 186-211 |
| 2 | Erratum: The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer (Medicine and Science in Sports and Exercise (2016) 95:31 (e4392) DOI: 10.1097/MD.0000000000004392) (Yen TW, Li J, Sparapani RA) Medicine (United States) 1 October 2016;95(42):e76a7 |
| 1 | Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer (Thompson JR, Menon SP, Dy GK) ADMET and DMPK 1 October 2016;4(3):186-211 2 Citations |
| 1 | Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer (D. Schott
W.A. Hall
T. Gilat Schmidt
E. Dalah
K. Oshima
E.S. Paulson
P.M. Knechtges
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016 |
| 1 | A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy (S. Moningi
A. Amer
L.E. Colbert
Y. Lee
W.A. Hall
B.A. Erickson
G.R. Varadhachary
P. Das
C.M. Taniguchi
J.B. Fleming
M. Katz
C.H. Crane
E.J. Koay) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016 |
| 1 | Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer (A.N. Viswanathan
K. Winter
B.E. Miller
Y. Xiao
A. Jhingran
L. Portelance
W.R. Bosch
U. Matulonis
N. Horowitz
R. Mannel
L. Souhami
B.A. Erickson
W. Small Jr.
D.K. Gaffney) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S49-S50, OCTOBER 01, 2016 |
| 1 | Correlation of SMAD4 Expression in Pretreatment Cytologic Specimens and Postneoadjuvant Treatment Surgical Specimens in Patients With Pancreatic Cancer (J.R. Kharofa
C. Barnes
A. Mackinnon
B. George
P. Ritch
K. Christians
D. Evans
B.A. Erickson) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S141, OCTOBER 01, 2016 |
| 1 | Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer (Y. Song
X. Chen
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E303-E304, OCTOBER 01, 2016 |
| 1 | Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer (D. Schott
W.A. Hall
T. Gilat Schmidt
E. Dalah
K. Oshima
E.S. Paulson
P.M. Knechtges
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016 |
| 1 | Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures (E.M. Gore
C. Hu
V. Bar Ad
C.G. Robinson
M.D. Wheatley
J.A. Bogart
Y. Garces
V.S. Kavadi
S. Narayan
P. Iyengar
J.S. Witt
J.W. Welsh
C.D. Koprowski
J.M. Larner
J.D. Bradley) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S129-S130, OCTOBER 01, 2016 |
| 1 | Early Cardiotoxicity in Thoracic Radiation Therapy for Lung and Esophageal Cancer (J. Borkenhagen
C. Rapp
S. Klawikowski
L.E. Rein
E.M. Gore
) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E428, OCTOBER 01, 2016 |
| 1 | Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer (J. Paul
E.M. Gore
A. Li) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S193, OCTOBER 01, 2016 |
| 1 | A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy (S. Moningi
A. Amer
L.E. Colbert
Y. Lee
W.A. Hall
B.A. Erickson
G.R. Varadhachary
P. Das
C.M. Taniguchi
J.B. Fleming
M. Katz
C.H. Crane
E.J. Koay) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016 |
| 1 | NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results (D. Watkins Bruner
S.L. Pugh
W.R. Lee
J.J. Dignam
D. Low
G.P. Swanson
A.B. Shah
D.P. D'Souza
J.M. Michalski
I.S. Dayes
S.A. Seaward
P.L. Nguyen
W.A. Hall
T.M. Pisansky
Y. Chen
H.M. Sandler
B. Movsas
) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S2-S3, OCTOBER 01, 2016 |
| 1 | Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) (L.E. Colbert
K.V. Dharmarajan
J. Switchenko
C.M. Taniguchi
W.A. Hall
T.W. Gillespie
D.A. Kooby
J. Lipscomb
J.C. Landry) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016 |
| 1 | Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery (L.A. Kachnic
J. Moughan
M. Suntharalingam
D.H. Ilson
A.A. Konski
W. Burrows
C. Anker
V. Bar Ad
H.V. Thakrar
J.P. Hayes
E.M. Gore
V.S. Kavadi
R.U. Komaki
A. Raben
J.K. Giguere
J. Pollock
J.S. Greenberger
G.M. Videtic
K.S. Roof
D. Watkins Bruner
) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S31, OCTOBER 01, 2016 |
| 4 | Management of independent motion between multiple targets in lung cancer radiation therapy. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li XA) Pract Radiat Oncol 2017;7(1):26-34 5 Citations |
| 1 | Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. (Hoang DT, Iczkowski KA, Kilari D, See W, Nevalainen MT) Oncotarget 2017 Jan 10;8(2):3724-3745 102 Citations |
| 1 | Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles. (Rana S, Cheng C, Zhao L, Park S, Larson G, Vargas C, Dunn M, Zheng Y) J Med Radiat Sci 2017 Mar;64(1):18-24 14 Citations |
| 1 | Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER. (Subbiah IM, Wheler JJ, Hess KR, Hong DS, Naing A, Fu S, Kurzrock R, Tsimberidou AM) Int J Cancer 2017 Jan 01;140(1):208-215 9 Citations |
| 1 | 3. After a cancer diagnosis: Seven questions to ask. Waukesha Freeman 2016 Oct:3B (Sailaja Kamaraju) Waukesha Freeman Community Magazine/ Journal |
| 1 | Near-infrared photothermal therapy of Prussian-blue-functionalized lanthanide-ion-doped inorganic/plasmonic multifunctional nanostructures for the selective targeting of HER2-expressing breast cancer cells. (Parchur AK, Li Q, Zhou A) Biomater Sci 2016 Nov 15;4(12):1781-1791 37 Citations |
| 5 | Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? (Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S) J Surg Oncol 2016 Oct;114(5):581-586 26 Citations |
| 1 | Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue. (Chattopadhyay E, De Sarkar N, Singh R, Ray A, Roy R, Paul RR, Pal M, Ghose S, Ghosh S, Kabiraj D, Banerjee R, Roy B) Tumour Biol 2016 Sep;37(9):11861-11871 11 Citations |
| 1 | Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer. (Wang Y, Mark KM, Ung MH, Kettenbach A, Miller T, Xu W, Cheng W, Xia T, Cheng C) Genome Med 2016 Oct 27;8(1):114 3 Citations |
| 1 | The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth. (Rosati R, Patki M, Chari V, Dakshnamurthy S, McFall T, Saxton J, Kidder BL, Shaw PE, Ratnam M) J Biol Chem 2016 Dec 09;291(50):25983-25998 13 Citations |
| 1 | Brain metastases from breast cancer during pregnancy (Sharma A, Nguyen HS, Lozen A, Sharma A, Mueller W) Surgical Neurology International 1 November 2016;7(24):S603-S606 10 Citations |
| 1 | Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. (Park J, Wysocki RW, Amoozgar Z, Maiorino L, Fein MR, Jorns J, Schott AF, Kinugasa-Katayama Y, Lee Y, Won NH, Nakasone ES, Hearn SA, Küttner V, Qiu J, Almeida AS, Perurena N, Kessenbrock K, Goldberg MS, Egeblad M) Sci Transl Med 2016 Oct 19;8(361):361ra138 712 Citations |
| 1 | Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery? (Awan M, Sharma N, Towe CW, Efird JT, Machtay M, Biswas T) Expert Review of Anticancer Therapy 1 November 2016;16(11):1131-1144 |
| 1 | Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer. (Riese MJ, Moon EK, Johnson BD, Albelda SM) Front Cell Dev Biol 2016;4:108 48 Citations |
| 1 | Re: Cui T, Kovell RC, Terlecki RP. Is it time to abandon the digital rectal examination? Lessons from the PLCO Cancer Screening Trial and peer-reviewed literature. Curr Med Res Opin 2016;32:1-7. (Nyitray AG, Chiao EY) Curr Med Res Opin 2017 Feb;33(2):315-316 3 Citations |
| 1 | Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers. (Hatakeyama H, Wu SY, Lyons YA, Pradeep S, Wang W, Huang Q, Court KA, Liu T, Nie S, Rodriguez-Aguayo C, Shen F, Huang Y, Hisamatsu T, Mitamura T, Jennings N, Shim J, Dorniak PL, Mangala LS, Petrillo M, Petyuk VA, Schepmoes AA, Shukla AK, Torres-Lugo M, Lee JS, Rodland KD, Fagotti A, Lopez-Berestein G, Li C, Sood AK) Cell Rep 2016 Nov 01;17(6):1621-1631 22 Citations |
| 1 | EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition. (Hsu YT, Osmulski P, Wang Y, Huang YW, Liu L, Ruan J, Jin VX, Kirma NB, Gaczynska ME, Huang TH) Cancer Res 2016 Nov 01;76(21):6171-6182 47 Citations |
| 1 | A map of mobile DNA insertions in the NCI-60 human cancer cell panel. (Zampella JG, Rodić N, Yang WR, Huang CR, Welch J, Gnanakkan VP, Cornish TC, Boeke JD, Burns KH) Mob DNA 2016;7:20 3 Citations |
| 1 | Patient-reported health status during pediatric cancer treatment. (Dobrozsi S, Yan K, Hoffmann R, Panepinto J) Pediatr Blood Cancer 2017 Apr;64(4) 21 Citations |
| 1 | Fertility drugs and cancer: a guideline. (Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine) Fertil Steril 2016 Dec;106(7):1617-1626 36 Citations |
| 1 | Changing global policy to deliver safe, equitable, and affordable care for women's cancers. (Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G, Mohammed SI, Qiao YL, Rashid SF, Summers D, Sarfati D, Temmerman M, Trimble EL, Padela AI, Aggarwal A, Sullivan R) Lancet 2017 Feb 25;389(10071):871-880 78 Citations |
| 1 | Personalizing Rectal Cancer Management. (Ludwig KA, Vargas D, Reynolds H) Dis Colon Rectum 2016 Dec;59(12):1227-1229 3 Citations |
| 1 | Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth. (Yang L, Achreja A, Yeung TL, Mangala LS, Jiang D, Han C, Baddour J, Marini JC, Ni J, Nakahara R, Wahlig S, Chiba L, Kim SH, Morse J, Pradeep S, Nagaraja AS, Haemmerle M, Kyunghee N, Derichsweiler M, Plackemeier T, Mercado-Uribe I, Lopez-Berestein G, Moss T, Ram PT, Liu J, Lu X, Mok SC, Sood AK, Nagrath D) Cell Metab 2016 Nov 08;24(5):685-700 333 Citations |
| 2 | Commentary on: Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study. (Wang TS, Evans DB) Surgery 2017 Feb;161(2):472-474 8 Citations |
| 1 | Impact of Compliance on Dysphagia Rehabilitation in Head and Neck Cancer Patients: Results from a Multi-center Clinical Trial. (Krisciunas GP, Castellano K, McCulloch TM, Lazarus CL, Pauloski BR, Meyer TK, Graner D, Van Daele DJ, Silbergleit AK, Crujido LR, Rybin D, Doros G, Kotz T, Langmore SE) Dysphagia 2017 Apr;32(2):327-336 20 Citations |
| 1 | Residue influences quality of life independently of penetration and aspiration in head and neck cancer survivors. (Meyer TK, Pisegna JM, Krisciunas GP, Pauloski BR, Langmore SE) Laryngoscope 2017 Jul;127(7):1615-1621 33 Citations |
| 4 | Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. (Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB) J Oncol Pract 2016 Oct;12(10):915-923 20 Citations |
| 5 | Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study. (Yen TW, Pezzin LE, Li J, Sparapani R, Laud PW, Nattinger AB) Cancer 2017 May 15;123(6):957-966 32 Citations |
| 1 | Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey. (Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL) Cancer 2017 Mar 01;123(5):869-878 86 Citations |
| 2 | Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer. (Younan G, Tsai S, Evans DB, Christians KK) Surg Clin North Am 2016 Dec;96(6):1351-1370 48 Citations |
| 1 | Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence. (Hempel HA, Cuka NS, Kulac I, Barber JR, Cornish TC, Platz EA, De Marzo AM, Sfanos KS) Prostate 2017 Mar;77(4):412-424 49 Citations |
| 1 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. (Liu F, Tai A, Lee P, Biswas T, Ding GX, El Naqa I, Grimm J, Jackson A, Kong FS, LaCouture T, Loo B Jr, Miften M, Solberg T, Li XA) Radiother Oncol 2017 Feb;122(2):286-294 50 Citations |
| 1 | Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis. (Syrjala KL, Sutton SK, Jim HS, Knight JM, Wood WA, Lee SJ, Jacobsen PB, Abidi MH, Yi JC) Cancer 2017 Apr 15;123(8):1416-1423 27 Citations |
| 1 | Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab. (Basho RK, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Herbrich SM, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Ibrahim NK, Murray JL 3rd, Koenig KB, Hong D, Subbiah V, Kurzrock R, Janku F, Moulder SL) JAMA Oncol 2017 Apr 01;3(4):509-515 167 Citations |
| 2 | Patient-reported neuropathic pain in adolescent and young adult cancer patients. (Acquazzino MA, Igler EC, Dasgupta M, Simpson P, Browning MB, Brandow AM) Pediatr Blood Cancer 2017 Mar;64(3) 6 Citations |
| 4 | Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. (Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S) J Gastrointest Surg 2017 Mar;21(3):496-505 10 Citations |
| 1 | Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer. (Hosford SR, Dillon LM, Bouley SJ, Rosati R, Yang W, Chen VS, Demidenko E, Morra RP Jr, Miller TW) Clin Cancer Res 2017 Jun 01;23(11):2795-2805 27 Citations |
| 1 | Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer. (Kreuziger LB, Streiff M) Hematology Am Soc Hematol Educ Program 2016 Dec 02;2016(1):206-207 5 Citations |
| 1 | Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis. (Darabi M, Asadi Lari M, Motevalian SA, Motlagh A, Arsang-Jang S, Karimi Jaberi M) Epidemiol Health 2016;38:e2016056 35 Citations |
| 2 | Cutaneous Metastasis due to Breast Cancer in a Patient with Primary Biliary Cirrhosis: A Case Report. (Kamaraju S, Depke J, Povletich J, Currey A, Weil E) Case Rep Oncol 2016;9(3):718-725 5 Citations |
| 1 | American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. (Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D) Brachytherapy 2017;16(1):85-94 45 Citations |
| 1 | Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer Patients. (Kurzrock R, Stewart DJ) Clin Cancer Res 2017 Mar 01;23(5):1137-1148 40 Citations |
| 1 | Does a second resection provide a survival benefit in patients diagnosed with incidental T1b/T2 gallbladder cancer following cholecystectomy? (Watson H, Dasari B, Wyatt J, Hidalgo E, Prasad R, Lodge P, Toogood G) HPB (Oxford) 2017 Feb;19(2):104-107 23 Citations |
| 1 | Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 Jan;27(1):11-20 11 Citations |
| 1 | Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. (Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN) Ann Surg 2018 Mar;267(3):514-520 65 Citations |
| 2 | Triathlon training for women breast cancer survivors: feasibility and initial efficacy. (Ng AV, Cybulski AN, Engel AA, Papanek PE, Sheffer MA, Waltke LJ, Tjoe JA) Support Care Cancer 2017 May;25(5):1465-1473 14 Citations |
| 4 | Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D. (Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE) Med Care 2017 May;55(5):463-469 15 Citations |
| 1 | Ontology of cancer related social-ecological variables (Balasubramanian DK, Khan JZ, Bian J, Guo Y, Hogan WR, Hicks A) CEUR Workshop Proceedings 2017;2137 |
| 1 | Prognostic modeling and analysis of tumor response to fractionated radiotherapy for patients with squamous cell lung cancer (Zhong H, Sharifi H, Li H, Mao W, Chetty IJ) Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2017;10209 LNCS:549-559 1 Citation |
| 1 | ADAMTS16 mutations sensitize ovarian cancer cells to platinumbased chemotherapy (Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W) Oncotarget 2017;8(51):88410-88420 12 Citations |
| 1 | Landscape of Microsatellite Instability Across 39 Cancer Types. (Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, Reeser JW, Yu L, Roychowdhury S) JCO Precis Oncol 2017;2017 915 Citations |
| 1 | SU-F-J-173: Online Replanning for Dose Painting Based On Changing ADC Map of Pancreas Cancer. (Ates O, Ahunbay E, Erickson B, Li X) Med Phys 2016 Jun;43(6):3447-3448 |
| 1 | SU-F-T-525: Monitordeep-Inspiratory Breathhold with a Laser Sensor for Radiation Therapy of Left Breast Cancer. (Tai A, Li DJ, Currey A, Li XA) Med Phys 2016 Jun;43(6):3584 |
| 1 | Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach. (Zhang X, Li Y, Akinyemiju T, Ojesina AI, Buckhaults P, Liu N, Xu B, Yi N) Genetics 2017 Jan;205(1):89-100 33 Citations |
| 2 | Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. (Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM) Ann Palliat Med 2017 Jan;6(1):26-35 19 Citations |
| 3 | Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression. (Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):642-650 20 Citations |
| 1 | Evaluation of adaptive treatment planning for patients with non-small cell lung cancer. (Zhong H, Siddiqui SM, Movsas B, Chetty IJ) Phys Med Biol 2017 Jun 07;62(11):4346-4360 21 Citations |
| 1 | Use of Spinal Cord Diffusion Tensor Imaging to Quantify Neural Ablation and Evaluate Outcome after Percutaneous Cordotomy for Intractable Cancer Pain. (Vedantam A, Hou P, Chi TL, Dougherty PM, Hess KR, Viswanathan A) Stereotact Funct Neurosurg 2017;95(1):34-39 7 Citations |
| 1 | Towards an obesity-cancer knowledge base: Biomedical entity identification and relation detection (Lossio-Ventura JA, Hogan W, Modave F, Hicks A, Hanna J, Guo Y, He Z, Bian J) Proceedings - 2016 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2016 17 January 2017:1081-1088 17 Citations |
| 1 | Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation. (Awan MJ, Lavertu P, Zender C, Rezaee R, Fowler N, Karapetyan L, Gibson M, Wasman J, Faulhaber P, Machtay M, Yao M) Eur J Nucl Med Mol Imaging 2017 Jun;44(6):988-997 17 Citations |
| 3 | Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. (Roy I, Boyle KA, Vonderhaar EP, Zimmerman NP, Gorse E, Mackinnon AC, Hwang RF, Franco-Barraza J, Cukierman E, Tsai S, Evans DB, Dwinell MB) Lab Invest 2017 Mar;97(3):302-317 28 Citations |
| 3 | Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017;7(2):126-136 50 Citations |
| 1 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. (von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G) Gynecol Oncol 2017 Mar;144(3):459-467 62 Citations |
| 1 | Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. (Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm G, Konicke K, Koyfman SA, Lam C, Lee P, Leitenberger JJ, Loh T, Lowenstein S, Madankumar R, Moreau JF, Nijhawan RI, Ochoa S, Olasz EB, Otchere E, Otley C, Oulton J, Patel PH, Patel VA, Prabhu AV, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Zajdel N, Zelac D, Arron ST) JAMA Dermatol 2017 Mar 01;153(3):296-303 234 Citations |
| 1 | Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin. (Shee K, Kono AT, D'Anna SP, Seltzer MA, Lu X, Miller TW, Chamberlin MD) Case Rep Oncol 2016;9(3):840-846 6 Citations |
| 1 | American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. (Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B) Brachytherapy 2017;16(1):22-43 35 Citations |
| 1 | Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin. (Packiam VT, Johnson SC, Steinberg GD) Cancer 2017 Feb 01;123(3):390-400 45 Citations |
| 4 | Integrated genomic and molecular characterization of cervical cancer. (Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis) Nature 2017 Mar 16;543(7645):378-384 1119 Citations |
| 1 | hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. (Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP) Oncotarget 2017 Feb 28;8(9):14806-14820 28 Citations |
| 1 | Bladder cancer in Iran: Geographical distribution and risk factors (Jafari-Koshki T, Arsang-Jang S, Mahaki B) International Journal of Cancer Management February 2017;10(2) 22 Citations |
| 1 | Reply to Runqiang Yuan and Hongxing Huang's Letter to the Editor re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214-20. (Sivaraman A, Barret E) Eur Urol 2017 May;71(5):e148-e149 |
| 1 | Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death. (Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV) Cell Death Dis 2017 Feb 02;8(2):e2584 67 Citations |
| 1 | Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer. (Husain H, Scur M, Murtuza A, Bui N, Woodward B, Kurzrock R) Mol Cancer Ther 2017 Feb;16(2):265-272 34 Citations |
| 1 | Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. (Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D) ACS Nano 2017 Feb 28;11(2):2227-2238 433 Citations |
| 1 | Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastases. (Webster PJ, Littlejohns AT, Gaunt HJ, Young RS, Rode B, Ritchie JE, Stead LF, Harrison S, Droop A, Martin HL, Tomlinson DC, Hyman AJ, Appleby HL, Boxall S, Bruns AF, Li J, Prasad RK, Lodge JPA, Burke DA, Beech DJ) Oncotarget 2017 Jun 27;8(26):42288-42299 7 Citations |
| 4 | Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. (Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B) Oncotarget 2017 Apr 04;8(14):22550-22562 29 Citations |
| 1 | Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations. (Foley TM, Payne SN, Pasch CA, Yueh AE, Van De Hey DR, Korkos DP, Clipson L, Maher ME, Matkowskyj KA, Newton MA, Deming DA) Mol Cancer Res 2017 Feb 09;15(3):317-327 46 Citations |
| 1 | Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. (Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, Li W, Tao M, Napier D, Shi Q, Deng J, Evers BM, Zhou BP) Nat Commun 2017 Feb 15;8:14228 115 Citations |
| 1 | Predictors of response to platinum (Pt)-based chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) (Kilari, D., Bylow, K. and Berlin, K.E.K.) 2017 Genitourinary Cancers Symposium |
| 2 | Housing Discrimination, Residential Racial Segregation, and Colorectal Cancer Survival in Southeastern Wisconsin. (Zhou Y, Bemanian A, Beyer KM) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):561-568 69 Citations |
| 1 | Postoperative MRI Evaluation of a Radiofrequency Cordotomy Lesion for Intractable Cancer Pain. (Vedantam A, Hou P, Chi TL, Hess KR, Dougherty PM, Bruera E, Viswanathan A) AJNR Am J Neuroradiol 2017 Apr;38(4):835-839 8 Citations |
| 1 | Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration. (Parascandolo A, Rappa F, Cappello F, Kim J, Cantu DA, Chen H, Mazzoccoli G, Hematti P, Castellone MD, Salvatore M, Laukkanen MO) Sci Rep 2017 Feb 20;7:41416 32 Citations |
| 1 | Accuracy and Thoroughness of Treatment Summaries Provided as Part of Survivorship Care Plans Prepared by Two Cancer Centers. (Tevaarwerk AJ, Hocking WG, Zeal JL, Gribble M, Seaborne L, Buhr KA, Wisinski KB, Burkard ME, Wiegmann DA, Sesto ME) J Oncol Pract 2017 May;13(5):e486-e495 14 Citations |
| 1 | HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. (Beachler DC, Waterboer T, Pierce Campbell ChM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR) Papillomavirus Res 2016 Dec;2:141-144 9 Citations |
| 1 | Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. (Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group) J Clin Oncol 2017 Apr 10;35(11):1211-1222 82 Citations |
| 1 | Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. (Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA, Cleary S, Galandiuk S, Scott DJ, Fisichella PM, Shaheen NJ, Haisley KR, Hunter JG) J Gastrointest Surg 2017 Aug;21(8):1342-1349 4 Citations |
| 1 | LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. (Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV) Cancer Res 2017 Apr 15;77(8):1880-1891 34 Citations |
| 1 | Keratinocyte Cancer Therapies Enter the Era of Targeted and Immunotherapy: Join the Club. (Olasz EB, Babakoohi S, Lazarova Z) JAMA Dermatol 2017 Apr 01;153(4):253-255 |
| 1 | Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. (Cardenas CE, Mohamed ASR, Tao R, Wong AJR, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI) Int J Radiat Oncol Biol Phys 2017 Jul 01;98(3):532-540 54 Citations |
| 1 | Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. (Pakish JB, Zhang Q, Chen Z, Liang H, Chisholm GB, Yuan Y, Mok SC, Broaddus RR, Lu KH, Yates MS) Clin Cancer Res 2017 Aug 01;23(15):4473-4481 107 Citations |
| 2 | Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts. (Bian B, Bigonnet M, Gayet O, Loncle C, Maignan A, Gilabert M, Moutardier V, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Ouaissi M, Secq V, Poizat F, Nicolle R, Blum Y, Marisa L, Rubis M, Raoul JL, Bradner JE, Qi J, Lomberk G, Urrutia R, Saul A, Dusetti N, Iovanna J) EMBO Mol Med 2017 Apr;9(4):482-497 60 Citations |
| 1 | Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis. (Costa R, Gill N, Rademaker AW, Carneiro BA, Chae YK, Kumthekar P, Gradishar WJ, Kurzrock R, Giles FJ) Cancer Treat Rev 2017 Apr;55:10-15 24 Citations |
| 1 | AZD1775 induces toxicity through double-stranded DNA breaks independently of chemotherapeutic agents in p53-mutated colorectal cancer cells. (Webster PJ, Littlejohns AT, Gaunt HJ, Prasad KR, Beech DJ, Burke DA) Cell Cycle 2017;16(22):2176-2182 22 Citations |
| 2 | Measures Matter: The Local Exposure/Isolation (LEx/Is) Metrics and Relationships between Local-Level Segregation and Breast Cancer Survival. (Bemanian A, Beyer KM) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):516-524 36 Citations |
| 1 | Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese. (Dong J, Cheng Y, Zhu M, Wen Y, Wang C, Wang Y, Geng L, Shen W, Liu J, Li Z, Zhang J, Ma H, Dai J, Jin G, Hu Z, Shen H) Int J Cancer 2017 Aug 01;141(3):447-456 17 Citations |
| 1 | Utilization of Health Care Services and Ambulatory Resources Associated with Chronic Noncancer Pain. (Kay C, Wozniak E, Bernstein J) Pain Med 2017 Jul 01;18(7):1236-1246 10 Citations |
| 1 | Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country. (Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M) Gynecol Oncol Rep 2017 May;20:58-61 19 Citations |
| 1 | 4. Cancer Myths and Facts, Readers Digest 2017 Mar, http://www.rd.com/health/conditions/causes-of-cancer-myths/ (Sailaja Kamaraju) Readers Digest Community Magazine/ Journal |
| 1 | Treatment outcomes in veterans with HPV-positive head and neck cancer. (Feinstein AJ, Shay SG, Chang E, Lewis MS, Wang MB) Am J Otolaryngol 2017;38(2):188-192 16 Citations |
| 1 | Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping. (Gandaglia G, Karnes RJ, Sivaraman A, Moschini M, Fossati N, Zaffuto E, DellʼOglio P, Cathelineau X, Montorsi F, Sanchez-Salas R, Briganti A) Urol Oncol 2017 Jul;35(7):461.e7-461.e14 22 Citations |
| 1 | Hydrogen peroxide activated quinone methide precursors with enhanced DNA cross-linking capability and cytotoxicity towards cancer cells. (Wang Y, Fan H, Balakrishnan K, Lin Z, Cao S, Chen W, Fan Y, Guthrie QA, Sun H, Teske KA, Gandhi V, Arnold LA, Peng X) Eur J Med Chem 2017 Jun 16;133:197-207 29 Citations |
| 3 | Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer. (Smith ZL, Gonzaga JE, Haasler GB, Gore EM, Dua KS) Dig Dis Sci 2017 Jun;62(6):1647-1656 9 Citations |
| 3 | Technical Note: Is bulk electron density assignment appropriate for MRI-only based treatment planning for lung cancer? (Prior P, Chen X, Gore E, Johnstone C, Li XA) Med Phys 2017 Jul;44(7):3437-3443 20 Citations |
| 1 | Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. (Li Z, Zhu Y, Li C, Trinh R, Ren X, Sun F, Wang Y, Shang P, Wang T, Wang M, Morrison SL, Zhang J) Oncoimmunology 2017;6(3):e1290038 24 Citations |
| 1 | Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer. (Osman J, Savari S, Chandrashekar NK, Bellamkonda K, Douglas D, Sjölander A) Oncotarget 2017 May 23;8(21):34773-34786 26 Citations |
| 1 | Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. (Sunkel B, Wu D, Chen Z, Wang CM, Liu X, Ye Z, Horning AM, Liu J, Mahalingam D, Lopez-Nicora H, Lin CL, Goodfellow PJ, Clinton SK, Jin VX, Chen CL, Huang TH, Wang Q) Nucleic Acids Res 2017 Jun 20;45(11):6993 7 Citations |
| 1 | Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer. (Rabinowicz N, Mangala LS, Brown KR, Checa-Rodriguez C, Castiel A, Moskovich O, Zarfati G, Trakhtenbrot L, Levy-Barda A, Jiang D, Rodriguez-Aguayo C, Pradeep S, van Praag Y, Lopez-Berestein G, David A, Novikov I, Huertas P, Rottapel R, Sood AK, Izraeli S) Oncotarget 2017 Apr 18;8(16):27380-27392 9 Citations |
| 1 | Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer. (Hampsch RA, Shee K, Bates D, Lewis LD, Désiré L, Leblond B, Demidenko E, Stefan K, Huang YH, Miller TW) Oncotarget 2017 Mar 28;8(13):21806-21817 32 Citations |
| 1 | Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients. (Nikanjam M, Liu S, Yang J, Kurzrock R) Oncologist 2017 May;22(5):576-584 37 Citations |
| 5 | Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies. (Kalyanaraman B, Cheng G, Hardy M, Ouari O, Sikora A, Zielonka J, Dwinell MB) Cell Biochem Biophys 2017 Dec;75(3-4):311-317 21 Citations |
| 1 | Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC) J Oncol Pharm Pract 2018 Apr;24(3):229-231 2 Citations |
| 1 | Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. (Kalyanaraman B) Redox Biol 2017 Aug;12:833-842 174 Citations |
| 1 | Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. (Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Ader J, Diller L, Schwartz CL) Pediatr Blood Cancer 2017 Oct;64(10) 13 Citations |
| 1 | Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. (Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA) Biol Blood Marrow Transplant 2017 Aug;23(8):1342-1349 48 Citations |
| 1 | A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. (Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G) Ann Oncol 2017 May 01;28(5):996-1004 73 Citations |
| 3 | Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. (Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM, Gore E, Li XA) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):463-472 19 Citations |
| 1 | Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. (Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):296-303 109 Citations |
| 1 | Deformable MRI-CT registration for breast cancer radiation treatment planning using a sequentially applied semi-physical model regularization method (Cungeng Yang, Julia White, Guang-Pei Chen and X Allen Li) Biomedical Physics & Engineering Express |
| 1 | Negative psychological consequences of breast cancer among recently diagnosed ethnically diverse women. (Tejeda S, Stolley MR, Vijayasiri G, Campbell RT, Estwing Ferrans C, Warnecke RB, Rauscher GH) Psychooncology 2017 Dec;26(12):2245-2252 22 Citations |
| 1 | Institutional variation in surgical care for early-stage breast cancer at community hospitals. (Dodgion CM, Lipsitz SR, Decker MR, Hu YY, Quamme SRP, Karcz A, D'Avolio L, Greenberg CC) J Surg Res 2017 May 01;211:196-205 2 Citations |
| 1 | Pediatric Gynecologic Cancers. (Pommert L, Bradley W) Curr Oncol Rep 2017 Jul;19(7):44 25 Citations |
| 1 | DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients. (Jadhav RR, Santucci-Pereira J, Wang YV, Liu J, Nguyen TD, Wang J, Jenkins S, Russo J, Huang TH, Jin VX, Lamartiniere CA) Genes (Basel) 2017 May 15;8(5) 35 Citations |
| 2 | PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. (Ronen S, Abbott DW, Kravtsov O, Abdelkader A, Xu Y, Banerjee A, Iczkowski KA) Hum Pathol 2017 Jul;65:85-91 35 Citations |
| 1 | No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children's hospital. (Jacob SA, Shaw PH) Pediatr Blood Cancer 2017 Dec;64(12) 28 Citations |
| 2 | Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N) J Cancer 2017;8(6):1009-1017 8 Citations |
| 1 | Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. (Sharabi A, Kim SS, Kato S, Sanders PD, Patel SP, Sanghvi P, Weihe E, Kurzrock R) Oncologist 2017 Jun;22(6):631-637 95 Citations |
| 1 | Comparative analysis of the effect of bevacizumab maintenance regimens after first-line chemotherapy in patients with metastatic colorectal cancer (MCRC): A single institution experience (Song Y, Mohamed A, Ismail H, Abdallah N, Suprapaneni M, Dyson G, Kamgar M, Akhras A, Mettu J, Ahmed A, Tesfaye AA, Philip PA, Shields AF) Journal of Clinical Oncology 35, no. 15_suppl.e15032 |
| 8 | Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. (Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A) Breast Cancer Res Treat 2017 Aug;165(1):53-64 15 Citations |
| 3 | Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. (Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA) PLoS One 2017;12(6):e0178961 75 Citations |
| 1 | Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization. (Fairchild AH, White SB) Semin Intervent Radiol 2017 Jun;34(2):87-91 6 Citations |
| 1 | Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. (Iannaccone M, D'Ascenzo F, Vadalà P, Wilton SB, Noussan P, Colombo F, Raposeiras Roubín S, Abu Assi E, González-Juanatey JR, Simao Henriques JP, Saucedo J, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Garbo R, Huczek Z, Nie SP, Fujii T, Correia LC, Kawashiri MA, García Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Gaita F, Yamagishi M, Kalpak O, Kedev S) Eur Heart J Acute Cardiovasc Care 2018 Oct;7(7):631-638 98 Citations |
| 1 | Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer. (Hu Q, Hisamatsu T, Haemmerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong STC, Sood AK, Afshar-Kharghan V) Clin Cancer Res 2017 Sep 15;23(18):5611-5621 61 Citations |
| 2 | Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors. (Stolley M, Sheean P, Gerber B, Arroyo C, Schiffer L, Banerjee A, Visotcky A, Fantuzzi G, Strahan D, Matthews L, Dakers R, Carridine-Andrews C, Seligman K, Springfield S, Odoms-Young A, Hong S, Hoskins K, Kaklamani V, Sharp L) J Clin Oncol 2017 Aug 20;35(24):2820-2828 45 Citations |
| 1 | Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD) J Thorac Oncol 2017 Sep;12(9):1413-1420 18 Citations |
| 2 | Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. (Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD) J Thorac Oncol 2017 Oct;12(10):1561-1570 130 Citations |
| 1 | Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: insights from the 2017 ASCO Gastrointestinal Cancers Symposium. (Iyer R, Phan AT, Boudreaux JP) Clin Adv Hematol Oncol 2017 Apr;15 Suppl 4(4):1-24 4 Citations |
| 1 | Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. (Walter KR, Goodman ML, Singhal H, Hall JA, Li T, Holloran SM, Trinca GM, Gibson KA, Jin VX, Greene GL, Hagan CR) Mol Cancer Res 2017 Oct;15(10):1331-1340 31 Citations |
| 1 | P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site. (Marotti JD, Muller KE, Tafe LJ, Demidenko E, Miller TW) Int J Breast Cancer 2017;2017:4537532 11 Citations |
| 1 | Symptom Levels in Care-Seeking Bangladeshi and Nepalese Adults With Advanced Cancer. (Love RR, Ferdousy T, Paudel BD, Nahar S, Dowla R, Adibuzzaman M, Ahsan GMT, Uddin M, Salim R, Ahamed SI) J Glob Oncol 2017 Jun;3(3):257-260 5 Citations |
| 1 | Symptom self-management strategies reported by adolescents and young adults with cancer receiving chemotherapy. (Linder LA, Erickson JM, Stegenga K, Macpherson CF, Wawrzynski S, Wilson C, Ameringer S) Support Care Cancer 2017 Dec;25(12):3793-3806 37 Citations |
| 3 | Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features. (Hopp EE, Cossette SM, Kumar SN, Eastwood D, Ramchandran R, Bishop E) Cancer Invest 2017 Aug 09;35(7):456-462 4 Citations |
| 1 | Effective Screening and Classification of Cervical Precancer Biopsy Imagery. (Jagtap J, Patil N, Parchur AK, Pantola C, Agarwal A, Pandey K, Pradhan A) IEEE Trans Nanobioscience 2017 Dec;16(8):687-693 10 Citations |
| 1 | 5. After a cancer diagnosis: Seven questions to ask. Milwaukee Journal Sentinel 2017 July 24, www.jsonline.com/story/sponsor-story/froedtert/2017/07/24/after-a-cancer-diagnosis-7-questions-to-ask/103885628/ (Sailaja Kamaraju) Milwaukee Journal Sentinel Community Magazine/ Journal |
| 2 | Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. (Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F) J Immunol 2017 Sep 01;199(5):1933-1941 85 Citations |
| 1 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/gynecologic oncology group study (Von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G) Obstetrical and Gynecological Survey 1 August 2017;72(8):481-482 |
| 1 | Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. (Cohn DE, Sill MW, Walker JL, O'Malley D, Nagel CI, Rutledge TL, Bradley W, Richardson DL, Moxley KM, Aghajanian C) Gynecol Oncol 2017 Sep;146(3):477-483 58 Citations |
| 1 | Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Beadle B, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P, MARCH Collaborative Group) Lancet Oncol 2017 Sep;18(9):1221-1237 265 Citations |
| 1 | Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications. (Zare M, Bastami M, Solali S, Alivand MR) J Cell Physiol 2018 May;233(5):3729-3744 83 Citations |
| 1 | Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions. (Mohamed ASR, Cardenas CE, Garden AS, Awan MJ, Rock CD, Westergaard SA, Brandon Gunn G, Belal AM, El-Gowily AG, Lai SY, Rosenthal DI, Fuller CD, Aristophanous M) Radiother Oncol 2017 Aug;124(2):248-255 30 Citations |
| 1 | Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. (Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML) J Clin Oncol 2017 Dec 20;35(36):4057-4065 126 Citations |
| 1 | A qualitative investigation among men who have sex with men on the acceptability of performing a self- or partner anal exam to screen for anal cancer. (Butame SA, Lawler S, Hicks JT, Wilkerson JM, Hwang LY, Baraniuk S, Ross MW, Chiao EY, Nyitray AG) Cancer Causes Control 2017 Oct;28(10):1157-1166 10 Citations |
| 1 | First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. (Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, van Hazel G, Sharma RA) Lancet Oncol 2017 Sep;18(9):1159-1171 295 Citations |
| 1 | Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. (Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P) JAMA Dermatol 2017 Oct 01;153(10):999-1006 84 Citations |
| 1 | A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study. (Thaker PH, Brady WE, Lankes HA, Odunsi K, Bradley WH, Moore KN, Muller CY, Anwer K, Schilder RJ, Alvarez RD, Fracasso PM) Gynecol Oncol 2017 Nov;147(2):283-290 47 Citations |
| 1 | Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now. (Deshmukh AA, Cantor SB, Fenwick E, Chiao EY, Nyitray AG, Stier EA, Goldstone SE, Wilkin T, Chhatwal J) Vaccine 2017 Sep 12;35(38):5102-5109 23 Citations |
| 1 | Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing. (Schwaederle M, Chattopadhyay R, Kato S, Fanta PT, Banks KC, Choi IS, Piccioni DE, Ikeda S, Talasaz A, Lanman RB, Bazhenova L, Kurzrock R) Cancer Res 2017 Oct 01;77(19):5419-5427 90 Citations |
| 1 | Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes. (Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Nunes-Silva I, Linares-Espinós E, Rozet F, Galiano M, Cathelineau X) J Urol 2018 Jan;199(1):140-146 32 Citations |
| 1 | A phase II clinical study to assess the feasibility of self and partner anal examinations to detect anal canal abnormalities including anal cancer. (Nyitray AG, Hicks JT, Hwang LY, Baraniuk S, White M, Millas S, Onwuka N, Zhang X, Brown EL, Ross MW, Chiao EY) Sex Transm Infect 2018 Mar;94(2):124-130 29 Citations |
| 1 | Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. (Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R) Mol Cancer Ther 2017 Nov;16(11):2598-2608 1739 Citations |
| 7 | Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 29 Citations |
| 4 | Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. (Palatnik A, Ye S, Kendziorski C, Iden M, Zigman JS, Hessner MJ, Rader JS) PLoS One 2017;12(8):e0181242 10 Citations |
| 1 | The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer. (Ariana M, Arabi N, Pornour M, Vaseghi H, Ganji SM, Alivand MR, Salari M, Akbari ME) J Cell Biochem 2018 Feb;119(2):2168-2178 11 Citations |
| 1 | Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort. (Smith ZL, Johnson SC, Golan S, McGinnis JR, Steinberg GD, Smith ND) J Urol 2018 Mar;199(3):663-668 9 Citations |
| 3 | Socioeconomic status and breast cancer treatment. (Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE) Breast Cancer Res Treat 2018 Jan;167(1):1-8 124 Citations |
| 5 | Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017;7(6):e449-e455 |
| 1 | Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers. (Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Wu XC, Wilson JF, Trentham-Dietz A) J Cancer Epidemiol 2017;2017:7574946 13 Citations |
| 1 | A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. (Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Hassanadeh C, Beitler JJ, Reddy CA, Marcrom S, Boggs DH, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Ferris RL, Heron DE) Int J Radiat Oncol Biol Phys 2018 Mar 01;100(3):595-605 114 Citations |
| 1 | PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer. (Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL) Cancer Res 2017 Nov 15;77(22):6353-6364 173 Citations |
| 1 | Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology. (Kruspe S, Dickey DD, Urak KT, Blanco GN, Miller MJ, Clark KC, Burghardt E, Gutierrez WR, Phadke SD, Kamboj S, Ginader T, Smith BJ, Grimm SK, Schappet J, Ozer H, Thomas A, McNamara JO 2nd, Chan CH, Giangrande PH) Mol Ther Nucleic Acids 2017 Sep 15;8:542-557 27 Citations |
| 2 | The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models. (Wang S, Zhou R, Sun F, Li R, Wang M, Wu M) Cancer Lett 2017 Nov 28;409:125-136 12 Citations |
| 1 | Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. (Wu J, Liu X, Nayak SG, Pitarresi JR, Cuitiño MC, Yu L, Hildreth BE 3rd, Thies KA, Schilling DJ, Fernandez SA, Leone G, Ostrowski MC) PLoS One 2017;12(9):e0184984 17 Citations |
| 1 | Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells. (Hezam K, Jiang J, Sun F, Zhang X, Zhang J) Rev Neurosci 2018 Jan 26;29(1):93-98 17 Citations |
| 1 | Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. (Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S) Ann Surg Oncol 2017 Dec;24(13):4051-4058 26 Citations |
| 5 | Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. (Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC) Surgery 2018 Feb;163(2):318-323 35 Citations |
| 1 | Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness. (Deshmukh AA, Chiao EY, Cantor SB, Stier EA, Goldstone SE, Nyitray AG, Wilkin T, Wang X, Chhatwal J) Cancer 2017 Dec 01;123(23):4709-4719 27 Citations |
| 2 | Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. (Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY) Int J Radiat Oncol Biol Phys 2018 Jun 01;101(2):274-284 54 Citations |
| 1 | Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer. (Du M, Giridhar KV, Tian Y, Tschannen MR, Zhu J, Huang CC, Kilari D, Kohli M, Wang L) Oncotarget 2017 Sep 08;8(38):63703-63714 54 Citations |
| 1 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. (Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP) Cell 2017 Oct 19;171(3):540-556.e25 1659 Citations |
| 1 | Cancer stemness in bone marrow micrometastases of human breast cancer. (Kuo MC, Kothari AN, Kuo PC, Mi Z) Surgery 2018 Feb;163(2):330-335 21 Citations |
| 1 | SurvivorCHESS to increase physical activity in colon cancer survivors: can we get them moving? (Mayer DK, Landucci G, Awoyinka L, Atwood AK, Carmack CL, Demark-Wahnefried W, McTavish F, Gustafson DH) J Cancer Surviv 2018 Feb;12(1):82-94 46 Citations |
| 5 | A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds. (Kalyanaraman B, Cheng G, Hardy M, Ouari O, Lopez M, Joseph J, Zielonka J, Dwinell MB) Redox Biol 2018 Apr;14:316-327 190 Citations |
| 1 | Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors (Jonathan R Thompson, Carlos Arce-Lara, Aniko Szabo, Smitha Menon) World Conference on Lung Cancer Abstract 693 |
| 1 | Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study. (Garrett GL, Yuan JT, Shin TM, Arron ST, Transplant Skin Cancer Network (TSCN)) J Am Acad Dermatol 2018 Feb;78(2):264-269 16 Citations |
| 1 | Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach. (Kato S, Kurasaki K, Ikeda S, Kurzrock R) Oncologist 2018 Feb;23(2):171-178 35 Citations |
| 1 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. (Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang Q, Aalfs CM, ABCTB Investigators, Adams M, Adlard J, Agata S, Ahmed S, Ahsan H, Aittomäki K, Al-Ejeh F, Allen J, Ambrosone CB, Amos CI, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Auber B, Auer PL, Ausems MGEM, Azzollini J, Bacot F, Balmaña J, Barile M, Barjhoux L, Barkardottir RB, Barrdahl M, Barnes D, Barrowdale D, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Bernstein L, Bignon YJ, Blazer KR, Blok MJ, Blomqvist C, Blot W, Bobolis K, Boeckx B, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Børresen-Dale AL, Bozsik A, Bradbury AR, Brand JS, Brauch H, Brenner H, Bressac-de Paillerets B, Brewer C, Brinton L, Broberg P, Brooks-Wilson A, Brunet J, Brüning T, Burwinkel B, Buys SS, Byun J, Cai Q, Caldés T, Caligo MA, Campbell I, Canzian F, Caron O, Carracedo A, Carter BD, Castelao JE, Castera L, Caux-Moncoutier V, Chan SB, Chang-Claude J, Chanock SJ, Chen X, Cheng TD, Chiquette J, Christiansen H, Claes KBM, Clarke CL, Conner T, Conroy DM, Cook J, Cordina-Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks E, Diez O, Ding YC, Ditsch N, Doheny KF, Domchek SM, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dubois S, Dugué PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles D, Eeles R, Ehrencrona H, Eilber U, Ejlertsen B, Ekici AB, Eliassen AH, EMBRACE, Engel C, Eriksson M, Fachal L, Faivre L, Fasching PA, Faust U, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost D, Gabrielson M, Gaddam P, Gammon MD, Ganz PA, Gapstur SM, Garber J, Garcia-Barberan V, García-Sáenz JA, Gaudet MM, Gauthier-Villars M, Gehrig A, GEMO Study Collaborators, Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Goodfellow P, Greene MH, Alnæs GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Guénel P, Guo Q, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hallberg E, Hamann U, Hamel N, Hankinson S, Hansen TVO, Harrington P, Hart SN, Hartikainen JM, Healey CS, HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kast K, kConFab/AOCS Investigators, Keeman R, Kerin MJ, Kets CM, Keupers M, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou I, Kosma VM, Kristensen VN, Kruse TA, Kwong A, Lænkholm AV, Laitman Y, Lalloo F, Lambrechts D, Landsman K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini C, Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Menéndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan AM, Mulot C, Nadesan S, Nathanson KL, NBSC Collaborators, Neuhausen SL, Nevanlinna H, Nevelsteen I, Niederacher D, Nielsen SF, Nordestgaard BG, Norman A, Nussbaum RL, Olah E, Olopade OI, Olson JE, Olswold C, Ong KR, Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice R, Presneau N, Prokofieva D, Pugh E, Pujana MA, Pylkäs K, Rack B, Radice) Nat Genet 2017 Dec;49(12):1767-1778 288 Citations |
| 1 | Comprehensive Analysis of Hypermutation in Human Cancer. (Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A) Cell 2017 Nov 16;171(5):1042-1056.e10 584 Citations |
| 1 | Association analysis identifies 65 new breast cancer risk loci. (Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal L, McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittomäki K, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Arun B, Auer PL, Bacot F, Barrdahl M, Baynes C, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Brinton L, Broberg P, Brock IW, Broeks A, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Butterbach K, Cai Q, Cai H, Caldés T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL, NBCS Collaborators, Collée M, Conroy DM, Cordina-Duverger E, Cornelissen S, Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gaborieau V, Gabrielson M, Gago-Dominguez M, Gao YT, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hamel N, Hankinson S, Harrington P, Hart SN, Hartikainen JM, Hartman M, Hein A, Heyworth J, Hicks B, Hillemanns P, Ho DN, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kasuga Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Kosma VM, Kristensen VN, Krüger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Menéndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Ruddy KJ, Rüdiger T, Rudolph A, Ruebner M, Rutgers EJT, Saloustros E, Sandler DP, Sangrajrang S, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets A, Sohn C, Southey MC, Spinelli JJ, Stegmaier C, Stewart-Brown S, Stone J, Stram DO, Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengström M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Thöne K, Tollenaar RAEM, Tomlinson I, Tong L, Torres D, Truong T, Tseng CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E, ABCTB Investigators, ConFab/AOCS Investigators, Lakhani SR, Antoniou AC, Droit A, Andrulis IL, Amos CI, Couch FJ, Pharoah PDP, C) Nature 2017 Nov 02;551(7678):92-94 1005 Citations |
| 1 | Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen. (Spurgeon ME, den Boon JA, Horswill M, Barthakur S, Forouzan O, Rader JS, Beebe DJ, Roopra A, Ahlquist P, Lambert PF) Proc Natl Acad Sci U S A 2017 Oct 24;114(43):E9076-E9085 62 Citations |
| 1 | Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study. (Tsimberidou AM, Hong DS, Ye Y, Cartwright C, Wheler JJ, Falchook GS, Naing A, Fu S, Piha-Paul S, Janku F, Meric-Bernstam F, Hwu P, Kee B, Kies MS, Broaddus R, Mendelsohn J, Hess KR, Kurzrock R) JCO Precis Oncol 2017;2017 131 Citations |
| 2 | Context is Key in Addressing Obesity and Lifestyle in Diverse Populations of Cancer Survivors. (Stolley MR, Beyer K, Gann P, Sheean P) Obesity (Silver Spring) 2017 Nov;25 Suppl 2:S25-S26 3 Citations |
| 6 | Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer. (Yen TWF, Laud PW, Pezzin LE, McGinley EL, Wozniak E, Sparapani R, Nattinger AB) Med Care 2018 Jan;56(1):78-84 15 Citations |
| 5 | Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. (Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS) J Med Imaging (Bellingham) 2018 Jan;5(1):011004 38 Citations |
| 1 | Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]. (Illendula A, Gilmour J, Grembecka J, Tirumala VSS, Boulton A, Kuntimaddi A, Schmidt C, Wang L, Pulikkan JA, Zong H, Parlak M, Kuscu C, Pickin A, Zhou Y, Gao Y, Mishra L, Adli M, Castilla LH, Rajewski RA, Janes KA, Guzman ML, Bonifer C, Bushweller JH) EBioMedicine 2017 Nov;25:188 |
| 2 | The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. (Koay EJ, Hall W, Park PC, Erickson B, Herman JM) Abdom Radiol (NY) 2018 Feb;43(2):393-403 6 Citations |
| 1 | Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer. (Garje R, Chau JJ, Chung J, Wanat K, Zakharia Y) J Immunother 2018 Jan;41(1):42-44 16 Citations |
| 1 | Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer. (Yang W, Hosford SR, Traphagen NA, Shee K, Demidenko E, Liu S, Miller TW) FASEB J 2018 Mar;32(3):1222-1235 25 Citations |
| 2 | Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy? (Chaudhary LN, Wilkinson KH, Kong A) Surg Oncol Clin N Am 2018 Jan;27(1):141-153 127 Citations |
| 1 | Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus. (Conley RB, Dickson D, Zenklusen JC, Al Naber J, Messner DA, Atasoy A, Chaihorsky L, Collyar D, Compton C, Ferguson M, Khozin S, Klein RD, Kotte S, Kurzrock R, Lin CJ, Liu F, Marino I, McDonough R, McNeal A, Miller V, Schilsky RL, Wang LI) Cell 2017 Nov 16;171(5):982-986 12 Citations |
| 1 | HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications. (Bayat S, Shekari Khaniani M, Choupani J, Alivand MR, Mansoori Derakhshan S) Biomed Pharmacother 2018 Jan;97:1445-1453 35 Citations |
| 1 | Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data. (Bien SA, Auer PL, Harrison TA, Qu C, Connolly CM, Greenside PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe J, Brenner H, Casey G, Chan AT, Hopper JL, Banbury BL, Chang-Claude J, Chanock SJ, Haile RW, Hoffmeister M, Fuchsberger C, Jenkins MA, Leal SM, Lemire M, Newcomb PA, Gallinger S, Potter JD, Schoen RE, Slattery ML, Smith JD, Le Marchand L, White E, Zanke BW, Abeçasis GR, Carlson CS, Peters U, Nickerson DA, Kundaje A, Hsu L, GECCO and CCFR) PLoS One 2017;12(11):e0186518 8 Citations |
| 1 | Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466 18 Citations |
| 1 | Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. (McFall T, McKnight B, Rosati R, Kim S, Huang Y, Viola-Villegas N, Ratnam M) J Biol Chem 2018 Jan 26;293(4):1163-1177 34 Citations |
| 1 | Weight management and physical activity throughout the cancer care continuum. (Demark-Wahnefried W, Schmitz KH, Alfano CM, Bail JR, Goodwin PJ, Thomson CA, Bradley DW, Courneya KS, Befort CA, Denlinger CS, Ligibel JA, Dietz WH, Stolley MR, Irwin ML, Bamman MM, Apovian CM, Pinto BM, Wolin KY, Ballard RM, Dannenberg AJ, Eakin EG, Longjohn MM, Raffa SD, Adams-Campbell LL, Buzaglo JS, Nass SJ, Massetti GM, Balogh EP, Kraft ES, Parekh AK, Sanghavi DM, Morris GS, Basen-Engquist K) CA Cancer J Clin 2018 Jan;68(1):64-89 119 Citations |
| 1 | Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. (Krishnamurthy N, Kurzrock R) Cancer Treat Rev 2018 Jan;62:50-60 823 Citations |
| 1 | Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. (Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC, Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Geriatr Oncol 2018 May;9(3):214-220 27 Citations |
| 4 | Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics. (Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA) J Invest Dermatol 2018 Apr;138(4):957-967 50 Citations |
| 1 | MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. (Lu Y, Hu Z, Mangala LS, Stine ZE, Hu X, Jiang D, Xiang Y, Zhang Y, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, DeMarzo AM, Sood AK, Zhang L, Dang CV) Cancer Res 2018 Jan 01;78(1):64-74 89 Citations |
| 5 | Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. (Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP) Abdom Radiol (NY) 2018 Feb;43(2):351-363 12 Citations |
| 1 | Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. (Choupani J, Mansoori Derakhshan S, Bayat S, Alivand MR, Shekari Khaniani M) J Cell Physiol 2018 Jun;233(6):4443-4457 36 Citations |
| 1 | Resolvins suppress tumor growth and enhance cancer therapy. (Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D) J Exp Med 2018 Jan 02;215(1):115-140 215 Citations |
| 1 | Alcohol, smoking and risk of oesophago-gastric cancer. (Dong J, Thrift AP) Best Pract Res Clin Gastroenterol 2017 Oct;31(5):509-517 97 Citations |
| 1 | Cognitive Behavioral Therapy for Insomnia, Mindfulness, and Yoga in Patients With Breast Cancer with Sleep Disturbance: A Literature Review (Zeichner SB, Zeichner RL, Gogineni K, Shatil S, Ioachimescu O) Breast Cancer: Basic and Clinical Research 5 December 2017;11 31 Citations |
| 1 | Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408. (Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H) Adv Radiat Oncol 2017;2(4):608-614 16 Citations |
| 1 | Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients. (Schwaederle M, Krishnamurthy N, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Patel SP, Parker BA, Kurzrock R) Cancer 2018 Mar 15;124(6):1288-1296 23 Citations |
| 5 | Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. (Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE) J Natl Compr Canc Netw 2017 Dec;15(12):1509-1517 4 Citations |
| 1 | Activated HGF-c-met axis in head and neck cancer (Arnold L, Enders J, Thomas SM) Cancers 12 December 2017;9(12) 57 Citations |
| 1 | Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. (Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR, Hokusai VTE Cancer Investigators) N Engl J Med 2018 Feb 15;378(7):615-624 1305 Citations |
| 1 | Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. (Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, Kumar AP, Sun L, Liu Z, Chao WT, Wang Q, Jin VX, Chen CL, Huang TH) Cancer Res 2018 Feb 15;78(4):853-864 83 Citations |
| 1 | OC-2-KB: A software pipeline to build an evidence-based obesity and cancer knowledge base (Lossio-Ventura JA, Hogan W, Modave F, Guo Y, He Z, Hicks A, Bian J) Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017 15 December 2017;2017-January:1284-1287 4 Citations |
| 1 | Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. (Huang Y, Hu W, Huang J, Shen F, Sun Y, Ivan C, Pradeep S, Dood R, Haemmerle M, Jiang D, Mangala LS, Noh K, Hansen JM, Dalton HJ, Previs RA, Nagaraja AS, McGuire M, Jennings NB, Broaddus R, Coleman RL, Sood AK) Mol Cancer Ther 2018 Feb;17(2):464-473 6 Citations |
| 5 | Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. (Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA) J Cancer Surviv 2018 Apr;12(2):268-275 8 Citations |
| 1 | Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment. (Qu LT, Peters S, Cobb AN, Godellas CV, Perez CB, Vaince FT) Am J Surg 2018 Mar;215(3):530-533 6 Citations |
| 1 | The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. (Rezahosseini O, Hanaei S, Hamadani M, Keshavarz-Fathi M, Rezaei N) Int Rev Immunol 2018 May 04;37(3):165-173 4 Citations |
| 1 | The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy. (McKenzie JA, Mbofung RM, Malu S, Zhang M, Ashkin E, Devi S, Williams L, Tieu T, Peng W, Pradeep S, Xu C, Zorro Manrique S, Liu C, Huang L, Chen Y, Forget MA, Haymaker C, Bernatchez C, Satani N, Muller F, Roszik J, Kalra A, Heffernan T, Sood A, Hu J, Amaria R, Davis RE, Hwu P) J Natl Cancer Inst 2018 Jul 01;110(7):777-786 73 Citations |
| 1 | Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions. (Maza M, Figueroa R, Laskow B, Juárez A, Alfaro K, Alonzo TA, Felix JC, Gage JC, Cremer M) J Low Genit Tract Dis 2018 Jan;22(1):47-51 3 Citations |
| 1 | Abdominoperineal resection for rectal cancer (Peterson CY, Garcia-Aguilar J) Fischer's Mastery of Surgery, Seventh Edition 1 January 2018;2:1841-1851 1 Citation |
| 1 | Operative standards for cancer surgery: Esophagus, melanoma, rectum, stomach, thyroid (Hunt KK, Katz MHG, Veeramachaneni N, Grubbs EG, Wang TS, Kanf JM, Fields RC, Maithee SK, Chang GJ, Halverson AL, Reddy RM, Martin LW, Francfsatti AB) Operative Standards for Cancer Surgery: Esophagus, Melanoma, Rectum, Stomach, Thyroid 1 January 2018;2:1-352 4 Citations |
| 3 | Pancreaticoduodenectomy and total pancreatectomy for cancer (Evans DB, Tolat PP, Christians KK) Fischer's Mastery of Surgery, Seventh Edition 1 January 2018;2:1552-1572 8 Citations |
| 1 | Proteins Flexibility as a Criterion for Elucidation of Activating Mutants in Personalized Cancer Medicine (Tsigelny IF, Kurzrock R, Skjevik ÅA, Kouznetsova VL, Boichard A, Ikeda S) Advances in Intelligent Systems and Computing 2018;676:75-82 |
| 1 | Cancer of the colon, rectum, and anus (Clarke CN, You YN, Feig BW) The MD Anderson Surgical Oncology Handbook, Sixth Edition 1 January 2018:304-356 1 Citation |
| 1 | Neurotoxicity Related to Radiotherapy and Chemotherapy for Nonsmall Cell and Small Cell Lung Cancer (Stinchcombe TE, Gore EM) IASLC Thoracic Oncology 1 January 2018:409-417.e2 1 Citation |
| 1 | Personalized Cancer Treatment and Patient Stratification Using Massive Parallel Sequencing (MPS) and Other OMICs Data (Abramovitz M, Williams C, De PK, Dey N, Willis S, Young B, Andreopoulou E, Symmans WF, Sicklick JK, Kurzrock R, Leyland-Jones B) Predictive Biomarkers in Oncology: Applications in Precision Medicine 1 January 2018:131-147 3 Citations |
| 1 | Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway (Xiang X, Wang Y, Zhang H, Piao J, Muthusamy S, Wang L, Deng Y, Zhang W, Kuang R, Billadeau DD, Huang S, Lai J, Urrutia R, Kang N) npj Precision Oncology 2018;2(1) 22 Citations |
| 1 | Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors. (Sheean P, Arroyo C, Woo J, Schiffer L, Stolley M) J Acad Nutr Diet 2018 Apr;118(4):568-577 3 Citations |
| 5 | Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies. (Kalyanaraman B, Cheng G, Hardy M, Ouari O, Bennett B, Zielonka J) Redox Biol 2018 May;15:347-362 179 Citations |
| 1 | Bleeding in cancer patients and its treatment: a review. (Johnstone C, Rich SE) Ann Palliat Med 2018 Apr;7(2):265-273 130 Citations |
| 1 | 5-FU/leucovorin, uifinotecan, oxaliplatin (FOLFIRINOX)induction followed by chemoXRT in borderline resectable pancreatic cancer. (Jordan Kharofa, Tracy R. Kelly, Paul S. Ritch, Ben George, Lauren Allison Wiebe, James P. Thomas, Kathleen K. Christians, Douglas B. Evans, Beth Erickson ) Journal of Clinical Oncology 10.1200/jco.2012.30.15_suppl.e1461 Journal of Clinical Oncology 30, no. 15_suppl -published online before print |
| 1 | An Introduction to Integrative Genomics and Systems Medicine in Cancer. (Cheng X, Jin VX) Genes (Basel) 2018 Jan 12;9(1) 2 Citations |
| 4 | ERBB signaling in CTCs of ovarian cancer and glioblastoma. (Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P) Genes Cancer 2017 Nov;8(11-12):746-751 19 Citations |
| 1 | Optimization of a technology-supported physical activity intervention for breast cancer survivors: Fit2Thrive study protocol. (Phillips SM, Collins LM, Penedo FJ, Courneya KS, Welch W, Cottrell A, Lloyd GR, Gavin K, Cella D, Ackermann RT, Siddique J, Spring B) Contemp Clin Trials 2018 Mar;66:9-19 25 Citations |
| 1 | Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway. (Wu D, Zhao B, Qi X, Peng F, Fu H, Chi X, Miao QR, Shao S) Cancer Lett 2018 Apr 01;418:135-146 39 Citations |
| 7 | Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 48 Citations |
| 1 | The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. (Vallance AE, van der Meulen J, Kuryba A, Charman SC, Botterill ID, Prasad KR, Hill J, Jayne DG, Walker K) Colorectal Dis 2018 Jun;20(6):486-495 37 Citations |
| 5 | Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency. (Doan NB, Alhajala H, Al-Gizawiy MM, Mueller WM, Rand SD, Connelly JM, Cochran EJ, Chitambar CR, Clark P, Kuo J, Schmainda KM, Mirza SP) Oncotarget 2017 Dec 22;8(68):112662-112674 56 Citations |
| 1 | Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus. (Schrock AB, Pavlick D, Klempner SJ, Chung JH, Forcier B, Welsh A, Young L, Leyland-Jones B, Bordoni R, Carvajal RD, Chao J, Kurzrock R, Sicklick JK, Ross JS, Stephens PJ, Devoe C, Braiteh F, Ali SM, Miller VA) Clin Cancer Res 2018 Apr 15;24(8):1881-1890 58 Citations |
| 2 | Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. (Jin Y, Hu W, Liu T, Rana U, Aguilera-Barrantes I, Kong A, Kumar SN, Wang B, Gao P, Wang X, Duan Y, Shi A, Song D, Yang M, Li S, Han B, Zhao G, Fan Z, Miao QR) Cancer Lett 2018 Apr 10;419:233-244 16 Citations |
| 1 | Measurement of physical activity and sedentary behavior in breast cancer survivors (Welch WA, Lloyd GR, Awick EA, Siddique J, McAuley E, Phillips SM) Journal of Community and Supportive Oncology February 2018;16(1):e21-e29 13 Citations |
| 1 | Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. (Chatterjee A, Bourne RM, Wang S, Devaraj A, Gallan AJ, Antic T, Karczmar GS, Oto A) Radiology 2018 Jun;287(3):864-873 88 Citations |
| 1 | Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. (Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA) Nat Commun 2018 Feb 02;9(1):476 39 Citations |
| 1 | Adequacy of Depression Treatment in Spouses of Cancer Survivors: Findings From a Nationally Representative US Survey. (Litzelman K, Keller AO, Tevaarwerk A, DuBenske L) J Gen Intern Med 2018 Jun;33(6):869-876 9 Citations |
| 1 | Reirradiation for Head and Neck Cancer: The Who and the How. (Margalit DN, Wong SJ) Int J Radiat Oncol Biol Phys 2018 Mar 01;100(3):618-620 10 Citations |
| 1 | Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. (Caudell JJ, Ward MC, Riaz N, Zakem SJ, Awan MJ, Dunlap NE, Isrow D, Hassanzadeh C, Vargo JA, Heron DE, Marcrom S, Boggs DH, Reddy CA, Dault J, Bonner JA, Higgins KA, Beitler JJ, Koyfman SA, Machtay M, Yao M, Trotti AM, Siddiqui F, Lee NY, Multi-Institution Reirradiation (MIRI) Collaborative) Int J Radiat Oncol Biol Phys 2018 Mar 01;100(3):606-617 77 Citations |
| 4 | Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery. (Ali F, Al-Kindi SG, Blank JJ, Peterson CY, Ludwig KA, Ridolfi TJ) Dis Colon Rectum 2018 Mar;61(3):375-381 48 Citations |
| 1 | Data descriptor: Dynamic contrastenhanced magnetic resonance imaging for head and neck cancers (Elhalawani H, Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Hormuth DA, Van Houdt PJ, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Van Der Heide UA, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD) Scientific Data 13 February 2018;5 4 Citations |
| 1 | Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. (Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW) J Exp Med 2018 Mar 05;215(3):895-910 63 Citations |
| 1 | Colon and rectal cancer (Kosinski L, George B, Turaga KK, Johnstone CA, Mahmoud M) The American Cancer Society's Oncology in Practice: Clinical Management 16 February 2018:124-148 |
| 4 | Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. (Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA) Transl Oncol 2018 Apr;11(2):391-398 41 Citations |
| 1 | A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. (Rudolph M, Sizemore ST, Lu Y, Teng KY, Basree MM, Reinbolt R, Timmers CD, Leone G, Ostrowski MC, Majumder S, Ramaswamy B) Breast Cancer Res Treat 2018 Jun;169(3):457-467 8 Citations |
| 3 | Correction: Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. (Palatnik A, Ye S, Kendziorski C, Iden M, Zigman JS, Hessner MJ, Rader JS) PLoS One 2018;13(2):e0193687 |
| 1 | Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. (Floros KV, Lochmann TL, Hu B, Monterrubio C, Hughes MT, Wells JD, Morales CB, Ghotra MS, Costa C, Souers AJ, Boikos SA, Leverson JD, Tan M, Serra V, Koblinski JE, Arribas J, Prat A, Paré L, Miller TW, Dozmorov MG, Harada H, Windle BE, Scaltriti M, Faber AC) Proc Natl Acad Sci U S A 2018 Mar 13;115(11):E2594-E2603 27 Citations |
| 1 | Utilization of a hybrid finite-element based registration method to quantify heterogeneous tumor response for adaptive treatment for lung cancer patients. (Sharifi H, Zhang H, Bagher-Ebadian H, Lu W, Ajlouni MI, Jin JY, Kong FS, Chetty IJ, Zhong H) Phys Med Biol 2018 Mar 21;63(6):065017 12 Citations |
| 1 | STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. (Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT) Clin Cancer Res 2018 Apr 15;24(8):1917-1931 44 Citations |
| 1 | Health Disparity or Bad Biology? An Analysis of Triple Negative Breast Cancer Patients in an Urban Academic Hospital (Petersen L, Cortina CS, Mulder LL, Bhat D, Roa R, Kopkash KA, Monahan D, Marcus E, Madrigrano A) Cancer Surgery 3(1):116. |
| 2 | More than a Conversation: the Power of Bringing Scientists and the Community Together to Change Perceptions About Cancer. (Olson J, Svoboda-Newman S, Gardner-Volle K, McNally M, Fabian E, Maurana C) J Cancer Educ 2019 Jun;34(3):571-576 1 Citation |
| 1 | Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer. (Yang W, Schwartz GN, Marotti JD, Chen V, Traphagen NA, Gui J, Miller TW) Oncotarget 2018 Feb 06;9(10):8810-8822 14 Citations |
| 1 | Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. (Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, Clubb RJ, An W, Ahmed D, El-Ansari R, Storck MD, Mishra NK, Guda C, Sheinin YM, Meza JL, Raja S, Rakha EA, Band V, Band H) Cancer Res 2018 May 15;78(10):2524-2535 34 Citations |
| 3 | Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer. (Song Y, Erickson B, Chen X, Li G, Wu G, Paulson E, Knechtges P, Li XA) Oncotarget 2018 Feb 09;9(11):10100-10109 6 Citations |
| 1 | Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? (Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J) Investig Clin Urol 2018 Mar;59(2):83-90 9 Citations |
| 2 | Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. (Pan P, Oshima K, Huang YW, Agle KA, Drobyski WR, Chen X, Zhang J, Yearsley MM, Yu J, Wang LS) Int J Cancer 2018 Aug 15;143(4):886-896 71 Citations |
| 1 | Physical activity and annual medical outlay in U.S. colorectal, breast and prostate cancer survivors. (Yan AF, Wang Y, Ng AV) Prev Med Rep 2018 Mar;9:118-123 14 Citations |
| 1 | Thyroid cancer in adolescents and young adults. (Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A) Pediatr Blood Cancer 2018 Aug;65(8):e27025 44 Citations |
| 1 | Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. (Klompmaker S, van Hilst J, Gerritsen SL, Adham M, Teresa Albiol Quer M, Bassi C, Berrevoet F, Boggi U, Busch OR, Cesaretti M, Dalla Valle R, Darnis B, De Pastena M, Del Chiaro M, Grützmann R, Diener MK, Dumitrascu T, Friess H, Ivanecz A, Karayiannakis A, Fusai GK, Labori KJ, Lombardo C, López-Ben S, Mabrut JY, Niesen W, Pardo F, Perinel J, Popescu I, Roeyen G, Sauvanet A, Prasad R, Sturesson C, Lesurtel M, Kleeff J, Salvia R, Besselink MG, E-AHPBA DP-CAR study group) Ann Surg Oncol 2018 May;25(5):1440-1447 77 Citations |
| 5 | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316-327]. (Kalyanaraman B, Cheng G, Hardy M, Ouari O, Lopez M, Joseph J, Zielonka J, Dwinell MB) Redox Biol 2018 Jun;16:426-427 6 Citations |
| 1 | Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. (Klompmaker S, van Hilst J, Gerritsen SL, Adham M, Teresa Albiol Quer M, Bassi C, Berrevoet F, Boggi U, Busch OR, Cesaretti M, Dalla Valle R, Darnis B, De Pastena M, Del Chiaro M, Grützmann R, Diener MK, Dumitrascu T, Friess H, Ivanecz A, Karayiannakis A, Fusai GK, Labori KJ, Lombardo C, López-Ben S, Mabrut JY, Niesen W, Pardo F, Perinel J, Popescu I, Roeyen G, Sauvanet A, Prasad R, Sturesson C, Lesurtel M, Kleeff J, Salvia R, Besselink MG, E-AHPBA DP-CAR study group) Ann Surg Oncol 2018 Dec;25(Suppl 3):988 1 Citation |
| 1 | A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment. (Li AW, Lalor LE, Bellodi Schmidt F, Luu M) Pediatr Dermatol 2018 May;35(3):e165-e169 4 Citations |
| 3 | Impact of pediatric cancer on family relationships. (Erker C, Yan K, Zhang L, Bingen K, Flynn KE, Panepinto J) Cancer Med 2018 May;7(5):1680-1688 44 Citations |
| 4 | Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. (Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, James MA) BMC Cancer 2018 Mar 27;18(1):335 296 Citations |
| 1 | Liquid Biopsies and Cancer Immunotherapy. (Thompson JR, Menon SP) Cancer J 2018;24(2):78-83 18 Citations |
| 1 | Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy. (Kurman JS, Murgu SD) J Thorac Dis 2018 Feb;10(2):1124-1128 43 Citations |
| 1 | Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. (Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, Cancer Genome Atlas Research Network, Piwnica-Worms H, Ma L, Liang H) Cell Rep 2018 Apr 03;23(1):213-226.e3 82 Citations |
| 1 | Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. (Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y, Cheng F, Tan L, Mojumdar K, Du D, Ge Z, Li J, Thomas GV, Birsoy K, Liu L, Zhang H, Zhao Z, Marchand C, Weinstein JN, Cancer Genome Atlas Research Network, Bathe OF, Liang H) Cell Rep 2018 Apr 03;23(1):255-269.e4 210 Citations |
| 1 | Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. (Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, Platinum Study Group) J Clin Oncol 2018 May 20;36(15):1505-1512 93 Citations |
| 1 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. (Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Cancer Genome Atlas Research Network, Monnat RJ Jr, Xiao Y, Wang C) Cell Rep 2018 Apr 03;23(1):239-254.e6 758 Citations |
| 1 | Select Patients With "Limited" Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively. (Gore EM) Int J Radiat Oncol Biol Phys 2018 May 01;101(1):6-7 |
| 2 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. (Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Cancer Genome Atlas Research Network, Weinstein JN, Mills GB, Levine DA, Akbani R) Cancer Cell 2018 Apr 09;33(4):690-705.e9 441 Citations |
| 2 | The Immune Landscape of Cancer. (Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I) Immunity 2018 Apr 17;48(4):812-830.e14 3717 Citations |
| 3 | Neoadjuvant chemoradiation for operable pancreatic cancer: The importance of local disease control (Barnes CA, Tsai S, Hall WA, Erickson BA, Evans DB) Pancreatic Cancer 11 April 2018:1219-1237 |
| 2 | Stromal inflammation in pancreatic cancer: Mechanisms and translational applications (Boyle KA, James MA, Tsai S, Evans DB, Dwinell MB) Pancreatic Cancer 11 April 2018:481-508 |
| 2 | Epigenetics and its applications to the progression model of pancreatic cancer (Lomberk G, Urrutia R) Pancreatic Cancer 11 April 2018:177-208 |
| 2 | Notch signaling in pancreatic morphogenesis and pancreatic cancer pathogenesis (Lomberk G, Urrutia R) Pancreatic Cancer 11 April 2018:457-479 |
| 2 | EGFR (ErbB) signaling pathways in pancreatic cancer pathogenesis (Williams M, Lomberk G, Urrutia R) Pancreatic Cancer 11 April 2018:383-408 4 Citations |
| 1 | Pancreatic Cancer (Neoptolemos JP, Urrutia R, Abbruzzese JL, Büchler MW) Pancreatic Cancer 11 April 2018:1-1661 18 Citations |
| 3 | Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. (Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL) Gynecol Oncol 2018 Jun;149(3):565-569 23 Citations |
| 1 | Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation. (Bergom C, Currey A, Desai N, Tai A, Strauss JB) Front Oncol 2018;8:87 128 Citations |
| 1 | Colonic ischemia mimicking obstruction due to sigmoid colon cancer: A case report. (Kimura J, Lefor AK, Kubota T) Int J Surg Case Rep 2018;46:38-40 2 Citations |
| 1 | Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers. (Sen S, Kato S, Agarwal R, Piha-Paul S, Hess K, Karp D, Janku F, Fu S, Naing A, Pant S, Falchook G, Tang C, Wu X, Ye Y, Tsimberidou A, Subbiah V, Kurzrock R, Byers L, Westin S, Lim J, Bean S, Bass A, Nguyen L, Meric-Bernstam F, Hong D) Br J Cancer 2018 May;118(11):1419-1424 6 Citations |
| 5 | Assessment of end-of-treatment transition needs for pediatric cancer and hematopoietic stem cell transplant patients and their families. (Karst JS, Hoag JA, Chan SF, Schmidt DJ, Anderson LJ, Englebert NE, Igler EC, Bingen KM) Pediatr Blood Cancer 2018 Aug;65(8):e27109 28 Citations |
| 1 | Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases. (Dwyer RH, Scheidt MJ, Marshall JS, Tsoraides SS) J Robot Surg 2018 Dec;12(4):603-606 35 Citations |
| 1 | Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer. (Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M) PLoS One 2018;13(4):e0193907 22 Citations |
| 5 | Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. (Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2018 Jun;117(8):1664-1671 5 Citations |
| 1 | Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. (Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK) Oncogene 2018 Aug;37(32):4428-4442 103 Citations |
| 1 | Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients. (Sanchez-Salas R, de la Rosette J, Polascik TJ, Carneiro A, Sivaraman A, Cathelineau X, Walz J) Eur Urol 2018 Nov;74(5):537-539 6 Citations |
| 1 | Symptoms In Bangladeshi Patients with Incurable Cancers: Implications for Interventions. (Love RR, Tanimul Ahsan GM, Ferdousy T, Nahar S, Ahamed SI) Indian J Palliat Care 2018;24(2):173-175 |
| 1 | Increasing provider awareness of and recommendations for yoga and meditation classes for cancer patients. (Koula MJ, Knight JM) Support Care Cancer 2018 Oct;26(10):3635-3640 13 Citations |
| 1 | Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001). (Konstantinopoulos PA, Brady WE, Farley J, Armstrong A, Uyar DS, Gershenson DM) Gynecol Oncol 2018 Jul;150(1):9-13 50 Citations |
| 1 | Cancer in Pregnancy. (McCormick A, Peterson E) Obstet Gynecol Clin North Am 2018 Jun;45(2):187-200 47 Citations |
| 1 | Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. (Du M, Thompson J, Fisher H, Zhang P, Huang CC, Wang L) Lung Cancer 2018 Jun;120:113-121 40 Citations |
| 1 | Cancer research in the United States: A critical review of current status and proposal for alternative models. (Kantarjian HM, Prat F, Steensma DP, Kurzrock R, Stewart DJ, Sekeres MA, Leveque J) Cancer 2018 Jul 15;124(14):2881-2889 18 Citations |
| 1 | Metastatic colon cancer derived from a diverticulum incidentally found at herniorrhaphy: a case report. (Kimura J, Lefor AK, Fukai S, Yoshikawa K, Sasamatsu S, Sakamoto T, Mizokami K, Kanzaki M, Kubota T, Saito A, Izumi H, Honjo K, Nagakari K, Fukunaga M) Surg Case Rep 2018 May 15;4(1):47 |
| 1 | Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression. (Kumar D, New J, Vishwakarma V, Joshi R, Enders J, Lin F, Dasari S, Gutierrez WR, Leef G, Ponnurangam S, Chavan H, Ganaden L, Thornton MM, Dai H, Tawfik O, Straub J, Shnayder Y, Kakarala K, Tsue TT, Girod DA, Van Houten B, Anant S, Krishnamurthy P, Thomas SM) Cancer Res 2018 Jul 15;78(14):3769-3782 105 Citations |
| 3 | Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes. (Lomberk G, Blum Y, Nicolle R, Nair A, Gaonkar KS, Marisa L, Mathison A, Sun Z, Yan H, Elarouci N, Armenoult L, Ayadi M, Ordog T, Lee JH, Oliver G, Klee E, Moutardier V, Gayet O, Bian B, Duconseil P, Gilabert M, Bigonnet M, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Secq V, De Reyniès A, Dusetti N, Iovanna J, Urrutia R) Nat Commun 2018 May 17;9(1):1978 189 Citations |
| 1 | Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. (von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L) Gynecol Oncol 2018 Jul;150(1):119-126 17 Citations |
| 1 | The impact of pharmacokinetic gene profiles across human cancers. (Zimmermann MT, Therneau TM, Kocher JA) BMC Cancer 2018 May 21;18(1):577 3 Citations |
| 2 | Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence. (Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC) Ann Surg Oncol 2018 Sep;25(9):2526-2534 79 Citations |
| 10 | Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 31 Citations |
| 2 | Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project. (Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC) AJNR Am J Neuroradiol 2018 Jun;39(6):1008-1016 45 Citations |
| 1 | Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13. (Chen Z, Wu D, Thomas-Ahner JM, Lu C, Zhao P, Zhang Q, Geraghty C, Yan PS, Hankey W, Sunkel B, Cheng X, Antonarakis ES, Wang QE, Liu Z, Huang TH, Jin VX, Clinton SK, Luo J, Huang J, Wang Q) Proc Natl Acad Sci U S A 2018 Jun 26;115(26):6810-6815 121 Citations |
| 1 | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. (Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H) JAMA Oncol 2018 Sep 01;4(9):1263-1266 293 Citations |
| 1 | Implementing precision cancer medicine in the genomic era. (Chen HZ, Bonneville R, Roychowdhury S) Semin Cancer Biol 2019 Apr;55:16-27 28 Citations |
| 1 | Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. (Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, Wang L, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L) Prostate Cancer Prostatic Dis 2018 Sep;21(3):411-418 31 Citations |
| 1 | ADH1B promotes mesothelial clearance and ovarian cancer infiltration. (Gharpure KM, Lara OD, Wen Y, Pradeep S, LaFargue C, Ivan C, Rupaimoole R, Hu W, Mangala LS, Wu SY, Nagaraja AS, Baggerly K, Sood AK) Oncotarget 2018 May 18;9(38):25115-25126 23 Citations |
| 1 | Chemotherapy-induced muscle wasting: Association with NF-κB and cancer cachexia (Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, Guttridge DC) European Journal of Translational Myology 6 June 2018;28(2):158-166 104 Citations |
| 1 | Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. (Ballard DD, Rahman S, Ginnebaugh B, Khan A, Dua KS) Endosc Int Open 2018 Jun;6(6):E714-E721 |
| 4 | The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer. (Kong AL, Nattinger AB, McGinley E, Pezzin LE) Breast Cancer Res Treat 2018 Sep;171(2):477-488 7 Citations |
| 1 | Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway. (Xiang X, Wang Y, Zhang H, Piao J, Muthusamy S, Wang L, Deng Y, Zhang W, Kuang R, Billadeau DD, Huang S, Lai J, Urrutia R, Kang N) NPJ Precis Oncol 2018;2(1):2 |
| 1 | Clinicopathologic Features and Radiation Therapy Utilization in Patients with Male Breast Cancer: A National Cancer Database Study. (Weir J, Zhao YD, Herman T, Algan Ö) Breast Cancer (Auckl) 2018;12:1178223418770687 23 Citations |
| 1 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. (Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z) Nat Commun 2018 Jun 11;9(1):2256 82 Citations |
| 1 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. (Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA, Profile Study, Australian Prostate Cancer BioResource (APCB), IMPACT Study, Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Cancer of the Prostate in Sweden (CAPS), Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium) Nat Genet 2018 Jul;50(7):928-936 604 Citations |
| 2 | Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT. (Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X, Zheng C, Robbins J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2018 Nov 15;102(4):1308-1318 29 Citations |
| 1 | Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy. (Abtin M, Alivand MR, Khaniani MS, Bastami M, Zaeifizadeh M, Derakhshan SM) J Cell Biochem 2018 Sep;119(9):7151-7165 45 Citations |
| 1 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. (Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A, PCF/SU2C International Prostate Cancer Dream Team, Robinson DR, Chinnaiyan AM) Cell 2018 Jun 14;173(7):1770-1782.e14 439 Citations |
| 1 | Surviving childhood cancer: a sobering story. (Eapen M) Blood 2018 Jun 14;131(24):2603-2604 |
| 1 | Predictive Cytological Topography (PiCT): a Radio-Pathomics Approach to Mapping Prostate Cancer (McGarry, Sean Hurrell, Sarah Iczkowski, Kenneth Kaczmarowski, Amy Banerjee, Anjishnu Keuter, Tucker Jacobsohn, Kenneth Hall, William Nevalainen, Marja Hohenwalter, Mark See, William Nencka, Andrew LaViolette, Peter) Proc. ISMRM (2018): 0775 |
| 1 | The RadPath Surfer: A Radiologic-Pathologic tool for visualizing prostate cancer histology (McGarry, Sean Hurrell, Sarah Jacobsohn, Kenneth Iczkowski, Kenneth Griffin, Michael Duvnjak, Petar Nencka, Andrew Hohenwalter, Mark LaViolette, Peter) Proc. ISMRM (2018): 4387 |
| 4 | Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. (McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS) Int J Radiat Oncol Biol Phys 2018 Aug 01;101(5):1179-1187 47 Citations |
| 1 | An assessment of patient burdens from head and neck cancer survivorship care. (Massa ST, Rohde RL, Mckinstry C, Gresham M, Osazuwa-Peters N, Ward GM, Walker RJ) Oral Oncol 2018 Jul;82:115-121 19 Citations |
| 1 | Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer. (Riyahi S, Choi W, Liu CJ, Zhong H, Wu AJ, Mechalakos JG, Lu W) Phys Med Biol 2018 Jul 19;63(14):145020 30 Citations |
| 1 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. (Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Gusev A, Barfield RT, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Barrdahl M, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broberg P, Brucker SY, Burwinkel B, Caldés T, Canzian F, Carter BD, Castelao JE, Chang-Claude J, Chen X, Cheng TD, Christiansen H, Clarke CL, NBCS Collaborators, Collée M, Cornelissen S, Couch FJ, Cox D, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Eccles DM, Eilber U, Eliassen AH, Engel C, Eriksson M, Fachal L, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Closas M, Gaudet MM, Ghoussaini M, Giles GG, Goldberg MS, Goldgar DE, González-Neira A, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hallberg E, Hamann U, Harrington P, Hein A, Hicks B, Hillemanns P, Hollestelle A, Hoover RN, Hopper JL, Huang G, Humphreys K, Hunter DJ, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones ME, Jung A, Kaaks R, Kerin MJ, Khusnutdinova E, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Li J, Lindström S, Lissowska J, Lo WY, Loibl S, Lubinski J, Luccarini C, Lux MP, MacInnis RJ, Maishman T, Kostovska IM, Mannermaa A, Manson JE, Margolin S, Mavroudis D, Meijers-Heijboer H, Meindl A, Menon U, Meyer J, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Nordestgaard BG, Olopade OI, Olson JE, Olsson H, Peterlongo P, Peto J, Plaseska-Karanfilska D, Prentice R, Presneau N, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Rudolph A, Saloustros E, Sandler DP, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Scott RJ, Scott CG, Seal S, Shah M, Shrubsole MJ, Smeets A, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper W, Taylor JA, Terry MB, Tessier DC, Thomas A, Thöne K, Tollenaar RAEM, Torres D, Truong T, Untch M, Vachon C, Van Den Berg D, Vincent D, Waisfisz Q, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett WC, Winqvist R, Wolk A, Xia L, Yang XR, Ziogas A, Ziv E, kConFab/AOCS Investigators, Dunning AM, Pharoah PDP, Simard J, Milne RL, Edwards SL, Kraft P, Easton DF, Chenevix-Trench G, Zheng W) Nat Genet 2018 Jul;50(7):968-978 161 Citations |
| 1 | miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation. (Zhang W, Chen JH, Shan T, Aguilera-Barrantes I, Wang LS, Huang TH, Rader JS, Sheng X, Huang YW) Lab Invest 2018 Nov;98(11):1397-1407 62 Citations |
| 1 | Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. (Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M) Prev Med 2018 Sep;114:149-155 31 Citations |
| 1 | Editorial Preface for Targeted Cancer Therapy (Chen G, Li W) Acta Pharmaceutica Sinica B July 2018;8(4):501-502 4 Citations |
| 1 | miRNA 196a2(rs11614913) & 146a(rs2910164) polymorphisms & breast cancer risk for women in an Iranian population. (Nejati-Azar A, Alivand MR) Per Med 2018 Jul 01;15(4):279-289 19 Citations |
| 4 | Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. (Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A) ACS Nano 2018 Jul 24;12(7):6597-6611 112 Citations |
| 1 | Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials? (Hlubocky FJ, Sachs GA, Larson ER, Nimeiri HS, Cella D, Wroblewski KE, Ratain MJ, Peppercorn JM, Daugherty CK) J Clin Oncol 2018 Aug 20;36(24):2483-2491 16 Citations |
| 1 | Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. (Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A) Cancer 2018 Sep 01;124(17):3510-3519 77 Citations |
| 2 | Impact of the Affordable Care Act (ACA) Medicaid Expansion on Cancer Admissions and Surgeries. (Eguia E, Cobb AN, Kothari AN, Molefe A, Afshar M, Aranha GV, Kuo PC) Ann Surg 2018 Oct;268(4):584-590 86 Citations |
| 2 | Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions. (Bhandari S, Abdul MKM, Hollabaugh W, Sharma K, Evans DB, Guda N) PLoS One 2018;13(7):e0199909 6 Citations |
| 1 | Correction to: the impact of pharmacokinetic gene profiles across human cancers. (Zimmermann MT, Therneau TM, Kocher JA) BMC Cancer 2018 Jul 18;18(1):743 |
| 1 | Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. (Dong J, Gu X, El-Serag HB, Thrift AP) Clin Gastroenterol Hepatol 2019 Mar;17(4):657-665.e13 25 Citations |
| 1 | Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. (Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, SIRFLOX and FOXFIRE Global Trial Investigators) Clin Colorectal Cancer 2018 Dec;17(4):e617-e629 59 Citations |
| 1 | Mitochondrial inheritance and cancer. (Dong J, Wong LJ, Mims MP) Transl Res 2018 Dec;202:24-34 15 Citations |
| 1 | FABP4 as a key determinant of metastatic potential of ovarian cancer. (Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly K, S Eberlin L, Sood AK) Nat Commun 2018 Jul 26;9(1):2923 174 Citations |
| 1 | MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer. (Heerkens HD, van Vulpen M, Erickson B, Reerink O, Intven MP, van den Berg CA, Molenaar IQ, Vleggaar FP, Meijer GJ) Br J Radiol 2018 Nov;91(1091):20170563 35 Citations |
| 1 | OC-2-KB: integrating crowdsourcing into an obesity and cancer knowledge base curation system. (Lossio-Ventura JA, Hogan W, Modave F, Guo Y, He Z, Yang X, Zhang H, Bian J) BMC Med Inform Decis Mak 2018 Jul 23;18(Suppl 2):55 15 Citations |
| 4 | Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation. (Boyle KA, Van Wickle J, Hill RB, Marchese A, Kalyanaraman B, Dwinell MB) J Biol Chem 2018 Sep 21;293(38):14891-14904 115 Citations |
| 5 | Community Breast Health Education for Immigrants and Refugees: Lessons Learned in Outreach Efforts to Reduce Cancer Disparities. (Kamaraju S, Olson J, DeNomie M, Visotcky A, Banerjee A, Asan O, Tavares E, Rao A, LaCroix M, Krause K, Neuner J, Stolley M) J Cancer Educ 2019 Dec;34(6):1092-1096 8 Citations |
| 1 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. (Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP) Cell 2018 Aug 09;174(4):1033 216 Citations |
| 1 | Identification of nine new susceptibility loci for endometrial cancer. (O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, Chen C, Chen MM, Cheng THT, Clarke CL, Clendenning M, Cook LS, Couch FJ, Cox A, Crous-Bous M, Czene K, Day F, Dennis J, Depreeuw J, Doherty JA, Dörk T, Dowdy SC, Dürst M, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, Fritschi L, Fung J, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankison SE, Healey CS, Hein A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hopper JL, Hunter DJ, Jones A, Krakstad C, Kristensen VN, Lambrechts D, Marchand LL, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Meindl A, Michailidou K, Milne RL, Mints M, Montgomery GW, Nassir R, Olsson H, Orlow I, Otton G, Palles C, Perry JRB, Peto J, Pooler L, Prescott J, Proietto T, Rebbeck TR, Risch HA, Rogers PAW, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Swerdlow AJ, Tham E, Trovik J, Turman C, Tyrer JP, Vachon C, VanDen Berg D, Vanderstichele A, Wang Z, Webb PM, Wentzensen N, Werner HMJ, Winham SJ, Wolk A, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Pharoah PDP, Dunning AM, Kraft P, De Vivo I, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ) Nat Commun 2018 Aug 09;9(1):3166 180 Citations |
| 1 | Imaging predictors of treatment outcomes in rectal cancer: An overview. (Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA) Crit Rev Oncol Hematol 2018 Sep;129:153-162 17 Citations |
| 1 | Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling. (Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H) Clin Cancer Res 2018 Dec 15;24(24):6355-6366 17 Citations |
| 2 | Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults. (Restifo D, Williams JS, Garacci E, Walker RJ, Ozieh MN, Egede LE) J Diabetes Complications 2018 Sep;32(9):819-823 7 Citations |
| 1 | Editorial Preface for Targeted Cancer Therapy. (Chen G, Li W) Acta Pharm Sin B 2018 Jul;8(4):501-502 4 Citations |
| 2 | Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy. (Qi XM, Wang F, Mortensen M, Wertz R, Chen G) Acta Pharm Sin B 2018 Jul;8(4):511-517 16 Citations |
| 2 | Promoting Team-Based Exercise Among African American Breast Cancer Survivors. (Piacentine LB, Robinson KM, Waltke LJ, Tjoe JA, Ng AV) West J Nurs Res 2018 Dec;40(12):1885-1902 11 Citations |
| 1 | Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. (Wang TS, Sosa JA) Nat Rev Endocrinol 2018 Nov;14(11):670-683 187 Citations |
| 1 | Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer. (Basho RK, Yam C, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Hong D, Kurzrock R, Hortobagyi GN, Janku F, Moulder SL) Oncologist 2018 Nov;23(11):1300-1309 48 Citations |
| 1 | Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer. (Bellamkonda K, Satapathy SR, Douglas D, Chandrashekar N, Selvanesan BC, Liu M, Savari S, Jonsson G, Sjölander A) Cancer Lett 2018 Nov 28;437:13-24 28 Citations |
| 1 | A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter? (Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD) Clin Transl Radiat Oncol 2018 Aug;12:40-46 16 Citations |
| 1 | What we did not learn from an exploratory analysis of economic hardship in newly diagnosed adolescents and young adults with cancer. (Lau N, Bona K, Steineck A, Rosenberg AR) Pediatr Blood Cancer 2018 Dec;65(12):e27411 1 Citation |
| 1 | Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. (Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW) FASEB J 2019 Feb;33(2):1644-1657 16 Citations |
| 1 | Obesity and mortality after locoregional breast cancer diagnosis. (Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu XC, Anderson RT, Lipscomb J, Kimmick GG, Cress R, Wilson JF, Sabatino SA, Fleming ST) Breast Cancer Res Treat 2018 Dec;172(3):647-657 7 Citations |
| 1 | Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer. (Johnson SC, Smith ZL, Nottingham C, Schwen ZR, Thomas S, Fishman EK, Lee NJ, Pierorazio PM, Eggener SE) Urology 2019 Jan;123:186-190 12 Citations |
| 1 | A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. (Sadler JBA, Wenzel DM, Strohacker LK, Guindo-Martínez M, Alam SL, Mercader JM, Torrents D, Ullman KS, Sundquist WI, Martin-Serrano J) Proc Natl Acad Sci U S A 2018 Sep 18;115(38):E8900-E8908 47 Citations |
| 1 | Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer. (Rosati R, Polin L, Ducker C, Li J, Bao X, Selvakumar D, Kim S, Xhabija B, Larsen M, McFall T, Huang Y, Kidder BL, Fribley A, Saxton J, Kakuta H, Shaw P, Ratnam M) Clin Cancer Res 2018 Dec 15;24(24):6509-6522 14 Citations |
| 1 | The effect of yoga on barriers to occupational engagement in African American breast cancer survivors (Julie Hunley, Sailaja Kamaraju, Phyllis Holder, Aniko Szabo, Rita Burlingame-Toppen, Melinda Stolley) Cancer Medicine Journal Med J 2018: 1(1) 3-11 |
| 1 | GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. (Parish AJ, Nguyen V, Goodman AM, Murugesan K, Frampton GM, Kurzrock R) Cancer 2018 Oct 15;124(20):4080-4089 39 Citations |
| 1 | Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems. (Ljungman L, Ahlgren J, Petersson LM, Flynn KE, Weinfurt K, Gorman JR, Wettergren L, Lampic C) Psychooncology 2018 Dec;27(12):2770-2777 116 Citations |
| 1 | Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics. (Nikanjam M, Cohen PR, Kato S, Sicklick JK, Kurzrock R) Ann Oncol 2018 Nov 01;29(11):2192-2199 40 Citations |
| 1 | Prevalence and sociodemographic factors associated with depression among hospitalized patients with head and neck cancer-Results from a national study. (Rohde RL, Adjei Boakye E, Challapalli SD, Patel SH, Geneus CJ, Tobo BB, Simpson MC, Mohammed KA, Deshields T, Varvares MA, Osazuwa-Peters N) Psychooncology 2018 Dec;27(12):2809-2814 22 Citations |
| 1 | Stem cell fate in cancer growth, progression and therapy resistance. (Lytle NK, Barber AG, Reya T) Nat Rev Cancer 2018 Nov;18(11):669-680 509 Citations |
| 1 | Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. (Morton LM, Kerns SL, Dolan ME) Am Soc Clin Oncol Educ Book 2018 May 23;38(38):775-786 |
| 1 | What Makes a Pancreatic Cancer Resectable? (Evans DB) Am Soc Clin Oncol Educ Book 2018 May 23;38:300-305 |
| 1 | Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents. (Chen W, Fan H, Balakrishnan K, Wang Y, Sun H, Fan Y, Gandhi V, Arnold LA, Peng X) J Med Chem 2018 Oct 25;61(20):9132-9145 48 Citations |
| 1 | Use of Immune Checkpoint Inhibitors (ICIs) in Patients with Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS) (Jonathan R Thompson, Carlos Arce-Lara, Smitha Menon) World Conference on Lung Cancer 2018 |
| 1 | Sarcopenia is Associated with Metastatic Burden and is a Negative Prognostic Factor in Metastatic Non-Small Cell Lung Cancer (Chad Glisch, Aniko Szabo, Jonathan R Thompson, Smitha Menon, Jay Patel) World Conference on Lung Cancer 2018 |
| 1 | Breast Cancer Risk Among Women in Jail. (Pickett ML, Allison M, Twist K, Klemp JR, Ramaswamy M) Biores Open Access 2018;7(1):139-144 17 Citations |
| 3 | Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations. (Currey A, Patten CR, Bergom C, Wilson JF, Kong AL) Breast J 2018 Nov;24(6):902-910 10 Citations |
| 1 | Impact of inter-and intra-fraction anatomic motions on delta-radiomics for radiation therapy of pancreatic cancer (H Nasief, A Li) International Journal of Radiation Oncology, Biology, Physics 102 (3), S212-S213 |
| 1 | Trends and outcomes of sphincter-preserving surgery for rectal cancer: a national cancer database study. (Shahjehan F, Kasi PM, Habermann E, Day CN, Colibaseanu DT, Mathis KL, Larson DW, Merchea A) Int J Colorectal Dis 2019 Feb;34(2):239-245 23 Citations |
| 1 | PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients. (Concha-Benavente F, Kansy B, Moskovitz J, Moy J, Chandran U, Ferris RL) Cancer Immunol Res 2018 Dec;6(12):1548-1560 134 Citations |
| 5 | Investigating the Association Between Advanced Practice Providers and Chemotherapy-Related Adverse Events in Women With Breast Cancer: A Nested Case-Control Study. (Yen TWF, Nattinger AB, McGinley EL, Fergestrom N, Pezzin LE, Laud PW) J Oncol Pract 2018 Oct 10:JOP1800277 2 Citations |
| 1 | PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. (Hisamatsu T, McGuire M, Wu SY, Rupaimoole R, Pradeep S, Bayraktar E, Noh K, Hu W, Hansen JM, Lyons Y, Gharpure KM, Nagaraja AS, Mangala LS, Mitamura T, Rodriguez-Aguayo C, Eun YG, Rose J, Bartholomeusz G, Ivan C, Lee JS, Matsuo K, Frumovitz M, Wong KK, Lopez-Berestein G, Sood AK) Mol Cancer Ther 2019 Jan;18(1):162-172 25 Citations |
| 7 | Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 141 Citations |
| 1 | Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer. (White SB, Zhang Z, Chen J, Gogineni VR, Larson AC) J Vasc Interv Radiol 2018 Dec;29(12):1764-1769 57 Citations |
| 1 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 195 Citations |
| 1 | A feasibility study of breast cancer genetic risk assessment in a federally qualified health center. (Hoskins KF, Tejeda S, Vijayasiri G, Chukwudozie IB, Remo MH, Shah HA, Abraham IE, Balay LE, Maga TK, Searles ER, Korah VJ, Biggers A, Stolley MR, Warnecke RB) Cancer 2018 Sep 15;124(18):3733-3741 21 Citations |
| 1 | Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer. (Kayano PP, Carneiro A, Castilho TML, Sivaraman A, Claros OR, Baroni RH, Garcia RG, Mariotti GC, Smaletz O, Filippi RZ, Lemos GC) Int Braz J Urol 2018;44(6):1106-1113 21 Citations |
| 1 | Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing. (Ikeda S, Elkin SK, Tomson BN, Carter JL, Kurzrock R) Cancer Biol Ther 2019;20(2):219-226 37 Citations |
| 1 | Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. (Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, Lesoin A, Schwartz PE, Buscema J, Fabbro M, Lortholary A, Goff B, Kurzrock R, Martin LP, Gray HJ, Fu S, Sheldon-Waniga E, Lin HM, Venkatakrishnan K, Zhou X, Leonard EJ, Schilder RJ) JAMA Oncol 2019 Jan 01;5(1):e183773 77 Citations |
| 1 | Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. (Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P) N Engl J Med 2018 Dec 27;379(26):2495-2505 2092 Citations |
| 1 | Using a Heuristic App to Improve Symptom Self-Management in Adolescents and Young Adults with Cancer. (Erickson JM, Ameringer S, Linder L, Macpherson CF, Elswick RK Jr, Luebke JM, Stegenga K) J Adolesc Young Adult Oncol 2019 Apr;8(2):131-141 31 Citations |
| 1 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. (Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB, Cancer Genome Atlas Research Network, Camargo F, Liang H) Cell Rep 2018 Oct 30;25(5):1304-1317.e5 330 Citations |
| 1 | Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial (Friedlander M, Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza AM, González-Martín A, Aghajanian C, Bradley W, Lowe ES, Bloomfield R, Disilvestro P) Annals of Oncology November 2018;29:ix174-ix175 |
| 1 | Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer. (Polusani SR, Huang YW, Huang G, Chen CW, Wang CM, Lin LL, Osmulski P, Lucio ND, Liu L, Hsu YT, Zhou Y, Lin CL, Aguilera-Barrantes I, Valente PT, Kost ER, Chen CL, Shim EY, Lee SE, Ruan J, Gaczynska ME, Yan P, Goodfellow PJ, Mutch DG, Jin VX, Nicholson BJ, Huang TH, Kirma NB) Cancer Res 2019 Jan 01;79(1):196-208 18 Citations |
| 1 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry. (Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA) Nat Commun 2018 Nov 05;9(1):4616 47 Citations |
| 1 | 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) : Washington, D.C., USA. 7-11 November 2018. () J Immunother Cancer 2018 Nov 06;6(Suppl 1):115 15 Citations |
| 1 | An avatar for precision cancer therapy. (Kato S, Kurzrock R) Nat Biotechnol 2018 Nov 09;36(11):1053-1055 9 Citations |
| 1 | Patient-Reported Outcomes and Factors Associated With Patient Satisfaction After Surgical Treatment of Facial Nonmelanoma Skin Cancer. (Sasor SE, Cook JA, Loewenstein SN, Wooden WA, Cohen AC, Chu MW, Tholpady SS) JAMA Surg 2019 Feb 01;154(2):179-181 5 Citations |
| 1 | Rising Proportion of Young Individuals With Rectal and Colon Cancer. (Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A) Clin Colorectal Cancer 2019 Mar;18(1):e87-e95 111 Citations |
| 1 | Pharmacokinetics and clinical response to single agent rucaparib in a dialysis dependent patient with BRCA associated breast and recurrent ovarian cancer. (Harold JA, Free SC, Bradley WH) Gynecol Oncol Rep 2018 Nov;26:91-93 4 Citations |
| 3 | Social adjustment of adolescent cancer patients transitioning off active treatment: A short-term prospective mixed methods study. (Chan SF, Hoag JA, Karst JS, Bingen KM) Pediatr Blood Cancer 2019 Mar;66(3):e27530 9 Citations |
| 1 | MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers. (Fricke SL, Payne SN, Favreau PF, Kratz JD, Pasch CA, Foley TM, Yueh AE, Van De Hey DR, Depke MG, Korkos DP, Sha GC, DeStefanis RA, Clipson L, Burkard ME, Lemmon KK, Parsons BM, Kenny PA, Matkowskyj KA, Newton MA, Skala MC, Deming DA) Mol Cancer Ther 2019 Feb;18(2):346-355 26 Citations |
| 6 | Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity. (Pan J, Lee Y, Cheng G, Zielonka J, Zhang Q, Bajzikova M, Xiong D, Tsaih SW, Hardy M, Flister M, Olsen CM, Wang Y, Vang O, Neuzil J, Myers CR, Kalyanaraman B, You M) iScience 2018 May 25;3:192-207 45 Citations |
| 1 | Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer. (Xiong D, Wang Y, Singavi AK, Mackinnon AC, George B, You M) iScience 2018 Nov 30;9:258-277 75 Citations |
| 2 | Breast cancer survivors' preferences for social support features in technology-supported physical activity interventions: findings from a mixed methods evaluation. (Lloyd GR, Hoffman SA, Welch WA, Blanch-Hartigan D, Gavin KL, Cottrell A, Cadmus-Bertram L, Spring B, Penedo F, Courneya KS, Phillips SM) Transl Behav Med 2020 May 20;10(2):423-434 13 Citations |
| 4 | Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study. (Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J) Clin Cardiol 2019 Jan;42(1):93-100 27 Citations |
| 1 | Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis. (Ariana M, Pornour M, Mehr SS, Vaseghi H, Ganji SM, Alivand MR, Salari M, Akbari ME) Per Med 2019 Jan;16(1):25-34 18 Citations |
| 1 | Improved long-term patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast proton therapy. (Teichman SL, Do S, Lum S, Teichman TS, Preston W, Cochran SE, Garberoglio CA, Grove R, Davis CA, Slater JD, Bush DA) Cancer Med 2018 Dec;7(12):6064-6076 11 Citations |
| 1 | Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment. (Jiang X, Seo YD, Sullivan KM, Pillarisetty VG) Methods Mol Biol 2019;1884:283-295 29 Citations |
| 1 | Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer. (Winn AN, Fergestrom NM, Neuner JM) Med Care 2019 Jan;57(1):85-93 10 Citations |
| 1 | Factors Affecting Adolescents' Willingness to Communicate Symptoms During Cancer Treatment: A Systematic Review from the Children's Oncology Group. (McLaughlin CA, Gordon K, Hoag J, Ranney L, Terwilliger NB, Ureda T, Rodgers C) J Adolesc Young Adult Oncol 2019 Apr;8(2):105-113 15 Citations |
| 1 | Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. (Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK) JAMA Oncol 2019 Feb 01;5(2):236-242 40 Citations |
| 1 | Factors associated with self-reported anal cancer screening history in men who have sex with men. (Hicks JT, Hwang LY, Baraniuk S, White M, Chiao EY, Onwuka N, Ross MW, Nyitray AG) Sex Health 2019 Feb;16(1):96-98 7 Citations |
| 4 | Genetic variations in human papillomavirus and cervical cancer outcomes. (Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ) Int J Cancer 2019 May 01;144(9):2206-2214 28 Citations |
| 1 | Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer. (Reeve BB, Wang M, Weinfurt K, Flynn KE, Usinger DS, Chen RC) J Sex Med 2018 Dec;15(12):1792-1810 11 Citations |
| 1 | A new pyrrole based small molecule from Tinospora cordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity. (Rashmi KC, Harsha Raj M, Paul M, Girish KS, Salimath BP, Aparna HS) Chem Biol Interact 2019 Feb 01;299:120-130 37 Citations |
| 1 | Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. (Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R) Mol Cancer Ther 2019 Feb;18(2):448-458 66 Citations |
| 1 | Three-dimensional analysis reveals altered chromatin interaction by enhancer inhibitors harbors TCF7L2-regulated cancer gene signature. (Gerrard DL, Wang Y, Gaddis M, Zhou Y, Wang J, Witt H, Lin S, Farnham PJ, Jin VX, Frietze SE) J Cell Biochem 2019 Mar;120(3):3056-3070 8 Citations |
| 1 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. (Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Bremer M, Brenner H, Brentnall A, Brock IW, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Campa D, Carter BD, Castelao JE, Chanock SJ, Chlebowski R, Christiansen H, Clarke CL, Collée JM, Cordina-Duverger E, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fletcher O, Flyger H, Försti A, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Gilyazova IR, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hankinson SE, Harkness EF, Hart SN, He W, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Jakimovska M, Jakubowska A, Janni W, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kaczmarek K, Kataja V, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Knight JA, Ko YD, Kosma VM, Koutros S, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Lilyquist J, Lindblom A, Lindström S, Lissowska J, Lo WY, Loibl S, Long J, Lubiński J, Lux MP, MacInnis RJ, Maishman T, Makalic E, Maleva Kostovska I, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Martinez ME, Mavroudis D, McLean C, Meindl A, Menon U, Middha P, Miller N, Moreno F, Mulligan AM, Mulot C, Muñoz-Garzon VM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, Offit K, Olson JE, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Peto J, Pinchev M, Plaseska-Karanfilska D, Polley EC, Prentice R, Presneau N, Prokofyeva D, Purrington K, Pylkäs K, Rack B, Radice P, Rau-Murthy R, Rennert G, Rennert HS, Rhenius V, Robson M, Romero A, Ruddy KJ, Ruebner M, Saloustros E, Sandler DP, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Schwentner L, Scott C, Scott RJ, Seynaeve C, Shah M, Sherman ME, Shrubsole MJ, Shu XO, Slager S, Smeets A, Sohn C, Soucy P, Southey MC, Spinelli JJ, Stegmaier C, Stone J, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Truong T, Tzardi M, Ulmer HU, Untch M, Vachon CM, van Veen EM, Vijai J, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zhang Y, Zheng W, Ziogas A, ABCTB Investigators, kConFab/AOCS Investigators, NBCS Collaborators, Dunning AM, Thompson DJ, Chenevix-Trench G, Chang-Claude J, Schmidt MK, Hall P, Milne RL, Pharoah PDP, Antoniou AC, Chatterjee N, Kraft P, García-Closas M, Simard J, Easton DF) Am J Hum Genet 2019 Jan 03;104(1):21-34 706 Citations |
| 1 | Exploring drivers of gene expression in the Cancer Genome Atlas. (Rau A, Flister M, Rui H, Auer PL) Bioinformatics 2019 Jan 01;35(1):62-68 20 Citations |
| 1 | Kinetic modeling of tumor regression incorporating the concept of cancer stem-like cells for patients with locally advanced lung cancer. (Zhong H, Brown S, Devpura S, Li XA, Chetty IJ) Theor Biol Med Model 2018 Dec 27;15(1):23 4 Citations |
| 1 | Pancreas Cancer-Associated Weight Loss. (Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L, Precision Promise Consortium) Oncologist 2019 May;24(5):691-701 113 Citations |
| 1 | The Future of Multidisciplinary Care in Pancreatic Cancer (Tsai S, Evans DB) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:1-7 |
| 1 | Treatment Sequencing for Borderline Resectable Pancreatic Cancer (Clarke CN) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:55-65 |
| 1 | Coordination of Endoscopic Ultrasound-Guided FNA and Biliary Drainage in Pancreatic Cancer (Dua KS) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:29-38 |
| 2 | Role of Radiation for Locally Advanced Pancreatic Cancer (Erickson BA, Hall WA) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:113-132 |
| 2 | Neoadjuvant Chemoradiation for Localized Pancreatic Cancer (Hall WA, Erickson BA) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:85-96 |
| 2 | Treatment Sequencing for Locally Advanced Pancreatic Cancer (Christians KK, Erickson BA) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:105-112 |
| 1 | New Classification of Locally Advanced Pancreatic Cancer (Christians KK) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:97-103 1 Citation |
| 2 | Management of Localized Pancreatic Cancer: Current Treatment and Challenges (Tsai S, Ritch PS, Erickson BA, Evans DB) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:1-205 2 Citations |
| 1 | Cancer regional therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond (Fong Y, Gamblin TC, Han ES, Lee B, Zager JS) Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond 1 January 2019:1-488 4 Citations |
| 1 | Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline summary (Shapiro CL, Lacchetti C, Neuner J) Journal of Oncology Practice 2019;15(12):665-669 5 Citations |
| 1 | CDK12-mutated prostate cancer: Clinical outcomes with standard therapies and immune checkpoint blockade (Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A) JCO Precision Oncology 2019;3:382-392 67 Citations |
| 1 | Education Milestones for Newly Diagnosed Pediatric, Adolescent, and Young Adult Cancer Patients: A Quality Improvement Initiative. (Dobrozsi S, Tomlinson K, Chan S, Belongia M, Herda C, Maloney K, Long C, Vertz L, Bingen K) J Pediatr Oncol Nurs 2019;36(2):103-118 14 Citations |
| 1 | Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes. (Tray N, Taff J, Singh B, Suh J, Ngo N, Kwa M, Troxel AB, Chae YK, Kurzrock R, Patel SP, Sharon E, Denkert C, Ross JS, Adams S) Breast 2019 Apr;44:29-32 45 Citations |
| 1 | Identification of targets for prostate cancer immunotherapy. (Papanicolau-Sengos A, Yang Y, Pabla S, Lenzo FL, Kato S, Kurzrock R, DePietro P, Nesline M, Conroy J, Glenn S, Chatta G, Morrison C) Prostate 2019 Apr;79(5):498-505 24 Citations |
| 1 | Downregulation of HDAC2 and HDAC3 via oleuropein as a potent prevention and therapeutic agent in MCF-7 breast cancer cells. (Bayat S, Mansoori Derakhshan S, Mansoori Derakhshan N, Shekari Khaniani M, Alivand MR) J Cell Biochem 2019 Jun;120(6):9172-9180 38 Citations |
| 1 | The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program. (Van Daele DJ, Langmore SE, Krisciunas GP, Lazarus CL, Pauloski BR, McCulloch TM, Gramigna GD, Messing BP, Wagner CW, Mott SL) Head Neck 2019 Mar;41(3):606-614 20 Citations |
| 1 | Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer. (Shahjehan F, Merchea A, Cochuyt JJ, Li Z, Colibaseanu DT, Kasi PM) Front Oncol 2018;8:620 54 Citations |
| 4 | Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer. (Harold JA, Uyar D, Rader JS, Bishop E, Nugent M, Simpson P, Bradley WH) Int J Gynecol Cancer 2019 Jan;29(1):53-59 7 Citations |
| 1 | Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics. (Okamura R, Boichard A, Kato S, Sicklick JK, Bazhenova L, Kurzrock R) JCO Precis Oncol 2018;2018 283 Citations |
| 1 | Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? (Kishan AU, Hall WA, Spratt DE) Eur Urol 2019 May;75(5):e133-e134 |
| 1 | Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy. (Li Y, Awan MJ, Chang T, Lavertu P, Zender C, Rezaee R, Fowler N, Wasman J, Avril NE, Chen N, Machtay M, Yao M) Eur J Nucl Med Mol Imaging 2019 Apr;46(4):794-800 10 Citations |
| 1 | Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. (Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ) Nutr Cancer 2019;71(1):21-40 84 Citations |
| 1 | Expression of brain-derived neurotrophic factor (BDNF) and its naturally occurring antisense in breast cancer samples (Esfahani ZT, Dashti S, Taheri M, Kholghi-Oskooei V, Arsang-Jang S, Ghafouri-Fard S) Meta Gene February 2019;19:69-73 9 Citations |
| 1 | The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. (Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ) Int J Gynaecol Obstet 2019 Apr;145(1):40-46 20 Citations |
| 1 | Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer (Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, Disilvestro P) Obstetrical and Gynecological Survey 1 February 2019;74(2):86-87 2 Citations |
| 1 | Predict drug sensitivity of cancer cells with pathway activity inference. (Wang X, Sun Z, Zimmermann MT, Bugrim A, Kocher JP) BMC Med Genomics 2019 Jan 31;12(Suppl 1):15 32 Citations |
| 1 | Dosing Oncology Therapeutics in Combination Therapy for Renal Dysfunction: The University of California San Diego Study of Personalized Cancer Therapy to Determine Response and Toxicity (UCSD-PREDICT) Experience. (Nikanjam M, Wing J, Capparelli E, Kurzrock R) Cureus 2018 Nov 26;10(11):e3634 |
| 1 | Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review. (Marra G, Gontero P, Walz JC, Sivaraman A, Tourinho-Barbosa R, Cathelineau X, Sanchez-Salas R) World J Urol 2019 Aug;37(8):1517-1534 25 Citations |
| 3 | Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. (Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C) J Immunother Cancer 2019 Feb 01;7(1):27 71 Citations |
| 1 | Thyroid Cancer. (Ioachimescu AG) Endocrinol Metab Clin North Am 2019 Mar;48(1):xv-xvi 4 Citations |
| 1 | Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer. (Kurzrock R, Hickish T, Wyrwicz L, Saunders M, Wu Q, Stecher M, Mohanty P, Dinarello CA, Simard J) Oncoimmunology 2019;8(3):1551651 37 Citations |
| 1 | Immunotherapy in extensive small cell lung cancer. (Verma V, Sharma G, Singh A) Exp Hematol Oncol 2019;8:5 30 Citations |
| 1 | Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults. (Salsman JM, Bingen K, Barr RD, Freyer DR) Pediatr Blood Cancer 2019 Jul;66(7):e27660 104 Citations |
| 1 | Culture, identity, strength and spirituality: A qualitative study to understand experiences of African American women breast cancer survivors and recommendations for intervention development. (Yan AF, Stevens P, Holt C, Walker A, Ng A, McManus P, Basen-Enguist K, Weinhardt LS, Underwood SM, Asan O, Wang MQ) Eur J Cancer Care (Engl) 2019 May;28(3):e13013 21 Citations |
| 1 | Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. (Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B) JAMA Oncol 2019 May 01;5(5):664-670 41 Citations |
| 1 | Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]. (ShreeMahadevan L, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, Triest B, Krishnan S, Hall W) Crit Rev Oncol Hematol 2019 Feb;134:71 1 Citation |
| 1 | The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity. (Fardi M, Alivand M, Baradaran B, Farshdousti Hagh M, Solali S) J Cell Physiol 2019 Sep;234(9):14783-14799 79 Citations |
| 1 | A Step toward Understanding Diet Quality in Urban African-American Breast Cancer Survivors: A Cross-sectional Analysis of Baseline Data from the Moving Forward Study. (Springfield S, Odoms-Young A, Tussing-Humphreys LM, Freels S, Stolley MR) Nutr Cancer 2019;71(1):61-76 7 Citations |
| 1 | CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. (Han Y, Sun F, Zhang X, Wang T, Jiang J, Cai J, Gao Q, Hezam K, Liu Y, Xie J, Wang M, Zhang J) J Cancer Res Clin Oncol 2019 May;145(5):1179-1190 38 Citations |
| 1 | Genome-wide association study of germline variants and breast cancer-specific mortality. (Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brentnall A, Brinton L, Broberg P, Brock IW, Brucker SY, Burwinkel B, Caldas C, Caldés T, Campa D, Canzian F, Carracedo A, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Cheng TD, Chin SF, Clarke CL, NBCS Collaborators, Cordina-Duverger E, Couch FJ, Cox DG, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dunn JA, Dunning AM, Durcan L, Dwek M, Earl HM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Figueroa J, Flesch-Janys D, Flyger H, Gabrielson M, Gago-Dominguez M, Galle E, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Georgoulias V, Giles GG, Glendon G, Goldgar DE, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hankinson S, Harkness EF, Harrington PA, Hart SN, Hartikainen JM, Hein A, Hillemanns P, Hiller L, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Janni W, John EM, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kabisch M, Kaczmarek K, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kitahara CM, Knight JA, Ko YD, Koppert LB, Kosma VM, Kraft P, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Li L, Lindblom A, Lindström S, Linet M, Lissowska J, Lo WY, Loibl S, Lubiński J, Lux MP, MacInnis RJ, Maierthaler M, Maishman T, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Mavroudis D, McLean C, Meindl A, Middha P, Miller N, Milne RL, Moreno F, Mulligan AM, Mulot C, Nassir R, Neuhausen SL, Newman WT, Nielsen SF, Nordestgaard BG, Norman A, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Petridis C, Pinchev M, Prajzendanc K, Prentice R, Presneau N, Prokofieva D, Pylkäs K, Rack B, Radice P, Ramachandran D, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Saloustros E, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schwentner L, Scott RJ, Scott C, Seynaeve C, Shah M, Simard J, Smeets A, Sohn C, Southey MC, Swerdlow AJ, Talhouk A, Tamimi RM, Tapper WJ, Teixeira MR, Tengström M, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Torres D, Truong T, Turman C, Turnbull C, Ulmer HU, Untch M, Vachon C, van Asperen CJ, van den Ouweland AMW, van Veen EM, Wendt C, Whittemore AS, Willett W, Winqvist R, Wolk A, Yang XR, Zhang Y, Easton DF, Fasching PA, Nevanlinna H, Eccles DM, Pharoah PDP, Schmidt MK) Br J Cancer 2019 Mar;120(6):647-657 46 Citations |
| 1 | Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. (Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O) J Endocr Soc 2019 Mar 01;3(3):544-559 50 Citations |
| 1 | Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial. (Viswanathan A, Vedantam A, Hess KR, Ochoa J, Dougherty PM, Reddy AS, Koyyalagunta D, Reddy S, Bruera E) Oncologist 2019 Jul;24(7):e590-e596 21 Citations |
| 1 | The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients. (Zuberi M, Mir R, Khan I, Javid J, Guru SA, Bhat M, Sumi MP, Ahmad I, Masroor M, Yadav P, Vishnubhatla S, Saxena A) Microrna 2020;9(1):49-57 |
| 1 | Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients. (Bliss LA, Strong EA, Gamblin TC) J Surg Oncol 2019 Apr;119(5):623-628 6 Citations |
| 2 | Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes. (Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL) Clin Breast Cancer 2019 Jun;19(3):157-164 26 Citations |
| 1 | Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. (Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude J, Chen S, Connolly CM, Easton DF, Feskens EJM, Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu C, Riboli E, Rennert G, Sala N, Schafmayer C, Scacheri PC, Schmit SL, Severi G, Slattery ML, Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Casey G, Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U) Hum Genet 2019 Apr;138(4):307-326 37 Citations |
| 1 | Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly. (Tangalakis LL, Cortina CS, Son JD, Poirier J, Madrigrano A) Clin Breast Cancer 2019 Jun;19(3):197-199 1 Citation |
| 1 | GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. (Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ) Gynecol Oncol 2019 May;153(2):335-342 7 Citations |
| 1 | Management of Nodal Disease in Advanced Cervical Cancer. (Jürgenliemk-Schulz IM, Beriwal S, de Leeuw AAC, Lindegaard JC, Nomden CN, Pötter R, Tanderup K, Viswanathan AN, Erickson B) Semin Radiat Oncol 2019 Apr;29(2):158-165 35 Citations |
| 1 | Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study. (Wang CB, Shahjehan F, Merchea A, Li Z, Bekaii-Saab TS, Grothey A, Colibaseanu DT, Kasi PM) Front Oncol 2019;9:76 52 Citations |
| 1 | Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network. (Chrischilles EA, Riley D, Letuchy E, Koehler L, Neuner J, Jernigan C, Gryzlak B, Segal N, McDowell B, Smith B, Sugg SL, Armer JM, Lizarraga IM) Breast Cancer Res Treat 2019 Jun;175(3):675-689 37 Citations |
| 4 | Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space. (McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS) Tomography 2019 Mar;5(1):127-134 43 Citations |
| 1 | Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. (Meric-Bernstam F, Hurwitz H, Raghav KPS, McWilliams RR, Fakih M, VanderWalde A, Swanton C, Kurzrock R, Burris H, Sweeney C, Bose R, Spigel DR, Beattie MS, Blotner S, Stone A, Schulze K, Cuchelkar V, Hainsworth J) Lancet Oncol 2019 Apr;20(4):518-530 432 Citations |
| 1 | Clinical determinants for successful circulating tumor DNA analysis in prostate cancer. (Schweizer MT, Gulati R, Beightol M, Konnick EQ, Cheng HH, Klemfuss N, De Sarkar N, Yu EY, Montgomery RB, Nelson PS, Pritchard CC) Prostate 2019 May;79(7):701-708 23 Citations |
| 1 | Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. (Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC) Clin Epigenetics 2019 Mar 12;11(1):45 41 Citations |
| 1 | Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues. (Esfandi F, Taheri M, Omrani MD, Shadmehr MB, Arsang-Jang S, Shams R, Ghafouri-Fard S) BMC Cancer 2019 Mar 12;19(1):222 46 Citations |
| 2 | Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. (Sun A, Hu C, Wong SJ, Gore E, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar LE, Choy H) JAMA Oncol 2019 Jun 01;5(6):847-855 56 Citations |
| 1 | Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival. (Roy R, Chatterjee A, Das D, Ray A, Singh R, Chattopadhyay E, Sarkar N, Eccles M, Pal M, Maitra A, Roy B) Epigenomics 2019 Apr;11(5):473-487 12 Citations |
| 1 | Correction to Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. (Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D) ACS Nano 2019 Apr 23;13(4):4855 5 Citations |
| 1 | Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer. (Petras KG, Rademaker AW, Refaat T, Choi M, Thomas TO, Pauloski BR, Mittal BB) Radiat Oncol 2019 Mar 18;14(1):49 11 Citations |
| 1 | Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. (Bakke J, Wright WC, Zamora AE, Oladimeji P, Crawford JC, Brewer CT, Autry RJ, Evans WE, Thomas PG, Chen T) BMC Cancer 2019 Mar 21;19(1):253 21 Citations |
| 1 | RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. (Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, Fazli L, Zhang Q, Musselman CA, Wang Y, Huang J, Gleave ME, Collins C, Dong X) Eur Urol 2019 Aug;76(2):157-166 22 Citations |
| 2 | Breast cancer survivors' preferences for mHealth physical activity interventions: findings from a mixed methods study. (Phillips SM, Courneya KS, Welch WA, Gavin KL, Cottrell A, Nielsen A, Solk P, Blanch-Hartigan D, Cella D, Ackermann RT, Spring B, Penedo F) J Cancer Surviv 2019 Apr;13(2):292-305 34 Citations |
| 1 | Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. (Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT) Cancer 2019 Jun 15;125(12):2027-2038 60 Citations |
| 3 | Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients. (Plasterer C, Tsaih SW, Lemke A, Schilling R, Dwinell M, Rau A, Auer P, Rui H, Flister MJ) G3 (Bethesda) 2019 May 07;9(5):1739-1743 6 Citations |
| 1 | FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis. (Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK) Oncogene 2019 Jun;38(26):5265-5280 44 Citations |
| 2 | Sedentary behavior after breast cancer: motivational, demographic, disease, and health status correlates of sitting time in breast cancer survivors. (Gavin KL, Welch WA, Conroy DE, Kozey-Keadle S, Pellegrini C, Cottrell A, Nielsen A, Solk P, Siddique J, Phillips SM) Cancer Causes Control 2019 Jun;30(6):569-580 11 Citations |
| 1 | Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis. (Zhang X, Tang T, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ) J Geriatr Oncol 2019 Nov;10(6):874-883 98 Citations |
| 1 | Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. (Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J, BILCAP study group) Lancet Oncol 2019 May;20(5):663-673 921 Citations |
| 1 | GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. (Ma S, Pradeep S, Villar-Prados A, Wen Y, Bayraktar E, Mangala LS, Kim MS, Wu SY, Hu W, Rodriguez-Aguayo C, Leuschner C, Liang X, Ram PT, Schlacher K, Coleman RL, Sood AK) Mol Cancer Ther 2019 May;18(5):969-979 14 Citations |
| 1 | Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. (Shatsky R, Parker BA, Bui NQ, Helsten T, Schwab RB, Boles SG, Kurzrock R) Mol Cancer Ther 2019 May;18(5):1001-1011 35 Citations |
| 1 | The expression of CCAT2, UCA1, PANDA and GHET1 long non-coding RNAs in lung cancer (Esfandi F, Fallah H, Arsang-Jang S, Taheri M, Ghafouri-Fard S) Reports of Biochemistry and Molecular Biology April 2019;8(1) 10 Citations |
| 3 | RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN) J Surg Res 2019 Aug;240:130-135 15 Citations |
| 2 | SOX11 hypermethylation as a tumor biomarker in endometrial cancer. (Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW) Biochimie 2019 Jul;162:8-14 16 Citations |
| 1 | Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. (Goodman ML, Trinca GM, Walter KR, Papachristou EK, D'Santos CS, Li T, Liu Q, Lai Z, Chalise P, Madan R, Fan F, Markiewicz MA, Jin VX, Carroll JS, Hagan CR) J Immunol 2019 May 15;202(10):3076-3086 37 Citations |
| 1 | Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation. (Merchea A, Shahjehan F, Croome KP, Cochuyt JJ, Li Z, Colibaseanu DT, Kasi PM) J Oncol 2019;2019:5796108 21 Citations |
| 1 | Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer. (Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG) Clin Cancer Res 2019 Jul 01;25(13):3934-3945 170 Citations |
| 1 | Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. (Zhou Y, Gerrard DL, Wang J, Li T, Yang Y, Fritz AJ, Rajendran M, Fu X, Stein G, Schiff R, Lin S, Frietze S, Jin VX) Nat Commun 2019 Apr 03;10(1):1522 57 Citations |
| 1 | Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. (Chatterjee A, Gallan AJ, He D, Fan X, Mustafi D, Yousuf A, Antic T, Karczmar GS, Oto A) Abdom Radiol (NY) 2019 Jun;44(6):2233-2243 32 Citations |
| 1 | Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. (Lee P, Loo BW Jr, Biswas T, Ding GX, El Naqa IM, Jackson A, Kong FM, LaCouture T, Miften M, Solberg T, Tome WA, Tai A, Yorke E, Li XA) Int J Radiat Oncol Biol Phys 2021 May 01;110(1):160-171 42 Citations |
| 1 | Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. (Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK) EBioMedicine 2019 Apr;42:375-385 36 Citations |
| 1 | Predictors of swallow function after transoral surgery for locally advanced oropharyngeal cancer. (Gross JH, Townsend M, Hong HY, Miller E, Kallogjeri D, Zenga J, Pipkorn P, Jackson RS, Haughey B, Rich JT) Laryngoscope 2020 Jan;130(1):94-100 11 Citations |
| 1 | Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. (Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM) Int J Radiat Oncol Biol Phys 2019 Aug 01;104(5):1057-1065 11 Citations |
| 5 | Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference? (Neuner JM, Nattinger AB, Yen T, McGinley E, Nattinger M, Pezzin LE) Breast Cancer Res Treat 2019 Jul;176(1):205-215 11 Citations |
| 2 | Effects of reallocating sedentary time with physical activity on quality of life indicators in breast cancer survivors. (Welch WA, Ehlers D, Gavin KL, Aguinaga S, Cottrell A, Nielsen A, Solk P, McAuley E, Phillips SM) Psychooncology 2019 Jul;28(7):1430-1437 20 Citations |
| 1 | Adherence to American Cancer Society and American Institute of Cancer Research dietary guidelines in overweight African American breast cancer survivors. (Springfield S, Odoms-Young A, Tussing-Humphreys L, Freels S, Stolley M) J Cancer Surviv 2019 Apr;13(2):257-268 21 Citations |
| 1 | Prevalence and factors associated with malnutrition in older patients with cancer. (Zhang X, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ) J Geriatr Oncol 2019 Sep;10(5):763-769 37 Citations |
| 1 | Protocols in genetic mice models of pancreatic cancer (Al-Qambar B, Chaker M, Kamgar M, Tesfaye A, Uwe-Wagner K, Azmi AS) Animal Models in Cancer Drug Discovery 17 April 2019:107-123 |
| 1 | Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. (Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T) Nature 2019 May;569(7754):131-135 324 Citations |
| 1 | Chronic Stress and Ovarian Function in Female Childhood Cancer Survivors. (Hardy TM, Garnier-Villarreal M, Ohlendorf JM, McCarthy DO) Oncol Nurs Forum 2019 May 01;46(3):E75-E85 4 Citations |
| 1 | Nationwide Trends in Heart-Sparing Techniques Utilized in Radiation Therapy for Breast Cancer. (Desai N, Currey A, Kelly T, Bergom C) Adv Radiat Oncol 2019;4(2):246-252 38 Citations |
| 1 | Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. (Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I, Loriot Y, Afshar M, Miller V, Wunder F, Bresson C, Martini JF, Raynaud J, Mendelsohn J, Batist G, Onn A, Tabernero J, Schilsky RL, Lazar V, Lee JJ, Kurzrock R) Nat Med 2019 May;25(5):751-758 419 Citations |
| 1 | Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. (Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, Ross JS, Benson A, Webster J, Stephens PJ, Lee JJ, Fanta PT, Lippman SM, Leyland-Jones B, Kurzrock R) Nat Med 2019 May;25(5):744-750 505 Citations |
| 1 | Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized Methodology. (Bakavicius A, Sanchez-Salas R, Muttin F, Sivaraman A, Dell'Oglio P, Barret E, Rozet F, Mombet A, Prapotnich D, Cathala N, Cathelineau X) J Endourol 2019 Jul;33(7):509-515 19 Citations |
| 1 | Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. (Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ) Ann Surg Oncol 2019 Jul;26(7):2234-2240 17 Citations |
| 1 | Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. (Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM) Radiother Oncol 2019 Jun;135:19-24 22 Citations |
| 1 | Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand. (Mei L, Zhang J, He K, Zhang J) J Hematol Oncol 2019 Apr 24;12(1):43 99 Citations |
| 1 | Differentiated Thyroid Cancer in the Pediatric/Adolescent Population: Evolution of Treatment. (Remiker AS, Chuang J, Corathers S, Rutter MM, Rutter MJ, Myer CM 4th, Gelfand MJ, Trout AT, Geller JI) J Pediatr Hematol Oncol 2019 Oct;41(7):532-536 10 Citations |
| 1 | The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models. (Zhou R, Wang S, Wen H, Wang M, Wu M) Exp Cell Res 2019 Jul 15;380(2):141-148 17 Citations |
| 1 | Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival. (Kato S, Schwaederlé MC, Fanta PT, Okamura R, Leichman L, Lippman SM, Lanman RB, Raymond VM, Talasaz A, Kurzrock R) JCO Precis Oncol 2019;3 43 Citations |
| 3 | STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. (Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J, Johnson BD, Dwinell MB) J Immunother Cancer 2019 Apr 29;7(1):115 142 Citations |
| 1 | Use of Cabozantinib in a Patient With EGFR-Mutated Non-Small-Cell Lung Cancer Harboring Acquired CCDC6-RET Fusion. (Chae YK, Viveiros P, Heleno CT, Bilal H, Sukhadia BA, Oh MS, Sheikh MM, Iams WT, Park LC) JCO Precis Oncol 2019;3 2 Citations |
| 1 | Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. (Krook MA, Barker H, Chen HZ, Reeser JW, Wing MR, Martin D, Smith AM, Dao T, Bonneville R, Samorodnitsky E, Miya J, Freud AG, Monk JP, Clinton SK, Roychowdhury S) Prostate Cancer Prostatic Dis 2019 Dec;22(4):624-632 7 Citations |
| 1 | Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study. (Cremer M, Alfaro K, Garai J, Salinas M, Maza M, Zevallos A, Taxa L, Diaz AC, Castle P, Alonzo TA, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Felix JC) Int J Gynecol Cancer 2019 Jun 02;29(5):851-856 6 Citations |
| 1 | The broken cycle: E2F dysfunction in cancer. (Kent LN, Leone G) Nat Rev Cancer 2019 Jun;19(6):326-338 537 Citations |
| 1 | Genomic correlates of clinical outcome in advanced prostate cancer. (Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM, Sboner A, Fedrizzi T, Mosquera JM, Robinson BD, De Sarkar N, Kunju LP, Tomlins S, Wu YM, Nava Rodrigues D, Loda M, Gopalan A, Reuter VE, Pritchard CC, Mateo J, Bianchini D, Miranda S, Carreira S, Rescigno P, Filipenko J, Vinson J, Montgomery RB, Beltran H, Heath EI, Scher HI, Kantoff PW, Taplin ME, Schultz N, deBono JS, Demichelis F, Nelson PS, Rubin MA, Chinnaiyan AM, Sawyers CL) Proc Natl Acad Sci U S A 2019 Jun 04;116(23):11428-11436 888 Citations |
| 1 | Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial. (Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ, TRINOVA-3/ENGOT-ov2/GOG-3001 investigators) Lancet Oncol 2019 Jun;20(6):862-876 77 Citations |
| 2 | Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. (Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL) Osteoporos Int 2019 Aug;30(8):1699-1703 3 Citations |
| 1 | Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. (Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, Burnet NG, Dearnaley DP, Gulliford SL, Hall E, Sydes MR, Aguado-Barrera ME, Gómez-Caamaño A, Carballo AM, Peleteiro P, Lobato-Busto R, Stock R, Stone NN, Ostrer H, Usmani N, Singhal S, Tsuji H, Imai T, Saito S, Eeles R, DeRuyck K, Parliament M, Dunning AM, Vega A, Rosenstein BS, West CML) J Natl Cancer Inst 2020 Feb 01;112(2):179-190 79 Citations |
| 1 | Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults. (Huang JT, Coughlin CC, Hawryluk EB, Hook K, Humphrey SR, Kruse L, Lawley L, Al-Sayegh H, London WB, Marghoob A, Phung TL, Pope E, Gerami P, Schmidt B, Robinson S, Bartenstein D, Bahrani E, Brahmbhatt M, Chen L, Haddock E, Mansour D, Nguyen J, Raisanen T, Tran G, Travis K, Wolner Z, Eichenfield LF) J Pediatr 2019 Aug;211:152-158 24 Citations |
| 1 | Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial. (Cara Amanda Mathews, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Sergeevna Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S. Sonke, Charlie Gourley, Susana N. Banerjee, Amit M. Oza, Antonio González-Martín, Carol Aghajanian, William Hampton Bradley, Elizabeth S. Lowe, Ralph Bloomfield, Paul Disilvestro) Journal of Clinical Oncology DOI: 10.1200/JCO.2019.37.15_suppl.5541 Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 5541-5541. |
| 1 | Disparities in genetic referrals for breast cancer among the Asian immigrant populations: How can we eliminate them? (Sailaja Kamaraju, Amanda Jacquart, Samantha Stachowiak, Jennifer Geurts, Morgan Deepas, Jessica Olson, Lubna Chaudhary, Christopher Chitambar, Joan Neuner, Yee CChung Cheng) Annals of Public Health Reports DOI: 10.36959/856/489 |
| 1 | Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. (Adashek JJ, Junior PNA, Galanina N, Kurzrock R) J Immunother Cancer 2019 May 22;7(1):130 7 Citations |
| 1 | The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation. (Mansouri N, Alivand MR, Bayat S, Khaniani MS, Derakhshan SM) J Cell Biochem 2019 Oct;120(10):17042-17049 17 Citations |
| 1 | Multicenter Randomized Controlled Trial of Omega-3 Fatty Acids Versus Omega-6 Fatty Acids for the Control of Cancer-Related Fatigue Among Breast Cancer Survivors. (Peppone LJ, Inglis JE, Mustian KM, Heckler CE, Padula GDA, Mohile SG, Kamen CS, Culakova E, Lin PJ, Kerns SL, Cole S, Janelsins MC) JNCI Cancer Spectr 2019 Jun;3(2):pkz005 25 Citations |
| 1 | Folic Acid-Functionalized Black Phosphorus Quantum Dots for Targeted Chemo-Photothermal Combination Cancer Therapy. (Luo M, Cheng W, Zeng X, Mei L, Liu G, Deng W) Pharmaceutics 2019 May 21;11(5) 61 Citations |
| 1 | Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018. (Shahjehan F, Kamatham S, Kasi PM) Front Oncol 2019;9:358 10 Citations |
| 3 | Modeling post-translational modifications and cancer-associated mutations that impact the heterochromatin protein 1α-importin α heterodimers. (Zimmermann MT, Williams MM, Klee EW, Lomberk GA, Urrutia R) Proteins 2019 Nov;87(11):904-916 4 Citations |
| 4 | Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. (Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ) Breast Cancer Res Treat 2019 Aug;177(1):77-91 5 Citations |
| 1 | The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: A Greater Plains Collaborative study. (McDowell BD, Klemp J, Blaes A, Cohee AA, Trentham-Dietz A, Kamaraju S, Otte JL, Mott SL, Chrischilles EA) Support Care Cancer 2020 Feb;28(2):887-895 8 Citations |
| 1 | Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. (Beyer AM, Bonini MG, Moslehi J) Am J Physiol Heart Circ Physiol 2019 Jul 01;317(1):H164-H167 21 Citations |
| 1 | Progress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics. (Thorat ND, Townely H, Brennan G, Parchur AK, Silien C, Bauer J, Tofail SAM) ACS Biomater Sci Eng 2019 Jun 10;5(6):2669-2687 32 Citations |
| 1 | Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer. (Hosford SR, Shee K, Wells JD, Traphagen NA, Fields JL, Hampsch RA, Kettenbach AN, Demidenko E, Miller TW) Mol Oncol 2019 Aug;13(8):1778-1794 17 Citations |
| 1 | A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. (Kurzrock R, Ball DW, Zahurak ML, Nelkin BD, Subbiah V, Ahmed S, O'Connor A, Karunsena E, Parkinson RM, Bishop JA, Ha Y, Sharma R, Gocke CD, Zinner R, Rudek MA, Sherman SI, Azad NS) Clin Cancer Res 2019 Sep 15;25(18):5475-5484 18 Citations |
| 1 | Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting. (Mardinian K, Okamura R, Kato S, Kurzrock R) Int J Cancer 2020 Jan 15;146(2):566-576 17 Citations |
| 6 | The p52 isoform of SHC1 is a key driver of breast cancer initiation. (Wright KD, Miller BS, El-Meanawy S, Tsaih SW, Banerjee A, Geurts AM, Sheinin Y, Sun Y, Kalyanaraman B, Rui H, Flister MJ, Sorokin A) Breast Cancer Res 2019 Jun 15;21(1):74 35 Citations |
| 1 | Fine Mapping in Chromosome 3q28 Identified Two Variants Associated with Lung Cancer Risk in Asian Population. (Wen Y, Zhu C, Li N, Li Z, Cheng Y, Dong J, Zhu M, Wang Y, Dai J, Ma H, Jin G, Dai M, Hu Z, Shen H) J Cancer 2019;10(8):1862-1869 1 Citation |
| 8 | Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer. (Zenga J, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Laryngoscope 2020 Mar;130(3):666-671 16 Citations |
| 1 | Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression. (Bowen C, Ostrowski MC, Leone G, Gelmann EP) Cancer Res 2019 Aug 15;79(16):4124-4134 27 Citations |
| 1 | Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues. (Chen H, Kichaev G, Bien SA, MacDonald JW, Wang L, Bammler TK, Auer P, Pasaniuc B, Lindström S) Hum Genet 2019 Oct;138(10):1091-1104 7 Citations |
| 1 | Surgery in the Older Patient with Breast Cancer. (Frebault J, Bergom C, Kong AL) Curr Oncol Rep 2019 Jun 25;21(8):69 4 Citations |
| 4 | Improving Communication in Breast Cancer Treatment Consultation: Use of a Computer Test of Health Numeracy. (Schapira MM, Fletcher KE, Ganschow PS, Jacobs EA, Walker CM, Smallwood AJ, Gil D, Faghri A, Kong AL, Yen TW, McDunn S, Marcus E, Neuner JM) J Womens Health (Larchmt) 2019 Oct;28(10):1407-1417 7 Citations |
| 1 | The validity of three malnutrition screening markers among older patients with cancer. (Zhang X, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ) BMJ Support Palliat Care 2020 Sep;10(3):363-368 11 Citations |
| 1 | Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer. (Chae YK, Viveiros P, Lopes G, Sukhadia B, Sheikh MM, Saravia D, Florou V, Sokol ES, Frampton GM, Chalmers ZR, Ali SM, Ross JS, Chang S, Wang S, Chiec L, Rahbari A, Mohindra N, Villaflor V, Shin SH, Oh M, Anker J, Park LC, Wang V, Chuang J, Park W) J Thorac Oncol 2019 Oct;14(10):1807-1817 36 Citations |
| 1 | HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. (Duan T, Xu Z, Sun F, Wang Y, Zhang J, Luo C, Wang M) Biomed Pharmacother 2019 Sep;117:109121 58 Citations |
| 2 | B Cells as an Immune-Regulatory Signature in Ovarian Cancer. (Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S) Cancers (Basel) 2019 Jun 26;11(7) 41 Citations |
| 1 | Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study. (Ljungman L, Eriksson LE, Flynn KE, Gorman JR, Ståhl O, Weinfurt K, Wiklander M, Lampic C, Wettergren L) J Sex Med 2019 Jul;16(7):1049-1059 38 Citations |
| 4 | Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer. (Lorenz JW, Schott D, Rein L, Mostafaei F, Noid G, Lawton C, Bedi M, Li XA, Schultz CJ, Paulson E, Hall WA) Cureus 2019 Apr 20;11(4):e4510 |
| 1 | Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. (Seo DW, Sherman S, Dua KS, Slivka A, Roy A, Costamagna G, Deviere J, Peetermans J, Rousseau M, Nakai Y, Isayama H, Kozarek R, Biliary SEMS During Neoadjuvant Therapy Study Group) Gastrointest Endosc 2019 Oct;90(4):602-612.e4 80 Citations |
| 1 | Durvalumab in cancer medicine: a comprehensive review. (Alvarez-Argote J, Dasanu CA) Expert Opin Biol Ther 2019 Sep;19(9):927-935 44 Citations |
| 8 | Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 49 Citations |
| 1 | Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer. (Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB) Ann Surg 2019 Sep;270(3):400-413 131 Citations |
| 1 | Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study. (Ehrhardt MJ, Chen Y, Sandlund JT, Bluhm EC, Hayashi RJ, Becktell K, Leisenring WM, Metzger ML, Ness KK, Krull KR, Oeffinger KC, Gibson TM, Cairo MS, Gross TG, Robison LL, Armstrong GT, Yasui Y, Hudson MM, Mulrooney DA) J Clin Oncol 2019 Oct 01;37(28):2556-2570 22 Citations |
| 3 | Housing discrimination and racial cancer disparities among the 100 largest US metropolitan areas. (Beyer KMM, Laud PW, Zhou Y, Nattinger AB) Cancer 2019 Nov 01;125(21):3818-3827 39 Citations |
| 1 | Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer. (Haddad BR, Erickson A, Udhane V, LaViolette PS, Rone JD, Kallajoki MA, See WA, Rannikko A, Mirtti T, Nevalainen MT) Cancer Epidemiol Biomarkers Prev 2019 Oct;28(10):1642-1651 10 Citations |
| 3 | Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer. (Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM) Clin Lung Cancer 2019 Nov;20(6):435-441 30 Citations |
| 2 | Priority Symptoms, Causes, and Self-Management Strategies Reported by AYAs With Cancer. (Linder LA, Stegenga K, Erickson J, Ameringer S, Newman AR, Chiu YS, Macpherson CF) J Pain Symptom Manage 2019 Nov;58(5):774-783 9 Citations |
| 2 | Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 13 Citations |
| 2 | Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer. (Basree MM, Shinde N, Koivisto C, Cuitino M, Kladney R, Zhang J, Stephens J, Palettas M, Zhang A, Kim HK, Acero-Bedoya S, Trimboli A, Stover DG, Ludwig T, Ganju R, Weng D, Shields P, Freudenheim J, Leone GW, Sizemore GM, Majumder S, Ramaswamy B) Breast Cancer Res 2019 Jul 17;21(1):80 35 Citations |
| 1 | Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. (Choi IS, Kato S, Fanta PT, Leichman L, Okamura R, Raymond VM, Lanman RB, Lippman SM, Kurzrock R) Mol Cancer Ther 2019 Oct;18(10):1852-1862 19 Citations |
| 1 | Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine. (Compton CC, Robb JA, Anderson MW, Berry AB, Birdsong GG, Bloom KJ, Branton PA, Crothers JW, Cushman-Vokoun AM, Hicks DG, Khoury JD, Laser J, Marshall CB, Misialek MJ, Natale KE, Nowak JA, Olson D, Pfeifer JD, Schade A, Vance GH, Walk EE, Yohe SL) Arch Pathol Lab Med 2019 Nov;143(11):1346-1363 89 Citations |
| 1 | The Expression of CCAT2, UCA1, PANDA and GHET1 Long Non-coding RNAs in Lung Cancer. (Esfandi F, Fallah H, Arsang-Jang S, Taheri M, Ghafouri-Fard S) Rep Biochem Mol Biol 2019 Apr;8(1):36-41 |
| 1 | Colorectal cancer screening among Hispanics/Latinos in the HCHS/SOL sociocultural ancillary study. (Castañeda SF, Gallo LC, Nodora J, Talavera GA, Penedo FJ, Evenson KR, Lopez-Gurrola M, Smoller-Wassertheil S, Sanchez-Johnsen LAP, Gonzalez P, Perreira KM, Gupta S) Prev Med Rep 2019 Sep;15:100947 17 Citations |
| 2 | Preferences for mHealth physical activity interventions during chemotherapy for breast cancer: a qualitative evaluation. (Nielsen AM, Welch WA, Gavin KL, Cottrell AM, Solk P, Torre EA, Blanch-Hartigan D, Phillips SM) Support Care Cancer 2020 Apr;28(4):1919-1928 23 Citations |
| 1 | Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis. (Ye H, Zhu W, Mei L, Lu Z) Medicine (Baltimore) 2019 Aug;98(31):e16685 7 Citations |
| 1 | Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation. (Jorns JM) Arch Pathol Lab Med 2019 Dec;143(12):1444-1449 21 Citations |
| 6 | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. (Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE) Cancer 2019 Nov 15;125(22):3960-3965 6 Citations |
| 1 | Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals. (Kurzrock R, Gurski LA, Carlson RW, Ettinger DS, Horwitz SM, Kumar SK, Million L, von Mehren M, Benson AB 3rd) Ann Oncol 2019 Oct 01;30(10):1647-1652 12 Citations |
| 6 | Use of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer. (Hu KY, Simpson MT, Blank JJ, Szabo A, Eastwood D, Ludwig KA, Peterson CY, Ridolfi TJ) J Surg Res 2019 Nov;243:447-452 11 Citations |
| 1 | Modeling Human Cancer-induced Cachexia. (Talbert EE, Cuitiño MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, Reiser PJ, Webb A, Timmers CD, Eiferman DS, Evans DC, Dillhoff ME, Schmidt CR, Guttridge DC) Cell Rep 2019 Aug 06;28(6):1612-1622.e4 93 Citations |
| 1 | How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy (PA Philip, M Kamgar) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care PA Philip, M Kamgar (2019).'How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy', in T Bekaii-Saab, B El-Rayes, T Pawlik (ed.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care: Springer Publishing Company, PP. 183-190 |
| 1 | Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics. (Nikanjam M, Cohen PR, Kato S, Sicklick JK, Kurzrock R) Ann Oncol 2019 Oct 01;30(10):1675 4 Citations |
| 1 | Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. (Nissim S, Leshchiner I, Mancias JD, Greenblatt MB, Maertens O, Cassa CA, Rosenfeld JA, Cox AG, Hedgepeth J, Wucherpfennig JI, Kim AJ, Henderson JE, Gonyo P, Brandt A, Lorimer E, Unger B, Prokop JW, Heidel JR, Wang XX, Ukaegbu CI, Jennings BC, Paulo JA, Gableske S, Fierke CA, Getz G, Sunyaev SR, Wade Harper J, Cichowski K, Kimmelman AC, Houvras Y, Syngal S, Williams C, Goessling W) Nat Genet 2019 Sep;51(9):1308-1314 45 Citations |
| 1 | Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. (Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM 3rd, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT) Clin Cancer Res 2019 Dec 01;25(23):7078-7088 24 Citations |
| 1 | Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. (Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C) Head Neck 2019 Nov;41(11):3924-3932 9 Citations |
| 2 | The Immune Landscape of Cancer. (Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I) Immunity 2019 Aug 20;51(2):411-412 223 Citations |
| 1 | Skin Cancer Education in the Rural Salon. (Bahnson AB, Kondratuk KE, Anderson SM) S D Med 2019 Jun;72(6):267-271 4 Citations |
| 2 | Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine. (Lomberk G, Dusetti N, Iovanna J, Urrutia R) Nat Commun 2019 Aug 28;10(1):3875 74 Citations |
| 1 | Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Practical Radiation Oncology September - October 2019;9(5):322-332 136 Citations |
| 1 | Role of Radioembolization for Biliary Tract and Primary Liver Cancer. (Taylor AC, Maddirela D, White SB) Surg Oncol Clin N Am 2019 Oct;28(4):731-743 11 Citations |
| 1 | Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Pract Radiat Oncol 2019;9(5):322-332 136 Citations |
| 4 | Identification and validation of a prognostic proteomic signature for cervical cancer. (Rader JS, Pan A, Corbin B, Iden M, Lu Y, Vellano CP, Akbani R, Mills GB, Simpson P) Gynecol Oncol 2019 Nov;155(2):324-330 6 Citations |
| 1 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. (Nikanjam M, Arguello D, Gatalica Z, Swensen J, Barkauskas DA, Kurzrock R) Int J Cancer 2020 Jun 01;146(11):3087-3097 20 Citations |
| 1 | Phase I trials as valid therapeutic options for patients with cancer. (Adashek JJ, LoRusso PM, Hong DS, Kurzrock R) Nat Rev Clin Oncol 2019 Dec;16(12):773-778 88 Citations |
| 2 | Goals of Treatment Sequencing for Localized Pancreatic Cancer. (Evans DB, Kamgar M, Tsai S) Ann Surg Oncol 2019 Nov;26(12):3815-3819 5 Citations |
| 1 | Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. (Solk P, Gavin K, Fanning J, Welch W, Lloyd G, Cottrell A, Nielsen A, Santa Maria CA, Gradishar W, Khan SA, Kulkarni S, Siddique J, Phillips SM) Qual Life Res 2019 Dec;28(12):3333-3346 19 Citations |
| 1 | Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes. (Asombang AW, Chishinga N, Nkhoma A, Chipaila J, Nsokolo B, Manda-Mapalo M, Montiero JFG, Banda L, Dua KS) World J Gastroenterol 2019 Aug 21;25(31):4512-4533 75 Citations |
| 1 | Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity. (McAlarnen LA, Ryan K, Adams W, Gliniewicz A, Winder AD, Liotta MR, Potkul RK, Small W Jr, Harkenrider MM) Gynecol Oncol Rep 2019 Aug;29:1-6 5 Citations |
| 5 | Racial disparities of liver cancer mortality in Wisconsin. (Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM) Cancer Causes Control 2019 Dec;30(12):1277-1282 8 Citations |
| 1 | Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. (Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J) J Clin Oncol 2019 Nov 01;37(31):2916-2946 154 Citations |
| 1 | Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer. (Shahjehan F, Kamatham S, Ritter A, Kasi PM) Clin Case Rep 2019 Sep;7(9):1729-1734 2 Citations |
| 1 | Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer. (Kasi PM, Koep T, Schnettler E, Shahjehan F, Kamatham V, Baldeo C, Hughes CL) Technol Cancer Res Treat 2019 Jan 01;18:1533033819873924 12 Citations |
| 1 | Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. (Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B) Ann Thorac Surg 2020 Feb;109(2):404-411 10 Citations |
| 5 | Prevalence and scope of advanced practice provider oncology care among Medicare beneficiaries with breast cancer. (Yen TWF, Laud PW, McGinley EL, Pezzin LE, Nattinger AB) Breast Cancer Res Treat 2020 Jan;179(1):57-65 2 Citations |
| 2 | Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. (Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT) Mol Cancer Ther 2020 Jan;19(1):231-246 20 Citations |
| 1 | Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider. (Farkas A, Vanderberg R, Merriam S, DiNardo D) J Womens Health (Larchmt) 2020 Jan;29(1):46-56 10 Citations |
| 1 | A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. (Shee K, Wells JD, Ung M, Hampsch RA, Traphagen NA, Yang W, Liu SC, Zeldenrust MA, Wang L, Kalari KR, Yu J, Boughey JC, Demidenko E, Kettenbach AN, Cheng C, Goetz MP, Miller TW) Clin Cancer Res 2020 Jan 01;26(1):159-170 1 Citation |
| 1 | Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. (González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ, PRIMA/ENGOT-OV26/GOG-3012 Investigators) N Engl J Med 2019 Dec 19;381(25):2391-2402 1617 Citations |
| 4 | A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer (Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA) Physics and Imaging in Radiation Oncology October 2019;12:22-29 1 Citation |
| 1 | Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues. (Li AM, Boichard A, Kurzrock R) Cancer Biol Ther 2020;21(1):95-100 39 Citations |
| 8 | Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. (Zenga J, Divi V, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Jackson RS, Pipkorn P) Oral Oncol 2019 Nov;98:125-131 26 Citations |
| 1 | In vivo longitudinal imaging of RNA interference-induced endocrine therapy resistance in breast cancer. (Biswal NC, Fu X, Jagtap JM, Shea MJ, Kumar V, Lords T, Roy R, Schiff R, Joshi A) J Biophotonics 2020 Jan;13(1):e201900180 1 Citation |
| 4 | SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer. (He C, Danes JM, Hart PC, Zhu Y, Huang Y, de Abreu AL, O'Brien J, Mathison AJ, Tang B, Frasor JM, Wakefield LM, Ganini D, Stauder E, Zielonka J, Gantner BN, Urrutia RA, Gius D, Bonini MG) Proc Natl Acad Sci U S A 2019 Nov 19;116(47):23534-23541 62 Citations |
| 1 | Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial. (Ilson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, Van Cutsem E, Thuss-Patience P, Beretta GD, Mansoor W, Zhavrid E, Alsina M, George B, Catenacci D, McGuigan S, Makris L, Doi T, Shitara K) JAMA Oncol 2020 Jan 01;6(1):e193531 20 Citations |
| 6 | Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes. (Gong X, Hou Z, Endsley MP, Gronseth EI, Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, Gershan J, Deepak P, Geethadevi A, Chaluvally-Raghavan P, Fan Y, Harder DR, Ramchandran R, Wang L) NPJ Precis Oncol 2019;3:24 62 Citations |
| 3 | A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. (Nasief H, Zheng C, Schott D, Hall W, Tsai S, Erickson B, Allen Li X) NPJ Precis Oncol 2019;3:25 128 Citations |
| 1 | Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer. (Check DK, Winn AN, Fergestrom N, Reeder-Hayes KE, Neuner JM, Roberts AW) J Natl Cancer Inst 2020 Jul 01;112(7):765-768 9 Citations |
| 1 | Creating a bridge for transition: From pediatric cancer survival to life-long, risk-based health care of the adult cancer survivor. (Schwartz CL) Cancer 2020 Feb 01;126(3):473-476 2 Citations |
| 1 | High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature. (Kapke JT, Schneidewend RJ, Jawa ZA, Huang CC, Connelly JM, Chitambar CR) Hematol Oncol Stem Cell Ther 2019 Dec;12(4):189-193 28 Citations |
| 1 | Barriers and Facilitators of Colorectal Cancer Screening Among a Hispanic Community in Michigan. (Gonzalez JJ, Wahab A, Samalik J, Ramirez E, Saint-Phard T, Gonzalez E, Adekolujo OS) J Racial Ethn Health Disparities 2020 Feb;7(1):137-143 8 Citations |
| 1 | Effect of HER2 receptor expression on cardiac ejection fraction in cancer patients treated with trastuzumab. (Cole Lightfoot, Carolyn Oxencis, Elizabeth Weil, Angela Urmanksi, Briana Amundson, Lisa Rein, Sailaja Kamaraju) Open Journal of Cardiology and Heart Diseases DOI: 10.31031/OJCHD.2019.03.000554 |
| 1 | A psychosocial intervention’s impact on quality of life in ayas with cancer: A post hoc analysis from the promoting resilience in stress management (prism) randomized controlled trial (Steineck A, Bradford MC, Lau N, Scott S, Yi-Frazier JP, Rosenberg AR) Children November 2019;6(11) 27 Citations |
| 1 | Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study (Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C) Head and Neck 1 November 2019;41(11):3924-3932 9 Citations |
| 1 | Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator (Pan J, Zhang Q, Palen K, Wang L, Qiao L, Johnson B, Sei S, Shoemaker RH, Lubet RA, Wang Y, You M) EBioMedicine November 2019;49:72-81 45 Citations |
| 1 | Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers. (Paudyal R, Lu Y, Hatzoglou V, Moreira A, Stambuk HE, Oh JH, Cunanan KM, Aramburu Nunez D, Mazaheri Y, Gonen M, Ho A, Fagin JA, Wong RJ, Shaha A, Tuttle RM, Shukla-Dave A) NMR Biomed 2020 Jan;33(1):e4166 19 Citations |
| 1 | Examining key sociodemographic characteristics of adolescents and young adults with cancer: A post hoc analysis of the Promoting Resilience in Stress Management randomized clinical trial. (Lau N, Bradford MC, Steineck A, Scott S, Bona K, Yi-Frazier JP, McCauley E, Rosenberg AR) Palliat Med 2020 Mar;34(3):336-348 24 Citations |
| 1 | Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy. (Shee K, Wells JD, Jiang A, Miller TW) PLoS One 2019;14(11):e0224267 34 Citations |
| 3 | Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. (Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC) Ann Surg Oncol 2020 Apr;27(4):1156-1163 8 Citations |
| 1 | Understanding approaches to measurement and impact of depth of invasion of oral cavity cancers: A survey of American Head and Neck Society Membership. (Bulbul MG, Zenga J, Puram SV, Tarabichi O, Parikh AS, Varvares MA) Oral Oncol 2019 Dec;99:104461 11 Citations |
| 2 | Communication and Shared Decision Making in the Breast Cancer Treatment Consultation: A Comparative Analysis of English- and Spanish-Speaking Patients. (Schapira MM, Faghri A, Jacobs EA, Fletcher KE, Ganschow PS, Gil D, Smallwood AJ, Walker CM, Neuner JM) MDM Policy Pract 2019;4(2):2381468319881651 10 Citations |
| 4 | Exploring health behaviors, quality of life, and support needs in African-American prostate cancer survivors: a pilot study to support future interventions. (Stolley MR, Sheean P, Matthews L, Banerjee A, Visotcky A, Papanek P, Woodley L, Flynn KE) Support Care Cancer 2020 Jul;28(7):3135-3143 9 Citations |
| 1 | Emotional Communication in Advanced Pediatric Cancer Conversations. (Sisk BA, Friedrich AB, DuBois J, Mack JW) J Pain Symptom Manage 2020 Apr;59(4):808-817.e2 24 Citations |
| 2 | A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer. (Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA) Phys Imaging Radiat Oncol 2019 Oct;12:22-29 1 Citation |
| 6 | Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2020 Feb;24(2):235-242 10 Citations |
| 1 | Opportunities and Challenges of Genomically Guided Decision Making for Patients With Prostate Cancer. (Hall WA) Pract Radiat Oncol 2020;10(2):93-94 |
| 1 | The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. (Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ) Prev Med 2020 Feb;131:105931 11 Citations |
| 2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. (Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR) Abdom Radiol (NY) 2020 Mar;45(3):729-742 24 Citations |
| 3 | Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era. (Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS) Curr Oncol Rep 2019 Nov 25;21(12):104 4 Citations |
| 1 | Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer. (Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, Papageorge AG, Stachler MD, Liao J, Zhou J, Wu Z, Akarca FG, de Klerk LK, Derks S, Pierobon M, Hoadley KA, Wang TC, Church G, Wong KK, Petricoin EF, Cox AD, Lowy DR, Der CJ, Bass AJ) Cancer Discov 2020 Feb;10(2):288-305 116 Citations |
| 1 | Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer. (Patel H, Okamura R, Fanta P, Patel C, Lanman RB, Raymond VM, Kato S, Kurzrock R) J Hematol Oncol 2019 Dec 04;12(1):130 75 Citations |
| 1 | Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells. (Lupien LE, Bloch K, Dehairs J, Traphagen NA, Feng WW, Davis WL, Dennis T, Swinnen JV, Wells WA, Smits NC, Kuemmerle NB, Miller TW, Kinlaw WB) J Lipid Res 2020 Feb;61(2):205-218 34 Citations |
| 1 | Immunotherapy and targeted therapy-the new roadmap in cancer treatment. (Shahid K, Khalife M, Dabney R, Phan AT) Ann Transl Med 2019 Oct;7(20):595 |
| 4 | Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse. (Urrutia G, Salmonson A, Toro-Zapata J, de Assuncao TM, Mathison A, Dusetti N, Iovanna J, Urrutia R, Lomberk G) Mol Cancer Res 2020 Mar;18(3):448-462 13 Citations |
| 1 | Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. (Khaki AR, Li A, Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P) Cancer 2020 Mar 15;126(6):1208-1216 81 Citations |
| 1 | Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. (Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U, Zaky S, Devlin PM) Pract Radiat Oncol 2020;10(1):8-20 142 Citations |
| 1 | Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer. (Dashti S, Ghafouri-Fard S, Esfandi F, Oskooei VK, Arsang-Jang S, Taheri M) Exp Mol Pathol 2020 Feb;112:104359 12 Citations |
| 1 | Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer. (Shahjehan F, Kamatham S, Chandrasekharan C, Kasi PM) Drugs Today (Barc) 2019 Nov;55(11):683-693 11 Citations |
| 1 | New-onset persistent opioid use following breast cancer treatment in older adult women. (Roberts AW, Fergestrom N, Neuner JM, Winn AN) Cancer 2020 Feb 15;126(4):814-822 19 Citations |
| 2 | A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology. (Arispe Angulo KR, Jawa Z, Visotcky A, Majidi SS, Chitambar CR, Jorns JM) Histopathology 2020 Apr;76(5):661-670 2 Citations |
| 1 | Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer. (Goldman JW, Waterhouse DM, George B, O'Dwyer PJ, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, Kelly K) Front Oncol 2019;9:1256 11 Citations |
| 1 | Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model. (Berger A, Colpitts SJ, Seabrook MSS, Furlonger CL, Bendix MB, Moreau JM, McKillop WM, Medin JA, Paige CJ) J Immunother Cancer 2019 Dec 19;7(1):355 17 Citations |
| 1 | Contemporary utilization patterns and outcomes of thrombolytic administration for ischemic stroke among patients with cancer. (Owusu-Guha J, Guha A, Miller PE, Pawar S, Dey AK, Ahmad T, Attar H, Awan FT, Mitchell D, Desai NR, Addison D) Int J Stroke 2021 Feb;16(2):150-162 10 Citations |
| 7 | miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer. (Parashar D, Geethadevi A, Aure MR, Mishra J, George J, Chen C, Mishra MK, Tahiri A, Zhao W, Nair B, Lu Y, Mangala LS, Rodriguez-Aguayo C, Lopez-Berestein G, Camara AKS, Liang M, Rader JS, Ramchandran R, You M, Sood AK, Kristensen VN, Mills GB, Pradeep S, Chaluvally-Raghavan P) Cell Rep 2019 Dec 24;29(13):4389-4406.e10 63 Citations |
| 1 | Functional nanostructures for drug resistance breast cancer theranostics (Jagtap JM, Sharma G, Parchur AK) Nanomedicines for Breast Cancer Theranostics 1 January 2020:131-152 |
| 2 | Colorectal Cancer in Elderly Patients: Considerations in Treatment and Management (Peterson CY, Blank J, Ludwig K) Principles and Practice of Geriatric Surgery: Third Edition: With 261 Figures and 155 Tables 1 January 2020:903-929 2 Citations |
| 1 | Cell Cycle Arrest: An Impending Therapeutic Strategy to Curb Cancer (Kumar G, Mittal S, Parashar D, Jadhav K, Geethadevi A, Cheema PS, Tuli HS) Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 1 January 2020:45-63 2 Citations |
| 1 | Regulatory Roles of Autophagy in Cancer (Mittal S, Kumar G, Parashar D, Geethadevi A, Jadhav K, Balasubramani GL, Cheema PS, Srivastava CM, Tuli HS) Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 1 January 2020:89-107 3 Citations |
| 1 | Metastasis: A Major Driver of Cancer Pathogenesis (Cheema PS, Kumar G, Mittal S, Parashar D, Geethadevi A, Jadhav K, Tuli HS) Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 1 January 2020:185-211 4 Citations |
| 1 | Relationship of cisplatin-related adverse health outcomes with disability and unemployment among testicular cancer survivors (Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB) JNCI Cancer Spectrum 2020;4(4) 13 Citations |
| 1 | Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer (González-Martín A, Pothuri B, Vergote I, Christensen RDP, Graybill W, Mirza MR, Mccormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ) Obstetrical and Gynecological Survey 1 January 2020;75(1):29-31 2 Citations |
| 1 | Are cancer patients at higher risk of death with covid-19? (Adashek JJ, Hajjar J, Chemaly RF, Kurzrock R) Journal of Immunotherapy and Precision Oncology 2020;3(2):49-51 11 Citations |
| 1 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. (Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, Moradi Marjaneh M, Jiang X, Agata S, Aittomäki K, Alonso MR, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Aronson KJ, Arun BK, Auber B, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Beeghly-Fadiel A, Benitez J, Bermisheva M, Białkowska K, Blanco AM, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Bosse K, Brauch H, Brenner H, Briceno I, Brock IW, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldés T, Caligo MA, Camp NJ, Campbell I, Canzian F, Carroll JS, Carter BD, Castelao JE, Chiquette J, Christiansen H, Chung WK, Claes KBM, Clarke CL, GEMO Study Collaborators, EMBRACE Collaborators, Collée JM, Cornelissen S, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Domchek SM, Dörk T, Dos-Santos-Silva I, Droit A, Dubois S, Dumont M, Duran M, Durcan L, Dwek M, Eccles DM, Engel C, Eriksson M, Evans DG, Fasching PA, Fletcher O, Floris G, Flyger H, Foretova L, Foulkes WD, Friedman E, Fritschi L, Frost D, Gabrielson M, Gago-Dominguez M, Gambino G, Ganz PA, Gapstur SM, Garber J, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Tibiletti MG, Greene MH, Grip M, Gronwald J, Grundy A, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hartikainen JM, Hartman M, He W, Healey CS, Heemskerk-Gerritsen BAM, Heyworth J, Hillemanns P, Hogervorst FBL, Hollestelle A, Hooning MJ, Hopper JL, Howell A, Huang G, Hulick PJ, Imyanitov EN, KConFab Investigators, HEBON Investigators, ABCTB Investigators, Isaacs C, Iwasaki M, Jager A, Jakimovska M, Jakubowska A, James PA, Janavicius R, Jankowitz RC, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kang D, Kapoor PM, Karlan BY, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Kirk J, Kitahara CM, Ko YD, Konstantopoulou I, Kosma VM, Koutros S, Kubelka-Sabit K, Kwong A, Kyriacou K, Laitman Y, Lambrechts D, Lee E, Leslie G, Lester J, Lesueur F, Lindblom A, Lo WY, Long J, Lophatananon A, Loud JT, Lubiński J, MacInnis RJ, Maishman T, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Matsuo K, Maurer T, Mavroudis D, Mayes R, McGuffog L, McLean C, Mebirouk N, Meindl A, Miller A, Miller N, Montagna M, Moreno F, Muir K, Mulligan AM, Muñoz-Garzon VM, Muranen TA, Narod SA, Nassir R, Nathanson KL, Neuhausen SL, Nevanlinna H, Neven P, Nielsen FC, Nikitina-Zake L, Norman A, Offit K, Olah E, Olopade OI, Olsson H, Orr N, Osorio A, Pankratz VS, Papp J, Park SK, Park-Simon TW, Parsons MT, Paul J, Pedersen IS, Peissel B, Peshkin B, Peterlongo P, Peto J, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Prokofyeva D, Pujana MA, Pylkäs K, Radice P, Ramus SJ, Rantala J, Rau-Murthy R, Rennert G, Risch HA, Robson M, Romero A, Rossing M, Saloustros E, Sánchez-Herrero E, Sandler DP, Santamariña M, Saunders C, Sawyer EJ, Scheuner MT, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schöttker B, Schürmann P, Scott C, Scott RJ, Senter L, Seynaeve CM, Shah M, Sharma P, Shen CY, Shu XO, Singer CF, Slavin TP, Smichkoska S, Southey MC, Spinelli JJ, Spurdle AB, Stone J, Stoppa-Lyonnet D, Sutter C, Swerdlow AJ, Tamimi RM, Tan YY, Tapper WJ, Taylor JA, Teixeira MR, Tengström M, Teo SH, Terry MB, Teulé A, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Torres-Mejía G, Troester MA, Truong T, Tung N, Tzardi M, Ulmer HU, Vachon CM, van Asperen CJ, van der Kolk LE, van Rensburg EJ, Vega A, Viel A, Vijai J, Vogel MJ, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wildiers H, Winqvist R, Wolk A, Wu AH, Yannoukakos D, Zhang Y, Zheng W, Hunter D, Pharoah PDP, Chang-Claude J, García-Closas M, Schmidt MK, Milne RL, Kristensen VN, French ) Nat Genet 2020 Jan;52(1):56-73 119 Citations |
| 2 | Engaging young African American women breast cancer survivors: A novel storytelling approach to identify patient-centred research priorities. (Yan A, Millon-Underwood S, Walker A, Patten C, Nevels D, Dookeran K, Hennessy R, Knobloch MJ, Egede L, Stolley M) Health Expect 2020 Apr;23(2):473-482 10 Citations |
| 1 | American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. (Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava M) Brachytherapy 2020;19(2):127-138 24 Citations |
| 1 | The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments. (Boichard A, Richard SB, Kurzrock R) Cancers (Basel) 2020 Jan 09;12(1) 6 Citations |
| 1 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. (Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Børresen-Dale AL, Brauch H, Brenner H, Brucker SY, Burwinkel B, Caldas C, Canzian F, Chang-Claude J, Chanock SJ, Chin SF, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Devilee P, Dunn JA, Dunning AM, Dwek M, Earl HM, Eccles DM, Eliassen AH, Ellberg C, Evans DG, Fasching PA, Figueroa J, Flyger H, Gago-Dominguez M, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Giles GG, Goldgar DE, González-Neira A, Grip M, Guénel P, Guo Q, Haiman CA, Håkansson N, Hamann U, Harrington PA, Hiller L, Hooning MJ, Hopper JL, Howell A, Huang CS, Huang G, Hunter DJ, Jakubowska A, John EM, Kaaks R, Kapoor PM, Keeman R, Kitahara CM, Koppert LB, Kraft P, Kristensen VN, Lambrechts D, Le Marchand L, Lejbkowicz F, Lindblom A, Lubiński J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Maurer T, Mavroudis D, Meindl A, Milne RL, Mulligan AM, Neuhausen SL, Nevanlinna H, Newman WG, Olshan AF, Olson JE, Olsson H, Orr N, Peterlongo P, Petridis C, Prentice RL, Presneau N, Punie K, Ramachandran D, Rennert G, Romero A, Sachchithananthan M, Saloustros E, Sawyer EJ, Schmutzler RK, Schwentner L, Scott C, Simard J, Sohn C, Southey MC, Swerdlow AJ, Tamimi RM, Tapper WJ, Teixeira MR, Terry MB, Thorne H, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Turnbull C, Vachon CM, van der Kolk LE, Wang Q, Winqvist R, Wolk A, Yang XR, Ziogas A, Pharoah PDP, Hall P, Wessels LFA, Chenevix-Trench G, Bader GD, Dörk T, Easton DF, Canisius S, Schmidt MK) Nat Commun 2020 Jan 16;11(1):312 29 Citations |
| 1 | Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study. (Miller NJ, Khaki AR, Diamantopoulos LN, Bilen MA, Santos V, Agarwal N, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Lyman GH, Grivas P) J Urol 2020 Jul;204(1):63-70 40 Citations |
| 1 | The Utility of Digital Anal Rectal Examinations in a Public Health Screening Program for Anal Cancer. (Nyitray AG, D'Souza G, Stier EA, Clifford G, Chiao EY) J Low Genit Tract Dis 2020 Apr;24(2):192-196 29 Citations |
| 3 | Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. (Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B, Li XA) Front Oncol 2019;9:1464 40 Citations |
| 1 | What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. (Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC) Clin Colorectal Cancer 2020 Mar;19(1):e1-e7 17 Citations |
| 1 | Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications. (Moghadasi M, Alivand M, Fardi M, Moghadam KS, Solali S) Pathol Res Pract 2020 Mar;216(3):152827 16 Citations |
| 1 | Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. (Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, Lin CY, Lin YC, Chang PC, Lin SY, Chen Y) Sci Adv 2020 Jan;6(3):eaax5032 208 Citations |
| 1 | Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds. (Jardim DL, De Melo Gagliato D, Nikanjam M, Barkauskas DA, Kurzrock R) Oncoimmunology 2020;9(1):1710052 19 Citations |
| 1 | Percutaneous Cordotomy for Pain Palliation in Advanced Cancer: A Randomized Clinical Trial Study Protocol. (Viswanathan A, Vedantam A, Williams LA, Koyyalagunta D, Abdi S, Dougherty PM, Mendoza T, Bassett RL, Hou P, Bruera E) Neurosurgery 2020 Aug 01;87(2):394-402 4 Citations |
| 2 | Combined burden and functional impact tests for cancer driver discovery using DriverPower. (Shuai S, PCAWG Drivers and Functional Interpretation Working Group, Gallinger S, Stein LD, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):734 28 Citations |
| 2 | Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. (Rubanova Y, Shi R, Harrigan CF, Li R, Wintersinger J, Sahin N, Deshwar AG, PCAWG Evolution and Heterogeneity Working Group, Morris QD, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):731 31 Citations |
| 2 | Inferring structural variant cancer cell fraction. (Cmero M, Yuan K, Ong CS, Schröder J, PCAWG Evolution and Heterogeneity Working Group, Corcoran NM, Papenfuss T, Hovens CM, Markowetz F, Macintyre G, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):730 34 Citations |
| 2 | High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations. (Zhang Y, Chen F, Fonseca NA, He Y, Fujita M, Nakagawa H, Zhang Z, Brazma A, PCAWG Transcriptome Working Group, PCAWG Structural Variation Working Group, Creighton CJ, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):736 58 Citations |
| 2 | Pathway and network analysis of more than 2500 whole cancer genomes. (Reyna MA, Haan D, Paczkowska M, Verbeke LPC, Vazquez M, Kahraman A, Pulido-Tamayo S, Barenboim J, Wadi L, Dhingra P, Shrestha R, Getz G, Lawrence MS, Pedersen JS, Rubin MA, Wheeler DA, Brunak S, Izarzugaza JMG, Khurana E, Marchal K, von Mering C, Sahinalp SC, Valencia A, PCAWG Drivers and Functional Interpretation Working Group, Reimand J, Stuart JM, Raphael BJ, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):729 73 Citations |
| 2 | Genomic footprints of activated telomere maintenance mechanisms in cancer. (Sieverling L, Hong C, Koser SD, Ginsbach P, Kleinheinz K, Hutter B, Braun DM, Cortés-Ciriano I, Xi R, Kabbe R, Park PJ, Eils R, Schlesner M, PCAWG-Structural Variation Working Group, Brors B, Rippe K, Jones DTW, Feuerbach L, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):733 83 Citations |
| 2 | A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. (Jiao W, Atwal G, Polak P, Karlic R, Cuppen E, PCAWG Tumor Subtypes and Clinical Translation Working Group, Danyi A, de Ridder J, van Herpen C, Lolkema MP, Steeghs N, Getz G, Morris QD, Stein LD, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):728 139 Citations |
| 2 | Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. (Carlevaro-Fita J, Lanzós A, Feuerbach L, Hong C, Mas-Ponte D, Pedersen JS, PCAWG Drivers and Functional Interpretation Group, Johnson R, PCAWG Consortium) Commun Biol 2020 Feb 05;3(1):56 153 Citations |
| 2 | Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. (Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ, Chin L, Dixon JR, Futreal PA, PCAWG Structural Variation Working Group, PCAWG Consortium) Nat Genet 2020 Mar;52(3):294-305 172 Citations |
| 2 | The landscape of viral associations in human cancers. (Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H, PCAWG Pathogens, Cooper CS, Eils R, Ferretti V, Lichter P, PCAWG Consortium) Nat Genet 2020 Mar;52(3):320-330 266 Citations |
| 2 | Comprehensive molecular characterization of mitochondrial genomes in human cancers. (Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H, PCAWG Consortium) Nat Genet 2020 Mar;52(3):342-352 269 Citations |
| 2 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. (Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, Detering H, Li Y, Rodriguez-Castro J, Dueso-Barroso A, Bruzos AL, Dentro SC, Blanco MG, Contino G, Ardeljan D, Tojo M, Roberts ND, Zumalave S, Edwards PA, Weischenfeldt J, Puiggròs M, Chong Z, Chen K, Lee EA, Wala JA, Raine KM, Butler A, Waszak SM, Navarro FCP, Schumacher SE, Monlong J, Maura F, Bolli N, Bourque G, Gerstein M, Park PJ, Wedge DC, Beroukhim R, Torrents D, Korbel JO, Martincorena I, Fitzgerald RC, Van Loo P, Kazazian HH, Burns KH, PCAWG Structural Variation Working Group, Campbell PJ, Tubio JMC, PCAWG Consortium) Nat Genet 2020 Mar;52(3):306-319 274 Citations |
| 2 | Genomic basis for RNA alterations in cancer. (PCAWG Transcriptome Core Group, Calabrese C, Davidson NR, Demircioğlu D, Fonseca NA, He Y, Kahles A, Lehmann KV, Liu F, Shiraishi Y, Soulette CM, Urban L, Greger L, Li S, Liu D, Perry MD, Xiang Q, Zhang F, Zhang J, Bailey P, Erkek S, Hoadley KA, Hou Y, Huska MR, Kilpinen H, Korbel JO, Marin MG, Markowski J, Nandi T, Pan-Hammarström Q, Pedamallu CS, Siebert R, Stark SG, Su H, Tan P, Waszak SM, Yung C, Zhu S, Awadalla P, Creighton CJ, Meyerson M, Ouellette BFF, Wu K, Yang H, PCAWG Transcriptome Working Group, Brazma A, Brooks AN, Göke J, Rätsch G, Schwarz RF, Stegle O, Zhang Z, PCAWG Consortium) Nature 2020 Feb;578(7793):129-136 298 Citations |
| 2 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. (Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, Shuai S, Lanzós A, Herrmann C, Maruvka YE, Shen C, Amin SB, Bandopadhayay P, Bertl J, Boroevich KA, Busanovich J, Carlevaro-Fita J, Chakravarty D, Chan CWY, Craft D, Dhingra P, Diamanti K, Fonseca NA, Gonzalez-Perez A, Guo Q, Hamilton MP, Haradhvala NJ, Hong C, Isaev K, Johnson TA, Juul M, Kahles A, Kahraman A, Kim Y, Komorowski J, Kumar K, Kumar S, Lee D, Lehmann KV, Li Y, Liu EM, Lochovsky L, Park K, Pich O, Roberts ND, Saksena G, Schumacher SE, Sidiropoulos N, Sieverling L, Sinnott-Armstrong N, Stewart C, Tamborero D, Tubio JMC, Umer HM, Uusküla-Reimand L, Wadelius C, Wadi L, Yao X, Zhang CZ, Zhang J, Haber JE, Hobolth A, Imielinski M, Kellis M, Lawrence MS, von Mering C, Nakagawa H, Raphael BJ, Rubin MA, Sander C, Stein LD, Stuart JM, Tsunoda T, Wheeler DA, Johnson R, Reimand J, Gerstein M, Khurana E, Campbell PJ, López-Bigas N, PCAWG Drivers and Functional Interpretation Working Group, PCAWG Structural Variation Working Group, Weischenfeldt J, Beroukhim R, Martincorena I, Pedersen JS, Getz G, PCAWG Consortium) Nature 2020 Feb;578(7793):102-111 396 Citations |
| 2 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. (Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, Gordenin D, Klimczak LJ, Zhang CZ, Pellman DS, PCAWG Structural Variation Working Group, Park PJ, PCAWG Consortium) Nat Genet 2020 Mar;52(3):331-341 439 Citations |
| 2 | Patterns of somatic structural variation in human cancer genomes. (Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, Imielinski M, PCAWG Structural Variation Working Group, Weischenfeldt J, Beroukhim R, Campbell PJ, PCAWG Consortium) Nature 2020 Feb;578(7793):112-121 499 Citations |
| 2 | The evolutionary history of 2,658 cancers. (Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD, PCAWG Evolution & Heterogeneity Working Group, Spellman PT, Wedge DC, Van Loo P, PCAWG Consortium) Nature 2020 Feb;578(7793):122-128 644 Citations |
| 2 | The repertoire of mutational signatures in human cancer. (Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, Islam SMA, Lopez-Bigas N, Klimczak LJ, McPherson JR, Morganella S, Sabarinathan R, Wheeler DA, Mustonen V, PCAWG Mutational Signatures Working Group, Getz G, Rozen SG, Stratton MR, PCAWG Consortium) Nature 2020 Feb;578(7793):94-101 2057 Citations |
| 2 | Pan-cancer analysis of whole genomes. (ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium) Nature 2020 Feb;578(7793):82-93 1892 Citations |
| 8 | ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis. (Chen C, Gupta P, Parashar D, Nair GG, George J, Geethadevi A, Wang W, Tsaih SW, Bradley W, Ramchandran R, Rader JS, Chaluvally-Raghavan P, Pradeep S) Oncogene 2020 Apr;39(14):2921-2933 34 Citations |
| 1 | Lymphocytic mastitis mimicking breast cancer in an elderly woman. (Wang L, Jorns JM) Breast J 2020 Jul;26(7):1414-1415 |
| 1 | Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers. (Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H, PCAWG Consortium) Nat Genet 2023 May;55(5):893 1 Citation |
| 1 | ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells. (Dausinas P, Pulakanti K, Rao S, Cole JM, Dahl R, Cowden Dahl KD) Gene 2020 May 15;738:144458 21 Citations |
| 2 | Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. (Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B) Pract Radiat Oncol 2020;10(6):e495-e507 55 Citations |
| 1 | The paradox of cancer genes in non-malignant conditions: implications for precision medicine. (Adashek JJ, Kato S, Lippman SM, Kurzrock R) Genome Med 2020 Feb 17;12(1):16 33 Citations |
| 4 | Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. (Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN) J Surg Oncol 2020 May;121(6):975-983 7 Citations |
| 1 | Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors. (Cohen PR, Kurzrock R) J Am Acad Dermatol 2020 Jun;82(6):e253-e254 8 Citations |
| 1 | Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer. (Kamatham S, Shahjehan F, Kasi PM) Front Pharmacol 2020;11:23 7 Citations |
| 1 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. (Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barnes DR, Barrowdale D, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Białkowska K, Blanco A, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brüning T, Burwinkel B, Cai Q, Caldés T, Caligo MA, Campbell I, Canisius S, Campa D, Carter BD, Carter J, Castelao JE, Chang-Claude J, Chanock SJ, Christiansen H, Chung WK, Claes KBM, Clarke CL, GEMO Study Collaborators, EMBRACE Collaborators, GC-HBOC study Collaborators, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Daly MB, de la Hoya M, De Leeneer K, Dennis J, Devilee P, Diez O, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Ejlertsen B, Ellberg C, Engel C, Eriksson M, Fasching PA, Fletcher O, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gabrielson M, Ganz PA, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Haiman CA, Hall P, Hamann U, Hake C, He W, Heyworth J, Hogervorst FBL, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Huang G, Hulick PJ, Humphreys K, Imyanitov EN, ABCTB Investigators, HEBON Investigators, BCFR Investigators, OCGN Investigators, Isaacs C, Jakimovska M, Jakubowska A, James P, Janavicius R, Jankowitz RC, John EM, Johnson N, Joseph V, Jung A, Karlan BY, Khusnutdinova E, Kiiski JI, Konstantopoulou I, Kristensen VN, Laitman Y, Lambrechts D, Lazaro C, Leroux D, Leslie G, Lester J, Lesueur F, Lindor N, Lindström S, Lo WY, Loud JT, Lubiński J, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martens JWM, Martinez ME, Matricardi L, Maurer T, Mavroudis D, McGuffog L, Meindl A, Menon U, Michailidou K, Kapoor PM, Miller A, Montagna M, Moreno F, Moserle L, Mulligan AM, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Nevelsteen I, Nielsen FC, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Olsson H, Osorio A, Papp J, Park-Simon TW, Parsons MT, Pedersen IS, Peixoto A, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Plaseska-Karanfilska D, Poppe B, Pradhan N, Prajzendanc K, Presneau N, Punie K, Pylkäs K, Radice P, Rantala J, Rashid MU, Rennert G, Risch HA, Robson M, Romero A, Saloustros E, Sandler DP, Santos C, Sawyer EJ, Schmidt MK, Schmidt DF, Schmutzler RK, Schoemaker MJ, Scott RJ, Sharma P, Shu XO, Simard J, Singer CF, Skytte AB, Soucy P, Southey MC, Spinelli JJ, Spurdle AB, Stone J, Swerdlow AJ, Tapper WJ, Taylor JA, Teixeira MR, Terry MB, Teulé A, Thomassen M, Thöne K, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Torres D, Truong T, Tung N, Vachon CM, van Asperen CJ, van den Ouweland AMW, van Rensburg EJ, Vega A, Viel A, Vieiro-Balo P, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Winqvist R, Yang XR, Yannoukakos D, Ziogas A, Milne RL, Easton DF, Chenevix-Trench G, Zheng W, Kraft P, Jiang X) Genet Epidemiol 2020 Jul;44(5):442-468 32 Citations |
| 1 | Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence. (Haskins CB, Neuner JM, McDowell BD, Carnahan RM, Fiedorowicz JG, Wallace RB, Smith BJ, Chrischilles EA) Clin Breast Cancer 2020 Jun;20(3):e261-e280 2 Citations |
| 1 | A mechanism for the response of KRASG13D expressing colorectal cancers to EGFR inhibitors. (McFall T, Stites EC) Mol Cell Oncol 2020;7(2):1701914 10 Citations |
| 1 | Tumor slice culture as a biologic surrogate of human cancer. (Kenerson HL, Sullivan KM, Seo YD, Stadeli KM, Ussakli C, Yan X, Lausted C, Pillarisetty VG, Park JO, Riehle KJ, Yeh M, Tian Q, Yeung RS) Ann Transl Med 2020 Feb;8(4):114 |
| 1 | Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden. (Bieg-Bourne CC, Okamura R, Kurzrock R) Mol Oncol 2020 Jun;14(6):1242-1251 15 Citations |
| 3 | The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence. (Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM) Pharmacoepidemiol Drug Saf 2020 May;29(5):550-557 3 Citations |
| 1 | Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer. (Du M, Tian Y, Tan W, Wang L, Wang L, Kilari D, Huang CC, Wang L, Kohli M) Prostate Cancer Prostatic Dis 2020 Dec;23(4):705-713 18 Citations |
| 4 | RNA Sequencing Reveals Cancer-Associated Changes in Laryngeal Cells Exposed to Non-Acid Pepsin. (Samuels TL, Zimmermann MT, Zeighami A, Demos W, Southwood JE, Blumin JH, Bock JM, Johnston N) Laryngoscope 2021 Jan;131(1):121-129 30 Citations |
| 1 | Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. (Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE) JAMA Oncol 2020 May 01;6(5):735-743 75 Citations |
| 1 | Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline. (Simone CB 2nd, Bogart JA, Cabrera AR, Daly ME, DeNunzio NJ, Detterbeck F, Faivre-Finn C, Gatschet N, Gore E, Jabbour SK, Kruser TJ, Schneider BJ, Slotman B, Turrisi A, Wu AJ, Zeng J, Rosenzweig KE) Pract Radiat Oncol 2020;10(3):158-173 142 Citations |
| 1 | Dendrimer–didox nanocomplex for enhanced anticancer activity (Kaul M, Alhajala H, Chitambar CR, Chauhan A) Journal of Nanoparticle Research 1 April 2020;22(4) 2 Citations |
| 1 | Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity. (Kamaraju S, Drope J, Sankaranarayanan R, Shastri S) Am Soc Clin Oncol Educ Book 2020 Mar;40:1-12 |
| 4 | H+/K+ATPase Expression in the Larynx of Laryngopharyngeal Reflux and Laryngeal Cancer Patients. (McCormick CA, Samuels TL, Battle MA, Frolkis T, Blumin JH, Bock JM, Wells C, Yan K, Altman KW, Johnston N) Laryngoscope 2021 Jan;131(1):130-135 16 Citations |
| 1 | Review of precision cancer medicine: Evolution of the treatment paradigm. (Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R) Cancer Treat Rev 2020 Jun;86:102019 448 Citations |
| 5 | Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I. (Zhang Q, Cheng G, Pan J, Zielonka J, Xiong D, Myers CR, Feng L, Shin SS, Kim YH, Bui D, Hu M, Bennett B, Schmainda K, Wang Y, Kalyanaraman B, You M) Cell Commun Signal 2020 Apr 07;18(1):58 25 Citations |
| 4 | Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer. (Palangmonthip W, Wu R, Tarima S, Bobholz SA, LaViolette PS, Gallan AJ, Iczkowski KA) Prostate 2020 Jun;80(9):687-697 5 Citations |
| 1 | Advance Care Planning in Cancer: Patient Preferences for Personnel and Timing. (Kubi B, Istl AC, Lee KT, Conca-Cheng A, Johnston FM) JCO Oncol Pract 2020 Sep;16(9):e875-e883 46 Citations |
| 1 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline
resectable pancreatic cancer (Chad A. Barnes, MD, Mohammed Aldakkak, MD, Kathleen K. Christians, MD,
Callisia N. Clarke, MD, MS, Kulwinder Dua, MD, Ben George, MD, Paul S. Ritch, MD,
Mandana Kamgar, MD, William A. Hall, MD, Naveen Kulkarni, MD,
Beth A. Erickson, MD, Douglas B. Evans, MD, Susan Tsai, MD, MHS,) Elsevier |
| 1 | Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study. (Li Q, He Z, Guo Y, Zhang H, George TJ, Hogan W, Charness N, Bian J) AMIA Annu Symp Proc 2019;2019:1101-1110 9 Citations |
| 1 | Identifying Cancer Patients at Risk for Heart Failure Using Machine Learning Methods. (Yang X, Gong Y, Waheed N, March K, Bian J, Hogan WR, Wu Y) AMIA Annu Symp Proc 2019;2019:933-941 14 Citations |
| 1 | Author Correction: Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. (Zhou Y, Gerrard DL, Wang J, Li T, Yang Y, Fritz AJ, Rajendran M, Fu X, Stein G, Schiff R, Lin S, Frietze S, Jin VX) Nat Commun 2020 Apr 20;11(1):1967 1 Citation |
| 4 | Team triathlon effects on physiological, psychological, and immunological measures in women breast cancer survivors. (Tjoe JA, Piacentine LB, Papanek PE, Raff H, Richards J, Harkins AL, Yin J, Ng AV) Support Care Cancer 2020 Dec;28(12):6095-6104 7 Citations |
| 6 | Developmental differences in health-related quality of life in adolescent and young adult cancer survivors. (Becktell K, Simpson P, Phelan R, Schmidt D, Anderson L, Nichols J, Bingen K) Qual Life Res 2020 Sep;29(9):2435-2444 5 Citations |
| 1 | Flavonoid-Based Cancer Therapy: An Updated Review. (Hosseinzadeh E, Hassanzadeh A, Marofi F, Alivand MR, Solali S) Anticancer Agents Med Chem 2020;20(12):1398-1414 35 Citations |
| 1 | AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. (Hampsch RA, Wells JD, Traphagen NA, McCleery CF, Fields JL, Shee K, Dillon LM, Pooler DB, Lewis LD, Demidenko E, Huang YH, Marotti JD, Goen AE, Kinlaw WB, Miller TW) Clin Cancer Res 2020 Jul 15;26(14):3707-3719 64 Citations |
| 4 | Adolescents and Young Adults with Cancer Using a Symptom Heuristics App: Provider Perceptions and Actions. (Macpherson CF, Stegenga K, Erickson JM, Linder LA, Newman AR, Elswick RK, Charlson J, Thomas S, Ameringer S) J Adolesc Young Adult Oncol 2020 Oct;9(5):579-585 3 Citations |
| 1 | Ethical framework for head and neck cancer care impacted by COVID-19. (Shuman AG, Campbell BH, AHNS Ethics & Professionalism Service) Head Neck 2020 Jun;42(6):1214-1217 24 Citations |
| 2 | Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain. (Thies KA, Hammer AM, Hildreth BE 3rd, Steck SA, Spehar JM, Kladney RD, Geisler JA, Das M, Russell LO, Bey JF 4th, Bolyard CM, Pilarski R, Trimboli AJ, Cuitiño MC, Koivisto CS, Stover DG, Schoenfield L, Otero J, Godbout JP, Chakravarti A, Ringel MD, Ramaswamy B, Li Z, Kaur B, Leone G, Ostrowski MC, Sizemore ST, Sizemore GM) Cancer Res 2021 Feb 01;81(3):606-618 37 Citations |
| 4 | Variant anatomy of the biliary system as a cause of pancreatic and peri-ampullary cancers. (Muraki T, Reid MD, Pehlivanoglu B, Gonzalez RS, Sekhar A, Memis B, Xue Y, Cheng J, Jang KT, Mittal P, Cardona K, Kooby DA, Maithel S, Sarmiento JM, El-Rayes B, Lomberk G, Urrutia RA, Christians K, Tsai S, Evans DB, Adsay V) HPB (Oxford) 2020 Dec;22(12):1675-1685 11 Citations |
| 1 | Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199). (Mai PL, Miller A, Gail MH, Skates S, Lu K, Sherman ME, Ioffe OB, Rodriguez G, Cohn DE, Boggess J, Rutherford T, Kauff ND, Rader JS, Phillips KA, DiSilvestro PA, Olawaiye AB, Ridgway MR, Greene MH, Piedmonte M, Walker JL) JNCI Cancer Spectr 2020 Feb;4(1):pkz075 15 Citations |
| 1 | Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research. (Yabroff KR, Reeder-Hayes K, Zhao J, Halpern MT, Lopez AM, Bernal-Mizrachi L, Collier AB, Neuner J, Phillips J, Blackstock W, Patel M) J Natl Cancer Inst 2020 Jul 01;112(7):671-687 85 Citations |
| 1 | Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers. (Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H, PCAWG Consortium) Nat Genet 2023 May;55(5):892 2 Citations |
| 1 | Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Radiother Oncol 2020 May;146:223-229 152 Citations |
| 1 | Are Cancer Patients at Higher Risk of Death With COVID-19? (Adashek JJ, Hajjar J, Chemaly RF, Kurzrock R) J Immunother Precis Oncol 2020 May;3(2):49-51 11 Citations |
| 7 | Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:460 23 Citations |
| 1 | Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Radiotherapy and Oncology May 2020;146:223-229 152 Citations |
| 8 | Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB (Oxford) 2020 Dec;22(12):1745-1752 2 Citations |
| 1 | Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. (Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B) J Surg Oncol 2020 Sep;122(3):495-505 11 Citations |
| 2 | Feasibility and acceptability of a game-based symptom-reporting app for children with cancer: perspectives of children and parents. (Linder LA, Newman AR, Stegenga K, Chiu YS, Wawrzynski SE, Kramer H, Weir C, Narus S, Altizer R) Support Care Cancer 2021 Jan;29(1):301-310 25 Citations |
| 1 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. (Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q, Jung A, Abu-Ful Z, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Freeman LEB, Becher H, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernstein L, Bojesen SE, Brauch H, Brenner H, Brüning T, Cai Q, Campa D, Canzian F, Carracedo A, Carter BD, Castelao JE, Chanock SJ, Chatterjee N, Chenevix-Trench G, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Dai JY, Earp HS, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fritschi L, Gabrielson M, Gago-Dominguez M, Gao C, Gapstur SM, Gaudet MM, Giles GG, González-Neira A, Guénel P, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Hatse S, Heyworth J, Holleczek B, Hoover RN, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab/AOCS Investigators, John EM, Jones ME, Kaaks R, Keeman R, Kitahara CM, Ko YD, Koutros S, Kurian AW, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Linet M, Lissowska J, Llaneza A, MacInnis RJ, Martinez ME, Maurer T, McLean C, Neuhausen SL, Newman WG, Norman A, O'Brien KM, Olshan AF, Olson JE, Olsson H, Orr N, Perou CM, Pita G, Polley EC, Prentice RL, Rennert G, Rennert HS, Ruddy KJ, Sandler DP, Saunders C, Schoemaker MJ, Schöttker B, Schumacher F, Scott C, Scott RJ, Shu XO, Smeets A, Southey MC, Spinelli JJ, Stone J, Swerdlow AJ, Tamimi RM, Taylor JA, Troester MA, Vachon CM, van Veen EM, Wang X, Weinberg CR, Weltens C, Willett W, Winham SJ, Wolk A, Yang XR, Zheng W, Ziogas A, Dunning AM, Pharoah PDP, Schmidt MK, Kraft P, Easton DF, Milne RL, García-Closas M, Chang-Claude J) J Natl Cancer Inst 2021 Mar 01;113(3):329-337 42 Citations |
| 1 | Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis. (El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau MR) Clin Gastroenterol Hepatol 2021 May;19(5):1067-1070.e2 15 Citations |
| 8 | Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 12 Citations |
| 1 | Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells. (Pan P, Zhu Z, Oshima K, Aldakkak M, Tsai S, Huang YW, Dong W, Zhang J, Lin CW, Wang Y, Yearsley M, Yu J, Wang LS) Food Front 2020 Mar;1(1):70-82 12 Citations |
| 1 | Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. (Sapienza LG, Ning MS, de la Pena R, McNew LK, Jhingran A, Georgeon L, Rasool N, Gomes MJL, Abu-Isa E, Baiocchi G) Int J Gynecol Cancer 2020 Oct;30(10):1535-1541 5 Citations |
| 4 | Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. (Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC) J Surg Oncol 2020 Aug;122(2):176-182 11 Citations |
| 1 | Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation. (Kmak JA, Agarwal N, He Y, Heilmann AM, Miller VA, Ross JS, Pal SK, Ali SM, Kilari D) Case Rep Oncol 2020;13(1):456-461 2 Citations |
| 1 | BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer. (Kasi PM, Kamatham S, Shahjehan F, Li Z, Johnson PW, Merchea A, Colibaseanu DT) J Gastrointest Oncol 2020 Apr;11(2):236-241 11 Citations |
| 1 | Reciprocal fine-tuning of progesterone and prolactin-regulated gene expression in breast cancer cells. (Holloran SM, Nosirov B, Walter KR, Trinca GM, Lai Z, Jin VX, Hagan CR) Mol Cell Endocrinol 2020 Jul 01;511:110859 6 Citations |
| 4 | Facilitators of behavior change and weight loss in an intervention for African American Breast Cancer Survivors. (Kwarteng JL, Beyer KMM, Banerjee A, Stolley MR) Cancer Causes Control 2020 Aug;31(8):737-747 14 Citations |
| 2 | From Theory to Practice: Implementation of Strategies to Reduce Acute Care Visits in Patients With Cancer. (Daly B, Michaelis LC, Sprandio JD, Kapke JT, Narra RK, Malosh E, Zervoudakis A, Holland J, Zablocki M) Am Soc Clin Oncol Educ Book 2020 May;40:85-94 |
| 1 | Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. (Bi M, Zhang Z, Jiang YZ, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang TH, Shao ZM, Schiff R, Chen L, Liu Z) Nat Cell Biol 2020 Jun;22(6):701-715 93 Citations |
| 1 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. (Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Arun BK, Auer PL, Azzollini J, Barrowdale D, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bialkowska K, Blanco A, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Bondavalli D, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brucker SY, Brüning T, Burwinkel B, Buys SS, Byers H, Caldés T, Caligo MA, Calvello M, Campa D, Castelao JE, Chang-Claude J, Chanock SJ, Christiaens M, Christiansen H, Chung WK, Claes KBM, Clarke CL, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Diez O, Domchek SM, Dörk T, Dwek M, Eccles DM, Ekici AB, Evans DG, Fasching PA, Figueroa J, Foretova L, Fostira F, Friedman E, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, García-Sáenz JA, Gaudet MM, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Häberle L, Hahnen E, Haiman CA, Hake CR, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huebner H, Hulick PJ, Imyanitov EN, kConFab Investigators, ABCTB Investigators, Isaacs C, Izatt L, Jager A, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khan S, Khusnutdinova E, Kitahara CM, Ko YD, Konstantopoulou I, Koppert LB, Koutros S, Kristensen VN, Laenkholm AV, Lambrechts D, Larsson SC, Laurent-Puig P, Lazaro C, Lazarova E, Lejbkowicz F, Leslie G, Lesueur F, Lindblom A, Lissowska J, Lo WY, Loud JT, Lubinski J, Lukomska A, MacInnis RJ, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Matricardi L, McGuffog L, McLean C, Mebirouk N, Meindl A, Menon U, Miller A, Mingazheva E, Montagna M, Mulligan AM, Mulot C, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen FC, Nikitina-Zake L, Nodora J, Offit K, Olah E, Olopade OI, Olsson H, Orr N, Papi L, Papp J, Park-Simon TW, Parsons MT, Peissel B, Peixoto A, Peshkin B, Peterlongo P, Peto J, Phillips KA, Piedmonte M, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Prokofyeva D, Rack B, Radice P, Ramus SJ, Rantala J, Rashid MU, Rennert G, Rennert HS, Risch HA, Romero A, Rookus MA, Rübner M, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Scheuner MT, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schöttker B, Schürmann P, Senter L, Sharma P, Sherman ME, Shu XO, Singer CF, Smichkoska S, Soucy P, Southey MC, Spinelli JJ, Stone J, Stoppa-Lyonnet D, EMBRACE Study, GEMO Study Collaborators, Swerdlow AJ, Szabo CI, Tamimi RM, Tapper WJ, Taylor JA, Teixeira MR, Terry M, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van den Ouweland AMW, van der Kolk LE, van Veen EM, vanRensburg EJ, Vega A, Wappenschmidt B, Weinberg CR, Weitzel JN, Wildiers H, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zheng W, Zorn KK, Milne RL, Kraft P, Simard J, Pharoah PDP, Michailidou K, Antoniou AC, Schmidt MK, Chenevix-Trench G, Easton DF, Chatterjee N, García-Closas M) Nat Genet 2020 Jun;52(6):572-581 290 Citations |
| 1 | In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples. (Dashti S, Taherian-Esfahani Z, Kholghi-Oskooei V, Noroozi R, Arsang-Jang S, Ghafouri-Fard S, Taheri M) Sci Rep 2020 May 20;10(1):8316 23 Citations |
| 1 | Parental Status in Treatment Decision Making among Women with Nonmetastatic Breast Cancer. (Jewett PI, Vogel RI, Schroeder MC, Neuner JM, Blaes AH) Med Decis Making 2020 May;40(4):540-544 |
| 1 | Wellness Coaching: An Intervention to Increase Healthy Behavior in Breast Cancer Survivors. (Stan DL, Cutshall SM, Adams TF, Ghosh K, Clark MM, Wieneke KC, Kebede EB, Donelan Dunlap BJ, Ruddy KJ, Hazelton JK, Butts AM, Jenkins SM, Croghan IT, Bauer BA) Clin J Oncol Nurs 2020 Jun 01;24(3):305-315 15 Citations |
| 1 | Delving deeper into disparity: The impact of health literacy on the surgical care of breast cancer patients. (Portelli Tremont JN, Downs-Canner S, Maduekwe U) Am J Surg 2020 Oct;220(4):806-810 12 Citations |
| 1 | Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. (Nyquist MD, Corella A, Coleman I, De Sarkar N, Kaipainen A, Ha G, Gulati R, Ang L, Chatterjee P, Lucas J, Pritchard C, Risbridger G, Isaacs J, Montgomery B, Morrissey C, Corey E, Nelson PS) Cell Rep 2020 May 26;31(8):107669 178 Citations |
| 1 | Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood (Pulliero A, You M, Chaluvally-Raghavan P, Marengo B, Domenicotti C, Banelli B, Degan P, Molfetta L, Gianiorio F, Izzotti A) Oncotarget 1 June 2020;11(22):2106-2119 11 Citations |
| 1 | Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Pract Radiat Oncol 2020;10(4):220-234 158 Citations |
| 1 | De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies. (Mehanna H, Rischin D, Wong SJ, Gregoire V, Ferris R, Waldron J, Le QT, Forster M, Gillison M, Laskar S, Tahara M, Psyrri A, Vermorken J, Porceddu S) J Clin Oncol 2020 Aug 01;38(22):2552-2557 66 Citations |
| 1 | Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer. (Zhang Z, Yu W, Tang D, Zhou Y, Bi M, Wang H, Zheng Y, Chen M, Li L, Xu X, Zhang W, Tao H, Jin VX, Liu Z, Chen L) RNA Biol 2020 Nov;17(11):1590-1602 10 Citations |
| 1 | Early stage triple negative breast cancer: Management and future directions. (Chaudhary LN) Semin Oncol 2020 Aug;47(4):201-208 31 Citations |
| 1 | Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells. (Che M, Kweon SM, Teo JL, Yuan YC, Melstrom LG, Waldron RT, Lugea A, Urrutia RA, Pandol SJ, Lai KKY) Cancers (Basel) 2020 Jun 05;12(6) 15 Citations |
| 1 | RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity. (Ansa-Addo EA, Huang HC, Riesenberg B, Iamsawat S, Borucki D, Nelson MH, Nam JH, Chung D, Paulos CM, Liu B, Yu XZ, Philpott C, Howe PH, Li Z) Sci Adv 2020 May;6(22):eaaz3865 31 Citations |
| 4 | Qualitative Assessment of Unmet Information Management Needs of Informal Cancer Caregivers: Four Themes to Inform Oncology Practice. (Crotty BH, Asan O, Holt J, Tyszka J, Erickson J, Stolley M, Pezzin LE, Nattinger AB) JCO Clin Cancer Inform 2020 Jun;4:521-528 8 Citations |
| 1 | Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model. (Alson D, Schuyler SC, Yan BX, Samimuthu K, Qiu JT) Front Immunol 2020;11:927 9 Citations |
| 1 | Computational Modeling of Interstitial Fluid Pressure and Velocity in Head and Neck Cancer Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Feasibility Analysis. (LoCastro E, Paudyal R, Mazaheri Y, Hatzoglou V, Oh JH, Lu Y, Konar AS, Vom Eigen K, Ho A, Ewing JR, Lee N, Deasy JO, Shukla-Dave A) Tomography 2020 Jun;6(2):129-138 19 Citations |
| 1 | Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood. (Pulliero A, You M, Chaluvally-Raghavan P, Marengo B, Domenicotti C, Banelli B, Degan P, Molfetta L, Gianiorio F, Izzotti A) Oncotarget 2020 Jun 02;11(22):2106-2119 11 Citations |
| 8 | Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer. (Bobholz SA, Lowman AK, Barrington A, Brehler M, McGarry S, Cochran EJ, Connelly J, Mueller WM, Agarwal M, O'Neill D, Nencka AS, Banerjee A, LaViolette PS) Tomography 2020 Jun;6(2):160-169 33 Citations |
| 1 | Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers. (Ozkan-Dagliyan I, Diehl JN, George SD, Schaefer A, Papke B, Klotz-Noack K, Waters AM, Goodwin CM, Gautam P, Pierobon M, Peng S, Gilbert TSK, Lin KH, Dagliyan O, Wennerberg K, Petricoin EF 3rd, Tran NL, Bhagwat SV, Tiu RV, Peng SB, Herring LE, Graves LM, Sers C, Wood KC, Cox AD, Der CJ) Cell Rep 2020 Jun 16;31(11):107764 67 Citations |
| 2 | Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer. (Annapragada A, Sikora A, Bollard C, Conejo-Garcia J, Cruz CR, Demehri S, Demetriou M, Demirdjian L, Fong L, Horowitz M, Hutson A, Kadash-Edmondson K, Kufe D, Lipkin S, Liu S, McCarthy C, Morgan M, Morris Z, Pan Y, Pasquini M, Schoenberger S, Van Allen E, Vilar E, Xing Y, Zha W, IOTN Consortium, Odunsi A) J Immunother Cancer 2020 Jun;8(1) 10 Citations |
| 1 | Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer. (Wainberg ZA, Hochster HS, Kim EJ, George B, Kaylan A, Chiorean EG, Waterhouse DM, Guiterrez M, Parikh A, Jain R, Carrizosa DR, Soliman HH, Lila T, Reiss DJ, Pierce DW, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, O'Dwyer PJ) Clin Cancer Res 2020 Sep 15;26(18):4814-4822 105 Citations |
| 1 | Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. (Chamberlin MD, Wells JD, Shee K, Bean JR, Marotti JD, Wells WA, Trask HW, Kolling FW, Bhatt A, Kaufman PA, Schwartz GN, Gemery JM, McNulty NJ, Tsapakos MJ, Barth RJ, Arrick BA, Gui J, Miller TW) Breast Cancer Res Treat 2020 Aug;182(3):665-677 1 Citation |
| 1 | Cancer and cardiovascular disease. (Knisely JPS, Henry SA, Saba SG, Puckett LL) Lancet 2020 Jun 20;395(10241):1904 2 Citations |
| 2 | A Randomized Controlled Trial of a Physical Activity Intervention for Self-management of Fatigue in Adolescents and Young Adults With Cancer. (Erickson JM, Tokarek N, Ke W, Swartz A) Cancer Nurs 2021 Jul-Aug 01;44(4):263-271 12 Citations |
| 1 | Downregulation of Cancer-Associated lncRNAs in Peripheral Blood of Multiple Sclerosis Patients. (Safa A, Taheri M, Fallah H, Salmani T, Arsang-Jang S, Ghafouri-Fard S, Omrani MD) J Mol Neurosci 2020 Oct;70(10):1533-1540 19 Citations |
| 1 | Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Int J Radiat Oncol Biol Phys 2020 Jul 15;107(4):631-640 41 Citations |
| 2 | Patient-Centric Head and Neck Cancer Radiation Therapy: Role of Advanced Imaging. (Shukla M, Forghani R, Agarwal M) Neuroimaging Clin N Am 2020 Aug;30(3):341-357 3 Citations |
| 1 | Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch KJ, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Practical Radiation Oncology July - August 2020;10(4):220-234 158 Citations |
| 1 | Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board. (Bernhardt EB, Chamberlin MD, Gorlov IP, de Abreu FB, Bloch KJ, Peterson JD, Tsongalis GJ, Shirai K, Dragnev KH, Miller TW, Tafe LJ) Pract Lab Med 2020 Aug;21:e00174 5 Citations |
| 1 | A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer. (Oza AM, Estevez-Diz M, Grischke EM, Hall M, Marmé F, Provencher D, Uyar D, Weberpals JI, Wenham RM, Laing N, Tracy M, Freshwater T, Lee MA, Liu J, Qiu J, Rose S, Rubin EH, Moore K) Clin Cancer Res 2020 Sep 15;26(18):4767-4776 79 Citations |
| 1 | Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer. (Shee K, Seigne JD, Karagas MR, Marsit CJ, Hinds JW, Schned AR, Pettus JR, Armstrong DA, Miller TW, Andrew AS) Cancer Biomark 2020;29(1):101-110 11 Citations |
| 8 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 16 Citations |
| 1 | Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. (White MG, Kothari A, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B) Ann Surg Oncol 2020 Dec;27(13):4963-4969 18 Citations |
| 1 | The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505. (Evans DB) Ann Surg 2020 Sep 01;272(3):487 12 Citations |
| 1 | Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) International Journal of Radiation Oncology Biology Physics 15 July 2020;107(4):631-640 41 Citations |
| 1 | Malnutrition and overall survival in older patients with cancer. (Zhang X, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ) Clin Nutr 2021 Mar;40(3):966-977 39 Citations |
| 1 | CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade. (Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A) JCO Precis Oncol 2020;4:382-392 |
| 1 | Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer. (Aubry S, Strassle PD, Maduekwe U, Downs-Canner S) J Surg Res 2020 Dec;256:13-22 1 Citation |
| 1 | Environmental and ecological factors of stomach cancer incidence and mortality: a systematic review study on ecological studies. (Khazaei S, Mohammadbeigi A, Jenabi E, Asgarian A, Heidari H, Saghafipour A, Arsang-Jang S, Ansari H) Rev Environ Health 2020 Nov 18;35(4):443-452 8 Citations |
| 1 | Characteristics of nonmelanoma skin cancer in children without identifiable risk factors. (Zhong CS, Coughlin CC, Hawryluk EB, Hook K, Humphrey SR, Kruse L, Lawley L, Kao PC, London WB, Marghoob AA, Phung TL, Pope E, Skin Cancer in Children and Young Adults Consortium, Eichenfield LF, Huang JT) J Am Acad Dermatol 2021 May;84(5):1472-1476 2 Citations |
| 1 | Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers. (Okamura R, Kurzrock R, Mallory RJ, Fanta PT, Burgoyne AM, Clary BM, Kato S, Sicklick JK) Int J Cancer 2021 Feb 01;148(3):702-712 50 Citations |
| 1 | Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors. (Kerns SL, Fung C, Fossa SD, Dinh PC Jr, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB) JNCI Cancer Spectr 2020 Aug;4(4):pkaa022 |
| 1 | Second cancer incidence in CLL patients receiving BTK inhibitors. (Bond DA, Huang Y, Fisher JL, Ruppert AS, Owen DH, Bertino EM, Rogers KA, Bhat SA, Grever MR, Jaglowski SM, Maddocks KJ, Byrd JC, Woyach JA) Leukemia 2020 Dec;34(12):3197-3205 45 Citations |
| 1 | Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm. (Chakrabarti S, Kamgar M, Mahipal A) Cancers (Basel) 2020 Jul 24;12(8) 60 Citations |
| 1 | Cyclin D-CDK4/6 functions in cancer. (Gao X, Leone GW, Wang H) Adv Cancer Res 2020;148:147-169 144 Citations |
| 2 | Patient-Centric Head and Neck Cancer Radiation Therapy: Role of Advanced Imaging (Shukla M, Forghani R, Agarwal M) Neuroimaging Clinics of North America August 2020;30(3):341-357 3 Citations |
| 1 | Early stage triple negative breast cancer: Management and future directions (Chaudhary LN) Seminars in Oncology August 2020;47(4):201-208 31 Citations |
| 1 | High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. (Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R) Mol Cancer Ther 2020 Oct;19(10):2139-2145 56 Citations |
| 1 | Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial. (DiSilvestro P, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian CA, Bradley WH, Mathews CA, Liu J, Lowe ES, Bloomfield R, Moore KN) J Clin Oncol 2020 Oct 20;38(30):3528-3537 81 Citations |
| 1 | Choice of local therapy for young women with early-stage breast cancer who have young-aged children. (Pan IW, Yen TWF, Huo J, Chen C, Smith BD, Shih YT) Cancer 2020 Nov 01;126(21):4761-4769 1 Citation |
| 1 | Utilization of Pelvic MRI for Nodal Staging in Rectal Cancer Staging. (Fair ES, Duvnjak P) Acad Radiol 2020 Dec;27(12):1718-1719 1 Citation |
| 8 | Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. (Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES) PLoS One 2020;15(8):e0236570 58 Citations |
| 2 | ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. (Lan W, Santofimia-Castaño P, Swayden M, Xia Y, Zhou Z, Audebert S, Camoin L, Huang C, Peng L, Jiménez-Alesanco A, Velázquez-Campoy A, Abián O, Lomberk G, Urrutia R, Rizzuti B, Geli V, Soubeyran P, Neira JL, Iovanna J) JCI Insight 2020 Sep 17;5(18) 30 Citations |
| 1 | Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. (Yan F, Li H, Kaczmar JM, Sharma AK, Day TA, Neskey DM, Pipkorn P, Zenga J, Graboyes EM) JAMA Otolaryngol Head Neck Surg 2020 Dec 01;146(12):1109-1119 9 Citations |
| 1 | Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions (Chakrabarti S, Peterson CY, Sriram D, Mahipal A) World Journal of Gastrointestinal Oncology 15 August 2020;12(8):808-832 80 Citations |
| 1 | Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease. (Kalyanaraman B) Redox Biol 2020 Sep;36:101665 27 Citations |
| 8 | Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. (Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY) Surgery 2021 Mar;169(3):629-635 8 Citations |
| 1 | Margin Practices in Oral Cavity Cancer Resections: Survey of American Head and Neck Society Members. (Bulbul MG, Zenga J, Tarabichi O, Parikh AS, Sethi RK, Robbins KT, Puram SV, Varvares MA) Laryngoscope 2021 Apr;131(4):782-787 31 Citations |
| 1 | Circulating Tumor Cells: From the Laboratory to the Cancer Clinic. (Agashe R, Kurzrock R) Cancers (Basel) 2020 Aug 21;12(9) 31 Citations |
| 1 | Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer. (Axelrod ML, Nixon MJ, Gonzalez-Ericsson PI, Bergman RE, Pilkinton MA, McDonnell WJ, Sanchez V, Opalenik SR, Loi S, Zhou J, Mackay S, Rexer BN, Abramson VG, Jansen VM, Mallal S, Donaldson J, Tolaney SM, Krop IE, Garrido-Castro AC, Marotti JD, Shee K, Miller TW, Sanders ME, Mayer IA, Salgado R, Balko JM) Clin Cancer Res 2020 Nov 01;26(21):5668-5681 43 Citations |
| 2 | Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy. (Kim RY, Evans DB, Christians KK) Hepatobiliary Surg Nutr 2020 Aug;9(4):497-500 |
| 1 | Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017. (Deshmukh AA, Suk R, Shiels MS, Damgacioglu H, Lin YY, Stier EA, Nyitray AG, Chiao EY, Nemutlu GS, Chhatwal J, Schmeler K, Sigel K, Sonawane K) J Natl Cancer Inst 2021 Jun 01;113(6):792-796 45 Citations |
| 1 | RAS and RHO family GTPase mutations in cancer: twin sons of different mothers? (Hodge RG, Schaefer A, Howard SV, Der CJ) Crit Rev Biochem Mol Biol 2020 Aug;55(4):386-407 33 Citations |
| 1 | Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer. (Adashek JJ, Arroyo-Martinez Y, Menta AK, Kurzrock R, Kato S) Front Oncol 2020;10:1312 21 Citations |
| 1 | Selpercatinib Aimed at RET-Altered Cancers. (Kurzrock R) N Engl J Med 2020 Aug 27;383(9):868-869 24 Citations |
| 1 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. (Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Brinton L, Buchanan DD, Chanock SJ, Chen C, Chen MM, Cheng THT, Cook LS, Crous-Bous M, Czene K, De Vivo I, Dennis J, Dörk T, Dowdy SC, Dunning AM, Dürst M, Easton DF, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankinson SE, Hein A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hunter DJ, Jones A, Kraft P, Krakstad C, Lambrechts D, Le Marchand L, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Milne RL, Mints M, Nassir R, Otton G, Palles C, Pooler L, Proietto T, Rebbeck TR, Renner SP, Risch HA, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Tham E, Tomlinson I, Trovik J, Turman C, Tyrer JP, Van Den Berg D, Wang Z, Wentzensen N, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Webb PM, Thompson DJ, Spurdle AB, Glubb DM, O'Mara TA) Int J Cancer 2021 Jan 15;148(2):307-319 47 Citations |
| 2 | NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. (Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF) Int J Radiat Oncol Biol Phys 2021 Jan 01;109(1):174-185 101 Citations |
| 3 | Optimized cardiac functional MRI of small-animal models of cancer radiation therapy. (Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C) Magn Reson Imaging 2020 Nov;73:130-137 6 Citations |
| 5 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery (United States) September 2020;168(3):440-447 16 Citations |
| 1 | Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy. (Evans DB) Surgery 2021 May;169(5):1032-1033 3 Citations |
| 1 | Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer. (Patwari A, Bhatlapenumarthi V) Breast J 2020 Nov;26(11):2233-2234 2 Citations |
| 3 | Utility of PD-L1 testing on non-small cell lung cancer cytology specimens: An institutional experience with interobserver variability analysis. (Kravtsov O, Hartley CP, Sheinin Y, Hunt BC, Felix JC, Giorgadze T) Ann Diagn Pathol 2020 Oct;48:151602 4 Citations |
| 1 | Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. (Majumder M, Johnson RH, Palanisamy V) Crit Rev Biochem Mol Biol 2020 Oct;55(5):409-424 33 Citations |
| 1 | Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. (Charo LM, Eskander RN, Okamura R, Patel SP, Nikanjam M, Lanman RB, Piccioni DE, Kato S, McHale MT, Kurzrock R) Mol Oncol 2021 Jan;15(1):67-79 37 Citations |
| 1 | Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions. (Chakrabarti S, Peterson CY, Sriram D, Mahipal A) World J Gastrointest Oncol 2020 Aug 15;12(8):808-832 80 Citations |
| 1 | miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications. (Safi A, Bastami M, Delghir S, Ilkhani K, Seif F, Alivand MR) Anticancer Agents Med Chem 2021;21(9):1069-1081 9 Citations |
| 1 | Lessons From COVID-19: Addressing Health Equity in Cancer Care. (Siker ML, Deville C Jr, Suneja G, Winkfield K) Int J Radiat Oncol Biol Phys 2020 Oct 01;108(2):475-478 10 Citations |
| 1 | Weekend readmissions associated with mortality following pancreatic resection for cancer. (Kothari AN, Qu LT, Gil LA, di Chiaro B, Sweigert PJ, Kulshrestha S, Kuo PC, Abood GJ) Surg Oncol 2020 Sep;34:218-222 2 Citations |
| 1 | Patterns of Nodal Metastases and Predictors of Occult Disease in HPV-Associated Oropharynx Cancer. (Stanford-Moore GB, Ochoa E, Larson A, Han M, Hoppe K, Ryan WR) Otolaryngol Head Neck Surg 2021 Mar;164(3):624-630 8 Citations |
| 1 | NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. (Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK) Int J Radiat Oncol Biol Phys 2021 Feb 01;109(2):413-424 92 Citations |
| 1 | The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators. (Ilkhani K, Bastami M, Delgir S, Safi A, Talebian S, Alivand MR) Anticancer Agents Med Chem 2021;21(2):254-266 25 Citations |
| 5 | Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer. (McGarry SD, Bukowy JD, Iczkowski KA, Lowman AK, Brehler M, Bobholz S, Nencka A, Barrington A, Jacobsohn K, Unteriner J, Duvnjak P, Griffin M, Hohenwalter M, Keuter T, Huang W, Antic T, Paner G, Palangmonthip W, Banerjee A, LaViolette PS) J Med Imaging (Bellingham) 2020 Sep;7(5):054501 14 Citations |
| 1 | Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers. (Vu P, Khagi Y, Riviere P, Goodman A, Kurzrock R) JCO Precis Oncol 2020;4 16 Citations |
| 1 | Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer. (Bollig CA, Lee DS, Mazul AL, Stepan K, Puram SV, Massa ST, Zenga J, Faden DL, Doering MM, Jackson RS, Pipkorn P) Otolaryngol Head Neck Surg 2021 Apr;164(4):733-740 5 Citations |
| 2 | Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer. (Winn AN, Check DK, Farkas A, Fergestrom NM, Neuner JM, Roberts AW) JAMA Netw Open 2020 Sep 01;3(9):e2016858 17 Citations |
| 1 | Big Data Solutions for Controversies in Breast Cancer Treatment. (Cobb AN, Janjua HM, Kuo PC) Clin Breast Cancer 2021 Jun;21(3):e199-e203 8 Citations |
| 1 | Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis. (Wrenn SM, Wang TS, Toumi A, Kiernan CM, Solórzano CC, Stephen AE) Am J Surg 2021 Feb;221(2):448-454 20 Citations |
| 1 | Gay and Bisexual Men in the US Lack Basic Information About Anal Cancer. (Wheldon CW, Maness SB, Islam JY, Deshmukh AA, Nyitray AG) J Low Genit Tract Dis 2021 Jan 01;25(1):48-52 17 Citations |
| 1 | Transcriptomics and solid tumors: The next frontier in precision cancer medicine. (Tsimberidou AM, Fountzilas E, Bleris L, Kurzrock R) Semin Cancer Biol 2022 Sep;84:50-59 54 Citations |
| 2 | The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells. (Yang Y, Choppavarapu L, Fang K, Naeini AS, Nosirov B, Li J, Yang K, He Z, Zhou Y, Schiff R, Li R, Hu Y, Wang J, Jin VX) Biochim Biophys Acta Gene Regul Mech 2020 Nov;1863(11):194631 11 Citations |
| 1 | Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. (Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, Johnson-Thompson M, Olshan AF, Troester MA) Cancer 2020 Nov 15;126(22):4957-4966 70 Citations |
| 2 | Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. (Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, MC3 Working Group, PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L, PCAWG Consortium) Nat Commun 2020 Sep 21;11(1):4748 33 Citations |
| 1 | Hematopoietic stem cell transplantation and lymphodepletion for the treatment of cancer (Barr KM, Khoshbin AP, Gershan JA, Johnson BD) Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition 24 September 2020:143-156 |
| 1 | The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Gynecol Oncol 2020 Dec;159(3):607-610 29 Citations |
| 1 | Commentary: Venous resection and reconstruction at the time of pancreatectomy for cancer. (Christians KK) Surgery 2020 Dec;168(6):1058-1059 2 Citations |
| 1 | Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. (Han L, Gallan AJ, Steinberg GD, Sweis RF, Paner GP) Hum Pathol 2020 Dec;106:54-61 6 Citations |
| 1 | Utility of PD-L1 testing on non-small cell lung cancer cytology specimens: An institutional experience with interobserver variability analysis (Kravtsov O, Hartley CP, Sheinin Y, Hunt BC, Felix JC, Giorgadze T) Annals of Diagnostic Pathology October 2020;48 4 Citations |
| 1 | Lessons From COVID-19: Addressing Health Equity in Cancer Care (Siker ML, Deville C, Suneja G, Winkfield K) International Journal of Radiation Oncology Biology Physics 1 October 2020;108(2):475-478 10 Citations |
| 2 | Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination. (Phillips SM, Welch WA, Fanning J, Santa-Maria CA, Gavin KL, Auster-Gussman LA, Solk P, Lu M, Cullather E, Khan SA, Kulkarni SA, Gradishar W, Siddique J) Cancer Epidemiol Biomarkers Prev 2020 Dec;29(12):2608-2616 17 Citations |
| 8 | Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 39 Citations |
| 1 | The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review. (Chakrabarti S, Xie H, Urrutia R, Mahipal A) Cancers (Basel) 2020 Sep 29;12(10) 38 Citations |
| 1 | Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area. (Collin LJ, Gaglioti AH, Beyer KM, Zhou Y, Moore MA, Nash R, Switchenko JM, Miller-Kleinhenz JM, Ward KC, McCullough LE) Cancer Epidemiol Biomarkers Prev 2021 Jan;30(1):53-60 114 Citations |
| 4 | Community and Research Perspectives on Cancer Disparities in Wisconsin. (Olson J, Cawthra T, Beyer K, Frazer D, Ignace L, Maurana C, Millon-Underwood S, Pinsoneault L, Salazar J, Walker A, Williams C, Stolley M) Prev Chronic Dis 2020 Oct 08;17:E122 5 Citations |
| 3 | Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer. (Danes JM, de Abreu ALP, Kerketta R, Huang Y, Palma FR, Gantner BN, Mathison AJ, Urrutia RA, Bonini MG) FASEB J 2020 Dec;34(12):16034-16048 12 Citations |
| 1 | A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy (Bergom C, Rubenstein J, Wilson JF, Welsh A, Ibrahim ESH, Prior P, Schottstaedt AM, Eastwood D, Zhang MJ, Currey A, Puckett L, Strande JL, Bradley JA, White J) Frontiers in Oncology 16 October 2020;10 10 Citations |
| 6 | Bronchoalveolar lavage-based COVID-19 testing in patients with cancer. (Abid MB, Chhabra S, Buchan B, Graham MB, Abedin S, Thapa B, D'Souza A, George B, Hamadani M) Hematol Oncol Stem Cell Ther 2021 Mar;14(1):65-70 17 Citations |
| 4 | Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network. (Bukowy JD, Foss H, McGarry SD, Lowman AK, Hurrell SL, Iczkowski KA, Banerjee A, Bobholz SA, Barrington A, Dayton A, Unteriner J, Jacobsohn K, See WA, Nevalainen MT, Nencka AS, Ethridge T, Jarrard DF, LaViolette PS) J Med Imaging (Bellingham) 2020 Sep;7(5):057501 7 Citations |
| 1 | Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. (Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS) Adv Radiat Oncol 2020;5(5):897-904 2 Citations |
| 1 | Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome. (Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, Piątosa B, Pietrucha B, Kałwak K, Ussowicz M, Pieczonka A, Drabko K, Lejman M, Koltan S, Gozdzik J, Styczynski J, Fedorova A, Miakova N, Deripapa E, Kostyuchenko L, Krenova Z, Hlavackova E, Gennery AR, Sykora KW, Ghosh S, Albert MH, Balashov D, Eapen M, Svec P, Seidel MG, Kilic SS, Tomaszewska A, Wiesik-Szewczyk E, Kreins A, Greil J, Buechner J, Lund B, Gregorek H, Chrzanowska K, Mlynarski W) Clin Cancer Res 2021 Jan 15;27(2):575-584 26 Citations |
| 8 | Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling. (Parashar D, Nair B, Geethadevi A, George J, Nair A, Tsaih SW, Kadamberi IP, Gopinadhan Nair GK, Lu Y, Ramchandran R, Uyar DS, Rader JS, Ram PT, Mills GB, Pradeep S, Chaluvally-Raghavan P) Cancer Res 2020 Dec 15;80(24):5554-5568 31 Citations |
| 1 | Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. (Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB) Clin Cancer Res 2021 Jan 01;27(1):226-236 17 Citations |
| 1 | Characteristics of uncertainty in advanced pediatric cancer conversations. (Sisk BA, Friedrich AB, DuBois J, Mack JW) Patient Educ Couns 2021 May;104(5):1066-1074 10 Citations |
| 1 | Standardized uptake value (SUVmax) in 18F-FDG PET/CT is correlated with the total number of main oncogenic anomalies in cancer patients. (Haghighat Jahromi A, Chang G, Kurzrock R, Hoh CK) Cancer Biol Ther 2020 Nov 01;21(11):1067-1071 4 Citations |
| 1 | The influence of breast cancer subtype on survival after palliative radiation for osseous metastases. (Abdelhakiem MK, Johnstone C, Bergom C, Currey A, Robbins JR) Cancer Med 2020 Dec;9(23):8979-8988 6 Citations |
| 1 | Are Physical Activity and Sedentary Behavior Associated With Cancer-Related Symptoms in Real Time?: A Daily Diary Study. (Paxton RJ, Bui C, Fullwood D, Daniel D, Stolley M, Oliver JS, Wang K, Dubay JW) Cancer Nurs 2022 Jan-Feb 01;45(1):E246-E254 2 Citations |
| 1 | Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors. (McFall T, Schomburg NK, Rossman KL, Stites EC) Cell Commun Signal 2020 Nov 05;18(1):179 9 Citations |
| 1 | Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy. (Sous D, Armstrong AE, Huang JT, Shah S, Carlberg VM, Coughlin CC) Pediatr Dermatol 2021 Jan;38(1):8-17 4 Citations |
| 2 | A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy. (Bergom C, Rubenstein J, Wilson JF, Welsh A, Ibrahim EH, Prior P, Schottstaedt AM, Eastwood D, Zhang MJ, Currey A, Puckett L, Strande JL, Bradley JA, White J) Front Oncol 2020;10:506739 10 Citations |
| 1 | A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. (Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Avuzzi B, Giandini T, Valdagni R, Cicchetti A, Azria D, Jacquet MF, Rosenstein BS, Stock RG, Collado K, Vega A, Aguado-Barrera ME, Calvo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T) Front Oncol 2020;10:541281 24 Citations |
| 1 | Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clin Genitourin Cancer 2021 Jun;19(3):267-270.e1 2 Citations |
| 3 | Can Regionalization of Care Reduce Socioeconomic Disparities in Breast Cancer Survival? (Nattinger AB, Rademacher N, McGinley EL, Bickell NA, Pezzin LE) Med Care 2021 Jan;59(1):77-81 9 Citations |
| 1 | Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis. (Muraki T, Pehlivanoglu B, Memis B, Reid MD, Uehara T, Basturk O, Pernicka JG, Klimstra DS, Jarnagin WR, Ito T, Hasebe O, Okaniwa S, Horigome N, Hisa T, Mittal P, Sarmiento JM, Maithel SK, Koshiol J, Tsai S, Evans D, Erkan M, Adsay V) Ann Surg 2022 Jul 01;276(1):e32-e39 17 Citations |
| 1 | Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer. (DeLucia DC, Cardillo TM, Ang L, Labrecque MP, Zhang A, Hopkins JE, De Sarkar N, Coleman I, da Costa RMG, Corey E, True LD, Haffner MC, Schweizer MT, Morrissey C, Nelson PS, Lee JK) Clin Cancer Res 2021 Feb 01;27(3):759-774 48 Citations |
| 2 | Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. (Maranto C, Udhane V, Jia J, Verma R, Müller-Newen G, LaViolette PS, Pereckas M, Sabharwal L, Terhune S, Pattabiraman N, Njar VCO, Imig JD, Wang L, Nevalainen MT) Cancers (Basel) 2020 Nov 18;12(11) 5 Citations |
| 1 | Adverse childhood experiences (ACEs) and medically traumatic events (TEs) in adolescents and young adults (AYAs) with cancer: a report from the Promoting Resilience in Stress Management (PRISM) randomized controlled trial. (Scott SR, O'Daffer AG, Bradford MC, Fladeboe K, Lau N, Steineck A, Taylor M, Yi-Frazier JP, Rosenberg AR) Support Care Cancer 2021 Jul;29(7):3773-3781 7 Citations |
| 1 | Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing. (Bonneville R, Paruchuri A, Wing MR, Krook MA, Reeser JW, Chen HZ, Dao T, Samorodnitsky E, Smith AM, Yu L, Nowacki N, Chen W, Roychowdhury S) Mol Cancer Res 2021 Mar;19(3):465-474 6 Citations |
| 1 | Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer. (Heninger E, Sethakorn N, Kosoff D, Hematti P, Kuczler MD, Pienta KJ, Lang JM) Oncotarget 2020 Nov 17;11(46):4253-4265 3 Citations |
| 1 | Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer (Ludwig K, Kong AL) Current Breast Cancer Reports December 2020;12(4):391-397 |
| 1 | De-Escalation of Local-Regional Therapy for Older Breast Cancer Patients (Cortina CS) Current Breast Cancer Reports December 2020;12(4):344-350 |
| 5 | Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB December 2020;22(12):1745-1752 2 Citations |
| 2 | Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. (Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, MC3 Working Group, PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L, PCAWG Consortium) Nat Commun 2020 Nov 30;11(1):6232 |
| 2 | Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression. (Mittal S, Gupta P, Chaluvally-Raghavan P, Pradeep S) Cancers (Basel) 2020 Nov 28;12(12) 46 Citations |
| 1 | Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. (Krook MA, Reeser JW, Ernst G, Barker H, Wilberding M, Li G, Chen HZ, Roychowdhury S) Br J Cancer 2021 Mar;124(5):880-892 219 Citations |
| 1 | Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee. (Cherven B, Sampson A, Bober SL, Bingen K, Frederick N, Freyer DR, Quinn GP) CA Cancer J Clin 2021 May;71(3):250-263 56 Citations |
| 1 | Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients. (Haghighat Jahromi A, Barkauskas DA, Zabel M, Goodman AM, Frampton G, Nikanjam M, Hoh CK, Kurzrock R) EJNMMI Res 2020 Dec 09;10(1):150 10 Citations |
| 6 | Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S) Am J Surg 2021 Jul;222(1):10-17 63 Citations |
| 1 | Image Based Fractal Analysis for Detection of Cancer Cells (Qin J, Puckett L, Qian X) Proceedings - 2020 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2020 16 December 2020:1482-1486 5 Citations |
| 1 | Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation. (McDonald BA, Vedam S, Yang J, Wang J, Castillo P, Lee B, Sobremonte A, Ahmed S, Ding Y, Mohamed ASR, Balter P, Hughes N, Thorwarth D, Nachbar M, Philippens MEP, Terhaard CHJ, Zips D, Böke S, Awan MJ, Christodouleas J, Fuller CD, MR-Linac Consortium Head and Neck Tumor Site Group) Int J Radiat Oncol Biol Phys 2021 Apr 01;109(5):1606-1618 55 Citations |
| 1 | Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer. (Parra SG, López-Orellana LM, Molina Duque AR, Carns JL, Schwarz RA, Smith CA, Ortiz Silvestre M, Diaz Bazan S, Escobar PA, Felix JC, Ramalingam P, Castle PE, Cremer ML, Maza M, Schmeler KM, Richards-Kortum RR) Int J Cancer 2021 May 15;148(10):2571-2578 13 Citations |
| 1 | Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. (Mahadevan A, Moningi S, Grimm J, Li XA, Forster KM, Palta M, Prior P, Goodman KA, Narang A, Heron DE, Lo SS, Urbanic J, Herman JM) Int J Radiat Oncol Biol Phys 2021 May 01;110(1):206-216 30 Citations |
| 1 | Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy. (Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, Gupta D) Pediatr Dermatol 2021 Jan;38(1):18-30 9 Citations |
| 2 | Challenges of genomic testing for hereditary breast and ovarian cancers (McAlarnen L, Stearns K, Uyar D) Application of Clinical Genetics 2021;14:1-9 16 Citations |
| 3 | Breast cancer magnification-independent multi-class histopathology classification using dual-step model (Lang N, Saxena D, Yen T, Jorns J, Yu B, Ye DH) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2021;11603 5 Citations |
| 1 | The impact of COVID-19 on cancer clinical trials conducted by nci-designated comprehensive cancer centers (Gupta D, Kato S, Kurzrock R) Journal of Immunotherapy and Precision Oncology 2021;4(2):56-63 5 Citations |
| 2 | The role of residential history in cancer research: A scoping review. (Namin S, Zhou Y, Neuner J, Beyer K) Soc Sci Med 2021 Feb;270:113657 13 Citations |
| 1 | Guideline‑concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast
cancer (Yen, T. W., Garacci, Z., Laud, P. W., Pezzin, L. E., & Nattinger, A. B.) Breast Cancer Yen, T. W., Garacci, Z., Laud, P. W., Pezzin, L. E., & Nattinger, A. B. (2021). Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer. Breast Cancer, 28(3), 698-709. |
| 1 | Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. (Sakhuja S, Fowler ME, Ojesina AI) Prev Med Rep 2021 Mar;21:101263 2 Citations |
| 1 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. (Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Stevens VL, Gapstur SM, Carter BD, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Giles GG, Southey MC, MacInnis RJ, Cybulski C, Wokołorczyk D, Lubiński J, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nordestgaard BG, Nielsen SF, Weischer M, Bojesen SE, Røder MA, Iversen P, Batra J, Chambers S, Moya L, Horvath L, Clements JA, Tilley W, Risbridger GP, Gronberg H, Aly M, Szulkin R, Eklund M, Nordström T, Pashayan N, Dunning AM, Ghoussaini M, Travis RC, Key TJ, Riboli E, Park JY, Sellers TA, Lin HY, Albanes D, Weinstein SJ, Mucci LA, Giovannucci E, Lindstrom S, Kraft P, Hunter DJ, Penney KL, Turman C, Tangen CM, Goodman PJ, Thompson IM Jr, Hamilton RJ, Fleshner NE, Finelli A, Parent MÉ, Stanford JL, Ostrander EA, Geybels MS, Koutros S, Freeman LEB, Stampfer M, Wolk A, Håkansson N, Andriole GL, Hoover RN, Machiela MJ, Sørensen KD, Borre M, Blot WJ, Zheng W, Yeboah ED, Mensah JE, Lu YJ, Zhang HW, Feng N, Mao X, Wu Y, Zhao SC, Sun Z, Thibodeau SN, McDonnell SK, Schaid DJ, West CML, Burnet N, Barnett G, Maier C, Schnoeller T, Luedeke M, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Koudou YA, John EM, Grindedal EM, Maehle L, Khaw KT, Ingles SA, Stern MC, Vega A, Gómez-Caamaño A, Fachal L, Rosenstein BS, Kerns SL, Ostrer H, Teixeira MR, Paulo P, Brandão A, Watya S, Lubwama A, Bensen JT, Fontham ETH, Mohler J, Taylor JA, Kogevinas M, Llorca J, Castaño-Vinyals G, Cannon-Albright L, Teerlink CC, Huff CD, Strom SS, Multigner L, Blanchet P, Brureau L, Kaneva R, Slavov C, Mitev V, Leach RJ, Weaver B, Brenner H, Cuk K, Holleczek B, Saum KU, Klein EA, Hsing AW, Kittles RA, Murphy AB, Logothetis CJ, Kim J, Neuhausen SL, Steele L, Ding YC, Isaacs WB, Nemesure B, Hennis AJM, Carpten J, Pandha H, Michael A, De Ruyck K, De Meerleer G, Ost P, Xu J, Razack A, Lim J, Teo SH, Newcomb LF, Lin DW, Fowke JH, Neslund-Dudas C, Rybicki BA, Gamulin M, Lessel D, Kulis T, Usmani N, Singhal S, Parliament M, Claessens F, Joniau S, Van den Broeck T, Gago-Dominguez M, Castelao JE, Martinez ME, Larkin S, Townsend PA, Aukim-Hastie C, Bush WS, Aldrich MC, Crawford DC, Srivastava S, Cullen JC, Petrovics G, Casey G, Roobol MJ, Jenster G, van Schaik RHN, Hu JJ, Sanderson M, Varma R, McKean-Cowdin R, Torres M, Mancuso N, Berndt SI, Van Den Eeden SK, Easton DF, Chanock SJ, Cook MB, Wiklund F, Nakagawa H, Witte JS, Eeles RA, Kote-Jarai Z, Haiman CA) Nat Genet 2021 Jan;53(1):65-75 293 Citations |
| 4 | Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer. (Yen TWF, Garacci Z, Laud PW, Pezzin LE, Nattinger AB) Breast Cancer 2021 May;28(3):698-709 2 Citations |
| 1 | A Brief Dermatology Curriculum in Skin Cancer Detection and Prevention to Improve Medical Student Knowledge and Confidence. (Compres E, Holzem K, Ibler E, Bierman JA, Rademaker AW, Kundu RV) MedEdPORTAL 2020 Dec 29;16:11049 4 Citations |
| 1 | Comprehensive serum proteomic analysis in early endometrial cancer. (Uyar DS, Huang YW, Chesnik MA, Doan NB, Mirza SP) J Proteomics 2021 Mar 15;234:104099 9 Citations |
| 1 | Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits. (Gorbet MJ, Singh A, Mao C, Fiering S, Ranjan A) Int J Hyperthermia 2020 Dec;37(3):18-33 14 Citations |
| 1 | Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. (Huang YW, Lin CW, Pan P, Shan T, Echeveste CE, Mo YY, Wang HT, Aldakkak M, Tsai S, Oshima K, Yearsley M, Xiao J, Cao H, Sun C, Du M, Bai W, Yu J, Wang LS) Front Immunol 2020;11:570683 20 Citations |
| 2 | Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer. (Gill HS, Dasari SP, Pandit S, Ritter TE, Raju SB, Chartier AR, Jha P) Case Rep Infect Dis 2020;2020:6676163 |
| 1 | In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology. (Mao C, Gorbet MJ, Singh A, Ranjan A, Fiering S) Int J Hyperthermia 2020 Dec;37(3):4-17 15 Citations |
| 1 | Correction to "Progress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics". (Thorat ND, Townley H, Brennan G, Parchur AK, Silien C, Bauer J, Tofail SAM) ACS Biomater Sci Eng 2020 Jan 13;6(1):758 1 Citation |
| 1 | Impact of KRAS alterations in localized pancreatic cancer (PC). (AV Shreenivas, K Annunzio, M Kamgar, S Chakrabarti, JP Thomas, S Madhavan, K Dua, AH Khan, WA Hall, B Erickson, KK Christians, C Clarke, DB Evans, S Tsai, A Szabo, R Urrutia, MT Zimmermann, HV Reddi, B George) Journal of Clinical Oncology 39 (3_suppl), 431-431 |
| 1 | A Population-Based Study of Genes Previously Implicated in Breast Cancer. (Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, Gao C, Lilyquist J, Yadav S, Boddicker NJ, Samara R, Klebba J, Ambrosone CB, Anton-Culver H, Auer P, Bandera EV, Bernstein L, Bertrand KA, Burnside ES, Carter BD, Eliassen H, Gapstur SM, Gaudet M, Haiman C, Hodge JM, Hunter DJ, Jacobs EJ, John EM, Kooperberg C, Kurian AW, Le Marchand L, Lindstroem S, Lindstrom T, Ma H, Neuhausen S, Newcomb PA, O'Brien KM, Olson JE, Ong IM, Pal T, Palmer JR, Patel AV, Reid S, Rosenberg L, Sandler DP, Scott C, Tamimi R, Taylor JA, Trentham-Dietz A, Vachon CM, Weinberg C, Yao S, Ziogas A, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Kraft P, Polley EC, Couch FJ) N Engl J Med 2021 Feb 04;384(5):440-451 527 Citations |
| 1 | Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers. (McAlarnen L, Stearns K, Uyar D) Appl Clin Genet 2021;14:1-9 16 Citations |
| 1 | Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells (Wang Y, Wu J, Chen H, Yang Y, Xiao C, Yi X, Shi C, Zhong K, He H, Li Y, Wu Z, Zhou G, Rao Q, Wang X, Zhou X, Lomberk G, Liu B, Zhao J, Ge J, Zhou W, Chu X, Chen C, Zhou X, Wang L, Guan K, Qu L) Science Advances 27 January 2021;7(5) 29 Citations |
| 1 | Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer. (Many BT, Lautz TB, Dobrozsi S, Wilkinson KH, Rossoff J, Le-Nguyen A, Dakhallah N, Piche N, Weinschenk W, Cooke-Barker J, Goodhue C, Zamora A, Kim ES, Talbot LJ, Quevedo OG, Murphy AJ, Commander SJ, Tracy ET, Short SS, Meyers RL, Rinehardt HN, Aldrink JH, Heaton TE, Ortiz MV, Baertschiger R, Wong KE, Lapidus-Krol E, Butter A, Davidson J, Stark R, Ramaraj A, Malek M, Mastropolo R, Morgan K, Murphy JT, Janek K, Le HD, Dasgupta R, Lal DR, PEDIATRIC SURGICAL ONCOLOGY RESEARCH COLLABORATIVE) Pediatrics 2021 Feb;147(2) 12 Citations |
| 1 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. (Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP, MACH-NC Collaborative Group) Radiother Oncol 2021 Mar;156:281-293 223 Citations |
| 1 | Cancer of Unknown Primary in the Molecular Era. (Kato S, Alsafar A, Walavalkar V, Hainsworth J, Kurzrock R) Trends Cancer 2021 May;7(5):465-477 50 Citations |
| 1 | CA19-9 Response to 1st-Line Neoadjuvant FOLFIRINOX and 2nd-Line Gemcitabine-Based Chemotherapy in Patients with Operable Pancreatic Cancer (S Thalji, M Kamgar, B George, M Aldakkak, K Christians, CN Clarke, B Erickson, W Hall, P Tolat, A Khan, DB Evans, S Tsai) ANNALS OF SURGICAL ONCOLOGY 28 (SUPPL 1), S20-S20 |
| 1 | Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics. (Jardim DL, Millis SZ, Ross JS, Woo MS, Ali SM, Kurzrock R) Oncologist 2021 Apr;26(4):e715-e718 7 Citations |
| 2 | KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery. (Kato S, McFall T, Takahashi K, Bamel K, Ikeda S, Eskander RN, Plaxe S, Parker B, Stites E, Kurzrock R) Oncologist 2021 Apr;26(4):e530-e536 8 Citations |
| 1 | Cytokeratin 7, GATA3, and SOX-10 is a Comprehensive Panel in Diagnosing Triple Negative Breast Cancer Brain Metastases. (Statz E, Jorns JM) Int J Surg Pathol 2021 Aug;29(5):470-474 12 Citations |
| 4 | STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer. (Vonderhaar EP, Barnekow NS, McAllister D, McOlash L, Eid MA, Riese MJ, Tarakanova VL, Johnson BD, Dwinell MB) Cell Mol Gastroenterol Hepatol 2021;12(1):41-58 39 Citations |
| 1 | Discharge Opioid Prescription Patterns After Kidney Cancer Surgery. (Okoro C, Holt S, Ellison JS, Raskolnikov D, Gore JL) Urology 2021 Jul;153:228-235 3 Citations |
| 1 | Obesity Status on associations between cancer-related beliefs and health behaviors in cancer survivors: Implications for patient-clinician communication. (Lin AW, Marchese SH, Finch LE, Stump T, Gavin KL, Spring B) Patient Educ Couns 2021 Aug;104(8):2067-2072 4 Citations |
| 1 | Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia. (Tapeh BE, Alivand MR, Solalii S) Anticancer Agents Med Chem 2021;21(17):2315-2326 5 Citations |
| 1 | Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth. (Stump CT, Ho G, Mao C, Veliz FA, Beiss V, Fields J, Steinmetz NF, Fiering S) Cancers (Basel) 2021 Feb 05;13(4) 16 Citations |
| 1 | Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells. (Wang Y, Wu J, Chen H, Yang Y, Xiao C, Yi X, Shi C, Zhong K, He H, Li Y, Wu Z, Zhou G, Rao Q, Wang X, Zhou X, Lomberk G, Liu B, Zhao J, Ge J, Zhou W, Chu X, Chen C, Zhou X, Wang L, Guan K, Qu L) Sci Adv 2021 Jan;7(5) 29 Citations |
| 1 | Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial. (Feng FY, Huang HC, Spratt DE, Zhao SG, Sandler HM, Simko JP, Davicioni E, Nguyen PL, Pollack A, Efstathiou JA, Dicker AP, Todorovic T, Margrave J, Liu YS, Dabbas B, Thompson DJS, Das R, Dignam JJ, Sweeney C, Attard G, Bahary JP, Lukka HR, Hall WA, Pisansky TM, Shah AB, Pugh SL, Shipley WU, Tran PT) JAMA Oncol 2021 Apr 01;7(4):544-552 97 Citations |
| 1 | Immune profiling and immunotherapeutic targets in pancreatic cancer. (Lenzo FL, Kato S, Pabla S, DePietro P, Nesline MK, Conroy JM, Burgher B, Glenn ST, Kuvshinoff B, Kurzrock R, Morrison C) Ann Transl Med 2021 Jan;9(2):119 |
| 3 | Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer. (Xin G, Chen Y, Topchyan P, Kasmani MY, Burns R, Volberding PJ, Wu X, Cohn A, Chen Y, Lin CW, Ho PC, Silverstein R, Dwinell MB, Cui W) Cancer Immunol Res 2021 Apr;9(4):454-469 30 Citations |
| 1 | Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer. (Chesnut GT, Tin AL, Sivaraman A, Takeda T, Lee T, Fainberg J, Benfante N, Sjoberg DD, Vargas HA, Fine SW, Scardino PT, Eastham JA, Coleman JA, Touijer KA, Zelefsky MJ, Ehdaie B) Urol Oncol 2021 Aug;39(8):495.e17-495.e24 2 Citations |
| 1 | Cutaneous Metastatic Cancer: Carcinoma Hemorrhagiectoides Presenting as the Shield Sign. (Cohen PR, Kurzrock R) Cureus 2021 Jan 11;13(1):e12627 |
| 1 | Relapsed breast cancer complicated by isolated brain metastasis. (Ehsan H, Imtiaz H, Sana MK, Sheikh MM, Wahab A) Clin Case Rep 2021 Feb;9(2):887-890 5 Citations |
| 1 | Immune function in childhood cancer survivors: a Children's Oncology Group review. (Guilcher GMT, Rivard L, Huang JT, Wright NAM, Anderson L, Eissa H, Pelletier W, Ramachandran S, Schechter T, Shah AJ, Wong K, Chow EJ) Lancet Child Adolesc Health 2021 Apr;5(4):284-294 29 Citations |
| 2 | Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. (Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA) Ann Diagn Pathol 2021 Jun;52:151725 3 Citations |
| 4 | Frequent omission of radiation after flap reconstruction of head and neck cancer: Are we dooming patients to failure? (North LM, Harvey E, Vanle B, Shreenivas A, Shukla M, Wong S, Awan M, Zenga J) Oral Oncol 2021 Aug;119:105225 1 Citation |
| 1 | Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. (Yan F, Li H, de Almeida JR, Kaczmar JM, Pipkorn P, Zenga J, Richardson MS, Neskey DM, Sharma AK, Day TA, Graboyes EM) Otolaryngol Head Neck Surg 2021 Oct;165(4):536-549 6 Citations |
| 2 | Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522. (Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group) Oral Oncol 2021 May;116:105241 5 Citations |
| 1 | Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant. (Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T) Oncologist 2021 Jun;26(6):467-e924 5 Citations |
| 1 | Breast Cancer Risk and Screening in Transgender Individuals (Roznovjak D, Petroll A, Cortina CS) Current Breast Cancer Reports March 2021;13(1):56-61 7 Citations |
| 1 | Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer (AN Krepline, JL Geurts, B George, M Kamgar, S Madhavan, BA Erickson, WA Hall, MO Griffin, DB Evans, S Tsai, RY Kim) Surgery 169 (3), 629-635 |
| 1 | Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer. (Weeks SE, Kammerud SC, Metge BJ, AlSheikh HA, Schneider DA, Chen D, Wei S, Mobley JA, Ojesina AI, Shevde LA, Samant RS) Cell Death Dis 2021 Mar 04;12(3):242 15 Citations |
| 1 | A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers? (Aryanpour Z, Asban A, Boyd C, Herring B, Eustace N, Carmona Matos DM, McCaw T, Ramonell KM, Fazendin JM, Lindeman B, Iyer P, Chen H) Am J Surg 2021 Oct;222(4):802-805 16 Citations |
| 1 | Surgical outcomes and survival rates of colon cancer in children and young adults. (Akinkuotu AC, Maduekwe UN, Hayes-Jordan A) Am J Surg 2021 Apr;221(4):718-724 11 Citations |
| 1 | Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer (Crockett CB, Samson P, Chuter R, Dubec M, Faivre-Finn C, Green OL, Hackett SL, McDonald F, Robinson C, Shiarli AM, Straza MW, Verhoeff JJC, Werner-Wasik M, Vlacich G, Cobben D) Frontiers in Oncology 10 March 2021;11 29 Citations |
| 1 | Therapeutic applications of the cancer immunoediting hypothesis. (Desai R, Coxon AT, Dunn GP) Semin Cancer Biol 2022 Jan;78:63-77 33 Citations |
| 1 | Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. (Aissa AF, Islam ABMMK, Ariss MM, Go CC, Rader AE, Conrardy RD, Gajda AM, Rubio-Perez C, Valyi-Nagy K, Pasquinelli M, Feldman LE, Green SJ, Lopez-Bigas N, Frolov MV, Benevolenskaya EV) Nat Commun 2021 Mar 12;12(1):1628 138 Citations |
| 2 | Sometimes less is more in palliating advanced oesophageal cancer. (Puckett LL, Shukla ME) Lancet Gastroenterol Hepatol 2021 Apr;6(4):256-258 |
| 1 | Comprehensive serum proteomic analysis in early endometrial cancer (Uyar DS, Huang YW, Chesnik MA, Doan NB, Mirza SP) Journal of Proteomics 15 March 2021;234 9 Citations |
| 1 | A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C) Br J Cancer 2021 May;124(10):1690-1698 21 Citations |
| 3 | Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. (Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C) Endocrinology 2021 Aug 01;162(8) 9 Citations |
| 3 | Every Day Counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer. (Sheean P, Matthews L, Visotcky A, Banerjee A, Moosreiner A, Kelley K, Chitambar CR, Papanek PE, Stolley M) Breast Cancer Res Treat 2021 Jun;187(3):729-741 22 Citations |
| 1 | STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications. (Krishnamurthy N, Goodman AM, Barkauskas DA, Kurzrock R) Eur J Cancer 2021 May;148:215-229 32 Citations |
| 3 | Germline evaluation of patients undergoing tumor genomic profiling: An academic cancer center's experience with implementing a germline review protocol. (Stachowiak S, Jacquart A, Zimmermann MT, George B, Dong H, Geurts JL) J Genet Couns 2021 Jun;30(3):900-910 1 Citation |
| 1 | Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery. (Jackson RS, Stepan K, Bollig C, Sharma RK, Patel M, Massa S, Puram SV, Zevallos JP, Pipkorn P, Zenga J) Otolaryngol Head Neck Surg 2021 Nov;165(5):682-689 7 Citations |
| 1 | Factors influencing treatment of veterans with advanced prostate cancer. (Caram MEV, Burns J, Kumbier K, Sparks JB, Tsao PA, Chapman CH, Bauman J, Hollenbeck BK, Shahinian VB, Skolarus TA) Cancer 2021 Jul 01;127(13):2311-2318 9 Citations |
| 1 | Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts. (Iczkowski KA, van Leenders GJLH, Tarima S, Wu R, Van der Kwast T, Berney DM, Evans AJ, Wheeler TM, Ro JY, Samaratunga H, Delahunt B, Srigley J, Varma M, Tsuzuki T, Egevad L) Ann Diagn Pathol 2021 Jun;52:151733 8 Citations |
| 1 | Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer. (Crockett CB, Samson P, Chuter R, Dubec M, Faivre-Finn C, Green OL, Hackett SL, McDonald F, Robinson C, Shiarli AM, Straza MW, Verhoeff JJC, Werner-Wasik M, Vlacich G, Cobben D) Front Oncol 2021;11:617681 29 Citations |
| 1 | Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. (Baca SC, Takeda DY, Seo JH, Hwang J, Ku SY, Arafeh R, Arnoff T, Agarwal S, Bell C, O'Connor E, Qiu X, Alaiwi SA, Corona RI, Fonseca MAS, Giambartolomei C, Cejas P, Lim K, He M, Sheahan A, Nassar A, Berchuck JE, Brown L, Nguyen HM, Coleman IM, Kaipainen A, De Sarkar N, Nelson PS, Morrissey C, Korthauer K, Pomerantz MM, Ellis L, Pasaniuc B, Lawrenson K, Kelly K, Zoubeidi A, Hahn WC, Beltran H, Long HW, Brown M, Corey E, Freedman ML) Nat Commun 2021 Mar 30;12(1):1979 92 Citations |
| 1 | Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer (Bollig CA, Lee DS, Mazul AL, Stepan K, Puram SV, Massa ST, Zenga J, Faden DL, Doering MM, Jackson RS, Pipkorn P) Otolaryngology - Head and Neck Surgery (United States) April 2021;164(4):733-740 5 Citations |
| 1 | Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer (Olson J, Sheean P, Matthews L, Chitambar CR, Banerjee A, Visotcky A, Bonini M, Stolley M) Future Science OA 1 April 2021;7(4) 8 Citations |
| 1 | Mass spectrometry in the lipid study of cancer. (Nabi MM, Mamun MA, Islam A, Hasan MM, Waliullah ASM, Tamannaa Z, Sato T, Kahyo T, Setou M) Expert Rev Proteomics 2021 Mar;18(3):201-219 15 Citations |
| 1 | Clinical and Psychosocial Challenges of Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. (Chaudhary LN) JCO Oncol Pract 2021 Jun;17(6):317-319 6 Citations |
| 1 | Pan-Cancer Transcriptional Models Predicting Chemosensitivity in Human Tumors. (Wells JD, Griffin JR, Miller TW) Cancer Inform 2021;20:11769351211002494 |
| 4 | Reducing distress and depression in cancer patients during survivorship. (Molinaro J, Banerjee A, Lyndon S, Slocum S, Danhieux-Poole C, Restivo-Pritzl C, Uselmann AM, Wallace L, Knight JM) Psychooncology 2021 Jun;30(6):962-969 6 Citations |
| 1 | Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer. (Poelaert BJ, Knoche SM, Larson AC, Pandey P, Seshacharyulu P, Khan N, Maurer HC, Olive KP, Sheinin Y, Ahmad R, Singh AB, Batra SK, Rachagani S, Solheim JC) Cancers (Basel) 2021 Mar 26;13(7) 4 Citations |
| 2 | Preferences in trust regarding the provision of cancer information among adults. (Williams JS, Fong-Gurzinsky J, Nagavally S, Walker RJ, Asan O, Ozieh MN, Egede LE) J Natl Med Assoc 2021 Aug;113(4):457-464 10 Citations |
| 1 | Reply to: Comments on Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer. (Parra SG, López-Orellana LM, Molina Duque AR, Carns JL, Schwarz RA, Smith CA, Ortiz Silvestre M, Diaz Bazan S, Felix JC, Ramalingam P, Castle PE, Cremer ML, Maza M, Schmeler KM, Richards-Kortum RR) Int J Cancer 2021 Apr 04 |
| 1 | The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. (Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT) J Geriatr Oncol 2021 Jul;12(6):937-944 6 Citations |
| 3 | Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer. (Olson J, Sheean P, Matthews L, Chitambar CR, Banerjee A, Visotcky A, Bonini M, Stolley M) Future Sci OA 2021 Mar 04;7(4):FSO694 |
| 1 | Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective. (Ward EP, Evans DB, Tsai S) J Surg Oncol 2021 May;123(6):1405-1413 4 Citations |
| 1 | Hospitalization and mortality outcomes in the first 5 years after a childhood cancer diagnosis: a population-based study. (Steineck A, Chow EJ, Doody DR, Mueller BA) Cancer Causes Control 2021 Jul;32(7):739-752 2 Citations |
| 1 | Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. (Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I, innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators) Lancet Oncol 2021 May;22(5):609-619 289 Citations |
| 1 | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting. (Miller MS, Allen PJ, Brown PH, Chan AT, Clapper ML, Dashwood RH, Demehri S, Disis ML, DuBois RN, Glynn RJ, Kensler TW, Khan SA, Johnson BD, Liby KT, Lipkin SM, Mallery SR, Meuillet EJ, Roden RBS, Schoen RE, Sharp ZD, Shirwan H, Siegfried JM, Rao CV, You M, Vilar E, Szabo E, Mohammed A) J Cancer Prev 2021 Mar 30;26(1):71-82 |
| 1 | Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers. (Salsman JM, Danhauer SC, Moore JB, Ip EH, McLouth LE, Nightingale CL, Cheung CK, Bingen KM, Tucker-Seeley RD, Little-Greene D, Howard DS, Reeve BB) Cancer 2021 Jun 01;127(11):1739-1748 26 Citations |
| 2 | A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. (Kloesch B, Ionasz V, Paliwal S, Hruschka N, Martinez de Villarreal J, Öllinger R, Mueller S, Dienes HP, Schindl M, Gruber ES, Stift J, Herndler-Brandstetter D, Lomberk GA, Seidler B, Saur D, Rad R, Urrutia RA, Real FX, Martinelli P) Gut 2022 Apr;71(4):766-777 54 Citations |
| 1 | Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies. (Eskander RN, Kurzrock R) Med 2021 Mar 12;2(3):211-213 1 Citation |
| 4 | The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database. (Campbell DA, Pipkorn P, Divi V, Stadler M, Massey B, Campbell B, Richmon JD, Graboyes E, Puram S, Zenga J) Am J Otolaryngol 2021;42(5):103012 3 Citations |
| 1 | Assessment of Phenylboronic Acid Nitrogen Mustards as Potent and Selective Drug Candidates for Triple-Negative Breast Cancer. (Fan H, Zaman MAU, Chen W, Ali T, Campbell A, Zhang Q, Setu NI, Saxon E, Zahn NM, Benko AM, Arnold LA, Peng X) ACS Pharmacol Transl Sci 2021 Apr 09;4(2):687-702 10 Citations |
| 1 | Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial. (Friedlander M, Moore KN, Colombo N, Scambia G, Kim BG, Oaknin A, Lisyanskaya A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley WH, Liu J, Mathews C, Selle F, Lortholary A, Lowe ES, Hettle R, Flood E, Parkhomenko E, DiSilvestro P) Lancet Oncol 2021 May;22(5):632-642 46 Citations |
| 1 | Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (Petit C, Lacas B, Pignon JP, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O'Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P, MACH-NC and MARCH Collaborative Groups) Lancet Oncol 2021 May;22(5):727-736 67 Citations |
| 1 | Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors. (Kato S, Porter R, Okamura R, Lee S, Zelichov O, Tarcic G, Vidne M, Kurzrock R) Eur J Cancer 2021 May;149:184-192 3 Citations |
| 1 | High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer. (Traphagen NA, Hosford SR, Jiang A, Marotti JD, Brauer BL, Demidenko E, Miller TW) Oncogene 2021 May;40(19):3408-3421 14 Citations |
| 1 | Prediction of Speech, Swallowing, and Quality of Life in Oral Cavity Cancer Patients: A Pilot Study. (Bulbul MG, Wu M, Lin D, Emerick K, Deschler D, Richmon J, Goldsmith T, Zenga J, Puram SV, Varvares MA) Laryngoscope 2021 Nov;131(11):2497-2504 15 Citations |
| 1 | Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors. (Dilawari A, Rentscher KE, Zhai W, Zhou X, Ahles TA, Ahn J, Bethea TN, Carroll JE, Cohen HJ, Graham DA, Jim H, McDonald B, Nakamura ZM, Patel SK, Root JC, Small BJ, Saykin AJ, Tometich D, Van Dyk K, Mandelblatt JS, Thinking and Living with Cancer Study) Res Sq 2021 Apr 14 |
| 1 | Pulmonary Hypertension as a Complication of Pediatric Cancer. (Kirkpatrick EC) Glob Pediatr Health 2021;8:2333794X211009094 5 Citations |
| 1 | A Technology-Based Physical Activity Intervention for Patients With Metastatic Breast Cancer (Fit2ThriveMB): Protocol for a Randomized Controlled Trial. (Phillips S, Solk P, Welch W, Auster-Gussman L, Lu M, Cullather E, Torre E, Whitaker M, Izenman E, La J, Lee J, Spring B, Gradishar W) JMIR Res Protoc 2021 Apr 23;10(4):e24254 9 Citations |
| 3 | Postmastectomy breast reconstruction in women aged 70 and older: An analysis of the National Cancer Database (NCDB). (Cortina CS, Bergom CR, Kijack J, Thorgerson AA, Huang CS, Kong AL) Surgery 2021 Jul;170(1):30-38 14 Citations |
| 5 | Evaluation of fatigue and related factors in survivors of pediatric cancer and hematopoietic stem cell transplant. (Karst JS, Hoag JA, Anderson LJ, Schmidt DJ, Schroedl RL, Bingen KM) J Child Health Care 2022 Sep;26(3):383-393 4 Citations |
| 1 | Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy (Evans DB) Surgery (United States) May 2021;169(5):1032-1033 3 Citations |
| 1 | The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clinical and Translational Radiation Oncology May 2021;28:124-128 7 Citations |
| 1 | Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer (Mahadevan A, Moningi S, Grimm J, Li XA, Forster KM, Palta M, Prior P, Goodman KA, Narang A, Heron DE, Lo SS, Urbanic J, Herman JM) International Journal of Radiation Oncology Biology Physics 1 May 2021;110(1):206-216 30 Citations |
| 1 | Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. (Asnani A, Moslehi JJ, Adhikari BB, Baik AH, Beyer AM, de Boer RA, Ghigo A, Grumbach IM, Jain S, Zhu H, American Heart Association Council on Basic Cardiovascular Sciences; Cardio-Oncology Science Subcommittee of Council on Genomic and Precision Medicine and Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Council on Arteriosclerosis, Thrombosis and Vascular Biology) Circ Res 2021 Jun 25;129(1):e21-e34 51 Citations |
| 2 | Corrigendum to: Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer (EMBO Molecular Medicine, (2012), 4, 9, (964-979), 10.1002/emmm.201201255) (Cano CE, José Sandí M, Hamidi T, Calvo EL, Turrini O, Bartholin L, Loncle C, Secq V, Garcia S, Lomberk G, Kroemer G, Urrutia R, Iovanna JL) EMBO Molecular Medicine 7 May 2021;13(5) 1 Citation |
| 1 | Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. (Ouyang X, Liu Y, Zhou Y, Guo J, Wei TT, Liu C, Lee B, Chen B, Zhang A, Casey KM, Wang L, Kooreman NG, Habtezion A, Engleman EG, Wu JC) Stem Cell Reports 2021 Jun 08;16(6):1468-1477 33 Citations |
| 1 | Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. (Cano CE, José Sandí M, Hamidi T, Calvo EL, Turrini O, Bartholin L, Loncle C, Secq V, Garcia S, Lomberk G, Kroemer G, Urrutia R, Iovanna JL) EMBO Mol Med 2021 May 07;13(5):e14243 1 Citation |
| 1 | Tincture of Time: The Evolution of Goals in Adolescents and Young Adults with Cancer. (Steineck A, Barton KS, Bradford MC, Yi-Frazier JP, Rosenberg AR) J Adolesc Young Adult Oncol 2021 Dec;10(6):703-710 2 Citations |
| 3 | The association of stressful life events on weight loss efforts among African American breast cancer survivors. (Kwarteng JL, Matthews L, Banerjee A, Sharp LK, Gerber BS, Stolley MR) J Cancer Surviv 2022 Jun;16(3):604-613 2 Citations |
| 1 | The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clin Transl Radiat Oncol 2021 May;28:124-128 7 Citations |
| 1 | Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy. (Banister HR, Hammond ST, Parr SK, Sutterfield SL, Turpin VG, Treinen S, Bell MJ, Ade CJ) Cardiooncology 2021 May 13;7(1):18 7 Citations |
| 1 | The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database. (Barrett TF, Mazul AL, Stepan KO, Wood CB, Paniello RC, Zevallos JP, Massa S, Jackson RS, Schmitt NC, Zenga J, Kang SY, Pipkorn P, Rich JT, Puram SV) Oral Oncol 2021 Jul;118:105330 6 Citations |
| 1 | MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers. (Nejati K, Alivand M, Arabzadeh A) Pathol Res Pract 2021 Jul;223:153452 23 Citations |
| 1 | Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth. (Nyquist MD, Ang LS, Corella A, Coleman IM, Meers MP, Christiani AJ, Pierce C, Janssens DH, Meade HE, Bose A, Brady L, Howard T, De Sarkar N, Frank SB, Dumpit RF, Dalton JT, Corey E, Plymate SR, Haffner MC, Mostaghel EA, Nelson PS) J Clin Invest 2021 May 17;131(10) 30 Citations |
| 1 | Prevalence and predictors of peripheral neuropathy after chemotherapy: Outcomes from the Detroit Research on Cancer Survivorship (ROCS) cohort. (K Sreeram, R Seaton, M Kamgar, H Assad, MK Greenwald, JJ Ruterbusch, JL Beebe-Dimmer, AG Schwartz, MS Simon) Journal of Clinical Oncology 39 (15_suppl), 12069-12069 |
| 1 | HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update. (Wang L, Asirvatham JR, Ma Y, Reisenbichler ES, Jorns JM) Breast J 2021 Aug;27(8):631-637 6 Citations |
| 1 | MAGNITUDE OF CA19-9 DECLINE IN RESPONSE TO NEOADJUVANT CHEMORADIATION IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC CANCER (Sam Thalji, William Hall, Mohammed Aldakkak, Kathleen Christians, Callisia N Clarke, Ben George, Mandana Kamgar, Bryan Hunt, Srivats Madhavan, Naveen Kulkarni, Beth A Erickson, Douglas B Evans, Susan Tsai. ) Gastroenterology 160 (6), S-902 |
| 1 | Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies. (Chakiryan NH, Dahmen A, Bandini M, Pederzoli F, Marandino L, Albersen M, Roussel E, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Chahoud J, Briganti A, Salvioni R, Montorsi F, Necchi A, Spiess PE) J Urol 2021 Oct;206(4):960-969 14 Citations |
| 2 | Sudden Paralysis in a 39-Year-Old Woman With Metastatic Breast Cancer. (Griffiths C, Connelly J, Chaudhary LN) JAMA Oncol 2021 Aug 01;7(8):1239-1240 1 Citation |
| 1 | Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clinical Genitourinary Cancer June 2021;19(3):267-270.e1 2 Citations |
| 1 | Treating Positive Axillary Disease in Elderly Breast Cancer Patients: The Impact of Age on Radiation Therapy (Cortina CS, Woodfin AA, Tangalakis LL, Wang X, Son JD, Poirier J, Rao R, Kopkash K, Madrigrano A) Breast Care 1 June 2021;16(3):276-282 4 Citations |
| 1 | Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides. (Zhao Y, Wang S, Fei W, Feng Y, Shen L, Yang X, Wang M, Wu M) Int J Mol Sci 2021 May 26;22(11) 10 Citations |
| 1 | Incidence and Treatment Efficacy of Trigger Finger in the Breast Cancer Population on Aromatase Inhibitors. (Regent-Smith AJ, Childers EJ, Dzwierzynski WW, Morgan AL) Hand (N Y) 2023 Mar;18(2):250-253 5 Citations |
| 1 | The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. (Delgir S, Bastami M, Ilkhani K, Safi A, Seif F, Alivand MR) Mutat Res Rev Mutat Res 2021;787:108366 36 Citations |
| 1 | Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA. (Schweizer MT, Sivakumar S, Tukachinsky H, Coleman I, De Sarkar N, Yu EY, Konnick EQ, Nelson PS, Pritchard CC, Montgomery B) JAMA Oncol 2021 Jun 04;7(9):1-5 53 Citations |
| 1 | New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. (Hessmann E, Schneider G, 1(st) Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting) Gastroenterology 2021 Sep;161(3):785-791 5 Citations |
| 1 | Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII. (Parr SK, Steele CC, Hammond ST, Turpin VRG, Ade CJ) Int J Cardiol Hypertens 2021 Jun;9:100085 7 Citations |
| 2 | Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care. (Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL) Ann Surg Oncol 2022 Apr;29(4):2176-2180 47 Citations |
| 1 | Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score. (Gao C, Polley EC, Hart SN, Huang H, Hu C, Gnanaolivu R, Lilyquist J, Boddicker NJ, Na J, Ambrosone CB, Auer PL, Bernstein L, Burnside ES, Eliassen AH, Gaudet MM, Haiman C, Hunter DJ, Jacobs EJ, John EM, Lindström S, Ma H, Neuhausen SL, Newcomb PA, O'Brien KM, Olson JE, Ong IM, Patel AV, Palmer JR, Sandler DP, Tamimi R, Taylor JA, Teras LR, Trentham-Dietz A, Vachon CM, Weinberg CR, Yao S, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Couch FJ, Kraft P) J Clin Oncol 2021 Aug 10;39(23):2564-2573 55 Citations |
| 1 | Disparate Use of Chemoradiation in Elderly Patients With Localized Anal Cancer. (Miller ED, Nalin AP, Diaz Pardo DA, Arnett AL, Huang E, Gasior AC, Malalur P, Chen HZ, Williams TM, Bazan JG) J Natl Compr Canc Netw 2021 Jun 10;20(6):644-652.e2 6 Citations |
| 1 | Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth. (Nyquist MD, Ang LS, Corella A, Coleman IM, Meers MP, Christiani AJ, Pierce C, Janssens DH, Meade HE, Bose A, Brady L, Howard T, De Sarkar N, Frank SB, Dumpit RF, Dalton JT, Corey E, Plymate SR, Haffner MC, Mostaghel EA, Nelson PS) J Clin Invest 2021 Jun 15;131(12) |
| 6 | Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States. (Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, Rademacher N, Namin S, Kwarteng J, Beltrán Ponce S, Nattinger AB) J Clin Oncol 2021 Sep 01;39(25):2749-2757 46 Citations |
| 1 | A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores. (Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT) Breast Cancer Res Treat 2021 Sep;189(2):455-461 7 Citations |
| 1 | The expression of miRNA-152-3p and miRNA-185 in tumor tissues versus margin tissues of patients with chemo-treated breast cancer. (Safi A, Delgir S, Ilkhani K, Samei A, Mousavi SR, Zeynali-Khasraghi Z, Bastami M, Alivand MR) BMC Res Notes 2021 Jun 16;14(1):234 5 Citations |
| 1 | Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls. (Rentscher KE, Zhou X, Small BJ, Cohen HJ, Dilawari AA, Patel SK, Bethea TN, Van Dyk KM, Nakamura ZM, Ahn J, Zhai W, Ahles TA, Jim HSL, McDonald BC, Saykin AJ, Root JC, Graham DMA, Carroll JE, Mandelblatt JS) Cancer 2021 Oct 01;127(19):3671-3679 58 Citations |
| 1 | How Do Pathologists in Academic Institutions Across the United States and Canada Evaluate Sentinel Lymph Nodes in Breast Cancer? A Practice Survey. (Asirvatham JR, Jorns JM) Am J Clin Pathol 2021 Nov 08;156(6):980-988 4 Citations |
| 2 | A closer look at 30 day hospital readmissions after head and neck cancer surgery. (Puccia R, Ramamurthi A, Grond SE, McCormick C, Ng A, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz C, Wong S, Shreenivas A, Zenga J) Am J Otolaryngol 2021;42(5):103146 2 Citations |
| 1 | Down-regulation of a panel of immune-related lncRNAs in breast cancer. (Ghafouri-Fard S, Asadi M, Sohrabi B, Arsang-Jang S, Mehravaran E, Taheri M, Samsami M) Pathol Res Pract 2021 Aug;224:153534 12 Citations |
| 2 | Providing Palliative and Hospice Care to Children, Adolescents and Young Adults with Cancer. (Pyke-Grimm KA, Fisher B, Haskamp A, Bell CJ, Newman AR) Semin Oncol Nurs 2021 Jun;37(3):151166 13 Citations |
| 1 | Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection. (Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, D3CODE Team, Chang GJ) Ann Surg Oncol 2021 Dec;28(13):8046-8053 20 Citations |
| 1 | Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic (Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW) Endocrinology, Diabetes and Metabolism July 2021;4(3) 1 Citation |
| 1 | Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. (Waters AM, Khatib TO, Papke B, Goodwin CM, Hobbs GA, Diehl JN, Yang R, Edwards AC, Walsh KH, Sulahian R, McFarland JM, Kapner KS, Gilbert TSK, Stalnecker CA, Javaid S, Barkovskaya A, Grover KR, Hibshman PS, Blake DR, Schaefer A, Nowak KM, Klomp JE, Hayes TK, Kassner M, Tang N, Tanaseichuk O, Chen K, Zhou Y, Kalkat M, Herring LE, Graves LM, Penn LZ, Yin HH, Aguirre AJ, Hahn WC, Cox AD, Der CJ) Cell Rep 2021 Jun 29;35(13):109291 19 Citations |
| 2 | Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening. (Nyitray AG, Schick V, Swartz MD, Giuliano AR, Fernandez ME, Deshmukh AA, Ridolfi TJ, Ajala C, Brzezinski B, Sandoval M, Nedjai B, Smith JS, Chiao EY) BMJ Open 2021 Jun 29;11(6):e051118 9 Citations |
| 2 | Neighborhood characteristics and cancer survivorship: An overview of the current literature on neighborhood landscapes and cancer care (Namin S, Zhou Y, Neuner J, Beyer K) International Journal of Environmental Research and Public Health 1 July 2021;18(13) 11 Citations |
| 1 | Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ) JAMA Oncol 2021 Aug 01;7(8):1225-1230 130 Citations |
| 1 | Learning from and Leveraging Multi-Level Changes in Responses to the COVID 19 Pandemic to Facilitate Breast Cancer Prevention Efforts. (Bowen DJ, Rentscher KE, Wu A, Darien G, Haile HG, Mandelblatt J, Kavanaugh-Lynch M) Int J Environ Res Public Health 2021 Jun 30;18(13) 4 Citations |
| 1 | Safeguarding COVID-19 and cancer management: drug design and therapeutic approach. (Thorat N, Pricl S, Parchur AK, Somvanshi SB, Li Q, Umrao S, Townley H) Open Res Eur 2021;1:77 1 Citation |
| 1 | The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer. (Delgir S, Ilkhani K, Safi A, Rahmati Y, Montazari V, Zaynali-Khasraghi Z, Seif F, Bastami M, Alivand MR) BMC Med Genomics 2021 Jul 07;14(1):180 17 Citations |
| 1 | Surgical Management of Postradiation, Dropped Head Spinal Deformity in Patients with Head and Neck Cancer. (Verla T, Vedantam A, North RY, Xu DS, Raber MR, Fuentes A, Liou NE, Ropper AE) World Neurosurg 2021 Dec;156:e1-e8 6 Citations |
| 1 | Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study. (Puckett LL, Saba SG, Henry S, Rosen S, Rooney E, Filosa SL, Gilbo P, Pappas K, Laxer A, Eacobacci K, Kapyur AN, Robeny J, Musial S, Chaudhry A, Chaudhry R, Lesser ML, Riegel A, Ramoutarpersaud S, Rahmani N, Shah A, Papas V, Dawodu T, Charlton J, Knisely JPS, Lee L) Cancer Med 2021 Aug;10(15):5051-5061 16 Citations |
| 1 | Treating Positive Axillary Disease in Elderly Breast Cancer Patients: The Impact of Age on Radiation Therapy. (Cortina CS, Woodfin AA, Tangalakis LL, Wang X, Son JD, Poirier J, Rao R, Kopkash K, Madrigrano A) Breast Care (Basel) 2021 Jun;16(3):276-282 4 Citations |
| 6 | Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks. (Urrutia G, de Assuncao TM, Mathison AJ, Salmonson A, Kerketta R, Zeighami A, Stodola TJ, Adsay V, Pehlivanoglu B, Dwinell MB, Zimmermann MT, Iovanna JL, Urrutia R, Lomberk G) Front Cell Dev Biol 2021;9:681153 7 Citations |
| 1 | Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. (Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW) Endocrinol Diabetes Metab 2021 Jul;4(3):e00246 1 Citation |
| 1 | Neighborhood Characteristics and Cancer Survivorship: An Overview of the Current Literature on Neighborhood Landscapes and Cancer Care. (Namin S, Zhou Y, Neuner J, Beyer K) Int J Environ Res Public Health 2021 Jul 05;18(13) 11 Citations |
| 2 | AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism. (Palma FR, Ratti BA, Paviani V, Coelho DR, Miguel R, Danes JM, Zaichik SV, de Abreu AL, Silva SO, Chen Y, Silverstein RL, Karan U, Jones DP, Bonini MG) Oncogene 2021 Sep;40(36):5455-5467 13 Citations |
| 1 | Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. (Boddicker NJ, Hu C, Weitzel JN, Kraft P, Nathanson KL, Goldgar DE, Na J, Huang H, Gnanaolivu RD, Larson N, Yussuf A, Yao S, Vachon CM, Trentham-Dietz A, Teras L, Taylor JA, Scott CE, Sandler DP, Pesaran T, Patel AV, Palmer JR, Ong IM, Olson JE, O'Brien K, Neuhausen S, Martinez E, Ma H, Lindstrom S, Le Marchand L, Kooperberg C, Karam R, Hunter DJ, Hodge JM, Haiman C, Gaudet MM, Gao C, LaDuca H, Lacey JV, Dolinsky JS, Chao E, Carter BD, Burnside ES, Bertrand KA, Bernstein L, Auer PW, Ambrosone C, Yadav S, Hart SN, Polley EC, Domchek SM, Couch FJ) J Clin Oncol 2021 Nov 01;39(31):3430-3440 24 Citations |
| 1 | Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening. (Adashek JJ, Janku F, Kurzrock R) Cancers (Basel) 2021 Jul 18;13(14) 54 Citations |
| 1 | Global identification and characterization of tRNA-derived RNA fragment landscapes across human cancers. (Sun X, Yang J, Yu M, Yao D, Zhou L, Li X, Qiu Q, Lin W, Lu B, Chen E, Wang P, Chen W, Tao S, Xu H, Williams A, Liu Y, Pan X, Cowley AW Jr, Lu W, Liang M, Liu P, Lu Y) NAR Cancer 2020 Dec;2(4):zcaa031 20 Citations |
| 1 | Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. (Wang TF, Baumann Kreuziger L, Leader A, Spectre G, Lim MY, Gahagan A, Gangaraju R, Sanfilippo KM, Mallick R, Zwicker JI, Carrier M) J Thromb Haemost 2021 Aug;19(8):2068-2081 30 Citations |
| 1 | GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study. (Thaker PH, Bradley WH, Leath CA 3rd, Gunderson Jackson C, Borys N, Anwer K, Musso L, Matsuzaki J, Bshara W, Odunsi K, Alvarez RD) Clin Cancer Res 2021 Oct 15;27(20):5536-5545 18 Citations |
| 2 | Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study. (Javle M, Borad MJ, Azad NS, Kurzrock R, Abou-Alfa GK, George B, Hainsworth J, Meric-Bernstam F, Swanton C, Sweeney CJ, Friedman CF, Bose R, Spigel DR, Wang Y, Levy J, Schulze K, Cuchelkar V, Patel A, Burris H) Lancet Oncol 2021 Sep;22(9):1290-1300 281 Citations |
| 1 | The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers. (Gupta D, Kato S, Kurzrock R) J Immunother Precis Oncol 2021 May;4(2):56-63 |
| 4 | Pharmacy deserts and patients with breast cancer receipt of influenza vaccines. (Neuner JM, Zhou Y, Fergestrom N, Winn A, Pezzin L, Laud PW, Beyer K) J Am Pharm Assoc (2003) 2021;61(6):e25-e31 8 Citations |
| 1 | A novel combined resilience and advance care planning intervention for adolescents and young adults with advanced cancer: A feasibility and acceptability cohort study. (Fladeboe KM, O'Donnell MB, Barton KS, Bradford MC, Steineck A, Junkins CC, Yi-Frazier JP, Rosenberg AR) Cancer 2021 Dec 01;127(23):4504-4511 25 Citations |
| 1 | Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial. (Colombo N, Moore K, Scambia G, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley WH, Kim JW, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P) Gynecol Oncol 2021 Oct;163(1):41-49 27 Citations |
| 1 | PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. (Koshkin VS, Patel VG, Ali A, Bilen MA, Ravindranathan D, Park JJ, Kellezi O, Cieslik M, Shaya J, Cabal A, Brown L, Labriola M, Graham LS, Pritchard C, Tripathi A, Nusrat S, Barata P, Jang A, Chen SR, Garje R, Acharya L, Hwang C, Pilling A, Oh W, Jun T, Natesan D, Nguyen C, Kilari D, Pierro M, Thapa B, Cackowski F, Mack A, Heath E, Marshall CH, Tagawa ST, Halabi S, Schweizer MT, Armstrong A, Dorff T, Alva A, McKay R) Prostate Cancer Prostatic Dis 2022 Sep;25(3):388-396 25 Citations |
| 1 | Missing the target in cancer therapy. (Adashek JJ, Goloubev A, Kato S, Kurzrock R) Nat Cancer 2021 Apr;2:369-371 25 Citations |
| 1 | SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. (Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R) JCI Insight 2021 Sep 22;6(18) 43 Citations |
| 4 | The Substantial Omission of Indicated Postoperative Radiotherapy in Patients With Advanced-Stage Oral Cancer in the US-A Call to Action. (Awan M, Akakpo KE, Shukla M, Graboyes EM, Pipkorn P, Puram SV, Zenga J) JAMA Otolaryngol Head Neck Surg 2021 Oct 01;147(10):907-909 3 Citations |
| 7 | Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. (Geethadevi A, Nair A, Parashar D, Ku Z, Xiong W, Deng H, Li Y, George J, McAllister DM, Sun Y, Kadamberi IP, Gupta P, Dwinell MB, Bradley WH, Rader JS, Rui H, Schwabe RF, Zhang N, Pradeep S, An Z, Chaluvally-Raghavan P) Cancer Res 2021 Oct 15;81(20):5336-5352 39 Citations |
| 1 | Prevalence and predictors of peripheral neuropathy after breast cancer treatment. (Kamgar M, Greenwald MK, Assad H, Hastert TA, McLaughlin EM, Reding KW, Paskett ED, Bea JW, Shadyab AH, Neuhouser ML, Nassir R, Crane TE, Sreeram K, Simon MS) Cancer Med 2021 Oct;10(19):6666-6676 28 Citations |
| 3 | Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. (Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC, Kong AL) Clin Breast Cancer 2022 Jan;22(1):49-59 15 Citations |
| 2 | User-centered development of a smartphone application (Fit2Thrive) to promote physical activity in breast cancer survivors. (Welch WA, Solk P, Auster-Gussman L, Gavin KL, Whitaker M, Cullather E, Izenman E, Courneya KS, Ackermann R, Spring B, Cella D, Penedo F, Phillips SM) Transl Behav Med 2022 Feb 16;12(2):203-213 10 Citations |
| 1 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. (Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Cheng TD, Clarke CL, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Dörk T, Dossus L, Dunning AM, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, Gago-Dominguez M, García-Sáenz JA, Giles GG, Grip M, Guénel P, Gündert M, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hart SN, Hartikainen JM, Hartmann A, He W, Hooning MJ, Hoppe R, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab Investigators, Jager A, Jakubowska A, Janni W, John EM, Jung AY, Kaaks R, Keupers M, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lacey JV, Lambrechts D, Le Marchand L, Lindblom A, Linet M, Luben RN, Lubiński J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Martens JWM, Martinez ME, Mavroudis D, Michailidou K, Milne RL, Mulligan AM, Muranen TA, Nevanlinna H, Newman WG, Nielsen SF, Nordestgaard BG, Olshan AF, Olsson H, Orr N, Park-Simon TW, Patel AV, Peissel B, Peterlongo P, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Rack B, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Ruebner M, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott C, Shah M, Smichkoska S, Southey MC, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teras LR, Terry MB, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Vachon CM, Wang Q, Hurson AN, Winqvist R, Wolk A, Ziogas A, Brauch H, García-Closas M, Pharoah PDP, Easton DF, Chenevix-Trench G, Schmidt MK) Breast Cancer Res 2021 Aug 18;23(1):86 9 Citations |
| 1 | Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer. (Tsimberidou AM, Shaw JV, Juric D, Verschraegen C, Weise AM, Sarantopoulos J, Lopes G, Nemunaitis J, Mita M, Park H, Ellers-Lenz B, Tian H, Xiong W, Kaleta R, Kurzrock R) J Hematol Oncol 2021 Aug 18;14(1):127 15 Citations |
| 1 | Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer. (Flynn KE, Lin L, Carter J, Baser RE, Goldfarb S, Saban S, Weinfurt KP) J Sex Med 2021 Oct;18(10):1768-1774 4 Citations |
| 1 | Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database. (Fonseca AL, Cherla D, Kothari AN, Tzeng CD, Heslin MJ, Mehari KR, Johnston FM, Tran-Cao HS) Ann Surg Oncol 2022 Jan;29(1):342-351 24 Citations |
| 6 | A closer look at 30 day hospital readmissions after head and neck cancer surgery (Puccia R, Ramamurthi A, Grond SE, McCormick C, Ng A, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz C, Wong S, Shreenivas A, Zenga J) American Journal of Otolaryngology - Head and Neck Medicine and Surgery 1 September 2021;42(5) 2 Citations |
| 1 | Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. (Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R) Mol Cancer Ther 2021 Nov;20(11):2274-2279 6 Citations |
| 1 | EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers. (Kandimalla R, Xu J, Link A, Matsuyama T, Yamamura K, Parker MI, Uetake H, Balaguer F, Borazanci E, Tsai S, Evans D, Meltzer SJ, Baba H, Brand R, Von Hoff D, Li W, Goel A) Clin Cancer Res 2021 Nov 15;27(22):6135-6144 44 Citations |
| 1 | Impact of Hepatic Metastasectomy in the Multimodal Treatment of Metastatic Breast Cancer. (Ellis OV, Hornock SL, Bohan PMK, Dilday JC, Chang SC, Bader JO, Vreeland TJ, Nelson DW) J Surg Res 2021 Dec;268:650-659 5 Citations |
| 1 | Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. (Jones CU, Pugh SL, Sandler HM, Chetner MP, Amin MB, Bruner DW, Zietman AL, Den RB, Leibenhaut MH, Longo JM, Bahary JP, Rosenthal SA, Souhami L, Michalski JM, Hartford AC, Amin PP, Roach M 3rd, Yee D, Efstathiou JA, Rodgers JP, Feng FY, Shipley WU) Int J Radiat Oncol Biol Phys 2022 Feb 01;112(2):294-303 21 Citations |
| 1 | A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer. (Dubey S, Singh M, Nelson A, Karan D) J Immunol Res 2021;2021:9483433 9 Citations |
| 1 | Rural-urban differences in HPV testing for cervical cancer screening. (Locklar LRB, Do DP) J Rural Health 2022 Mar;38(2):409-415 15 Citations |
| 1 | The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update. (Torki Z, Ghavi D, Hashemi S, Rahmati Y, Rahmanpour D, Pornour M, Alivand MR) Cancer Chemother Pharmacol 2021 Nov;88(5):771-793 12 Citations |
| 1 | Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. (Sokolova AO, Marshall CH, Lozano R, Gulati R, Ledet EM, De Sarkar N, Grivas P, Higano CS, Montgomery B, Nelson PS, Olmos D, Sokolov V, Schweizer MT, Yezefski TA, Yu EY, Paller CJ, Sartor O, Castro E, Antonarakis ES, Cheng HH) Prostate 2021 Dec;81(16):1382-1389 12 Citations |
| 1 | Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship. (Nouri R, Hasani A, Shirazi KM, Alivand MR, Sepehri B, Sotoodeh S, Hemmati F, Rezaee MA) Curr Pharm Biotechnol 2022;23(10):1257-1268 22 Citations |
| 1 | Precision Medicine and Pancreatic Cancer. (George B) Surg Oncol Clin N Am 2021 Oct;30(4):693-708 3 Citations |
| 2 | Advanced Endoscopic Techniques for the Diagnosis of Pancreatic Cancer and Management of Biliary and GastricOutlet Obstruction. (Nakai Y, Smith Z, Chang KJ, Dua KS) Surg Oncol Clin N Am 2021 Oct;30(4):639-656 4 Citations |
| 1 | Updates on the Management of Pancreatic Cancer. (Tsai S, Evans DB) Surg Oncol Clin N Am 2021 Oct;30(4):xvii-xviii 4 Citations |
| 2 | Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer. (Hall WA, Erickson B, Crane CH) Surg Oncol Clin N Am 2021 Oct;30(4):719-730 5 Citations |
| 2 | Multimodality Imaging for the Staging of Pancreatic Cancer. (McKinney M, Griffin MO, Tolat PP) Surg Oncol Clin N Am 2021 Oct;30(4):621-637 6 Citations |
| 1 | Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors. (Dilawari A, Rentscher KE, Zhai W, Zhou X, Ahles TA, Ahn J, Bethea TN, Carroll JE, Cohen HJ, Graham DA, Jim HSL, McDonald B, Nakamura ZM, Patel SK, Root JC, Small BJ, Saykin AJ, Tometich D, Van Dyk K, Mandelblatt JS, Thinking and Living with Cancer Study) Breast Cancer Res Treat 2021 Nov;190(2):287-293 8 Citations |
| 1 | Health Care Disparities and the Future of Pancreatic Cancer Care. (Papageorge MV, Evans DB, Tseng JF) Surg Oncol Clin N Am 2021 Oct;30(4):759-771 11 Citations |
| 1 | Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers. (Portelance L, Corradini S, Erickson B, Lalondrelle S, Padgett K, van der Leij F, van Lier A, Jürgenliemk-Schulz I) Front Oncol 2021;11:628131 17 Citations |
| 2 | NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. (Sun Y, Yang N, Utama FE, Udhane SS, Zhang J, Peck AR, Yanac A, Duffey K, Langenheim JF, Udhane V, Xia G, Peterson JF, Jorns JM, Nevalainen MT, Rouet R, Schofield P, Christ D, Ormandy CJ, Rosenberg AL, Chervoneva I, Tsaih SW, Flister MJ, Fuchs SY, Wagner KU, Rui H) Sci Adv 2021 Sep 17;7(38):eabc8145 11 Citations |
| 2 | Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes. (Iden M, Tsaih SW, Huang YW, Liu P, Xiao M, Flister MJ, Rader JS) Br J Cancer 2021 Nov;125(10):1408-1419 14 Citations |
| 1 | Noncancerous Genitourinary Conditions as a Public Health Priority: Conceptualizing the Hidden Burden. (Brady SS, Bavendam TG, Bradway CK, Conroy B, Dowling-Castronovo A, Epperson CN, Hijaz AK, Hsi RS, Huss K, Kim M, Lazar J, Lee RK, Liu CK, Loizou CN, Miran S, Mody L, Norton JM, Reynolds WS, Sutcliffe S, Zhang N, Hokanson JA) Urology 2022 Aug;166:39-49 9 Citations |
| 2 | Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance. (Li J, Fang K, Choppavarapu L, Yang K, Yang Y, Wang J, Cao R, Jatoi I, Jin VX) Clin Epigenetics 2021 Sep 17;13(1):175 13 Citations |
| 2 | Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination. (Auster-Gussman LA, Gavin KL, Siddique J, Welch WA, Solk P, Whitaker M, Cullather E, Fanning J, Maria CS, Gradishar W, Khan S, Kulkarni S, Phillips SM) Psychooncology 2022 Mar;31(3):425-435 10 Citations |
| 1 | Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. (Wenzel L, Huang HQ, Cella D, McKinney CO, Zevon MA, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, von Gruenigen VE) Gynecol Oncol 2021 Nov;163(2):392-397 |
| 1 | Developing a Novel Interactive Colorectal Cancer Educational Session for First-Year Medical Students to Enhance Interest in Public Health. (Marcellon R, Donovan K, Zhou H, Fiust-Klink S, Calawerts W, Patel M, Watman O, Miller D, Sorum P, Manjunath K, Stetzer R, Wales D, Mason H, Waxman M, Dacus H, Feustel P, Tadros M) J Cancer Educ 2023 Feb;38(1):127-133 1 Citation |
| 1 | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review. (Foruzandeh Z, Zeinali-Sehrig F, Nejati K, Rahmanpour D, Pashazadeh F, Seif F, Alivand MR) Cell Mol Biol Lett 2021 Sep 23;26(1):41 20 Citations |
| 4 | Ecological Study of Variability in the Relationship between Liver Cancer Mortality and Racial Residential Segregation. (Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM) Int J Environ Res Public Health 2021 Sep 15;18(18) 5 Citations |
| 1 | Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiotherapy (WA Hall, HY Khan, M Kamgar, S Tsai, K Christians, DB Evans, P Philip, C Clarke, B George, B Erickson, AS Azmi.) AACR Pancreatic Virtual Meeting; Poster Presentation |
| 1 | Phase II clinical trial of subtype directed neoadjuvant therapy in patients with
localized pancreatic cancer. (S Tsai, E Borazanci, M Gulley, N Rashid, J Merker, AH Khan, P Chisholm, B Hunt, T Giorgadze, W Hall, M Kamgar, DB Evans, JJ Yeh) AACR Pancreatic Virtual Meeting; Poster Presentation |
| 1 | Importance of Cancer Screening at the Time of Dermatomyositis Diagnosis (Kotlo, S. Nepal, D. Madenberg, D.) |
| 2 | Advanced Endoscopic Techniques for the Diagnosis of Pancreatic Cancer and Management of Biliary and GastricOutlet Obstruction (Nakai Y, Smith Z, Chang KJ, Dua KS) Surgical Oncology Clinics of North America October 2021;30(4):639-656 4 Citations |
| 1 | Multimodality Imaging for the Staging of Pancreatic Cancer (McKinney M, Griffin MO, Tolat PP) Surgical Oncology Clinics of North America October 2021;30(4):621-637 6 Citations |
| 1 | The biology of stress in cancer: Applying the biobehavioral framework to adolescent and young adult oncology research. (Taylor MR, Knight JM, Rosenberg AR) Brain Behav Immun Health 2021 Nov;17:100321 7 Citations |
| 1 | Second-generation jak2 inhibitors for advanced prostate cancer: Are we ready for clinical development? (Beinhoff P, Sabharwal L, Udhane V, Maranto C, Laviolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT) Cancers October-2 2021;13(20) 15 Citations |
| 1 | Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial (Colombo N, Moore K, Scambia G, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley WH, Kim JW, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P) Gynecologic Oncology October 2021;163(1):41-49 27 Citations |
| 1 | Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. (Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) BJU Int 2022 Nov;130(5):592-603 4 Citations |
| 1 | PET/MRI Improves Management of Children with Cancer. (Baratto L, Hawk KE, States L, Qi J, Gatidis S, Kiru L, Daldrup-Link HE) J Nucl Med 2021 Oct;62(10):1334-1340 17 Citations |
| 1 | Targeting ARID1A mutations in cancer. (Mullen J, Kato S, Sicklick JK, Kurzrock R) Cancer Treat Rev 2021 Nov;100:102287 100 Citations |
| 1 | Peripheral neuropathy after breast cancer: An analysis of data from the Women’s Health Initiative Life and Longevity After Cancer cohort. (M Kamgar, H Assad, TA Hastert, E McLaughlin, K Reding, ED Paskett, JW Bea, AH Shadyab, ML Neuhouser, R Nassir, TE Crane, K Sreeram, MK Greenwald, MS Simon) J Clin Oncol 38: 2020 (suppl; abstr e24093), 2020 ASCO Scientific Program, Online Publication, Virtual, May 2020 |
| 1 | Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers. (Pham TV, Goodman AM, Sivakumar S, Frampton G, Kurzrock R) Genome Med 2021 Oct 12;13(1):159 11 Citations |
| 1 | SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. (Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R) Mol Cancer Ther 2021 Dec;20(12):2341-2351 89 Citations |
| 4 | A Cautionary Note Regarding Obesity and Young Adult Rectal Cancer. (Peterson KJ, Blank JJ, Deshpande RR, Liu Y, Peterson CY, Ludwig KA, Ridolfi TJ) J Gastrointest Surg 2022 Apr;26(4):927-928 |
| 1 | PET/MRI Improves Management of Children with Cancer. () |
| 1 | Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. (Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI, VENUS Network Investigators) Blood Adv 2021 Dec 28;5(24):5546-5553 36 Citations |
| 1 | Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. (Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ) J Clin Oncol 2021 Dec 10;39(35):3918-3926 33 Citations |
| 1 | Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis. (Rastogi S, Kalaiselvan V, Ali S, Ahmad A, Guru SA, Sarwat M) Biology (Basel) 2021 Oct 19;10(10) 12 Citations |
| 3 | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? (Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT) Cancers (Basel) 2021 Oct 17;13(20) 15 Citations |
| 1 | Differences in Sociodemographic Correlates of Human Papillomavirus-Associated Cancer Survival in the United States. (Osazuwa-Peters N, Simpson MC, Rohde RL, Challapalli SD, Massa ST, Adjei Boakye E) Cancer Control 2021;28:10732748211041894 14 Citations |
| 1 | Real-Time Motion Tracking and Correction During Tomotherapy for Prostate Cancer: Impact of Fiducial Migration. (Chen GP, Tai A, Omari EA, Bedi M, Lawton CAF, Li A) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e539-e540 |
| 1 | Final Report of NRG Oncology RTOG 0022: A Phase I/II Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. (Garden AS, Harris J, Eisbruch A, Chao KSC, Morrison WH, Harari PM, Swanson TA, Jones CU, Yom SS, Spencer SA, Scrimger RA, Shenouda G, Shukla ME, Lau H, Mierzwa ML, Torres-Saavedra P, Le QT) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):S143 |
| 1 | Should Daily Online Adaptive Replanning be Utilized for Every Treatment in MRI-Guided Radiotherapy for Pancreatic Cancer? (Omari E, Nasief H, Zhang Y, Parchur AK, Paulson ES, Chen X, Ahunbay EE, Hall WA, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e66 |
| 2 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. (Conger R, Mora J, Straza MW Jr, Erickson BA, Lawton CAF, Schultz CJ, Currey AD, Bedi M, Saeed H, Tsai S, Siker ML, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e105 |
| 1 | Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer. (Kalyanaraman B) RSC Chem Biol 2021 Oct 07;2(5):1402-1414 12 Citations |
| 1 | Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial. (Banerjee S, Moore KN, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Oza A, González-Martín A, Aghajanian C, Bradley WH, Holmes E, Lowe ES, DiSilvestro P) Lancet Oncol 2021 Dec;22(12):1721-1731 251 Citations |
| 1 | A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). (Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R) Clin Cancer Res 2022 Jan 15;28(2):271-278 78 Citations |
| 1 | Should Daily Online Adaptive Replanning be Utilized for Every Treatment in MRI-Guided Radiotherapy for Pancreatic Cancer? (E Omari, H Nasief, Y Zhang, AK Parchur, ES Paulson, X Chen, EE Ahunbay, WA Hall, BA Erickson, A Li) International Journal of Radiation Oncology, Biology, Physics Volume 111 Issue 3 Pages e66 |
| 1 | Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer (G. Noid
A. Tai
H. Zhong
J. Shah
E.M. Gore
A. Li) International Journal of Radiation Oncology Biology Physics G. Noid, A. Tai, H. Zhong, J. Shah, E.M. Gore, A. Li, Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 |
| 1 | Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial (B. Movsas, J. Rodgers, M. A. Elshaikh, A. A. Martinez, G. Morton, D. J. Krauss, D. Yan, D. E. Citrin, B. Hershatter, J. M. Michalski, R. J. Ellis III, V. S. Kavadi, E. M. Gore, G. S. Gustafson, C. A. Schulz, V. Velker, A. C. Olson, T. G. Karrison, H. M. Sandler, D. W. Bruner) International Journal of Radiation Oncology Biology Physics B. Movsas, J. Rodgers, M.A. Elshaikh, A.A. Martinez, G. Morton, D.J. Krauss, D. Yan, D.E. Citrin, B. Hershatter, J.M. Michalski, R.J. Ellis, V.S. Kavadi, E.M. Gore, G.S. Gustafson, C.A. Schulz, V. Velker, A.C. Olson, T.G. Karrison, H.M. Sandler, D.W. Bruner, Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial, International |
| 3 | Breast cancer-related lymphedema rates after modern axillary treatments: How accurate are our estimates? (Cortina CS, Yen TWF, Bergom C, Fields B, Craft MA, Currey A, Kong AL) Surgery 2022 Mar;171(3):682-686 6 Citations |
| 1 | Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. (Cook DR, Kang M, Martin TD, Galanko JA, Loeza GH, Trembath DG, Justilien V, Pickering KA, Vincent DF, Jarosch A, Jurmeister P, Waters AM, Hibshman PS, Campbell AD, Ford CA, Keku TO, Yeh JJ, Lee MS, Cox AD, Fields AP, Sandler RS, Sansom OJ, Sers C, Schaefer A, Der CJ) Cancer Res 2022 Jan 01;82(1):90-104 22 Citations |
| 1 | Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes (Iden M, Tsaih SW, Huang YW, Liu P, Xiao M, Flister MJ, Rader JS) British Journal of Cancer 9 November 2021;125(10):1408-1419 14 Citations |
| 1 | Commentary: The relationship of cancer and heart disease-it's complicated. (Wyler von Ballmoos MC, Almassi GH) J Thorac Cardiovasc Surg 2022 Jul;164(1):115-116 2 Citations |
| 6 | Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. (McGarry SD, Brehler M, Bukowy JD, Lowman AK, Bobholz SA, Duenweg SR, Banerjee A, Hurrell SL, Malyarenko D, Chenevert TL, Cao Y, Li Y, You D, Fedorov A, Bell LC, Quarles CC, Prah MA, Schmainda KM, Taouli B, LoCastro E, Mazaheri Y, Shukla-Dave A, Yankeelov TE, Hormuth DA 2nd, Madhuranthakam AJ, Hulsey K, Li K, Huang W, Huang W, Muzi M, Jacobs MA, Solaiyappan M, Hectors S, Antic T, Paner GP, Palangmonthip W, Jacobsohn K, Hohenwalter M, Duvnjak P, Griffin M, See W, Nevalainen MT, Iczkowski KA, LaViolette PS) J Magn Reson Imaging 2022 Jun;55(6):1745-1758 10 Citations |
| 1 | The impeded diffusion fraction quantitative imaging assay demonstrated in multi-exponential diffusion phantom and prostate cancer. (Malyarenko DI, Swanson SD, McGarry SD, LaViolette PS, Chenevert TL) Magn Reson Med 2022 Apr;87(4):2053-2062 4 Citations |
| 1 | Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer (He L, Lomberk G) Frontiers in Cell and Developmental Biology 16 November 2021;9 1 Citation |
| 1 | Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features. (Nouri R, Hasani A, Masnadi Shirazi K, Alivand MR, Sepehri B, Sotoudeh S, Hemmati F, Fattahzadeh A, Abdinia B, Ahangarzadeh Rezaee M) Can J Infect Dis Med Microbiol 2021;2021:2131787 19 Citations |
| 1 | PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. (Jeung HC, Puentes R, Aleshin A, Indarte M, Correa RG, Bankston LA, Layng FIAL, Ahmed Z, Wistuba I, Yao Y, Duenas DG, Zhang S, Meuillet EJ, Marassi F, Liddington RC, Kirkpatrick L, Powis G) Exp Cell Res 2021 Dec 15;409(2):112930 1 Citation |
| 2 | Disparities in rectal cancer care: A call to action for all. (Calata J, Peterson CY) Am J Surg 2022 May;223(5):846-847 3 Citations |
| 1 | Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: Results from Fit2Thrive. (Phillips SM, Penedo FJ, Collins LM, Solk P, Siddique J, Song J, Cella D, Courneya KS, Ackermann RT, Welch WA, Auster-Gussman LA, Whitaker M, Cullather E, Izenman E, Spring B) Cancer 2022 Mar 01;128(5):1122-1132 20 Citations |
| 1 | Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group. (Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM) Cancer Epidemiol Biomarkers Prev 2022 Mar 01;31(3):536-542 21 Citations |
| 1 | Empowering childhood cancer survivors through integrated, individualized health insurance education (Kimball BC, Kudek MR, van Ly D, Eagle S, Hausman V, Plaunt E, Lee HY, Sadak KT) Precision Cancer Medicine December 2021;4 |
| 1 | Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling (Jiang Y, Guo Y, Hao J, Guenter R, Lathia J, Beck AW, Hattaway R, Hurst D, Wang QJ, Liu Y, Cao Q, Krontiras H, Chen H, Silverstein R, Ren B) Communications Biology December 2021;4(1) 17 Citations |
| 1 | Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial (Banerjee S, Moore KN, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Oza A, González-Martín A, Aghajanian C, Bradley WH, Holmes E, Lowe ES, DiSilvestro P) The Lancet Oncology December 2021;22(12):1721-1731 251 Citations |
| 1 | Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. (Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T) Nature 2021 Dec;600(7889):E18 4 Citations |
| 1 | Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden. (Boichard A, Lippman SM, Kurzrock R) J Hematol Oncol 2021 Dec 02;14(1):201 4 Citations |
| 1 | Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. (Janelsins MC, Lei L, Netherby-Winslow C, Kleckner AS, Kerns S, Gilmore N, Belcher E, Thompson BD, Werner ZA, Hopkins JO, Long J, Cole S, Culakova E) J Neuroimmunol 2022 Jan 15;362:577769 13 Citations |
| 1 | Collateral Victim or Rescue Worker?-The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer. (He L, Lomberk G) Front Cell Dev Biol 2021;9:735107 1 Citation |
| 1 | Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer. (De Sarkar N, Dasgupta S, Chatterjee P, Coleman I, Ha G, Ang LS, Kohlbrenner EA, Frank SB, Nunez TA, Salipante SJ, Corey E, Morrissey C, Van Allen E, Schweizer MT, Haffner MC, Patel R, Hanratty B, Lucas JM, Dumpit RF, Pritchard CC, Montgomery RB, Nelson PS) JCI Insight 2021 Dec 08;6(23) 16 Citations |
| 1 | Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. (Koshkin VS, Henderson N, James M, Natesan D, Freeman D, Nizam A, Su CT, Khaki AR, Osterman CK, Glover MJ, Chiang R, Makrakis D, Talukder R, Lemke E, Olsen TA, Jain J, Jang A, Ali A, Jindal T, Chou J, Friedlander TW, Hoimes C, Basu A, Zakharia Y, Barata PC, Bilen MA, Emamekhoo H, Davis NB, Shah SA, Milowsky MI, Gupta S, Campbell MT, Grivas P, Sonpavde GP, Kilari D, Alva AS) Cancer 2022 Mar 15;128(6):1194-1205 55 Citations |
| 1 | Engaging veteran stakeholders to identify patient-centred research priorities for optimizing implementation of lung cancer screening. (Yan A, Hooyer K, Asan O, Flower M, Whittle J) Health Expect 2022 Feb;25(1):408-418 8 Citations |
| 2 | Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis. (Jung Y, Kraikivski P, Shafiekhani S, Terhune SS, Dash RK) NPJ Syst Biol Appl 2021 Dec 09;7(1):46 42 Citations |
| 1 | Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer. (Tsai S, Evans DB) J Surg Oncol 2022 Jan;125(1):69-74 2 Citations |
| 1 | Analysis of CDK12 alterations in a pan-cancer database. (Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR) Cancer Med 2022 Feb;11(3):753-763 6 Citations |
| 2 | Establishment of In Vivo Ovarian Cancer Mouse Models Using Intraperitoneal Tumor Cell Injection. (Mittal S, Gupta P, Chaluvally-Raghavan P, Pradeep S) Methods Mol Biol 2022;2424:247-254 4 Citations |
| 1 | Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B) Int J Radiat Oncol Biol Phys 2022 Jan 01;112(1):83-92 11 Citations |
| 1 | Association of Inventory to Measure and Assess imaGe Disturbance - Head and Neck Scores With Clinically Meaningful Body Image-Related Distress Among Head and Neck Cancer Survivors. (Macias D, Hand BN, Pipkorn P, Williams AM, Chang SS, Zenga J, Nilsen ML, Rhoten BA, Huang AT, Osazuwa-Peters N, Maurer S, Balliet W, Li H, Ruggiero KJ, Sterba KR, Graboyes EM) Front Psychol 2021;12:794038 13 Citations |
| 1 | Symptom Profiles of Adolescents and Young Adults in Active Cancer Treatment by Diagnostic Groups. (Ameringer S, Elswick RK Jr, Stegenga K, Macpherson CF, Erickson JM, Linder L) Cancer Nurs 2022 Jul-Aug 01;45(4):306-315 2 Citations |
| 1 | Case 7: A Cancer Pain Crisis (Zehm A, Kamdar MM) Hospitalized Chronic Pain Patient: A Multidisciplinary Treatment Guide 1 January 2022:87-89 |
| 2 | By the time they run into the hospital, their life is already at stake: A qualitative study of healthcare professional perceptions on priorities for cervical cancer policy in Uganda (Anumolu N, Lechleitner K, Patel N, Mijumbi A, Jankowski C, Anguzu R, Kasasa S, Weber R, Dickson-Gomez J, Banura C, Beyer K) Journal of Global Health Reports 2022;6 2 Citations |
| 1 | Social Genomics and Cancer: Neural Regulation of the Cancer Genome (Knight JM, Cole SW) Psychological Aspects of Cancer: a Guide to Emotional and Psychological Consequences of Cancer, their Causes, and their Management, Second Edition 1 January 2022:345-357 2 Citations |
| 1 | Identify Cancer Patients at Risk for Heart Failure using Electronic Health Record and Genetic Data (Yu Z, Yang X, Chen Y, Fang R, Hogan WR, Gong Y, Wu Y) Proceedings - 2022 IEEE 10th International Conference on Healthcare Informatics, ICHI 2022 2022:138-142 3 Citations |
| 1 | Ovarian cancer resistance to PARPi and platinum-containing chemotherapy (Summey R, Uyar D) Cancer Drug Resistance 2022;5(3):637-646 7 Citations |
| 1 | Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126 (Hall WA, Deshmukh S, Bruner DW, Michalski JM, Purdy JA, Bosch W, Bahary JP, Patel MP, Parliament MB, Lock MI, Lau HY, Souhami L, Fisher SA, Kwok Y, Seider MJ, Vigneault E, Rosenthal SA, Gustafson GS, Gay HA, Pugh SL, Sandler HM, Movsas B) International Journal of Radiation Oncology Biology Physics 1 January 2022;112(1):83-92 11 Citations |
| 2 | A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal. (Baumann Kreuziger L, Feng M, Bartosic A, Simpson P, Wang TF) Blood Coagul Fibrinolysis 2022 Apr 01;33(3):171-175 5 Citations |
| 1 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes. (Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baten A, Becher H, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Clarke CL, NBCS Collaborators, Collée JM, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dwek M, Eccles DM, Evans DG, Fasching PA, Figueroa J, Floris G, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Giles GG, Goldberg MS, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haiman CA, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, ABCTB Investigators, kConFab/AOCS Investigators, Jakimovska M, Jakubowska A, John EM, Jones ME, Jung A, Kaaks R, Kauppila S, Keeman R, Khusnutdinova E, Kitahara CM, Ko YD, Koutros S, Kristensen VN, Krüger U, Kubelka-Sabit K, Kurian AW, Kyriacou K, Lambrechts D, Lee DG, Lindblom A, Linet M, Lissowska J, Llaneza A, Lo WY, MacInnis RJ, Mannermaa A, Manoochehri M, Margolin S, Martinez ME, McLean C, Meindl A, Menon U, Nevanlinna H, Newman WG, Nodora J, Offit K, Olsson H, Orr N, Park-Simon TW, Patel AV, Peto J, Pita G, Plaseska-Karanfilska D, Prentice R, Punie K, Pylkäs K, Radice P, Rennert G, Romero A, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Schmutzler RK, Schoemaker MJ, Schöttker B, Sherman ME, Shu XO, Smichkoska S, Southey MC, Spinelli JJ, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Teras LR, Terry MB, Torres D, Troester MA, Vachon CM, van Deurzen CHM, van Veen EM, Wagner P, Weinberg CR, Wendt C, Wesseling J, Winqvist R, Wolk A, Yang XR, Zheng W, Couch FJ, Simard J, Kraft P, Easton DF, Pharoah PDP, Schmidt MK, García-Closas M, Chatterjee N) Breast Cancer Res 2022 Jan 04;24(1):2 17 Citations |
| 1 | Survival After Adrenalectomy for Metastatic Lung Cancer. (Krumeich LN, Roses RE, Kuo LE, Lindeman BM, Nehs MA, Tavakkoli A, Parangi S, Hodin RA, Fraker DL, James BC, Wang TS, Solórzano CC, Lubitz CC, Wachtel H) Ann Surg Oncol 2022 Apr;29(4):2571-2579 11 Citations |
| 1 | Worsening Restless Leg Syndrome Symptoms as a Presentation of Colon Cancer: A Reminder to Work Up the Anemia. (Zhou DJ, Vuppala AD, Pedavally S) Gerontol Geriatr Med 2021;7:23337214211067875 |
| 1 | Hyperprogression in Gastric Cancer: Is MDM2 Amplification the Dark Horse? (Dayyani F, Kato S, Kurzrock R) JCO Precis Oncol 2021 Nov;5:931-932 1 Citation |
| 1 | Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine. (Charo LM, Eskander RN, Sicklick J, Kim KH, Lim HJ, Okamura R, Lee S, Subramanian R, Schwab R, Shatsky R, Plaxe S, Kato S, Kurzrock R) JCO Precis Oncol 2022 Jan;6:e2000508 13 Citations |
| 1 | Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. (Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, Parada LF) Dev Cell 2022 Jan 10;57(1):32-46.e8 94 Citations |
| 1 | Cancer Screening Differences Among Muslims and Non-Muslims: Insights from the Chicago Multiethnic Prevention and Surveillance Study. (Majeed AM, Khan ZA, Aschebrook-Kilfoy B, Kibriya MG, Ahsan H, Padela AI) J Racial Ethn Health Disparities 2023 Feb;10(1):176-182 4 Citations |
| 1 | Down-regulation of MEG3, PANDA and CASC2 as p53-related lncRNAs in breast cancer. (Ghafouri-Fard S, Sohrabi B, Hussen BM, Mehravaran E, Jamali E, Arsang-Jang S, Fathi M, Taheri M, Samsami M) Breast Dis 2022;41(1):137-143 13 Citations |
| 1 | Sphincter-Sparing Resection for Rectal Cancer. Clin Colon Rectal Surg 2007;20:203-212. (Ludwig KA.) Clin Colon Rectal Surg 2007 |
| 1 | Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report. (Mohammed A, Dashwood RH, Dickinson S, Disis ML, Jaffee EM, Johnson BD, Khleif SN, Pollak MN, Schlom J, Shoemaker RH, Stanton SE, Wondrak GT, You M, Zhu H, Miller MS) J Cancer Prev 2021 Dec 30;26(4):309-317 |
| 1 | Endothelial dysfunction as a complication of anti-cancer therapy. (Terwoord JD, Beyer AM, Gutterman DD) Pharmacol Ther 2022 Sep;237:108116 33 Citations |
| 2 | Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium) Radiother Oncol 2022 Mar;168:75-82 12 Citations |
| 1 | Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin. (Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Apr;20(2):165-175 4 Citations |
| 2 | Student-centered Pipeline to Advance Research in Cancer Careers (SPARCC): Diversifying the Clinical Cancer Research Workforce. (Kaljo K, Ngui EM, Treat R, Rader JS) J Cancer Educ 2023 Feb;38(1):370-377 2 Citations |
| 1 | In vivo MRI-based 3D printed molds and individualized sectioning apparatuses improve MRI-histopathologic co-registration in brain cancer patients (Salmon AE, Pellatt BJ, Mickevicius NJ, Cochran EJ, LaViolette PS) Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine |
| 7 | Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer (Beltrán Ponce SE, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM) Journal of Gastrointestinal Oncology February 2022;13(1):185-196 1 Citation |
| 7 | Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers February-2 2022;14(4) 15 Citations |
| 2 | Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research (Bikomeye JC, Beyer AM, Kwarteng JL, Beyer KMM) International Journal of Environmental Research and Public Health February-2 2022;19(4) 25 Citations |
| 2 | Impact of the COVID-19 pandemic on cancer patients and psycho-oncology providers: Perspectives, observations, and experiences of the American Psychosocial Oncology Society membership. (McAndrew NS, Strong Y, Morris KJ, Sannes TS, Pirl WF, Cole S, Mohanraj L, Knight JM) Psychooncology 2022 Jun;31(6):1031-1040 8 Citations |
| 1 | Home mortgage discrimination and incidence of triple-negative and Luminal A breast cancer among non-Hispanic Black and non-Hispanic White females in California, 2006-2015. (Michaels EK, Canchola AJ, Beyer KMM, Zhou Y, Shariff-Marco S, Gomez SL) Cancer Causes Control 2022 May;33(5):727-735 6 Citations |
| 1 | Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue. (Fernandez AI, Liu M, Bellizzi A, Brock J, Fadare O, Hanley K, Harigopal M, Jorns JM, Kuba MG, Ly A, Podoll M, Rabe K, Sanders MA, Singh K, Snir OL, Soong TR, Wei S, Wen H, Wong S, Yoon E, Pusztai L, Reisenbichler E, Rimm DL) JAMA Oncol 2022 Apr 01;8(4):1-4 232 Citations |
| 1 | Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer. (Cobb AN, Adesoye T, Teshome M) Ann Surg Oncol 2022 May;29(5):2756-2758 |
| 1 | Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study. (Akhtar OS, Groman A, Singh A, Ghione P, Lund I, Hernandez-Ilizaliturri FJ, Torka P) Leuk Lymphoma 2022 May;63(5):1127-1136 3 Citations |
| 1 | Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. (Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B, ARASENS Trial Investigators) N Engl J Med 2022 Mar 24;386(12):1132-1142 562 Citations |
| 9 | Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers (Basel) 2022 Feb 15;14(4) 15 Citations |
| 4 | Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research. (Bikomeye JC, Beyer AM, Kwarteng JL, Beyer KMM) Int J Environ Res Public Health 2022 Feb 19;19(4) 25 Citations |
| 1 | First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report. (Salkini MW, Yang X, Hashmi FH, Kandzari SJ, Hogan T, Morley C, Zekan D, Werner Z, Williams DJ, Guo YI, Matthew TL, Spangler M, Yu JJ) Anticancer Res 2022 Mar;42(3):1339-1344 2 Citations |
| 1 | Effect of Community and Socio-Economic Factors on Cardiovascular, Cancer and Cardio-Oncology Patients with COVID-19 (Batra A, Swaby J, Raval P, Zhu H, Weintraub NL, Terris M, Karim NA, Keruakous A, Gutterman D, Beyer K, Stolley M, Brown SA, Guha A) COVID March 2022;2(3):350-368 |
| 1 | Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination (Auster-Gussman LA, Gavin KL, Siddique J, Welch WA, Solk P, Whitaker M, Cullather E, Fanning J, Maria CS, Gradishar W, Khan S, Kulkarni S, Phillips SM) Psycho-Oncology March 2022;31(3):425-435 10 Citations |
| 2 | New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma. (Puzyrenko A, Cortina CS, Jorns JM) Int J Surg Pathol 2022 Oct;30(7):728-733 1 Citation |
| 1 | Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research. (Kalyanaraman B) FASEB J 2022 Apr;36(4):e22226 15 Citations |
| 1 | Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience. (Louie BH, Kato S, Kim KH, Lim HJ, Lee S, Okamura R, Fanta PT, Kurzrock R) Mol Oncol 2022 Jul;16(13):2575-2584 12 Citations |
| 2 | Local Control of Cancers With Various Ablation Techniques. (Wooldridge AN, Key B, Neilson JC, Tutton SM, King DM) Instr Course Lect 2022;71:203-212 |
| 5 | Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model. (Zenga J, Awan MJ, Frei A, Petrie E, Sharma GP, Shreenivas A, Shukla M, Himburg HA) Head Neck 2022 Jun;44(6):1324-1334 4 Citations |
| 1 | Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. (Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, D3CODE Team) JCO Oncol Pract 2022 Jul;18(7):e1091-e1099 18 Citations |
| 6 | Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer. (Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM) J Gastrointest Oncol 2022 Feb;13(1):185-196 1 Citation |
| 1 | Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy (Magbanua MJM, Gumusay O, Kurzrock R, van ‘t Veer LJ, Rugo HS) Frontiers in Oncology 15 March 2022;12 10 Citations |
| 7 | Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer. (Gupta P, Kadamberi IP, Mittal S, Tsaih SW, George J, Kumar S, Vijayan DK, Geethadevi A, Parashar D, Topchyan P, McAlarnen L, Volkman BF, Cui W, Zhang KYJ, Di Vizio D, Chaluvally-Raghavan P, Pradeep S) Adv Sci (Weinh) 2022 May;9(14):e2104452 46 Citations |
| 1 | A Study of Social and Behavioral Determinants of Health in Lung Cancer Patients Using Transformers-based Natural Language Processing Models. (Yu Z, Yang X, Dang C, Wu S, Adekkanattu P, Pathak J, George TJ, Hogan WR, Guo Y, Bian J, Wu Y) AMIA Annu Symp Proc 2021;2021:1225-1233 27 Citations |
| 1 | A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer. (Solomon B, Callejo A, Bar J, Berchem G, Bazhenova L, Saintigny P, Wunder F, Raynaud J, Girard N, Lee JJ, Sulaiman R, Prouse B, Bresson C, Ventura H, Magidi S, Rubin E, Young B, Onn A, Leyland-Jones B, Schilsky RL, Lazar V, Felip E, Kurzrock R) Cancer Med 2022 Jul;11(14):2790-2800 17 Citations |
| 1 | Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study. (Bethea TN, Zhai W, Zhou X, Ahles TA, Ahn J, Cohen HJ, Dilawari AA, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Root J, Saykin AJ, Small BJ, Van Dyk KM, Mandelblatt JS, Carroll JE) Cancer Med 2022 Sep;11(17):3352-3363 8 Citations |
| 2 | Pepsinogen/Proton Pump Co-Expression in Barrett's Esophageal Cells Induces Cancer-Associated Changes. (Stabenau KA, Samuels TL, Lam TK, Mathison AJ, Wells C, Altman KW, Battle MA, Johnston N) Laryngoscope 2023 Jan;133(1):59-69 8 Citations |
| 1 | Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy. (Beiss V, Mao C, Fiering SN, Steinmetz NF) Mol Pharm 2022 May 02;19(5):1573-1585 20 Citations |
| 1 | Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). (Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Calvo-Crespo P, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Dunning AM, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Mollà M, Lambrecht M, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa-Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Lorenzo B, Talbot CJ, Valdagni R, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, REQUITE Consortium, Lievens Y) Lung Cancer 2022 Apr;166:228-241 9 Citations |
| 1 | Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies. (Gupta D, Kurzrock R, Lee S, Okamura R, Lim HJ, Kim KH, Sicklick JK, Kato S) NPJ Precis Oncol 2022 Mar 28;6(1):18 1 Citation |
| 1 | Patient Navigation Based Care-delivery to Reduce Inequities in Cancer Care Among Immigrants and Refugees: A Commentary on the Successes and the Unmet Needs. International Journal of Cancer Care Delivery (19. Kamaraju S, Merrill J, Wu J, Jeames S, Conroy M, Min H, Powell M, Padela, A) International Journal of Cancer Care Delivery file:///C:/Users/skamaraju/Downloads/33154-patient-navigation-based-care-delivery-to-reduce-inequities-in-cancer-care-among-immigrants-and-refugees-a-commentary-on-the-successes-and-the-unmet%20(1).pdf |
| 1 | A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis (Schapira MM, Chhatre S, Prigge JM, Meline J, Kaminstein D, Rodriguez KL, Fraenkel L, Kravetz JD, Whittle J, Bastian LA, Vachani A, Akers S, Schrand S, Ibarra JV, Asan O) JMIR Formative Research 1 April 2022;6(4) 7 Citations |
| 1 | A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis (Schack LMH, Naderi E, Fachal L, Dorling L, Luccarini C, Dunning AM, Barnett G, Barrera MEA, Burnet NG, Calvo LM, Diergaarde B, Dudding T, Dunning AM, Duprez F, Kerns SL, Kiang MCL, Langendijk H, Mehanna H, Ness A, Sim AYL, Spiessens A, Summersgill HR, Tajes JF, Vega A, Welsh C, Wen EOH, West C, Ong EHW, Chua MLK, Langendijk JA, Alizadeh BZ, Overgaard J, Eriksen JG, Andreassen CN, Alsner J) British Journal of Cancer 1 April 2022;126(7):1082-1090 12 Citations |
| 1 | Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin (Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) Clinical Genitourinary Cancer April 2022;20(2):165-175 4 Citations |
| 1 | Professional views on priorities for cervical cancer policy in Uganda: a qualitative study. (Anumolu N, Lechleitner K, Patel N, Jankowksi C, Anguzu R, Kasasa S, Dickson-Gomez J, Banura C, Weber R, Beyer K) Lancet Glob Health 2022 Mar;10 Suppl 1:S16 |
| 1 | Parish level social factors predict population-based cervical cancer incidence in Kampala, Uganda, 2008-15: an ecological study. (Beyer KMM, Kasasa S, Anguzu R, Nambooze S, Amulen PM, Jankowski C, Nansereko B, Zhou Y, Lukande R, Wabinga H) Lancet Glob Health 2022 Mar;10 Suppl 1:S12 1 Citation |
| 1 | Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy. (Magbanua MJM, Gumusay O, Kurzrock R, van 't Veer LJ, Rugo HS) Front Oncol 2022;12:802579 10 Citations |
| 1 | Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting. (Kato S, Li B, Adashek JJ, Cha SW, Bianchi-Frias D, Qian D, Kim L, So TW, Mitchell M, Kamei N, Hoiness R, Hoo J, Gray PN, Iyama T, Kashiwagi M, Lu HM, Kurzrock R) Oncoimmunology 2022;11(1):2052410 11 Citations |
| 1 | A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis. (Schapira MM, Chhatre S, Prigge JM, Meline J, Kaminstein D, Rodriguez KL, Fraenkel L, Kravetz JD, Whittle J, Bastian LA, Vachani A, Akers S, Schrand S, Ibarra JV, Asan O) JMIR Form Res 2022 Apr 08;6(4):e29039 7 Citations |
| 5 | Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE) J Am Pharm Assoc (2003) 2022;62(4):1321-1328.e3 6 Citations |
| 1 | Phosphorylated MED1 links transcription recycling and cancer growth. (Chen Z, Ye Z, Soccio RE, Nakadai T, Hankey W, Zhao Y, Huang F, Yuan F, Wang H, Cui Z, Sunkel B, Wu D, Dzeng RK, Thomas-Ahner JM, Huang THM, Clinton SK, Huang J, Lazar MA, Jin VX, Roeder RG, Wang Q) Nucleic Acids Res 2022 May 06;50(8):4450-4463 7 Citations |
| 1 | Cetuximab in Patients with Non-Small Cell Lung Cancer and EGFR Exon 20 Insertion Alterations. (Nikanjam M, Kato S, Adashek JJ, Kurzrock R) Clin Oncol Case Rep 2022 Jan;5(1) |
| 1 | Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study. (Global Health Research Group on Children’s Non-Communicable Diseases Collaborative) BMJ Open 2022 Apr 11;12(4):e054690 17 Citations |
| 1 | Exploratory Analysis of Associations Between Whole Blood Mitochondrial Gene Expression and Cancer-Related Fatigue Among Breast Cancer Survivors. (Kleckner AS, Kleckner IR, Culakova E, Wojtovich AP, Klinedinst NJ, Kerns SL, Hardy SJ, Inglis JE, Padula GDA, Mustian KM, Janelsins MC, Dorsey SG, Saligan LN, Peppone LJ) Nurs Res 2022 Sep-Oct 01;71(5):411-417 2 Citations |
| 3 | An Opportunity in Cancer Prevention: Human Papillomavirus Vaccine Delivery in the Hospital. (Moore E, Bauer SC, Rogers A, McFadden V) Hosp Pediatr 2022 May 01;12(5):e157-e162 1 Citation |
| 1 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. (Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, Lush M, Michailidou K, Bolla MK, Aronson KJ, Murphy RA, Brooks-Wilson A, Lee DG, Cordina-Duverger E, Guénel P, Truong T, Mulot C, Teras LR, Patel AV, Dossus L, Kaaks R, Hoppe R, Lo WY, Brüning T, Hamann U, Czene K, Gabrielson M, Hall P, Eriksson M, Jung A, Becher H, Couch FJ, Larson NL, Olson JE, Ruddy KJ, Giles GG, MacInnis RJ, Southey MC, Le Marchand L, Wilkens LR, Haiman CA, Olsson H, Augustinsson A, Krüger U, Wagner P, Scott C, Winham SJ, Vachon CM, Perou CM, Olshan AF, Troester MA, Hunter DJ, Eliassen HA, Tamimi RM, Brantley K, Andrulis IL, Figueroa J, Chanock SJ, Ahearn TU, García-Closas M, Evans GD, Newman WG, van Veen EM, Howell A, Wolk A, Håkansson N, Anton-Culver H, Ziogas A, Jones ME, Orr N, Schoemaker MJ, Swerdlow AJ, Kitahara CM, Linet M, Prentice RL, Easton DF, Milne RL, Kraft P, Chang-Claude J, Lindström S) Sci Rep 2022 Apr 13;12(1):6199 3 Citations |
| 1 | Clinicopathological features and surgical outcomes of pancreatic metastasis from thyroid cancer. (Takeda E, Kimura J, Okabayashi T, Sui K, Tabuchi M, Murokawa T, Iwata J) Am J Surg 2022 Sep;224(3):856-862 |
| 1 | Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients. (Samson A, West EJ, Carmichael J, Scott KJ, Turnbull S, Kuszlewicz B, Dave RV, Peckham-Cooper A, Tidswell E, Kingston J, Johnpulle M, da Silva B, Jennings VA, Bendjama K, Stojkowitz N, Lusky M, Prasad KR, Toogood GJ, Auer R, Bell J, Twelves CJ, Harrington KJ, Vile RG, Pandha H, Errington-Mais F, Ralph C, Newton DJ, Anthoney A, Melcher AA, Collinson F) Cancer Immunol Res 2022 Jun 03;10(6):745-756 29 Citations |
| 1 | Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers. (Han L, Seward C, Leone G, Ostrowski MC) Adv Cancer Res 2022;154:169-201 2 Citations |
| 1 | Management of cancer-associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement (Held N, Jung B, Baumann Kreuziger L) Research and Practice in Thrombosis and Haemostasis May 2022;6(4) 4 Citations |
| 6 | Correction to: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance (Cancers, (2022), 14, 958) (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers May-2 2022;14(10) 2 Citations |
| 1 | Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy. (Whitaker M, Welch WA, Fanning J, Santa-Maria CA, Auster-Gussman LA, Solk P, Khan SA, Kulkarni SA, Gradishar W, Siddique J, Phillips SM) Support Care Cancer 2022 Aug;30(8):6613-6622 6 Citations |
| 1 | Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients (West EJ, Scott KJ, Tidswell E, Bendjama K, Stojkowitz N, Lusky M, Kurzawa M, Prasad R, Toogood G, Ralph C, Anthoney DA, Melcher AA, Collinson FJ, Samson A) Cancers May-1 2022;14(9) 8 Citations |
| 2 | High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda. (Beyer K, Kasasa S, Anguzu R, Lukande R, Nambooze S, Amulen PM, Zhou Y, Nansereko B, Jankowski C, Oyana T, Savino D, Feustel K, Wabinga H) J Glob Health 2022;12:04032 4 Citations |
| 1 | Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. (Song Y, Bugada L, Li R, Hu H, Zhang L, Li C, Yuan H, Rajanayake KK, Truchan NA, Wen F, Gao W, Sun D) Sci Transl Med 2022 May 04;14(643):eabl3649 71 Citations |
| 1 | Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review. (Foruzandeh Z, Dorabadi DG, Sadeghi F, Zeinali-Sehrig F, Zaefizadeh M, Rahmati Y, Alivand MR) Mol Biol Rep 2022 Oct;49(10):9825-9840 4 Citations |
| 2 | Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner. (Wu J, Liu X, Reeser JAW, Trimboli AJ, Pécot T, Sizemore GM, Naidu SK, Fernandez SA, Yu L, Hallett M, Park M, Leone GW, Hildreth BE, Ostrowski MC) Mol Cancer Res 2022 Aug 05;20(8):1233-1246 7 Citations |
| 1 | Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma. (Chandrashekar N, Pandi A) J Food Biochem 2022 Sep;46(9):e14230 36 Citations |
| 1 | Variable Mutation Expression in Human Cancers: A "Hide-and-Seek" Mechanism Linked to Differential MHC-I Presentation Dynamics. (Boichard A, Kurzrock R) Mol Cancer Ther 2022 Jul 05;21(7):1219-1226 |
| 1 | Pathophysiological role of NNAT in ER+ breast cancer. (Semenikhina M, Plasterer C, Tsaih SW, Flister M, Palygin O) FASEB J 2022 May;36 Suppl 1 |
| 6 | Defining the Mutational Landscape That Affects the Histone Demethylase KDM6A/UTX in Human Cancer. (Chi YI, Stodola TJ, de Assuncao TM, Volkman B, Smith B, Mathison AJ, Lomberk G, Zimmermann MT, Urrutia R) FASEB J 2022 May;36 Suppl 1 |
| 4 | Epigenomic mechanisms used by KrasG12D to regulate inflammatory gene clusters in epithelial pancreatic cancer cells, which are critical for reprogramming the tumor microenvironment. (Du M, Abrudan JL, Urrutia G, de Assuncao TM, Mathison AJ, Zimmermann MT, Lomberk G, Urrutia R) FASEB J 2022 May;36 Suppl 1 |
| 1 | Association Between Observer-Rated Disfigurement and Body Image-Related Distress Among Head and Neck Cancer Survivors. (Macias D, Hand BN, Zenga J, Pipkorn P, Nilsen ML, Williams AM, Graboyes EM) JAMA Otolaryngol Head Neck Surg 2022 Jul 01;148(7):688-689 7 Citations |
| 1 | Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer. (Coleman IM, DeSarkar N, Morrissey C, Xin L, Roudier MP, Sayar E, Li D, Corey E, Haffner MC, Nelson PS) Clin Cancer Res 2022 Jul 15;28(14):3127-3140 19 Citations |
| 1 | RHOA takes the RHOad less traveled to cancer. (Schaefer A, Der CJ) Trends Cancer 2022 Aug;8(8):655-669 20 Citations |
| 1 | Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. (Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ) Br J Surg 2022 May 16;109(6):489-492 22 Citations |
| 1 | Latent Class Models of Early-life Trauma and Incident Breast Cancer. (Woo JMP, Simanek A, O'Brien KM, Parks C, Gaston S, Auer PL, Konkel RH, Jackson CL, Meier HCS, Sandler DP) Epidemiology 2022 Sep 01;33(5):729-738 5 Citations |
| 1 | Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes. (Chang A, Sloan EK, Antoni MH, Knight JM, Telles R, Lutgendorf SK) Integr Cancer Ther 2022;21:15347354221096081 28 Citations |
| 1 | Playing with a purpose: The impact of therapeutic recreation during hospitalization for cancer therapy or stem cell transplantation (Hoag, J.A., Bingen, K., Karst, J., Palou, A., Yan, K., & Zhang, J. ) Journal of Pediatric Oncology Nursing |
| 1 | Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study. (Root JC, Zhou X, Ahn J, Small BJ, Zhai W, Bethea T, Carroll JE, Cohen HJ, Dilawari A, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher K, Saykin AJ, Van Dyk K, Mandelblatt JS, Ahles TA) Breast Cancer Res Treat 2022 Jul;194(2):413-422 10 Citations |
| 3 | Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database. (Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC, Kong AL) Clin Breast Cancer 2022 Aug;22(6):547-552 1 Citation |
| 1 | Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer. (Murugesan K, Jin DX, Comment LA, Fabrizio D, Hegde PS, Elvin JA, Alexander B, Levy MA, Frampton GM, Montesion M, Roychowdhury S, Kurzrock R, Ross JS, Albacker LA, Huang RSP) Oncologist 2022 Sep 02;27(9):732-739 5 Citations |
| 1 | Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. (Hinestrosa JP, Kurzrock R, Lewis JM, Schork NJ, Schroeder G, Kamat AM, Lowy AM, Eskander RN, Perrera O, Searson D, Rastegar K, Hughes JR, Ortiz V, Clark I, Balcer HI, Arakelyan L, Turner R, Billings PR, Adler MJ, Lippman SM, Krishnan R) Commun Med (Lond) 2022;2:29 93 Citations |
| 8 | Structural bioinformatics enhances the interpretation of somatic mutations in KDM6A found in human cancers. (Chi YI, Stodola TJ, De Assuncao TM, Leverence EN, Smith BC, Volkman BF, Mathison AJ, Lomberk G, Zimmermann MT, Urrutia R) Comput Struct Biotechnol J 2022;20:2200-2211 9 Citations |
| 9 | Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958. (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P) Cancers (Basel) 2022 May 16;14(10) 2 Citations |
| 1 | Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. (Babu VS, Mallipatna A, Sa D, Dudeja G, Kannan R, Shetty R, Nair AP, Gundimeda S, Chaurasia SS, Verma NK, Lakshminarayanan R, Heymans S, Barathi VA, Guha N, Ghosh A) Cells 2022 May 18;11(10) 7 Citations |
| 2 | Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds. (Zhang Q, Xiong D, Pan J, Wang Y, Hardy M, Kalyanaraman B, You M) Cancers (Basel) 2022 May 21;14(10) 10 Citations |
| 1 | Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice (Mileshkin L, Bochtler T, Gatta G, Kurzrock R, Beringer A, Müller-Ohldach M, Surinach A, Perret C, Thomas M, Gondos A, Krämer A) Cancers June-2 2022;14(12) 5 Citations |
| 2 | Trends in Healthcare Expenditures among Adults in the United States by Cancer Diagnosis Status, 2008-2016: A Cross-Sectional Study. (Walker SL, Williams JS, Lu K, Dawson AZ, Egede LE) Cancer Epidemiol Biomarkers Prev 2022 Aug 02;31(8):1661-1668 2 Citations |
| 1 | Management of cancer-associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement. (Held N, Jung B, Baumann Kreuziger L) Res Pract Thromb Haemost 2022 May;6(4):e12726 4 Citations |
| 1 | Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. (Katsoulakis E, Kudner R, Chapman C, Park J, Puckett L, Solanki A, Kapoor R, Hagan M, Kelly M, Palta J, Tishler R, Hitchcock Y, Chera B, Feygelman V, Walker G, Sher D, Kujundzic K, Wilson E, Dawes S, Yom SS, Harrison L) Pract Radiat Oncol 2022;12(5):409-423 4 Citations |
| 11 | A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiome. (Zenga J, Atkinson S, Yen T, Massey B, Stadler M, Bruening J, Peppard W, Reuben M, Hayward M, Mesich B, Buchan B, Ledeboer N, Sanchez JL, Fraser R, Lin CW, Holtz ML, Awan M, Wong SJ, Puram SV, Salzman N) EBioMedicine 2022 Jul;81:104099 8 Citations |
| 2 | The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. (Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY) Int J Radiat Oncol Biol Phys 2022 Oct 01;114(2):266-274 3 Citations |
| 1 | Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. (Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA) Nat Commun 2022 Jun 10;13(1):3352 1 Citation |
| 1 | Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future. (Alfaro K, Soler M, Maza M, Flores M, López L, Rauda JC, Chacón A, Erazo P, Villatoro N, Mumenthaler E, Masch R, Conzuelo G, Felix JC, Cremer M) Cancers (Basel) 2022 Jun 03;14(11) 3 Citations |
| 1 | Trends and disparities in pulmonary embolism mortality among patients with cancer. (Janus SE, Chami T, Karnib M, Mously H, Hajjari J, Badhwar AK, Al-Juhaishi T, Li J, Shishehbor MH, Al-Kindi SG) Vasc Med 2022 Oct;27(5):493-495 |
| 1 | An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer. (Fracasso PM, Duska LR, Thaker PH, Gao F, Zoberi I, Dehdashti F, Siegel BA, Uliel L, Menias CO, Rehm PK, Goodner SA, Creekmore AN, Lothamer HL, Rader JS) Am J Clin Oncol 2022 Jul 01;45(7):286-293 1 Citation |
| 1 | Clinical Features and Body Composition in Men with Hormone-Sensitive Metastatic Prostate Cancer: A Pilot Study Examining Differences by Race. (Sheean PM, O'Connor P, Joyce C, Vasilopoulos V, Badami A, Stolley M) Prostate Cancer 2022;2022:9242243 4 Citations |
| 1 | Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. (Sullivan KM, Jiang X, Guha P, Lausted C, Carter JA, Hsu C, Labadie KP, Kohli K, Kenerson HL, Daniel SK, Yan X, Meng C, Abbasi A, Chan M, Seo YD, Park JO, Crispe IN, Yeung RS, Kim TS, Gujral TS, Tian Q, Katz SC, Pillarisetty VG) Gut 2023 Feb;72(2):325-337 82 Citations |
| 5 | Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC) J Cancer 2022;13(8):2472-2476 6 Citations |
| 1 | Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. (Ramsey ML, Tomlinson J, Pearlman R, Abushahin L, Aeilts A, Chen HZ, Chen Y, Compton A, Elkhatib R, Geiger L, Hays J, Jeter J, Jin N, Malalur P, Roychowdhury S, Ruple J, Prebish J, Stanich PP, Hampel H) Fam Cancer 2023 Jan;22(1):91-97 21 Citations |
| 1 | ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT. (Damico N, Meyer J, Das P, Murphy J, Miller E, Koontz B, Hall W, McBride M, Pereira G, Catalano P, Chakravarthy AB, O'Dwyer PJ, Dorth J) Pract Radiat Oncol 2022;12(4):335-347 15 Citations |
| 1 | Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601. (Jackson WC, Tang M, Schipper MJ, Sandler HM, Zumsteg ZS, Efstathiou JA, Shipley WU, Seiferheld W, Lukka HR, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Hall WA, Dess RT, Lovett RD, Balogh AG, Feng FY, Spratt DE) J Clin Oncol 2022 Sep 20;40(27):3172-3179 19 Citations |
| 1 | Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice. (Mileshkin L, Bochtler T, Gatta G, Kurzrock R, Beringer A, Müller-Ohldach M, Surinach A, Perret C, Thomas M, Gondos A, Krämer A) Cancers (Basel) 2022 Jun 13;14(12) 5 Citations |
| 1 | Commentary: The relationship of cancer and heart disease—it's complicated (Wyler von Ballmoos MC, Almassi GH) Journal of Thoracic and Cardiovascular Surgery July 2022;164(1):115-116 2 Citations |
| 1 | Symptoms and daily experiences reported by children with cancer using a game-based app (Linder LA, Newman A, Bernier Carney KM, Wawrzynski S, Stegenga K, Chiu YS, Jung SH, Iacob E, Lewis M, Linder C, Fox K, Altizer R) Journal of Pediatric Nursing 1 July 2022;65:33-43 13 Citations |
| 3 | ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology. (Martinez EO, Jorns JM, Kong AL, Cortina CS) Ann Surg Oncol 2022 Oct;29(10):6347-6348 1 Citation |
| 3 | Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database. (Martinez EO, Jorns JM, Kong AL, Kijak J, Lee WY, Huang CC, Cortina CS) Ann Surg Oncol 2022 Oct;29(10):6339-6346 10 Citations |
| 1 | Identifying intragenic functional modules of genomic variations associated with cancer phenotypes by learning representation of association networks. (Kim M, Huffman JE, Justice A, Goethert I, Agasthya G, VA Million Veteran Program, Danciu I) BMC Med Genomics 2022 Jul 06;15(1):151 1 Citation |
| 1 | STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer. (Lefler JE, MarElia-Bennett CB, Thies KA, Hildreth BE 3rd, Sharma SM, Pitarresi JR, Han L, Everett C, Koivisto C, Cuitino MC, Timmers CD, O'Quinn E, Parrish M, Romeo MJ, Linke AJ, Hobbs GA, Leone G, Guttridge DC, Zimmers TA, Lesinski GB, Ostrowski MC) Life Sci Alliance 2022 Nov;5(11) 27 Citations |
| 1 | Association Between Residence in Historically Redlined Districts Indicative of Structural Racism and Racial and Ethnic Disparities in Breast Cancer Outcomes. (Plascak JJ, Beyer K, Xu X, Stroup AM, Jacob G, Llanos AAM) JAMA Netw Open 2022 Jul 01;5(7):e2220908 42 Citations |
| 1 | Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (Wong JSM, Tan GHC, Cheok SHX, Ong CJ, Chia CS, Teo MCC) Pleura Peritoneum 2022 Jun 01;7(2):95-102 5 Citations |
| 1 | Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. (Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX) Ann Surg Oncol 2022 Oct;29(10):6381-6392 3 Citations |
| 2 | A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials. (Chrabaszcz S, Rajeev R, Witmer HDD, Dhiman A, Klooster B, Gamblin TC, Banerjee A, Johnston FM, Turaga KK) Am J Clin Oncol 2022 Aug 01;45(8):366-372 2 Citations |
| 1 | No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity. (Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, Burnet NG, Summersgill H, Webb A, De Ruysscher D, Seibold P, Chang-Claude J, Talbot CJ, Rattay T, Parliament M, De Ruyck K, Rosenstein BS, Pharoah PDP, Dunning AM, Vega A, West CML, RGC and REQUITE Consortia) Int J Radiat Oncol Biol Phys 2022 Nov 01;114(3):494-501 3 Citations |
| 1 | ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved. (Cobb AN, Sun SX) Ann Surg Oncol 2022 Oct;29(10):6393-6394 |
| 1 | CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope. (Karn V, Sandhya S, Hsu W, Parashar D, Singh HN, Jha NK, Gupta S, Dubey NK, Kumar S) Cancer Cell Int 2022 Jul 25;22(1):234 40 Citations |
| 1 | Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. (Parashar D, Singh A, Gupta S, Sharma A, Sharma MK, Roy KK, Chauhan SC, Kashyap VK) Genes (Basel) 2022 Jul 15;13(7) 19 Citations |
| 1 | Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (Park J, Venkatesulu BP, Kujundzic K, Katsoulakis E, Solanki AA, Puckett LL, Kapoor R, Chapman CH, Hagan M, Kelly MD, Palta J, Ashman JB, Jacqmin D, Kachnic LA, Minsky BD, Olsen J, Raldow AC, Wo JY, Dawes S, Wilson E, Kudner R, Das P) Pract Radiat Oncol 2022;12(5):424-436 4 Citations |
| 1 | Cancer: slaying the nine-headed Hydra. (Adashek JJ, Subbiah V, Westphalen CB, Naing A, Kato S, Kurzrock R) Ann Oncol 2023 Jan;34(1):61-69 23 Citations |
| 1 | Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. (Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG) J Hepatobiliary Pancreat Sci 2023 Jan;30(1):e1-e2 2 Citations |
| 1 | ASTRO Supports Access to Evidence-Based Cancer Care for All Patients, Regardless of Pregnancy Status, and Protection for Physicians Recommending and Providing Evidence-Based Care. (Jacobson GM, Bajaj GK, Buatti JM, Dawson L, Deville C, Eichler TJ, Erickson B, Ford E, Gibbs IC, Mantz C, Marples B, Michalski JM, Sandler H, Smith B, Vapiwala N, Yashar C) Int J Radiat Oncol Biol Phys 2022 Nov 01;114(3):390-392 1 Citation |
| 1 | Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. (Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium) Kidney Int 2022 Oct;102(4):930-935 8 Citations |
| 1 | Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction. (Fraunhoffer NA, Abuelafia AM, Bigonnet M, Gayet O, Roques J, Nicolle R, Lomberk G, Urrutia R, Dusetti N, Iovanna J) NPJ Precis Oncol 2022 Aug 17;6(1):57 15 Citations |
| 1 | ASO Visual Abstract: Primary Breast Neuroendocrine Tumors-An Analysis of the National Cancer Database. (Martinez EO, Jorns JM, Kong AL, Kijak J, Lee WY, Huang CC, Cortina CS) Ann Surg Oncol 2022 Oct;29(10):6349 |
| 1 | Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model. (Peng ZH, Jogdeo CM, Li J, Xie Y, Wang Y, Sheinin YM, Kopeček J, Oupický D) Pharmaceutics 2022 Aug 18;14(8) 4 Citations |
| 1 | Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study. (Van Dyk K, Ahn J, Zhou X, Zhai W, Ahles TA, Bethea TN, Carroll JE, Cohen HJ, Dilawari AA, Graham D, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Saykin AJ, Small BJ, Mandelblatt JS, Root JC) J Geriatr Oncol 2022 Nov;13(8):1132-1140 10 Citations |
| 1 | Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report. (Turcotte LM, Whitton JA, Leisenring WM, Howell RM, Neglia JP, Phelan R, Oeffinger KC, Ness KK, Woods WG, Kolb EA, Robison LL, Armstrong GT, Chow EJ) Blood 2023 Jan 05;141(1):90-101 6 Citations |
| 2 | Recent Advances in Intraoperative Lumpectomy Margin Assessment for Breast Cancer (Luo T, Lu T, Yu B, Yen TWF) Current Breast Cancer Reports September 2022;14(3):93-102 |
| 1 | An Overview of Cancer in the First 315,000 All of Us Participants. (Aschebrook-Kilfoy B, Zakin P, Craver A, Shah S, Kibriya MG, Stepniak E, Ramirez A, Clark C, Cohn E, Ohno-Machado L, Cicek M, Boerwinkle E, Schully SD, Mockrin S, Gebo K, Mayo K, Ratsimbazafy F, Sanders A, Shah RC, Argos M, Ho J, Kim K, Daviglus M, Greenland P, Ahsan H, All of Us Research Program Investigators) PLoS One 2022;17(9):e0272522 14 Citations |
| 1 | Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy (Krishnamurthy N, Kato S, Lippman S, Kurzrock R) Journal for ImmunoTherapy of Cancer 2 September 2022;10(9) 14 Citations |
| 1 | Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. (Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, Kurzrock R) Cancer Treat Rev 2022 Nov;110:102461 155 Citations |
| 1 | Seeking virtual support: Digital technology use in adolescent and young adults with advanced cancer. (Steineck A, Lau N, Fladeboe KM, Walsh CA, Rosenberg AR, Yi-Frazier JP, Barton KS) Pediatr Blood Cancer 2022 Nov;69(11):e29938 9 Citations |
| 1 | Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial. (DiSilvestro P, Banerjee S, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Oza A, González-Martín A, Aghajanian C, Bradley W, Mathews C, Liu J, McNamara J, Lowe ES, Ah-See ML, Moore KN, SOLO1 Investigators) J Clin Oncol 2023 Jan 20;41(3):609-617 253 Citations |
| 1 | The Importance of mir-491-5p in Various Cancers. (Fakeri M, Armandzadeh SM, Olyaei SS, Foruzandeh Z, Alivand MR) Curr Mol Med 2023;23(9):921-933 3 Citations |
| 2 | Effect of the environment on home-based self-sampling kits for anal cancer screening. (Nitkowski J, Giuliano A, Ridolfi T, Chiao E, Fernandez ME, Schick V, Swartz MD, Smith JS, Schneider EA, Brzezinski B, Nyitray AG) J Virol Methods 2022 Dec;310:114616 5 Citations |
| 1 | Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. (Lazar V, Girard N, Raymond E, Martini JF, Galbraith S, Raynaud J, Bresson C, Solomon B, Magidi S, Nechushtan H, Onn A, Berger R, Chen H, Al-Omari A, Ikeda S, Lassen U, Sekacheva M, Felip E, Tabernero J, Batist G, Spatz A, Pramesh CS, Girard P, Blay JY, Philip T, Berindan-Neagoe I, Porgador A, Rubin E, Kurzrock R, Schilsky RL) JCO Precis Oncol 2022 Sep;6:e2200072 |
| 1 | Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. (Puckett LL, Kodali D, Solanki AA, Park JH, Katsoulakis E, Kudner R, Kapoor R, Kujundzic K, Chapman CH, Hagan M, Kelly M, Palta J, Bazan JG, Dragun A, Fisher C, Haffty B, Nichols E, Shah C, Salehpour M, Dawes S, Wilson E, Buchholz TA) Pract Radiat Oncol 2023;13(3):217-230 6 Citations |
| 1 | Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. (Mehra N, Fizazi K, de Bono JS, Barthélémy P, Dorff T, Stirling A, Machiels JP, Bimbatti D, Kilari D, Dumez H, Buttigliero C, van Oort IM, Castro E, Chen HC, Di Santo N, DeAnnuntis L, Healy CG, Scagliotti GV) Oncologist 2022 Oct 01;27(10):e783-e795 12 Citations |
| 2 | Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. (Hall WA, Kishan AU, Hall E, Nagar H, Vesprini D, Paulson E, Van der Heide UA, Lawton CAF, Kerkmeijer LGW, Tree AC) Front Oncol 2022;12:962897 1 Citation |
| 1 | Dealing with the Vicissitudes and Abject Consequences of Head and Neck Cancer: A Vital Role for Psycho-Oncology. (Mascarella MA, Morand GB, Hier MP, Mlynarek A, Albert JG, Kissane D, Henry M) Curr Oncol 2022 Sep 19;29(9):6714-6723 4 Citations |
| 1 | Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. (Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R) NPJ Precis Oncol 2022 Sep 22;6(1):67 10 Citations |
| 1 | EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells. (d'Hose D, Mathieu B, Mignion L, Hardy M, Ouari O, Jordan BF, Sonveaux P, Gallez B) Molecules 2022 Sep 10;27(18) 6 Citations |
| 1 | Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients. (Phillips JD, Pooler DB, Ness DB, Fay K, Tau S, Demidenko E, Hampsch RA, Lewis LD, Miller TW) Br J Clin Pharmacol 2023 Mar;89(3):1027-1035 6 Citations |
| 1 | High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting. (Joshi RS, Boichard A, Adashek JJ, Kurzrock R) Cancer Biol Ther 2022 Dec 31;23(1):1-6 3 Citations |
| 2 | Ovarian cancer resistance to PARPi and platinum-containing chemotherapy. (Summey R, Uyar D) Cancer Drug Resist 2022;5(3):637-646 7 Citations |
| 1 | The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models (Joe R, Matsumura Y, Siddiqui A, Foulks J, Beg M, Thompson J, Yamamoto N, Spira A, Sarantopoulos J, Melear J, Lou Y, Lebedinsky C, Li J, Watanabe A, Warner S) European Journal of Cancer October 2022;174:S57-S58 1 Citation |
| 1 | Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. (Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jim HSL, Jacobsen PB, McDonald BC, Patel SK, Rentscher K, Root J, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Mandelblatt JS) J Clin Oncol 2023 Jan 10;41(2):295-306 26 Citations |
| 1 | Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study. (Hall WA, Shoag J, Spratt DE) Eur Urol 2022 Dec;82(6):661-662 2 Citations |
| 1 | Metaplastic Breast Cancer: Characteristics and Survival Outcomes. (Thapa B, Arobelidze S, Clark BA, Xuefei J, Daw H, Cheng YC, Patel M, Spiro TP, Haddad A) Cureus 2022 Aug;14(8):e28551 |
| 1 | Association of adenosine signaling gene signature with estrogen receptor-positive breast and prostate cancer bone metastasis. (Shropshire DB, Acosta FM, Fang K, Benavides J, Sun LZ, Jin VX, Jiang JX) Front Med (Lausanne) 2022;9:965429 3 Citations |
| 1 | The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. (van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, Giraldo A, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Lambrecht M, Lang P, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Valladares B, Talbot CJ, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, Lievens Y, REQUITE consortium) Radiother Oncol 2022 Nov;176:127-137 8 Citations |
| 1 | The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity. (Najafi F, Kelaye SK, Kazemi B, Foruzandeh Z, Allahverdizadeh F, Vakili S, Rad KK, Derakhshani M, Solali S, Alivand MR) Pathol Res Pract 2022 Nov;239:154130 5 Citations |
| 2 | Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma. (Moreno GA, Molina MI, Eastwood D, Auer PL, Jorns JM) Breast Cancer Res Treat 2022 Dec;196(3):453-461 1 Citation |
| 3 | Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. (Noid G, Godfrey G, Hall W, Shah J, Paulson E, Knechtges P, Erickson B, Allen Li X) Int J Radiat Oncol Biol Phys 2023 Mar 01;115(3):803-808 13 Citations |
| 1 | Sucrose Nonfermenting-Related Kinase Expression Is Related to a Metabolic Switch in Ovarian Cancer Cells That Results in Increased Fatty Acid Oxidation. (Chowdhury S, Ramchandran R, Palecek SP, Acevedo-Acevedo S, Bishop E) Cancer Invest 2023 Apr;41(4):330-344 1 Citation |
| 1 | Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer. (Huang J, Du M, Soupir A, Wang L, Tan W, Kalari KR, Kilari D, Park J, Huang CC, Kohli M, Wang L) Cancers (Basel) 2022 Sep 28;14(19) 2 Citations |
| 2 | Impact of a Cancer Health Education Curriculum Among Milwaukee Public High School Students. (Kerschner A, Jensik K, Berg D, Visotcky A, Banerjee A, Stolley M) J Cancer Educ 2023 Jun;38(3):1034-1041 1 Citation |
| 1 | Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism. (Satilmis H, Verheye E, Vlummens P, Oudaert I, Vandewalle N, Fan R, Knight JM, De Beule N, Ates G, Massie A, Moreaux J, Maes A, De Bruyne E, Vanderkerken K, Menu E, Sloan EK, De Veirman K) J Pathol 2023 Jan;259(1):69-80 13 Citations |
| 2 | Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. (Turner KM, Morris MC, Delman AM, Hanseman D, Johnston FM, Greer J, Walle KV, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Maduekwe U, Kothari A, Staley CA, Maithel SK, Lambert LA, Kim AC, Cloyd JM, Wilson GC, Sussman JJ, Ahmad SA, Patel SH) J Gastrointest Surg 2022 Dec;26(12):2569-2578 3 Citations |
| 1 | Challenges of Reaching Patients With Cancer on Social Media: Lessons From the Failed #CancerRealTalk Experience. (Beltrán Ponce S, McAlarnen LA, Teplinsky E) JCO Oncol Pract 2023 Feb;19(2):63-65 3 Citations |
| 2 | Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic. (Global Health Research Group on Children’s Non-Communicable Diseases Collaborative) BMJ Glob Health 2022 Oct;7(10) 9 Citations |
| 1 | Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. (Roth ME, Parsons SK, Ganz PA, Wagner LI, Hinds PS, Alexander S, Bingen K, Bober SL, Brackett J, Cella D, Henry NL, Indelicato DJ, Johnson RH, Miller TP, Rosenberg SM, Schmitz KH, Thanarajasingam G, Reeve BB, Salsman JM) J Natl Cancer Inst 2023 Jan 10;115(1):21-28 18 Citations |
| 5 | Predicting Neoadjuvant Treatment Response in Rectal Cancer Using Machine Learning: Evaluation of MRI-Based Radiomic and Clinical Models. (Peterson KJ, Simpson MT, Drezdzon MK, Szabo A, Ausman RA, Nencka AS, Knechtges PM, Peterson CY, Ludwig KA, Ridolfi TJ) J Gastrointest Surg 2023 Jan;27(1):122-130 6 Citations |
| 1 | Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. (Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA) Pract Radiat Oncol 2023;13(1):41-65 45 Citations |
| 1 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma (Wang Q, Strohbehn IA, Zhao S, Seethapathy H, Strohbehn SD, Hanna P, Lee M, Fadden R, Sullivan RJ, Boland GM, Reynolds KL, Sise ME) Kidney International Reports November 2022;7(11):2517-2521 2 Citations |
| 1 | Improving Outcomes Prediction Using a Combination of MRI Wavelet Delta-Radiomic Textures and Clinical Biomarkers for MR-Guided Adaptive Radiation Therapy of Pancreatic Cancer (HG Nasief, X Chen, BA Erickson, ES Paulson, A Li, WA Hall) International Journal of Radiation Oncology, Biology, Physics Volume 114 Issue 3 Pages S79-S80 |
| 1 | Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy (Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, Kurzrock R) Cancer Treatment Reviews November 2022;110 155 Citations |
| 2 | Physiology of chemokines in the cancer microenvironment. (Drouillard D, Craig BT, Dwinell MB) Am J Physiol Cell Physiol 2023 Jan 01;324(1):C167-C182 17 Citations |
| 1 | Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung. (Lazar V, Raynaud J, Magidi S, Bresson C, Martini JF, Galbraith S, Wunder F, Onn A, Batist G, Girard N, Lassen U, Pramesh CS, Al-Omari A, Ikeda S, Berchem G, Blay JY, Solomon B, Felip E, Tabernero J, Rubin E, Philip T, Porgador A, Berindan-Neagoe I, Schilsky RL, Kurzrock R) Ther Adv Med Oncol 2022;14:17588359221133893 3 Citations |
| 4 | Incorporating uncertainty bounds in daily deformable dose accumulation for adaptive radiation therapy of head-and-neck cancer. (García-Alvarez JA, Zhong H, Schultz CJ, Li XA, Kainz K) Med Phys 2023 Apr;50(4):2474-2487 3 Citations |
| 3 | Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer. (Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN) Breast Cancer Res Treat 2023 Jan;197(1):223-233 8 Citations |
| 1 | Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug discovery. (Xie D, Jia S, Ping D, Wang D, Cao L) Cytotechnology 2022 Dec;74(6):657-667 2 Citations |
| 1 | Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes. (De Sarkar N, Patton RD, Doebley AL, Hanratty B, Adil M, Kreitzman AJ, Sarthy JF, Ko M, Brahma S, Meers MP, Janssens DH, Ang LS, Coleman IM, Bose A, Dumpit RF, Lucas JM, Nunez TA, Nguyen HM, McClure HM, Pritchard CC, Schweizer MT, Morrissey C, Choudhury AD, Baca SC, Berchuck JE, Freedman ML, Ahmad K, Haffner MC, Montgomery RB, Corey E, Henikoff S, Nelson PS, Ha G) Cancer Discov 2023 Mar 01;13(3):632-653 29 Citations |
| 4 | The impact of greenspace or nature-based interventions on cardiovascular health or cancer-related outcomes: A systematic review of experimental studies. (Bikomeye JC, Balza JS, Kwarteng JL, Beyer AM, Beyer KMM) PLoS One 2022;17(11):e0276517 22 Citations |
| 2 | ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update. (Expert Panel on Interventional Radiology, Knavel Koepsel EM, Smolock AR, Pinchot JW, Kim CY, Ahmed O, Chamarthy MRK, Hecht EM, Hwang GL, Kaplan DE, Luh JY, Marrero JA, Monroe EJ, Poultsides GA, Scheidt MJ, Hohenwalter EJ) J Am Coll Radiol 2022 Nov;19(11S):S390-S408 1 Citation |
| 1 | Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. (Heumann P, Aguado-Barrera ME, Avuzzi B, Azria D, Briers E, Bultijnck R, Choudhury A, De Ruysscher D, Farcy-Jacquet MP, Fonteyne V, Gómez Caamaño A, Helmbold I, Johnson K, Kerns SL, Lambrecht M, Lingard Z, Rancati T, Rosenstein BS, Sperk E, Paul Symonds R, Talbot C, Valdagni R, Vega A, Veldeman L, Ward T, Webb A, West CM, Chang-Claude J, Seibold P, REQUITE Consortium) Radiother Oncol 2023 Jan;178:109426 3 Citations |
| 1 | Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies (Gupta D, Kurzrock R, Lee S, Okamura R, Lim HJ, Kim KH, Sicklick JK, Kato S) npj Precision Oncology December 2022;6(1) 1 Citation |
| 1 | Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study (Hall WA, Shoag J, Spratt DE) European Urology December 2022;82(6):661-662 2 Citations |
| 2 | Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction (Fraunhoffer NA, Abuelafia AM, Bigonnet M, Gayet O, Roques J, Nicolle R, Lomberk G, Urrutia R, Dusetti N, Iovanna J) npj Precision Oncology December 2022;6(1) 15 Citations |
| 1 | CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope (Karn V, Sandhya S, Hsu W, Parashar D, Singh HN, Jha NK, Gupta S, Dubey NK, Kumar S) Cancer Cell International December 2022;22(1) 40 Citations |
| 1 | Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer. (Van Cutsem E, Hochster H, Shitara K, Mayer R, Ohtsu A, Falcone A, Yoshino T, Doi T, Ilson DH, Arkenau HT, George B, Benhadji KA, Makris L, Tabernero J) ESMO Open 2022 Dec;7(6):100633 5 Citations |
| 2 | Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. (Hall WA, Evans DB, Tsai S) JAMA Oncol 2023 Feb 01;9(2):275-276 2 Citations |
| 1 | A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA. (Doebley AL, Ko M, Liao H, Cruikshank AE, Santos K, Kikawa C, Hiatt JB, Patton RD, De Sarkar N, Collier KA, Hoge ACH, Chen K, Zimmer A, Weber ZT, Adil M, Reichel JB, Polak P, Adalsteinsson VA, Nelson PS, MacPherson D, Parsons HA, Stover DG, Ha G) Nat Commun 2022 Dec 03;13(1):7475 47 Citations |
| 1 | Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy. (Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN) Pract Radiat Oncol 2023;13(3):e261-e269 22 Citations |
| 1 | Sociodemographic Differences in Patient-Reported Pain and Pain Management of Patients With Head and Neck Cancer in a Community Oncology Setting. (Canick JE, Bhardwaj A, Patel A, Kuziez D, Larsen R, Misra S, Pearson B, Smith BD, Rohde RL, Adjei Boakye E, Kahmke RR, Osazuwa-Peters N) JCO Oncol Pract 2023 Mar;19(3):e397-e406 3 Citations |
| 5 | Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. (Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C Consortium) Ann Surg Oncol 2023 Mar;30(3):1305-1308 4 Citations |
| 3 | Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy. (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Adv Radiat Oncol 2023;8(1):101122 9 Citations |
| 1 | Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study. (Ade CJ, Dockery L, Walter AC, Benbrook DM, Vesely SK, Hammond ST, Moore KN, Holman LL) Nutr Cancer 2023;75(2):662-669 1 Citation |
| 1 | Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis. (Chen Z, Gong X, Cheng C, Fu Y, Wu W, Luo Z) Clin Breast Cancer 2023 Feb;23(2):143-154 4 Citations |
| 1 | Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. (Solanki AA, Puckett LL, Kujundzic K, Katsoulakis E, Park J, Kapoor R, Hagan M, Kelly M, Palta J, Ballas LK, DeMarco J, Hoffman KE, Lawton CAF, Michalski J, Potters L, Zelefsky M, Kudner R, Dawes S, Wilson E, Sandler H) Pract Radiat Oncol 2023;13(2):e149-e165 4 Citations |
| 1 | Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. (Soler M, Alfaro K, Masch RJ, Conzuelo Rodriguez G, Qu X, Wu S, Sun J, Hernández Jovel DM, Bonilla J, Puentes LO, Murillo R, Alonzo TA, Felix JC, Castle P, Cremer M) JCO Glob Oncol 2022 Dec;8:e2200112 4 Citations |
| 1 | Inorganic nitrate supplementation may improve diastolic function and the O2 cost of exercise in cancer survivors: a pilot study. (Turpin VG, Lovoy GM, Parr SK, Hammond ST, Post HK, Caldwell JT, Banister HR, Scheuermann BC, Colburn TD, Ade CJ) Support Care Cancer 2022 Dec 19;31(1):63 |
| 1 | Exploring the relationship between DNA methylation age measures and psychoneurological symptoms in women with early-stage breast cancer. (Yang GS, Yang K, Weaver MT, Lynch Kelly D, Dorsey SG, Jackson-Cook CK, Lyon DE) Support Care Cancer 2022 Dec 20;31(1):65 6 Citations |
| 1 | Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer. (Schweizer MT, Gulati R, Yezefski T, Cheng HH, Mostaghel E, Haffner MC, Patel RA, De Sarkar N, Ha G, Dumpit R, Woo B, Lin A, Panlasigui P, McDonald N, Lai M, Nega K, Hammond J, Grivas P, Hsieh A, Montgomery B, Nelson PS, Yu EY) Prostate Cancer Prostatic Dis 2023 Mar;26(1):194-200 12 Citations |
| 1 | Low-Risk Papillary Thyroid Cancer Presents a Treatment Dilemma in the Dutch Healthcare System. (Johnson S, Wang T) World J Surg 2023 May;47(5):1219-1220 |
| 1 | Recent insights into Cannabinoids: Functions, mechanisms, clinical trials, and technological advancements in cancer and neurological diseases (Pant T, Juric M, Bosnjak ZJ) Phytopharmaceuticals and Biotechnology of Herbal Plants 28 December 2022:225-237 |
| 1 | Longitudinal Sedentary Time and Symptoms in Breast Cancer Patients during Chemotherapy Using Ecological Momentary Assessment. (Welch WA, Solk P, Auster-Gussman L, Whitaker M, Siddique J, Fanning J, Mishory A, Khan S, Santa-Maria C, Kulkarni S, Phillips SM) Med Sci Sports Exerc 2023 May 01;55(5):966-974 4 Citations |
| 2 | Electronic Medical Record-Based Electronic Messaging Among Patients with Breast Cancer: A Systematic Review. (Conroy M, Powell M, Suelzer E, Pamulapati S, Min H, Wright T, Kamaraju S) Appl Clin Inform 2023 Jan;14(1):134-143 8 Citations |
| 1 | Autologous CD34+ stem cell humanization in head and neck cancer modeling: The translational importance of T cell maturation (Zenga J, Awan MJ, Frei A, Shukla M, Shreenivas A, Wong SJ, Himburg HA) Oral Oncology Reports 2022, 100010. ISSN 2772-9060, https://doi.org/10.1016/j.oor.2022.100010. |
| 2 | Prophylactic Cranial Irradiation in Non-small Cell Lung Cancer (Saeed H, Shukla ME, Gore EM) Medical Radiology 2023;Part F1269:581-595 |
| 1 | Age-Appropriate Cancer Screenings Through a Dermatology Lens (Calley B, Berce P, Chang CK, Neman S, Viteri AM, Means A, Vaughn OLA) Wisconsin Medical Journal 2023;122(4):262-267 |
| 1 | Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Exploration of Targeted Anti-tumor Therapy 2023;4(6):1301-1309 |
| 1 | Prospects for targeting ACKR1 in cancer and other diseases (Crawford KS, Volkman BF) Frontiers in Immunology 2023;14 20 Citations |
| 1 | Editorial: MR-guided focused ultrasound treatment techniques in cancers: from physics to clinics (Lu Y, Zhang Z, Liu S) Frontiers in Oncology 2023;13 2 Citations |
| 1 | Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy (Dhani H, Hinestrosa JP, Izaguirre-Carbonell J, Balcer HI, Kurzrock R, Billings PR) Frontiers in Oncology 2023;13 4 Citations |
| 1 | ERBB family fusions are recurrent and actionable oncogenic targets across cancer types (Schubert L, Elliott A, Le AT, Estrada-Bernal A, Doebele RC, Lou E, Borghaei H, Demeure MJ, Kurzrock R, Reuss JE, Ou SHI, Braxton DR, Thomas CA, Darabi S, Korn WM, El-Deiry WS, Liu SV) Frontiers in Oncology 2023;13 7 Citations |
| 2 | Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Advances in Radiation Oncology 1 January 2023;8(1) 9 Citations |
| 1 | Neighborhood Deprivation and Rurality Associated with Patient-Reported Outcomes and Survival in Men with Prostate Cancer in NRG RTOG 0415 (Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, Katherine A Yeager, Qi Zhang, W Robert Lee, Amit B Shah, Ian S Dayes, David P D'Souza, Jeff M Michalski, Jason A Efstathiou, John M Longo, Thomas M Pisansky, Jordan M Maier, Sergio L Faria, Anand B Desai, Samantha A Seaward, Howard M Sandler, Mary E Cooley, Deborah W Bruner ) Int J Radiation Oncology Biology Phys. Bai J, Pugh SL, Eldridge R, Yeager KA, Zhang Q, Lee WR, Shah AB, Dayes IS, D'Souza DP, Michalski JM, Efstathiou JA, Longo JM, Pisansky TM, Maier JM, Faria SL, Desai AB, Seaward SA, Sandler HM, Cooley ME, Bruner DW. Neighborhood Deprivation and Rurality Associated with Patient-Reported Outcomes and Survival in Men with Prostate Cancer in NRG RTOG 0415. Int J Radiat Oncol Biol Phys. 2023 Feb 1:S0360-3016(23)00082-2. doi: 10.1016/j.ijrobp.2023.01.035. Epub ahead of print. PMID: 36736921. |
| 1 | Impact of Medicaid Expansion on Stage at Diagnosis for US Adults with Pancreatic Cancer: a Population-Based Study. (Mobley EM, Guerrier C, Tfirn I, Gutter MS, Vigal K, Pather K, Braithwaite D, Nataliansyah MM, Tsai S, Baskovich B, Awad ZT, Parker AS) J Racial Ethn Health Disparities 2023 Dec;10(6):2826-2835 2 Citations |
| 1 | Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. (Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY) Int J Radiat Oncol Biol Phys 2023 Jul 01;116(3):521-529 24 Citations |
| 1 | Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis. (Sadler SJ, Torio EF, Golby AJ) Cancer 2023 Mar 01;129(5):671-684 2 Citations |
| 2 | Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study. (Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C, EMBRACE Collaborative Group) J Clin Oncol 2023 Apr 01;41(10):1933-1942 31 Citations |
| 1 | Physiological relevance of in-vitro cell-nanoparticle interaction studies as a predictive tool in cancer nanomedicine research. (Boinapalli Y, Shankar Pandey R, Singh Chauhan A, Sudheesh MS) Int J Pharm 2023 Feb 05;632:122579 6 Citations |
| 4 | Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer. (Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE) J Clin Oncol 2023 Apr 10;41(11):2067-2075 4 Citations |
| 1 | Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number? (Hathout L, Fields EC, Erickson BA) Int J Radiat Oncol Biol Phys 2023 Feb 01;115(2):297-301 1 Citation |
| 1 | Mobile health (mHealth) interventions in prostate cancer survivorship: a scoping review. (Ogunsanya ME, Sifat M, Bamidele OO, Ezenwankwo EF, Clifton S, Ton C, Knight JM, Odedina FT, Greer JA, Dwyer K, Kendzor DE) J Cancer Surviv 2023 Jun;17(3):557-568 3 Citations |
| 1 | Assessing Breast and Ovarian Cancer Risk Prior to Gender-Affirming Surgery. (Cortina CS) JAMA Surg 2023 Apr 01;158(4):339-340 11 Citations |
| 1 | Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients. (Mapuskar KA, Vasquez Martinez G, Pulliam CF, Petronek MS, Steinbach EJ, Monga V, Furqan M, Jetton JG, Saunders DP, Pearce A, Davidson S, Pitre L, Dunlap NE, Fairbanks R, Lee CM, Mott SL, Bodeker KL, Cl H, Buatti JM, Anderson CM, Beardsley RA, Holmlund JT, Zepeda-Orozco D, Spitz DR, Allen BG) Redox Biol 2023 Apr;60:102599 12 Citations |
| 3 | High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. (Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H) JCO Precis Oncol 2023 Jan;7:e2100498 9 Citations |
| 1 | Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial. (Hohneck A, Meissner R, Reyser C, Heinemann L, Christians K, Merx K, Weingärtner S, Mavratzas A, Schulte N, Burkholder I, Hofmann WK, Hofheinz RD) Oncol Res Treat 2023;46(1-2):1-10 1 Citation |
| 1 | Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis. (Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R) NPJ Genom Med 2023 Jan 20;8(1):1 20 Citations |
| 1 | Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. (Chow EJ, Aggarwal S, Doody DR, Aplenc R, Armenian SH, Baker KS, Bhatia S, Blythe N, Colan SD, Constine LS, Freyer DR, Kopp LM, Laverdière C, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Lipshultz SE) J Clin Oncol 2023 Apr 20;41(12):2248-2257 30 Citations |
| 1 | Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA. (Doebley AL, Ko M, Liao H, Cruikshank AE, Santos K, Kikawa C, Hiatt JB, Patton RD, De Sarkar N, Collier KA, Hoge ACH, Chen K, Zimmer A, Weber ZT, Adil M, Reichel JB, Polak P, Adalsteinsson VA, Nelson PS, MacPherson D, Parsons HA, Stover DG, Ha G) Nat Commun 2023 Jan 25;14(1):403 1 Citation |
| 1 | Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine population. (Rosenberg S, Ben Cohen G, Kato S, Okamura R, Lippman SM, Kurzrock R) Mol Oncol 2023 Sep;17(9):1844-1856 1 Citation |
| 1 | The role of cancer cell bioenergetics in dormancy and drug resistance. (Tau S, Miller TW) Cancer Metastasis Rev 2023 Mar;42(1):87-98 10 Citations |
| 1 | Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit. (Verhagen NB, Kothari AN) Ann Surg Oncol 2023 Apr;30(4):2109-2110 |
| 1 | Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. (Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M 3rd, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F) Eur Urol 2024 Apr;85(4):373-381 5 Citations |
| 1 | Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR. (Hanna PE, Wang Q, Strohbehn I, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME) medRxiv 2023 Jan 18 |
| 1 | Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415. (Bai J, Pugh SL, Eldridge R, Yeager KA, Zhang Q, Lee WR, Shah AB, Dayes IS, D'Souza DP, Michalski JM, Efstathiou JA, Longo JM, Pisansky TM, Maier JM, Faria SL, Desai AB, Seaward SA, Sandler HM, Cooley ME, Bruner DW) Int J Radiat Oncol Biol Phys 2023 May 01;116(1):39-49 8 Citations |
| 1 | Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesions. (Braxton AM, Kiemen AL, Grahn MP, Forjaz A, Babu JM, Zheng L, Jiang L, Cheng H, Song Q, Reichel R, Graham S, Damanakis AI, Fischer CG, Mou S, Metz C, Granger J, Liu XD, Bachmann N, Almagro-Pérez C, Jiang AC, Yoo J, Kim B, Du S, Foster E, Hsu JY, Rivera PA, Chu LC, Liu F, Niknafs N, Fishman EK, Yuille A, Roberts NJ, Thompson ED, Scharpf RB, Cornish TC, Jiao Y, Karchin R, Hruban RH, Wu PH, Wirtz D, Wood LD) bioRxiv 2023 Jan 28 |
| 1 | Cervical Cancer Screening. (Gavinski K, DiNardo D) Med Clin North Am 2023 Mar;107(2):259-269 15 Citations |
| 1 | Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. (Knisely A, Seo YD, Wargo JA, Chelvanambi M) Cancers (Basel) 2023 Jan 27;15(3) 13 Citations |
| 9 | CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3013-3021 5 Citations |
| 1 | Trends in Pediatric Cancer Care in Florida from 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population. (Shaw PH, Metts J, Amankwah E, Eslin DE, Bradfield S, Slayton WB, Hays B, Calkins B, Rico J, Krischer J. ) Cureus Cureus. 2023 15(2): e35061. doi:10.7759/cureus.35061 |
| 3 | Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review. (Beltrán Ponce SE, Abunike SA, Bikomeye JC, Sieracki R, Niyonzima N, Mulamira P, Kibudde S, Ortiz de Choudens S, Siker M, Small C, Beyer KMM) JCO Glob Oncol 2023 Feb;9:e2200218 9 Citations |
| 2 | Worsening Rash in a Patient With Metastatic Breast Cancer. (Pierro MJ, Zhang AJ, Chaudhary LN) JAMA Oncol 2023 Apr 01;9(4):564-565 |
| 5 | Historical redlining and breast cancer treatment and survival among older women in the United States. (Bikomeye JC, Zhou Y, McGinley EL, Canales B, Yen TWF, Tarima S, Ponce SB, Beyer KMM) J Natl Cancer Inst 2023 Jun 08;115(6):652-661 22 Citations |
| 3 | Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy. (Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS) JCO Oncol Pract 2023 May;19(5):e794-e800 24 Citations |
| 1 | Immunohistochemical (IHC) subtypes of metastatic bladder cancer (mBC) using GATA3 and CK5/6. (Ariel Ann Nelson, Mariel Molina Nunez, Kathryn A. Bylow, Aniko Szabo, Kenneth Iczkowski,
Deepak Kilari) Journal of Clinical Oncology Journal of Clinical Oncology 41, no. 6_suppl (February 20, 2023) 557-557. |
| 1 | Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. (Joshi M, Tuanquin L, Zhu J, Walter V, Schell T, Kaag M, Kilari D, Liao J, Holder SL, Emamekhoo H, Sankin A, Merrill S, Zheng H, Warrick J, Hauke R, Gartrel B, Stein M, Drabick J, Degraff DJ, Zakharia Y) J Immunother Cancer 2023 Feb;11(2) 16 Citations |
| 1 | Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy. (Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline M, Conroy J, Rubin E, Eskander R, Kurzrock R) Res Sq 2023 Feb 16 |
| 1 | Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer. (Cronin M, Crowley A, Davey MG, Ryan P, Abdelshafy M, Elkoumy A, Elzomor H, Arsang-Jang S, Ganly S, Nash P, Crowley J, Sharif F, Simpkin A, Lowery A, Wijns W, Kerin M, Soliman O) J Clin Med 2023 Feb 06;12(4) 11 Citations |
| 3 | Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeqTMKids for molecular profiling of childhood malignancies. (Schilter KF, Smith BA, Nie Q, Stoll K, Felix JC, Jarzembowski JA, Reddi HV) Front Genet 2023;14:1067457 3 Citations |
| 4 | Autologous CD34+ stem cell humanization in head and neck cancer modeling: The translational importance of T cell maturation (Zenga J, Awan MJ, Frei A, Shukla M, Shreenivas A, Wong SJ, Himburg HA) Oral Oncology Reports March 2023;5 |
| 1 | Risk Factors for Breast Cancer-Related Lymphedema, Risk Reduction, and Myths about Precautionary Behaviors (Cobb A, DeSnyder SM) Current Breast Cancer Reports March 2023;15(1):1-11 2 Citations |
| 2 | Climate mitigation and adaptation is cancer prevention and control (Rublee C, Bikomeye J, Rao S, Husain M, Beyer K) Journal of Climate Change and Health 1 March 2023;10 5 Citations |
| 1 | Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. (Reddy DR, Cuenca JA, Botdorf J, Muthu M, Hanmandlu A, Wegner R, Crommett J, Gutierrez C, Rathi N, Sajith B, Knafl M, Abbas HA, Woodman SE, Nates JL, D3CODE Team Collaborators) Mayo Clin Proc 2023 Mar;98(3):451-457 3 Citations |
| 1 | Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention. (Pan J, Xiong D, Zhang Q, Palen K, Shoemaker RH, Johnson B, Sei S, Wang Y, You M) Front Immunol 2023;14:1036563 4 Citations |
| 2 | ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3022 |
| 7 | Evaluation of a transition to survivorship program for pediatric, adolescent, and young adult cancer patients and caregivers. (Bingen K, Karst J, Anderson L, Chan S, Jordan A, Morin J, Nichols J, Palou-Torres A, Phelan R, Schmidt D, Yan K, Hoag JA) Pediatr Blood Cancer 2023 May;70(5):e30277 3 Citations |
| 4 | Dynamic NIR Fluorescence Imaging and Machine Learning Framework for Stratifying High vs. Low Notch-Dll4 Expressing Host Microenvironment in Triple-Negative Breast Cancer. (Shafiee S, Jagtap J, Zayats M, Epperlein J, Banerjee A, Geurts A, Flister M, Zhuk S, Joshi A) Cancers (Basel) 2023 Feb 25;15(5) 3 Citations |
| 2 | Commentary: "Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data". (Sun LY, Echefu G, Doshi K, Roberts ML, Hamid A, Cheng RK, Olson J, Brown SA) Front Cardiovasc Med 2023;10:982028 2 Citations |
| 1 | Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. (Garden AS, Harris J, Eisbruch A, Chao KSC, Morrison WH, Harari PM, Swanson TA, Jones CU, Yom SS, Spencer SA, Scrimger R, Shenouda G, Shukla M, Lau HY, Mierzwa M, Torres-Saavedra P, Le QT) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2):333-340 4 Citations |
| 4 | Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology. (Duenweg SR, Brehler M, Bobholz SA, Lowman AK, Winiarz A, Kyereme F, Nencka A, Iczkowski KA, LaViolette PS) PLoS One 2023;18(3):e0278084 6 Citations |
| 1 | Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis. (Subbiah V, Kurzrock R) J Clin Oncol 2023 Jun 10;41(17):3100-3103 32 Citations |
| 1 | Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort. (Sreeram K, Seaton R, Greenwald MK, Kamgar M, Assad H, Baird T, Schwartz AG, Ruterbusch J, Simon MS) Cancer Causes Control 2023 May;34(5):459-468 4 Citations |
| 1 | Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population. (Shaw PH, Metts J, Amankwah E, Eslin DE, Bradfield S, Slayton WB, Hays B, Calkins B, Rico J, Krischer J) Cureus 2023 Feb;15(2):e35061 |
| 1 | Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers. (Yuan Y, Ju YS, Kim Y, Li J, Wang Y, Yoon CJ, Yang Y, Martincorena I, Creighton CJ, Weinstein JN, Xu Y, Han L, Kim HL, Nakagawa H, Park K, Campbell PJ, Liang H, PCAWG Consortium) Nat Genet 2023 Jun;55(6):1078 |
| 1 | Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer. (Akdemir KC, Le VT, Chandran S, Li Y, Verhaak RG, Beroukhim R, Campbell PJ, Chin L, Dixon JR, Futreal PA, PCAWG Structural Variation Working Group, PCAWG Consortium) Nat Genet 2023 Jun;55(6):1079 |
| 1 | Author Correction: The landscape of viral associations in human cancers. (Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H, PCAWG Pathogens, Cooper CS, Eils R, Ferretti V, Lichter P, PCAWG Consortium) Nat Genet 2023 Jun;55(6):1077 |
| 1 | Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. (Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, Detering H, Li Y, Rodriguez-Castro J, Dueso-Barroso A, Bruzos AL, Dentro SC, Blanco MG, Contino G, Ardeljan D, Tojo M, Roberts ND, Zumalave S, Edwards PA, Weischenfeldt J, Puiggròs M, Chong Z, Chen K, Lee EA, Wala JA, Raine KM, Butler A, Waszak SM, Navarro FCP, Schumacher SE, Monlong J, Maura F, Bolli N, Bourque G, Gerstein M, Park PJ, Wedge DC, Beroukhim R, Torrents D, Korbel JO, Martincorena I, Fitzgerald RC, Van Loo P, Kazazian HH, Burns KH, PCAWG Structural Variation Working Group, Campbell PJ, Tubio JMC, PCAWG Consortium) Nat Genet 2023 Jun;55(6):1080 1 Citation |
| 1 | Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. (Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, Gordenin D, Klimczak LJ, Zhang CZ, Pellman DS, PCAWG Structural Variation Working Group, Park PJ, PCAWG Consortium) Nat Genet 2023 Jun;55(6):1076 1 Citation |
| 3 | Digital Anal Rectal Examination Usage Among Individuals at Increased Risk for Anal Cancer. (Nyitray AG, Ridolfi TJ, Nitkowski J, McAuliffe TL, Deshmukh AA, Giuliano AR, Chiao EY, Prevent Anal Cancer Self-Swab Study Team) J Low Genit Tract Dis 2023 Jul 01;27(3):242-247 2 Citations |
| 9 | Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 3 Citations |
| 1 | Breast cancer screening among immigrant Muslim arab women in the United States: Analyzing relationships between beliefs, knowledge, spousal support and mammogram utilization. (Alkhaifi S, Padela AI, Hodge F, Brecht ML) J Natl Med Assoc 2023 Jun;115(3):302-313 1 Citation |
| 1 | Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer. (Semenkovich NP, Samson PP, Badiyan SN, Vlacich G, Stowe HB, Wang YE, Star R, Devarakonda S, Govindan R, Waqar SN, Robinson CG, Pellini B, Chaudhuri AA) Res Sq 2023 Mar 22 |
| 1 | Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. (Traphagen NA, Schwartz GN, Tau S, Jiang A, Hosford SR, Goen AE, Roberts AM, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW) bioRxiv 2023 Mar 17 |
| 1 | Prospects for targeting ACKR1 in cancer and other diseases. (Crawford KS, Volkman BF) Front Immunol 2023;14:1111960 20 Citations |
| 1 | Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer (PAC) Self-Swab Study (Nyitray, Alan; Nitkowski, Jenna; McAuliffe, Timothy L.; Brzezinski, Bridgett; Swartz, Michael; Deshmukh, Ashish; Ridolfi, Timothy J.; Lundeen, Sarah J. ; Cockerham, Leslie; Wenten, Dave; Petroll, Andrew; Hilgeman, Brian; Smith, Jennifer; Chiao, Elizabeth Y.; Giuliano, Anna; Schick, Vanessa) International Journal of Cancer |
| 2 | The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes. (Blaine-Sauer S, Samuels TL, Yan K, Johnston N) Int J Mol Sci 2023 Apr 05;24(7) 10 Citations |
| 1 | Cancer Risk in Barrett's Esophagus: A Clinical Review. (Beydoun AS, Stabenau KA, Altman KW, Johnston N) Int J Mol Sci 2023 Mar 23;24(7) 13 Citations |
| 1 | ChatGPT, Large Language Models, and Generative AI as Future Augments of Surgical Cancer Care. (Kothari AN) Ann Surg Oncol 2023 Jun;30(6):3174-3176 26 Citations |
| 3 | Invited Commentary: Current and Future Opportunities in Mitigating Breast Cancer Disparity. (Cortina CS, Cobb AN, Kong AL) J Am Coll Surg 2023 Jun 01;236(6):1239-1241 |
| 8 | Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Res Sq 2023 Apr 07 |
| 1 | Matched case-control analysis of breast cancer-specific factors impacting the risk of developing SARS-CoV-2 infection (28. Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar C, Chaudhary LN) Wisconsin Medical Journal WMJONLINE-D-22-00080R1 |
| 1 | Current Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast Cancer. (Pan IW, Yen TWF, Bedrosian I, Shih YT) JCO Oncol Pract 2023 Jul;19(7):446-455 2 Citations |
| 1 | Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors. (Gupta S, Hanna PE, Ouyang T, Yamada KS, Sawtell R, Wang Q, Katz-Agranov N, Feghali L, Krasner CN, Bouberhan S, Castro CM, Sise ME) J Natl Cancer Inst 2023 Jul 06;115(7):831-837 8 Citations |
| 11 | Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S) Ann Surg 2023 Dec 01;278(6):e1224-e1231 3 Citations |
| 2 | Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel. (Puckett LL, Titi M, Kujundzic K, Dawes SL, Gore EM, Katsoulakis E, Park JH, Solanki AA, Kapoor R, Kelly M, Palta J, Chetty IJ, Jabbour SK, Liao Z, Movsas B, Thomas CR Jr, Timmerman RD, Werner-Wasik M, Kudner R, Wilson E, Simone CB 2nd) Pract Radiat Oncol 2023;13(5):413-428 9 Citations |
| 1 | Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. (Hallemeier CL, Moughan J, Haddock MG, Herskovic AM, Minsky BD, Suntharalingam M, Zeitzer KL, Garg MK, Greenwald BD, Komaki RU, Puckett LL, Kim H, Lloyd S, Bush DA, Kim HE, Lad TE, Meyer JE, Okawara GS, Raben A, Schefter TE, Barker JL Jr, Falkson CI, Videtic GMM, Jacob R, Winter KA, Crane CH) JAMA Netw Open 2023 Apr 03;6(4):e238504 4 Citations |
| 1 | A multi-site trial of an electronic health integrated physical activity promotion intervention in breast and endometrial cancers survivors: MyActivity study protocol. (Cadmus-Bertram L, Solk P, Agnew M, Starikovsky J, Schmidt C, Morelli WA, Hodgson V, Freeman H, Muller L, Mishory A, Naxi S, Carden L, Tevaarwerk AJ, Wolter M, Barber E, Spencer R, Sesto ME, Gradishar W, Gangnon R, Spring B, Nahum-Shani I, Phillips SM) Contemp Clin Trials 2023 Jul;130:107187 3 Citations |
| 1 | Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis. (Maduekwe UN, Stephenson BJK, Yeh JJ, Troester MA, Sanoff HK) J Surg Oncol 2023 Aug;128(2):254-261 |
| 1 | Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. (Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim HSL, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Carroll JE) Cancer 2023 Aug 01;129(15):2409-2421 6 Citations |
| 1 | Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. (Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker VM, Olson AC, Cury FL, Papagikos MA, Karrison TG, Sandler HM, Bruner DW) J Clin Oncol 2023 Jun 10;41(17):3217-3224 9 Citations |
| 1 | Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study (Balakrishnan A, Barmpounakis P, Demiris N, Jah A, Spiers HVM, Talukder S, Martin JL, Gibbs P, Harper SJF, Huguet EL, Kosmoliaptsis V, Liau SS, Praseedom RK, Basu B, de Aretxabala X, Lendoire J, Maithel S, Branes A, Andersson B, Serrablo A, Adsay V, Abe T, Abu Hilal M, Achalandabaso Boira MdM, Adham M, Adam M, Ahmad M, Al-Sarireh B, Albiol M, Alhaboob N, Alseidi A, Ammar H, Anand A, Antonakis P, Araya V, Ashley SW, Atanasov G, Ausania F, Balestri R, Banerjee A, Banting S, Barauskas G, Bartsch F, Belli A, Beretta S, Berrevoet F, Fernandez GB, Bolm L, Bonal M, Bozkurt E, Braat AE, Bradshaw L, Burdine L, Byrne M, Caceres M, Castro Santiago MJ, Chan B, Chong L, Çoker A, Conde Rodriguez M, Croagh D, Crutchley A, Cutolo C, D'Hondt M, D'Souza D, Daams F, Dalla Valle R, Davide J, de Bellis M, de Boer M, de Meyere C, de Reuver P, Dixon M, Dorovinis P, Bauer GE, Eduarda M, Eker H, Erdmann J, Erkan M, Felekouras E, Felli E, Fernandes E, Figueroa Rivera E, Fulop A, Galun D, Gerhards M, Ghorbani P, Giannone F, Gil L, Giorgakis E, Giuffrida M, Giuliante F, Gkekas I, Gomez Bravo M, Groot Koerkamp B, Guevara O, Guglielmi A, Gulla A, Gupta R, Gupta A) eClinicalMedicine May 2023;59 26 Citations |
| 1 | Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort (Sreeram K, Seaton R, Greenwald MK, Kamgar M, Assad H, Baird T, Schwartz AG, Ruterbusch J, Simon MS) Cancer Causes and Control May 2023;34(5):459-468 4 Citations |
| 1 | Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. (Bagheri M, Aisha Mohamed G, Mohamed Saleem MA, Ognjenovic NB, Lu H, Kolling FW, Wilkins OM, Das S, La Croix IS, Nagaraj SH, Muller KE, Gerber SA, Miller TW, Pattabiraman DR) bioRxiv 2023 Apr 21 |
| 2 | Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. (Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2):370-377 14 Citations |
| 3 | Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells. (Cheng G, Hardy M, Kalyanaraman B) Sci Rep 2023 May 04;13(1):7254 3 Citations |
| 2 | Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells. (Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann MT, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J) EBioMedicine 2023 Jun;92:104602 3 Citations |
| 1 | Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer. (Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan M) HPB (Oxford) 2023 Aug;25(8):933-940 |
| 6 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Adv Radiat Oncol 2023;8(4):101206 2 Citations |
| 1 | HPV-related oropharyngeal cancer early detection in gay and bisexual men is an "orphan" practice: A qualitative analysis among healthcare providers. (Zoschke IN, Bennis SL, Wilkerson JM, Stull CL, Nyitray AG, Khariwala SS, Nichols CM, Rosser BRS, Flash C, Ross MW) Front Public Health 2023;11:1165107 6 Citations |
| 1 | FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells. (Karmakar D, Lahiri P, Bedi M, Ghosh A, Ghosh A, Barui A, Varshney SK, Lahiri B, Sengupta S) J Cell Biochem 2023 Jun;124(6):849-860 1 Citation |
| 1 | Identification and validation of miR-583 and mir-877-5p as biomarkers in patients with breast cancer: an integrated experimental and bioinformatics research. (Foruzandeh Z, Alivand MR, Ghiami-Rad M, Zaefizadeh M, Ghorbian S) BMC Res Notes 2023 May 08;16(1):72 4 Citations |
| 1 | Interactive Health Literacy and Symptom Self-management in Patients With Lung Cancer: A Critical Realist Analysis. (Campbell JK, Erickson JM) Cancer Nurs 2024 Sep-Oct 01;47(5):397-407 3 Citations |
| 6 | Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self-Swab Study. (Nyitray AG, Nitkowski J, McAuliffe TL, Brzezinski B, Swartz MD, Fernandez ME, Deshmukh AA, Ridolfi TJ, Lundeen SJ, Cockerham L, Wenten D, Petroll A, Hilgeman B, Smith JS, Chiao EY, Giuliano AR, Schick V, Prevent Anal Cancer Self-Swab Study Team) Int J Cancer 2023 Aug 15;153(4):843-853 20 Citations |
| 1 | ERBB family fusions are recurrent and actionable oncogenic targets across cancer types. (Schubert L, Elliott A, Le AT, Estrada-Bernal A, Doebele RC, Lou E, Borghaei H, Demeure MJ, Kurzrock R, Reuss JE, Ou SI, Braxton DR, Thomas CA, Darabi S, Korn WM, El-Deiry WS, Liu SV) Front Oncol 2023;13:1115405 7 Citations |
| 8 | Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer. (Matoska T, Banerjee A, Shreenivas A, Jurkowski L, Shukla ME, Gore EM, Linsky P, Gasparri M, George B, Johnstone C, Johnstone D, Puckett LL) Cancers (Basel) 2023 Apr 28;15(9) 3 Citations |
| 1 | From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer. (Seo YD, Wargo JA) Cell Rep Med 2023 May 16;4(5):101039 5 Citations |
| 1 | Effect of the Fit2Thrive Intervention on Patient-reported Outcomes in Breast Cancer Survivors: A Randomized Full Factorial Trial. (Solk P, Song J, Welch WA, Spring B, Cella D, Penedo F, Ackermann R, Courneya KS, Siddique J, Freeman H, Starikovsky J, Mishory A, Alexander J, Wolter M, Carden L, Phillips SM) Ann Behav Med 2023 Aug 21;57(9):765-776 2 Citations |
| 1 | CenhANCER: a comprehensive cancer enhancer database for primary tissues and cell lines. (Luo ZH, Shi MW, Zhang Y, Wang DY, Tong YB, Pan XL, Cheng S) Database (Oxford) 2023 May 18;2023 3 Citations |
| 1 | Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS). (Shitara K, George B, Taieb J, Sundar R, Fakih MG, Makris L, Benhadji KA, Ghidini M) J Cancer Res Clin Oncol 2023 Sep;149(11):9361-9374 |
| 1 | Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry. (Mukherjee K, Elsayed M, Choksi E, Loya MF, Duszak R, Akce M, Majdalany BS, Bercu ZL, Cristescu M, Kokabi N) Cardiovasc Intervent Radiol 2023 Jul;46(7):870-879 1 Citation |
| 1 | Evaluation and management of pediatric thyroid nodules and thyroid cancer at a single institution after adoption of the American Thyroid Association 2015 guidelines. (Matalka L, Rahman AF, Sparks S, Lindeman B, Iyer P) J Pediatr Endocrinol Metab 2023 Jul 26;36(7):659-666 5 Citations |
| 1 | Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. (Oh JH, Lee S, Thor M, Rosenstein BS, Tannenbaum A, Kerns S, Deasy JO) Radiother Oncol 2023 Aug;185:109723 3 Citations |
| 1 | Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy. (Dhani H, Hinestrosa JP, Izaguirre-Carbonell J, Balcer HI, Kurzrock R, Billings PR) Front Oncol 2023;13:1170513 4 Citations |
| 3 | Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells (Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann M, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J) eBioMedicine June 2023;92 3 Citations |
| 1 | Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. (Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW) Clin Cancer Res 2023 Aug 01;29(15):2767-2773 4 Citations |
| 1 | Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study. (Rentscher KE, Bethea TN, Zhai W, Small BJ, Zhou X, Ahles TA, Ahn J, Breen EC, Cohen HJ, Extermann M, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Root JC, Saykin AJ, Van Dyk K, Mandelblatt JS, Carroll JE) Cancer 2023 Sep 01;129(17):2741-2753 19 Citations |
| 1 | Impact of cytoreductive nephrectomy (CRN) on overall survival (OS) in metastatic non–clear cell renal cancer (nccRCC). (Ariel Ann Nelson, Aniko Szabo, Deepak Kilari) Journal of Clinical Oncology J Clin Oncol 41, 2023 (suppl 6; abstr 730) |
| 1 | Evaluating Nurses' Time to Response by Severity and Cancer Stage in a Remote Symptom Monitoring Program for Patients With Breast Cancer. (Caston NE, Franks JA, Balas N, Eltoum N, Thigpen H, Patterson M, Azuero A, Ojesina AI, Dent DN, Hildreth K, Lalor FR, McGowen C, Huang CS, Dionne-Odom JN, Weiner BJ, Jackson BE, Basch EM, Stover AM, Howell D, Pierce JY, Rocque GB) JCO Clin Cancer Inform 2023 Jun;7:e2300015 8 Citations |
| 1 | The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA. (Jung E, Chung YH, Mao C, Fiering SN, Steinmetz NF) Mol Pharm 2023 Jul 03;20(7):3589-3597 2 Citations |
| 2 | Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis. (SenthilKumar G, Kothari AN, Maduekwe UN, Fournier K, Abbott DE, Wilson GC, Patel SH, Greer J, Johnston F, Dineen SP, Powers BD, Baumgartner J, Veerapong J, Leiting J, Grotz TE, Maithel SK, Staley C, Raoof M, Lambert L, Lee A, Kim A, Cloyd JM, Mogal H) Ann Surg Oncol 2023 Sep;30(9):5743-5753 6 Citations |
| 3 | Medication self-management behaviors of adolescents and young adults with cancer. (Erickson JM, Kamke-Jordan A, Lancaster IJ, Palou-Torres A, Esch M, Gonzalez A, Charlson J, Bingen K) Support Care Cancer 2023 Jun 10;31(7):390 2 Citations |
| 2 | Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer. (Thalji SZ, Cortina CS, Frebault J, Cho Y, Thorgerson A, Bergom CR, Huang CC, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6462-6470 2 Citations |
| 1 | Impact of Frailty Upon Surgical Decision-Making for Left-Sided Colon Cancer. (Sibia US, Badve SB, Istl AC, Klune JR, Riker AI) Ochsner J 2023;23(2):120-128 1 Citation |
| 3 | Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies. (Cheng G, Karoui H, Hardy M, Kalyanaraman B) Free Radic Biol Med 2023 Aug 20;205:175-187 2 Citations |
| 2 | Applications of Viscoelastic Testing in Breast Cancer Patients: A Systematic Review Focusing on Hypercoagulability and Free Flap Thrombosis. (Pamulapati S, Conroy M, Madireddy S, Kamaraju S, Cortina C, Moore H, Hartmann J) Semin Thromb Hemost 2024 Apr;50(3):413-422 2 Citations |
| 3 | Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer. (Kharel A, Shen J, Brown R, Chen Y, Nguyen C, Alson D, Bluemn T, Fan J, Gai K, Zhang B, Kudek M, Zhu N, Cui W) Cell Rep 2023 Jun 27;42(6):112649 10 Citations |
| 1 | Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. (Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC) bioRxiv 2023 Jun 10 |
| 1 | Executive Summary of the Ovarian Cancer Evidence Review Conference. (Burke W, Barkley J, Barrows E, Brooks R, Gecsi K, Huber-Keener K, Jeudy M, Mei S, O'Hara JS, Chelmow D) Obstet Gynecol 2023 Jul 01;142(1):179-195 11 Citations |
| 1 | Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference. (Mei S, Chelmow D, Gecsi K, Barkley J, Barrows E, Brooks R, Huber-Keener K, Jeudy M, O'Hara JS, Burke W) Obstet Gynecol 2023 Jul 01;142(1):196-210 16 Citations |
| 3 | A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence. (Moroney J, Trivella J, George B, White SB) Cancers (Basel) 2023 May 17;15(10) 2 Citations |
| 1 | Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA. (Semenkovich NP, Szymanski JJ, Earland N, Chauhan PS, Pellini B, Chaudhuri AA) J Immunother Cancer 2023 Jun;11(6) 27 Citations |
| 2 | ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population. (Thalji SZ, Cortina CS, Kong AL) Ann Surg Oncol 2023 Oct;30(11):6471-6472 1 Citation |
| 1 | Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials. (Fountzilas E, Vo HH, Mueller P, Kurzrock R, Tsimberidou AM) Eur J Cancer 2023 Aug;189:112927 9 Citations |
| 1 | Female reproductive health in pediatric, adolescent, and young adult cancer survivors. (Hoefgen HR, Benoit J, Chan S, Jayasinghe Y, Lustberg M, Pohl V, Saraf A, Schmidt D, Appiah LC) Pediatr Blood Cancer 2023 Sep;70 Suppl 5:e29170 3 Citations |
| 1 | Development and psychometric evaluation of the Symptom Self-Management Behaviors Tool for adolescents/young adults with cancer. (Stegenga K, Erickson JM, Linder L, Macpherson CF, Elswick RK Jr, Ameringer S) Palliat Support Care 2024 Apr;22(2):274-280 |
| 4 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Advances in Radiation Oncology 1 July 2023;8(4) 2 Citations |
| 1 | Impact of pre-treatment hemoglobin (Hgb) on outcomes in metastatic castration resistant prostate cancer (mCRPC) with lutetium-177-PSMA-617 (Lu-177 (Ariel Ann Nelson, Kristin Riemersma, Kathryn A. Bylow, Michael Holt, Deepak Kilari) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr e17065) |
| 1 | Disparities in medical oncology visit adherence among African American (AA) men with prostate cancer (pCa) (Ariel Ann Nelson, Christina Ladwig, Kristin Riemersma, Kathryn A. Bylow, Deepak Kilari) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr e18671) |
| 4 | Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer. (To T, Lu T, Jorns JM, Patton M, Schmidt TG, Yen T, Yu B, Ye DH) Front Oncol 2023;13:1179025 5 Citations |
| 1 | NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer. (Plasterer C, Semenikhina M, Tsaih SW, Flister MJ, Palygin O) Mol Med 2023 Jul 03;29(1):87 3 Citations |
| 1 | Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer. (Hanna PE, Wang Q, Strohbehn IA, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME) JAMA Netw Open 2023 Jul 03;6(7):e2321715 15 Citations |
| 1 | Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer. (Mukherjee A, Ye Y, Wiener HW, Kuniholm MH, Minkoff H, Michel K, Palefsky J, D'Souza G, Rahangdale L, Butler KR, Kempf MC, Sudenga SL, Aouizerat BE, Ojesina AI, Shrestha S) Cancer Epidemiol Biomarkers Prev 2023 Sep 01;32(9):1190-1197 2 Citations |
| 1 | Using gut microorganisms to treat cancer. (Seo YD, Ajami N, Wargo JA) Nat Med 2023 Aug;29(8):1910-1911 1 Citation |
| 1 | Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. (Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Focal Therapy Society) Eur Urol 2023 Dec;84(6):547-560 17 Citations |
| 5 | Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer. (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN) Sci Rep 2023 Jul 08;13(1):11051 12 Citations |
| 7 | Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer. (Zenga J, Awan M, Hadi Razeghi Kondelaji M, Hansen C, Shafiee S, Frei A, Foeckler J, Kuehn R, Bruening J, Massey B, Wong S, Joshi A, Himburg HA) Oral Oncol 2023 Sep;144:106487 2 Citations |
| 1 | Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study. (McCurdy A, Seow H, Pond GP, Gayowsky A, Chakraborty R, Visram A, Kaedbey R, D'Souza A, Mohyuddin GR, Wildes TM, Fonseca R, Mian H) Haematologica 2023 Dec 01;108(12):3384-3391 12 Citations |
| 1 | "I won't get to live my life the way I planned it": A qualitative analysis of the experiences of adolescents and young adults with advanced cancer. (Barton KS, Steineck A, Walsh CA, Lau N, O'Donnell MB, Rosenberg AR) Pediatr Blood Cancer 2023 Oct;70(10):e30554 4 Citations |
| 1 | Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. (Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW) Clin Cancer Res 2023 Sep 15;29(18):3717-3728 8 Citations |
| 1 | Can Immunotherapy Replace Radiation in Locally Advanced Endometrial Cancer?: Treatment for Advanced Endometrial Cancer. (Hathout L, Erickson B, Gehrig P, Harkenrider M, Klopp A, Small W Jr) Pract Radiat Oncol 2023;13(6):551-557 2 Citations |
| 1 | ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. (Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B, Biobank Japan, Blok MJ, Boddicker N, Brunet J, Burnside ES, Calvello M, Campbell I, Chan SH, Chen F, Chiang JB, Coppa A, Cortesi L, Crujeiras-González A, Consortium CZECANCA, De Leeneer K, De Putter R, DePersia A, Devereux L, Domchek S, Efremidis A, Engel C, Ernst C, Evans DGR, Feliubadaló L, Fostira F, Fuentes-Ríos O, Gómez-García EB, González S, Haiman C, Hansen TVO, Hauke J, Hodge J, Hu C, Huang H, Ishak NDB, Iwasaki Y, Konstantopoulou I, Kraft P, Lacey J, Lázaro C, Li N, Lim WK, Lindstrom S, Lori A, Martinez E, Martins A, Matsuda K, Matullo G, McInerny S, Michailidou K, Montagna M, Monteiro ANA, Mori L, Nathanson K, Neuhausen SL, Nevanlinna H, Olson JE, Palmer J, Pasini B, Patel A, Piane M, Poppe B, Radice P, Renieri A, Resta N, Richardson ME, Rosseel T, Ruddy KJ, Santamariña M, Dos Santos ES, Teras L, Toland AE, Trentham-Dietz A, Vachon CM, Volk AE, Weber-Lassalle N, Weitzel JN, Wiesmuller L, Winham S, Yadav S, Yannoukakos D, Yao S, Zampiga V, Zethoven M, Zhang ZW, Zima T, Spurdle AB, Vega A, Rossing M, Del Valle J, De Nicolo A, Hahnen E, Claes KBM, Ngeow J, Momozawa Y, James PA, Couch FJ, Macurek L, Kleibl Z) Clin Cancer Res 2023 Aug 15;29(16):3037-3050 17 Citations |
| 1 | Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. (Poppe MM, Tai A, Li XA, Miften M, Olch A, Marks LB, Qureshi BM, Spunt SL, Shnorhavorian M, Nelson G, Ronckers C, Kalapurakal J, Marples B, Constine LS, Liu AK) Int J Radiat Oncol Biol Phys 2024 Jun 01;119(2):560-574 6 Citations |
| 12 | Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Breast Cancer Res Treat 2023 Oct;201(3):387-396 6 Citations |
| 6 | X-ray and MR Contrast Bearing Nanoparticles Enhance the Therapeutic Response of Image-Guided Radiation Therapy for Oral Cancer. (Sharma G, Razeghi Kondelaji MH, Sharma GP, Hansen C, Parchur AK, Shafiee S, Jagtap JM, Fish B, Bergom C, Paulson E, Hall WA, Himburg HA, Joshi A) Technol Cancer Res Treat 2023;22:15330338231189593 4 Citations |
| 2 | Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. (Conroy M, Kamaraju S, Powell M, Harris A, Beckius A, Nagavally S, Dawson A, Min H, Wright T, Wainaina N, Binder AF) Clin Breast Cancer 2023 Oct;23(7):e434-e440 1 Citation |
| 2 | Engaging the community served: a U.S. Cancer Center's Facebook live cancer awareness campaign for Spanish-speaking Latinos during COVID-19. (Mora J, Romo R, Dempsey S, Silva B, Nevels D, Leone GW, Stolley M) Cancer Causes Control 2023 Dec;34(12):1037-1042 2 Citations |
| 1 | Evaluation and management of pediatric thyroid nodules and thyroid cancer at a single institution after adoption of the American Thyroid Association 2015 guidelines (Matalka L., Rahman A.F., Sparks S., Lindeman B., Iyer P.) J Pediatr Endocrinol Metab |
| 3 | Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology. (Duenweg SR, Bobholz SA, Lowman AK, Stebbins MA, Winiarz A, Nath B, Kyereme F, Iczkowski KA, LaViolette PS) J Pathol Inform 2023;14:100321 12 Citations |
| 1 | Obesity Associated with Prediabetes Increases the Risk of Breast Cancer Development and Progression-A Study on an Obese Rat Model with Impaired Glucose Tolerance. (Kallamadi PR, Esari D, Addi UR, Kesavan R, Putcha UK, Nagini S, Reddy GB) Int J Mol Sci 2023 Jul 14;24(14) 4 Citations |
| 1 | Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer (Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan M) HPB August 2023;25(8):933-940 |
| 1 | Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials (Fountzilas E, Vo HH, Mueller P, Kurzrock R, Tsimberidou AM) European Journal of Cancer August 2023;189 9 Citations |
| 6 | Isolation and survival: The impact of local and MSA isolation on survival among non-Hispanic Black women diagnosed with breast cancer in the United States using a SEER-Medicare cohort. (Canales B, Laud PW, Tarima S, Zhou Y, Bikomeye JC, McGinley EL, Yen TWF, Bemanian A, Beyer KMM) Health Place 2023 Sep;83:103090 2 Citations |
| 1 | Editorial: MR-guided focused ultrasound treatment techniques in cancers: from physics to clinics. (Lu Y, Zhang Z, Liu S) Front Oncol 2023;13:1233833 2 Citations |
| 1 | Executive Summary of the Lower Anogenital Tract Cancer Evidence Review Conference. (Chelmow D, Cejtin H, Conageski C, Farid H, Gecsi K, Kesterson J, Khan MJ, Long M, O'Hara JS, Burke W) Obstet Gynecol 2023 Sep 01;142(3):708-724 4 Citations |
| 3 | Synthesis of fluorinated triphenylphosphonium analogs that improve cancer cell selectivity and in vivo detection. (Keyes RF, McAllister D, Dwinell MB, Smith BC) STAR Protoc 2023 Sep 15;4(3):102437 |
| 1 | Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer. (Ordonez-Rubiano SC, Maschinot CA, Wang S, Sood S, Baracaldo-Lancheros LF, Strohmier BP, McQuade AJ, Smith BC, Dykhuizen EC) J Med Chem 2023 Aug 24;66(16):11250-11270 7 Citations |
| 1 | Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. (Badgery HE, Muhlen-Schulte T, Zalcberg JR, D'souza B, Gerstenmaier JF, Pickett C, Samra J, Croagh D, Pancreatic Cancer Image Biobank Authorship Group) HPB (Oxford) 2023 Nov;25(11):1393-1401 8 Citations |
| 1 | A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. (Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baert T, Freeman LEB, Becher H, Beckmann MW, Benitez J, Bojesen SE, Brauch H, Brenner H, Brooks-Wilson A, Campa D, Canzian F, Carracedo A, Castelao JE, Chanock SJ, Chenevix-Trench G, CTS Consortium, Cordina-Duverger E, Couch FJ, Cox A, Cross SS, Czene K, Dossus L, Dugué PA, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Fletcher O, Flyger H, Gabrielson M, Gago-Dominguez M, Giles GG, González-Neira A, Grassmann F, Grundy A, Guénel P, Haiman CA, Håkansson N, Hall P, Hamann U, Hankinson SE, Harkness EF, Holleczek B, Hoppe R, Hopper JL, Houlston RS, Howell A, Hunter DJ, Ingvar C, ABCTB Investigators, kConFab Investigators, Isaksson K, Jernström H, John EM, Jones ME, Kaaks R, Keeman R, Kitahara CM, Ko YD, Koutros S, Kurian AW, Lacey JV, Lambrechts D, Larson NL, Larsson S, Le Marchand L, Lejbkowicz F, Li S, Linet M, Lissowska J, Martinez ME, Maurer T, Mulligan AM, Mulot C, Murphy RA, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, O'Brien KM, Olson JE, Patel AV, Prentice R, Rees-Punia E, Rennert G, Rhenius V, Ruddy KJ, Sandler DP, Scott CG, Shah M, Shu XO, Smeets A, Southey MC, Stone J, Tamimi RM, Taylor JA, Teras LR, Tomczyk K, Troester MA, Truong T, Vachon CM, Wang SS, Weinberg CR, Wildiers H, Willett W, Winham SJ, Wolk A, Yang XR, Zamora MP, Zheng W, Ziogas A, Dunning AM, Pharoah PDP, García-Closas M, Schmidt MK, Kraft P, Milne RL, Lindström S, Easton DF, Chang-Claude J) Breast Cancer Res 2023 Aug 09;25(1):93 5 Citations |
| 1 | A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer (Christina Small, Phillip Prior, Haidy Nasief , Ross Zeitlin , Hina Saeed , Eric Paulson , Natalya Morrow , Jason Rownd , Beth Erickson , Meena Bedi ) Brachytherapy |
| 1 | Trends in Diet and Cancer Research: A Bibliometric and Visualization Analysis. (Giles ED, Purcell SA, Olson J, Vrieling A, Hirko KA, Woodruff K, Playdon MC, Thomas GA, Gilmore LA, Moberly HK, Newell-Fugate AE) Cancers (Basel) 2023 Jul 25;15(15) 8 Citations |
| 7 | A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer. (Small C, Prior P, Nasief H, Zeitlin R, Saeed H, Paulson E, Morrow N, Rownd J, Erickson B, Bedi M) Brachytherapy 2023;22(6):728-735 3 Citations |
| 1 | Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis. (Disel U, Sivakumar S, Pham T, Fleischmann Z, Anu RI, Sokol ES, Kurzrock R) Oncologist 2024 Feb 02;29(2):e213-e223 2 Citations |
| 1 | Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer. (Hanna PE, Strohbehn IA, Moreno D, Harden D, Seethapathy R, Sawtell R, Wang Q, Ouyang T, Katz-Agranov N, Dinulos J, Wander SA, Gupta S, Sise ME) NPJ Breast Cancer 2023 Aug 19;9(1):70 8 Citations |
| 1 | Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration. (Dorff T, Zengin Z, Henderson N, Ali A, Nguyen C, Hwang C, Barata PC, Bilen M, Graham L, Mo G, Kilari D, Tripathi A, Labriola M, Rothstein S, Garje R, Koshkin V, Patel V, Schweizer M, Armstrong A, McKay R, Alva A) Res Sq 2023 Aug 10 |
| 1 | Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy. (Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline MK, Conroy JM, Rubin E, Eskander RN, Kurzrock R) Mol Cancer Ther 2023 Nov 01;22(11):1352-1362 3 Citations |
| 1 | Lung Cancer Screening Decision Aid Designed for a Primary Care Setting: A Randomized Clinical Trial. (Schapira MM, Hubbard RA, Whittle J, Vachani A, Kaminstein D, Chhatre S, Rodriguez KL, Bastian LA, Kravetz JD, Asan O, Prigge JM, Meline J, Schrand S, Ibarra JV, Dye DA, Rieder JB, Frempong JO, Fraenkel L) JAMA Netw Open 2023 Aug 01;6(8):e2330452 13 Citations |
| 1 | Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study (Noh S, Bertini C, Mira-Avendano I, Kaous M, Patel B, Faiz SA, Shannon VR, Balachandran DD, Bashoura L, Adachi R, Evans SE, Dickey B, Wu C, Shroff GS, Manzano JG, Granwehr B, Holloway S, Dickson K, Mohammed A, Muthu M, Song H, Aroe A, Aloia TA, Lee Andrews II, Badami KK, Baganz JA, Bajwa P, Baker LR, Barbosa GR, Beird HC, Bourgeois M, Brock K, Burton EM, Cata J, Chung C, Cutherell M, Cuenca J, Cyr PB, Dabaja B, Dagher H, Daniels KM, Domask M, Draetta G, Edelkamp P, Fisher S, French KE, Futreal A, Gaeta M, Gibbons C, Godoy M, Goldstein D, Gunther J, Hernandez C, Hutcheson K, Jaffray D, Jin J, John TM, Kell T, Knafl M, Kothari A, Kwan RC, Lee JJ, Liao Y, Litton J, Liu A, McEnery KW, McGuire M, Mescher B, Musunuru T, Muthu M, Nates J, Owen CS, Padmakumar P, Page M, Palaskas N, Patel JJ, Prabhakaran S, Ramsey L, Ravi V, Russell L, Sajith B, Scheet PA, Schmidt S, Shaw KR, Shete S, Shoenthal DP, Stoltenberg LJ, Subbiah I, Suitor C, Tawbi H, Thompson P, Turin A, Unni S, Vicknamparampil B, Weber MC, Weinstein J, Williams Z, Woodman SE, Wozny MC, Wu C) Cancer Medicine September 2023;12(17):17753-17765 3 Citations |
| 2 | Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. (Simone CB 2nd, Serebrenik AA, Gore EM, Mohindra P, Brown SL, Wang D, Chetty IJ, Vujaskovic Z, Menon S, Thompson J, Fine G, Kaytor MD, Movsas B) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):404-414 6 Citations |
| 1 | Machine learning reveals genetic modifiers of the immune microenvironment of cancer. (Riley-Gillis B, Tsaih SW, King E, Wollenhaupt S, Reeb J, Peck AR, Wackman K, Lemke A, Rui H, Dezso Z, Flister MJ) iScience 2023 Sep 15;26(9):107576 |
| 1 | Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis. (Ledesma-Leon T, Solis-Pazmino P, Lincango EP, Figueroa LA, Ellenhorn J, Nasseri Y, Cohen J, Romero-Arenas M, Garcia C, Sanabria A, Rojas T, Torres-Román J, Camacho E, Vallejo S, Alvarado-Mafla B, Dream S, James BC, Ponce OJ, Sharma A, Brito JP) Endocrine 2024 Feb;83(2):330-341 8 Citations |
| 2 | Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer. (SenthilKumar G, Merrill J, Maduekwe UN, Cloyd JM, Fournier K, Abbott DE, Zafar N, Patel S, Johnston F, Dineen S, Baumgartner J, Grotz TE, Maithel SK, Raoof M, Lambert L, Hendrix R, Kothari AN) J Surg Res 2023 Dec;292:275-288 3 Citations |
| 1 | Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation. (Aquino AM, Alonso-Costa LG, Santos SAA, Rocha VA, Barbisan LF, Bedrat A, Justulin LA, Flaws JA, Lemos B, Scarano WR) Chemosphere 2023 Nov;341:140020 4 Citations |
| 1 | The role of 18 F-FDG-PET/CT in the management of differentiated thyroid cancer. (Haidar M, Kassas M, Chehade F, Chahinian R, Abi-Ghosn J, Haddad MM) Nucl Med Commun 2023 Nov 01;44(11):1046-1052 3 Citations |
| 1 | Impact of state telehealth policies on telehealth use among patients with newly diagnosed cancer. (Yen TWF, Pan IW, Shih YT) JNCI Cancer Spectr 2023 Aug 31;7(5) 6 Citations |
| 1 | Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. (Hwang C, Henderson NC, Chu SC, Holland B, Cackowski FC, Pilling A, Jang A, Rothstein S, Labriola M, Park JJ, Ghose A, Bilen MA, Mustafa S, Kilari D, Pierro MJ, Thapa B, Tripathi A, Garje R, Ravindra A, Koshkin VS, Hernandez E, Schweizer MT, Armstrong AJ, McKay RR, Dorff TB, Alva AS, Barata PC) JAMA Netw Open 2023 Sep 05;6(9):e2334208 6 Citations |
| 6 | Perspectives on Virtual Care for Childhood Cancer Survivors in Non-Metropolitan Areas during the COVID-19 Pandemic. (Phelan R, Aremu TO, Karst J, Anderson L, Jordan A, Morin J, Nichols J, Singh A, Schmidt D, Hoag JA, Napurski C, Zweber H, Sadak KT) Curr Oncol 2023 Sep 01;30(9):8111-8116 6 Citations |
| 1 | Age-Appropriate Cancer Screenings Through a Dermatology Len. (Calley B, Berce P, Chang CK, Neman S, Viteri AM, Means A, Akinshemoyin Vaughn OL) WMJ 2023 Sep;122(4):262-267 |
| 3 | T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. (Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM, Vincent-Sheldon S, LaViolette PS) Cancers (Basel) 2023 Sep 06;15(18) 7 Citations |
| 1 | Integration of the social determinants of health into quality indicators for colorectal cancer surgery: a scoping review protocol. (Bondzi-Simpson A, Ribeiro T, Benipal H, Barabash V, Lofters A, Sutradhar R, Snyder RA, Clarke C, Coburn NG, Hallet J) BMJ Open 2023 Sep 26;13(9):e075270 1 Citation |
| 3 | ALK fusions in the pan-cancer setting: another tumor-agnostic target? (Shreenivas A, Janku F, Gouda MA, Chen HZ, George B, Kato S, Kurzrock R) NPJ Precis Oncol 2023 Sep 29;7(1):101 28 Citations |
| 1 | Executive Summary of the Ovarian Cancer Evidence Review Conference (Burke W, Barkley J, Barrows E, Brooks R, Gecsi K, Huber-Keener K, Jeudy M, Mei S, O'Hara JS, Chelmow D) Obstetrical and Gynecological Survey 1 October 2023;78(10):583-584 |
| 1 | Microbiological diversity of fermented food Bhaati Jaanr and its antioxidant and anti-inflammatory properties: Effect against colon cancer (Jaiswal S, Pant T, Suryavanshi M, Antony U) Food Bioscience October 2023;55 4 Citations |
| 1 | Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. (Hong YS, Battle SL, Shi W, Puiu D, Pillalamarri V, Xie J, Pankratz N, Lake NJ, Lek M, Rotter JI, Rich SS, Kooperberg C, Reiner AP, Auer PL, Heard-Costa N, Liu C, Lai M, Murabito JM, Levy D, Grove ML, Alonso A, Gibbs R, Dugan-Perez S, Gondek LP, Guallar E, Arking DE) Nat Commun 2023 Sep 30;14(1):6113 11 Citations |
| 1 | Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac (SE Beltran Ponce, LA Daamen, J Van der Voort vanZyp, JM Westerhoff, FJ Pos, JP Christodouleas, A Choudhury, U van der Heide, CAF Lawton, MW Straza, M Bedi, ES Paulson, HG Nasief, A Li, H Verkooijen, A Tree, WA Hall) International Journal of Radiation Oncology, Biology, Physics |
| 1 | Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer. (Semenkovich NP, Badiyan SN, Samson PP, Stowe HB, Wang YE, Star R, Devarakonda S, Govindan R, Waqar SN, Robinson CG, Vlacich G, Pellini B, Chaudhuri AA) NPJ Precis Oncol 2023 Oct 02;7(1):100 7 Citations |
| 4 | Differential Response in Quantitative MRI Parameters Detected in Head and Neck Cancer Patients Treated with Concurrent Immunotherapy during Hypo-Fractionated MR-gRT. (Bonate R, Paulson ES, Frei A, Shukla ME, Tarima S, Wong S, Himburg HA, Zenga J, Awan MJ) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S65 |
| 2 | Differential Response to Radiation Fractionation in Head and Neck Cancer Patient-Derived Xenografts. (Musaddiq A, Zenga J, Frei A, Shukla ME, Himburg HA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e253 |
| 1 | Characterizing the Impact of Race and Redlining on Receipt of Guideline-Compliant Locoregional Therapy among Older Women with Breast Cancer. (Beltran Ponce SE, Canales B, McGinley E, Yen T, Tarima S, Zhou Y, Bikomeye JC, Beyer K) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e7 |
| 2 | Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer. (Amjad A, Chen X, Hall WA, Lawton CAF, Li A, Paulson ES) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e638-e639 |
| 3 | Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac. (Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S114-S115 |
| 3 | Patterns of Locoregional Pancreatic Cancer Recurrence after Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Ponce SEB, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, de Choudens SO, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e284-e285 |
| 1 | Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study. (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, Christodouleas JP, Hall WA, Verkooijen H, Intven MPW) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e291 |
| 1 | Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer. (Phillips R, Proudfoot J, Davicioni E, Spratt DE, Feng FY, Simko J, Den RB, Pollack A, Rosenthal SA, Sartor O, Sweeney C, Attard G, Patel SI, Hall WA, Efstathiou JA, Shah AB, Hoffman KE, Pugh S, Sandler HM, Tran PT) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S34-S35 |
| 1 | Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer. (Rajbhandari N, Hamilton M, Quintero CM, Ferguson LP, Fox R, Schürch CM, Wang J, Nakamura M, Lytle NK, McDermott M, Diaz E, Pettit H, Kritzik M, Han H, Cridebring D, Wen KW, Tsai S, Goggins MG, Lowy AM, Wechsler-Reya RJ, Von Hoff DD, Newman AM, Reya T) Cancer Cell 2023 Nov 13;41(11):1989-2005.e9 6 Citations |
| 1 | Men who have sex with men experience low anxiety and few barriers to performing anal self or companion examinations: a qualitative study of the Prevent Anal Cancer Palpation Study. (Flores RA, Wilkerson JM, Travis A, Almirol E, Washington D, Weaver L, Liebert C, Chiao E, Hazra A, Nyitray AG) Cult Health Sex 2024 Jul;26(7):920-935 1 Citation |
| 1 | Association between heart failure and the incidence of cancer: a systematic review and meta-analysis. (Jaiswal V, Ang SP, Agrawal V, Hameed M, Saleeb MRA, Jaiswal A, Shah M, Lao NM, Chia JE, Paudel K, Gimelli A, Zacks J) Eur Heart J Open 2023 Sep;3(5):oead073 12 Citations |
| 1 | Teaming with artificial intelligence to support global cancer surgical care. (Jaraczewski TJ, SenthilKumar G, Ramamurthi A, Nimmer K, Yang X, Kothari AN) J Surg Oncol 2023 Nov;128(6):943-946 |
| 1 | Data-adaptive and pathway-based tests for association studies between somatic mutations and germline variations in human cancers. (Chen Z, Liang H, Wei P) Genet Epidemiol 2023 Dec;47(8):617-636 |
| 1 | Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers. (Zhang A, Lau NA, Wong A, Brown LG, Coleman IM, De Sarkar N, Li D, DeLucia DC, Labrecque MP, Nguyen HM, Conner JL, Dumpit RF, True LD, Lin DW, Corey E, Alumkal JJ, Nelson PS, Morrissey C, Lee JK) Cancer Res Commun 2023 Nov 20;3(11):2358-2374 4 Citations |
| 1 | Perspectives on Virtual Care for Childhood Cancer Survivors in Non-Metropolitan Areas during the COVID-19 Pandemic. (Phelan, R.; Aremu, T.O.; Karst, J.; Anderson, L.; Jordan, A.; Morin, J.; Nichols, J.; Singh, A.; Schmidt, D.; Hoag, J.A.; et al) Curr. Oncol 8111-8116. |
| 1 | PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies. (Lin KX, Istl AC, Quan D, Skaro A, Tang E, Zheng X) Cancer Immunol Immunother 2023 Dec;72(12):3875-3893 45 Citations |
| 1 | Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer-A State-of-the-Art Review. (Cronin M, Seher M, Arsang-Jang S, Lowery A, Kerin M, Wijns W, Soliman O) J Clin Med 2023 Sep 29;12(19) 4 Citations |
| 1 | Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. (Das K, Paul S, Ghosh A, Gupta S, Mukherjee T, Shankar P, Sharma A, Keshava S, Chauhan SC, Kashyap VK, Parashar D) Cancers (Basel) 2023 Oct 07;15(19) 19 Citations |
| 1 | Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review. (Cortina LE, Moverman DJ, Zhao Y, Goss D, Zenga J, Puram SV, Varvares MA) Oral Oncol 2023 Dec;147:106596 6 Citations |
| 1 | Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection. (Sanford NN, Hong TS, Hall WA) J Clin Oncol 2024 Mar 10;42(8):868-871 8 Citations |
| 1 | Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types. (Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Webb AJ, Choudhury A, Rosenstein BS, Taboada-Valladares B, Herskind C, Azria D, Dearnaley DP, de Ruysscher D, Sperk E, Hall E, Stobart H, Chang-Claude J, De Ruyck K, Veldeman L, Altabas M, De Santis MC, Farcy-Jacquet MP, Veldwijk MR, Sydes MR, Parliament M, Usmani N, Burnet NG, Seibold P, Symonds RP, Elliott RM, Bultijnck R, Gutiérrez-Enríquez S, Mollà M, Gulliford SL, Green S, Rancati T, Reyes V, Carballo A, Peleteiro P, Sosa-Fajardo P, Parker C, Fonteyne V, Johnson K, Lambrecht M, Vanneste B, Valdagni R, Giraldo A, Ramos M, Diergaarde B, Liu G, Leal SM, Chua MLK, Pring M, Overgaard J, Cascallar-Caneda LM, Duprez F, Talbot CJ, Barnett GC, Dunning AM, Vega A, Andreassen CN, Langendijk JA, West CML, Alizadeh BZ, Kerns SL, Radiogenomics Consortium) JNCI Cancer Spectr 2023 Oct 31;7(6) 3 Citations |
| 4 | National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS) Breast Cancer Res Treat 2024 Jan;203(2):317-328 8 Citations |
| 2 | Acceptability of Anal Human Papillomavirus Home Self-Sampling and Clinician Sampling Among Sexual and Gender Minority Individuals in Milwaukee, Wisconsin: The Prevent Anal Cancer Self-Swab Study. (Nitkowski J, Giuliano AR, Ridolfi T, Chiao E, Fernandez ME, Schick V, Swartz MD, Smith JS, Nyitray AG) LGBT Health 2024 Jan;11(1):47-56 4 Citations |
| 1 | SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. (Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S, SAPPHIRE Investigators) Ann Oncol 2024 Jan;35(1):66-76 33 Citations |
| 3 | Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy. (Duenweg SR, Brehler M, Lowman AK, Bobholz SA, Kyereme F, Winiarz A, Nath B, Iczkowski KA, Jacobsohn KM, LaViolette PS) Lab Invest 2023 Dec;103(12):100269 2 Citations |
| 4 | Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers. (Quashie EE, Li XA, Prior P, Awan M, Schultz C, Tai A) Phys Med Biol 2023 Dec 11;68(24) 3 Citations |
| 2 | 5-hydroxymethylcytosine sequencing in plasma cell-free DNA identifies unique epigenomic features in prostate cancer patients resistant to androgen deprivation therapies. (Li Q, Huang CC, Huang S, Tian Y, Huang J, Bitaraf A, Dong X, Nevalanen MT, Patel M, Wong J, Zhang J, Manley BJ, Park JY, Kohli M, Gore EM, Kilari D, Wang L) medRxiv 2024 Oct 17 |
| 2 | The accuracy of anal self- and companion exams among sexual minority men and transgender women: The Prevent Anal Cancer Palpation Study. (Nyitray AG, McAuliffe TL, Liebert C, Swartz MD, Deshmukh AA, Chiao EY, Weaver L, Almirol E, Kerman J, Schneider JA, Wilkerson JM, Hwang LY, Smith D, Hazra A, Prevent Anal Cancer Palpation Study Team) medRxiv 2023 Oct 19 |
| 1 | Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study. (Nakamura ZM, Small BJ, Zhai W, Ahles TA, Ahn J, Artese AL, Bethea TN, Breen EC, Cohen HJ, Extermann M, Graham D, Irwin MR, Isaacs C, Jim HSL, Kuhlman KR, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhou X, Mandelblatt JS, Carroll JE) J Cancer Surviv 2025 Apr;19(2):568-579 4 Citations |
| 1 | Survival differences by race and surgical approach in early-stage operable cervical Cancer. (Summey R, Benoit M, Williams-Brown MY) Gynecol Oncol 2023 Dec;179:63-69 1 Citation |
| 2 | Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells. (Xiong D, Yin Z, Huang M, Wang Y, Hardy M, Kalyanaraman B, Wong ST, You M) Cancer Commun (Lond) 2024 Mar;44(3):448-452 6 Citations |
| 1 | Revolutionizing cancer drug development: Harnessing the potential of basket trials. (Subbiah V, Burris HA 3rd, Kurzrock R) Cancer 2024 Jan;130(2):186-200 14 Citations |
| 1 | Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer. (Earland N, Semenkovich NP, Ramirez RJ, Gerndt SP, Harris PK, Gu Z, Hearn AI, Inkman M, Szymanski JJ, Whitfield D, Wahle BM, Xu Z, Chen K, Alahi I, Ni G, Chen A, Winckler W, Zhang J, Chaudhuri AA, Zevallos JP) Clin Cancer Res 2024 Apr 01;30(7):1409-1421 6 Citations |
| 1 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. (Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, Hoffman TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Laisk T, Figuerêdo J, Muir K, Ito S, Liu X, Biobank Japan Project, Uchio Y, Kubo M, Kamatani Y, Lophatananon A, Wan P, Andrews C, Lori A, Choudhury PP, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Giles GG, Southey MC, MacInnis RJ, Cybulski C, Wokolorczyk D, Lubinski J, Rentsch CT, Cho K, Mcmahon BH, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nordestgaard BG, Nielsen SF, Weischer M, Bojesen SE, Røder A, Stroomberg HV, Batra J, Chambers S, Horvath L, Clements JA, Tilly W, Risbridger GP, Gronberg H, Aly M, Szulkin R, Eklund M, Nordstrom T, Pashayan N, Dunning AM, Ghoussaini M, Travis RC, Key TJ, Riboli E, Park JY, Sellers TA, Lin HY, Albanes D, Weinstein S, Cook MB, Mucci LA, Giovannucci E, Lindstrom S, Kraft P, Hunter DJ, Penney KL, Turman C, Tangen CM, Goodman PJ, Thompson IM Jr, Hamilton RJ, Fleshner NE, Finelli A, Parent MÉ, Stanford JL, Ostrander EA, Koutros S, Beane Freeman LE, Stampfer M, Wolk A, Håkansson N, Andriole GL, Hoover RN, Machiela MJ, Sørensen KD, Borre M, Blot WJ, Zheng W, Yeboah ED, Mensah JE, Lu YJ, Zhang HW, Feng N, Mao X, Wu Y, Zhao SC, Sun Z, Thibodeau SN, McDonnell SK, Schaid DJ, West CML, Barnett G, Maier C, Schnoeller T, Luedeke M, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Koudou YA, John EM, Grindedal EM, Maehle L, Khaw KT, Ingles SA, Stern MC, Vega A, Gómez-Caamaño A, Fachal L, Rosenstein BS, Kerns SL, Ostrer H, Teixeira MR, Paulo P, Brandão A, Watya S, Lubwama A, Bensen JT, Butler EN, Mohler JL, Taylor JA, Kogevinas M, Dierssen-Sotos T, Castaño-Vinyals G, Cannon-Albright L, Teerlink CC, Huff CD, Pilie P, Yu Y, Bohlender RJ, Gu J, Strom SS, Multigner L, Blanchet P, Brureau L, Kaneva R, Slavov C, Mitev V, Leach RJ, Brenner H, Chen X, Holleczek B, Schöttker B, Klein EA, Hsing AW, Kittles RA, Murphy AB, Logothetis CJ, Kim J, Neuhausen SL, Steele L, Ding YC, Isaacs WB, Nemesure B, Hennis AJM, Carpten J, Pandha H, Michael A, De Ruyck K, De Meerleer G, Ost P, Xu J, Razack A, Lim J, Teo SH, Newcomb LF, Lin DW, Fowke JH, Neslund-Dudas CM, Rybicki BA, Gamulin M, Lessel D, Kulis T, Usmani N, Abraham A, Singhal S, Parliament M, Claessens F, Joniau S, Van den Broeck T, Gago-Dominguez M, Castelao JE, Martinez ME, Larkin S, Townsend PA, Aukim-Hastie C, Bush WS, Aldrich MC, Crawford DC, Srivastava S, Cullen J, Petrovics G, Casey G, Wang Y, Tettey Y, Lachance J, Tang W, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Yamoah K, Govindasami K, Chokkalingam AP, Keaton JM, Hellwege JN, Clark PE, Jalloh M, Gueye SM, Niang L, Ogunbiyi O, Shittu O, Amodu O, Adebiyi AO, Aisuodionoe-Shadrach OI, Ajibola HO, Jamda MA, Oluwole OP, Nwegbu M, Adusei B, Mante S, Darkwa-Abrahams A, Diop H, Gundell SM, Roobol MJ, Jenster G, van Schaik RHN, Hu JJ, Sanderson M, Kachuri L, Varma R, McKean-Cowdin R, Torres M, Preuss MH, Loos RJF, Zawistowski M, Zöllner S, Lu Z, Van Den Eeden SK, Easton DF, Ambs S, Edwards TL, Mägi R, Rebbeck TR, Fritsche L, Chanock SJ, Berndt SI, Wiklund F, Nakagawa H, Witte JS, Gaziano JM, Justice AC, Mancuso N, Terao C, Eeles RA, Kote-Jarai Z, Madduri RK, Conti DV, Haiman CA) Nat Genet 2023 Dec;55(12):2065-2074 44 Citations |
| 2 | Breast Cancer Screening and Prevention. (Farkas AH, Nattinger AB) Ann Intern Med 2023 Nov;176(11):ITC161-ITC176 17 Citations |
| 2 | Genomic structures and regulation patterns at HPV integration sites in cervical cancer. (Porter VL, O'Neill K, MacLennan S, Corbett RD, Ng M, Culibrk L, Hamadeh Z, Iden M, Schmidt R, Tsaih SW, Chang G, Fan J, Nip KM, Akbari V, Chan SK, Hopkins J, Moore RA, Chuah E, Mungall KL, Mungall AJ, Birol I, Jones SJM, Rader JS, Marra MA) bioRxiv 2023 Nov 05 |
| 2 | The impact of the COVID-19 pandemic on cancer care including innovations implemented in Sub-Saharan Africa: A systematic review. (Rine S, Lara ST, Bikomeye JC, Beltrán-Ponce S, Kibudde S, Niyonzima N, Lawal OO, Mulamira P, Beyer KM) J Glob Health 2023 Nov 17;13:06048 5 Citations |
| 1 | Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. (Fields EC, Erickson B, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) Int J Radiat Oncol Biol Phys 2023 Dec 01;117(5):1138-1142 2 Citations |
| 2 | Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018. (Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM) Transplant Cell Ther 2024 Feb;30(2):239.e1-239.e11 |
| 1 | Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States. (Stull C, Bennis SL, Rosser BRS, Wilkerson JM, Zoschke IN, Jiang Z, Nyitray AG, Khariwala SS, Ross MW) J Am Dent Assoc 2024 Jan;155(1):26-38.e1 |
| 1 | Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. (Tojjari A, Saeed A, Sadeghipour A, Kurzrock R, Cavalcante L) Cancers (Basel) 2023 Nov 13;15(22) 3 Citations |
| 1 | Gait speed is a biomarker of cancer-associated cachexia decline and recovery. (Roy I, Binder-Markey B, Sychowski D, Willbanks A, Phipps T, McAllister D, Bhakta A, Marquez E, D'Andrea D, Franz C, Pichika R, Dwinell MB, Jayabalan P, Lieber RL) bioRxiv 2023 Nov 15 |
| 2 | Reprogramming of 3D chromatin domains by antagonizing the β-catenin/CBP interaction attenuates insulin signaling in pancreatic cancer. (Zhou Y, Li T, He Z, Choppavarapu L, Hu X, Cao R, Leone GW, Kahn M, Jin VX) bioRxiv 2023 Nov 14 |
| 1 | Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers. (Fountzilas E, Hiep Vo H, Mueller P, Kurzrock R, Tsimberidou AM) Data Brief 2023 Dec;51:109698 3 Citations |
| 3 | Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN) Scientific Reports December 2023;13(1) 12 Citations |
| 1 | Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis (Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R) npj Genomic Medicine December 2023;8(1) 20 Citations |
| 1 | Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy (Fields EC, Erickson B, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) International Journal of Radiation Oncology Biology Physics 1 December 2023;117(5):1138-1142 2 Citations |
| 1 | ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer. (Expert Panel on Neurological Imaging, Gule-Monroe MK, Calle S, Policeni B, Juliano AF, Agarwal M, Chow LQM, Dubey P, Friedman ER, Hagiwara M, Hanrahan KD, Jain V, Rath TJ, Smith RB, Subramaniam RM, Taheri MR, Yom SS, Zander D, Burns J) J Am Coll Radiol 2023 Nov;20(11S):S521-S564 5 Citations |
| 1 | A new strategy for the treatment of heavily pretreated metastatic breast cancer: A case report and review of the literature. (Ge TT, Pan XJ, Zuo XM, Shi XG, Wang YK, Sun P, Gao X, Feng X, Gao S, Wang TS) Medicine (Baltimore) 2023 Dec 01;102(48):e36297 2 Citations |
| 1 | Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer. (Lester SC, Moon DH, Patel SH, Awan MJ, Bakst RL) Int J Radiat Oncol Biol Phys 2024 Jan 01;118(1):165-168 2 Citations |
| 1 | Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA. (Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W Jr, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M) J Clin Oncol 2024 Feb 01;42(4):390-398 46 Citations |
| 1 | Multi-Institutional Development and Validation of a Radiomic Model to Predict Prostate Cancer Recurrence Following Radical Prostatectomy. (Huynh LM, Bonebrake B, Tran J, Marasco JT, Ahlering TE, Wang S, Baine MJ) J Clin Med 2023 Nov 26;12(23) 4 Citations |
| 1 | Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place. (Adashek JJ, Kurzrock R) NPJ Precis Oncol 2023 Dec 08;7(1):129 8 Citations |
| 1 | Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. (Orme JJ, Taza F, De Sarkar N, Tewari AK, Arsalan Naqvi S, Riaz IB, Childs DS, Omar N, Adra N, Ashkar R, Cheng HH, Schweizer MT, Sokolova AO, Agarwal N, Barata P, Sartor O, Bastos D, Smaletz O, Berchuck JE, McClure H, Taplin ME, Aggarwal R, Sternberg CN, Vlachostergios PJ, Alva AS, Mehra N, Nelson PS, Hwang J, Dehm SM, Shi Q, Fleischmann Z, Sokol ES, Elliott A, Huang H, Bryce A, Marshall CH, Antonarakis ES) Eur Urol Oncol 2024 Aug;7(4):877-887 5 Citations |
| 1 | Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. (Nguyen CB, Kobe C, Kumbier KE, Bauman J, Burns JA, Tsao PA, Sparks JB, Skolarus TA, Caram MEV) JCO Oncol Pract 2024 Jan;20(1):59-68 |
| 1 | Considering molecular alterations as pan-cancer tissue-agnostic targets. (Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R) Nat Cancer 2023 Dec;4(12):1622-1626 6 Citations |
| 1 | Power-law growth models explain incidences and sizes of pancreatic cancer precursor lesions and confirm spatial genomic findings. (Kiemen AL, Wu PH, Braxton AM, Cornish TC, Hruban RH, Wood L, Wirtz D, Zwicker D) bioRxiv 2023 Dec 04 |
| 1 | The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. (Daamen LA, Parikh PJ, Hall WA) Semin Radiat Oncol 2024 Jan;34(1):23-35 8 Citations |
| 1 | RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling. (Schaefer A, Hodge RG, Zhang H, Hobbs GA, Dilly J, Huynh MV, Goodwin CM, Zhang F, Diehl JN, Pierobon M, Baldelli E, Javaid S, Guthrie K, Rashid NU, Petricoin EF, Cox AD, Hahn WC, Aguirre AJ, Bass AJ, Der CJ) Sci Signal 2023 Dec 19;16(816):eadg5289 1 Citation |
| 1 | Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. (Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, Yi M, Rottschaefer A, Pathak R, Nuguri S, Fung KM, Tsaih SW, Chervoneva I, Rui H, Tanaka T) Cell Rep Med 2023 Dec 19;4(12):101330 7 Citations |
| 1 | Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. (Lim J, Kurzrock R, Nishizaki D, Miyashita H, Adashek JJ, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman SM, Kato S) Cancer Med 2024 Jan;13(1):e6844 3 Citations |
| 2 | Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. (Gonzalez T, Nie Q, Chaudhary LN, Basel D, Reddi HV) Cancer Genet 2024 Apr;282-283:1-8 6 Citations |
| 1 | Prostate Cancers Invisible on Multiparametric MRI: Pathologic Features in Correlation with Whole-Mount Prostatectomy. (Chatterjee A, Gallan A, Fan X, Medved M, Akurati P, Bourne RM, Antic T, Karczmar GS, Oto A) Cancers (Basel) 2023 Dec 13;15(24) 6 Citations |
| 1 | Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy. (Shah RK, Cygan E, Kozlik T, Colina A, Zamora AE) Front Immunol 2023;14:1301100 1 Citation |
| 2 | Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations. (Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S) Arch Sex Behav 2024 May;53(5):1969-1980 4 Citations |
| 1 | Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States (Stull C, Bennis SL, Rosser BRS, Wilkerson JM, Zoschke IN, Jiang Z, Nyitray AG, Khariwala SS, Ross MW) Journal of the American Dental Association January 2024;155(1):26-38.e1 |
| 1 | The double burden of COVID-19 and cancer at the Uganda Cancer Institute (Anumolu N, Bojang M, Mulamira P, Jankowski C, Lechleitner K, Abunike S, Kasasa S, Lukande R, Niyonzima N, Beyer K) Journal of Global Health Reports 2024;8 |
| 1 | Patient-centered communication’s association with trust, satisfaction, and perception of electronic health records use among newly diagnosed patients with cancer (Elkefi S, Asan O, Yu Z, Yen T, Rowley S) Frontiers in Communication 2024;9 |
| 1 | A scoping review of human papillomavirus and cervical cancer knowledge, attitudes, practices, and prevention among female sex workers in Africa (Beroza AJ, Rine SAA, Bikomeye JC, Magezi RK, Simple O, Dickson-Gomez J, Kyomya MM, Katende D, Bojang M, Twaibu W, Magololo FM, Nyabigambo A, Musinguzi G, Mulamira P, Beyer K) Journal of Global Health Reports 2024;8 |
| 1 | Personalized Federated Learning for Gastric Cancer: Adaptive Inference from Large Heterogeneous Piecewise Electronic Health Record Based Biomedical Data (Hu H, Kothari AN, Banerjee A) Proceedings - 2024 IEEE International Conference on Big Data, BigData 2024 2024:4554-4563 |
| 1 | Men who have sex with men experience low anxiety and few barriers to performing anal self or companion examinations: a qualitative study of the Prevent Anal Cancer Palpation Study (Flores RA, Wilkerson JM, Travis A, Almirol E, Washington DJ, Weaver L, Liebert C, Chiao E, Hazra A, Nyitray AG) Culture, Health and Sexuality 2024;26(7):920-935 1 Citation |
| 1 | Shifting neoadjuvant chemotherapy treatment paradigms for breast cancer and its impact on axillary nodal management for clinically node-negative patients (Cortina CS) Gland Surgery 2024;13(7):1154-1158 1 Citation |
| 3 | Deep Learning for Automated Detection of Breast Cancer in Deep Ultraviolet Fluorescence Images with Diffusion Probabilistic Model (Ghahfarokhi SS, To T, Jorns J, Yen T, Yu B, Ye DH) Proceedings - International Symposium on Biomedical Imaging 2024 2 Citations |
| 1 | Multifunctional Nanomaterials: Recent Advancements in Cancer Therapeutics and Vaccines (Gupta S, Kaur R, Bhardwaj A, Parashar D) Indian Journal of Microbiology 2024 3 Citations |
| 1 | Editorial: Bladder preservation options for bladder cancer (Davis NB, Kilari D, Kessler ER, Smelser WW) Frontiers in Oncology 2024;14 |
| 5 | Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer (Uyar D, Michener CM, Bishop E, Hopp E, Simpson P, Zhang L, Rader JS, Rose PG, Mahdi HS, Debernardo R, Christian Q, Bradley W) Frontiers in Oncology 2024;14 1 Citation |
| 1 | The role of extracellular vesicles in the pathogenesis of gynecological cancer (Chatterjee M, Gupta S, Mukherjee T, Parashar D, Kumar U, Maitra A, Das K) Frontiers in Oncology 2024;14 1 Citation |
| 1 | Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer (Lester SC, Moon DH, Patel SH, Awan MJ, Bakst RL) International Journal of Radiation Oncology Biology Physics 1 January 2024;118(1):165-168 2 Citations |
| 4 | Type I interferon signaling promotes radioresistance in head and neck cancer (Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA) Translational Cancer Research 2024;13(5):2535-2543 3 Citations |
| 1 | The Use of MR-Guided Radiation Therapy for Pancreatic Cancer (Daamen LA, Parikh PJ, Hall WA) Seminars in Radiation Oncology January 2024;34(1):23-35 8 Citations |
| 1 | Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy. (Istl AC, Desravines N, Nudotor R, Stone R, Greer JB, Meyer CF, Johnston FM) Gynecol Oncol Rep 2024 Feb;51:101308 |
| 5 | Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN) WMJ 2023 Dec;122(5):418-421 1 Citation |
| 2 | Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm. (Rawashdeh B, Bell R, Hakeem A, Prasad R) Hepatobiliary Pancreat Dis Int 2024 Apr;23(2):154-159 1 Citation |
| 2 | Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. (Zhou W, Lim A, Elmadbouh OHM, Edderkaoui M, Osipov A, Mathison AJ, Urrutia R, Liu T, Wang Q, Pandol SJ) Free Radic Biol Med 2024 Feb 20;212:493-504 5 Citations |
| 5 | Disparities in Cardiovascular Disease-Related Outcomes Among Cancer Survivors in the United States: A Systematic Review of the Literature. (Bikomeye JC, Awoyinka I, Kwarteng JL, Beyer AM, Rine S, Beyer KMM) Heart Lung Circ 2024 May;33(5):576-604 6 Citations |
| 1 | Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). (Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB) Res Sq 2023 Dec 23 |
| 1 | Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Explor Target Antitumor Ther 2023;4(6):1301-1309 |
| 2 | FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression. (Ji J, Jing A, Ding Y, Ma X, Qian Q, Geng T, Cheng W, Zhang M, Sun Q, Ma S, Wang X, Yuan Q, Xu M, Qin J, Ma L, Yang J, He J, Du Q, Xia M, Xu Y, Chen Z, Zhu L, Liu W, Liu S, Liu B) Cell Death Dis 2024 Jan 11;15(1):33 7 Citations |
| 3 | The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study. (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao E, Fernandez ME, Schick V, Smith JS, Brzezinski B, Nyitray AG) medRxiv 2023 Dec 29 |
| 1 | Making progress against rare cancers: A case study on neuroendocrine tumors. (O'Rorke M, Chrischilles E, NET‐PRO Study Investigators) Cancer 2024 May 01;130(9):1568-1574 1 Citation |
| 1 | Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial. (Othus M, Patel SP, Chae YK, Dietrich E, Streicher H, Sharon E, Kurzrock R) J Natl Cancer Inst 2024 May 08;116(5):673-680 1 Citation |
| 1 | PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). (Aggarwal R, Heller G, Hillman DW, Xiao H, Picus J, Taplin ME, Dorff T, Appleman L, Weckstein D, Patnaik A, Bryce A, Shevrin D, Mohler J, Anderson D, Rao A, Tagawa S, Tan A, Halabi S, Dooley K, O'Brien P, Chen R, Ryan CJ, Eggener SE, Morris MJ, EORTC-55994 Study Group) J Clin Oncol 2024 Apr 01;42(10):1114-1123 12 Citations |
| 3 | Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M) Ann Surg Oncol 2024 May;31(5):3128-3140 3 Citations |
| 1 | Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study. (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW) Clin Transl Radiat Oncol 2024 Mar;45:100721 2 Citations |
| 1 | Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. (Mutch D, Voulgari A, Chen XM, Bradley WH, Oaknin A, Perez Fidalgo JA, Montosa FG, Herraez AC, Holloway RW, Powell MA, Nowicka M, Schaefer G, Merchant M, Yan Y) Cancer 2024 Jun 01;130(11):1940-1951 2 Citations |
| 1 | Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. (Mak KS, Scannell Bryan M, Dignam JJ, Shipley WU, Lin Y, Peters CA, Gore EM, Rosenthal SA, Zeitzer KL, D'Souza DP, Horwitz EM, Pisansky TM, Maier JM, Chafe SM, Robin TP, Roach M 3rd, Tran PT, Souhami L, Michalski JM, Hartford AC, Feng FY, Sandler HM, Efstathiou JA) Eur Urol Focus 2024 Mar;10(2):271-278 3 Citations |
| 7 | Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture. (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA) Transl Oncol 2024 Apr;42:101899 2 Citations |
| 2 | Challenges to genetic testing for germline mutations associated with breast cancer among African Americans. (Kamaraju S, Conroy M, Harris A, Georgen M, Min H, Powell M, Kurzrock R) Cancer Treat Rev 2024 Mar;124:102695 5 Citations |
| 1 | Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142. (correct author list should read:, Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) Int J Radiat Oncol Biol Phys 2024 Mar 01;118(3):869 |
| 1 | ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. (Cortina CS, Rogers CC, Teshome M) Ann Surg Oncol 2024 May;31(5):3196-3197 2 Citations |
| 1 | Is post-traumatic stress disorder a risk factor for development of opioid use disorder among individuals with chronic non-cancer pain? A systematic review. (Kendurkar A, Wilson J, Sunderland M, Dunlop A, Hayes C, Marel C, Mills KL) Br J Pain 2024 Feb;18(1):70-81 |
| 5 | Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in Patients with Preoperative COVID-19 Undergoing Cancer Surgery. (SenthilKumar G, Verhagen NB, Nimmer K, Yang X, Figueroa Castro CE, Szabo A, Taylor BW, Wainaina N, Gould JC, Kothari AN, N3C Consortium) J Am Coll Surg 2024 Jun 01;238(6):1085-1097 3 Citations |
| 1 | Challenges and Solutions to Support Oncology Professionals Serving Underserved Populations With Cancer in the United States: Results From the ASCO Serving the Underserved Task Force. (Patel MI, Hinyard L, Merrill JK, Smith KT, Lei J, Carrizosa D, Kamaraju S, Hlubocky FJ, Kalwar T, Fashoyin-Aje L, Gomez SL, Jeames S, Florez N, Kircher SM, Tap WD) JCO Oncol Pract 2024 May;20(5):688-698 |
| 1 | Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). (Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB) BMC Cancer 2024 Feb 13;24(1):201 |
| 1 | Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. (Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC) Epigenomics 2024 Mar;16(5):293-308 2 Citations |
| 1 | SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. (Patel SP, Guadarrama E, Chae YK, Dennis MJ, Powers BC, Liao CY, Ferri WA Jr, George TJ, Sharon E, Ryan CW, Othus M, Lopez G, Blanke CD, Kurzrock R) Cancer 2024 Sep 01;130(17):2918-2927 6 Citations |
| 1 | Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. (Shitara K, Falcone A, Fakih MG, George B, Sundar R, Ranjan S, Van Cutsem E) Oncologist 2024 May 03;29(5):e601-e615 2 Citations |
| 1 | Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma. (Williams EA, Vegas I, El-Senduny FF, Zhang J, Mata DA, Hiemenz MC, Hughes SR, Sa BC, Kraft GP, Gorbatov N, Foley-Peres K, Sanchez EZ, Milikowski C, Williams KJ, Ross JS, Kurzrock R, Montgomery EA, Lombard DB, Kumar S) Am J Surg Pathol 2024 Jun 01;48(6):699-707 2 Citations |
| 1 | Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer. (Adashek JJ, Pandya C, Maragakis NJ, De P, Cohen PR, Kato S, Kurzrock R) BMC Med 2024 Feb 19;22(1):74 6 Citations |
| 2 | Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. (Chen W, Dream S, Leung PY, Wu PK, Wong S, Park JI) NPJ Precis Oncol 2024 Feb 20;8(1):39 1 Citation |
| 6 | Examining the role of social relationships on health and health behaviors in African American men with prostate cancer: a qualitative analysis. (Awoyinka I, Tovar M, Young S, Beyer K, Kwarteng J, Knight J, Stolley M) Support Care Cancer 2024 Feb 21;32(3):178 1 Citation |
| 1 | Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. (Zengin ZB, Henderson NC, Park JJ, Ali A, Nguyen C, Hwang C, Barata PC, Bilen MA, Graham L, Mo G, Kilari D, Tripathi A, Labriola M, Rothstein S, Garje R, Koshkin VS, Patel VG, Schweizer MT, Armstrong AJ, McKay RR, Alva A, Dorff T) Prostate Cancer Prostatic Dis 2024 Feb 22 4 Citations |
| 1 | Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. (Ozambela M Jr, McCormick BZ, Rudzinski JK, Pieretti AC, González GMN, Meissner MA, Papadopoulos JN, Adibi M, Matin SF, Dahmen AS, Spiess PE, Pettaway CA) Urol Oncol 2024 Apr;42(4):120.e1-120.e9 3 Citations |
| 1 | PET/MRI improves management of children with cancer (Baratto L, Elizabeth Hawk K, States L, Qi J, Gatidis S, Kiru L, Daldrup-Link HE) Chinese Journal of Nuclear Medicine and Molecular Imaging 25 February 2024;44(2):124-128 |
| 1 | Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB) (Vineel Bhatlapenumarthi, Navonil De Sarkar, Anannya Patwari, Emmanuel S. Antonarakis, Ariel Ann Nelson, Deepak Kilari) J Clin Oncol J Clin Oncol 42, 2024 (suppl 4; abstr 206) |
| 3 | Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer. (Uyar D, Michener CM, Bishop E, Hopp E, Simpson P, Zhang L, Rader JS, Rose PG, Mahdi HS, Debernardo R, Christian Q, Bradley W) Front Oncol 2024;14:1291090 1 Citation |
| 1 | Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling. (Maranto C, Sabharwal L, Udhane V, Pitzen SP, McCluskey B, Qi S, O'Connor C, Devi S, Johnson S, Jacobsohn K, Banerjee A, Iczkowski KA, Wang L, Dehm SM, Nevalainen MT) Sci Adv 2024 Mar;10(9):eadi2742 3 Citations |
| 2 | Should surgeons reconsider the role of intraoperative sentinel lymph node evaluation for premenopausal breast cancer patients in the era of RxPONDER? (Cortina CS, Kong AL) Am J Surg 2024 Aug;234:184-185 |
| 1 | Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study (Daamen LA, Westerhoff JM, Couwenberg AM, Braam PM, Rütten H, den Hartogh MD, Christodouleas JP, Hall WA, Verkooijen HM, Intven MPW) Clinical and Translational Radiation Oncology March 2024;45 2 Citations |
| 1 | Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142 (International Journal of Radiation Oncology, Biology, Physics (2023) 117(5) (1138–1142), (S0360301623075922), (10.1016/j.ijrobp.2023.06.2516)) (Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) International Journal of Radiation Oncology Biology Physics 1 March 2024;118(3):869 |
| 1 | Sexual Behavior and Perceived Risk for Oropharyngeal Cancer Among Men Who Have Sex With Men: A Psychometric Scale Validation. (Bennis SL, Rohloff CT, Zhang Z, Kohli N, Zoschke IN, Rosser BRS, Nyitray AG, Wilkerson JM, Stull CL, Khariwala SS, Ross MW) Sex Transm Dis 2024 Apr 01;51(4):289-294 |
| 1 | Association of Tongue Strength and Maximum Incisal Opening with Oral Intake in Persons with Head and Neck Cancer Treated with Radiotherapy: A Retrospective Study. (Pauloski BR, Nitschke T, Schultz S, Bloedel S, Amman A, Kessler L, Lisowski K) Dysphagia 2024 Aug;39(4):726-734 |
| 2 | Equipping Faith-Based Communities for Cancer Support Ministry: A Pilot Study of Cancer Support Training for Members of African-American Churches in the USA. (Kwarteng JL, White K, Nevels D, Brown S, Stolley MR) J Relig Health 2024 Apr;63(2):1523-1537 |
| 3 | Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression. (Bursch KL, Goetz CJ, Jiao G, Nuñez R, Olp MD, Dhiman A, Khurana M, Zimmermann MT, Urrutia RA, Dykhuizen EC, Smith BC) J Biol Chem 2024 Apr;300(4):107146 2 Citations |
| 3 | Morphologic features of prostate cancer-encased native vessels: An image analysis study. (Fernandez Gonzalez De La Vega C, Duenweg S, Jain P, Rubenstein SI, Bobholz S, Barrett MJ, LaViolette PS, Iczkowski KA) Pathol Res Pract 2024 Apr;256:155239 1 Citation |
| 1 | Survival of the Hmong population diagnosed with colon and rectal cancers in the United States. (Walker MR, Lor K, Lor KB, Vidri RJ, Hampton JM, Maldonado C, Schiefelbein AM, LoConte NK) Cancer Med 2024 Mar;13(5):e7087 |
| 1 | Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model. (Mittal S, Kumar S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S) STAR Protoc 2024 Jun 21;5(2):102943 |
| 1 | Risk Factors for Severe Hypertension and Proteinuria after Treatment with Vascular Endothelial Growth Factor Signaling Pathway Inhibitors among Patients with Cancer (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S) Kidney International Reports doi: 10.1016/j.ekir.2024.03.005 |
| 1 | Future direction of total neoadjuvant therapy for locally advanced rectal cancer. (Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Rödel C, Dasari A, Yoshino T) Nat Rev Gastroenterol Hepatol 2024 Jun;21(6):444-455 17 Citations |
| 1 | Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. (Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S) ESMO Open 2024 Apr;9(4):102942 6 Citations |
| 1 | Necrotizing granulomatous epididymo-orchitis post intravesical BCG administration after brachytherapy for prostate cancer. (Jhaveri JK, Dahmen A, Lazarovich A, Nusbaum D, Trinh QD, Gupta N, Agarwal PK) Urol Case Rep 2024 May;54:102694 |
| 1 | Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival. (Leung PY, Chen W, Sari AN, Sitaram P, Wu PK, Tsai S, Park JI) World J Gastroenterol 2024 Feb 21;30(7):714-727 3 Citations |
| 1 | Screening for HPV-Related Oropharyngeal Cancer in Gay and Bisexual Men: Acceptability and Predicting Possible Use of "Oral Selfies" by Smartphone as a Secondary Prevention Approach. (Ross MW, Bennis SL, Zoschke N, Simon Rosser BR, Stull CL, Nyitray AG, Khariwala SS, Nichols M, Flash C, Wilkerson M) Venereology (Basel) 2023 Dec;2(4):180-193 |
| 1 | If it's a target, it's a pan-cancer target: Tissue is not the issue. (Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R) Cancer Treat Rev 2024 Apr;125:102721 11 Citations |
| 4 | Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy. (SenthilKumar G, Schottstaedt AM, Peterson LL, Pedersen LN, Chitambar CR, Vistocky A, Banerjee A, Longo JM, Kelly T, Currey A, Stolley MR, Bergom C) Cancer Res Commun 2024 May 07;4(5):1211-1226 3 Citations |
| 3 | Structural and Dynamic Analyses of Pathogenic Variants in PIK3R1 Reveal a Shared Mechanism Associated among Cancer, Undergrowth, and Overgrowth Syndromes. (Dsouza NR, Cottrell CE, Davies OMT, Tollefson MM, Frieden IJ, Basel D, Urrutia R, Drolet BA, Zimmermann MT) Life (Basel) 2024 Feb 23;14(3) 2 Citations |
| 1 | Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study. (McDeed AP, Van Dyk K, Zhou X, Zhai W, Ahles TA, Bethea TN, Carroll JE, Cohen HJ, Nakamura ZM, Rentscher KE, Saykin AJ, Small BJ, Root JC, Jim H, Patel SK, Mcdonald BC, Mandelblatt JS, Ahn J) JNCI Cancer Spectr 2024 Feb 29;8(2) |
| 1 | Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRASG12C-Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report (Stratton N, Thompson J) JTO Clinical and Research Reports April 2024;5(4) 2 Citations |
| 1 | If it's a target, it's a pan-cancer target: Tissue is not the issue (Adashek JJ, Kato S, Sicklick JK, Lippman SM, Kurzrock R) Cancer Treatment Reviews April 2024;125 11 Citations |
| 4 | Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. (Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE) Support Care Cancer 2024 Apr 02;32(4):265 |
| 1 | Development of a Patient-Reported Sexual Health Outcomes Battery for Use in Adolescent and Young Adult Cancer Clinical Trials. (Demedis J, Bingen K, Cherven B, Frederick NN, Freyer DR, Levine J, Bhutada JS, Quinn GP, Bober SL, DuVall AS) J Adolesc Young Adult Oncol 2024 Jun;13(3):369-373 |
| 1 | Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. (Park JJ, Chu A, Li J, Ali A, McKay RR, Hwang C, Labriola MK, Jang A, Kilari D, Mo G, Ravindranathan D, Graham LS, Sokolova A, Tripathi A, Pilling A, Jindal T, Ravindra A, Cackowski FC, Sweeney PL, Thapa B, Amery TS, Heath EI, Garje R, Zakharia Y, Koshkin VS, Bilen MA, Schweizer MT, Barata PC, Dorff TB, Cieslik M, Alva AS, Armstrong AJ) JCO Precis Oncol 2024 Apr;8:e2300567 6 Citations |
| 1 | Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer. (Bagheri M, Mohamed GA, Mohamed Saleem MA, Ognjenovic NB, Lu H, Kolling FW, Wilkins OM, Das S, LaCroix IS, Nagaraj SH, Muller KE, Gerber SA, Miller TW, Pattabiraman DR) Cell Rep Med 2024 Apr 16;5(4):101504 3 Citations |
| 1 | Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. (Zhang F, Sahu V, Peng K, Wang Y, Li T, Bala P, Aitymbayev D, Sahgal P, Schaefer A, Der CJ, Ryeom S, Yoon S, Sethi N, Bass AJ, Zhang H) Gut 2024 Jul 11;73(8):1280-1291 6 Citations |
| 1 | Adolescents and young adults with cancer: the clinical course of COVID-19 infections. (Wolfson JA, Davis ES, Saha A, Martinez I, McCall D, Kothari P, Brackett J, Dickens DS, Kahn AR, Schwalm C, Sharma A, Richman J, Cuglievan B, POCC Consortium, Bhatia S, Dai C, Levine JM, Johnston EE) J Natl Cancer Inst 2024 Aug 01;116(8):1366-1373 |
| 1 | High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy. (Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Conroy JM, DePietro P, Pabla S, Lippman SM, Kurzrock R) iScience 2024 Apr 19;27(4):109632 3 Citations |
| 1 | High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy (Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Conroy JM, DePietro P, Pabla S, Lippman SM, Kurzrock R) iScience 19 April 2024;27(4) 3 Citations |
| 2 | Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture. (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA) Transl Oncol 2024 Jun;44:101927 |
| 1 | CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1. (Geng T, Sun Q, He J, Chen Y, Cheng W, Shen J, Liu B, Zhang M, Wang S, Asan K, Song M, Gao Q, Song Y, Liu R, Liu X, Ding Y, Jing A, Ye X, Ren H, Zeng K, Zhou Y, Zhang B, Ma S, Liu W, Liu S, Ji J) Cell Signal 2024 Jul;119:111180 2 Citations |
| 1 | Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer. (Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, Strohbehn I, Moreno D, Harden D, Dinulos JE, Cosar D, Seethapathy H, Gainor JF, Shah SJ, Gupta S, Leaf DE, Fintelmann FJ, Sise ME) J Cachexia Sarcopenia Muscle 2024 Jun;15(3):1187-1198 6 Citations |
| 3 | The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study. (Nitkowski J, Ridolfi TJ, Lundeen SJ, Giuliano AR, Chiao EY, Fernandez ME, Schick V, Smith JS, Brzezinski B, Nyitray AG) Sex Health 2024 Apr;21 |
| 1 | Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer (Shreenivas A, Nishizaki D, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Kato S, Kurzrock R) International Journal of Molecular Sciences May 2024;25(9) |
| 1 | MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study (Sritharan K, Daamen L, Pathmanathan A, Schytte T, Pos F, Choudhury A, van der Voort van Zyp JRN, Kerkmeijer LGW, Hall W, Hall E, Verkooijen HM, Herbert T, Hafeez S, Mitchell A, Tree AC) Clinical and Translational Radiation Oncology May 2024;46 2 Citations |
| 1 | Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia. (Shanno JN, Daly AE, Anderman KJ, Santa Cruz HS, Webster AJ, Pride RM, Specht MC, Gadd MA, Oseni TO, Verdial FC, Ozmen T, Kwait R, Colwell AS, Smith BL) Ann Surg Oncol 2024 Aug;31(8):5148-5156 1 Citation |
| 1 | 3D genomic mapping reveals multifocality of human pancreatic precancers. (Braxton AM, Kiemen AL, Grahn MP, Forjaz A, Parksong J, Mahesh Babu J, Lai J, Zheng L, Niknafs N, Jiang L, Cheng H, Song Q, Reichel R, Graham S, Damanakis AI, Fischer CG, Mou S, Metz C, Granger J, Liu XD, Bachmann N, Zhu Y, Liu Y, Almagro-Pérez C, Jiang AC, Yoo J, Kim B, Du S, Foster E, Hsu JY, Rivera PA, Chu LC, Liu F, Fishman EK, Yuille A, Roberts NJ, Thompson ED, Scharpf RB, Cornish TC, Jiao Y, Karchin R, Hruban RH, Wu PH, Wirtz D, Wood LD) Nature 2024 May;629(8012):679-687 27 Citations |
| 1 | Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer. (Zaiem F, Bedi M, Kheil M, Abujamea A, Jain D, Rosen D, Alkaram W, Kim S, Ali-Fehmi R, Gogoi R) Gynecol Oncol Rep 2024 Jun;53:101402 |
| 1 | ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. (Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ) medRxiv 2024 Apr 27 |
| 1 | Recent and projected incidence trends and risk of anal cancer among people with HIV in North America. (Deshmukh AA, Lin YY, Damgacioglu H, Shiels M, Coburn SB, Lang R, Althoff KN, Moore R, Silverberg MJ, Nyitray AG, Chhatwal J, Sonawane K, Sigel K) J Natl Cancer Inst 2024 Sep 01;116(9):1450-1458 4 Citations |
| 1 | Piloting Skin Cancer Screenings to Prioritize Communities of Color. (Kerschner JE, Akinshemoyin Vaughn OL) WMJ 2024 May;123(2):150-151 |
| 1 | Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting. (Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Pabla S, Nesline MK, Ko H, Conroy JM, DePietro P, Sicklick JK, Kato S) Am J Cancer Res 2024;14(4):1634-1648 |
| 1 | Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer. (Shreenivas A, Nishizaki D, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Kato S, Kurzrock R) Int J Mol Sci 2024 Apr 26;25(9) |
| 2 | FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development. (Ji J, Qian Q, Cheng W, Ye X, Jing A, Ma S, Ding Y, Ma X, Wang Y, Sun Q, Wang X, Chen Y, Zhu L, Yuan Q, Xu M, Qin J, Ma L, Yang J, Zhang M, Geng T, Wang S, Wang D, Song Y, Zhang B, Xu Y, Xu L, Liu S, Liu W, Liu B) Cell Death Dis 2024 May 13;15(5):332 4 Citations |
| 1 | Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology. (Lazarovich A, Dahmen AS, Modi PK, Agarawal PK) J Urol 2024 Jul;212(1):236-237 |
| 1 | Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses. (Nikanjam M, Wells K, Kato S, Adashek JJ, Block S, Kurzrock R) Med 2024 Jul 12;5(7):689-717 2 Citations |
| 1 | Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a review. (Kurzrock R, Chaudhuri AA, Feller-Kopman D, Florez N, Gorden J, Wistuba II) Cancer Metastasis Rev 2024 Dec;43(4):1217-1231 4 Citations |
| 1 | Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. (Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza D, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Rodgers JP, Sandler HM) J Clin Oncol 2024 Jul 10;42(20):2377-2381 8 Citations |
| 1 | Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates. (Ajkunic A, Sayar E, Roudier MP, Patel RA, Coleman IM, De Sarkar N, Hanratty B, Adil M, Zhao J, Zaidi S, True LD, Sperger JM, Cheng HH, Yu EY, Montgomery RB, Hawley JE, Ha G, Persse T, Galipeau P, Lee JK, Harmon SA, Corey E, Lang JM, Sawyers CL, Morrissey C, Schweizer MT, Gulati R, Nelson PS, Haffner MC) NPJ Precis Oncol 2024 May 17;8(1):104 6 Citations |
| 2 | Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study. (Kiconco A, Kabanda R, Ronald A, Beyer KMM, John SA) BMC Womens Health 2024 May 18;24(1):296 3 Citations |
| 1 | Making Choices: A Multi-institutional, Longitudinal Cohort Study Assessing Changes in Treatment Outcome Valuation for Low-Risk Thyroid Cancer. (Antunez AG, Sinco BR, Saucke MC, Bushaw KJ, Jensen CB, Dream S, Fingeret AL, Livhits MJ, Mathur A, McDow A, Roman SA, Voils CI, Sydnor J, Pitt SC, CHOiCE Collaborative (Comparing Health Outcomes in Cancer Experience)) Ann Surg 2024 May 20 |
| 1 | Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient. (Schaffrin-Nabe D, Josten-Nabe A, Tannapfel A, Uhl W, Garmer M, Kurzrock R, Crook T, Limaye S, Schuster S, Patil D, Schaffrin M, Mokbel K, Voigtmann R) Front Oncol 2024;14:1395618 |
| 1 | Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. (Watt KD, Rolak S, Foley DP, Plichta JK, Pruthi S, Farr D, Zwald FO, Carvajal RD, Dudek AZ, Sanger CB, Rocco R, Chang GJ, Dizon DS, Langstraat CL, Teoh D, Agarwal PK, Al-Qaoud T, Eggener S, Kennedy CC, D'Cunha J, Mohindra NA, Stewart S, Habermann TH, Schuster S, Lunning M, Shah NN, Gertz MA, Mehta J, Suvannasankha A, Verna E, Farr M, Blosser CD, Hammel L, Al-Adra DP) Transplantation 2024 Dec 01;108(12):2336-2350 2 Citations |
| 7 | Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. (Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H, Chaudhary LN) J Pers Med 2024 Apr 29;14(5) |
| 1 | Alzheimer disease-related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study. (Mandelblatt J, Dage JL, Zhou X, Small BJ, Ahles TA, Ahn J, Artese A, Bethea TN, Breen EC, Carroll JE, Cohen HJ, Extermann M, Graham D, Claudine I, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Rebeck GW, Rentscher KE, Root JC, Russ KA, Tometich DB, Turner RS, Van Dyk K, Zhai W, Huang LW, Saykin AJ) J Natl Cancer Inst 2024 Sep 01;116(9):1495-1507 2 Citations |
| 5 | An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer. (Kamaraju S, McKoy J, Williams GR, Gilmore N, Minami C, Bylow K, Rajalingam H, Cortina CS, Beckert A, Stolley M, Bullock D, Kurzrock R, Jatoi A) Curr Oncol Rep 2024 Aug;26(8):855-864 |
| 4 | Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations (Cobb AN, Czaja R, Jorns J, Cortina CS) Current Breast Cancer Reports June 2024;16(2):150-160 1 Citation |
| 1 | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S) Kidney International Reports June 2024;9(6):1897-1902 3 Citations |
| 3 | Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture (Translational Oncology (2024) 42, (S1936523324000251), (10.1016/j.tranon.2024.101899)) (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA) Translational Oncology June 2024;44 |
| 1 | Phase II clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer (Jameson GS, Hosein PJ, Pierce E, Kamgar M, Gordon MS, Snyder C, Roe DJ, Wertheim BC, Davey M, Barrett MT, Von Hoff DD, Borazanci E) Cancer Medicine June 2024;13(12) |
| 1 | Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer. (Klomp JE, Diehl JN, Klomp JA, Edwards AC, Yang R, Morales AJ, Taylor KE, Drizyte-Miller K, Bryant KL, Schaefer A, Johnson JL, Huntsman EM, Yaron TM, Pierobon M, Baldelli E, Prevatte AW, Barker NK, Herring LE, Petricoin EF 3rd, Graves LM, Cantley LC, Cox AD, Der CJ, Stalnecker CA) Science 2024 Jun 07;384(6700):eadk0850 17 Citations |
| 1 | Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis. (Westerhoff JM, Lalmahomed TA, Meijers LTC, Henke L, Teunissen FR, Bruynzeel AME, Alongi F, Hall WA, Kishan AU, Intven MPW, Verkooijen HM, van der Voort van Zyp JRN, Daamen LA) Int J Radiat Oncol Biol Phys 2024 Sep 01;120(1):38-48 2 Citations |
| 4 | Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. (Geethadevi A, Ku Z, Tsaih SW, Parashar D, Kadamberi IP, Xiong W, Deng H, George J, Kumar S, Mittal S, Zhang N, Pradeep S, An Z, Chaluvally-Raghavan P) NPJ Precis Oncol 2024 Jun 05;8(1):127 3 Citations |
| 2 | Correction: Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study. (Kabanda R, Kiconco A, Ronald A, Beyer KMM, John SA) BMC Womens Health 2024 Jun 06;24(1):328 1 Citation |
| 5 | Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients. (Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS) Ann Surg Oncol 2024 Sep;31(9):5560-5569 1 Citation |
| 3 | Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry. (Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM) Blood Adv 2024 Aug 13;8(15):4102-4112 |
| 3 | ASO Visual Abstract: Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients. (Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS) Ann Surg Oncol 2024 Sep;31(9):5591-5592 |
| 2 | ASO Author Reflections: Opportunities to Mitigate Cancer Disparities in Transgender and Gender-Diverse Populations. (Istl AC, Lawton S, Cortina CS) Ann Surg Oncol 2024 Sep;31(9):5587-5588 |
| 8 | Type I interferon signaling promotes radioresistance in head and neck cancer. (Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HA) Transl Cancer Res 2024 May 31;13(5):2535-2543 3 Citations |
| 1 | Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review. (Gomez D, Feng JJ, Cheok S, Shah I, Dicharry H, Cote DJ, Briggs RG, Guerra GA, Peterson R, Salhia B, Neman J, Attenello F, Chow F, Musabelliu EK, Zada G) J Neurooncol 2024 Sep;169(3):457-467 3 Citations |
| 1 | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer. (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S) Kidney Int Rep 2024 Jun;9(6):1897-1902 3 Citations |
| 1 | MicroRNAs in extracellular vesicles: A potential role in cancer progression. (Parashar D, Mukherjee T, Gupta S, Kumar U, Das K) Cell Signal 2024 Sep;121:111263 9 Citations |
| 2 | Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors. (Summey RM, Gornstein E, Decker B, Dougherty KC, Rader JS, Hopp E) Cancer Med 2024 Jun;13(12):e7340 |
| 3 | Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model (Mittal S, Kumar S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S) STAR Protocols 21 June 2024;5(2) |
| 1 | Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study. (Istl AC, Nudotor R, Greer JB, Gross JM, Meyer CF, Johnston FM) J Surg Res 2024 Aug;300:559-566 |
| 1 | Advancing Precision Equity With Multicancer Detection Liquid Biopsies. (Semenkovich NP, Agarwal G, Chaudhuri AA) JAMA Oncol 2024 Aug 01;10(8):1023-1024 |
| 3 | 3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. (Zhou Y, He Z, Li T, Choppavarapu L, Hu X, Cao R, Leone GW, Kahn M, Jin VX) Cancers (Basel) 2024 Jun 12;16(12) 1 Citation |
| 5 | The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial. (Cortina CS, Purdy A, Brazauskas R, Stachowiak SM, Fodrocy J, Klement KA, Sasor SE, Krucoff KB, Robertson K, Buth J, Lakatos AEB, Petroll AE, Doren EL) Ann Surg Oncol 2024 Oct;31(11):7474-7482 4 Citations |
| 1 | Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers. (Willis C, Au T, Hejazi A, Griswold C, Schabath MB, Thompson J, Malhotra J, Federman N, Ko G, Appukkuttan S, Warnock N, Kong SX, Hocum B, Brixner D, Stenehjem D) J Manag Care Spec Pharm 2024 Jul;30(7):672-683 1 Citation |
| 1 | Long-term outcomes of endoscopic submucosal dissection for undifferentiated type early gastric cancer over 2 cm with R0 resection. (Bae JY, Ryu CB, Lee MS, Dua KS) World J Gastrointest Endosc 2024 Jun 16;16(6):326-334 |
| 1 | Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (van den Berg MC, Berg HF, Stokowy T, Hoivik EA, Woie K, Engerud H, Ojesina AI, Haldorsen IS, Trovik J, Bertelsen BI, Krakstad C, Halle MK) Int J Gynecol Cancer 2024 Jul 01;34(7):993-1000 |
| 1 | Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial. (Westerhoff JM, Sanford NN, Hall WA) Lancet Gastroenterol Hepatol 2024 Aug;9(8):687 |
| 1 | SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases. (Liu J, Sidiqi B, McComas K, Gogineni E, Andraos T, Crane CH, Chang DT, Goodman KA, Hall WA, Hoffe S, Mahadevan A, Narang AK, Lee P, Williams TM, Chuong MD) Pract Radiat Oncol 2024;14(6):555-573 2 Citations |
| 6 | In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations. (Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJ) Oral Oncol 2024 Sep;156:106947 1 Citation |
| 3 | Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). (Becktell K, Chen Y, Yasui Y, Phelan R, Armstrong GT, Link M, Oeffinger K, Snyder C, Daw N, Weil B, Weldon C, Chow EJ, Schwartz CL) Pediatr Blood Cancer 2024 Oct;71(10):e31189 1 Citation |
| 1 | The Severe Skin Cancer Consequences of Extended Tanning Bed Use, A Case Report. (Cooper JT, Clark MA) WMJ 2024 Jul;123(3):210-212 |
| 1 | Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. (Broderick A, Pan E, Li J, Chu A, Hwang C, Barata PC, Cackowski FC, Labriola M, Ghose A, Bilen MA, Kilari D, Thapa B, Piero M, Graham L, Tripathi A, Garje R, Koshkin VS, Hernandez E, Dorff TB, Schweizer MT, Alva AS, McKay RR, Armstrong AJ) Prostate Cancer Prostatic Dis 2024 Jul 17 1 Citation |
| 1 | Target Volume Optimization for Localized Prostate Cancer. (Patel KR, van der Heide UA, Kerkmeijer LGW, Schoots IG, Turkbey B, Citrin DE, Hall WA) Pract Radiat Oncol 2024;14(6):522-540 2 Citations |
| 5 | Effects of housing stability and contemporary mortgage lending bias on breast cancer stage at diagnosis among older women in the United States. (Rademacher N, Zhou Y, McGinley EL, Laud PW, Yen TWF, Ponce SB, Nattinger AB, Beyer KMM) Cancer Med 2024 Jul;13(14):e7397 |
| 1 | Power-law growth models explain incidences and sizes of pancreatic cancer precursor lesions and confirm spatial genomic findings. (Kiemen AL, Wu PH, Braxton AM, Cornish TC, Hruban RH, Wood LD, Wirtz D, Zwicker D) Sci Adv 2024 Jul 26;10(30):eado5103 |
| 1 | Low-dose orthotopic cancer implantation permits measurement of longitudinal functional changes associated with cachexia. (Roy I, Binder-Markey B, Willbanks A, Sychowski D, Phipps T, Barber A, McAllister D, D'Andrea D, Franz CK, Pichika R, Dwinell MB, Lieber RL) J Appl Physiol (1985) 2024 Sep 01;137(3):705-717 |
| 1 | ASO Author Reflections: A Breast Cancer Risk Assessment and the Decision for Gender-Affirming Chest Masculinization Surgery or Oncologic Risk-Reducing Mastectomies in Transgender and Gender-Diverse Individuals. (Cortina CS) Ann Surg Oncol 2024 Oct;31(11):7483-7484 1 Citation |
| 1 | Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. (Alvarez JA, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong T, Yothers G, Philip P, Nelson G, Al Baghdadi T, Alese OB, Zambare W, Omer D, Verheij FS, Bercz A, Kim MJ, Buckley J, Williams H, George M, Garcia R, Gallagher P, O'Reilly EM, Meyerhardt JA, Crawley J, Shergill A, Horvat N, Romesser PB, Hall W, Smith JJ) BMC Cancer 2024 Jul 26;24(1):901 6 Citations |
| 1 | Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. (Kachnic LA, Winter K, Suntharalingam M, Ilson D, Konski A, Lloyd S, McAvoy SA, Lad T, Olowokure OG, Samson P, Gore EM, Meyer JE, Videtic GMM, Clump DA, Raben A, Kayaleh O, Barker J Jr, Haddock MG, Hopkins JO, Bruner DW) Qual Life Res 2024 Oct;33(10):2833-2844 |
| 1 | Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial (Westerhoff JM, Sanford NN, Hall WA) The Lancet Gastroenterology and Hepatology August 2024;9(8):687 |
| 1 | Social support resources in adolescents and young adults with advanced cancer: a qualitative analysis. (Lau N, Steineck A, Walsh C, Fladeboe KM, Yi-Frazier JP, Rosenberg AR, Barton K) BMC Palliat Care 2024 Jul 31;23(1):193 1 Citation |
| 1 | Piloting a Patient-Driven Online Survey to Better Understand Cancer in Adolescents and Young Adults (AYA) in the United States. (Beaupin L, Borinstein S, Yeager ND, Rokitka D, Schweitzer J, Uwazurike O, Senall J, Amankwah E, Shaw PH) Cureus 2024 Jul;16(7):e63749 |
| 1 | Educational and occupational aspirations of adolescent and young adult cancer survivors: a qualitative analysis. (Rao P, Segel JE, Bingen K, Devine KA, Rumbaugh CL, Costigan HJ, Dandekar S, Wasserman E, Koehly LM, Blackall GF, Rakszawski K, Songdej N, Verdery AM, Lengerich EJ, Van Scoy LJ) Support Care Cancer 2024 Aug 06;32(9):572 |
| 2 | Surgeon Type and Anastomotic Leaks in Ovarian Cancer. (Istl AC, Desravines N, Maduekwe UN) JAMA Surg 2024 Oct 01;159(10):1194-1195 |
| 1 | Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study. (Artese AL, Zhou X, Tometich DB, Small BJ, Ahles TA, Ahn J, Bethea TN, Breen EC, Cohen HJ, Extermann M, Graham D, Isaacs C, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Root JC, Saykin AJ, Van Dyk K, Zhai W, Carroll JE, Mandelblatt J) J Natl Cancer Inst 2024 Dec 01;116(12):2009-2021 |
| 1 | Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study. (Graff JN, Hoimes CJ, Gerritsen WR, Vaishampayan UN, Elliott T, Hwang C, Ten Tije AJ, Omlin A, McDermott RS, Fradet Y, Tagawa ST, Kilari D, Ferrario C, Uemura H, Jones RJ, Fukasawa S, Peer A, Niu C, Poehlein CH, Qiu P, Suttner L, de Wit R, Schloss C, de Bono JS, Antonarakis ES) Prostate Cancer Prostatic Dis 2024 Aug 12 2 Citations |
| 1 | Using Low-cost Videoscopes to Obtain Accurate Video "Oral Selfies" as Screening for HPV-associated Oropharyngeal Cancer: A New Screening Technology? (Ross MW, Khariwala SS, Bennis SL, Zoschke IN, Rosser BRS, Nyitray AG, Nichols CM, Flash C, Wilkerson JM, Stull CL) Cancer Screen Prev 2024 Jun;3(2):125-129 |
| 1 | Self-collected versus clinician-collected anal swabs for anal cancer screening: A systematic review and meta-analysis. (Dyer CEF, Jin F, Hillman RJ, Nyitray AG, Roberts JM, Law C, Grulich AE, Poynten IM) Int J Cancer 2025 Jan 01;156(1):79-90 3 Citations |
| 1 | 3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure. (Kiemen AL, Almagro-Pérez C, Matos V, Forjaz A, Braxton AM, Dequiedt L, Parksong J, Cannon CD, Yuan X, Shin SM, Babu JM, Thompson ED, Cornish TC, Ho WJ, Wood LD, Wu PH, Barrutia AM, Hruban RH, Wirtz D) bioRxiv 2024 Aug 06 |
| 1 | Shifting neoadjuvant chemotherapy treatment paradigms for breast cancer and its impact on axillary nodal management for clinically node-negative patients. (Cortina CS) Gland Surg 2024 Jul 30;13(7):1154-1158 1 Citation |
| 1 | DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. (Graham LS, Henderson NC, Kellezi O, Hwang C, Barata PC, Bilen MA, Kilari D, Pierro M, Thapa B, Tripathi A, Mo G, Labriola M, Park JJ, Rothstein S, Garje R, Koshkin VS, Patel VG, Dorff T, Armstrong AJ, McKay RR, Alva A, Schweizer MT) JCO Precis Oncol 2024 Aug;8:e2400014 3 Citations |
| 1 | Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer. (Rogacki KR, Teo PT, Gopalakrishnan M, Pachigolla SL, Lyons CE, Abazeed ME, Das I, Mittal BB, Gentile M) Adv Radiat Oncol 2024 Sep;9(9):101545 |
| 7 | Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Beltran Ponce SE, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke CN, Aldakkak M, Evans DB, Christians K, Paulson ES, Erickson B, Hall WA) Pract Radiat Oncol 2025;15(1):e47-e56 |
| 1 | Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group. (MacFarland SP, Becktell K, Schneider KW, Kuiper RP, Lesmana H, Meade J, Nichols KE, Porter CC, Savage SA, Schultz KA, Scott H, States L, Tabori U, Tamura C, Tomlinson G, Zelley K, Durno C, Bauer A, Plon SE) Clin Cancer Res 2024 Oct 15;30(20):4566-4571 2 Citations |
| 3 | Deciphering the divergent transcriptomic landscapes of cervical cancer cells grown in 3D and 2D cell culture systems. (Kumar R, Iden M, Tsaih SW, Schmidt R, Ojesina AI, Rader JS) Front Cell Dev Biol 2024;12:1413882 1 Citation |
| 3 | Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer (Pollin G, Lomberk GA, Mathison AJ, Zimmermann MT, Urrutia R) Journal of Gastrointestinal Oncology 31 August 2024;15(4):1996-2001 |
| 1 | Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience. (Krishnan J, Patel A, Roy AM, Alharbi M, Kapoor A, Yao S, Khoury T, Hong CC, Held N, Chakraborty A, Kaliniski P, Salman A, Catalfamo K, Attwood K, Kirtani V, Shaikh SS, Chaudhary LN, Gandhi S) Clin Breast Cancer 2024 Dec;24(8):e701-e711.e2 2 Citations |
| 2 | ASO Visual Abstract: The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals-A Pilot Single-Arm Educational Intervention Trial. (Cortina CS, Purdy A, Brazauskas R, Stachowiak SM, Fodrocy J, Klement K, Sasor S, Krucoff K, Robertson K, Buth J, Lakatos AEB, Petroll AE, Doren EL) Ann Surg Oncol 2024 Aug 30 |
| 5 | In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations (Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJ) Oral Oncology September 2024;156 1 Citation |
| 1 | Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer. (Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D) Clin Genitourin Cancer 2024 Dec;22(6):102187 |
| 1 | Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk. (Kalia SS, Boddicker NJ, Yadav S, Huang H, Na J, Hu C, Ambrosone CB, Yao S, Haiman CA, Chen F, John EM, Kurian AW, Guo B, Lindstrӧm S, Auer P, Lacey JV Jr, Neuhausen SL, Martinez ME, Sandler DP, O'Brien KM, Taylor JA, Teras LR, Hodge JM, Lori A, Bodelon C, Trentham-Dietz A, Burnside ES, Vachon CM, Winham SJ, Goldgar DE, Domchek SM, Nathanson KL, Weitzel JN, Couch FJ, Kraft P) Cancer Epidemiol Biomarkers Prev 2024 Nov 01;33(11):1490-1499 |
| 1 | Sinonasal Tumors: What the Multidisciplinary Cancer Care Board Wants to Know. (Avey GD, Koszewski IJ, Agarwal M, Endelman LA, McDonald MA, Burr AR, Bruce JY, Penn L, Kennedy TA) Radiographics 2024 Oct;44(10):e240035 |
| 5 | Traveling Long Distances for Rectal Cancer Care: Institutional Outcomes and Patient Experiences. (Peterson KJ, Drezdzon MK, Sparapani R, Calata JF, Ridolfi TJ, Ludwig KA, Peterson CY) J Surg Res 2024 Oct;302:916-924 1 Citation |
| 4 | Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer. (Pollin G, Lomberk GA, Mathison AJ, Zimmermann MT, Urrutia R) J Gastrointest Oncol 2024 Aug 31;15(4):1996-2001 |
| 1 | Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. (Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS, NIAGARA Investigators) N Engl J Med 2024 Nov 14;391(19):1773-1786 40 Citations |
| 1 | Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease. (Hansen JL, Rumble ME, Coe CL, Juckett MB, Foster MA, Dickson D, Morris KE, Hematti P, Costanzo ES) Brain Behav Immun 2025 Jan;123:185-192 |
| 3 | Use of Hematopoietic Cell Transplant for Hematologic Cancers by Race, Ethnicity, and Age. (Hahn T, Herr MM, Brazauskas R, Patel J, Ailawadhi S, Saber W, Khera N) JAMA Netw Open 2024 Sep 03;7(9):e2433145 5 Citations |
| 5 | Evaluating the Accuracy, Quality, and Readability of Online Breast Cancer Information. (Valencia EA, Cortina CS, Cobb AN, Chaudhary LN, Kelly T, Kong AL) Ann Surg Open 2024 Sep;5(3):e465 |
| 1 | A Comparison of Commonly Utilized Diagnostic Biopsy Techniques for Pediatric Patients With Cancer: A Systematic Review by the APSA Cancer Committee. (Teke M, Rich BS, Walther A, Schwartz D, McDuffie LA, Butera G, Roach JP, Rothstein DH, Lal DR, Riehle K, Espinoza A, Cost N, Tracy E, Rodeberg D, Lautz T, Aldrink JH, Brown EG) J Pediatr Surg 2025 Feb;60(2):161893 |
| 1 | Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377. (Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY) Int J Radiat Oncol Biol Phys 2024 Dec 01;120(5):1461 |
| 4 | Effect on Travel Distance of a Statewide Regionalization Policy for Initial Breast Cancer Surgery. (Bickell NA, Nattinger AB, McGinley EL, Schymura MJ, Laud PW, Pezzin LE) J Clin Oncol 2025 Jan;43(1):57-64 |
| 1 | Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. (Alaklabi S, Roy AM, Zagami P, Chakraborty A, Held N, Elijah J, George A, Attwood K, Shaikh SS, Chaudhary LN, Abdou Y, Gandhi S) JCO Oncol Pract 2024 Oct 01:OP2400242 |
| 1 | A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. (Bodeker KL, Smith BJ, Berg DJ, Chandrasekharan C, Sharif S, Fei N, Vollstedt S, Brown H, Chandler M, Lorack A, McMichael S, Wulfekuhle J, Wagner BA, Buettner GR, Allen BG, Caster JM, Dion B, Kamgar M, Buatti JM, Cullen JJ) Redox Biol 2024 Nov;77:103375 2 Citations |
| 2 | The role of short-chain fatty acids in cancer prevention and cancer treatment. (Kalyanaraman B, Cheng G, Hardy M) Arch Biochem Biophys 2024 Nov;761:110172 6 Citations |
| 1 | Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy. (Kim G, Viswanathan AN, Bhatia R, Landman Y, Roumeliotis M, Erickson B, Schmidt EJ, Lee J) Phys Med Biol 2024 Oct 18;69(21) |
| 1 | Management of Pediatric Breast Masses for the Pediatric Surgeon: Expert Consensus Recommendations From the APSA Cancer Committee. (Schwartz D, Tracy ET, Naik-Mathuria B, Glick RD, Polites SF, Mattei P, Rodeberg D, Espinoza AF, Mansfield SA, Lal DR, Kotagal M, Lautz T, Aldrink J, Rich BS) J Pediatr Surg 2025 Feb;60(2):161916 |
| 1 | Prostate cancer and solid organ transplantation: patient management and outcomes. (Lazarovich A, Kristof TW, Steadman S, Dahmen AS, Josephson MA, Barth R, Morgan TM, Timsit MO, Eggener S) BJU Int 2025 Feb;135(2):339-345 |
| 1 | Editorial: Bladder preservation options for bladder cancer. (Davis NB, Kilari D, Kessler ER, Smelser WW) Front Oncol 2024;14:1493854 |
| 1 | The role of extracellular vesicles in the pathogenesis of gynecological cancer. (Chatterjee M, Gupta S, Mukherjee T, Parashar D, Kumar U, Maitra A, Das K) Front Oncol 2024;14:1477610 1 Citation |
| 1 | Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach? (Brunelli A, Antonoff MB, Petersen RH, Stiles BM, Wigle DA, Collaborators) J Thorac Cardiovasc Surg 2025 Mar;169(3):727-736.e8 |
| 1 | Cancer-related Fear and Worry in Patients with Low-Risk Thyroid Cancer: A Longitudinal Cohort Study. (Lee S, Antunez AG, Sinco B, Saucke MC, Bushaw KJ, Dream S, Fingeret A, Livhits MJ, Mathur A, McDow AD, Roman S, Voils CI, Pitt SC) J Clin Endocrinol Metab 2024 Oct 14 |
| 1 | SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer. (Chae YK, Othus M, Patel SP, Wilkinson KJ, Whitman-Purves EM, Lea J, Schallenkamp JM, Adra N, Appleman LJ, Alden M, Thomes Pepin J, Ellerton JA, Poklepovic A, Walter A, Rampurwala MM, Robinson WR, Kim HS, Chung LI, McLeod CM, Lopez G, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R) Clin Cancer Res 2024 Dec 16;30(24):5593-5600 |
| 1 | Champions to enhance implementation of clinical and community-based interventions in cancer: a scoping review. (Astorino Nicola J, Nataliansyah MM, Lopez-Olivo MA, Adegboyega A, Hirko KA, Chichester LR, Nock NL, Ginex P, Christy SM, Levett P) Implement Sci Commun 2024 Oct 22;5(1):119 |
| 1 | Unveiling the disparities within: Why we need to disaggregate data for Asian women with breast cancer. (Crown A, Kong AL) Am J Surg 2025 Feb;240:116013 1 Citation |
| 1 | Editorial: Novel computational fluid dynamics methods for diagnosis, monitoring, prediction, and personalized treatment for cardiovascular disease and cancer metastasis. (Keshavarz Motamed Z, Maftoon N, Dasi LP, LaDisa JF Jr) Front Bioeng Biotechnol 2024;12:1491950 1 Citation |
| 3 | Examining the false-negative rate of a negative axillary node ultrasound-guided core needle biopsy in breast cancer patients undergoing upfront surgery. (Rogers C, Zeien S, Puccetti K, Jorns JM, Kong AL, Cherian S, Cortina CS) Am J Surg 2025 Jan;239:116047 |
| 3 | Are there differences in overall survival among older breast cancer patients by race and ethnicity? (Cobb AN, Rogers C, Dong X, Huang CC, Kong AL, Cortina CS) Surgery 2025 Mar;179:108896 |
| 1 | Circulating Extracellular Vesicles: An Effective Biomarker for Cancer Progression (Chatterjee M, Gupta S, Nag S, Rehman I, Parashar D, Maitra A, Das K) Frontiers in Bioscience - Landmark November 2024;29(11) 1 Citation |
| 1 | HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival. (Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD) Eur J Surg Oncol 2025 Jan;51(1):108790 1 Citation |
| 1 | 5hmC-profiles in Puerto Rican Hispanic/Latino men with aggressive prostate cancer. (Patel MS, Almubarak M, Matta J, Ortiz-Sanchez C, Encarnacion J, Ruiz-Deya G, Dutil J, Dhillon J, Yamoah K, Berglund A, Park H, Kilari D, Balagurunathan Y, Wang L, Park JY) medRxiv 2024 Oct 27 |
| 3 | Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures. (Khan S, Alson D, Sun L, Maloney C, Sun D) Cancers (Basel) 2024 Oct 29;16(21) |
| 3 | NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. (Sanford NN, Narang AK, Aguilera TA, Bassetti MF, Chuong MD, Erickson BA, Goodman KA, Herman JM, Intven M, Kilcoyne A, Kim H, Paulson E, Reyngold M, Tsai S, Tchelebi LT, Tuli R, Versteijne E, Wei AC, Wo JY, Zhang Y, Hong TS, Hall WA) Int J Radiat Oncol Biol Phys 2025 Mar 15;121(4):918-929 2 Citations |
| 1 | Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach? (Brunelli A, Antonoff MB, Petersen RH, Stiles BM, Wigle DA, Collaborators
) Eur J Cardiothorac Surg 2024 Nov 04;66(5) |
| 1 | Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. (Patel KR, Nguyen PL, Proudfoot JA, Liu Y, Pra AD, Spratt DE, Pollack A, Sandler HM, Efstathiou JA, Lawton C, Simko JP, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Pugh SL, Davicioni E, Tran PT, Feng FY) Eur Urol Oncol 2024 Nov 13 |
| 2 | Disparities in Genetic Management of Breast and Ovarian Cancer Patients. (Duyar-Ayerdi S, Summey RM, Uyar D) Obstet Gynecol Surv 2024 Nov;79(11):673-682 |
| 1 | Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update. (Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher CM) Pract Radiat Oncol 2025;15(2):171-179 |
| 1 | The best management for most patients with incurable cancer is on a clinical trial. (Subbiah V, Kurzrock R) Ann Oncol 2025 Mar;36(3):240-243 1 Citation |
| 4 | Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer. (Fang K, Ohihoin AG, Liu T, Choppavarapu L, Nosirov B, Wang Q, Yu XZ, Kamaraju S, Leone G, Jin VX) Genome Med 2024 Nov 18;16(1):134 3 Citations |
| 1 | A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers. (Chae YK, Corthell L, Patel SP, Edwards R, Scalici JM, Kim HS, Chung LI, Othus M, McLeod CM, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R) Clin Cancer Res 2025 Jan 17;31(2):308-315 |
| 1 | Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis. (Wang S, Belemlilga D, Lei Y, Ganti AKP, Lin C, Asif S, Marasco JT, Oh K, Zhou S) Cancers (Basel) 2024 Nov 05;16(22) |
| 1 | Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer. (Huang F, Li K, Chen Z, Cui Z, Hankey W, Fang K, Yan J, Wang H, Jin VX, Dong Y, Wang Q) Oncogene 2025 Mar;44(8):481-493 1 Citation |
| 1 | Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease (Journal of Cancer Survivorship, (2023), 17, 3, (646-656), 10.1007/s11764-023-01354-9) (Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES) Journal of Cancer Survivorship December 2024;18(6):1835-1836 |
| 2 | Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer (Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D) Clinical Genitourinary Cancer December 2024;22(6) |
| 1 | Implementing Cancer Registry Data with the PCORnet Common Data Model: The Greater Plains Collaborative Experience (McDowell BD, O'Rorke MA, Schroeder MC, Chrischilles EA, Spinka CM, Waitman LR, Anuforo K, Araya A, Bah H, Barlocker J, Chandaka S, Cowell LG, Geary CR, Gupta S, Horne BD, Knosp BM, Lai AM, Mandhadi V, Mohammad Mosa AS, Reeder P, Ryu G, Shukwit B, Smith C, Stoddard AJ, Syed M, Syed S, Taylor BW, Vanwormer JJ) JCO Clinical Cancer Informatics 1 December 2024;8 |
| 1 | Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review (Kurzrock R, Chaudhuri AA, Feller-Kopman D, Florez N, Gorden J, Wistuba II) Cancer and Metastasis Reviews December 2024;43(4):1217-1231 4 Citations |
| 1 | Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer. (Chen Y, Salas LA, Marotti JD, Jenkins NP, Cheng C, Miller TW, Kettenbach AN, Christensen BC) Int J Cancer 2025 Mar 15;156(6):1191-1202 1 Citation |
| 1 | Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation. (Porter VL, Ng M, O'Neill K, MacLennan S, Corbett RD, Culibrk L, Hamadeh Z, Iden M, Schmidt R, Tsaih SW, Nakisige C, Origa M, Orem J, Chang G, Fan J, Nip KM, Akbari V, Chan SK, Hopkins J, Moore RA, Chuah E, Mungall KL, Mungall AJ, Birol I, Jones SJM, Rader JS, Marra MA) Genome Res 2025 Apr 14;35(4):653-670 |
| 1 | Smart Polymer-Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review. (Kamath AJ, Donadkar AD, Nair B, Kumar AR, Sabitha M, Sethi G, Chauhan AS, Nath LR) Phytother Res 2025 Feb;39(2):698-713 |
| 1 | Response to Watters et al., "Educational intervention targeting primary care residents improves skin cancer recognition in patients with skin of color". (Neman S, Humphrey SR) J Am Acad Dermatol 2025 Apr;92(4):e103-e104 |
| 1 | Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non-Small Cell Lung Cancer. (Sako C, Duan C, Maresca K, Kent S, Schmidt TG, Aerts HJWL, Parikh RB, Simon GR, Jordan P) JCO Clin Cancer Inform 2024 Dec;8:e2400133 |
| 1 | Benchmarks of Success in Radiotherapy versus Systemic Therapy National Clinical Trials Network (NCTN) Randomized Controlled Trials Sponsored by the National Cancer Institute (NCI). (Sanford NN, Shi Q, Hein DM, Hall WA) J Natl Cancer Inst 2024 Dec 05 |
| 1 | Psychological Considerations Associated with Lobular Breast Cancer. (Walker JC, Patel S, Cobain EF, Kleer CG, Neal CH, Migyanka F, Riba M, Jeruss JS) Curr Psychiatry Rep 2025 Feb;27(2):98-104 |
| 1 | If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide. (Adashek JJ, Munoz JL, Kurzrock R) Med 2025 Jan 10;6(1):100550 |
| 1 | Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence (Xie XP, Ganbold M, Li J, Lien M, Chipman ME, Wang T, Jayewickreme CD, Pedraza AM, Bale T, Tabar V, Brennan C, Sun D, Sharma R, Parada LF) Neuron 18 December 2024;112(24):4017-4032.e6 2 Citations |
| 1 | Utilization rates of dermatologist-created skin cancer screening certification services by nail technicians. (Le JT, Sii A, Bulacan C, Bollepalli H, Bao PH, Cooper JT, Clark MA) Arch Dermatol Res 2024 Dec 18;317(1):134 |
| 2 | Correction: Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study. (Kiconco A, Kabanda R, Ronald A, Beyer KMM, John SA) BMC Womens Health 2024 Dec 21;24(1):659 |
| 1 | Enhancing Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy Through MRI Radiomics Analysis (Jacob Marasco and Yu Lei and Ashok Bhandari and Garett Ostdiek-Wille and Alex Kolomaya and Charlene Rhodd and Fang Yu and Sumin Zhou and Chi Lin and Shuo Wang) Medical Research Archives MARASCO, Jacob T. et al. Enhancing Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy Through MRI Radiomics Analysis. Medical Research Archives, [S.l.], v. 12, n. 12, dec. 2024. ISSN 2375-1924 |
| 1 | A Photoinducible DNA Cross-Linking Agent with Potent Cytotoxicity and Selectivity Toward Triple-Negative Breast Cancer Cell Line. (Zhang Q, Ali T, Ponnamperumage TNF, Lin Z, Setu NI, Awoyera WO, Oddiri RT, Rasmussen AD, Felli MC, Frick DN, Peng X) Chem Res Toxicol 2025 Jan 20;38(1):216-228 |
| 6 | Locked Dimerized CXCL12 Exerts Radiosensitizing Effects in Head and Neck Cancer. (Espinosa OV, Awan M, Memon AA, Frei A, Foeckler J, Kuehn R, Bruening J, Massey B, Wong S, Shukla M, Kasprzak J, Joshi A, Dwinell M, Himburg HA, Zenga J) Head Neck 2024 Dec 26 |
| 6 | Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy (Bonate R, Awan MJ, Himburg HA, Wong S, Shukla M, Tarima S, Zenga J, Paulson ES) Physics and Imaging in Radiation Oncology January 2025;33 |
| 1 | New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy (Bouzaki A, Green D, van Herk M, Shortall J, Puri T, Kerns S, Azria D, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, Lambrecht M, Avuzzi B, Ruysscher DD, Seibold P, Sperk E, Talbot C, Vega A, Veldeman L, Webb A, Rosenstein B, West CM, Gioscio E, Rancati T, Osorio EV, McWilliam A) Physics and Imaging in Radiation Oncology January 2025;33 |
| 2 | EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice. (Jaune-Pons E, Wang X, Mousavi F, Klassen Z, El Kaoutari A, Berger K, Johnson C, Martin MB, Aggarwal S, Brar S, Khalid M, Ryan JF, Shooshtari P, Mathison AJ, Dusetti N, Urrutia R, Lomberk G, Pin CL) JCI Insight 2024 Dec 31;10(3) |
| 1 | HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival (Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD) European Journal of Surgical Oncology January 2025;51(1) 1 Citation |
| 1 | Self-collected versus clinician-collected anal swabs for anal cancer screening: A systematic review and meta-analysis (Dyer CEF, Jin F, Hillman RJ, Nyitray AG, Roberts JM, Law C, Grulich AE, Poynten IM) International Journal of Cancer 1 January 2025;156(1):79-90 3 Citations |
| 1 | Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer. (Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW) Cancer Res 2025 Mar 14;85(6):1145-1161 |
| 1 | Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. (Mayadev J, Zamarin D, Deng W, Lankes HA, Pesci G, Kim H, Chino JP, Banbury B, Sherry N, Sharon E, Ghamande SA, Ferguson C, Mell L, Holman L, Mathews C, O'Malley D, Olawaiye A, Hopp E, Leath C 3rd, Copeland L, Mannel R, O'Cearbhaill R, Aghajanian C, Schilder RJ) Nat Commun 2025 Jan 09;16(1):553 1 Citation |
| 1 | The Landmark Series: The Future of Pancreatic Cancer Clinical Trials. (Seo YD, Katz MHG, Snyder RA) Ann Surg Oncol 2025 Apr;32(4):2777-2785 |
| 2 | A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. (Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K) Clin Breast Cancer 2025 Apr;25(3):251-260 |
| 1 | Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer. (Zhang L, Liu S, He J, Hu Z, Zhu L, Huang H, Gao Q, Wang D, Chen L, Zhang X, Liu R, Wang J, Song Y, Zeng K, Li X, Chen Y, Zou X, Ma S, Wang X, Xu G, Liu W, Liu B) Sci Rep 2025 Jan 18;15(1):2384 |
| 3 | Characterizing the Impact of Race and Contemporary Redlining on Receipt of Guideline-Concordant Locoregional Therapy Among Older Women With Breast Cancer. (Beltrán Ponce S, Canales B, McGinley EL, Yen TWF, Tarima S, Zhou Y, Bikomeye JC, Beyer KMM) Adv Radiat Oncol 2025 Feb;10(2):101688 |
| 1 | A novel piperine derivative HJJ_3_5 inhibits colorectal cancer progression by modulating EMT signaling pathways. (Cheng W, Liu S, He J, Li H, Liu X, Hu Z, Wang X, Wu Z, Xu G, Liu W, Liu B) Biochem Biophys Res Commun 2025 Feb 16;749:151323 |
| 4 | Bowel function and quality-of-life outcomes in locally advanced rectal cancer: watch-and-wait vs total mesorectal excision. (Parikh TN, Peterson KJ, Brazauskas R, Calata JF, Peterson CY, Ludwig KA, Ridolfi TJ) J Gastrointest Surg 2025 Mar;29(3):101972 |
| 1 | A patient similarity-embedded Bayesian
approach to prognostic biomarker inference
with application to thoracic cancer immunity (Duo Yu, Melin Huang, Michael J. Kane, Brian P. Hobbs) Journal of the Royal Statistical Society Series C: Applied Statistics |
| 1 | Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer. ( Low SK, Thalji S, Aldakkak M, Ying G, Yohay S, Auckley E, Vakili P, Shahjehan F , Evans DB , Christians KK , Seo YD, Erickson B, Small C , Heyer V, Neupane B, George B, Kothari A, Hall WA , Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 710), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 2 | Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy. (Bonate R, Awan MJ, Himburg HA, Wong S, Shukla M, Tarima S, Zenga J, Paulson ES) Phys Imaging Radiat Oncol 2025 Jan;33:100693 |
| 1 | Assessing ChatGPT's Capability in Addressing Thyroid Cancer Patient Queries: A Comprehensive Mixed-Methods Evaluation. (Gorris MA, Randle RW, Obermiller CS, Thomas J, Toro-Tobon D, Dream SY, Fackelmayer OJ, Pandian TK, Mayson SE) J Endocr Soc 2025 Jan 06;9(2):bvaf003 |
| 1 | The impact of a personal cancer diagnosis on adolescent and young adult cancer survivors' social connectedness: A qualitative analysis. (Rao P, Segel JE, Bingen K, Devine KA, Scott AM, Koehly LM, Verdery AM, Rumbaugh CL, Wasserman E, Costigan HJ, Dandekar S, Rakszawski K, Songdej N, Blackall GF, Vasekar M, Naik S, Lengerich EJ, Van Scoy LJ) J Health Psychol 2025 Jan 31:13591053241311977 |
| 1 | Deep learning-based quick MLC sequencing for MRI-guided online adaptive radiotherapy: a feasibility study for pancreatic cancer patients. (Ahunbay A, Paulson E, Ahunbay E, Zhang Y) Phys Med Biol 2025 Feb 12;70(4) |
| 4 | Characterizing the Impact of Race and Contemporary Redlining on Receipt of Guideline-Concordant Locoregional Therapy Among Older Women With Breast Cancer (Beltrán Ponce S, Canales B, McGinley EL, Yen TWF, Tarima S, Zhou Y, Bikomeye JC, Beyer KMM) Advances in Radiation Oncology February 2025;10(2) |
| 1 | Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens (Flannery BT, Sandler HM, Lal P, Feldman MD, Santa-Rosario JC, Pathak T, Mirtti T, Farre X, Correa R, Chafe S, Shah A, Efstathiou JA, Hoffman K, Hallman MA, Straza M, Jordan R, Pugh SL, Feng F, Madabhushi A) Journal of Pathology February 2025;265(2):146-157 |
| 1 | Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis (Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CWD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST) Cancers February 2025;17(3) |
| 1 | Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer. (Kerns SL, Dinh PC Jr, Monahan PO, Stump T, Fung C, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Huddart R, Kollmannsberger C, Martin NE, Nevel K, Kincaid J, Einhorn LH, Travis LB) J Natl Cancer Inst 2025 Feb 03 |
| 1 | Body Weight and Breast Cancer Treatment Experiences: Results From the Share Thoughts on a Breast Cancer Study. (Nash SH, Verhage E, McDowell BD, Neuner J, Chrischilles E, Lizarraga IM, Schroeder M) Cancer Med 2025 Feb;14(3):e70628 |
| 1 | Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes. (Raychaudhuri R, Tuchayi AM, Low SK, Arafa AT, Graham LS, Gulati R, Pritchard CC, Montgomery RB, Haffner MC, Nelson PS, Yu EY, Hawley JE, Cheng HH, Mo G, Chen DL, Antonarakis ES, Kilari D, Hope TA, Iravani A, Schweizer MT) Eur Urol Oncol 2025 Feb 06 |
| 1 | Sepsis Mortality in Hospitalized Children With Cancer Is Associated With Lack of a Screening Tool. (Hakim H, Richardson T, Riggs R, Auletta JJ, DiGerolamo K, Hron JD, Kohorst M, Laurie K, Maixner M, Mulcahy Levy JM, Ohlsen TJD, Orsey AD, Prudowsky ZD, Raghu VK, Redfern W, Rozenfeld RA, Workman JK, Wilkes JJ, IPSO COLLABORATIVE INVESTIGATORS) Hosp Pediatr 2025 Mar 01;15(3):237-246 |
| 1 | The Impact of Clinically Significant Pleural Effusion on Survival of US Veterans With Cancer, Congestive Heart Failure, and Pneumonia: The Veterans Administration Lung Effusion Study. (Chopra A, Hu K, Gemoets DE, Judson MA) Chest 2025 Feb 13 |
| 1 | Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. (Dal Pra A, Ghadjar P, Ryu HM, Proudfoot JA, Hayoz S, Michalski JM, Spratt DE, Liu Y, Schär C, Berlin AM, Zwahlen DR, Simko JP, Hölscher T, Efstathiou JA, Polat B, Sandler HM, Hildebrandt G, Parliament MB, Mueller AC, Dayes IS, Plasswilm L, Correa RJM, Robertson JM, Karrison TG, Davicioni E, Hall WA, Feng FY, Pollack A, Thalmann GN, Nguyen PL, Aebersold DM, Tran PT, Zhao SG) Ann Oncol 2025 Feb 13 |
| 1 | Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR). (Jarzembowski JA, Webster F, Beiske K, Cohn SL, de Krijger RR, Irwin MS, Navarro S, Okita H, Shimada H, Stahlschmidt J, Vokuhl C, Wang LL, Cohen M, Reyes-Mugica M) Histopathology 2025 Feb 24 |
| 1 | Comparison of intensity normalization methods in prostate, brain, and breast cancer multi-parametric magnetic resonance imaging. (Duenweg SR, Bobholz SA, Lowman AK, Winiarz A, Nath B, Barrett MJ, Kyereme F, Vincent-Sheldon S, LaViolette P) Front Oncol 2025;15:1433444 |
| 1 | Minority Health Social Vulnerability and Its Association with Cancer Incidence: A Nationwide Ecological Investigation. (Shour AR, Jayarangaiah A, Anguzu R, Puthoff D, Onitilo A) Clin Med Res 2024 Dec;22(4):173-179 |
| 1 | Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer. (Ibrahim EH, Chaudhary L, Cheng YC, Sosa A, An D, Charlson J) Radiol Oncol 2025 Mar 01;59(1):79-90 |
| 2 | A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer. (Farazi M, Yang X, Gehl CJ, Barnett GC, Burnet NG, Chang-Claude J, Parker CC, Dunning AM, Azria D, Choudhury A, Rancati T, De Ruysscher D, Seibold P, Sperk E, Talbot CJ, Veldeman L, Webb AJ, Elliott R, Aguado-Barrera ME, Carballo AM, Fuentes-Ríos O, Gómez-Caamaño A, Peleteiro P, Vega A, Ostrer H, Rosenstein BS, Saito S, Parliament M, Usmani N, Marples B, Chen Y, Morrow G, Messing E, Janelsins MC, Hall W, West CML, Auer PL, Kerns S) Cancer Epidemiol Biomarkers Prev 2025 Mar 03 |
| 1 | 5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies. (Li Q, Huang CC, Huang S, Tian Y, Huang J, Bitaraf A, Dong X, Nevalainen MT, Patel M, Wong J, Zhang J, Manley BJ, Park JY, Kohli M, Gore EM, Kilari D, Wang L) Commun Med (Lond) 2025 Mar 04;5(1):61 |
| 1 | PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome. (Chen HZ, Kim NH, Nishizaki D, Nesline MK, Conroy JM, DePietro P, Pabla S, Kato S, Kurzrock R) NPJ Genom Med 2025 Mar 11;10(1):21 |
| 1 | Age-dependent cytokine surge in blood precedes cancer diagnosis. (Chen G, Mohsin A, Zheng H, Rosenberg-Hasson Y, Padilla C, Sarin KY, Dekker CL, Grant P, Maecker HT, Lu Y, Furman D, Shen-Orr S, Khatri P, Davis MM) Proc Natl Acad Sci U S A 2025 Mar 25;122(12):e2420502122 |
| 1 | Implementation and Efficacy of Total Wellness: A Community-Based Cancer Prevention and Lifestyle Intervention Program. (Riegel DC, Kwarteng JL, Pinsoneault L, Contreras S, Wasserman E, Visotcky A, Manriquez Prado A, Villarreal Espinosa O, Sheean P, Tovar M, Jensik K, Vidaver RM, Stolley MR) J Cancer Educ 2025 Mar 29 |
| 4 | Supporting Hematopoietic Stem Cell Transplant Family Caregivers: A Pilot Study of Nurse-Led Meaning-Centered Psychotherapy for Cancer Caregivers. (McAndrew NS, Wallace L, Guttormson J, McCracken C, Olex M, Banerjee A, Visotcky A, Bartowitz J, Seaman JB, Knight JM, Ferrell B, El-Jawahri A, Applebaum AJ) Psychooncology 2025 Apr;34(4):e70142 |
| 1 | Effects of urban greenspace on time to major adverse cardiovascular events among women with breast cancer in the US: Insights from the Greater Milwaukee, WI Area. (Bikomeye JC, Tarima S, Zhou Y, Kwarteng JL, Beyer AM, Yen TWF, Winn AN, Beyer KMM) Health Place 2025 Apr 04;93:103460 |
| 1 | Comparing durvalumab, olaparib, and cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior bevacizumab: the phase II NRG-GY023 trial. (Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF) Clin Cancer Res 2025 Apr 07 |
| 1 | Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression. (Huerta-Yepez S, Chen PC, Kaur K, Jain Y, Singh T, Esedebe F, Liao YJ, DiBernardo G, Moatamed NA, Mei A, Malarkannan S, Graeber TG, Memarzadeh S, Jewett A) BMJ Oncol 2025;4(1):e000618 |
| 1 | Contemporary Considerations for Breast Cancer Risk and Screening in Transgender, Nonbinary, and Gender-Diverse Populations (Huynh V, Conroy M, Carroll EF, Cortina CS) Current Breast Cancer Reports December 2025;17(1) |
